{"text_id": "16405935_1", "text": "Chloroquine - induced bilateral ptosis .", "tokens": ["Chloroquine", "-", "induced", "bilateral", "ptosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Chloroquine <extra_id_1> <extra_id_0> drug <extra_id_5> Chloroquine <extra_id_1> <extra_id_0> effect <extra_id_5> bilateral ptosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Chloroquine"}, {"type": "drug", "offset": [0], "text": "Chloroquine"}, {"type": "effect", "offset": [3, 4], "text": "bilateral ptosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Chloroquine"], ["drug", "Chloroquine"], ["effect", "bilateral ptosis"]]}]}
{"text_id": "2292051_1", "text": "Acute coronary events following cisplatin - based chemotherapy .", "tokens": ["Acute", "coronary", "events", "following", "cisplatin", "-", "based", "chemotherapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> cisplatin - based chemotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> route <extra_id_5> chemotherapy <extra_id_1> <extra_id_0> effect <extra_id_5> Acute coronary events <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "following", "args": [{"type": "treatment", "offset": [4, 5, 6, 7], "text": "cisplatin - based chemotherapy"}, {"type": "drug", "offset": [4], "text": "cisplatin"}, {"type": "route", "offset": [7], "text": "chemotherapy"}, {"type": "effect", "offset": [0, 1, 2], "text": "Acute coronary events"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "cisplatin - based chemotherapy"], ["drug", "cisplatin"], ["route", "chemotherapy"], ["effect", "Acute coronary events"]]}]}
{"text_id": "16298824_5", "text": "Progressive hypoxemia mandated endotracheal intubation 1 week after rituximab administration and led to death 4 weeks after admission .", "tokens": ["Progressive", "hypoxemia", "mandated", "endotracheal", "intubation", "1", "week", "after", "rituximab", "administration", "and", "led", "to", "death", "4", "weeks", "after", "admission", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> rituximab administration <extra_id_1> <extra_id_0> drug <extra_id_5> rituximab <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 1 week <extra_id_1> <extra_id_0> effect <extra_id_5> Progressive hypoxemia <extra_id_1> <extra_id_0> effect <extra_id_5> led to death <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "after", "args": [{"type": "treatment", "offset": [8, 9], "text": "rituximab administration"}, {"type": "drug", "offset": [8], "text": "rituximab"}, {"type": "time elapsed", "offset": [5, 6], "text": "1 week"}, {"type": "effect", "offset": [0, 1], "text": "Progressive hypoxemia"}, {"type": "effect", "offset": [11, 12, 13], "text": "led to death"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "time elapsed"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "rituximab administration"], ["drug", "rituximab"], ["time elapsed", "1 week"], ["effect", "Progressive hypoxemia"], ["effect", "led to death"]]}]}
{"text_id": "3982906_1", "text": "Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia .", "tokens": ["Cardiac", "decompensation", "following", "verapamil", "therapy", "in", "infants", "with", "supraventricular", "tachycardia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> subject <extra_id_5> infants with supraventricular tachycardia <extra_id_1> <extra_id_0> age <extra_id_5> infants <extra_id_1> <extra_id_0> subject disorder <extra_id_5> supraventricular tachycardia <extra_id_1> <extra_id_0> treatment <extra_id_5> verapamil therapy <extra_id_1> <extra_id_0> drug <extra_id_5> verapamil <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> supraventricular tachycardia <extra_id_1> <extra_id_0> effect <extra_id_5> Cardiac decompensation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "following", "args": [{"type": "subject", "offset": [6, 7, 8, 9], "text": "infants with supraventricular tachycardia"}, {"type": "age", "offset": [6], "text": "infants"}, {"type": "subject disorder", "offset": [8, 9], "text": "supraventricular tachycardia"}, {"type": "treatment", "offset": [3, 4], "text": "verapamil therapy"}, {"type": "drug", "offset": [3], "text": "verapamil"}, {"type": "treatment disorder", "offset": [8, 9], "text": "supraventricular tachycardia"}, {"type": "effect", "offset": [0, 1], "text": "Cardiac decompensation"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["subject", "infants with supraventricular tachycardia"], ["age", "infants"], ["subject disorder", "supraventricular tachycardia"], ["treatment", "verapamil therapy"], ["drug", "verapamil"], ["treatment disorder", "supraventricular tachycardia"], ["effect", "Cardiac decompensation"]]}]}
{"text_id": "10891991_1", "text": "An evaluation of ovarian structure and function should be considered in women of reproductive age being treated with valproate for epilepsy , especially if they develop menstrual cycle disturbances during treatment .", "tokens": ["An", "evaluation", "of", "ovarian", "structure", "and", "function", "should", "be", "considered", "in", "women", "of", "reproductive", "age", "being", "treated", "with", "valproate", "for", "epilepsy", ",", "especially", "if", "they", "develop", "menstrual", "cycle", "disturbances", "during", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> develop <extra_id_0> subject <extra_id_5> women of reproductive age <extra_id_1> <extra_id_0> age <extra_id_5> reproductive age <extra_id_1> <extra_id_0> gender <extra_id_5> women <extra_id_1> <extra_id_0> subject disorder <extra_id_5> epilepsy <extra_id_1> <extra_id_0> treatment <extra_id_5> valproate for epilepsy <extra_id_1> <extra_id_0> drug <extra_id_5> valproate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> epilepsy <extra_id_1> <extra_id_0> effect <extra_id_5> menstrual cycle disturbances <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [25], "text": "develop", "args": [{"type": "subject", "offset": [11, 12, 13, 14], "text": "women of reproductive age"}, {"type": "age", "offset": [13, 14], "text": "reproductive age"}, {"type": "gender", "offset": [11], "text": "women"}, {"type": "subject disorder", "offset": [20], "text": "epilepsy"}, {"type": "treatment", "offset": [18, 19, 20], "text": "valproate for epilepsy"}, {"type": "drug", "offset": [18], "text": "valproate"}, {"type": "treatment disorder", "offset": [20], "text": "epilepsy"}, {"type": "effect", "offset": [26, 27, 28], "text": "menstrual cycle disturbances"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "develop", "label": "adverse event", "asoc": [["subject", "women of reproductive age"], ["age", "reproductive age"], ["gender", "women"], ["subject disorder", "epilepsy"], ["treatment", "valproate for epilepsy"], ["drug", "valproate"], ["treatment disorder", "epilepsy"], ["effect", "menstrual cycle disturbances"]]}]}
{"text_id": "16527771_2", "text": "The visual loss in this patient seems to result from phenol neurotoxicity rather than mechanical compression of the intraorbital optic nerve .", "tokens": ["The", "visual", "loss", "in", "this", "patient", "seems", "to", "result", "from", "phenol", "neurotoxicity", "rather", "than", "mechanical", "compression", "of", "the", "intraorbital", "optic", "nerve", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> result <extra_id_0> subject <extra_id_5> patient <extra_id_1> <extra_id_0> treatment <extra_id_5> phenol <extra_id_1> <extra_id_0> drug <extra_id_5> phenol <extra_id_1> <extra_id_0> effect <extra_id_5> visual loss <extra_id_1> <extra_id_0> effect <extra_id_5> neurotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "result", "args": [{"type": "subject", "offset": [5], "text": "patient"}, {"type": "treatment", "offset": [10], "text": "phenol"}, {"type": "drug", "offset": [10], "text": "phenol"}, {"type": "effect", "offset": [1, 2], "text": "visual loss"}, {"type": "effect", "offset": [11], "text": "neurotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "result", "label": "adverse event", "asoc": [["subject", "patient"], ["treatment", "phenol"], ["drug", "phenol"], ["effect", "visual loss"], ["effect", "neurotoxicity"]]}]}
{"text_id": "12126225_3", "text": "A 77 - year - old man developed ankle , hand , and facial swelling 2 weeks after starting rosiglitazone .", "tokens": ["A", "77", "-", "year", "-", "old", "man", "developed", "ankle", ",", "hand", ",", "and", "facial", "swelling", "2", "weeks", "after", "starting", "rosiglitazone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 77 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 77 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> 2 weeks after starting rosiglitazone <extra_id_1> <extra_id_0> drug <extra_id_5> rosiglitazone <extra_id_1> <extra_id_0> duration <extra_id_5> 2 weeks <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 2 weeks <extra_id_1> <extra_id_0> effect <extra_id_5> ankle , hand , and facial swelling <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "A 77 - year - old man"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "77 - year - old"}, {"type": "gender", "offset": [6], "text": "man"}, {"type": "treatment", "offset": [15, 16, 17, 18, 19], "text": "2 weeks after starting rosiglitazone"}, {"type": "drug", "offset": [19], "text": "rosiglitazone"}, {"type": "duration", "offset": [15, 16], "text": "2 weeks"}, {"type": "time elapsed", "offset": [15, 16], "text": "2 weeks"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13, 14], "text": "ankle , hand , and facial swelling"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "duration", "effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 77 - year - old man"], ["age", "77 - year - old"], ["gender", "man"], ["treatment", "2 weeks after starting rosiglitazone"], ["drug", "rosiglitazone"], ["duration", "2 weeks"], ["time elapsed", "2 weeks"], ["effect", "ankle , hand , and facial swelling"]]}]}
{"text_id": "9892272_4", "text": "The development of cutaneous ecchymosis associated with a sudden fall in hemoglobin after the administration of alteplase should strongly suggest the possibility of diffuse subfascial hematoma .", "tokens": ["The", "development", "of", "cutaneous", "ecchymosis", "associated", "with", "a", "sudden", "fall", "in", "hemoglobin", "after", "the", "administration", "of", "alteplase", "should", "strongly", "suggest", "the", "possibility", "of", "diffuse", "subfascial", "hematoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> treatment <extra_id_5> alteplase <extra_id_1> <extra_id_0> drug <extra_id_5> alteplase <extra_id_1> <extra_id_0> effect <extra_id_5> cutaneous ecchymosis <extra_id_1> <extra_id_0> effect <extra_id_5> a sudden fall in hemoglobin <extra_id_1> <extra_id_0> effect <extra_id_5> diffuse subfascial hematoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "development", "args": [{"type": "treatment", "offset": [16], "text": "alteplase"}, {"type": "drug", "offset": [16], "text": "alteplase"}, {"type": "effect", "offset": [3, 4], "text": "cutaneous ecchymosis"}, {"type": "effect", "offset": [7, 8, 9, 10, 11], "text": "a sudden fall in hemoglobin"}, {"type": "effect", "offset": [23, 24, 25], "text": "diffuse subfascial hematoma"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["treatment", "alteplase"], ["drug", "alteplase"], ["effect", "cutaneous ecchymosis"], ["effect", "a sudden fall in hemoglobin"], ["effect", "diffuse subfascial hematoma"]]}]}
{"text_id": "8667442_1", "text": "Milk - alkali syndrome induced by 1,25(OH)2D in a patient with hypoparathyroidism .", "tokens": ["Milk", "-", "alkali", "syndrome", "induced", "by", "1,25(OH)2D", "in", "a", "patient", "with", "hypoparathyroidism", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a patient with hypoparathyroidism . <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hypoparathyroidism <extra_id_1> <extra_id_0> treatment <extra_id_5> 1,25(OH)2D <extra_id_1> <extra_id_0> drug <extra_id_5> 1,25(OH)2D <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hypoparathyroidism <extra_id_1> <extra_id_0> effect <extra_id_5> Milk - alkali syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "induced", "args": [{"type": "subject", "offset": [8, 9, 10, 11, 12], "text": "a patient with hypoparathyroidism ."}, {"type": "subject disorder", "offset": [11], "text": "hypoparathyroidism"}, {"type": "treatment", "offset": [6], "text": "1,25(OH)2D"}, {"type": "drug", "offset": [6], "text": "1,25(OH)2D"}, {"type": "treatment disorder", "offset": [11], "text": "hypoparathyroidism"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Milk - alkali syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a patient with hypoparathyroidism ."], ["subject disorder", "hypoparathyroidism"], ["treatment", "1,25(OH)2D"], ["drug", "1,25(OH)2D"], ["treatment disorder", "hypoparathyroidism"], ["effect", "Milk - alkali syndrome"]]}]}
{"text_id": "21189363_3", "text": "A 53 - year - old African American male with HIV was prescribed warfarin 5 mg / day for 12 months after diagnosis of idiopathic deep vein thrombosis and bilateral pulmonary emboli ( target INR 2.5 [ range 2.0 - 3.0 ] ) .", "tokens": ["A", "53", "-", "year", "-", "old", "African", "American", "male", "with", "HIV", "was", "prescribed", "warfarin", "5", "mg", "/", "day", "for", "12", "months", "after", "diagnosis", "of", "idiopathic", "deep", "vein", "thrombosis", "and", "bilateral", "pulmonary", "emboli", "(", "target", "INR", "2.5", "[", "range", "2.0", "-", "3.0", "]", ")", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> prescribed <extra_id_0> subject <extra_id_5> A 53 - year - old African American male with HIV <extra_id_1> <extra_id_0> age <extra_id_5> 53 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> male <extra_id_1> <extra_id_0> race <extra_id_5> African American <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> subject disorder <extra_id_5> idiopathic deep vein thrombosis and bilateral pulmonary emboli <extra_id_1> <extra_id_0> treatment <extra_id_5> warfarin 5 mg / day for 12 months <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> dosage <extra_id_5> 5 mg / day <extra_id_1> <extra_id_0> duration <extra_id_5> 12 months <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> idiopathic deep vein thrombosis and bilateral pulmonary emboli <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [12], "text": "prescribed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10], "text": "A 53 - year - old African American male with HIV"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "53 - year - old"}, {"type": "gender", "offset": [8], "text": "male"}, {"type": "race", "offset": [6, 7], "text": "African American"}, {"type": "subject disorder", "offset": [10], "text": "HIV"}, {"type": "subject disorder", "offset": [24, 25, 26, 27, 28, 29, 30, 31], "text": "idiopathic deep vein thrombosis and bilateral pulmonary emboli"}, {"type": "treatment", "offset": [13, 14, 15, 16, 17, 18, 19, 20], "text": "warfarin 5 mg / day for 12 months"}, {"type": "drug", "offset": [13], "text": "warfarin"}, {"type": "dosage", "offset": [14, 15, 16, 17], "text": "5 mg / day"}, {"type": "duration", "offset": [19, 20], "text": "12 months"}, {"type": "treatment disorder", "offset": [24, 25, 26, 27, 28, 29, 30, 31], "text": "idiopathic deep vein thrombosis and bilateral pulmonary emboli"}]}], "spot": ["potential therapeutic event"], "asoc": ["dosage", "duration", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder", "race"], "spot_asoc": [{"span": "prescribed", "label": "potential therapeutic event", "asoc": [["subject", "A 53 - year - old African American male with HIV"], ["age", "53 - year - old"], ["gender", "male"], ["race", "African American"], ["subject disorder", "HIV"], ["subject disorder", "idiopathic deep vein thrombosis and bilateral pulmonary emboli"], ["treatment", "warfarin 5 mg / day for 12 months"], ["drug", "warfarin"], ["dosage", "5 mg / day"], ["duration", "12 months"], ["treatment disorder", "idiopathic deep vein thrombosis and bilateral pulmonary emboli"]]}]}
{"text_id": "6460590_1", "text": "One type of SMON is associated with acrodermatitis enteropathica which has a very high frequency of occurrence in association with administration of clioquinol .", "tokens": ["One", "type", "of", "SMON", "is", "associated", "with", "acrodermatitis", "enteropathica", "which", "has", "a", "very", "high", "frequency", "of", "occurrence", "in", "association", "with", "administration", "of", "clioquinol", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> association <extra_id_0> treatment <extra_id_5> clioquinol <extra_id_1> <extra_id_0> drug <extra_id_5> clioquinol <extra_id_1> <extra_id_0> effect <extra_id_5> SMON <extra_id_1> <extra_id_0> effect <extra_id_5> acrodermatitis enteropathica <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "association", "args": [{"type": "treatment", "offset": [22], "text": "clioquinol"}, {"type": "drug", "offset": [22], "text": "clioquinol"}, {"type": "effect", "offset": [3], "text": "SMON"}, {"type": "effect", "offset": [7, 8], "text": "acrodermatitis enteropathica"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "association", "label": "adverse event", "asoc": [["treatment", "clioquinol"], ["drug", "clioquinol"], ["effect", "SMON"], ["effect", "acrodermatitis enteropathica"]]}]}
{"text_id": "1359782_2", "text": "Pulmonary infiltrates and skin pigmentation associated with sulfasalazine .", "tokens": ["Pulmonary", "infiltrates", "and", "skin", "pigmentation", "associated", "with", "sulfasalazine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> sulfasalazine <extra_id_1> <extra_id_0> drug <extra_id_5> sulfasalazine <extra_id_1> <extra_id_0> effect <extra_id_5> Pulmonary infiltrates and skin pigmentation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "associated", "args": [{"type": "treatment", "offset": [7], "text": "sulfasalazine"}, {"type": "drug", "offset": [7], "text": "sulfasalazine"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Pulmonary infiltrates and skin pigmentation"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "sulfasalazine"], ["drug", "sulfasalazine"], ["effect", "Pulmonary infiltrates and skin pigmentation"]]}]}
{"text_id": "18343993_1", "text": "A diagnosis of trastuzumab - induced pneumonitis was made .", "tokens": ["A", "diagnosis", "of", "trastuzumab", "-", "induced", "pneumonitis", "was", "made", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> trastuzumab <extra_id_1> <extra_id_0> drug <extra_id_5> trastuzumab <extra_id_1> <extra_id_0> effect <extra_id_5> pneumonitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "induced", "args": [{"type": "treatment", "offset": [3], "text": "trastuzumab"}, {"type": "drug", "offset": [3], "text": "trastuzumab"}, {"type": "effect", "offset": [6], "text": "pneumonitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "trastuzumab"], ["drug", "trastuzumab"], ["effect", "pneumonitis"]]}]}
{"text_id": "18676387_8", "text": "The co - administration of SSRIs and fentanyl may precipitate serotonin toxicity .", "tokens": ["The", "co", "-", "administration", "of", "SSRIs", "and", "fentanyl", "may", "precipitate", "serotonin", "toxicity", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> precipitate <extra_id_0> treatment <extra_id_5> co - administration of SSRIs and fentanyl <extra_id_1> <extra_id_0> drug <extra_id_5> SSRIs <extra_id_1> <extra_id_0> drug <extra_id_5> fentanyl <extra_id_1> <extra_id_0> combination drug <extra_id_5> SSRIs <extra_id_1> <extra_id_0> combination drug <extra_id_5> fentanyl <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "precipitate", "args": [{"type": "treatment", "offset": [1, 2, 3, 4, 5, 6, 7], "text": "co - administration of SSRIs and fentanyl"}, {"type": "drug", "offset": [5], "text": "SSRIs"}, {"type": "drug", "offset": [7], "text": "fentanyl"}, {"type": "combination drug", "offset": [5], "text": "SSRIs"}, {"type": "combination drug", "offset": [7], "text": "fentanyl"}, {"type": "effect", "offset": [10, 11], "text": "serotonin toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "precipitate", "label": "adverse event", "asoc": [["treatment", "co - administration of SSRIs and fentanyl"], ["drug", "SSRIs"], ["drug", "fentanyl"], ["combination drug", "SSRIs"], ["combination drug", "fentanyl"], ["effect", "serotonin toxicity"]]}]}
{"text_id": "7962394_2", "text": "Additionally , danazol produces hepatocellular damage in approximately 10 % of women .", "tokens": ["Additionally", ",", "danazol", "produces", "hepatocellular", "damage", "in", "approximately", "10", "%", "of", "women", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> produces <extra_id_0> subject <extra_id_5> 10 % of women <extra_id_1> <extra_id_0> gender <extra_id_5> women <extra_id_1> <extra_id_0> population <extra_id_5> 10 % <extra_id_1> <extra_id_0> treatment <extra_id_5> danazol <extra_id_1> <extra_id_0> drug <extra_id_5> danazol <extra_id_1> <extra_id_0> effect <extra_id_5> hepatocellular damage <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "produces", "args": [{"type": "subject", "offset": [8, 9, 10, 11], "text": "10 % of women"}, {"type": "gender", "offset": [11], "text": "women"}, {"type": "population", "offset": [8, 9], "text": "10 %"}, {"type": "treatment", "offset": [2], "text": "danazol"}, {"type": "drug", "offset": [2], "text": "danazol"}, {"type": "effect", "offset": [4, 5], "text": "hepatocellular damage"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "gender", "treatment"], "spot_asoc": [{"span": "produces", "label": "adverse event", "asoc": [["subject", "10 % of women"], ["gender", "women"], ["population", "10 %"], ["treatment", "danazol"], ["drug", "danazol"], ["effect", "hepatocellular damage"]]}]}
{"text_id": "17224428_2", "text": "We report the case of a man , treated with mesalazine for Crohn 's disease who developed drug - induced pericarditis .", "tokens": ["We", "report", "the", "case", "of", "a", "man", ",", "treated", "with", "mesalazine", "for", "Crohn", "'s", "disease", "who", "developed", "drug", "-", "induced", "pericarditis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a man <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> treatment <extra_id_5> mesalazine <extra_id_1> <extra_id_0> drug <extra_id_5> mesalazine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> effect <extra_id_5> drug - induced pericarditis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "developed", "args": [{"type": "subject", "offset": [5, 6], "text": "a man"}, {"type": "gender", "offset": [6], "text": "man"}, {"type": "subject disorder", "offset": [12, 13, 14], "text": "Crohn 's disease"}, {"type": "treatment", "offset": [10], "text": "mesalazine"}, {"type": "drug", "offset": [10], "text": "mesalazine"}, {"type": "treatment disorder", "offset": [12, 13, 14], "text": "Crohn 's disease"}, {"type": "effect", "offset": [17, 18, 19, 20], "text": "drug - induced pericarditis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a man"], ["gender", "man"], ["subject disorder", "Crohn 's disease"], ["treatment", "mesalazine"], ["drug", "mesalazine"], ["treatment disorder", "Crohn 's disease"], ["effect", "drug - induced pericarditis"]]}]}
{"text_id": "7019786_3", "text": "Two elderly women suffered an acute deterioration of renal function after treatment with cefoxitin sodium .", "tokens": ["Two", "elderly", "women", "suffered", "an", "acute", "deterioration", "of", "renal", "function", "after", "treatment", "with", "cefoxitin", "sodium", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> Two elderly women <extra_id_1> <extra_id_0> age <extra_id_5> elderly <extra_id_1> <extra_id_0> gender <extra_id_5> women <extra_id_1> <extra_id_0> population <extra_id_5> Two <extra_id_1> <extra_id_0> treatment <extra_id_5> treatment with cefoxitin sodium <extra_id_1> <extra_id_0> drug <extra_id_5> cefoxitin sodium <extra_id_1> <extra_id_0> effect <extra_id_5> acute deterioration of renal function <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "after", "args": [{"type": "subject", "offset": [0, 1, 2], "text": "Two elderly women"}, {"type": "age", "offset": [1], "text": "elderly"}, {"type": "gender", "offset": [2], "text": "women"}, {"type": "population", "offset": [0], "text": "Two"}, {"type": "treatment", "offset": [11, 12, 13, 14], "text": "treatment with cefoxitin sodium"}, {"type": "drug", "offset": [13, 14], "text": "cefoxitin sodium"}, {"type": "effect", "offset": [5, 6, 7, 8, 9], "text": "acute deterioration of renal function"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "gender", "treatment", "age"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "Two elderly women"], ["age", "elderly"], ["gender", "women"], ["population", "Two"], ["treatment", "treatment with cefoxitin sodium"], ["drug", "cefoxitin sodium"], ["effect", "acute deterioration of renal function"]]}]}
{"text_id": "228648_1", "text": "Prenatal cytomegalovirus ( CMV ) infection associated with severe brain damage was detected in an infant whose mother had been treated with prednisolone and azathioprine for systemic lupus erythematosus ( SLE ) .", "tokens": ["Prenatal", "cytomegalovirus", "(", "CMV", ")", "infection", "associated", "with", "severe", "brain", "damage", "was", "detected", "in", "an", "infant", "whose", "mother", "had", "been", "treated", "with", "prednisolone", "and", "azathioprine", "for", "systemic", "lupus", "erythematosus", "(", "SLE", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated <extra_id_0> subject <extra_id_5> an infant whose mother had been treated with prednisolone and azathioprine for systemic lupus erythematosus ( SLE ) <extra_id_1> <extra_id_0> age <extra_id_5> infant <extra_id_1> <extra_id_0> treatment <extra_id_5> prednisolone and azathioprine <extra_id_1> <extra_id_0> drug <extra_id_5> prednisolone <extra_id_1> <extra_id_0> drug <extra_id_5> azathioprine <extra_id_1> <extra_id_0> combination drug <extra_id_5> prednisolone <extra_id_1> <extra_id_0> combination drug <extra_id_5> azathioprine <extra_id_1> <extra_id_0> effect <extra_id_5> Prenatal cytomegalovirus ( CMV ) infection associated with severe brain damage <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "treated", "args": [{"type": "subject", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31], "text": "an infant whose mother had been treated with prednisolone and azathioprine for systemic lupus erythematosus ( SLE )"}, {"type": "age", "offset": [15], "text": "infant"}, {"type": "treatment", "offset": [22, 23, 24], "text": "prednisolone and azathioprine"}, {"type": "drug", "offset": [22], "text": "prednisolone"}, {"type": "drug", "offset": [24], "text": "azathioprine"}, {"type": "combination drug", "offset": [22], "text": "prednisolone"}, {"type": "combination drug", "offset": [24], "text": "azathioprine"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10], "text": "Prenatal cytomegalovirus ( CMV ) infection associated with severe brain damage"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "combination drug", "age", "treatment"], "spot_asoc": [{"span": "treated", "label": "adverse event", "asoc": [["subject", "an infant whose mother had been treated with prednisolone and azathioprine for systemic lupus erythematosus ( SLE )"], ["age", "infant"], ["treatment", "prednisolone and azathioprine"], ["drug", "prednisolone"], ["drug", "azathioprine"], ["combination drug", "prednisolone"], ["combination drug", "azathioprine"], ["effect", "Prenatal cytomegalovirus ( CMV ) infection associated with severe brain damage"]]}]}
{"text_id": "18344455_3", "text": "This article presents a 3(1/2) - year - old child on valproic acid , lamotrigine , and phenytoin who developed simultaneous hepatotoxicity and bone marrow toxicity during a parainfluenza virus type 3 infection .", "tokens": ["This", "article", "presents", "a", "3(1/2)", "-", "year", "-", "old", "child", "on", "valproic", "acid", ",", "lamotrigine", ",", "and", "phenytoin", "who", "developed", "simultaneous", "hepatotoxicity", "and", "bone", "marrow", "toxicity", "during", "a", "parainfluenza", "virus", "type", "3", "infection", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a 3(1/2) - year - old child <extra_id_1> <extra_id_0> age <extra_id_5> 3(1/2) - year - old <extra_id_1> <extra_id_0> age <extra_id_5> child <extra_id_1> <extra_id_0> treatment <extra_id_5> valproic acid , lamotrigine , and phenytoin <extra_id_1> <extra_id_0> drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> drug <extra_id_5> phenytoin <extra_id_1> <extra_id_0> combination drug <extra_id_5> phenytoin <extra_id_1> <extra_id_0> combination drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> combination drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> effect <extra_id_5> simultaneous hepatotoxicity and bone marrow toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8, 9], "text": "a 3(1/2) - year - old child"}, {"type": "age", "offset": [4, 5, 6, 7, 8], "text": "3(1/2) - year - old"}, {"type": "age", "offset": [9], "text": "child"}, {"type": "treatment", "offset": [11, 12, 13, 14, 15, 16, 17], "text": "valproic acid , lamotrigine , and phenytoin"}, {"type": "drug", "offset": [11, 12], "text": "valproic acid"}, {"type": "drug", "offset": [14], "text": "lamotrigine"}, {"type": "drug", "offset": [17], "text": "phenytoin"}, {"type": "combination drug", "offset": [17], "text": "phenytoin"}, {"type": "combination drug", "offset": [14], "text": "lamotrigine"}, {"type": "combination drug", "offset": [11, 12], "text": "valproic acid"}, {"type": "effect", "offset": [20, 21, 22, 23, 24, 25], "text": "simultaneous hepatotoxicity and bone marrow toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "combination drug", "age", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a 3(1/2) - year - old child"], ["age", "3(1/2) - year - old"], ["age", "child"], ["treatment", "valproic acid , lamotrigine , and phenytoin"], ["drug", "valproic acid"], ["drug", "lamotrigine"], ["drug", "phenytoin"], ["combination drug", "phenytoin"], ["combination drug", "lamotrigine"], ["combination drug", "valproic acid"], ["effect", "simultaneous hepatotoxicity and bone marrow toxicity"]]}]}
{"text_id": "10524732_1", "text": "Prolongation of the QT interval and ventricular tachyarrhymias have been described in patients on amiodarone therapy .", "tokens": ["Prolongation", "of", "the", "QT", "interval", "and", "ventricular", "tachyarrhymias", "have", "been", "described", "in", "patients", "on", "amiodarone", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> described <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> treatment <extra_id_5> amiodarone therapy <extra_id_1> <extra_id_0> drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> effect <extra_id_5> Prolongation of the QT interval and ventricular tachyarrhymias <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "described", "args": [{"type": "subject", "offset": [12], "text": "patients"}, {"type": "treatment", "offset": [14, 15], "text": "amiodarone therapy"}, {"type": "drug", "offset": [14], "text": "amiodarone"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Prolongation of the QT interval and ventricular tachyarrhymias"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "described", "label": "adverse event", "asoc": [["subject", "patients"], ["treatment", "amiodarone therapy"], ["drug", "amiodarone"], ["effect", "Prolongation of the QT interval and ventricular tachyarrhymias"]]}]}
{"text_id": "20367573_3", "text": "Thrombocytosis induced by enoxaparin has been reported as a rare adverse effect of this medication in adults .", "tokens": ["Thrombocytosis", "induced", "by", "enoxaparin", "has", "been", "reported", "as", "a", "rare", "adverse", "effect", "of", "this", "medication", "in", "adults", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> drug <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> effect <extra_id_5> Thrombocytosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "induced", "args": [{"type": "treatment", "offset": [3], "text": "enoxaparin"}, {"type": "drug", "offset": [3], "text": "enoxaparin"}, {"type": "effect", "offset": [0], "text": "Thrombocytosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "enoxaparin"], ["drug", "enoxaparin"], ["effect", "Thrombocytosis"]]}]}
{"text_id": "8792511_1", "text": "Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis , cutaneous eruptions , peripheral neuropathy , psychosis , toxic hepatitis , cholestatic jaundice , nephrotic syndrome , renal papillary necrosis , severe hypoalbuminemia without proteinuria , an infectious mononucleosis - like syndrome , and minor neurological and gastrointestinal complaints .", "tokens": ["Less", "common", "adverse", "events", "to", "dapsone", "include", "the", "idiosyncratic", "reactions", "of", "leukopenia", "and", "agranulocytosis", ",", "cutaneous", "eruptions", ",", "peripheral", "neuropathy", ",", "psychosis", ",", "toxic", "hepatitis", ",", "cholestatic", "jaundice", ",", "nephrotic", "syndrome", ",", "renal", "papillary", "necrosis", ",", "severe", "hypoalbuminemia", "without", "proteinuria", ",", "an", "infectious", "mononucleosis", "-", "like", "syndrome", ",", "and", "minor", "neurological", "and", "gastrointestinal", "complaints", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> include <extra_id_0> treatment <extra_id_5> dapsone <extra_id_1> <extra_id_0> drug <extra_id_5> dapsone <extra_id_1> <extra_id_0> effect <extra_id_5> the idiosyncratic reactions of leukopenia and agranulocytosis , cutaneous eruptions , peripheral neuropathy , psychosis , toxic hepatitis , cholestatic jaundice , nephrotic syndrome , renal papillary necrosis , severe hypoalbuminemia without proteinuria , an infectious mononucleosis - like syndrome , and minor neurological and gastrointestinal complaints <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "include", "args": [{"type": "treatment", "offset": [5], "text": "dapsone"}, {"type": "drug", "offset": [5], "text": "dapsone"}, {"type": "effect", "offset": [7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53], "text": "the idiosyncratic reactions of leukopenia and agranulocytosis , cutaneous eruptions , peripheral neuropathy , psychosis , toxic hepatitis , cholestatic jaundice , nephrotic syndrome , renal papillary necrosis , severe hypoalbuminemia without proteinuria , an infectious mononucleosis - like syndrome , and minor neurological and gastrointestinal complaints"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "include", "label": "adverse event", "asoc": [["treatment", "dapsone"], ["drug", "dapsone"], ["effect", "the idiosyncratic reactions of leukopenia and agranulocytosis , cutaneous eruptions , peripheral neuropathy , psychosis , toxic hepatitis , cholestatic jaundice , nephrotic syndrome , renal papillary necrosis , severe hypoalbuminemia without proteinuria , an infectious mononucleosis - like syndrome , and minor neurological and gastrointestinal complaints"]]}]}
{"text_id": "1849334_1", "text": "Muzolimine - induced severe neuromyeloencephalopathy : report of seven cases .", "tokens": ["Muzolimine", "-", "induced", "severe", "neuromyeloencephalopathy", ":", "report", "of", "seven", "cases", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Muzolimine <extra_id_1> <extra_id_0> dosage <extra_id_5> Muzolimine <extra_id_1> <extra_id_0> effect <extra_id_5> neuromyeloencephalopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Muzolimine"}, {"type": "dosage", "offset": [0], "text": "Muzolimine"}, {"type": "effect", "offset": [4], "text": "neuromyeloencephalopathy"}]}], "spot": ["adverse event"], "asoc": ["dosage", "treatment", "effect"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Muzolimine"], ["dosage", "Muzolimine"], ["effect", "neuromyeloencephalopathy"]]}]}
{"text_id": "19017039_1", "text": "A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency who developed a syringotropic hypersensitivity reaction after 9 months of therapy with infliximab and leflunomide is described .", "tokens": ["A", "17", "-", "year", "-", "old", "boy", "with", "refractory", "psoriatic", "arthritis", "and", "alpha", "-", "1", "antitrypsin", "deficiency", "who", "developed", "a", "syringotropic", "hypersensitivity", "reaction", "after", "9", "months", "of", "therapy", "with", "infliximab", "and", "leflunomide", "is", "described", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency <extra_id_1> <extra_id_0> age <extra_id_5> 17 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> boy <extra_id_1> <extra_id_0> subject disorder <extra_id_5> alpha - 1 antitrypsin deficiency <extra_id_1> <extra_id_0> subject disorder <extra_id_5> refractory psoriatic arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> 9 months of therapy with infliximab and leflunomide <extra_id_1> <extra_id_0> drug <extra_id_5> infliximab <extra_id_1> <extra_id_0> drug <extra_id_5> leflunomide <extra_id_1> <extra_id_0> duration <extra_id_5> 9 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 9 months <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> refractory psoriatic arthritis <extra_id_1> <extra_id_0> combination drug <extra_id_5> infliximab <extra_id_1> <extra_id_0> combination drug <extra_id_5> leflunomide <extra_id_1> <extra_id_0> effect <extra_id_5> syringotropic hypersensitivity reaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16], "text": "A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "17 - year - old"}, {"type": "gender", "offset": [6], "text": "boy"}, {"type": "subject disorder", "offset": [12, 13, 14, 15, 16], "text": "alpha - 1 antitrypsin deficiency"}, {"type": "subject disorder", "offset": [8, 9, 10], "text": "refractory psoriatic arthritis"}, {"type": "treatment", "offset": [24, 25, 26, 27, 28, 29, 30, 31], "text": "9 months of therapy with infliximab and leflunomide"}, {"type": "drug", "offset": [29], "text": "infliximab"}, {"type": "drug", "offset": [31], "text": "leflunomide"}, {"type": "duration", "offset": [24, 25], "text": "9 months"}, {"type": "time elapsed", "offset": [24, 25], "text": "9 months"}, {"type": "treatment disorder", "offset": [8, 9, 10], "text": "refractory psoriatic arthritis"}, {"type": "combination drug", "offset": [29], "text": "infliximab"}, {"type": "combination drug", "offset": [31], "text": "leflunomide"}, {"type": "effect", "offset": [20, 21, 22], "text": "syringotropic hypersensitivity reaction"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "duration", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 17 - year - old boy with refractory psoriatic arthritis and alpha - 1 antitrypsin deficiency"], ["age", "17 - year - old"], ["gender", "boy"], ["subject disorder", "alpha - 1 antitrypsin deficiency"], ["subject disorder", "refractory psoriatic arthritis"], ["treatment", "9 months of therapy with infliximab and leflunomide"], ["drug", "infliximab"], ["drug", "leflunomide"], ["duration", "9 months"], ["time elapsed", "9 months"], ["treatment disorder", "refractory psoriatic arthritis"], ["combination drug", "infliximab"], ["combination drug", "leflunomide"], ["effect", "syringotropic hypersensitivity reaction"]]}]}
{"text_id": "6311654_6", "text": "It is concluded that ' cerebral atrophy ' on CT scans may represent an accumulative effect of ACTH and that ACTH should be given with the utmost discretion , and in as low a dose as possible .", "tokens": ["It", "is", "concluded", "that", "'", "cerebral", "atrophy", "'", "on", "CT", "scans", "may", "represent", "an", "accumulative", "effect", "of", "ACTH", "and", "that", "ACTH", "should", "be", "given", "with", "the", "utmost", "discretion", ",", "and", "in", "as", "low", "a", "dose", "as", "possible", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> represent <extra_id_0> treatment <extra_id_5> ACTH <extra_id_1> <extra_id_0> drug <extra_id_5> ACTH <extra_id_1> <extra_id_0> drug <extra_id_5> ACTH <extra_id_1> <extra_id_0> effect <extra_id_5> cerebral atrophy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "represent", "args": [{"type": "treatment", "offset": [17], "text": "ACTH"}, {"type": "drug", "offset": [17], "text": "ACTH"}, {"type": "drug", "offset": [20], "text": "ACTH"}, {"type": "effect", "offset": [5, 6], "text": "cerebral atrophy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "represent", "label": "adverse event", "asoc": [["treatment", "ACTH"], ["drug", "ACTH"], ["drug", "ACTH"], ["effect", "cerebral atrophy"]]}]}
{"text_id": "7854541_2", "text": "Multifocal inflammatory leukoencephalopathy associated with levamisole therapy .", "tokens": ["Multifocal", "inflammatory", "leukoencephalopathy", "associated", "with", "levamisole", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated with <extra_id_0> treatment <extra_id_5> levamisole therapy <extra_id_1> <extra_id_0> drug <extra_id_5> levamisole <extra_id_1> <extra_id_0> effect <extra_id_5> Multifocal inflammatory leukoencephalopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3, 4], "text": "associated with", "args": [{"type": "treatment", "offset": [5, 6], "text": "levamisole therapy"}, {"type": "drug", "offset": [5], "text": "levamisole"}, {"type": "effect", "offset": [0, 1, 2], "text": "Multifocal inflammatory leukoencephalopathy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated with", "label": "adverse event", "asoc": [["treatment", "levamisole therapy"], ["drug", "levamisole"], ["effect", "Multifocal inflammatory leukoencephalopathy"]]}]}
{"text_id": "10904571_3", "text": "Muscle biopsy revealed variation in muscle fiber size and few vacuolated fibers which were features of colchicine - induced myopathy .", "tokens": ["Muscle", "biopsy", "revealed", "variation", "in", "muscle", "fiber", "size", "and", "few", "vacuolated", "fibers", "which", "were", "features", "of", "colchicine", "-", "induced", "myopathy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> colchicine <extra_id_1> <extra_id_0> drug <extra_id_5> colchicine <extra_id_1> <extra_id_0> effect <extra_id_5> variation in muscle fiber size and few vacuolated fibers <extra_id_1> <extra_id_0> effect <extra_id_5> myopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "induced", "args": [{"type": "treatment", "offset": [16], "text": "colchicine"}, {"type": "drug", "offset": [16], "text": "colchicine"}, {"type": "effect", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11], "text": "variation in muscle fiber size and few vacuolated fibers"}, {"type": "effect", "offset": [19], "text": "myopathy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "colchicine"], ["drug", "colchicine"], ["effect", "variation in muscle fiber size and few vacuolated fibers"], ["effect", "myopathy"]]}]}
{"text_id": "16298824_1", "text": "Acute respiratory distress syndrome after rituximab infusion .", "tokens": ["Acute", "respiratory", "distress", "syndrome", "after", "rituximab", "infusion", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> rituximab infusion <extra_id_1> <extra_id_0> drug <extra_id_5> rituximab <extra_id_1> <extra_id_0> route <extra_id_5> infusion <extra_id_1> <extra_id_0> effect <extra_id_5> Acute respiratory distress syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "after", "args": [{"type": "treatment", "offset": [5, 6], "text": "rituximab infusion"}, {"type": "drug", "offset": [5], "text": "rituximab"}, {"type": "route", "offset": [6], "text": "infusion"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Acute respiratory distress syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "rituximab infusion"], ["drug", "rituximab"], ["route", "infusion"], ["effect", "Acute respiratory distress syndrome"]]}]}
{"text_id": "11837564_2", "text": "Warfarin - associated bleeding complication saved life .", "tokens": ["Warfarin", "-", "associated", "bleeding", "complication", "saved", "life", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> Warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> bleeding complication saved life <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Warfarin"}, {"type": "drug", "offset": [0], "text": "Warfarin"}, {"type": "effect", "offset": [3, 4, 5, 6], "text": "bleeding complication saved life"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Warfarin"], ["drug", "Warfarin"], ["effect", "bleeding complication saved life"]]}]}
{"text_id": "17228132_3", "text": "Hepatotoxicity seen with erlotinib , a small molecule tyrosine kinase inhibitor to EGFR , is usually transient with mild elevation of transaminases .", "tokens": ["Hepatotoxicity", "seen", "with", "erlotinib", ",", "a", "small", "molecule", "tyrosine", "kinase", "inhibitor", "to", "EGFR", ",", "is", "usually", "transient", "with", "mild", "elevation", "of", "transaminases", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> seen <extra_id_0> treatment <extra_id_5> erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> effect <extra_id_5> Hepatotoxicity <extra_id_1> <extra_id_0> effect <extra_id_5> transient with mild elevation of transaminases <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "seen", "args": [{"type": "treatment", "offset": [3], "text": "erlotinib"}, {"type": "drug", "offset": [3], "text": "erlotinib"}, {"type": "effect", "offset": [0], "text": "Hepatotoxicity"}, {"type": "effect", "offset": [16, 17, 18, 19, 20, 21], "text": "transient with mild elevation of transaminases"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "seen", "label": "adverse event", "asoc": [["treatment", "erlotinib"], ["drug", "erlotinib"], ["effect", "Hepatotoxicity"], ["effect", "transient with mild elevation of transaminases"]]}]}
{"text_id": "426502_1", "text": "A patient with disseminated herpes zoster developed a syndrome of inappropriate antidiuretic hormone and profound hyponatremia secondary to the administration of adenine arabinoside .", "tokens": ["A", "patient", "with", "disseminated", "herpes", "zoster", "developed", "a", "syndrome", "of", "inappropriate", "antidiuretic", "hormone", "and", "profound", "hyponatremia", "secondary", "to", "the", "administration", "of", "adenine", "arabinoside", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A patient with disseminated herpes zoster <extra_id_1> <extra_id_0> subject disorder <extra_id_5> disseminated herpes zoster <extra_id_1> <extra_id_0> treatment <extra_id_5> adenine arabinoside <extra_id_1> <extra_id_0> drug <extra_id_5> adenine arabinoside <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> disseminated herpes zoster <extra_id_1> <extra_id_0> effect <extra_id_5> syndrome of inappropriate antidiuretic hormone and profound hyponatremia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5], "text": "A patient with disseminated herpes zoster"}, {"type": "subject disorder", "offset": [3, 4, 5], "text": "disseminated herpes zoster"}, {"type": "treatment", "offset": [21, 22], "text": "adenine arabinoside"}, {"type": "drug", "offset": [21, 22], "text": "adenine arabinoside"}, {"type": "treatment disorder", "offset": [3, 4, 5], "text": "disseminated herpes zoster"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13, 14, 15], "text": "syndrome of inappropriate antidiuretic hormone and profound hyponatremia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A patient with disseminated herpes zoster"], ["subject disorder", "disseminated herpes zoster"], ["treatment", "adenine arabinoside"], ["drug", "adenine arabinoside"], ["treatment disorder", "disseminated herpes zoster"], ["effect", "syndrome of inappropriate antidiuretic hormone and profound hyponatremia"]]}]}
{"text_id": "9545161_2", "text": "Administration of lamotrigine , especially in combination with valproic acid , may lead to the development of TEN .", "tokens": ["Administration", "of", "lamotrigine", ",", "especially", "in", "combination", "with", "valproic", "acid", ",", "may", "lead", "to", "the", "development", "of", "TEN", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> treatment <extra_id_5> Administration of lamotrigine <extra_id_1> <extra_id_0> treatment <extra_id_5> with valproic acid <extra_id_1> <extra_id_0> drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> combination drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> combination drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> effect <extra_id_5> TEN <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "development", "args": [{"type": "treatment", "offset": [0, 1, 2], "text": "Administration of lamotrigine"}, {"type": "treatment", "offset": [7, 8, 9], "text": "with valproic acid"}, {"type": "drug", "offset": [8, 9], "text": "valproic acid"}, {"type": "drug", "offset": [2], "text": "lamotrigine"}, {"type": "combination drug", "offset": [8, 9], "text": "valproic acid"}, {"type": "combination drug", "offset": [2], "text": "lamotrigine"}, {"type": "effect", "offset": [17], "text": "TEN"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["treatment", "Administration of lamotrigine"], ["treatment", "with valproic acid"], ["drug", "valproic acid"], ["drug", "lamotrigine"], ["combination drug", "valproic acid"], ["combination drug", "lamotrigine"], ["effect", "TEN"]]}]}
{"text_id": "19904536_2", "text": "Gemcitabine is a chemotherapy agent that may cause unpredictable side effects .", "tokens": ["Gemcitabine", "is", "a", "chemotherapy", "agent", "that", "may", "cause", "unpredictable", "side", "effects", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> Gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> Gemcitabine <extra_id_1> <extra_id_0> effect <extra_id_5> unpredictable side effects <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "cause", "args": [{"type": "treatment", "offset": [0], "text": "Gemcitabine"}, {"type": "drug", "offset": [0], "text": "Gemcitabine"}, {"type": "effect", "offset": [8, 9, 10], "text": "unpredictable side effects"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "Gemcitabine"], ["drug", "Gemcitabine"], ["effect", "unpredictable side effects"]]}]}
{"text_id": "7962394_1", "text": "Acute pancreatitis associated with danazol treatment for endometriosis .", "tokens": ["Acute", "pancreatitis", "associated", "with", "danazol", "treatment", "for", "endometriosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> danazol treatment <extra_id_1> <extra_id_0> drug <extra_id_5> danazol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> endometriosis <extra_id_1> <extra_id_0> effect <extra_id_5> Acute pancreatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [4, 5], "text": "danazol treatment"}, {"type": "drug", "offset": [4], "text": "danazol"}, {"type": "treatment disorder", "offset": [7], "text": "endometriosis"}, {"type": "effect", "offset": [0, 1], "text": "Acute pancreatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "danazol treatment"], ["drug", "danazol"], ["treatment disorder", "endometriosis"], ["effect", "Acute pancreatitis"]]}]}
{"text_id": "17034541_2", "text": "Several such HBV reactivations were reported after combined rituximab and multiagent chemotherapy for B - cell lymphomas .", "tokens": ["Several", "such", "HBV", "reactivations", "were", "reported", "after", "combined", "rituximab", "and", "multiagent", "chemotherapy", "for", "B", "-", "cell", "lymphomas", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> combined rituximab and multiagent chemotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> rituximab <extra_id_1> <extra_id_0> route <extra_id_5> chemotherapy <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> B - cell lymphomas <extra_id_1> <extra_id_0> effect <extra_id_5> Several such HBV reactivations <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "after", "args": [{"type": "treatment", "offset": [7, 8, 9, 10, 11], "text": "combined rituximab and multiagent chemotherapy"}, {"type": "drug", "offset": [8], "text": "rituximab"}, {"type": "route", "offset": [11], "text": "chemotherapy"}, {"type": "treatment disorder", "offset": [13, 14, 15, 16], "text": "B - cell lymphomas"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Several such HBV reactivations"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "treatment", "treatment disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "combined rituximab and multiagent chemotherapy"], ["drug", "rituximab"], ["route", "chemotherapy"], ["treatment disorder", "B - cell lymphomas"], ["effect", "Several such HBV reactivations"]]}]}
{"text_id": "8651254_3", "text": "The possibility can be raised that M - CSF accelerated the underlying renal disease in this case through enhancing macrophage accumulation into the glomerulus , leading to the development of nephrotic syndrome .", "tokens": ["The", "possibility", "can", "be", "raised", "that", "M", "-", "CSF", "accelerated", "the", "underlying", "renal", "disease", "in", "this", "case", "through", "enhancing", "macrophage", "accumulation", "into", "the", "glomerulus", ",", "leading", "to", "the", "development", "of", "nephrotic", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> accelerated <extra_id_0> treatment <extra_id_5> M - CSF <extra_id_1> <extra_id_0> drug <extra_id_5> M - CSF <extra_id_1> <extra_id_0> effect <extra_id_5> underlying renal disease in this case through enhancing macrophage accumulation into the glomerulus , leading to the development of nephrotic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "accelerated", "args": [{"type": "treatment", "offset": [6, 7, 8], "text": "M - CSF"}, {"type": "drug", "offset": [6, 7, 8], "text": "M - CSF"}, {"type": "effect", "offset": [11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31], "text": "underlying renal disease in this case through enhancing macrophage accumulation into the glomerulus , leading to the development of nephrotic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "accelerated", "label": "adverse event", "asoc": [["treatment", "M - CSF"], ["drug", "M - CSF"], ["effect", "underlying renal disease in this case through enhancing macrophage accumulation into the glomerulus , leading to the development of nephrotic syndrome"]]}]}
{"text_id": "2299784_1", "text": "A 59 - year - old woman with myasthenia gravis who received a large dose of pyridostigmine bromide developed postoperative psychosis and was diagnosed as having bromide intoxication .", "tokens": ["A", "59", "-", "year", "-", "old", "woman", "with", "myasthenia", "gravis", "who", "received", "a", "large", "dose", "of", "pyridostigmine", "bromide", "developed", "postoperative", "psychosis", "and", "was", "diagnosed", "as", "having", "bromide", "intoxication", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 59 - year - old woman with myasthenia gravis <extra_id_1> <extra_id_0> age <extra_id_5> 59 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> myasthenia gravis <extra_id_1> <extra_id_0> treatment <extra_id_5> a large dose of pyridostigmine bromide <extra_id_1> <extra_id_0> drug <extra_id_5> pyridostigmine bromide <extra_id_1> <extra_id_0> dosage <extra_id_5> a large dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> myasthenia gravis <extra_id_1> <extra_id_0> effect <extra_id_5> postoperative psychosis and was diagnosed as having bromide intoxication . <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9], "text": "A 59 - year - old woman with myasthenia gravis"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "59 - year - old"}, {"type": "gender", "offset": [6], "text": "woman"}, {"type": "subject disorder", "offset": [8, 9], "text": "myasthenia gravis"}, {"type": "treatment", "offset": [12, 13, 14, 15, 16, 17], "text": "a large dose of pyridostigmine bromide"}, {"type": "drug", "offset": [16, 17], "text": "pyridostigmine bromide"}, {"type": "dosage", "offset": [12, 13, 14], "text": "a large dose"}, {"type": "treatment disorder", "offset": [8, 9], "text": "myasthenia gravis"}, {"type": "effect", "offset": [19, 20, 21, 22, 23, 24, 25, 26, 27, 28], "text": "postoperative psychosis and was diagnosed as having bromide intoxication ."}]}], "spot": ["adverse event"], "asoc": ["dosage", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 59 - year - old woman with myasthenia gravis"], ["age", "59 - year - old"], ["gender", "woman"], ["subject disorder", "myasthenia gravis"], ["treatment", "a large dose of pyridostigmine bromide"], ["drug", "pyridostigmine bromide"], ["dosage", "a large dose"], ["treatment disorder", "myasthenia gravis"], ["effect", "postoperative psychosis and was diagnosed as having bromide intoxication ."]]}]}
{"text_id": "9103523_2", "text": "The volatile anesthetic halothane undergoes substantial biotransformation generating metabolites that mediate hepatotoxicity .", "tokens": ["The", "volatile", "anesthetic", "halothane", "undergoes", "substantial", "biotransformation", "generating", "metabolites", "that", "mediate", "hepatotoxicity", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> mediate <extra_id_0> treatment <extra_id_5> volatile anesthetic halothane <extra_id_1> <extra_id_0> drug <extra_id_5> halothane <extra_id_1> <extra_id_0> route <extra_id_5> volatile <extra_id_1> <extra_id_0> effect <extra_id_5> hepatotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "mediate", "args": [{"type": "treatment", "offset": [1, 2, 3], "text": "volatile anesthetic halothane"}, {"type": "drug", "offset": [3], "text": "halothane"}, {"type": "route", "offset": [1], "text": "volatile"}, {"type": "effect", "offset": [11], "text": "hepatotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "mediate", "label": "adverse event", "asoc": [["treatment", "volatile anesthetic halothane"], ["drug", "halothane"], ["route", "volatile"], ["effect", "hepatotoxicity"]]}]}
{"text_id": "15304176_1", "text": "Lichen planus induced by hepatitis B vaccination : a new case and review of the literature .", "tokens": ["Lichen", "planus", "induced", "by", "hepatitis", "B", "vaccination", ":", "a", "new", "case", "and", "review", "of", "the", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> hepatitis B vaccination <extra_id_1> <extra_id_0> drug <extra_id_5> hepatitis B vaccination <extra_id_1> <extra_id_0> effect <extra_id_5> Lichen planus <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [4, 5, 6], "text": "hepatitis B vaccination"}, {"type": "drug", "offset": [4, 5, 6], "text": "hepatitis B vaccination"}, {"type": "effect", "offset": [0, 1], "text": "Lichen planus"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "hepatitis B vaccination"], ["drug", "hepatitis B vaccination"], ["effect", "Lichen planus"]]}]}
{"text_id": "10410183_6", "text": "DISCUSSION : Olanzapine , like other atypical antipsychotic drugs , may cause muscle injury with concomitant elevations of serum CK of muscle origin .", "tokens": ["DISCUSSION", ":", "Olanzapine", ",", "like", "other", "atypical", "antipsychotic", "drugs", ",", "may", "cause", "muscle", "injury", "with", "concomitant", "elevations", "of", "serum", "CK", "of", "muscle", "origin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> Olanzapine <extra_id_1> <extra_id_0> treatment <extra_id_5> atypical antipsychotic drugs <extra_id_1> <extra_id_0> drug <extra_id_5> Olanzapine <extra_id_1> <extra_id_0> effect <extra_id_5> muscle injury with concomitant elevations of serum CK of muscle origin <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "cause", "args": [{"type": "treatment", "offset": [2], "text": "Olanzapine"}, {"type": "treatment", "offset": [6, 7, 8], "text": "atypical antipsychotic drugs"}, {"type": "drug", "offset": [2], "text": "Olanzapine"}, {"type": "effect", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22], "text": "muscle injury with concomitant elevations of serum CK of muscle origin"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "Olanzapine"], ["treatment", "atypical antipsychotic drugs"], ["drug", "Olanzapine"], ["effect", "muscle injury with concomitant elevations of serum CK of muscle origin"]]}]}
{"text_id": "4054170_1", "text": "According to the literature , chlorambucil central nervous toxicity is found almost exclusively in childhood nephrotic syndrome .", "tokens": ["According", "to", "the", "literature", ",", "chlorambucil", "central", "nervous", "toxicity", "is", "found", "almost", "exclusively", "in", "childhood", "nephrotic", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> found <extra_id_0> subject <extra_id_5> childhood nephrotic syndrome <extra_id_1> <extra_id_0> age <extra_id_5> childhood <extra_id_1> <extra_id_0> subject disorder <extra_id_5> nephrotic syndrome <extra_id_1> <extra_id_0> treatment <extra_id_5> chlorambucil <extra_id_1> <extra_id_0> drug <extra_id_5> chlorambucil <extra_id_1> <extra_id_0> effect <extra_id_5> central nervous toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "found", "args": [{"type": "subject", "offset": [14, 15, 16], "text": "childhood nephrotic syndrome"}, {"type": "age", "offset": [14], "text": "childhood"}, {"type": "subject disorder", "offset": [15, 16], "text": "nephrotic syndrome"}, {"type": "treatment", "offset": [5], "text": "chlorambucil"}, {"type": "drug", "offset": [5], "text": "chlorambucil"}, {"type": "effect", "offset": [6, 7, 8], "text": "central nervous toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "found", "label": "adverse event", "asoc": [["subject", "childhood nephrotic syndrome"], ["age", "childhood"], ["subject disorder", "nephrotic syndrome"], ["treatment", "chlorambucil"], ["drug", "chlorambucil"], ["effect", "central nervous toxicity"]]}]}
{"text_id": "22233409_1", "text": "Severe anaemia related to oseltamivir during treatment of chronic hepatitis C : a new drug interaction ?", "tokens": ["Severe", "anaemia", "related", "to", "oseltamivir", "during", "treatment", "of", "chronic", "hepatitis", "C", ":", "a", "new", "drug", "interaction", "?"], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> treatment <extra_id_5> oseltamivir during treatment of chronic hepatitis C <extra_id_1> <extra_id_0> drug <extra_id_5> oseltamivir <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic hepatitis C <extra_id_1> <extra_id_0> effect <extra_id_5> anaemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "related", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10], "text": "oseltamivir during treatment of chronic hepatitis C"}, {"type": "drug", "offset": [4], "text": "oseltamivir"}, {"type": "treatment disorder", "offset": [8, 9, 10], "text": "chronic hepatitis C"}, {"type": "effect", "offset": [1], "text": "anaemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["treatment", "oseltamivir during treatment of chronic hepatitis C"], ["drug", "oseltamivir"], ["treatment disorder", "chronic hepatitis C"], ["effect", "anaemia"]]}]}
{"text_id": "9824032_3", "text": "Two 65 - year - old white men with coronary heart disease , given niacin therapy for dyslipidemia for 5 months , developed intense dental and gingival pain that was associated with increases in dose and that was relieved with discontinuance of niacin treatment .", "tokens": ["Two", "65", "-", "year", "-", "old", "white", "men", "with", "coronary", "heart", "disease", ",", "given", "niacin", "therapy", "for", "dyslipidemia", "for", "5", "months", ",", "developed", "intense", "dental", "and", "gingival", "pain", "that", "was", "associated", "with", "increases", "in", "dose", "and", "that", "was", "relieved", "with", "discontinuance", "of", "niacin", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> Two 65 - year - old white men with coronary heart disease <extra_id_1> <extra_id_0> age <extra_id_5> 65 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> men <extra_id_1> <extra_id_0> population <extra_id_5> Two <extra_id_1> <extra_id_0> race <extra_id_5> white <extra_id_1> <extra_id_0> subject disorder <extra_id_5> coronary heart disease <extra_id_1> <extra_id_0> subject disorder <extra_id_5> dyslipidemia <extra_id_1> <extra_id_0> treatment <extra_id_5> niacin therapy for dyslipidemia for 5 months <extra_id_1> <extra_id_0> treatment <extra_id_5> increases in dose <extra_id_1> <extra_id_0> drug <extra_id_5> niacin <extra_id_1> <extra_id_0> dosage <extra_id_5> increases in dose <extra_id_1> <extra_id_0> duration <extra_id_5> 5 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 5 months <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> dyslipidemia <extra_id_1> <extra_id_0> effect <extra_id_5> intense dental and gingival pain <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [22], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11], "text": "Two 65 - year - old white men with coronary heart disease"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "65 - year - old"}, {"type": "gender", "offset": [7], "text": "men"}, {"type": "population", "offset": [0], "text": "Two"}, {"type": "race", "offset": [6], "text": "white"}, {"type": "subject disorder", "offset": [9, 10, 11], "text": "coronary heart disease"}, {"type": "subject disorder", "offset": [17], "text": "dyslipidemia"}, {"type": "treatment", "offset": [14, 15, 16, 17, 18, 19, 20], "text": "niacin therapy for dyslipidemia for 5 months"}, {"type": "treatment", "offset": [32, 33, 34], "text": "increases in dose"}, {"type": "drug", "offset": [14], "text": "niacin"}, {"type": "dosage", "offset": [32, 33, 34], "text": "increases in dose"}, {"type": "duration", "offset": [19, 20], "text": "5 months"}, {"type": "time elapsed", "offset": [19, 20], "text": "5 months"}, {"type": "treatment disorder", "offset": [17], "text": "dyslipidemia"}, {"type": "effect", "offset": [23, 24, 25, 26, 27], "text": "intense dental and gingival pain"}]}], "spot": ["adverse event"], "asoc": ["dosage", "time elapsed", "population", "duration", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder", "race"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "Two 65 - year - old white men with coronary heart disease"], ["age", "65 - year - old"], ["gender", "men"], ["population", "Two"], ["race", "white"], ["subject disorder", "coronary heart disease"], ["subject disorder", "dyslipidemia"], ["treatment", "niacin therapy for dyslipidemia for 5 months"], ["treatment", "increases in dose"], ["drug", "niacin"], ["dosage", "increases in dose"], ["duration", "5 months"], ["time elapsed", "5 months"], ["treatment disorder", "dyslipidemia"], ["effect", "intense dental and gingival pain"]]}]}
{"text_id": "2937155_3", "text": "Vancomycin - induced vasculitis .", "tokens": ["Vancomycin", "-", "induced", "vasculitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Vancomycin <extra_id_1> <extra_id_0> drug <extra_id_5> Vancomycin <extra_id_1> <extra_id_0> effect <extra_id_5> vasculitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Vancomycin"}, {"type": "drug", "offset": [0], "text": "Vancomycin"}, {"type": "effect", "offset": [3], "text": "vasculitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Vancomycin"], ["drug", "Vancomycin"], ["effect", "vasculitis"]]}]}
{"text_id": "9512187_2", "text": "In this report , one patient who developed gangrene after bleomycin and vincristine / vinblastine chemotherapy for AIDS - related Kaposi 's sarcoma and another HIV - infected patient who exhibited symptoms of severe Raynaud 's phenomenon related to the same regimen are presented .", "tokens": ["In", "this", "report", ",", "one", "patient", "who", "developed", "gangrene", "after", "bleomycin", "and", "vincristine", "/", "vinblastine", "chemotherapy", "for", "AIDS", "-", "related", "Kaposi", "'s", "sarcoma", "and", "another", "HIV", "-", "infected", "patient", "who", "exhibited", "symptoms", "of", "severe", "Raynaud", "'s", "phenomenon", "related", "to", "the", "same", "regimen", "are", "presented", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> one patient <extra_id_1> <extra_id_0> population <extra_id_5> one <extra_id_1> <extra_id_0> treatment <extra_id_5> bleomycin and vincristine / vinblastine <extra_id_1> <extra_id_0> drug <extra_id_5> bleomycin <extra_id_1> <extra_id_0> drug <extra_id_5> vincristine <extra_id_1> <extra_id_0> drug <extra_id_5> vinblastine <extra_id_1> <extra_id_0> combination drug <extra_id_5> bleomycin <extra_id_1> <extra_id_0> combination drug <extra_id_5> vincristine <extra_id_1> <extra_id_0> combination drug <extra_id_5> vinblastine <extra_id_1> <extra_id_0> effect <extra_id_5> gangrene <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "developed", "args": [{"type": "subject", "offset": [4, 5], "text": "one patient"}, {"type": "population", "offset": [4], "text": "one"}, {"type": "treatment", "offset": [10, 11, 12, 13, 14], "text": "bleomycin and vincristine / vinblastine"}, {"type": "drug", "offset": [10], "text": "bleomycin"}, {"type": "drug", "offset": [12], "text": "vincristine"}, {"type": "drug", "offset": [14], "text": "vinblastine"}, {"type": "combination drug", "offset": [10], "text": "bleomycin"}, {"type": "combination drug", "offset": [12], "text": "vincristine"}, {"type": "combination drug", "offset": [14], "text": "vinblastine"}, {"type": "effect", "offset": [8], "text": "gangrene"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "one patient"], ["population", "one"], ["treatment", "bleomycin and vincristine / vinblastine"], ["drug", "bleomycin"], ["drug", "vincristine"], ["drug", "vinblastine"], ["combination drug", "bleomycin"], ["combination drug", "vincristine"], ["combination drug", "vinblastine"], ["effect", "gangrene"]]}]}
{"text_id": "18676387_4", "text": "A 60 - yr - old woman , established on paroxetine for depression , underwent excision of a chest wall myxofibrosarcoma and chest wall reconstruction .", "tokens": ["A", "60", "-", "yr", "-", "old", "woman", ",", "established", "on", "paroxetine", "for", "depression", ",", "underwent", "excision", "of", "a", "chest", "wall", "myxofibrosarcoma", "and", "chest", "wall", "reconstruction", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> established <extra_id_0> subject <extra_id_5> A 60 - yr - old woman <extra_id_1> <extra_id_0> subject <extra_id_5> depression <extra_id_1> <extra_id_0> age <extra_id_5> 60 - yr - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> depression <extra_id_1> <extra_id_0> subject disorder <extra_id_5> myxofibrosarcoma <extra_id_1> <extra_id_0> treatment <extra_id_5> paroxetine <extra_id_1> <extra_id_0> treatment <extra_id_5> underwent excision of a chest wall myxofibrosarcoma and chest wall reconstruction <extra_id_1> <extra_id_0> drug <extra_id_5> paroxetine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> depression <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> myxofibrosarcoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [8], "text": "established", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "A 60 - yr - old woman"}, {"type": "subject", "offset": [12], "text": "depression"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "60 - yr - old"}, {"type": "gender", "offset": [6], "text": "woman"}, {"type": "subject disorder", "offset": [12], "text": "depression"}, {"type": "subject disorder", "offset": [20], "text": "myxofibrosarcoma"}, {"type": "treatment", "offset": [10], "text": "paroxetine"}, {"type": "treatment", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24], "text": "underwent excision of a chest wall myxofibrosarcoma and chest wall reconstruction"}, {"type": "drug", "offset": [10], "text": "paroxetine"}, {"type": "treatment disorder", "offset": [12], "text": "depression"}, {"type": "treatment disorder", "offset": [20], "text": "myxofibrosarcoma"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "established", "label": "potential therapeutic event", "asoc": [["subject", "A 60 - yr - old woman"], ["subject", "depression"], ["age", "60 - yr - old"], ["gender", "woman"], ["subject disorder", "depression"], ["subject disorder", "myxofibrosarcoma"], ["treatment", "paroxetine"], ["treatment", "underwent excision of a chest wall myxofibrosarcoma and chest wall reconstruction"], ["drug", "paroxetine"], ["treatment disorder", "depression"], ["treatment disorder", "myxofibrosarcoma"]]}]}
{"text_id": "7594371_3", "text": "We recommend the cautious use of ketorolac in patients with underlying illnesses where NSAID - induced ototoxicity could result in adverse otologic consequences .", "tokens": ["We", "recommend", "the", "cautious", "use", "of", "ketorolac", "in", "patients", "with", "underlying", "illnesses", "where", "NSAID", "-", "induced", "ototoxicity", "could", "result", "in", "adverse", "otologic", "consequences", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> where <extra_id_0> subject <extra_id_5> patients with underlying illnesses <extra_id_1> <extra_id_0> subject disorder <extra_id_5> underlying illnesses <extra_id_1> <extra_id_0> treatment <extra_id_5> ketorolac <extra_id_1> <extra_id_0> drug <extra_id_5> ketorolac <extra_id_1> <extra_id_0> effect <extra_id_5> NSAID - induced ototoxicity could result in adverse otologic consequences <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "where", "args": [{"type": "subject", "offset": [8, 9, 10, 11], "text": "patients with underlying illnesses"}, {"type": "subject disorder", "offset": [10, 11], "text": "underlying illnesses"}, {"type": "treatment", "offset": [6], "text": "ketorolac"}, {"type": "drug", "offset": [6], "text": "ketorolac"}, {"type": "effect", "offset": [13, 14, 15, 16, 17, 18, 19, 20, 21, 22], "text": "NSAID - induced ototoxicity could result in adverse otologic consequences"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "where", "label": "adverse event", "asoc": [["subject", "patients with underlying illnesses"], ["subject disorder", "underlying illnesses"], ["treatment", "ketorolac"], ["drug", "ketorolac"], ["effect", "NSAID - induced ototoxicity could result in adverse otologic consequences"]]}]}
{"text_id": "12460237_3", "text": "It has been suggested that PPE caused by cytarabine does not recur with subsequent cytarabine re - challenge .", "tokens": ["It", "has", "been", "suggested", "that", "PPE", "caused", "by", "cytarabine", "does", "not", "recur", "with", "subsequent", "cytarabine", "re", "-", "challenge", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> cytarabine <extra_id_1> <extra_id_0> drug <extra_id_5> cytarabine <extra_id_1> <extra_id_0> effect <extra_id_5> PPE <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "caused", "args": [{"type": "treatment", "offset": [8], "text": "cytarabine"}, {"type": "drug", "offset": [8], "text": "cytarabine"}, {"type": "effect", "offset": [5], "text": "PPE"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "cytarabine"], ["drug", "cytarabine"], ["effect", "PPE"]]}]}
{"text_id": "19299370_3", "text": "Probable enoxaparin - induced hepatotoxicity .", "tokens": ["Probable", "enoxaparin", "-", "induced", "hepatotoxicity", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> drug <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> effect <extra_id_5> hepatotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "induced", "args": [{"type": "treatment", "offset": [1], "text": "enoxaparin"}, {"type": "drug", "offset": [1], "text": "enoxaparin"}, {"type": "effect", "offset": [4], "text": "hepatotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "enoxaparin"], ["drug", "enoxaparin"], ["effect", "hepatotoxicity"]]}]}
{"text_id": "18176653_11", "text": "This paper contributed to the identification of possible reactions in the oral cavity due to antiretroviral medication .", "tokens": ["This", "paper", "contributed", "to", "the", "identification", "of", "possible", "reactions", "in", "the", "oral", "cavity", "due", "to", "antiretroviral", "medication", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> treatment <extra_id_5> antiretroviral medication <extra_id_1> <extra_id_0> drug <extra_id_5> antiretroviral medication <extra_id_1> <extra_id_0> effect <extra_id_5> reactions in the oral cavity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "due", "args": [{"type": "treatment", "offset": [15, 16], "text": "antiretroviral medication"}, {"type": "drug", "offset": [15, 16], "text": "antiretroviral medication"}, {"type": "effect", "offset": [8, 9, 10, 11, 12], "text": "reactions in the oral cavity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["treatment", "antiretroviral medication"], ["drug", "antiretroviral medication"], ["effect", "reactions in the oral cavity"]]}]}
{"text_id": "19281746_2", "text": "We report the first case of acute renal failure with hyperkalemia associated with the recently marketed direct renin inhibitor aliskiren .", "tokens": ["We", "report", "the", "first", "case", "of", "acute", "renal", "failure", "with", "hyperkalemia", "associated", "with", "the", "recently", "marketed", "direct", "renin", "inhibitor", "aliskiren", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> renin inhibitor aliskiren <extra_id_1> <extra_id_0> drug <extra_id_5> aliskiren <extra_id_1> <extra_id_0> effect <extra_id_5> acute renal failure with hyperkalemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "associated", "args": [{"type": "treatment", "offset": [17, 18, 19], "text": "renin inhibitor aliskiren"}, {"type": "drug", "offset": [19], "text": "aliskiren"}, {"type": "effect", "offset": [6, 7, 8, 9, 10], "text": "acute renal failure with hyperkalemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "renin inhibitor aliskiren"], ["drug", "aliskiren"], ["effect", "acute renal failure with hyperkalemia"]]}]}
{"text_id": "12126225_2", "text": "A 75 - year - old man developed bilateral lower leg edema 6 months after switching from troglitazone to pioglitazone .", "tokens": ["A", "75", "-", "year", "-", "old", "man", "developed", "bilateral", "lower", "leg", "edema", "6", "months", "after", "switching", "from", "troglitazone", "to", "pioglitazone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 75 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 75 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> 6 months after switching from troglitazone to pioglitazone <extra_id_1> <extra_id_0> drug <extra_id_5> pioglitazone <extra_id_1> <extra_id_0> drug <extra_id_5> 6 months <extra_id_1> <extra_id_0> drug <extra_id_5> troglitazone <extra_id_1> <extra_id_0> effect <extra_id_5> bilateral lower leg edema <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "A 75 - year - old man"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "75 - year - old"}, {"type": "gender", "offset": [6], "text": "man"}, {"type": "treatment", "offset": [12, 13, 14, 15, 16, 17, 18, 19], "text": "6 months after switching from troglitazone to pioglitazone"}, {"type": "drug", "offset": [19], "text": "pioglitazone"}, {"type": "drug", "offset": [12, 13], "text": "6 months"}, {"type": "drug", "offset": [17], "text": "troglitazone"}, {"type": "effect", "offset": [8, 9, 10, 11], "text": "bilateral lower leg edema"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 75 - year - old man"], ["age", "75 - year - old"], ["gender", "man"], ["treatment", "6 months after switching from troglitazone to pioglitazone"], ["drug", "pioglitazone"], ["drug", "6 months"], ["drug", "troglitazone"], ["effect", "bilateral lower leg edema"]]}]}
{"text_id": "10897389_2", "text": "Recurrent septicemia with lethal outcome during and after cyclosporine therapy in severe ulcerative colitis .", "tokens": ["Recurrent", "septicemia", "with", "lethal", "outcome", "during", "and", "after", "cyclosporine", "therapy", "in", "severe", "ulcerative", "colitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> cyclosporine <extra_id_1> <extra_id_0> drug <extra_id_5> cyclosporine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> severe ulcerative colitis <extra_id_1> <extra_id_0> effect <extra_id_5> Recurrent septicemia with lethal outcome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "after", "args": [{"type": "treatment", "offset": [8], "text": "cyclosporine"}, {"type": "drug", "offset": [8], "text": "cyclosporine"}, {"type": "treatment disorder", "offset": [11, 12, 13], "text": "severe ulcerative colitis"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Recurrent septicemia with lethal outcome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "cyclosporine"], ["drug", "cyclosporine"], ["treatment disorder", "severe ulcerative colitis"], ["effect", "Recurrent septicemia with lethal outcome"]]}]}
{"text_id": "11675845_9", "text": "Furthermore , the warfarin dose was again increased after discontinuation of ropinirole due to common gastrointestinal adverse effects .", "tokens": ["Furthermore", ",", "the", "warfarin", "dose", "was", "again", "increased", "after", "discontinuation", "of", "ropinirole", "due", "to", "common", "gastrointestinal", "adverse", "effects", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> due to <extra_id_0> treatment <extra_id_5> the warfarin dose was again increased after discontinuation of ropinirole <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> gastrointestinal adverse effects <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [12, 13], "text": "due to", "args": [{"type": "treatment", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10, 11], "text": "the warfarin dose was again increased after discontinuation of ropinirole"}, {"type": "drug", "offset": [3], "text": "warfarin"}, {"type": "treatment disorder", "offset": [15, 16, 17], "text": "gastrointestinal adverse effects"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "due to", "label": "potential therapeutic event", "asoc": [["treatment", "the warfarin dose was again increased after discontinuation of ropinirole"], ["drug", "warfarin"], ["treatment disorder", "gastrointestinal adverse effects"]]}]}
{"text_id": "10870485_1", "text": "Three months following splenectomy , multiple abscesses occurred in the muscles of both thighs while the patient was receiving the third course of the CHOP regimen .", "tokens": ["Three", "months", "following", "splenectomy", ",", "multiple", "abscesses", "occurred", "in", "the", "muscles", "of", "both", "thighs", "while", "the", "patient", "was", "receiving", "the", "third", "course", "of", "the", "CHOP", "regimen", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> while <extra_id_0> subject <extra_id_5> the patient <extra_id_1> <extra_id_0> treatment <extra_id_5> Three months following splenectomy <extra_id_1> <extra_id_0> treatment <extra_id_5> third course of the CHOP regimen <extra_id_1> <extra_id_0> drug <extra_id_5> CHOP <extra_id_1> <extra_id_0> duration <extra_id_5> third course <extra_id_1> <extra_id_0> time elapsed <extra_id_5> third course <extra_id_1> <extra_id_0> effect <extra_id_5> multiple abscesses occurred in the muscles of both thighs <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "while", "args": [{"type": "subject", "offset": [15, 16], "text": "the patient"}, {"type": "treatment", "offset": [0, 1, 2, 3], "text": "Three months following splenectomy"}, {"type": "treatment", "offset": [20, 21, 22, 23, 24, 25], "text": "third course of the CHOP regimen"}, {"type": "drug", "offset": [24], "text": "CHOP"}, {"type": "duration", "offset": [20, 21], "text": "third course"}, {"type": "time elapsed", "offset": [20, 21], "text": "third course"}, {"type": "effect", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13], "text": "multiple abscesses occurred in the muscles of both thighs"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "subject", "drug", "time elapsed", "treatment"], "spot_asoc": [{"span": "while", "label": "adverse event", "asoc": [["subject", "the patient"], ["treatment", "Three months following splenectomy"], ["treatment", "third course of the CHOP regimen"], ["drug", "CHOP"], ["duration", "third course"], ["time elapsed", "third course"], ["effect", "multiple abscesses occurred in the muscles of both thighs"]]}]}
{"text_id": "19949685_4", "text": "We report a rare case of colonic mucosal necrosis following Kalimate ( calcium polystryrene sulfonate ) , an analogue of Kayexalate without sorbitol in a 34 - yr - old man .", "tokens": ["We", "report", "a", "rare", "case", "of", "colonic", "mucosal", "necrosis", "following", "Kalimate", "(", "calcium", "polystryrene", "sulfonate", ")", ",", "an", "analogue", "of", "Kayexalate", "without", "sorbitol", "in", "a", "34", "-", "yr", "-", "old", "man", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> subject <extra_id_5> a 34 - yr - old man <extra_id_1> <extra_id_0> age <extra_id_5> 34 - yr - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> Kalimate ( calcium polystryrene sulfonate ) , an analogue of Kayexalate without sorbitol <extra_id_1> <extra_id_0> drug <extra_id_5> Kalimate <extra_id_1> <extra_id_0> drug <extra_id_5> ( calcium polystryrene sulfonate ) <extra_id_1> <extra_id_0> drug <extra_id_5> Kayexalate <extra_id_1> <extra_id_0> effect <extra_id_5> colonic mucosal necrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "following", "args": [{"type": "subject", "offset": [24, 25, 26, 27, 28, 29, 30], "text": "a 34 - yr - old man"}, {"type": "age", "offset": [25, 26, 27, 28, 29], "text": "34 - yr - old"}, {"type": "gender", "offset": [30], "text": "man"}, {"type": "treatment", "offset": [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22], "text": "Kalimate ( calcium polystryrene sulfonate ) , an analogue of Kayexalate without sorbitol"}, {"type": "drug", "offset": [10], "text": "Kalimate"}, {"type": "drug", "offset": [11, 12, 13, 14, 15], "text": "( calcium polystryrene sulfonate )"}, {"type": "drug", "offset": [20], "text": "Kayexalate"}, {"type": "effect", "offset": [6, 7, 8], "text": "colonic mucosal necrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["subject", "a 34 - yr - old man"], ["age", "34 - yr - old"], ["gender", "man"], ["treatment", "Kalimate ( calcium polystryrene sulfonate ) , an analogue of Kayexalate without sorbitol"], ["drug", "Kalimate"], ["drug", "( calcium polystryrene sulfonate )"], ["drug", "Kayexalate"], ["effect", "colonic mucosal necrosis"]]}]}
{"text_id": "8651254_2", "text": "It should be emphasized that the recurrence of nephrotic syndrome was observed after the following chemotherapy , including M - CSF , whereas the bone marrow still remained completely remitted .", "tokens": ["It", "should", "be", "emphasized", "that", "the", "recurrence", "of", "nephrotic", "syndrome", "was", "observed", "after", "the", "following", "chemotherapy", ",", "including", "M", "-", "CSF", ",", "whereas", "the", "bone", "marrow", "still", "remained", "completely", "remitted", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> chemotherapy , including M - CSF <extra_id_1> <extra_id_0> drug <extra_id_5> M - CSF <extra_id_1> <extra_id_0> effect <extra_id_5> nephrotic syndrome <extra_id_1> <extra_id_0> effect <extra_id_5> the bone marrow still remained completely remitted <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "after", "args": [{"type": "treatment", "offset": [15, 16, 17, 18, 19, 20], "text": "chemotherapy , including M - CSF"}, {"type": "drug", "offset": [18, 19, 20], "text": "M - CSF"}, {"type": "effect", "offset": [8, 9], "text": "nephrotic syndrome"}, {"type": "effect", "offset": [23, 24, 25, 26, 27, 28, 29], "text": "the bone marrow still remained completely remitted"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "chemotherapy , including M - CSF"], ["drug", "M - CSF"], ["effect", "nephrotic syndrome"], ["effect", "the bone marrow still remained completely remitted"]]}]}
{"text_id": "1420650_3", "text": "We consider asterixis to be an easily overlooked sign of neurotoxicity , which may occur even at low or moderate dosage levels , if certain drugs as lithium or clozapine are used in combination with CBZ .", "tokens": ["We", "consider", "asterixis", "to", "be", "an", "easily", "overlooked", "sign", "of", "neurotoxicity", ",", "which", "may", "occur", "even", "at", "low", "or", "moderate", "dosage", "levels", ",", "if", "certain", "drugs", "as", "lithium", "or", "clozapine", "are", "used", "in", "combination", "with", "CBZ", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occur <extra_id_0> treatment <extra_id_5> even at low or moderate dosage levels <extra_id_1> <extra_id_0> treatment <extra_id_5> certain drugs as lithium or clozapine are used in combination with CBZ <extra_id_1> <extra_id_0> drug <extra_id_5> CBZ <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> dosage <extra_id_5> low or moderate dosage <extra_id_1> <extra_id_0> combination drug <extra_id_5> CBZ <extra_id_1> <extra_id_0> combination drug <extra_id_5> lithium <extra_id_1> <extra_id_0> combination drug <extra_id_5> CBZ <extra_id_1> <extra_id_0> combination drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> effect <extra_id_5> asterixis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "occur", "args": [{"type": "treatment", "offset": [15, 16, 17, 18, 19, 20, 21], "text": "even at low or moderate dosage levels"}, {"type": "treatment", "offset": [24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35], "text": "certain drugs as lithium or clozapine are used in combination with CBZ"}, {"type": "drug", "offset": [35], "text": "CBZ"}, {"type": "drug", "offset": [27], "text": "lithium"}, {"type": "drug", "offset": [29], "text": "clozapine"}, {"type": "dosage", "offset": [17, 18, 19, 20], "text": "low or moderate dosage"}, {"type": "combination drug", "offset": [35], "text": "CBZ"}, {"type": "combination drug", "offset": [27], "text": "lithium"}, {"type": "combination drug", "offset": [35], "text": "CBZ"}, {"type": "combination drug", "offset": [29], "text": "clozapine"}, {"type": "effect", "offset": [2], "text": "asterixis"}]}], "spot": ["adverse event"], "asoc": ["effect", "drug", "dosage", "combination drug", "treatment"], "spot_asoc": [{"span": "occur", "label": "adverse event", "asoc": [["treatment", "even at low or moderate dosage levels"], ["treatment", "certain drugs as lithium or clozapine are used in combination with CBZ"], ["drug", "CBZ"], ["drug", "lithium"], ["drug", "clozapine"], ["dosage", "low or moderate dosage"], ["combination drug", "CBZ"], ["combination drug", "lithium"], ["combination drug", "CBZ"], ["combination drug", "clozapine"], ["effect", "asterixis"]]}]}
{"text_id": "19915794_3", "text": "Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450 , family 3 , subfamily A polypeptide - 4 - influencing drugs during hypokalemia due to licorice .", "tokens": ["Torsades", "de", "Pointes", "induced", "by", "a", "combination", "of", "garenoxacin", "and", "disopyramide", "and", "other", "cytochrome", "P450", ",", "family", "3", ",", "subfamily", "A", "polypeptide", "-", "4", "-", "influencing", "drugs", "during", "hypokalemia", "due", "to", "licorice", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> a combination of garenoxacin and disopyramide and other cytochrome P450 , family 3 , subfamily A polypeptide - 4 - influencing drugs <extra_id_1> <extra_id_0> drug <extra_id_5> garenoxacin <extra_id_1> <extra_id_0> drug <extra_id_5> disopyramide <extra_id_1> <extra_id_0> drug <extra_id_5> cytochrome P450 , family 3 , subfamily A polypeptide - 4 - influencing drugs <extra_id_1> <extra_id_0> combination drug <extra_id_5> garenoxacin <extra_id_1> <extra_id_0> combination drug <extra_id_5> disopyramide <extra_id_1> <extra_id_0> combination drug <extra_id_5> cytochrome P450 , family 3 , subfamily A polypeptide - 4 - influencing drugs <extra_id_1> <extra_id_0> effect <extra_id_5> Torsades de Pointes <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "induced", "args": [{"type": "treatment", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26], "text": "a combination of garenoxacin and disopyramide and other cytochrome P450 , family 3 , subfamily A polypeptide - 4 - influencing drugs"}, {"type": "drug", "offset": [8], "text": "garenoxacin"}, {"type": "drug", "offset": [10], "text": "disopyramide"}, {"type": "drug", "offset": [13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26], "text": "cytochrome P450 , family 3 , subfamily A polypeptide - 4 - influencing drugs"}, {"type": "combination drug", "offset": [8], "text": "garenoxacin"}, {"type": "combination drug", "offset": [10], "text": "disopyramide"}, {"type": "combination drug", "offset": [13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26], "text": "cytochrome P450 , family 3 , subfamily A polypeptide - 4 - influencing drugs"}, {"type": "effect", "offset": [0, 1, 2], "text": "Torsades de Pointes"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "a combination of garenoxacin and disopyramide and other cytochrome P450 , family 3 , subfamily A polypeptide - 4 - influencing drugs"], ["drug", "garenoxacin"], ["drug", "disopyramide"], ["drug", "cytochrome P450 , family 3 , subfamily A polypeptide - 4 - influencing drugs"], ["combination drug", "garenoxacin"], ["combination drug", "disopyramide"], ["combination drug", "cytochrome P450 , family 3 , subfamily A polypeptide - 4 - influencing drugs"], ["effect", "Torsades de Pointes"]]}]}
{"text_id": "19904536_14", "text": "Physicians should suspect pulmonary toxicity in patients with respiratory distress after gemcitabine chemotherapy , mainly in elderly patients .", "tokens": ["Physicians", "should", "suspect", "pulmonary", "toxicity", "in", "patients", "with", "respiratory", "distress", "after", "gemcitabine", "chemotherapy", ",", "mainly", "in", "elderly", "patients", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> patients with respiratory distress <extra_id_1> <extra_id_0> subject <extra_id_5> mainly in elderly patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> respiratory distress <extra_id_1> <extra_id_0> treatment <extra_id_5> gemcitabine chemotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> route <extra_id_5> chemotherapy <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> respiratory distress <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "after", "args": [{"type": "subject", "offset": [6, 7, 8, 9], "text": "patients with respiratory distress"}, {"type": "subject", "offset": [14, 15, 16, 17], "text": "mainly in elderly patients"}, {"type": "subject disorder", "offset": [8, 9], "text": "respiratory distress"}, {"type": "treatment", "offset": [11, 12], "text": "gemcitabine chemotherapy"}, {"type": "drug", "offset": [11], "text": "gemcitabine"}, {"type": "route", "offset": [12], "text": "chemotherapy"}, {"type": "treatment disorder", "offset": [8, 9], "text": "respiratory distress"}, {"type": "effect", "offset": [3, 4], "text": "pulmonary toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "patients with respiratory distress"], ["subject", "mainly in elderly patients"], ["subject disorder", "respiratory distress"], ["treatment", "gemcitabine chemotherapy"], ["drug", "gemcitabine"], ["route", "chemotherapy"], ["treatment disorder", "respiratory distress"], ["effect", "pulmonary toxicity"]]}]}
{"text_id": "6683487_4", "text": "To our knowledge , no prior cases of penicillamine - induced TTP in RA have been reported .", "tokens": ["To", "our", "knowledge", ",", "no", "prior", "cases", "of", "penicillamine", "-", "induced", "TTP", "in", "RA", "have", "been", "reported", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> penicillamine <extra_id_1> <extra_id_0> drug <extra_id_5> penicillamine <extra_id_1> <extra_id_0> effect <extra_id_5> TTP <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "induced", "args": [{"type": "treatment", "offset": [8], "text": "penicillamine"}, {"type": "drug", "offset": [8], "text": "penicillamine"}, {"type": "effect", "offset": [11], "text": "TTP"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "penicillamine"], ["drug", "penicillamine"], ["effect", "TTP"]]}]}
{"text_id": "15157248_1", "text": "An immediate hemolytic reaction induced by repeated administration of oxaliplatin .", "tokens": ["An", "immediate", "hemolytic", "reaction", "induced", "by", "repeated", "administration", "of", "oxaliplatin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> repeated administration of oxaliplatin <extra_id_1> <extra_id_0> drug <extra_id_5> oxaliplatin <extra_id_1> <extra_id_0> frequency <extra_id_5> repeated <extra_id_1> <extra_id_0> effect <extra_id_5> immediate hemolytic reaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "induced", "args": [{"type": "treatment", "offset": [6, 7, 8, 9], "text": "repeated administration of oxaliplatin"}, {"type": "drug", "offset": [9], "text": "oxaliplatin"}, {"type": "frequency", "offset": [6], "text": "repeated"}, {"type": "effect", "offset": [1, 2, 3], "text": "immediate hemolytic reaction"}]}], "spot": ["adverse event"], "asoc": ["effect", "frequency", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "repeated administration of oxaliplatin"], ["drug", "oxaliplatin"], ["frequency", "repeated"], ["effect", "immediate hemolytic reaction"]]}]}
{"text_id": "11215836_1", "text": "He was diagnosed with possible serotonin syndrome ; his symptoms resolved after clomipramine was stopped but before clozapine was restarted eight days later .", "tokens": ["He", "was", "diagnosed", "with", "possible", "serotonin", "syndrome", ";", "his", "symptoms", "resolved", "after", "clomipramine", "was", "stopped", "but", "before", "clozapine", "was", "restarted", "eight", "days", "later", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resolved <extra_id_0> subject <extra_id_5> He <extra_id_1> <extra_id_0> gender <extra_id_5> He <extra_id_1> <extra_id_0> treatment <extra_id_5> clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> effect <extra_id_5> possible serotonin syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "resolved", "args": [{"type": "subject", "offset": [0], "text": "He"}, {"type": "gender", "offset": [0], "text": "He"}, {"type": "treatment", "offset": [17], "text": "clozapine"}, {"type": "drug", "offset": [17], "text": "clozapine"}, {"type": "effect", "offset": [4, 5, 6], "text": "possible serotonin syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "gender", "treatment"], "spot_asoc": [{"span": "resolved", "label": "adverse event", "asoc": [["subject", "He"], ["gender", "He"], ["treatment", "clozapine"], ["drug", "clozapine"], ["effect", "possible serotonin syndrome"]]}]}
{"text_id": "15379082_1", "text": "Disulfiram - induced fulminant hepatic failure in an active duty soldier .", "tokens": ["Disulfiram", "-", "induced", "fulminant", "hepatic", "failure", "in", "an", "active", "duty", "soldier", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> an active duty soldier <extra_id_1> <extra_id_0> treatment <extra_id_5> Disulfiram <extra_id_1> <extra_id_0> drug <extra_id_5> Disulfiram <extra_id_1> <extra_id_0> effect <extra_id_5> fulminant hepatic failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "subject", "offset": [7, 8, 9, 10], "text": "an active duty soldier"}, {"type": "treatment", "offset": [0], "text": "Disulfiram"}, {"type": "drug", "offset": [0], "text": "Disulfiram"}, {"type": "effect", "offset": [3, 4, 5], "text": "fulminant hepatic failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "an active duty soldier"], ["treatment", "Disulfiram"], ["drug", "Disulfiram"], ["effect", "fulminant hepatic failure"]]}]}
{"text_id": "11026106_2", "text": "Minocycline - induced autoimmune hepatitis is usually identical to sporadic autoimmune hepatitis .", "tokens": ["Minocycline", "-", "induced", "autoimmune", "hepatitis", "is", "usually", "identical", "to", "sporadic", "autoimmune", "hepatitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Minocycline <extra_id_1> <extra_id_0> drug <extra_id_5> Minocycline <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> sporadic autoimmune hepatitis <extra_id_1> <extra_id_0> effect <extra_id_5> autoimmune hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Minocycline"}, {"type": "drug", "offset": [0], "text": "Minocycline"}, {"type": "treatment disorder", "offset": [9, 10, 11], "text": "sporadic autoimmune hepatitis"}, {"type": "effect", "offset": [3, 4], "text": "autoimmune hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Minocycline"], ["drug", "Minocycline"], ["treatment disorder", "sporadic autoimmune hepatitis"], ["effect", "autoimmune hepatitis"]]}]}
{"text_id": "1592841_2", "text": "RESULTS : Both patients experienced a previously unreported side effect -- falling backward -- associated with bupropion use .", "tokens": ["RESULTS", ":", "Both", "patients", "experienced", "a", "previously", "unreported", "side", "effect", "--", "falling", "backward", "--", "associated", "with", "bupropion", "use", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> Both patients <extra_id_1> <extra_id_0> population <extra_id_5> Both <extra_id_1> <extra_id_0> treatment <extra_id_5> bupropion <extra_id_1> <extra_id_0> drug <extra_id_5> bupropion <extra_id_1> <extra_id_0> effect <extra_id_5> falling backward <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "associated", "args": [{"type": "subject", "offset": [2, 3], "text": "Both patients"}, {"type": "population", "offset": [2], "text": "Both"}, {"type": "treatment", "offset": [16], "text": "bupropion"}, {"type": "drug", "offset": [16], "text": "bupropion"}, {"type": "effect", "offset": [11, 12], "text": "falling backward"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "Both patients"], ["population", "Both"], ["treatment", "bupropion"], ["drug", "bupropion"], ["effect", "falling backward"]]}]}
{"text_id": "2554727_1", "text": "Horner 's syndrome and demyelinating peripheral neuropathy caused by high - dose cytosine arabinoside .", "tokens": ["Horner", "'s", "syndrome", "and", "demyelinating", "peripheral", "neuropathy", "caused", "by", "high", "-", "dose", "cytosine", "arabinoside", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> high - dose cytosine arabinoside <extra_id_1> <extra_id_0> drug <extra_id_5> cytosine arabinoside <extra_id_1> <extra_id_0> dosage <extra_id_5> high - dose <extra_id_1> <extra_id_0> effect <extra_id_5> Horner 's syndrome and demyelinating peripheral neuropathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "caused", "args": [{"type": "treatment", "offset": [9, 10, 11, 12, 13], "text": "high - dose cytosine arabinoside"}, {"type": "drug", "offset": [12, 13], "text": "cytosine arabinoside"}, {"type": "dosage", "offset": [9, 10, 11], "text": "high - dose"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Horner 's syndrome and demyelinating peripheral neuropathy"}]}], "spot": ["adverse event"], "asoc": ["dosage", "treatment", "drug", "effect"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "high - dose cytosine arabinoside"], ["drug", "cytosine arabinoside"], ["dosage", "high - dose"], ["effect", "Horner 's syndrome and demyelinating peripheral neuropathy"]]}]}
{"text_id": "16035204_1", "text": "We report an unusual case of massive fluoxetine ingestion resulting in neurological and cardiovascular toxicity resulting in death .", "tokens": ["We", "report", "an", "unusual", "case", "of", "massive", "fluoxetine", "ingestion", "resulting", "in", "neurological", "and", "cardiovascular", "toxicity", "resulting", "in", "death", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resulting in <extra_id_0> subject <extra_id_5> an unusual case <extra_id_1> <extra_id_0> treatment <extra_id_5> massive fluoxetine ingestion <extra_id_1> <extra_id_0> drug <extra_id_5> fluoxetine <extra_id_1> <extra_id_0> dosage <extra_id_5> massive <extra_id_1> <extra_id_0> route <extra_id_5> ingestion <extra_id_1> <extra_id_0> effect <extra_id_5> neurological and cardiovascular toxicity resulting in death <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9, 10], "text": "resulting in", "args": [{"type": "subject", "offset": [2, 3, 4], "text": "an unusual case"}, {"type": "treatment", "offset": [6, 7, 8], "text": "massive fluoxetine ingestion"}, {"type": "drug", "offset": [7], "text": "fluoxetine"}, {"type": "dosage", "offset": [6], "text": "massive"}, {"type": "route", "offset": [8], "text": "ingestion"}, {"type": "effect", "offset": [11, 12, 13, 14, 15, 16, 17], "text": "neurological and cardiovascular toxicity resulting in death"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "dosage", "treatment"], "spot_asoc": [{"span": "resulting in", "label": "adverse event", "asoc": [["subject", "an unusual case"], ["treatment", "massive fluoxetine ingestion"], ["drug", "fluoxetine"], ["dosage", "massive"], ["route", "ingestion"], ["effect", "neurological and cardiovascular toxicity resulting in death"]]}]}
{"text_id": "19039026_1", "text": "Biopsy - proven acute interstitial nephritis associated with the tyrosine kinase inhibitor sunitinib : a class effect ?", "tokens": ["Biopsy", "-", "proven", "acute", "interstitial", "nephritis", "associated", "with", "the", "tyrosine", "kinase", "inhibitor", "sunitinib", ":", "a", "class", "effect", "?"], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> tyrosine kinase inhibitor sunitinib <extra_id_1> <extra_id_0> drug <extra_id_5> sunitinib <extra_id_1> <extra_id_0> effect <extra_id_5> acute interstitial nephritis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "associated", "args": [{"type": "treatment", "offset": [9, 10, 11, 12], "text": "tyrosine kinase inhibitor sunitinib"}, {"type": "drug", "offset": [12], "text": "sunitinib"}, {"type": "effect", "offset": [3, 4, 5], "text": "acute interstitial nephritis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "tyrosine kinase inhibitor sunitinib"], ["drug", "sunitinib"], ["effect", "acute interstitial nephritis"]]}]}
{"text_id": "7653281_8", "text": "These results suggest that the hepatoxicity of ethanol in alcoholic beverages is enhanced by interaction with its congeners and acetaldehyde ; they also suggest that alcoholic beverages are not equivalent in their potential to cause liver damage .", "tokens": ["These", "results", "suggest", "that", "the", "hepatoxicity", "of", "ethanol", "in", "alcoholic", "beverages", "is", "enhanced", "by", "interaction", "with", "its", "congeners", "and", "acetaldehyde", ";", "they", "also", "suggest", "that", "alcoholic", "beverages", "are", "not", "equivalent", "in", "their", "potential", "to", "cause", "liver", "damage", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> enhanced <extra_id_0> treatment <extra_id_5> alcoholic <extra_id_1> <extra_id_0> drug <extra_id_5> alcoholic <extra_id_1> <extra_id_0> effect <extra_id_5> hepatoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "enhanced", "args": [{"type": "treatment", "offset": [9], "text": "alcoholic"}, {"type": "drug", "offset": [9], "text": "alcoholic"}, {"type": "effect", "offset": [5], "text": "hepatoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "enhanced", "label": "adverse event", "asoc": [["treatment", "alcoholic"], ["drug", "alcoholic"], ["effect", "hepatoxicity"]]}]}
{"text_id": "21881031_11", "text": "Cisplatin was the common drug in the cases presented and therefore could be related to the INR elevations .", "tokens": ["Cisplatin", "was", "the", "common", "drug", "in", "the", "cases", "presented", "and", "therefore", "could", "be", "related", "to", "the", "INR", "elevations", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> subject <extra_id_5> the cases <extra_id_1> <extra_id_0> treatment <extra_id_5> Cisplatin <extra_id_1> <extra_id_0> drug <extra_id_5> Cisplatin <extra_id_1> <extra_id_0> effect <extra_id_5> INR elevations <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "related", "args": [{"type": "subject", "offset": [6, 7], "text": "the cases"}, {"type": "treatment", "offset": [0], "text": "Cisplatin"}, {"type": "drug", "offset": [0], "text": "Cisplatin"}, {"type": "effect", "offset": [16, 17], "text": "INR elevations"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["subject", "the cases"], ["treatment", "Cisplatin"], ["drug", "Cisplatin"], ["effect", "INR elevations"]]}]}
{"text_id": "889156_1", "text": "The use of beclomethasone diproprionate inhaler complicated by the development of an eosinophilic pneumonia reaction .", "tokens": ["The", "use", "of", "beclomethasone", "diproprionate", "inhaler", "complicated", "by", "the", "development", "of", "an", "eosinophilic", "pneumonia", "reaction", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> treatment <extra_id_5> beclomethasone diproprionate inhaler <extra_id_1> <extra_id_0> drug <extra_id_5> beclomethasone diproprionate <extra_id_1> <extra_id_0> route <extra_id_5> inhaler <extra_id_1> <extra_id_0> effect <extra_id_5> eosinophilic pneumonia reaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "development", "args": [{"type": "treatment", "offset": [3, 4, 5], "text": "beclomethasone diproprionate inhaler"}, {"type": "drug", "offset": [3, 4], "text": "beclomethasone diproprionate"}, {"type": "route", "offset": [5], "text": "inhaler"}, {"type": "effect", "offset": [12, 13, 14], "text": "eosinophilic pneumonia reaction"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["treatment", "beclomethasone diproprionate inhaler"], ["drug", "beclomethasone diproprionate"], ["route", "inhaler"], ["effect", "eosinophilic pneumonia reaction"]]}]}
{"text_id": "24791374_1", "text": "Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine : a case of severe drug interaction .", "tokens": ["Propafenone", "associated", "severe", "central", "nervous", "system", "and", "cardiovascular", "toxicity", "due", "to", "mirtazapine", ":", "a", "case", "of", "severe", "drug", "interaction", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due to <extra_id_0> treatment <extra_id_5> Propafenone <extra_id_1> <extra_id_0> treatment <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> drug <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> drug <extra_id_5> Propafenone <extra_id_1> <extra_id_0> combination drug <extra_id_5> Propafenone <extra_id_1> <extra_id_0> combination drug <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> effect <extra_id_5> central nervous system and cardiovascular toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9, 10], "text": "due to", "args": [{"type": "treatment", "offset": [0], "text": "Propafenone"}, {"type": "treatment", "offset": [11], "text": "mirtazapine"}, {"type": "drug", "offset": [11], "text": "mirtazapine"}, {"type": "drug", "offset": [0], "text": "Propafenone"}, {"type": "combination drug", "offset": [0], "text": "Propafenone"}, {"type": "combination drug", "offset": [11], "text": "mirtazapine"}, {"type": "effect", "offset": [3, 4, 5, 6, 7, 8], "text": "central nervous system and cardiovascular toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "due to", "label": "adverse event", "asoc": [["treatment", "Propafenone"], ["treatment", "mirtazapine"], ["drug", "mirtazapine"], ["drug", "Propafenone"], ["combination drug", "Propafenone"], ["combination drug", "mirtazapine"], ["effect", "central nervous system and cardiovascular toxicity"]]}]}
{"text_id": "9892272_2", "text": "Physicians should be aware of the possible association between the use of alteplase and the development of subfascial hemorrhage .", "tokens": ["Physicians", "should", "be", "aware", "of", "the", "possible", "association", "between", "the", "use", "of", "alteplase", "and", "the", "development", "of", "subfascial", "hemorrhage", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> treatment <extra_id_5> alteplase <extra_id_1> <extra_id_0> drug <extra_id_5> alteplase <extra_id_1> <extra_id_0> effect <extra_id_5> subfascial hemorrhage <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "development", "args": [{"type": "treatment", "offset": [12], "text": "alteplase"}, {"type": "drug", "offset": [12], "text": "alteplase"}, {"type": "effect", "offset": [17, 18], "text": "subfascial hemorrhage"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["treatment", "alteplase"], ["drug", "alteplase"], ["effect", "subfascial hemorrhage"]]}]}
{"text_id": "9260733_2", "text": "We report the case of a patient who developed polyserositis ( pericardial effusion , pleural effusion , and pericarditis ) after being started on clozapine , and whose symptoms remitted upon discontinuation of clozapine .", "tokens": ["We", "report", "the", "case", "of", "a", "patient", "who", "developed", "polyserositis", "(", "pericardial", "effusion", ",", "pleural", "effusion", ",", "and", "pericarditis", ")", "after", "being", "started", "on", "clozapine", ",", "and", "whose", "symptoms", "remitted", "upon", "discontinuation", "of", "clozapine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> started on clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> effect <extra_id_5> polyserositis ( pericardial effusion , pleural effusion , and pericarditis ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "after", "args": [{"type": "subject", "offset": [5, 6], "text": "a patient"}, {"type": "treatment", "offset": [22, 23, 24], "text": "started on clozapine"}, {"type": "drug", "offset": [24], "text": "clozapine"}, {"type": "effect", "offset": [9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19], "text": "polyserositis ( pericardial effusion , pleural effusion , and pericarditis )"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "started on clozapine"], ["drug", "clozapine"], ["effect", "polyserositis ( pericardial effusion , pleural effusion , and pericarditis )"]]}]}
{"text_id": "15580406_3", "text": "Vogt - Koyanagi - Harada disease occurring during interferon alpha therapy for chronic hepatitis C.", "tokens": ["Vogt", "-", "Koyanagi", "-", "Harada", "disease", "occurring", "during", "interferon", "alpha", "therapy", "for", "chronic", "hepatitis", "C."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurring <extra_id_0> treatment <extra_id_5> interferon alpha <extra_id_1> <extra_id_0> drug <extra_id_5> interferon alpha <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic hepatitis C. <extra_id_1> <extra_id_0> effect <extra_id_5> Vogt - Koyanagi - Harada disease <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "occurring", "args": [{"type": "treatment", "offset": [8, 9], "text": "interferon alpha"}, {"type": "drug", "offset": [8, 9], "text": "interferon alpha"}, {"type": "treatment disorder", "offset": [12, 13, 14], "text": "chronic hepatitis C."}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "Vogt - Koyanagi - Harada disease"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "occurring", "label": "adverse event", "asoc": [["treatment", "interferon alpha"], ["drug", "interferon alpha"], ["treatment disorder", "chronic hepatitis C."], ["effect", "Vogt - Koyanagi - Harada disease"]]}]}
{"text_id": "12324937_3", "text": "Gemcitabine - associated hemolytic - uremic syndrome .", "tokens": ["Gemcitabine", "-", "associated", "hemolytic", "-", "uremic", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> Gemcitabine <extra_id_1> <extra_id_0> effect <extra_id_5> hemolytic - uremic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Gemcitabine"}, {"type": "drug", "offset": [0], "text": "Gemcitabine"}, {"type": "effect", "offset": [3, 4, 5, 6], "text": "hemolytic - uremic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Gemcitabine"], ["drug", "Gemcitabine"], ["effect", "hemolytic - uremic syndrome"]]}]}
{"text_id": "7673653_2", "text": "Extrapyramidal side effects induced by some selective serotonin reuptake inhibitors ( SSRIs ) , i.e. fluoxetine and sertraline , have been previously reported in patients with depression and obsessive - compulsive disorder ( OCD ) .", "tokens": ["Extrapyramidal", "side", "effects", "induced", "by", "some", "selective", "serotonin", "reuptake", "inhibitors", "(", "SSRIs", ")", ",", "i.e.", "fluoxetine", "and", "sertraline", ",", "have", "been", "previously", "reported", "in", "patients", "with", "depression", "and", "obsessive", "-", "compulsive", "disorder", "(", "OCD", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced by <extra_id_0> subject <extra_id_5> patients with depression and obsessive - compulsive disorder ( OCD ) <extra_id_1> <extra_id_0> subject disorder <extra_id_5> depression <extra_id_1> <extra_id_0> subject disorder <extra_id_5> obsessive - compulsive disorder ( OCD ) <extra_id_1> <extra_id_0> treatment <extra_id_5> some selective serotonin reuptake inhibitors ( SSRIs ) , i.e. fluoxetine and sertraline <extra_id_1> <extra_id_0> drug <extra_id_5> fluoxetine <extra_id_1> <extra_id_0> drug <extra_id_5> sertraline <extra_id_1> <extra_id_0> drug <extra_id_5> serotonin reuptake inhibitors <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> depression <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> obsessive - compulsive disorder ( OCD ) <extra_id_1> <extra_id_0> effect <extra_id_5> Extrapyramidal side effects <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3, 4], "text": "induced by", "args": [{"type": "subject", "offset": [24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34], "text": "patients with depression and obsessive - compulsive disorder ( OCD )"}, {"type": "subject disorder", "offset": [26], "text": "depression"}, {"type": "subject disorder", "offset": [28, 29, 30, 31, 32, 33, 34], "text": "obsessive - compulsive disorder ( OCD )"}, {"type": "treatment", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17], "text": "some selective serotonin reuptake inhibitors ( SSRIs ) , i.e. fluoxetine and sertraline"}, {"type": "drug", "offset": [15], "text": "fluoxetine"}, {"type": "drug", "offset": [17], "text": "sertraline"}, {"type": "drug", "offset": [7, 8, 9], "text": "serotonin reuptake inhibitors"}, {"type": "treatment disorder", "offset": [26], "text": "depression"}, {"type": "treatment disorder", "offset": [28, 29, 30, 31, 32, 33, 34], "text": "obsessive - compulsive disorder ( OCD )"}, {"type": "effect", "offset": [0, 1, 2], "text": "Extrapyramidal side effects"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced by", "label": "adverse event", "asoc": [["subject", "patients with depression and obsessive - compulsive disorder ( OCD )"], ["subject disorder", "depression"], ["subject disorder", "obsessive - compulsive disorder ( OCD )"], ["treatment", "some selective serotonin reuptake inhibitors ( SSRIs ) , i.e. fluoxetine and sertraline"], ["drug", "fluoxetine"], ["drug", "sertraline"], ["drug", "serotonin reuptake inhibitors"], ["treatment disorder", "depression"], ["treatment disorder", "obsessive - compulsive disorder ( OCD )"], ["effect", "Extrapyramidal side effects"]]}]}
{"text_id": "7776854_1", "text": "Our cases constitute the most severe cases of benzarone hepatotoxicity reported so far , and comprise the first cases of ( sub)fulminant hepatitis and cirrhosis related to benzarone .", "tokens": ["Our", "cases", "constitute", "the", "most", "severe", "cases", "of", "benzarone", "hepatotoxicity", "reported", "so", "far", ",", "and", "comprise", "the", "first", "cases", "of", "(", "sub)fulminant", "hepatitis", "and", "cirrhosis", "related", "to", "benzarone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> of <extra_id_0> treatment <extra_id_5> benzarone <extra_id_1> <extra_id_0> drug <extra_id_5> benzarone <extra_id_1> <extra_id_0> drug <extra_id_5> benzarone <extra_id_1> <extra_id_0> effect <extra_id_5> hepatotoxicity <extra_id_1> <extra_id_0> effect <extra_id_5> ( sub)fulminant hepatitis and cirrhosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "of", "args": [{"type": "treatment", "offset": [8], "text": "benzarone"}, {"type": "drug", "offset": [8], "text": "benzarone"}, {"type": "drug", "offset": [27], "text": "benzarone"}, {"type": "effect", "offset": [9], "text": "hepatotoxicity"}, {"type": "effect", "offset": [20, 21, 22, 23, 24], "text": "( sub)fulminant hepatitis and cirrhosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "of", "label": "adverse event", "asoc": [["treatment", "benzarone"], ["drug", "benzarone"], ["drug", "benzarone"], ["effect", "hepatotoxicity"], ["effect", "( sub)fulminant hepatitis and cirrhosis"]]}]}
{"text_id": "16986159_1", "text": "We present a depressive patient who developed mild parkinsonian signs and camptocormia after the introduction of olanzapine .", "tokens": ["We", "present", "a", "depressive", "patient", "who", "developed", "mild", "parkinsonian", "signs", "and", "camptocormia", "after", "the", "introduction", "of", "olanzapine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> depressive patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> depressive <extra_id_1> <extra_id_0> treatment <extra_id_5> introduction of olanzapine <extra_id_1> <extra_id_0> drug <extra_id_5> olanzapine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> depressive <extra_id_1> <extra_id_0> effect <extra_id_5> mild parkinsonian signs and camptocormia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "developed", "args": [{"type": "subject", "offset": [3, 4], "text": "depressive patient"}, {"type": "subject disorder", "offset": [3], "text": "depressive"}, {"type": "treatment", "offset": [14, 15, 16], "text": "introduction of olanzapine"}, {"type": "drug", "offset": [16], "text": "olanzapine"}, {"type": "treatment disorder", "offset": [3], "text": "depressive"}, {"type": "effect", "offset": [7, 8, 9, 10, 11], "text": "mild parkinsonian signs and camptocormia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "depressive patient"], ["subject disorder", "depressive"], ["treatment", "introduction of olanzapine"], ["drug", "olanzapine"], ["treatment disorder", "depressive"], ["effect", "mild parkinsonian signs and camptocormia"]]}]}
{"text_id": "18585545_3", "text": "Here , we describe levofloxacin - induced delirium with psychotic features in a relatively young , otherwise healthy female .", "tokens": ["Here", ",", "we", "describe", "levofloxacin", "-", "induced", "delirium", "with", "psychotic", "features", "in", "a", "relatively", "young", ",", "otherwise", "healthy", "female", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> relatively young , otherwise healthy female <extra_id_1> <extra_id_0> treatment <extra_id_5> levofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> levofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> delirium with psychotic features <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "induced", "args": [{"type": "subject", "offset": [13, 14, 15, 16, 17, 18], "text": "relatively young , otherwise healthy female"}, {"type": "treatment", "offset": [4], "text": "levofloxacin"}, {"type": "drug", "offset": [4], "text": "levofloxacin"}, {"type": "effect", "offset": [7, 8, 9, 10], "text": "delirium with psychotic features"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "relatively young , otherwise healthy female"], ["treatment", "levofloxacin"], ["drug", "levofloxacin"], ["effect", "delirium with psychotic features"]]}]}
{"text_id": "9770151_1", "text": "Although praziquantel administration may have been effective in killing the parasite in both patients , we are concerned about the production of marked inflammation as a result of treatment .", "tokens": ["Although", "praziquantel", "administration", "may", "have", "been", "effective", "in", "killing", "the", "parasite", "in", "both", "patients", ",", "we", "are", "concerned", "about", "the", "production", "of", "marked", "inflammation", "as", "a", "result", "of", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> production <extra_id_0> subject <extra_id_5> parasite in both patients <extra_id_1> <extra_id_0> population <extra_id_5> both <extra_id_1> <extra_id_0> subject disorder <extra_id_5> parasite <extra_id_1> <extra_id_0> treatment <extra_id_5> praziquantel <extra_id_1> <extra_id_0> drug <extra_id_5> praziquantel <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> parasite <extra_id_1> <extra_id_0> effect <extra_id_5> marked inflammation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "production", "args": [{"type": "subject", "offset": [10, 11, 12, 13], "text": "parasite in both patients"}, {"type": "population", "offset": [12], "text": "both"}, {"type": "subject disorder", "offset": [10], "text": "parasite"}, {"type": "treatment", "offset": [1], "text": "praziquantel"}, {"type": "drug", "offset": [1], "text": "praziquantel"}, {"type": "treatment disorder", "offset": [10], "text": "parasite"}, {"type": "effect", "offset": [22, 23], "text": "marked inflammation"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "production", "label": "adverse event", "asoc": [["subject", "parasite in both patients"], ["population", "both"], ["subject disorder", "parasite"], ["treatment", "praziquantel"], ["drug", "praziquantel"], ["treatment disorder", "parasite"], ["effect", "marked inflammation"]]}]}
{"text_id": "12460237_4", "text": "We report a patient with recurrent , increasingly severe episodes of PPE , ultimately complicated by a severe bullous eruption , following successive cycles of high - dose cytarabine for the treatment of acute lymphoblastic leukaemia .", "tokens": ["We", "report", "a", "patient", "with", "recurrent", ",", "increasingly", "severe", "episodes", "of", "PPE", ",", "ultimately", "complicated", "by", "a", "severe", "bullous", "eruption", ",", "following", "successive", "cycles", "of", "high", "-", "dose", "cytarabine", "for", "the", "treatment", "of", "acute", "lymphoblastic", "leukaemia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute lymphoblastic leukaemia <extra_id_1> <extra_id_0> treatment <extra_id_5> cycles of high - dose cytarabine for the treatment of acute lymphoblastic leukaemia <extra_id_1> <extra_id_0> drug <extra_id_5> cytarabine <extra_id_1> <extra_id_0> dosage <extra_id_5> high - dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute lymphoblastic leukaemia <extra_id_1> <extra_id_0> effect <extra_id_5> recurrent , increasingly severe episodes of PPE , ultimately complicated by a severe bullous eruption <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [21], "text": "following", "args": [{"type": "subject", "offset": [2, 3], "text": "a patient"}, {"type": "subject disorder", "offset": [33, 34, 35], "text": "acute lymphoblastic leukaemia"}, {"type": "treatment", "offset": [23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35], "text": "cycles of high - dose cytarabine for the treatment of acute lymphoblastic leukaemia"}, {"type": "drug", "offset": [28], "text": "cytarabine"}, {"type": "dosage", "offset": [25, 26, 27], "text": "high - dose"}, {"type": "treatment disorder", "offset": [33, 34, 35], "text": "acute lymphoblastic leukaemia"}, {"type": "effect", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19], "text": "recurrent , increasingly severe episodes of PPE , ultimately complicated by a severe bullous eruption"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "dosage", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["subject", "a patient"], ["subject disorder", "acute lymphoblastic leukaemia"], ["treatment", "cycles of high - dose cytarabine for the treatment of acute lymphoblastic leukaemia"], ["drug", "cytarabine"], ["dosage", "high - dose"], ["treatment disorder", "acute lymphoblastic leukaemia"], ["effect", "recurrent , increasingly severe episodes of PPE , ultimately complicated by a severe bullous eruption"]]}]}
{"text_id": "19151423_3", "text": "The addition of ciprofloxacin to chronic simvastatin therapy led to the development of rhabdomyolysis .", "tokens": ["The", "addition", "of", "ciprofloxacin", "to", "chronic", "simvastatin", "therapy", "led", "to", "the", "development", "of", "rhabdomyolysis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> led <extra_id_0> treatment <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> treatment <extra_id_5> chronic simvastatin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> chronic simvastatin <extra_id_1> <extra_id_0> combination drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> combination drug <extra_id_5> chronic simvastatin <extra_id_1> <extra_id_0> effect <extra_id_5> rhabdomyolysis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "led", "args": [{"type": "treatment", "offset": [3], "text": "ciprofloxacin"}, {"type": "treatment", "offset": [5, 6], "text": "chronic simvastatin"}, {"type": "drug", "offset": [3], "text": "ciprofloxacin"}, {"type": "drug", "offset": [5, 6], "text": "chronic simvastatin"}, {"type": "combination drug", "offset": [3], "text": "ciprofloxacin"}, {"type": "combination drug", "offset": [5, 6], "text": "chronic simvastatin"}, {"type": "effect", "offset": [13], "text": "rhabdomyolysis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "led", "label": "adverse event", "asoc": [["treatment", "ciprofloxacin"], ["treatment", "chronic simvastatin"], ["drug", "ciprofloxacin"], ["drug", "chronic simvastatin"], ["combination drug", "ciprofloxacin"], ["combination drug", "chronic simvastatin"], ["effect", "rhabdomyolysis"]]}]}
{"text_id": "2051906_3", "text": "Reversible cholestasis with bile duct injury following azathioprine therapy .", "tokens": ["Reversible", "cholestasis", "with", "bile", "duct", "injury", "following", "azathioprine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> azathioprine <extra_id_1> <extra_id_0> drug <extra_id_5> azathioprine <extra_id_1> <extra_id_0> effect <extra_id_5> Reversible cholestasis with bile duct injury <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "following", "args": [{"type": "treatment", "offset": [7], "text": "azathioprine"}, {"type": "drug", "offset": [7], "text": "azathioprine"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "Reversible cholestasis with bile duct injury"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "azathioprine"], ["drug", "azathioprine"], ["effect", "Reversible cholestasis with bile duct injury"]]}]}
{"text_id": "11876387_1", "text": "Aggressive endometrial carcinoma in a breast cancer patient treated with tamoxifen with normal transvaginal ultrasonography .", "tokens": ["Aggressive", "endometrial", "carcinoma", "in", "a", "breast", "cancer", "patient", "treated", "with", "tamoxifen", "with", "normal", "transvaginal", "ultrasonography", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated <extra_id_0> subject <extra_id_5> breast cancer patient <extra_id_1> <extra_id_0> subject <extra_id_5> with normal transvaginal ultrasonography <extra_id_1> <extra_id_0> subject disorder <extra_id_5> breast cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> drug <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> breast cancer <extra_id_1> <extra_id_0> effect <extra_id_5> Aggressive endometrial carcinoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "treated", "args": [{"type": "subject", "offset": [5, 6, 7], "text": "breast cancer patient"}, {"type": "subject", "offset": [11, 12, 13, 14], "text": "with normal transvaginal ultrasonography"}, {"type": "subject disorder", "offset": [5, 6], "text": "breast cancer"}, {"type": "treatment", "offset": [10], "text": "tamoxifen"}, {"type": "drug", "offset": [10], "text": "tamoxifen"}, {"type": "treatment disorder", "offset": [5, 6], "text": "breast cancer"}, {"type": "effect", "offset": [0, 1, 2], "text": "Aggressive endometrial carcinoma"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "adverse event", "asoc": [["subject", "breast cancer patient"], ["subject", "with normal transvaginal ultrasonography"], ["subject disorder", "breast cancer"], ["treatment", "tamoxifen"], ["drug", "tamoxifen"], ["treatment disorder", "breast cancer"], ["effect", "Aggressive endometrial carcinoma"]]}]}
{"text_id": "10410183_3", "text": "CASE SUMMARY : A 39 - year - old white Jewish schizophrenic man treated with olanzapine developed an elevated serum CK concentration with a peak concentration of 4000 IU / L ( normal < 230 ) .", "tokens": ["CASE", "SUMMARY", ":", "A", "39", "-", "year", "-", "old", "white", "Jewish", "schizophrenic", "man", "treated", "with", "olanzapine", "developed", "an", "elevated", "serum", "CK", "concentration", "with", "a", "peak", "concentration", "of", "4000", "IU", "/", "L", "(", "normal", "<", "230", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 39 - year - old white Jewish schizophrenic man <extra_id_1> <extra_id_0> age <extra_id_5> 39 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> race <extra_id_5> white Jewish <extra_id_1> <extra_id_0> subject disorder <extra_id_5> schizophrenic <extra_id_1> <extra_id_0> treatment <extra_id_5> olanzapine <extra_id_1> <extra_id_0> drug <extra_id_5> olanzapine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> schizophrenic <extra_id_1> <extra_id_0> effect <extra_id_5> an elevated serum CK concentration <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12], "text": "A 39 - year - old white Jewish schizophrenic man"}, {"type": "age", "offset": [4, 5, 6, 7, 8], "text": "39 - year - old"}, {"type": "gender", "offset": [12], "text": "man"}, {"type": "race", "offset": [9, 10], "text": "white Jewish"}, {"type": "subject disorder", "offset": [11], "text": "schizophrenic"}, {"type": "treatment", "offset": [15], "text": "olanzapine"}, {"type": "drug", "offset": [15], "text": "olanzapine"}, {"type": "treatment disorder", "offset": [11], "text": "schizophrenic"}, {"type": "effect", "offset": [17, 18, 19, 20, 21], "text": "an elevated serum CK concentration"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder", "race"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 39 - year - old white Jewish schizophrenic man"], ["age", "39 - year - old"], ["gender", "man"], ["race", "white Jewish"], ["subject disorder", "schizophrenic"], ["treatment", "olanzapine"], ["drug", "olanzapine"], ["treatment disorder", "schizophrenic"], ["effect", "an elevated serum CK concentration"]]}]}
{"text_id": "20378385_2", "text": "Visceral leishmaniasis and macrophagic activation syndrome in a patient with rheumatoid arthritis under treatment with adalimumab .", "tokens": ["Visceral", "leishmaniasis", "and", "macrophagic", "activation", "syndrome", "in", "a", "patient", "with", "rheumatoid", "arthritis", "under", "treatment", "with", "adalimumab", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> under <extra_id_0> subject <extra_id_5> a patient with rheumatoid arthritis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> adalimumab <extra_id_1> <extra_id_0> drug <extra_id_5> adalimumab <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> effect <extra_id_5> Visceral leishmaniasis and macrophagic activation syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "under", "args": [{"type": "subject", "offset": [7, 8, 9, 10, 11], "text": "a patient with rheumatoid arthritis"}, {"type": "subject disorder", "offset": [10, 11], "text": "rheumatoid arthritis"}, {"type": "treatment", "offset": [15], "text": "adalimumab"}, {"type": "drug", "offset": [15], "text": "adalimumab"}, {"type": "treatment disorder", "offset": [10, 11], "text": "rheumatoid arthritis"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "Visceral leishmaniasis and macrophagic activation syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "under", "label": "adverse event", "asoc": [["subject", "a patient with rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "adalimumab"], ["drug", "adalimumab"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "Visceral leishmaniasis and macrophagic activation syndrome"]]}]}
{"text_id": "15866658_1", "text": "Herein we report four patients who underwent liver transplantation and developed neutropenia while receiving MMF .", "tokens": ["Herein", "we", "report", "four", "patients", "who", "underwent", "liver", "transplantation", "and", "developed", "neutropenia", "while", "receiving", "MMF", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> four patients who underwent liver transplantation <extra_id_1> <extra_id_0> population <extra_id_5> four <extra_id_1> <extra_id_0> subject disorder <extra_id_5> liver transplantation <extra_id_1> <extra_id_0> treatment <extra_id_5> MMF <extra_id_1> <extra_id_0> drug <extra_id_5> MMF <extra_id_1> <extra_id_0> effect <extra_id_5> neutropenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8], "text": "four patients who underwent liver transplantation"}, {"type": "population", "offset": [3], "text": "four"}, {"type": "subject disorder", "offset": [7, 8], "text": "liver transplantation"}, {"type": "treatment", "offset": [14], "text": "MMF"}, {"type": "drug", "offset": [14], "text": "MMF"}, {"type": "effect", "offset": [11], "text": "neutropenia"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "four patients who underwent liver transplantation"], ["population", "four"], ["subject disorder", "liver transplantation"], ["treatment", "MMF"], ["drug", "MMF"], ["effect", "neutropenia"]]}]}
{"text_id": "1621023_2", "text": "In addition , a 31 - year - old man with obsessive - compulsive disorder developed RBD soon after starting fluoxetine therapy , which persisted at PSG study 19 months after fluoxetine discontinuation .", "tokens": ["In", "addition", ",", "a", "31", "-", "year", "-", "old", "man", "with", "obsessive", "-", "compulsive", "disorder", "developed", "RBD", "soon", "after", "starting", "fluoxetine", "therapy", ",", "which", "persisted", "at", "PSG", "study", "19", "months", "after", "fluoxetine", "discontinuation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a 31 - year - old man with obsessive - compulsive disorder <extra_id_1> <extra_id_0> age <extra_id_5> 31 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> obsessive - compulsive disorder <extra_id_1> <extra_id_0> treatment <extra_id_5> starting fluoxetine therapy <extra_id_1> <extra_id_0> drug <extra_id_5> fluoxetine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> obsessive - compulsive disorder <extra_id_1> <extra_id_0> effect <extra_id_5> RBD <extra_id_1> <extra_id_0> effect <extra_id_5> which persisted at PSG study 19 months after fluoxetine discontinuation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "a 31 - year - old man with obsessive - compulsive disorder"}, {"type": "age", "offset": [4, 5, 6, 7, 8], "text": "31 - year - old"}, {"type": "gender", "offset": [9], "text": "man"}, {"type": "subject disorder", "offset": [11, 12, 13, 14], "text": "obsessive - compulsive disorder"}, {"type": "treatment", "offset": [19, 20, 21], "text": "starting fluoxetine therapy"}, {"type": "drug", "offset": [20], "text": "fluoxetine"}, {"type": "treatment disorder", "offset": [11, 12, 13, 14], "text": "obsessive - compulsive disorder"}, {"type": "effect", "offset": [16], "text": "RBD"}, {"type": "effect", "offset": [23, 24, 25, 26, 27, 28, 29, 30, 31, 32], "text": "which persisted at PSG study 19 months after fluoxetine discontinuation"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a 31 - year - old man with obsessive - compulsive disorder"], ["age", "31 - year - old"], ["gender", "man"], ["subject disorder", "obsessive - compulsive disorder"], ["treatment", "starting fluoxetine therapy"], ["drug", "fluoxetine"], ["treatment disorder", "obsessive - compulsive disorder"], ["effect", "RBD"], ["effect", "which persisted at PSG study 19 months after fluoxetine discontinuation"]]}]}
{"text_id": "17034541_3", "text": "This is the first case of HBV reactivation occurring during the year following rituximab monotherapy in the absence of any other immunosuppressive factor .", "tokens": ["This", "is", "the", "first", "case", "of", "HBV", "reactivation", "occurring", "during", "the", "year", "following", "rituximab", "monotherapy", "in", "the", "absence", "of", "any", "other", "immunosuppressive", "factor", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurring <extra_id_0> treatment <extra_id_5> the year following rituximab monotherapy in the absence of any other immunosuppressive factor <extra_id_1> <extra_id_0> drug <extra_id_5> rituximab <extra_id_1> <extra_id_0> time elapsed <extra_id_5> the year following <extra_id_1> <extra_id_0> effect <extra_id_5> HBV reactivation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "occurring", "args": [{"type": "treatment", "offset": [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22], "text": "the year following rituximab monotherapy in the absence of any other immunosuppressive factor"}, {"type": "drug", "offset": [13], "text": "rituximab"}, {"type": "time elapsed", "offset": [10, 11, 12], "text": "the year following"}, {"type": "effect", "offset": [6, 7], "text": "HBV reactivation"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "time elapsed"], "spot_asoc": [{"span": "occurring", "label": "adverse event", "asoc": [["treatment", "the year following rituximab monotherapy in the absence of any other immunosuppressive factor"], ["drug", "rituximab"], ["time elapsed", "the year following"], ["effect", "HBV reactivation"]]}]}
{"text_id": "16765687_2", "text": "Rapid resolution of topiramate - induced angle - closure glaucoma with methylprednisolone and mannitol .", "tokens": ["Rapid", "resolution", "of", "topiramate", "-", "induced", "angle", "-", "closure", "glaucoma", "with", "methylprednisolone", "and", "mannitol", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> resolution <extra_id_0> treatment <extra_id_5> methylprednisolone and mannitol <extra_id_1> <extra_id_0> drug <extra_id_5> methylprednisolone <extra_id_1> <extra_id_0> drug <extra_id_5> mannitol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> topiramate - induced angle - closure glaucoma <extra_id_1> <extra_id_0> combination drug <extra_id_5> methylprednisolone <extra_id_1> <extra_id_0> combination drug <extra_id_5> mannitol <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> topiramate <extra_id_1> <extra_id_0> drug <extra_id_5> topiramate <extra_id_1> <extra_id_0> effect <extra_id_5> angle - closure glaucoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [1], "text": "resolution", "args": [{"type": "treatment", "offset": [11, 12, 13], "text": "methylprednisolone and mannitol"}, {"type": "drug", "offset": [11], "text": "methylprednisolone"}, {"type": "drug", "offset": [13], "text": "mannitol"}, {"type": "treatment disorder", "offset": [3, 4, 5, 6, 7, 8, 9], "text": "topiramate - induced angle - closure glaucoma"}, {"type": "combination drug", "offset": [11], "text": "methylprednisolone"}, {"type": "combination drug", "offset": [13], "text": "mannitol"}]}, {"type": "adverse event", "offset": [5], "text": "induced", "args": [{"type": "treatment", "offset": [3], "text": "topiramate"}, {"type": "drug", "offset": [3], "text": "topiramate"}, {"type": "effect", "offset": [6, 7, 8, 9], "text": "angle - closure glaucoma"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "drug", "treatment", "combination drug", "treatment disorder"], "spot_asoc": [{"span": "resolution", "label": "potential therapeutic event", "asoc": [["treatment", "methylprednisolone and mannitol"], ["drug", "methylprednisolone"], ["drug", "mannitol"], ["treatment disorder", "topiramate - induced angle - closure glaucoma"], ["combination drug", "methylprednisolone"], ["combination drug", "mannitol"]]}, {"span": "induced", "label": "adverse event", "asoc": [["treatment", "topiramate"], ["drug", "topiramate"], ["effect", "angle - closure glaucoma"]]}]}
{"text_id": "20178709_1", "text": "A case of aseptic pleuropericarditis in a patient with chronic plaque psoriasis under methotrexate therapy .", "tokens": ["A", "case", "of", "aseptic", "pleuropericarditis", "in", "a", "patient", "with", "chronic", "plaque", "psoriasis", "under", "methotrexate", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> a patient with chronic plaque psoriasis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> chronic plaque psoriasis <extra_id_1> <extra_id_0> treatment <extra_id_5> methotrexate therapy <extra_id_1> <extra_id_0> drug <extra_id_5> methotrexate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic plaque psoriasis <extra_id_1> <extra_id_0> effect <extra_id_5> aseptic pleuropericarditis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "in", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10, 11], "text": "a patient with chronic plaque psoriasis"}, {"type": "subject disorder", "offset": [9, 10, 11], "text": "chronic plaque psoriasis"}, {"type": "treatment", "offset": [13, 14], "text": "methotrexate therapy"}, {"type": "drug", "offset": [13], "text": "methotrexate"}, {"type": "treatment disorder", "offset": [9, 10, 11], "text": "chronic plaque psoriasis"}, {"type": "effect", "offset": [3, 4], "text": "aseptic pleuropericarditis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "a patient with chronic plaque psoriasis"], ["subject disorder", "chronic plaque psoriasis"], ["treatment", "methotrexate therapy"], ["drug", "methotrexate"], ["treatment disorder", "chronic plaque psoriasis"], ["effect", "aseptic pleuropericarditis"]]}]}
{"text_id": "20118434_3", "text": "METHOD : The authors followed a patient with chronic HCV who received interferon and ribavirin and who developed hallucinations ultimately requiring psychiatric hospitalization .", "tokens": ["METHOD", ":", "The", "authors", "followed", "a", "patient", "with", "chronic", "HCV", "who", "received", "interferon", "and", "ribavirin", "and", "who", "developed", "hallucinations", "ultimately", "requiring", "psychiatric", "hospitalization", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a patient with chronic HCV <extra_id_1> <extra_id_0> subject disorder <extra_id_5> chronic HCV <extra_id_1> <extra_id_0> treatment <extra_id_5> interferon and ribavirin <extra_id_1> <extra_id_0> drug <extra_id_5> interferon <extra_id_1> <extra_id_0> drug <extra_id_5> ribavirin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic HCV <extra_id_1> <extra_id_0> combination drug <extra_id_5> interferon <extra_id_1> <extra_id_0> combination drug <extra_id_5> ribavirin <extra_id_1> <extra_id_0> effect <extra_id_5> hallucinations <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "developed", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9], "text": "a patient with chronic HCV"}, {"type": "subject disorder", "offset": [8, 9], "text": "chronic HCV"}, {"type": "treatment", "offset": [12, 13, 14], "text": "interferon and ribavirin"}, {"type": "drug", "offset": [12], "text": "interferon"}, {"type": "drug", "offset": [14], "text": "ribavirin"}, {"type": "treatment disorder", "offset": [8, 9], "text": "chronic HCV"}, {"type": "combination drug", "offset": [12], "text": "interferon"}, {"type": "combination drug", "offset": [14], "text": "ribavirin"}, {"type": "effect", "offset": [18], "text": "hallucinations"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a patient with chronic HCV"], ["subject disorder", "chronic HCV"], ["treatment", "interferon and ribavirin"], ["drug", "interferon"], ["drug", "ribavirin"], ["treatment disorder", "chronic HCV"], ["combination drug", "interferon"], ["combination drug", "ribavirin"], ["effect", "hallucinations"]]}]}
{"text_id": "7019786_1", "text": "Cefoxitin - associated renal failure .", "tokens": ["Cefoxitin", "-", "associated", "renal", "failure", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Cefoxitin <extra_id_1> <extra_id_0> drug <extra_id_5> Cefoxitin <extra_id_1> <extra_id_0> effect <extra_id_5> renal failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Cefoxitin"}, {"type": "drug", "offset": [0], "text": "Cefoxitin"}, {"type": "effect", "offset": [3, 4], "text": "renal failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Cefoxitin"], ["drug", "Cefoxitin"], ["effect", "renal failure"]]}]}
{"text_id": "9824032_2", "text": "The cause of these previously unreported side effects of niacin therapy is uncertain but may be related to prostaglandin - mediated vasodilatation , hyperalgesia of sensory nerve receptors , and potentiation of inflammation in the gingiva with referral of pain to the teeth .", "tokens": ["The", "cause", "of", "these", "previously", "unreported", "side", "effects", "of", "niacin", "therapy", "is", "uncertain", "but", "may", "be", "related", "to", "prostaglandin", "-", "mediated", "vasodilatation", ",", "hyperalgesia", "of", "sensory", "nerve", "receptors", ",", "and", "potentiation", "of", "inflammation", "in", "the", "gingiva", "with", "referral", "of", "pain", "to", "the", "teeth", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> treatment <extra_id_5> niacin <extra_id_1> <extra_id_0> drug <extra_id_5> niacin <extra_id_1> <extra_id_0> effect <extra_id_5> prostaglandin - mediated vasodilatation , hyperalgesia of sensory nerve receptors , and potentiation of inflammation in the gingiva with referral of pain to the teeth <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "related", "args": [{"type": "treatment", "offset": [9], "text": "niacin"}, {"type": "drug", "offset": [9], "text": "niacin"}, {"type": "effect", "offset": [18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42], "text": "prostaglandin - mediated vasodilatation , hyperalgesia of sensory nerve receptors , and potentiation of inflammation in the gingiva with referral of pain to the teeth"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["treatment", "niacin"], ["drug", "niacin"], ["effect", "prostaglandin - mediated vasodilatation , hyperalgesia of sensory nerve receptors , and potentiation of inflammation in the gingiva with referral of pain to the teeth"]]}]}
{"text_id": "12773807_1", "text": "Disseminated cellulitic cryptococcosis in the setting of prednisone monotherapy for pemphigus vulgaris .", "tokens": ["Disseminated", "cellulitic", "cryptococcosis", "in", "the", "setting", "of", "prednisone", "monotherapy", "for", "pemphigus", "vulgaris", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in the setting of <extra_id_0> treatment <extra_id_5> prednisone monotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> prednisone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> pemphigus vulgaris <extra_id_1> <extra_id_0> effect <extra_id_5> Disseminated cellulitic cryptococcosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3, 4, 5, 6], "text": "in the setting of", "args": [{"type": "treatment", "offset": [7, 8], "text": "prednisone monotherapy"}, {"type": "drug", "offset": [7], "text": "prednisone"}, {"type": "treatment disorder", "offset": [10, 11], "text": "pemphigus vulgaris"}, {"type": "effect", "offset": [0, 1, 2], "text": "Disseminated cellulitic cryptococcosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "in the setting of", "label": "adverse event", "asoc": [["treatment", "prednisone monotherapy"], ["drug", "prednisone"], ["treatment disorder", "pemphigus vulgaris"], ["effect", "Disseminated cellulitic cryptococcosis"]]}]}
{"text_id": "10458196_5", "text": "PURPOSE : To report two cases in which topical brimonidine resulted in apparent central nervous system depression and unresponsiveness in an infant .", "tokens": ["PURPOSE", ":", "To", "report", "two", "cases", "in", "which", "topical", "brimonidine", "resulted", "in", "apparent", "central", "nervous", "system", "depression", "and", "unresponsiveness", "in", "an", "infant", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resulted <extra_id_0> subject <extra_id_5> an infant <extra_id_1> <extra_id_0> age <extra_id_5> infant <extra_id_1> <extra_id_0> treatment <extra_id_5> topical brimonidine <extra_id_1> <extra_id_0> drug <extra_id_5> brimonidine <extra_id_1> <extra_id_0> route <extra_id_5> topical <extra_id_1> <extra_id_0> effect <extra_id_5> apparent central nervous system depression and unresponsiveness <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "resulted", "args": [{"type": "subject", "offset": [20, 21], "text": "an infant"}, {"type": "age", "offset": [21], "text": "infant"}, {"type": "treatment", "offset": [8, 9], "text": "topical brimonidine"}, {"type": "drug", "offset": [9], "text": "brimonidine"}, {"type": "route", "offset": [8], "text": "topical"}, {"type": "effect", "offset": [12, 13, 14, 15, 16, 17, 18], "text": "apparent central nervous system depression and unresponsiveness"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "resulted", "label": "adverse event", "asoc": [["subject", "an infant"], ["age", "infant"], ["treatment", "topical brimonidine"], ["drug", "brimonidine"], ["route", "topical"], ["effect", "apparent central nervous system depression and unresponsiveness"]]}]}
{"text_id": "15266150_1", "text": "A patient with monocular open - angle glaucoma had trichiasis , a condition associated with the use of a prostaglandin analog .", "tokens": ["A", "patient", "with", "monocular", "open", "-", "angle", "glaucoma", "had", "trichiasis", ",", "a", "condition", "associated", "with", "the", "use", "of", "a", "prostaglandin", "analog", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> had <extra_id_0> subject <extra_id_5> A patient with monocular open - angle glaucoma <extra_id_1> <extra_id_0> subject disorder <extra_id_5> monocular open - angle glaucoma <extra_id_1> <extra_id_0> treatment <extra_id_5> a prostaglandin analog <extra_id_1> <extra_id_0> drug <extra_id_5> prostaglandin analog <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> monocular open - angle glaucoma <extra_id_1> <extra_id_0> effect <extra_id_5> trichiasis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "had", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "A patient with monocular open - angle glaucoma"}, {"type": "subject disorder", "offset": [3, 4, 5, 6, 7], "text": "monocular open - angle glaucoma"}, {"type": "treatment", "offset": [18, 19, 20], "text": "a prostaglandin analog"}, {"type": "drug", "offset": [19, 20], "text": "prostaglandin analog"}, {"type": "treatment disorder", "offset": [3, 4, 5, 6, 7], "text": "monocular open - angle glaucoma"}, {"type": "effect", "offset": [9], "text": "trichiasis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "had", "label": "adverse event", "asoc": [["subject", "A patient with monocular open - angle glaucoma"], ["subject disorder", "monocular open - angle glaucoma"], ["treatment", "a prostaglandin analog"], ["drug", "prostaglandin analog"], ["treatment disorder", "monocular open - angle glaucoma"], ["effect", "trichiasis"]]}]}
{"text_id": "20203465_2", "text": "The hospital course of the acute renal failure is presented with a review of the literature on cases of acute renal failure after IVIG .", "tokens": ["The", "hospital", "course", "of", "the", "acute", "renal", "failure", "is", "presented", "with", "a", "review", "of", "the", "literature", "on", "cases", "of", "acute", "renal", "failure", "after", "IVIG", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> IVIG <extra_id_1> <extra_id_0> drug <extra_id_5> IVIG <extra_id_1> <extra_id_0> effect <extra_id_5> acute renal failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [22], "text": "after", "args": [{"type": "treatment", "offset": [23], "text": "IVIG"}, {"type": "drug", "offset": [23], "text": "IVIG"}, {"type": "effect", "offset": [19, 20, 21], "text": "acute renal failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "IVIG"], ["drug", "IVIG"], ["effect", "acute renal failure"]]}]}
{"text_id": "15752306_6", "text": "These cases highlight the occurrence of livedo reticularis as an uncommon side - effect of interferon alpha treatment .", "tokens": ["These", "cases", "highlight", "the", "occurrence", "of", "livedo", "reticularis", "as", "an", "uncommon", "side", "-", "effect", "of", "interferon", "alpha", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> side - effect <extra_id_0> subject <extra_id_5> These cases <extra_id_1> <extra_id_0> treatment <extra_id_5> interferon alpha <extra_id_1> <extra_id_0> drug <extra_id_5> interferon alpha <extra_id_1> <extra_id_0> effect <extra_id_5> livedo reticularis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11, 12, 13], "text": "side - effect", "args": [{"type": "subject", "offset": [0, 1], "text": "These cases"}, {"type": "treatment", "offset": [15, 16], "text": "interferon alpha"}, {"type": "drug", "offset": [15, 16], "text": "interferon alpha"}, {"type": "effect", "offset": [6, 7], "text": "livedo reticularis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "side - effect", "label": "adverse event", "asoc": [["subject", "These cases"], ["treatment", "interferon alpha"], ["drug", "interferon alpha"], ["effect", "livedo reticularis"]]}]}
{"text_id": "2595431_1", "text": "Metoclopramide - induced parkinsonism is not rare , and appropriate dose reduction in patients with renal failure will help reduce the incidence of this morbidity .", "tokens": ["Metoclopramide", "-", "induced", "parkinsonism", "is", "not", "rare", ",", "and", "appropriate", "dose", "reduction", "in", "patients", "with", "renal", "failure", "will", "help", "reduce", "the", "incidence", "of", "this", "morbidity", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> patients with renal failure <extra_id_1> <extra_id_0> subject disorder <extra_id_5> renal failure <extra_id_1> <extra_id_0> treatment <extra_id_5> Metoclopramide <extra_id_1> <extra_id_0> drug <extra_id_5> Metoclopramide <extra_id_1> <extra_id_0> effect <extra_id_5> parkinsonism <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "subject", "offset": [13, 14, 15, 16], "text": "patients with renal failure"}, {"type": "subject disorder", "offset": [15, 16], "text": "renal failure"}, {"type": "treatment", "offset": [0], "text": "Metoclopramide"}, {"type": "drug", "offset": [0], "text": "Metoclopramide"}, {"type": "effect", "offset": [3], "text": "parkinsonism"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "patients with renal failure"], ["subject disorder", "renal failure"], ["treatment", "Metoclopramide"], ["drug", "Metoclopramide"], ["effect", "parkinsonism"]]}]}
{"text_id": "3982906_3", "text": "The risk of cardiac decompensation in infants with supraventricular tachycardia and congestive cardiac failure should be kept in mind prior to administration of verapamil .", "tokens": ["The", "risk", "of", "cardiac", "decompensation", "in", "infants", "with", "supraventricular", "tachycardia", "and", "congestive", "cardiac", "failure", "should", "be", "kept", "in", "mind", "prior", "to", "administration", "of", "verapamil", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> risk <extra_id_0> subject <extra_id_5> infants with supraventricular tachycardia and congestive cardiac failure <extra_id_1> <extra_id_0> age <extra_id_5> infants <extra_id_1> <extra_id_0> subject disorder <extra_id_5> congestive cardiac failure <extra_id_1> <extra_id_0> subject disorder <extra_id_5> supraventricular tachycardia <extra_id_1> <extra_id_0> treatment <extra_id_5> verapamil <extra_id_1> <extra_id_0> drug <extra_id_5> verapamil <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> supraventricular tachycardia <extra_id_1> <extra_id_0> effect <extra_id_5> cardiac decompensation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "risk", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10, 11, 12, 13], "text": "infants with supraventricular tachycardia and congestive cardiac failure"}, {"type": "age", "offset": [6], "text": "infants"}, {"type": "subject disorder", "offset": [11, 12, 13], "text": "congestive cardiac failure"}, {"type": "subject disorder", "offset": [8, 9], "text": "supraventricular tachycardia"}, {"type": "treatment", "offset": [23], "text": "verapamil"}, {"type": "drug", "offset": [23], "text": "verapamil"}, {"type": "treatment disorder", "offset": [8, 9], "text": "supraventricular tachycardia"}, {"type": "effect", "offset": [3, 4], "text": "cardiac decompensation"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "risk", "label": "adverse event", "asoc": [["subject", "infants with supraventricular tachycardia and congestive cardiac failure"], ["age", "infants"], ["subject disorder", "congestive cardiac failure"], ["subject disorder", "supraventricular tachycardia"], ["treatment", "verapamil"], ["drug", "verapamil"], ["treatment disorder", "supraventricular tachycardia"], ["effect", "cardiac decompensation"]]}]}
{"text_id": "19226083_1", "text": "Serotonin toxicity as a consequence of linezolid use in revision hip arthroplasty .", "tokens": ["Serotonin", "toxicity", "as", "a", "consequence", "of", "linezolid", "use", "in", "revision", "hip", "arthroplasty", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> consequence <extra_id_0> treatment <extra_id_5> linezolid use in revision hip arthroplasty <extra_id_1> <extra_id_0> treatment <extra_id_5> Serotonin <extra_id_1> <extra_id_0> drug <extra_id_5> Serotonin <extra_id_1> <extra_id_0> drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> effect <extra_id_5> Serotonin toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "consequence", "args": [{"type": "treatment", "offset": [6, 7, 8, 9, 10, 11], "text": "linezolid use in revision hip arthroplasty"}, {"type": "treatment", "offset": [0], "text": "Serotonin"}, {"type": "drug", "offset": [0], "text": "Serotonin"}, {"type": "drug", "offset": [6], "text": "linezolid"}, {"type": "effect", "offset": [0, 1], "text": "Serotonin toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "consequence", "label": "adverse event", "asoc": [["treatment", "linezolid use in revision hip arthroplasty"], ["treatment", "Serotonin"], ["drug", "Serotonin"], ["drug", "linezolid"], ["effect", "Serotonin toxicity"]]}]}
{"text_id": "6933231_1", "text": "Intracranial hemorrhage and focal seizures secondary to use of L - asparaginase during induction therapy of acute lymphocytic leukemia .", "tokens": ["Intracranial", "hemorrhage", "and", "focal", "seizures", "secondary", "to", "use", "of", "L", "-", "asparaginase", "during", "induction", "therapy", "of", "acute", "lymphocytic", "leukemia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> secondary to <extra_id_0> treatment <extra_id_5> L - asparaginase <extra_id_1> <extra_id_0> drug <extra_id_5> L - asparaginase <extra_id_1> <extra_id_0> effect <extra_id_5> Intracranial hemorrhage and focal seizures <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5, 6], "text": "secondary to", "args": [{"type": "treatment", "offset": [9, 10, 11], "text": "L - asparaginase"}, {"type": "drug", "offset": [9, 10, 11], "text": "L - asparaginase"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Intracranial hemorrhage and focal seizures"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "secondary to", "label": "adverse event", "asoc": [["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["effect", "Intracranial hemorrhage and focal seizures"]]}]}
{"text_id": "20203465_1", "text": "Case report : acute renal failure after administering intravenous immunoglobulin .", "tokens": ["Case", "report", ":", "acute", "renal", "failure", "after", "administering", "intravenous", "immunoglobulin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> administering intravenous immunoglobulin <extra_id_1> <extra_id_0> drug <extra_id_5> immunoglobulin <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> effect <extra_id_5> acute renal failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "after", "args": [{"type": "treatment", "offset": [7, 8, 9], "text": "administering intravenous immunoglobulin"}, {"type": "drug", "offset": [9], "text": "immunoglobulin"}, {"type": "route", "offset": [8], "text": "intravenous"}, {"type": "effect", "offset": [3, 4, 5], "text": "acute renal failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "administering intravenous immunoglobulin"], ["drug", "immunoglobulin"], ["route", "intravenous"], ["effect", "acute renal failure"]]}]}
{"text_id": "16116136_4", "text": "Primary CNS lymphoma regressed on withdrawal of MM .", "tokens": ["Primary", "CNS", "lymphoma", "regressed", "on", "withdrawal", "of", "MM", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> regressed <extra_id_0> treatment <extra_id_5> withdrawal of MM <extra_id_1> <extra_id_0> drug <extra_id_5> MM <extra_id_1> <extra_id_0> effect <extra_id_5> Primary CNS lymphoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [3], "text": "regressed", "args": [{"type": "treatment", "offset": [5, 6, 7], "text": "withdrawal of MM"}, {"type": "drug", "offset": [7], "text": "MM"}, {"type": "effect", "offset": [0, 1, 2], "text": "Primary CNS lymphoma"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "regressed", "label": "potential therapeutic event", "asoc": [["treatment", "withdrawal of MM"], ["drug", "MM"], ["effect", "Primary CNS lymphoma"]]}]}
{"text_id": "19423610_9", "text": "Methylene blue is used in a variety of surgical settings as well as for treatment of various types of hypotensive shock and methemoglobinaemia .", "tokens": ["Methylene", "blue", "is", "used", "in", "a", "variety", "of", "surgical", "settings", "as", "well", "as", "for", "treatment", "of", "various", "types", "of", "hypotensive", "shock", "and", "methemoglobinaemia", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> Methylene blue <extra_id_1> <extra_id_0> drug <extra_id_5> Methylene blue <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hypotensive shock <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> methemoglobinaemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [14], "text": "treatment", "args": [{"type": "treatment", "offset": [0, 1], "text": "Methylene blue"}, {"type": "drug", "offset": [0, 1], "text": "Methylene blue"}, {"type": "treatment disorder", "offset": [19, 20], "text": "hypotensive shock"}, {"type": "treatment disorder", "offset": [22], "text": "methemoglobinaemia"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "Methylene blue"], ["drug", "Methylene blue"], ["treatment disorder", "hypotensive shock"], ["treatment disorder", "methemoglobinaemia"]]}]}
{"text_id": "2327115_1", "text": "Ciprofloxacin is one drug that has been reported to cause interstitial nephritis .", "tokens": ["Ciprofloxacin", "is", "one", "drug", "that", "has", "been", "reported", "to", "cause", "interstitial", "nephritis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> Ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> Ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> interstitial nephritis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "cause", "args": [{"type": "treatment", "offset": [0], "text": "Ciprofloxacin"}, {"type": "drug", "offset": [0], "text": "Ciprofloxacin"}, {"type": "effect", "offset": [10, 11], "text": "interstitial nephritis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "Ciprofloxacin"], ["drug", "Ciprofloxacin"], ["effect", "interstitial nephritis"]]}]}
{"text_id": "24791374_4", "text": "Subsequent to the first dose of mirtazapine the patient experienced seizures , bradycardia and prolonged QRS as well as QTc intervals on EKG .", "tokens": ["Subsequent", "to", "the", "first", "dose", "of", "mirtazapine", "the", "patient", "experienced", "seizures", ",", "bradycardia", "and", "prolonged", "QRS", "as", "well", "as", "QTc", "intervals", "on", "EKG", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> Subsequent <extra_id_0> subject <extra_id_5> the patient <extra_id_1> <extra_id_0> treatment <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> drug <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> effect <extra_id_5> seizures , bradycardia and prolonged QRS as well as QTc intervals on EKG <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [0], "text": "Subsequent", "args": [{"type": "subject", "offset": [7, 8], "text": "the patient"}, {"type": "treatment", "offset": [6], "text": "mirtazapine"}, {"type": "drug", "offset": [6], "text": "mirtazapine"}, {"type": "effect", "offset": [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22], "text": "seizures , bradycardia and prolonged QRS as well as QTc intervals on EKG"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "Subsequent", "label": "adverse event", "asoc": [["subject", "the patient"], ["treatment", "mirtazapine"], ["drug", "mirtazapine"], ["effect", "seizures , bradycardia and prolonged QRS as well as QTc intervals on EKG"]]}]}
{"text_id": "6519218_1", "text": "In a 61 - year - old man receiving chronic low - dosage amiodarone an interstitial pneumopathy was observed .", "tokens": ["In", "a", "61", "-", "year", "-", "old", "man", "receiving", "chronic", "low", "-", "dosage", "amiodarone", "an", "interstitial", "pneumopathy", "was", "observed", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> observed <extra_id_0> subject <extra_id_5> a 61 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 61 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> chronic low - dosage amiodarone <extra_id_1> <extra_id_0> drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> dosage <extra_id_5> low - dosage <extra_id_1> <extra_id_0> effect <extra_id_5> interstitial pneumopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "observed", "args": [{"type": "subject", "offset": [1, 2, 3, 4, 5, 6, 7], "text": "a 61 - year - old man"}, {"type": "age", "offset": [2, 3, 4, 5, 6], "text": "61 - year - old"}, {"type": "gender", "offset": [7], "text": "man"}, {"type": "treatment", "offset": [9, 10, 11, 12, 13], "text": "chronic low - dosage amiodarone"}, {"type": "drug", "offset": [13], "text": "amiodarone"}, {"type": "dosage", "offset": [10, 11, 12], "text": "low - dosage"}, {"type": "effect", "offset": [15, 16], "text": "interstitial pneumopathy"}]}], "spot": ["adverse event"], "asoc": ["dosage", "effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "observed", "label": "adverse event", "asoc": [["subject", "a 61 - year - old man"], ["age", "61 - year - old"], ["gender", "man"], ["treatment", "chronic low - dosage amiodarone"], ["drug", "amiodarone"], ["dosage", "low - dosage"], ["effect", "interstitial pneumopathy"]]}]}
{"text_id": "2299784_2", "text": "Bromide intoxication secondary to pyridostigmine bromide therapy .", "tokens": ["Bromide", "intoxication", "secondary", "to", "pyridostigmine", "bromide", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> secondary <extra_id_0> treatment <extra_id_5> pyridostigmine bromide <extra_id_1> <extra_id_0> drug <extra_id_5> pyridostigmine bromide <extra_id_1> <extra_id_0> effect <extra_id_5> Bromide intoxication <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "secondary", "args": [{"type": "treatment", "offset": [4, 5], "text": "pyridostigmine bromide"}, {"type": "drug", "offset": [4, 5], "text": "pyridostigmine bromide"}, {"type": "effect", "offset": [0, 1], "text": "Bromide intoxication"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "secondary", "label": "adverse event", "asoc": [["treatment", "pyridostigmine bromide"], ["drug", "pyridostigmine bromide"], ["effect", "Bromide intoxication"]]}]}
{"text_id": "15482394_1", "text": "An objective causality assessment indicated a probable relationship between clotting abnormality and warfarin administration , although the degree of elevation of the INR was unusual in the light of the daily warfarin dose and duration of its exposure .", "tokens": ["An", "objective", "causality", "assessment", "indicated", "a", "probable", "relationship", "between", "clotting", "abnormality", "and", "warfarin", "administration", ",", "although", "the", "degree", "of", "elevation", "of", "the", "INR", "was", "unusual", "in", "the", "light", "of", "the", "daily", "warfarin", "dose", "and", "duration", "of", "its", "exposure", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> relationship <extra_id_0> treatment <extra_id_5> warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> clotting abnormality <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "relationship", "args": [{"type": "treatment", "offset": [12], "text": "warfarin"}, {"type": "drug", "offset": [12], "text": "warfarin"}, {"type": "effect", "offset": [9, 10], "text": "clotting abnormality"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "relationship", "label": "adverse event", "asoc": [["treatment", "warfarin"], ["drug", "warfarin"], ["effect", "clotting abnormality"]]}]}
{"text_id": "1621023_3", "text": "Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive - compulsive disorder .", "tokens": ["Prominent", "eye", "movements", "during", "NREM", "sleep", "and", "REM", "sleep", "behavior", "disorder", "associated", "with", "fluoxetine", "treatment", "of", "depression", "and", "obsessive", "-", "compulsive", "disorder", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> depression and obsessive - compulsive disorder <extra_id_1> <extra_id_0> subject disorder <extra_id_5> depression <extra_id_1> <extra_id_0> subject disorder <extra_id_5> obsessive - compulsive disorder <extra_id_1> <extra_id_0> treatment <extra_id_5> fluoxetine treatment <extra_id_1> <extra_id_0> drug <extra_id_5> fluoxetine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> depression <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> obsessive - compulsive disorder <extra_id_1> <extra_id_0> effect <extra_id_5> Prominent eye movements during NREM sleep and REM sleep behavior disorder <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "associated", "args": [{"type": "subject", "offset": [16, 17, 18, 19, 20, 21], "text": "depression and obsessive - compulsive disorder"}, {"type": "subject disorder", "offset": [16], "text": "depression"}, {"type": "subject disorder", "offset": [18, 19, 20, 21], "text": "obsessive - compulsive disorder"}, {"type": "treatment", "offset": [13, 14], "text": "fluoxetine treatment"}, {"type": "drug", "offset": [13], "text": "fluoxetine"}, {"type": "treatment disorder", "offset": [16], "text": "depression"}, {"type": "treatment disorder", "offset": [18, 19, 20, 21], "text": "obsessive - compulsive disorder"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10], "text": "Prominent eye movements during NREM sleep and REM sleep behavior disorder"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "depression and obsessive - compulsive disorder"], ["subject disorder", "depression"], ["subject disorder", "obsessive - compulsive disorder"], ["treatment", "fluoxetine treatment"], ["drug", "fluoxetine"], ["treatment disorder", "depression"], ["treatment disorder", "obsessive - compulsive disorder"], ["effect", "Prominent eye movements during NREM sleep and REM sleep behavior disorder"]]}]}
{"text_id": "17228132_1", "text": "Acute drug induced hepatitis due to erlotinib .", "tokens": ["Acute", "drug", "induced", "hepatitis", "due", "to", "erlotinib", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> treatment <extra_id_5> erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> effect <extra_id_5> Acute drug induced hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "due", "args": [{"type": "treatment", "offset": [6], "text": "erlotinib"}, {"type": "drug", "offset": [6], "text": "erlotinib"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Acute drug induced hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["treatment", "erlotinib"], ["drug", "erlotinib"], ["effect", "Acute drug induced hepatitis"]]}]}
{"text_id": "17420198_5", "text": "He developed episodic movements possibly consistent with EPS secondary to aripiprazole usage .", "tokens": ["He", "developed", "episodic", "movements", "possibly", "consistent", "with", "EPS", "secondary", "to", "aripiprazole", "usage", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> treatment <extra_id_5> secondary to aripiprazole usage <extra_id_1> <extra_id_0> drug <extra_id_5> aripiprazole <extra_id_1> <extra_id_0> effect <extra_id_5> episodic movements possibly consistent with EPS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "developed", "args": [{"type": "treatment", "offset": [8, 9, 10, 11], "text": "secondary to aripiprazole usage"}, {"type": "drug", "offset": [10], "text": "aripiprazole"}, {"type": "effect", "offset": [2, 3, 4, 5, 6, 7], "text": "episodic movements possibly consistent with EPS"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["treatment", "secondary to aripiprazole usage"], ["drug", "aripiprazole"], ["effect", "episodic movements possibly consistent with EPS"]]}]}
{"text_id": "12221670_4", "text": "Ticlopidine - induced aplastic anemia : two new case reports , review , and meta - analysis of 55 additional cases .", "tokens": ["Ticlopidine", "-", "induced", "aplastic", "anemia", ":", "two", "new", "case", "reports", ",", "review", ",", "and", "meta", "-", "analysis", "of", "55", "additional", "cases", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Ticlopidine <extra_id_1> <extra_id_0> drug <extra_id_5> Ticlopidine <extra_id_1> <extra_id_0> effect <extra_id_5> aplastic anemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Ticlopidine"}, {"type": "drug", "offset": [0], "text": "Ticlopidine"}, {"type": "effect", "offset": [3, 4], "text": "aplastic anemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Ticlopidine"], ["drug", "Ticlopidine"], ["effect", "aplastic anemia"]]}]}
{"text_id": "8313300_2", "text": "The case of a bipolar patient who developed thyrotoxicosis with severe exophthalmos while on lithium therapy is described .", "tokens": ["The", "case", "of", "a", "bipolar", "patient", "who", "developed", "thyrotoxicosis", "with", "severe", "exophthalmos", "while", "on", "lithium", "therapy", "is", "described", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> on <extra_id_0> subject <extra_id_5> The case of a bipolar patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> bipolar <extra_id_1> <extra_id_0> treatment <extra_id_5> lithium <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> bipolar <extra_id_1> <extra_id_0> effect <extra_id_5> thyrotoxicosis with severe exophthalmos <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "on", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5], "text": "The case of a bipolar patient"}, {"type": "subject disorder", "offset": [4], "text": "bipolar"}, {"type": "treatment", "offset": [14], "text": "lithium"}, {"type": "drug", "offset": [14], "text": "lithium"}, {"type": "treatment disorder", "offset": [4], "text": "bipolar"}, {"type": "effect", "offset": [8, 9, 10, 11], "text": "thyrotoxicosis with severe exophthalmos"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "on", "label": "adverse event", "asoc": [["subject", "The case of a bipolar patient"], ["subject disorder", "bipolar"], ["treatment", "lithium"], ["drug", "lithium"], ["treatment disorder", "bipolar"], ["effect", "thyrotoxicosis with severe exophthalmos"]]}]}
{"text_id": "1477441_2", "text": "CONCLUSIONS : Fixed drug rash induced by methylphenidate is a possible but rare phenomenon .", "tokens": ["CONCLUSIONS", ":", "Fixed", "drug", "rash", "induced", "by", "methylphenidate", "is", "a", "possible", "but", "rare", "phenomenon", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> methylphenidate <extra_id_1> <extra_id_0> drug <extra_id_5> methylphenidate <extra_id_1> <extra_id_0> effect <extra_id_5> Fixed drug rash <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "induced", "args": [{"type": "treatment", "offset": [7], "text": "methylphenidate"}, {"type": "drug", "offset": [7], "text": "methylphenidate"}, {"type": "effect", "offset": [2, 3, 4], "text": "Fixed drug rash"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "methylphenidate"], ["drug", "methylphenidate"], ["effect", "Fixed drug rash"]]}]}
{"text_id": "17876386_1", "text": "It has been reported that fluoroquinolone antimicrobials prolong the corrected QT interval but rarely cause torsade de pointes .", "tokens": ["It", "has", "been", "reported", "that", "fluoroquinolone", "antimicrobials", "prolong", "the", "corrected", "QT", "interval", "but", "rarely", "cause", "torsade", "de", "pointes", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> prolong <extra_id_0> treatment <extra_id_5> fluoroquinolone antimicrobials <extra_id_1> <extra_id_0> drug <extra_id_5> fluoroquinolone <extra_id_1> <extra_id_0> effect <extra_id_5> corrected QT interval but rarely cause torsade de pointes <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "prolong", "args": [{"type": "treatment", "offset": [5, 6], "text": "fluoroquinolone antimicrobials"}, {"type": "drug", "offset": [5], "text": "fluoroquinolone"}, {"type": "effect", "offset": [9, 10, 11, 12, 13, 14, 15, 16, 17], "text": "corrected QT interval but rarely cause torsade de pointes"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "prolong", "label": "adverse event", "asoc": [["treatment", "fluoroquinolone antimicrobials"], ["drug", "fluoroquinolone"], ["effect", "corrected QT interval but rarely cause torsade de pointes"]]}]}
{"text_id": "12095907_2", "text": "Valproate - induced hyperammonemia as a cause of altered mental status .", "tokens": ["Valproate", "-", "induced", "hyperammonemia", "as", "a", "cause", "of", "altered", "mental", "status", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Valproate <extra_id_1> <extra_id_0> drug <extra_id_5> Valproate <extra_id_1> <extra_id_0> effect <extra_id_5> altered mental status <extra_id_1> <extra_id_0> effect <extra_id_5> hyperammonemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Valproate"}, {"type": "drug", "offset": [0], "text": "Valproate"}, {"type": "effect", "offset": [8, 9, 10], "text": "altered mental status"}, {"type": "effect", "offset": [3], "text": "hyperammonemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Valproate"], ["drug", "Valproate"], ["effect", "altered mental status"], ["effect", "hyperammonemia"]]}]}
{"text_id": "12114387_2", "text": "Severe erythroderma as a complication of continuous epoprostenol therapy .", "tokens": ["Severe", "erythroderma", "as", "a", "complication", "of", "continuous", "epoprostenol", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> continuous epoprostenol <extra_id_1> <extra_id_0> drug <extra_id_5> epoprostenol <extra_id_1> <extra_id_0> frequency <extra_id_5> continuous <extra_id_1> <extra_id_0> effect <extra_id_5> Severe erythroderma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "complication", "args": [{"type": "treatment", "offset": [6, 7], "text": "continuous epoprostenol"}, {"type": "drug", "offset": [7], "text": "epoprostenol"}, {"type": "frequency", "offset": [6], "text": "continuous"}, {"type": "effect", "offset": [0, 1], "text": "Severe erythroderma"}]}], "spot": ["adverse event"], "asoc": ["effect", "frequency", "treatment", "drug"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "continuous epoprostenol"], ["drug", "epoprostenol"], ["frequency", "continuous"], ["effect", "Severe erythroderma"]]}]}
{"text_id": "1775411_1", "text": "A patient is described who developed a rapid onset of pulmonary fibrosis following treatment with a new non - steroidal anti - inflammatory drug , nabumetone .", "tokens": ["A", "patient", "is", "described", "who", "developed", "a", "rapid", "onset", "of", "pulmonary", "fibrosis", "following", "treatment", "with", "a", "new", "non", "-", "steroidal", "anti", "-", "inflammatory", "drug", ",", "nabumetone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A patient <extra_id_1> <extra_id_0> treatment <extra_id_5> nabumetone <extra_id_1> <extra_id_0> drug <extra_id_5> nabumetone <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary fibrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "developed", "args": [{"type": "subject", "offset": [0, 1], "text": "A patient"}, {"type": "treatment", "offset": [25], "text": "nabumetone"}, {"type": "drug", "offset": [25], "text": "nabumetone"}, {"type": "effect", "offset": [10, 11], "text": "pulmonary fibrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A patient"], ["treatment", "nabumetone"], ["drug", "nabumetone"], ["effect", "pulmonary fibrosis"]]}]}
{"text_id": "10410183_10", "text": "CONCLUSIONS : Marked elevation of serum CK may be a possible complication of olanzapine therapy .", "tokens": ["CONCLUSIONS", ":", "Marked", "elevation", "of", "serum", "CK", "may", "be", "a", "possible", "complication", "of", "olanzapine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> olanzapine therapy <extra_id_1> <extra_id_0> drug <extra_id_5> olanzapine <extra_id_1> <extra_id_0> effect <extra_id_5> Marked elevation of serum CK <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "complication", "args": [{"type": "treatment", "offset": [13, 14], "text": "olanzapine therapy"}, {"type": "drug", "offset": [13], "text": "olanzapine"}, {"type": "effect", "offset": [2, 3, 4, 5, 6], "text": "Marked elevation of serum CK"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "olanzapine therapy"], ["drug", "olanzapine"], ["effect", "Marked elevation of serum CK"]]}]}
{"text_id": "18504683_3", "text": "We report 3 cases of children with acute lymphoblastic leukemia who developed seizures and altered sensorium after L - asparaginase therapy .", "tokens": ["We", "report", "3", "cases", "of", "children", "with", "acute", "lymphoblastic", "leukemia", "who", "developed", "seizures", "and", "altered", "sensorium", "after", "L", "-", "asparaginase", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> 3 cases of children with acute lymphoblastic leukemia <extra_id_1> <extra_id_0> age <extra_id_5> children <extra_id_1> <extra_id_0> population <extra_id_5> 3 <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute lymphoblastic leukemia <extra_id_1> <extra_id_0> treatment <extra_id_5> L - asparaginase <extra_id_1> <extra_id_0> drug <extra_id_5> L - asparaginase <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute lymphoblastic leukemia <extra_id_1> <extra_id_0> effect <extra_id_5> seizures and altered sensorium <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "after", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7, 8, 9], "text": "3 cases of children with acute lymphoblastic leukemia"}, {"type": "age", "offset": [5], "text": "children"}, {"type": "population", "offset": [2], "text": "3"}, {"type": "subject disorder", "offset": [7, 8, 9], "text": "acute lymphoblastic leukemia"}, {"type": "treatment", "offset": [17, 18, 19], "text": "L - asparaginase"}, {"type": "drug", "offset": [17, 18, 19], "text": "L - asparaginase"}, {"type": "treatment disorder", "offset": [7, 8, 9], "text": "acute lymphoblastic leukemia"}, {"type": "effect", "offset": [12, 13, 14, 15], "text": "seizures and altered sensorium"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment disorder", "drug", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "3 cases of children with acute lymphoblastic leukemia"], ["age", "children"], ["population", "3"], ["subject disorder", "acute lymphoblastic leukemia"], ["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["treatment disorder", "acute lymphoblastic leukemia"], ["effect", "seizures and altered sensorium"]]}]}
{"text_id": "2051906_1", "text": "A 67 - year - old patient , with primary polymyositis and without previous evidence of liver disease , developed clinical and biochemical features of severe cholestasis 3 months after initiation of azathioprine therapy .", "tokens": ["A", "67", "-", "year", "-", "old", "patient", ",", "with", "primary", "polymyositis", "and", "without", "previous", "evidence", "of", "liver", "disease", ",", "developed", "clinical", "and", "biochemical", "features", "of", "severe", "cholestasis", "3", "months", "after", "initiation", "of", "azathioprine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 67 - year - old patient , with primary polymyositis and without previous evidence of liver disease <extra_id_1> <extra_id_0> age <extra_id_5> 67 - year - old <extra_id_1> <extra_id_0> subject disorder <extra_id_5> primary polymyositis <extra_id_1> <extra_id_0> treatment <extra_id_5> 3 months after initiation of azathioprine <extra_id_1> <extra_id_0> drug <extra_id_5> azathioprine <extra_id_1> <extra_id_0> duration <extra_id_5> 3 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 3 months <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> primary polymyositis <extra_id_1> <extra_id_0> effect <extra_id_5> cholestasis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17], "text": "A 67 - year - old patient , with primary polymyositis and without previous evidence of liver disease"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "67 - year - old"}, {"type": "subject disorder", "offset": [9, 10], "text": "primary polymyositis"}, {"type": "treatment", "offset": [27, 28, 29, 30, 31, 32], "text": "3 months after initiation of azathioprine"}, {"type": "drug", "offset": [32], "text": "azathioprine"}, {"type": "duration", "offset": [27, 28], "text": "3 months"}, {"type": "time elapsed", "offset": [27, 28], "text": "3 months"}, {"type": "treatment disorder", "offset": [9, 10], "text": "primary polymyositis"}, {"type": "effect", "offset": [26], "text": "cholestasis"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "subject", "treatment disorder", "treatment", "duration", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 67 - year - old patient , with primary polymyositis and without previous evidence of liver disease"], ["age", "67 - year - old"], ["subject disorder", "primary polymyositis"], ["treatment", "3 months after initiation of azathioprine"], ["drug", "azathioprine"], ["duration", "3 months"], ["time elapsed", "3 months"], ["treatment disorder", "primary polymyositis"], ["effect", "cholestasis"]]}]}
{"text_id": "11483161_3", "text": "We report the occurrence of spontaneous intracranial bleeding in an human immunodeficiency virus ( HIV) - infected adolescent with hemophilia A who was receiving amprenavir ( APV ) .", "tokens": ["We", "report", "the", "occurrence", "of", "spontaneous", "intracranial", "bleeding", "in", "an", "human", "immunodeficiency", "virus", "(", "HIV)", "-", "infected", "adolescent", "with", "hemophilia", "A", "who", "was", "receiving", "amprenavir", "(", "APV", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurrence <extra_id_0> subject <extra_id_5> an human immunodeficiency virus ( HIV) - infected adolescent with hemophilia A <extra_id_1> <extra_id_0> subject disorder <extra_id_5> immunodeficiency virus ( HIV) - infected adolescent with hemophilia A <extra_id_1> <extra_id_0> treatment <extra_id_5> amprenavir ( APV ) <extra_id_1> <extra_id_0> drug <extra_id_5> amprenavir ( APV ) <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> immunodeficiency virus ( HIV) - infected adolescent with hemophilia A <extra_id_1> <extra_id_0> effect <extra_id_5> spontaneous intracranial bleeding <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "occurrence", "args": [{"type": "subject", "offset": [9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "an human immunodeficiency virus ( HIV) - infected adolescent with hemophilia A"}, {"type": "subject disorder", "offset": [11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "immunodeficiency virus ( HIV) - infected adolescent with hemophilia A"}, {"type": "treatment", "offset": [24, 25, 26, 27], "text": "amprenavir ( APV )"}, {"type": "drug", "offset": [24, 25, 26, 27], "text": "amprenavir ( APV )"}, {"type": "treatment disorder", "offset": [11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "immunodeficiency virus ( HIV) - infected adolescent with hemophilia A"}, {"type": "effect", "offset": [5, 6, 7], "text": "spontaneous intracranial bleeding"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "occurrence", "label": "adverse event", "asoc": [["subject", "an human immunodeficiency virus ( HIV) - infected adolescent with hemophilia A"], ["subject disorder", "immunodeficiency virus ( HIV) - infected adolescent with hemophilia A"], ["treatment", "amprenavir ( APV )"], ["drug", "amprenavir ( APV )"], ["treatment disorder", "immunodeficiency virus ( HIV) - infected adolescent with hemophilia A"], ["effect", "spontaneous intracranial bleeding"]]}]}
{"text_id": "8503421_3", "text": "We report the occurrence of renal failure due to cholesterol crystal embolization following thrombolytic therapy with intravenous recombinant tissue - type plasminogen activator ( t - PA ) .", "tokens": ["We", "report", "the", "occurrence", "of", "renal", "failure", "due", "to", "cholesterol", "crystal", "embolization", "following", "thrombolytic", "therapy", "with", "intravenous", "recombinant", "tissue", "-", "type", "plasminogen", "activator", "(", "t", "-", "PA", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurrence <extra_id_0> treatment <extra_id_5> thrombolytic therapy with intravenous recombinant tissue - type plasminogen activator ( t - PA ) <extra_id_1> <extra_id_0> drug <extra_id_5> recombinant tissue - type plasminogen activator <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> effect <extra_id_5> renal failure due to cholesterol crystal embolization <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "occurrence", "args": [{"type": "treatment", "offset": [13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27], "text": "thrombolytic therapy with intravenous recombinant tissue - type plasminogen activator ( t - PA )"}, {"type": "drug", "offset": [17, 18, 19, 20, 21, 22], "text": "recombinant tissue - type plasminogen activator"}, {"type": "route", "offset": [16], "text": "intravenous"}, {"type": "effect", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "renal failure due to cholesterol crystal embolization"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "occurrence", "label": "adverse event", "asoc": [["treatment", "thrombolytic therapy with intravenous recombinant tissue - type plasminogen activator ( t - PA )"], ["drug", "recombinant tissue - type plasminogen activator"], ["route", "intravenous"], ["effect", "renal failure due to cholesterol crystal embolization"]]}]}
{"text_id": "12921505_2", "text": "Argatroban for heparin - induced thrombocytopenia in hepato - renal failure and CVVHD .", "tokens": ["Argatroban", "for", "heparin", "-", "induced", "thrombocytopenia", "in", "hepato", "-", "renal", "failure", "and", "CVVHD", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> for <extra_id_0> treatment <extra_id_5> Argatroban <extra_id_1> <extra_id_0> drug <extra_id_5> Argatroban <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hepato - renal failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [1], "text": "for", "args": [{"type": "treatment", "offset": [0], "text": "Argatroban"}, {"type": "drug", "offset": [0], "text": "Argatroban"}, {"type": "treatment disorder", "offset": [7, 8, 9, 10], "text": "hepato - renal failure"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "for", "label": "potential therapeutic event", "asoc": [["treatment", "Argatroban"], ["drug", "Argatroban"], ["treatment disorder", "hepato - renal failure"]]}]}
{"text_id": "9876812_3", "text": "OBJECTIVE : To describe onset of syndrome of inappropriate antidiuretic hormone ( SIADH ) associated with vinorelbine therapy for advanced breast cancer .", "tokens": ["OBJECTIVE", ":", "To", "describe", "onset", "of", "syndrome", "of", "inappropriate", "antidiuretic", "hormone", "(", "SIADH", ")", "associated", "with", "vinorelbine", "therapy", "for", "advanced", "breast", "cancer", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated with <extra_id_0> treatment <extra_id_5> vinorelbine <extra_id_1> <extra_id_0> drug <extra_id_5> vinorelbine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> advanced breast cancer <extra_id_1> <extra_id_0> effect <extra_id_5> syndrome of inappropriate antidiuretic hormone ( SIADH ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14, 15], "text": "associated with", "args": [{"type": "treatment", "offset": [16], "text": "vinorelbine"}, {"type": "drug", "offset": [16], "text": "vinorelbine"}, {"type": "treatment disorder", "offset": [19, 20, 21], "text": "advanced breast cancer"}, {"type": "effect", "offset": [6, 7, 8, 9, 10, 11, 12, 13], "text": "syndrome of inappropriate antidiuretic hormone ( SIADH )"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "associated with", "label": "adverse event", "asoc": [["treatment", "vinorelbine"], ["drug", "vinorelbine"], ["treatment disorder", "advanced breast cancer"], ["effect", "syndrome of inappropriate antidiuretic hormone ( SIADH )"]]}]}
{"text_id": "19299370_4", "text": "PURPOSE : A case of probable enoxaparin - induced hepatotoxicity is described .", "tokens": ["PURPOSE", ":", "A", "case", "of", "probable", "enoxaparin", "-", "induced", "hepatotoxicity", "is", "described", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> drug <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> effect <extra_id_5> hepatotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "induced", "args": [{"type": "treatment", "offset": [6], "text": "enoxaparin"}, {"type": "drug", "offset": [6], "text": "enoxaparin"}, {"type": "effect", "offset": [9], "text": "hepatotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "enoxaparin"], ["drug", "enoxaparin"], ["effect", "hepatotoxicity"]]}]}
{"text_id": "12324937_6", "text": "RESULTS : Including our own patient , a total of 26 cases of gemcitabine - associated HUS were identified .", "tokens": ["RESULTS", ":", "Including", "our", "own", "patient", ",", "a", "total", "of", "26", "cases", "of", "gemcitabine", "-", "associated", "HUS", "were", "identified", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> effect <extra_id_5> HUS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "associated", "args": [{"type": "treatment", "offset": [13], "text": "gemcitabine"}, {"type": "drug", "offset": [13], "text": "gemcitabine"}, {"type": "effect", "offset": [16], "text": "HUS"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["effect", "HUS"]]}]}
{"text_id": "7663030_2", "text": "OBJECTIVE : To describe a probable case of transient global amnesia caused by propafenone .", "tokens": ["OBJECTIVE", ":", "To", "describe", "a", "probable", "case", "of", "transient", "global", "amnesia", "caused", "by", "propafenone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> propafenone <extra_id_1> <extra_id_0> drug <extra_id_5> propafenone <extra_id_1> <extra_id_0> effect <extra_id_5> transient global amnesia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "caused", "args": [{"type": "treatment", "offset": [13], "text": "propafenone"}, {"type": "drug", "offset": [13], "text": "propafenone"}, {"type": "effect", "offset": [8, 9, 10], "text": "transient global amnesia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "propafenone"], ["drug", "propafenone"], ["effect", "transient global amnesia"]]}]}
{"text_id": "8828999_2", "text": "Lithium - induced Creutzfeldt - Jakob syndrome .", "tokens": ["Lithium", "-", "induced", "Creutzfeldt", "-", "Jakob", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Lithium <extra_id_1> <extra_id_0> drug <extra_id_5> Lithium <extra_id_1> <extra_id_0> effect <extra_id_5> Creutzfeldt - Jakob syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Lithium"}, {"type": "drug", "offset": [0], "text": "Lithium"}, {"type": "effect", "offset": [3, 4, 5, 6], "text": "Creutzfeldt - Jakob syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Lithium"], ["drug", "Lithium"], ["effect", "Creutzfeldt - Jakob syndrome"]]}]}
{"text_id": "8038468_2", "text": "However , prolongation of 5 - FU half - life and an increase in INR have been reported with the concurrent use of 5 - FU and warfarin .", "tokens": ["However", ",", "prolongation", "of", "5", "-", "FU", "half", "-", "life", "and", "an", "increase", "in", "INR", "have", "been", "reported", "with", "the", "concurrent", "use", "of", "5", "-", "FU", "and", "warfarin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> reported <extra_id_0> treatment <extra_id_5> the concurrent use of 5 - FU and warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> combination drug <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> combination drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> prolongation of 5 - FU half - life and an increase in INR <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "reported", "args": [{"type": "treatment", "offset": [19, 20, 21, 22, 23, 24, 25, 26, 27], "text": "the concurrent use of 5 - FU and warfarin"}, {"type": "drug", "offset": [27], "text": "warfarin"}, {"type": "drug", "offset": [23, 24, 25], "text": "5 - FU"}, {"type": "combination drug", "offset": [23, 24, 25], "text": "5 - FU"}, {"type": "combination drug", "offset": [27], "text": "warfarin"}, {"type": "effect", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "prolongation of 5 - FU half - life and an increase in INR"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "reported", "label": "adverse event", "asoc": [["treatment", "the concurrent use of 5 - FU and warfarin"], ["drug", "warfarin"], ["drug", "5 - FU"], ["combination drug", "5 - FU"], ["combination drug", "warfarin"], ["effect", "prolongation of 5 - FU half - life and an increase in INR"]]}]}
{"text_id": "2979256_3", "text": "Nifedipine may induce , or aggravate , pre - existing , gastro - oesophageal reflux .", "tokens": ["Nifedipine", "may", "induce", ",", "or", "aggravate", ",", "pre", "-", "existing", ",", "gastro", "-", "oesophageal", "reflux", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induce , or aggravate <extra_id_0> treatment <extra_id_5> Nifedipine <extra_id_1> <extra_id_0> drug <extra_id_5> Nifedipine <extra_id_1> <extra_id_0> effect <extra_id_5> gastro - oesophageal reflux <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2, 3, 4, 5], "text": "induce , or aggravate", "args": [{"type": "treatment", "offset": [0], "text": "Nifedipine"}, {"type": "drug", "offset": [0], "text": "Nifedipine"}, {"type": "effect", "offset": [11, 12, 13, 14], "text": "gastro - oesophageal reflux"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induce , or aggravate", "label": "adverse event", "asoc": [["treatment", "Nifedipine"], ["drug", "Nifedipine"], ["effect", "gastro - oesophageal reflux"]]}]}
{"text_id": "3558331_1", "text": "Amoxapine - induced cognitive impairment in two patients .", "tokens": ["Amoxapine", "-", "induced", "cognitive", "impairment", "in", "two", "patients", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> two patients <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> treatment <extra_id_5> Amoxapine <extra_id_1> <extra_id_0> drug <extra_id_5> Amoxapine <extra_id_1> <extra_id_0> effect <extra_id_5> cognitive impairment <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "subject", "offset": [6, 7], "text": "two patients"}, {"type": "population", "offset": [6], "text": "two"}, {"type": "treatment", "offset": [0], "text": "Amoxapine"}, {"type": "drug", "offset": [0], "text": "Amoxapine"}, {"type": "effect", "offset": [3, 4], "text": "cognitive impairment"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "two patients"], ["population", "two"], ["treatment", "Amoxapine"], ["drug", "Amoxapine"], ["effect", "cognitive impairment"]]}]}
{"text_id": "2595431_4", "text": "We have reported six cases of metoclopramide - induced parkinsonism seen in consultation over a two - year period .", "tokens": ["We", "have", "reported", "six", "cases", "of", "metoclopramide", "-", "induced", "parkinsonism", "seen", "in", "consultation", "over", "a", "two", "-", "year", "period", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> six cases <extra_id_1> <extra_id_0> population <extra_id_5> six <extra_id_1> <extra_id_0> treatment <extra_id_5> metoclopramide <extra_id_1> <extra_id_0> drug <extra_id_5> metoclopramide <extra_id_1> <extra_id_0> effect <extra_id_5> parkinsonism <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "induced", "args": [{"type": "subject", "offset": [3, 4], "text": "six cases"}, {"type": "population", "offset": [3], "text": "six"}, {"type": "treatment", "offset": [6], "text": "metoclopramide"}, {"type": "drug", "offset": [6], "text": "metoclopramide"}, {"type": "effect", "offset": [9], "text": "parkinsonism"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "six cases"], ["population", "six"], ["treatment", "metoclopramide"], ["drug", "metoclopramide"], ["effect", "parkinsonism"]]}]}
{"text_id": "20126479_1", "text": "CONCLUSIONS : SD - OCT and AO detected abnormalities that correlate topographically with visual field loss from hydroxychloroquine toxicity as demonstrated by HVF 10 - 2 and may be useful in the detection of subclinical abnormalities that precede symptoms or objective visual field loss .", "tokens": ["CONCLUSIONS", ":", "SD", "-", "OCT", "and", "AO", "detected", "abnormalities", "that", "correlate", "topographically", "with", "visual", "field", "loss", "from", "hydroxychloroquine", "toxicity", "as", "demonstrated", "by", "HVF", "10", "-", "2", "and", "may", "be", "useful", "in", "the", "detection", "of", "subclinical", "abnormalities", "that", "precede", "symptoms", "or", "objective", "visual", "field", "loss", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> from <extra_id_0> treatment <extra_id_5> hydroxychloroquine <extra_id_1> <extra_id_0> drug <extra_id_5> hydroxychloroquine <extra_id_1> <extra_id_0> effect <extra_id_5> visual field loss <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "from", "args": [{"type": "treatment", "offset": [17], "text": "hydroxychloroquine"}, {"type": "drug", "offset": [17], "text": "hydroxychloroquine"}, {"type": "effect", "offset": [13, 14, 15], "text": "visual field loss"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "from", "label": "adverse event", "asoc": [["treatment", "hydroxychloroquine"], ["drug", "hydroxychloroquine"], ["effect", "visual field loss"]]}]}
{"text_id": "12552054_1", "text": "The authors report a case of Balint syndrome with irreversible posterior leukoencephalopathy on MRI following intrathecal methotrexate and cytarabine .", "tokens": ["The", "authors", "report", "a", "case", "of", "Balint", "syndrome", "with", "irreversible", "posterior", "leukoencephalopathy", "on", "MRI", "following", "intrathecal", "methotrexate", "and", "cytarabine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> intrathecal methotrexate and cytarabine <extra_id_1> <extra_id_0> drug <extra_id_5> methotrexate <extra_id_1> <extra_id_0> drug <extra_id_5> cytarabine <extra_id_1> <extra_id_0> route <extra_id_5> intrathecal <extra_id_1> <extra_id_0> combination drug <extra_id_5> cytarabine <extra_id_1> <extra_id_0> combination drug <extra_id_5> methotrexate <extra_id_1> <extra_id_0> effect <extra_id_5> Balint syndrome with irreversible posterior leukoencephalopathy on MRI <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "following", "args": [{"type": "treatment", "offset": [15, 16, 17, 18], "text": "intrathecal methotrexate and cytarabine"}, {"type": "drug", "offset": [16], "text": "methotrexate"}, {"type": "drug", "offset": [18], "text": "cytarabine"}, {"type": "route", "offset": [15], "text": "intrathecal"}, {"type": "combination drug", "offset": [18], "text": "cytarabine"}, {"type": "combination drug", "offset": [16], "text": "methotrexate"}, {"type": "effect", "offset": [6, 7, 8, 9, 10, 11, 12, 13], "text": "Balint syndrome with irreversible posterior leukoencephalopathy on MRI"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "intrathecal methotrexate and cytarabine"], ["drug", "methotrexate"], ["drug", "cytarabine"], ["route", "intrathecal"], ["combination drug", "cytarabine"], ["combination drug", "methotrexate"], ["effect", "Balint syndrome with irreversible posterior leukoencephalopathy on MRI"]]}]}
{"text_id": "20298401_5", "text": "RESULTS : We recently experienced a case of fatal erlotinib - induced ILD , diagnosed based on clinical and radiologic findings , which occurred in a patient with radiation fibrosis .", "tokens": ["RESULTS", ":", "We", "recently", "experienced", "a", "case", "of", "fatal", "erlotinib", "-", "induced", "ILD", ",", "diagnosed", "based", "on", "clinical", "and", "radiologic", "findings", ",", "which", "occurred", "in", "a", "patient", "with", "radiation", "fibrosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a patient with radiation fibrosis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> radiation fibrosis <extra_id_1> <extra_id_0> treatment <extra_id_5> erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> effect <extra_id_5> ILD <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "induced", "args": [{"type": "subject", "offset": [25, 26, 27, 28, 29], "text": "a patient with radiation fibrosis"}, {"type": "subject disorder", "offset": [28, 29], "text": "radiation fibrosis"}, {"type": "treatment", "offset": [9], "text": "erlotinib"}, {"type": "drug", "offset": [9], "text": "erlotinib"}, {"type": "effect", "offset": [12], "text": "ILD"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a patient with radiation fibrosis"], ["subject disorder", "radiation fibrosis"], ["treatment", "erlotinib"], ["drug", "erlotinib"], ["effect", "ILD"]]}]}
{"text_id": "7249424_1", "text": "Lithium is known to cause acute renal failure and tubulo - interstitial disease , but the recently described association with proteinuria or nephrotic syndrome is little recognized .", "tokens": ["Lithium", "is", "known", "to", "cause", "acute", "renal", "failure", "and", "tubulo", "-", "interstitial", "disease", ",", "but", "the", "recently", "described", "association", "with", "proteinuria", "or", "nephrotic", "syndrome", "is", "little", "recognized", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> association <extra_id_0> treatment <extra_id_5> Lithium <extra_id_1> <extra_id_0> drug <extra_id_5> Lithium <extra_id_1> <extra_id_0> effect <extra_id_5> acute renal failure and tubulo - interstitial disease <extra_id_1> <extra_id_0> effect <extra_id_5> proteinuria or nephrotic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "association", "args": [{"type": "treatment", "offset": [0], "text": "Lithium"}, {"type": "drug", "offset": [0], "text": "Lithium"}, {"type": "effect", "offset": [5, 6, 7, 8, 9, 10, 11, 12], "text": "acute renal failure and tubulo - interstitial disease"}, {"type": "effect", "offset": [20, 21, 22, 23], "text": "proteinuria or nephrotic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "association", "label": "adverse event", "asoc": [["treatment", "Lithium"], ["drug", "Lithium"], ["effect", "acute renal failure and tubulo - interstitial disease"], ["effect", "proteinuria or nephrotic syndrome"]]}]}
{"text_id": "19707032_2", "text": "Acute vision loss after intravitreal injection of bevacizumab ( avastin ) associated with ocular ischemic syndrome .", "tokens": ["Acute", "vision", "loss", "after", "intravitreal", "injection", "of", "bevacizumab", "(", "avastin", ")", "associated", "with", "ocular", "ischemic", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> intravitreal injection of bevacizumab ( avastin ) <extra_id_1> <extra_id_0> drug <extra_id_5> bevacizumab <extra_id_1> <extra_id_0> route <extra_id_5> intravitreal injection <extra_id_1> <extra_id_0> effect <extra_id_5> Acute vision loss <extra_id_1> <extra_id_0> effect <extra_id_5> ocular ischemic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "after", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10], "text": "intravitreal injection of bevacizumab ( avastin )"}, {"type": "drug", "offset": [7], "text": "bevacizumab"}, {"type": "route", "offset": [4, 5], "text": "intravitreal injection"}, {"type": "effect", "offset": [0, 1, 2], "text": "Acute vision loss"}, {"type": "effect", "offset": [13, 14, 15], "text": "ocular ischemic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "intravitreal injection of bevacizumab ( avastin )"], ["drug", "bevacizumab"], ["route", "intravitreal injection"], ["effect", "Acute vision loss"], ["effect", "ocular ischemic syndrome"]]}]}
{"text_id": "19390192_3", "text": "We present the case of an adult Crohn 's disease patient with a parvovirus B19 infection and leukopenia during long - term AZA therapy .", "tokens": ["We", "present", "the", "case", "of", "an", "adult", "Crohn", "'s", "disease", "patient", "with", "a", "parvovirus", "B19", "infection", "and", "leukopenia", "during", "long", "-", "term", "AZA", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> subject <extra_id_5> adult Crohn 's disease patient <extra_id_1> <extra_id_0> age <extra_id_5> adult <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> treatment <extra_id_5> long - term AZA therapy <extra_id_1> <extra_id_0> drug <extra_id_5> AZA <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> effect <extra_id_5> a parvovirus B19 infection and leukopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "during", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10], "text": "adult Crohn 's disease patient"}, {"type": "age", "offset": [6], "text": "adult"}, {"type": "subject disorder", "offset": [7, 8, 9], "text": "Crohn 's disease"}, {"type": "treatment", "offset": [19, 20, 21, 22, 23], "text": "long - term AZA therapy"}, {"type": "drug", "offset": [22], "text": "AZA"}, {"type": "treatment disorder", "offset": [7, 8, 9], "text": "Crohn 's disease"}, {"type": "effect", "offset": [12, 13, 14, 15, 16, 17], "text": "a parvovirus B19 infection and leukopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["subject", "adult Crohn 's disease patient"], ["age", "adult"], ["subject disorder", "Crohn 's disease"], ["treatment", "long - term AZA therapy"], ["drug", "AZA"], ["treatment disorder", "Crohn 's disease"], ["effect", "a parvovirus B19 infection and leukopenia"]]}]}
{"text_id": "16371793_1", "text": "Intravitreal triamcinolone acetonide for persisting cystoid macular edema after penetrating keratoplasty .", "tokens": ["Intravitreal", "triamcinolone", "acetonide", "for", "persisting", "cystoid", "macular", "edema", "after", "penetrating", "keratoplasty", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> for <extra_id_0> treatment <extra_id_5> Intravitreal triamcinolone acetonide <extra_id_1> <extra_id_0> drug <extra_id_5> triamcinolone acetonide <extra_id_1> <extra_id_0> route <extra_id_5> Intravitreal <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> persisting cystoid macular edema <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> penetrating keratoplasty <extra_id_1> <extra_id_0> effect <extra_id_5> persisting cystoid macular edema <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [3], "text": "for", "args": [{"type": "treatment", "offset": [0, 1, 2], "text": "Intravitreal triamcinolone acetonide"}, {"type": "drug", "offset": [1, 2], "text": "triamcinolone acetonide"}, {"type": "route", "offset": [0], "text": "Intravitreal"}, {"type": "treatment disorder", "offset": [4, 5, 6, 7], "text": "persisting cystoid macular edema"}]}, {"type": "adverse event", "offset": [8], "text": "after", "args": [{"type": "treatment", "offset": [9, 10], "text": "penetrating keratoplasty"}, {"type": "effect", "offset": [4, 5, 6, 7], "text": "persisting cystoid macular edema"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "route", "drug", "treatment", "treatment disorder"], "spot_asoc": [{"span": "for", "label": "potential therapeutic event", "asoc": [["treatment", "Intravitreal triamcinolone acetonide"], ["drug", "triamcinolone acetonide"], ["route", "Intravitreal"], ["treatment disorder", "persisting cystoid macular edema"]]}, {"span": "after", "label": "adverse event", "asoc": [["treatment", "penetrating keratoplasty"], ["effect", "persisting cystoid macular edema"]]}]}
{"text_id": "10987357_2", "text": "A 74 - year - old man received oral administration of pilsicainide , a pure sodium channel blocker with slow recovery kinetics , to convert paroxysmal atrial fibrillation to sinus rhythm and developed loss of consciousness two days later .", "tokens": ["A", "74", "-", "year", "-", "old", "man", "received", "oral", "administration", "of", "pilsicainide", ",", "a", "pure", "sodium", "channel", "blocker", "with", "slow", "recovery", "kinetics", ",", "to", "convert", "paroxysmal", "atrial", "fibrillation", "to", "sinus", "rhythm", "and", "developed", "loss", "of", "consciousness", "two", "days", "later", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 74 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 74 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> paroxysmal atrial fibrillation <extra_id_1> <extra_id_0> treatment <extra_id_5> oral administration of pilsicainide <extra_id_1> <extra_id_0> treatment <extra_id_5> two days later <extra_id_1> <extra_id_0> drug <extra_id_5> pilsicainide <extra_id_1> <extra_id_0> route <extra_id_5> oral <extra_id_1> <extra_id_0> time elapsed <extra_id_5> two days <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> paroxysmal atrial fibrillation <extra_id_1> <extra_id_0> effect <extra_id_5> loss of consciousness <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [32], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "A 74 - year - old man"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "74 - year - old"}, {"type": "gender", "offset": [6], "text": "man"}, {"type": "subject disorder", "offset": [25, 26, 27], "text": "paroxysmal atrial fibrillation"}, {"type": "treatment", "offset": [8, 9, 10, 11], "text": "oral administration of pilsicainide"}, {"type": "treatment", "offset": [36, 37, 38], "text": "two days later"}, {"type": "drug", "offset": [11], "text": "pilsicainide"}, {"type": "route", "offset": [8], "text": "oral"}, {"type": "time elapsed", "offset": [36, 37], "text": "two days"}, {"type": "treatment disorder", "offset": [25, 26, 27], "text": "paroxysmal atrial fibrillation"}, {"type": "effect", "offset": [33, 34, 35], "text": "loss of consciousness"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "route", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 74 - year - old man"], ["age", "74 - year - old"], ["gender", "man"], ["subject disorder", "paroxysmal atrial fibrillation"], ["treatment", "oral administration of pilsicainide"], ["treatment", "two days later"], ["drug", "pilsicainide"], ["route", "oral"], ["time elapsed", "two days"], ["treatment disorder", "paroxysmal atrial fibrillation"], ["effect", "loss of consciousness"]]}]}
{"text_id": "1977935_6", "text": "We believe that a drug interaction between terfenadine and ketoconazole resulted in the elevated terfenadine levels in plasma and in the cardiotoxicity previously seen only in cases of terfenadine overdose .", "tokens": ["We", "believe", "that", "a", "drug", "interaction", "between", "terfenadine", "and", "ketoconazole", "resulted", "in", "the", "elevated", "terfenadine", "levels", "in", "plasma", "and", "in", "the", "cardiotoxicity", "previously", "seen", "only", "in", "cases", "of", "terfenadine", "overdose", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resulted <extra_id_0> treatment <extra_id_5> a drug interaction between terfenadine and ketoconazole <extra_id_1> <extra_id_0> drug <extra_id_5> terfenadine <extra_id_1> <extra_id_0> drug <extra_id_5> ketoconazole <extra_id_1> <extra_id_0> combination drug <extra_id_5> terfenadine <extra_id_1> <extra_id_0> combination drug <extra_id_5> ketoconazole <extra_id_1> <extra_id_0> effect <extra_id_5> the elevated terfenadine levels in plasma and in the cardiotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "resulted", "args": [{"type": "treatment", "offset": [3, 4, 5, 6, 7, 8, 9], "text": "a drug interaction between terfenadine and ketoconazole"}, {"type": "drug", "offset": [7], "text": "terfenadine"}, {"type": "drug", "offset": [9], "text": "ketoconazole"}, {"type": "combination drug", "offset": [7], "text": "terfenadine"}, {"type": "combination drug", "offset": [9], "text": "ketoconazole"}, {"type": "effect", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20, 21], "text": "the elevated terfenadine levels in plasma and in the cardiotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "resulted", "label": "adverse event", "asoc": [["treatment", "a drug interaction between terfenadine and ketoconazole"], ["drug", "terfenadine"], ["drug", "ketoconazole"], ["combination drug", "terfenadine"], ["combination drug", "ketoconazole"], ["effect", "the elevated terfenadine levels in plasma and in the cardiotoxicity"]]}]}
{"text_id": "17420198_19", "text": "A patient with developmental disabilities who had no history of movement disorders developed EPS following initiation of aripiprazole .", "tokens": ["A", "patient", "with", "developmental", "disabilities", "who", "had", "no", "history", "of", "movement", "disorders", "developed", "EPS", "following", "initiation", "of", "aripiprazole", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> subject <extra_id_5> A patient with developmental disabilities who had no history of movement disorders <extra_id_1> <extra_id_0> subject disorder <extra_id_5> developmental disabilities <extra_id_1> <extra_id_0> treatment <extra_id_5> initiation of aripiprazole <extra_id_1> <extra_id_0> drug <extra_id_5> aripiprazole <extra_id_1> <extra_id_0> effect <extra_id_5> EPS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "following", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11], "text": "A patient with developmental disabilities who had no history of movement disorders"}, {"type": "subject disorder", "offset": [3, 4], "text": "developmental disabilities"}, {"type": "treatment", "offset": [15, 16, 17], "text": "initiation of aripiprazole"}, {"type": "drug", "offset": [17], "text": "aripiprazole"}, {"type": "effect", "offset": [13], "text": "EPS"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["subject", "A patient with developmental disabilities who had no history of movement disorders"], ["subject disorder", "developmental disabilities"], ["treatment", "initiation of aripiprazole"], ["drug", "aripiprazole"], ["effect", "EPS"]]}]}
{"text_id": "1261772_2", "text": "Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil .", "tokens": ["Fulminant", "hepatitis", "and", "lymphocyte", "sensitization", "due", "to", "propylthiouracil", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> treatment <extra_id_5> propylthiouracil <extra_id_1> <extra_id_0> drug <extra_id_5> propylthiouracil <extra_id_1> <extra_id_0> effect <extra_id_5> Fulminant hepatitis <extra_id_1> <extra_id_0> effect <extra_id_5> lymphocyte sensitization <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "due", "args": [{"type": "treatment", "offset": [7], "text": "propylthiouracil"}, {"type": "drug", "offset": [7], "text": "propylthiouracil"}, {"type": "effect", "offset": [0, 1], "text": "Fulminant hepatitis"}, {"type": "effect", "offset": [3, 4], "text": "lymphocyte sensitization"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["treatment", "propylthiouracil"], ["drug", "propylthiouracil"], ["effect", "Fulminant hepatitis"], ["effect", "lymphocyte sensitization"]]}]}
{"text_id": "2595431_2", "text": "Metoclopramide - induced parkinsonism .", "tokens": ["Metoclopramide", "-", "induced", "parkinsonism", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Metoclopramide <extra_id_1> <extra_id_0> drug <extra_id_5> Metoclopramide <extra_id_1> <extra_id_0> effect <extra_id_5> parkinsonism <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Metoclopramide"}, {"type": "drug", "offset": [0], "text": "Metoclopramide"}, {"type": "effect", "offset": [3], "text": "parkinsonism"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Metoclopramide"], ["drug", "Metoclopramide"], ["effect", "parkinsonism"]]}]}
{"text_id": "2140997_1", "text": "A case of severe acute hepatitis caused by cyproterone acetate in a 71 year old man with prostatic carcinoma is reported with a review of the literature on hepatic reactions to this drug .", "tokens": ["A", "case", "of", "severe", "acute", "hepatitis", "caused", "by", "cyproterone", "acetate", "in", "a", "71", "year", "old", "man", "with", "prostatic", "carcinoma", "is", "reported", "with", "a", "review", "of", "the", "literature", "on", "hepatic", "reactions", "to", "this", "drug", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> subject <extra_id_5> a 71 year old man with prostatic carcinoma <extra_id_1> <extra_id_0> age <extra_id_5> 71 year old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> prostatic carcinoma <extra_id_1> <extra_id_0> treatment <extra_id_5> cyproterone acetate <extra_id_1> <extra_id_0> drug <extra_id_5> cyproterone acetate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> prostatic carcinoma <extra_id_1> <extra_id_0> effect <extra_id_5> acute hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "caused", "args": [{"type": "subject", "offset": [11, 12, 13, 14, 15, 16, 17, 18], "text": "a 71 year old man with prostatic carcinoma"}, {"type": "age", "offset": [12, 13, 14], "text": "71 year old"}, {"type": "gender", "offset": [15], "text": "man"}, {"type": "subject disorder", "offset": [17, 18], "text": "prostatic carcinoma"}, {"type": "treatment", "offset": [8, 9], "text": "cyproterone acetate"}, {"type": "drug", "offset": [8, 9], "text": "cyproterone acetate"}, {"type": "treatment disorder", "offset": [17, 18], "text": "prostatic carcinoma"}, {"type": "effect", "offset": [4, 5], "text": "acute hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["subject", "a 71 year old man with prostatic carcinoma"], ["age", "71 year old"], ["gender", "man"], ["subject disorder", "prostatic carcinoma"], ["treatment", "cyproterone acetate"], ["drug", "cyproterone acetate"], ["treatment disorder", "prostatic carcinoma"], ["effect", "acute hepatitis"]]}]}
{"text_id": "17876386_2", "text": "Torsade de pointes associated with moxifloxacin : a rare but potentially fatal adverse event .", "tokens": ["Torsade", "de", "pointes", "associated", "with", "moxifloxacin", ":", "a", "rare", "but", "potentially", "fatal", "adverse", "event", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> moxifloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> moxifloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> Torsade de pointes <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "associated", "args": [{"type": "treatment", "offset": [5], "text": "moxifloxacin"}, {"type": "drug", "offset": [5], "text": "moxifloxacin"}, {"type": "effect", "offset": [0, 1, 2], "text": "Torsade de pointes"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "moxifloxacin"], ["drug", "moxifloxacin"], ["effect", "Torsade de pointes"]]}]}
{"text_id": "12187348_3", "text": "The authors report the first case of bucillamine - induced giant mammary hyperplasia .", "tokens": ["The", "authors", "report", "the", "first", "case", "of", "bucillamine", "-", "induced", "giant", "mammary", "hyperplasia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> bucillamine <extra_id_1> <extra_id_0> drug <extra_id_5> bucillamine <extra_id_1> <extra_id_0> effect <extra_id_5> giant mammary hyperplasia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "induced", "args": [{"type": "treatment", "offset": [7], "text": "bucillamine"}, {"type": "drug", "offset": [7], "text": "bucillamine"}, {"type": "effect", "offset": [10, 11, 12], "text": "giant mammary hyperplasia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "bucillamine"], ["drug", "bucillamine"], ["effect", "giant mammary hyperplasia"]]}]}
{"text_id": "9776099_1", "text": "NMS is a drug - related response to various medications , such as Haloperidol , which the patient was receiving .", "tokens": ["NMS", "is", "a", "drug", "-", "related", "response", "to", "various", "medications", ",", "such", "as", "Haloperidol", ",", "which", "the", "patient", "was", "receiving", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> response <extra_id_0> subject <extra_id_5> patient <extra_id_1> <extra_id_0> treatment <extra_id_5> Haloperidol <extra_id_1> <extra_id_0> drug <extra_id_5> Haloperidol <extra_id_1> <extra_id_0> effect <extra_id_5> NMS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "response", "args": [{"type": "subject", "offset": [17], "text": "patient"}, {"type": "treatment", "offset": [13], "text": "Haloperidol"}, {"type": "drug", "offset": [13], "text": "Haloperidol"}, {"type": "effect", "offset": [0], "text": "NMS"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "response", "label": "adverse event", "asoc": [["subject", "patient"], ["treatment", "Haloperidol"], ["drug", "Haloperidol"], ["effect", "NMS"]]}]}
{"text_id": "15920338_3", "text": "In deciding if tamoxifen therapy is warranted , all potentially life - threatening adverse events associated with tamoxifen should be considered , including endometrial adenocarcinoma or uterine sarcoma .", "tokens": ["In", "deciding", "if", "tamoxifen", "therapy", "is", "warranted", ",", "all", "potentially", "life", "-", "threatening", "adverse", "events", "associated", "with", "tamoxifen", "should", "be", "considered", ",", "including", "endometrial", "adenocarcinoma", "or", "uterine", "sarcoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated with <extra_id_0> treatment <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> drug <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> drug <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> drug <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> effect <extra_id_5> potentially life - threatening adverse events <extra_id_1> <extra_id_0> effect <extra_id_5> including endometrial adenocarcinoma or uterine sarcoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15, 16], "text": "associated with", "args": [{"type": "treatment", "offset": [17], "text": "tamoxifen"}, {"type": "drug", "offset": [3], "text": "tamoxifen"}, {"type": "drug", "offset": [17], "text": "tamoxifen"}, {"type": "drug", "offset": [3], "text": "tamoxifen"}, {"type": "effect", "offset": [9, 10, 11, 12, 13, 14], "text": "potentially life - threatening adverse events"}, {"type": "effect", "offset": [22, 23, 24, 25, 26, 27], "text": "including endometrial adenocarcinoma or uterine sarcoma"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated with", "label": "adverse event", "asoc": [["treatment", "tamoxifen"], ["drug", "tamoxifen"], ["drug", "tamoxifen"], ["drug", "tamoxifen"], ["effect", "potentially life - threatening adverse events"], ["effect", "including endometrial adenocarcinoma or uterine sarcoma"]]}]}
{"text_id": "9360190_2", "text": "Magnesium tocolysis as the cause of urinary calculus during pregnancy .", "tokens": ["Magnesium", "tocolysis", "as", "the", "cause", "of", "urinary", "calculus", "during", "pregnancy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> Magnesium tocolysis <extra_id_1> <extra_id_0> drug <extra_id_5> Magnesium <extra_id_1> <extra_id_0> effect <extra_id_5> urinary calculus during pregnancy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "cause", "args": [{"type": "treatment", "offset": [0, 1], "text": "Magnesium tocolysis"}, {"type": "drug", "offset": [0], "text": "Magnesium"}, {"type": "effect", "offset": [6, 7, 8, 9], "text": "urinary calculus during pregnancy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "Magnesium tocolysis"], ["drug", "Magnesium"], ["effect", "urinary calculus during pregnancy"]]}]}
{"text_id": "1359782_1", "text": "A patient with ulcerative colitis developed skin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology , while taking sulfasalazine .", "tokens": ["A", "patient", "with", "ulcerative", "colitis", "developed", "skin", "pigmentation", "and", "diffuse", "pulmonary", "shadowing", "without", "respiratory", "symptomatology", ",", "while", "taking", "sulfasalazine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A patient with ulcerative colitis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> ulcerative colitis <extra_id_1> <extra_id_0> treatment <extra_id_5> sulfasalazine <extra_id_1> <extra_id_0> drug <extra_id_5> sulfasalazine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> ulcerative colitis <extra_id_1> <extra_id_0> effect <extra_id_5> skin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4], "text": "A patient with ulcerative colitis"}, {"type": "subject disorder", "offset": [3, 4], "text": "ulcerative colitis"}, {"type": "treatment", "offset": [18], "text": "sulfasalazine"}, {"type": "drug", "offset": [18], "text": "sulfasalazine"}, {"type": "treatment disorder", "offset": [3, 4], "text": "ulcerative colitis"}, {"type": "effect", "offset": [6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "skin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A patient with ulcerative colitis"], ["subject disorder", "ulcerative colitis"], ["treatment", "sulfasalazine"], ["drug", "sulfasalazine"], ["treatment disorder", "ulcerative colitis"], ["effect", "skin pigmentation and diffuse pulmonary shadowing without respiratory symptomatology"]]}]}
{"text_id": "8098286_3", "text": "We report on a patient who developed hypersensitivity pneumonitis during treatment with the beta - blocker , celiprolol .", "tokens": ["We", "report", "on", "a", "patient", "who", "developed", "hypersensitivity", "pneumonitis", "during", "treatment", "with", "the", "beta", "-", "blocker", ",", "celiprolol", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> celiprolol <extra_id_1> <extra_id_0> drug <extra_id_5> celiprolol <extra_id_1> <extra_id_0> effect <extra_id_5> hypersensitivity pneumonitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "developed", "args": [{"type": "subject", "offset": [3, 4], "text": "a patient"}, {"type": "treatment", "offset": [17], "text": "celiprolol"}, {"type": "drug", "offset": [17], "text": "celiprolol"}, {"type": "effect", "offset": [7, 8], "text": "hypersensitivity pneumonitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "celiprolol"], ["drug", "celiprolol"], ["effect", "hypersensitivity pneumonitis"]]}]}
{"text_id": "10357715_1", "text": "Allergic and irritant contact dermatitis to calcipotriol .", "tokens": ["Allergic", "and", "irritant", "contact", "dermatitis", "to", "calcipotriol", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> to <extra_id_0> treatment <extra_id_5> calcipotriol <extra_id_1> <extra_id_0> drug <extra_id_5> calcipotriol <extra_id_1> <extra_id_0> effect <extra_id_5> contact dermatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "to", "args": [{"type": "treatment", "offset": [6], "text": "calcipotriol"}, {"type": "drug", "offset": [6], "text": "calcipotriol"}, {"type": "effect", "offset": [3, 4], "text": "contact dermatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "to", "label": "adverse event", "asoc": [["treatment", "calcipotriol"], ["drug", "calcipotriol"], ["effect", "contact dermatitis"]]}]}
{"text_id": "16573370_6", "text": "She had been prescribed two mood stabilizers and suffered from anticholinergic adverse effects and the movement disorder tardive dyskinesia ( TD ) .", "tokens": ["She", "had", "been", "prescribed", "two", "mood", "stabilizers", "and", "suffered", "from", "anticholinergic", "adverse", "effects", "and", "the", "movement", "disorder", "tardive", "dyskinesia", "(", "TD", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> suffered from <extra_id_0> treatment <extra_id_5> prescribed two mood stabilizers <extra_id_1> <extra_id_0> drug <extra_id_5> mood stabilizers <extra_id_1> <extra_id_0> effect <extra_id_5> anticholinergic adverse effects and the movement disorder tardive dyskinesia ( TD ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8, 9], "text": "suffered from", "args": [{"type": "treatment", "offset": [3, 4, 5, 6], "text": "prescribed two mood stabilizers"}, {"type": "drug", "offset": [5, 6], "text": "mood stabilizers"}, {"type": "effect", "offset": [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21], "text": "anticholinergic adverse effects and the movement disorder tardive dyskinesia ( TD )"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "suffered from", "label": "adverse event", "asoc": [["treatment", "prescribed two mood stabilizers"], ["drug", "mood stabilizers"], ["effect", "anticholinergic adverse effects and the movement disorder tardive dyskinesia ( TD )"]]}]}
{"text_id": "11675845_2", "text": "To report a case of increased international normalized ratio ( INR ) in a geriatric patient receiving warfarin and ropinirole .", "tokens": ["To", "report", "a", "case", "of", "increased", "international", "normalized", "ratio", "(", "INR", ")", "in", "a", "geriatric", "patient", "receiving", "warfarin", "and", "ropinirole", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> case <extra_id_0> subject <extra_id_5> a geriatric patient <extra_id_1> <extra_id_0> age <extra_id_5> geriatric <extra_id_1> <extra_id_0> treatment <extra_id_5> warfarin and ropinirole <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> ropinirole <extra_id_1> <extra_id_0> combination drug <extra_id_5> ropinirole <extra_id_1> <extra_id_0> combination drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> increased international normalized ratio ( INR ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "case", "args": [{"type": "subject", "offset": [13, 14, 15], "text": "a geriatric patient"}, {"type": "age", "offset": [14], "text": "geriatric"}, {"type": "treatment", "offset": [17, 18, 19], "text": "warfarin and ropinirole"}, {"type": "drug", "offset": [17], "text": "warfarin"}, {"type": "drug", "offset": [19], "text": "ropinirole"}, {"type": "combination drug", "offset": [19], "text": "ropinirole"}, {"type": "combination drug", "offset": [17], "text": "warfarin"}, {"type": "effect", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "increased international normalized ratio ( INR )"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "combination drug", "age", "treatment"], "spot_asoc": [{"span": "case", "label": "adverse event", "asoc": [["subject", "a geriatric patient"], ["age", "geriatric"], ["treatment", "warfarin and ropinirole"], ["drug", "warfarin"], ["drug", "ropinirole"], ["combination drug", "ropinirole"], ["combination drug", "warfarin"], ["effect", "increased international normalized ratio ( INR )"]]}]}
{"text_id": "11026106_1", "text": "Minocycline as a cause of drug - induced autoimmune hepatitis .", "tokens": ["Minocycline", "as", "a", "cause", "of", "drug", "-", "induced", "autoimmune", "hepatitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Minocycline <extra_id_1> <extra_id_0> drug <extra_id_5> Minocycline <extra_id_1> <extra_id_0> effect <extra_id_5> autoimmune hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Minocycline"}, {"type": "drug", "offset": [0], "text": "Minocycline"}, {"type": "effect", "offset": [8, 9], "text": "autoimmune hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Minocycline"], ["drug", "Minocycline"], ["effect", "autoimmune hepatitis"]]}]}
{"text_id": "21712512_1", "text": "Rapid onset of iatrogenic adrenal insufficiency in a patient with cystic fibrosis - related liver disease treated with inhaled corticosteroids and a moderate CYP3A4 inhibitor .", "tokens": ["Rapid", "onset", "of", "iatrogenic", "adrenal", "insufficiency", "in", "a", "patient", "with", "cystic", "fibrosis", "-", "related", "liver", "disease", "treated", "with", "inhaled", "corticosteroids", "and", "a", "moderate", "CYP3A4", "inhibitor", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> onset <extra_id_0> subject <extra_id_5> a patient with cystic fibrosis - related liver disease <extra_id_1> <extra_id_0> subject disorder <extra_id_5> cystic fibrosis - related liver disease <extra_id_1> <extra_id_0> treatment <extra_id_5> inhaled corticosteroids and a moderate CYP3A4 inhibitor <extra_id_1> <extra_id_0> drug <extra_id_5> inhaled corticosteroids <extra_id_1> <extra_id_0> drug <extra_id_5> CYP3A4 inhibitor . <extra_id_1> <extra_id_0> combination drug <extra_id_5> inhaled corticosteroids <extra_id_1> <extra_id_0> combination drug <extra_id_5> CYP3A4 inhibitor . <extra_id_1> <extra_id_0> effect <extra_id_5> iatrogenic adrenal insufficiency <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "onset", "args": [{"type": "subject", "offset": [7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "a patient with cystic fibrosis - related liver disease"}, {"type": "subject disorder", "offset": [10, 11, 12, 13, 14, 15], "text": "cystic fibrosis - related liver disease"}, {"type": "treatment", "offset": [18, 19, 20, 21, 22, 23, 24], "text": "inhaled corticosteroids and a moderate CYP3A4 inhibitor"}, {"type": "drug", "offset": [18, 19], "text": "inhaled corticosteroids"}, {"type": "drug", "offset": [23, 24, 25], "text": "CYP3A4 inhibitor ."}, {"type": "combination drug", "offset": [18, 19], "text": "inhaled corticosteroids"}, {"type": "combination drug", "offset": [23, 24, 25], "text": "CYP3A4 inhibitor ."}, {"type": "effect", "offset": [3, 4, 5], "text": "iatrogenic adrenal insufficiency"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "combination drug", "subject disorder"], "spot_asoc": [{"span": "onset", "label": "adverse event", "asoc": [["subject", "a patient with cystic fibrosis - related liver disease"], ["subject disorder", "cystic fibrosis - related liver disease"], ["treatment", "inhaled corticosteroids and a moderate CYP3A4 inhibitor"], ["drug", "inhaled corticosteroids"], ["drug", "CYP3A4 inhibitor ."], ["combination drug", "inhaled corticosteroids"], ["combination drug", "CYP3A4 inhibitor ."], ["effect", "iatrogenic adrenal insufficiency"]]}]}
{"text_id": "189279_1", "text": "A case of congestive heart failure in a child with Wilms ' tumor treated Adriamycin is presented and discussed .", "tokens": ["A", "case", "of", "congestive", "heart", "failure", "in", "a", "child", "with", "Wilms", "'", "tumor", "treated", "Adriamycin", "is", "presented", "and", "discussed", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> a child with Wilms ' tumor <extra_id_1> <extra_id_0> age <extra_id_5> child <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Wilms ' tumor <extra_id_1> <extra_id_0> treatment <extra_id_5> Adriamycin <extra_id_1> <extra_id_0> drug <extra_id_5> Adriamycin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Wilms ' tumor <extra_id_1> <extra_id_0> effect <extra_id_5> congestive heart failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "in", "args": [{"type": "subject", "offset": [7, 8, 9, 10, 11, 12], "text": "a child with Wilms ' tumor"}, {"type": "age", "offset": [8], "text": "child"}, {"type": "subject disorder", "offset": [10, 11, 12], "text": "Wilms ' tumor"}, {"type": "treatment", "offset": [14], "text": "Adriamycin"}, {"type": "drug", "offset": [14], "text": "Adriamycin"}, {"type": "treatment disorder", "offset": [10, 11, 12], "text": "Wilms ' tumor"}, {"type": "effect", "offset": [3, 4, 5], "text": "congestive heart failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "a child with Wilms ' tumor"], ["age", "child"], ["subject disorder", "Wilms ' tumor"], ["treatment", "Adriamycin"], ["drug", "Adriamycin"], ["treatment disorder", "Wilms ' tumor"], ["effect", "congestive heart failure"]]}]}
{"text_id": "19857154_4", "text": "We describe two patients who experienced serious quetiapine adverse effects potentially mediated through an interaction with ritonavir - boosted atazanavir .", "tokens": ["We", "describe", "two", "patients", "who", "experienced", "serious", "quetiapine", "adverse", "effects", "potentially", "mediated", "through", "an", "interaction", "with", "ritonavir", "-", "boosted", "atazanavir", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> experienced <extra_id_0> subject <extra_id_5> two patients <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> treatment <extra_id_5> ritonavir - boosted atazanavir <extra_id_1> <extra_id_0> drug <extra_id_5> ritonavir <extra_id_1> <extra_id_0> drug <extra_id_5> atazanavir <extra_id_1> <extra_id_0> combination drug <extra_id_5> ritonavir <extra_id_1> <extra_id_0> combination drug <extra_id_5> atazanavir <extra_id_1> <extra_id_0> effect <extra_id_5> serious quetiapine adverse effects <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "experienced", "args": [{"type": "subject", "offset": [2, 3], "text": "two patients"}, {"type": "population", "offset": [2], "text": "two"}, {"type": "treatment", "offset": [16, 17, 18, 19], "text": "ritonavir - boosted atazanavir"}, {"type": "drug", "offset": [16], "text": "ritonavir"}, {"type": "drug", "offset": [19], "text": "atazanavir"}, {"type": "combination drug", "offset": [16], "text": "ritonavir"}, {"type": "combination drug", "offset": [19], "text": "atazanavir"}, {"type": "effect", "offset": [6, 7, 8, 9], "text": "serious quetiapine adverse effects"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "experienced", "label": "adverse event", "asoc": [["subject", "two patients"], ["population", "two"], ["treatment", "ritonavir - boosted atazanavir"], ["drug", "ritonavir"], ["drug", "atazanavir"], ["combination drug", "ritonavir"], ["combination drug", "atazanavir"], ["effect", "serious quetiapine adverse effects"]]}]}
{"text_id": "19423610_3", "text": "We noted that the delirium resembled serotonin toxicity and that the patient had been taking paroxetine until 2 days before surgery .", "tokens": ["We", "noted", "that", "the", "delirium", "resembled", "serotonin", "toxicity", "and", "that", "the", "patient", "had", "been", "taking", "paroxetine", "until", "2", "days", "before", "surgery", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> taking <extra_id_0> treatment <extra_id_5> paroxetine until 2 days before surgery <extra_id_1> <extra_id_0> drug <extra_id_5> paroxetine <extra_id_1> <extra_id_0> effect <extra_id_5> delirium resembled serotonin toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "taking", "args": [{"type": "treatment", "offset": [15, 16, 17, 18, 19, 20], "text": "paroxetine until 2 days before surgery"}, {"type": "drug", "offset": [15], "text": "paroxetine"}, {"type": "effect", "offset": [4, 5, 6, 7], "text": "delirium resembled serotonin toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "taking", "label": "adverse event", "asoc": [["treatment", "paroxetine until 2 days before surgery"], ["drug", "paroxetine"], ["effect", "delirium resembled serotonin toxicity"]]}]}
{"text_id": "15289139_3", "text": "We document the abrupt development of an extensive choroidal detachment after initiation of dorzolamide therapy in a surgically untreated eye with primary open - angle glaucoma .", "tokens": ["We", "document", "the", "abrupt", "development", "of", "an", "extensive", "choroidal", "detachment", "after", "initiation", "of", "dorzolamide", "therapy", "in", "a", "surgically", "untreated", "eye", "with", "primary", "open", "-", "angle", "glaucoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> subject <extra_id_5> surgically untreated eye with primary open - angle glaucoma <extra_id_1> <extra_id_0> subject disorder <extra_id_5> surgically untreated eye with primary open - angle glaucoma <extra_id_1> <extra_id_0> treatment <extra_id_5> dorzolamide therapy <extra_id_1> <extra_id_0> drug <extra_id_5> dorzolamide <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> surgically untreated eye with primary open - angle glaucoma <extra_id_1> <extra_id_0> effect <extra_id_5> extensive choroidal detachment <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "development", "args": [{"type": "subject", "offset": [17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "surgically untreated eye with primary open - angle glaucoma"}, {"type": "subject disorder", "offset": [17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "surgically untreated eye with primary open - angle glaucoma"}, {"type": "treatment", "offset": [13, 14], "text": "dorzolamide therapy"}, {"type": "drug", "offset": [13], "text": "dorzolamide"}, {"type": "treatment disorder", "offset": [17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "surgically untreated eye with primary open - angle glaucoma"}, {"type": "effect", "offset": [7, 8, 9], "text": "extensive choroidal detachment"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["subject", "surgically untreated eye with primary open - angle glaucoma"], ["subject disorder", "surgically untreated eye with primary open - angle glaucoma"], ["treatment", "dorzolamide therapy"], ["drug", "dorzolamide"], ["treatment disorder", "surgically untreated eye with primary open - angle glaucoma"], ["effect", "extensive choroidal detachment"]]}]}
{"text_id": "15628319_1", "text": "Allergic side effects of AZA are rare , and reported allergic skin eruptions from AZA are very limited in Japan .", "tokens": ["Allergic", "side", "effects", "of", "AZA", "are", "rare", ",", "and", "reported", "allergic", "skin", "eruptions", "from", "AZA", "are", "very", "limited", "in", "Japan", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> from <extra_id_0> treatment <extra_id_5> AZA <extra_id_1> <extra_id_0> drug <extra_id_5> AZA <extra_id_1> <extra_id_0> effect <extra_id_5> allergic skin eruptions <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "from", "args": [{"type": "treatment", "offset": [14], "text": "AZA"}, {"type": "drug", "offset": [14], "text": "AZA"}, {"type": "effect", "offset": [10, 11, 12], "text": "allergic skin eruptions"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "from", "label": "adverse event", "asoc": [["treatment", "AZA"], ["drug", "AZA"], ["effect", "allergic skin eruptions"]]}]}
{"text_id": "17420198_18", "text": "Aripiprazole was subsequently discontinued secondary to its lack of efficacy for OCD and the development of a movement disorder .", "tokens": ["Aripiprazole", "was", "subsequently", "discontinued", "secondary", "to", "its", "lack", "of", "efficacy", "for", "OCD", "and", "the", "development", "of", "a", "movement", "disorder", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> treatment <extra_id_5> Aripiprazole <extra_id_1> <extra_id_0> drug <extra_id_5> Aripiprazole <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> OCD <extra_id_1> <extra_id_0> effect <extra_id_5> a movement disorder <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "development", "args": [{"type": "treatment", "offset": [0], "text": "Aripiprazole"}, {"type": "drug", "offset": [0], "text": "Aripiprazole"}, {"type": "treatment disorder", "offset": [11], "text": "OCD"}, {"type": "effect", "offset": [16, 17, 18], "text": "a movement disorder"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["treatment", "Aripiprazole"], ["drug", "Aripiprazole"], ["treatment disorder", "OCD"], ["effect", "a movement disorder"]]}]}
{"text_id": "12921505_1", "text": "After 39 hours on argatroban , the infusion was stopped when minor bleeding was observed with a concurrent activated partial thromboplastin time ( aPTT ) of 100 seconds .", "tokens": ["After", "39", "hours", "on", "argatroban", ",", "the", "infusion", "was", "stopped", "when", "minor", "bleeding", "was", "observed", "with", "a", "concurrent", "activated", "partial", "thromboplastin", "time", "(", "aPTT", ")", "of", "100", "seconds", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> After <extra_id_0> treatment <extra_id_5> argatroban <extra_id_1> <extra_id_0> drug <extra_id_5> argatroban <extra_id_1> <extra_id_0> duration <extra_id_5> 39 hours <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 39 hours <extra_id_1> <extra_id_0> effect <extra_id_5> minor bleeding was observed with a concurrent activated partial thromboplastin time ( aPTT ) of 100 seconds <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [0], "text": "After", "args": [{"type": "treatment", "offset": [4], "text": "argatroban"}, {"type": "drug", "offset": [4], "text": "argatroban"}, {"type": "duration", "offset": [1, 2], "text": "39 hours"}, {"type": "time elapsed", "offset": [1, 2], "text": "39 hours"}, {"type": "effect", "offset": [11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27], "text": "minor bleeding was observed with a concurrent activated partial thromboplastin time ( aPTT ) of 100 seconds"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "drug", "time elapsed", "treatment"], "spot_asoc": [{"span": "After", "label": "adverse event", "asoc": [["treatment", "argatroban"], ["drug", "argatroban"], ["duration", "39 hours"], ["time elapsed", "39 hours"], ["effect", "minor bleeding was observed with a concurrent activated partial thromboplastin time ( aPTT ) of 100 seconds"]]}]}
{"text_id": "17324248_3", "text": "Piloerection induced by replacing fluvoxamine with milnacipran .", "tokens": ["Piloerection", "induced", "by", "replacing", "fluvoxamine", "with", "milnacipran", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> replacing fluvoxamine with milnacipran <extra_id_1> <extra_id_0> drug <extra_id_5> milnacipran <extra_id_1> <extra_id_0> drug <extra_id_5> fluvoxamine <extra_id_1> <extra_id_0> effect <extra_id_5> Piloerection <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "induced", "args": [{"type": "treatment", "offset": [3, 4, 5, 6], "text": "replacing fluvoxamine with milnacipran"}, {"type": "drug", "offset": [6], "text": "milnacipran"}, {"type": "drug", "offset": [4], "text": "fluvoxamine"}, {"type": "effect", "offset": [0], "text": "Piloerection"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "replacing fluvoxamine with milnacipran"], ["drug", "milnacipran"], ["drug", "fluvoxamine"], ["effect", "Piloerection"]]}]}
{"text_id": "17536204_2", "text": "BACKGROUND : Headaches have been reported as a potential side effect of capecitabine therapy .", "tokens": ["BACKGROUND", ":", "Headaches", "have", "been", "reported", "as", "a", "potential", "side", "effect", "of", "capecitabine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> of <extra_id_0> treatment <extra_id_5> capecitabine <extra_id_1> <extra_id_0> drug <extra_id_5> capecitabine <extra_id_1> <extra_id_0> effect <extra_id_5> Headaches <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "of", "args": [{"type": "treatment", "offset": [12], "text": "capecitabine"}, {"type": "drug", "offset": [12], "text": "capecitabine"}, {"type": "effect", "offset": [2], "text": "Headaches"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "of", "label": "adverse event", "asoc": [["treatment", "capecitabine"], ["drug", "capecitabine"], ["effect", "Headaches"]]}]}
{"text_id": "15533031_2", "text": "We report the case of a patient with increased cerebral cortical excitability following intoxication with flupirtine , a centrally acting analgesic and antispastic drug .", "tokens": ["We", "report", "the", "case", "of", "a", "patient", "with", "increased", "cerebral", "cortical", "excitability", "following", "intoxication", "with", "flupirtine", ",", "a", "centrally", "acting", "analgesic", "and", "antispastic", "drug", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> flupirtine <extra_id_1> <extra_id_0> drug <extra_id_5> flupirtine <extra_id_1> <extra_id_0> effect <extra_id_5> increased cerebral cortical excitability <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "following", "args": [{"type": "subject", "offset": [5, 6], "text": "a patient"}, {"type": "treatment", "offset": [15], "text": "flupirtine"}, {"type": "drug", "offset": [15], "text": "flupirtine"}, {"type": "effect", "offset": [8, 9, 10, 11], "text": "increased cerebral cortical excitability"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "flupirtine"], ["drug", "flupirtine"], ["effect", "increased cerebral cortical excitability"]]}]}
{"text_id": "18810448_1", "text": "In this report we described a case of juvenile idiopathic arthritis patient who developed thymic enlargement ( true thymic hyperplasia ) , mediastinal lymphadenopathy and pleurisy associated with systemic symptoms under Etanercept treatment .", "tokens": ["In", "this", "report", "we", "described", "a", "case", "of", "juvenile", "idiopathic", "arthritis", "patient", "who", "developed", "thymic", "enlargement", "(", "true", "thymic", "hyperplasia", ")", ",", "mediastinal", "lymphadenopathy", "and", "pleurisy", "associated", "with", "systemic", "symptoms", "under", "Etanercept", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a case of juvenile idiopathic arthritis patient <extra_id_1> <extra_id_0> age <extra_id_5> juvenile <extra_id_1> <extra_id_0> subject disorder <extra_id_5> idiopathic arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> Etanercept <extra_id_1> <extra_id_0> drug <extra_id_5> Etanercept <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> idiopathic arthritis <extra_id_1> <extra_id_0> effect <extra_id_5> thymic enlargement ( true thymic hyperplasia ) , mediastinal lymphadenopathy and pleurisy associated with systemic symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "developed", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "a case of juvenile idiopathic arthritis patient"}, {"type": "age", "offset": [8], "text": "juvenile"}, {"type": "subject disorder", "offset": [9, 10], "text": "idiopathic arthritis"}, {"type": "treatment", "offset": [31], "text": "Etanercept"}, {"type": "drug", "offset": [31], "text": "Etanercept"}, {"type": "treatment disorder", "offset": [9, 10], "text": "idiopathic arthritis"}, {"type": "effect", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29], "text": "thymic enlargement ( true thymic hyperplasia ) , mediastinal lymphadenopathy and pleurisy associated with systemic symptoms"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a case of juvenile idiopathic arthritis patient"], ["age", "juvenile"], ["subject disorder", "idiopathic arthritis"], ["treatment", "Etanercept"], ["drug", "Etanercept"], ["treatment disorder", "idiopathic arthritis"], ["effect", "thymic enlargement ( true thymic hyperplasia ) , mediastinal lymphadenopathy and pleurisy associated with systemic symptoms"]]}]}
{"text_id": "17228132_4", "text": "CASE REPORT : We report a case of acute severe hepatitis resulting from erlotinib monotherapy in a patient with locally advanced pancreatic cancer .", "tokens": ["CASE", "REPORT", ":", "We", "report", "a", "case", "of", "acute", "severe", "hepatitis", "resulting", "from", "erlotinib", "monotherapy", "in", "a", "patient", "with", "locally", "advanced", "pancreatic", "cancer", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resulting <extra_id_0> subject <extra_id_5> a patient with locally advanced pancreatic cancer <extra_id_1> <extra_id_0> subject disorder <extra_id_5> locally advanced pancreatic cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> erlotinib monotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> locally advanced pancreatic cancer <extra_id_1> <extra_id_0> effect <extra_id_5> acute severe hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "resulting", "args": [{"type": "subject", "offset": [16, 17, 18, 19, 20, 21, 22], "text": "a patient with locally advanced pancreatic cancer"}, {"type": "subject disorder", "offset": [19, 20, 21, 22], "text": "locally advanced pancreatic cancer"}, {"type": "treatment", "offset": [13, 14], "text": "erlotinib monotherapy"}, {"type": "drug", "offset": [13], "text": "erlotinib"}, {"type": "treatment disorder", "offset": [19, 20, 21, 22], "text": "locally advanced pancreatic cancer"}, {"type": "effect", "offset": [8, 9, 10], "text": "acute severe hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "resulting", "label": "adverse event", "asoc": [["subject", "a patient with locally advanced pancreatic cancer"], ["subject disorder", "locally advanced pancreatic cancer"], ["treatment", "erlotinib monotherapy"], ["drug", "erlotinib"], ["treatment disorder", "locally advanced pancreatic cancer"], ["effect", "acute severe hepatitis"]]}]}
{"text_id": "12121061_1", "text": "Ticlopidine - induced marrow aplasia treated with cyclosporine .", "tokens": ["Ticlopidine", "-", "induced", "marrow", "aplasia", "treated", "with", "cyclosporine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Ticlopidine <extra_id_1> <extra_id_0> drug <extra_id_5> Ticlopidine <extra_id_1> <extra_id_0> effect <extra_id_5> marrow aplasia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Ticlopidine"}, {"type": "drug", "offset": [0], "text": "Ticlopidine"}, {"type": "effect", "offset": [3, 4], "text": "marrow aplasia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Ticlopidine"], ["drug", "Ticlopidine"], ["effect", "marrow aplasia"]]}]}
{"text_id": "18665833_1", "text": "Stuttering priapism complicating warfarin therapy in a patient with protein C deficiency .", "tokens": ["Stuttering", "priapism", "complicating", "warfarin", "therapy", "in", "a", "patient", "with", "protein", "C", "deficiency", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> a patient with protein C deficiency <extra_id_1> <extra_id_0> subject disorder <extra_id_5> protein C deficiency <extra_id_1> <extra_id_0> treatment <extra_id_5> warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> protein C deficiency <extra_id_1> <extra_id_0> effect <extra_id_5> Stuttering priapism <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "in", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10, 11], "text": "a patient with protein C deficiency"}, {"type": "subject disorder", "offset": [9, 10, 11], "text": "protein C deficiency"}, {"type": "treatment", "offset": [3], "text": "warfarin"}, {"type": "drug", "offset": [3], "text": "warfarin"}, {"type": "treatment disorder", "offset": [9, 10, 11], "text": "protein C deficiency"}, {"type": "effect", "offset": [0, 1], "text": "Stuttering priapism"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "a patient with protein C deficiency"], ["subject disorder", "protein C deficiency"], ["treatment", "warfarin"], ["drug", "warfarin"], ["treatment disorder", "protein C deficiency"], ["effect", "Stuttering priapism"]]}]}
{"text_id": "17965530_1", "text": "Reports of colonic perforation as a result of the administration of calcium polystyrene sulfonate and sorbitol are rare .", "tokens": ["Reports", "of", "colonic", "perforation", "as", "a", "result", "of", "the", "administration", "of", "calcium", "polystyrene", "sulfonate", "and", "sorbitol", "are", "rare", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> result <extra_id_0> treatment <extra_id_5> calcium polystyrene sulfonate <extra_id_1> <extra_id_0> treatment <extra_id_5> sorbitol <extra_id_1> <extra_id_0> drug <extra_id_5> calcium polystyrene sulfonate <extra_id_1> <extra_id_0> drug <extra_id_5> sorbitol <extra_id_1> <extra_id_0> route <extra_id_5> the administration <extra_id_1> <extra_id_0> combination drug <extra_id_5> calcium polystyrene sulfonate <extra_id_1> <extra_id_0> combination drug <extra_id_5> sorbitol <extra_id_1> <extra_id_0> effect <extra_id_5> colonic perforation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "result", "args": [{"type": "treatment", "offset": [11, 12, 13], "text": "calcium polystyrene sulfonate"}, {"type": "treatment", "offset": [15], "text": "sorbitol"}, {"type": "drug", "offset": [11, 12, 13], "text": "calcium polystyrene sulfonate"}, {"type": "drug", "offset": [15], "text": "sorbitol"}, {"type": "route", "offset": [8, 9], "text": "the administration"}, {"type": "combination drug", "offset": [11, 12, 13], "text": "calcium polystyrene sulfonate"}, {"type": "combination drug", "offset": [15], "text": "sorbitol"}, {"type": "effect", "offset": [2, 3], "text": "colonic perforation"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "result", "label": "adverse event", "asoc": [["treatment", "calcium polystyrene sulfonate"], ["treatment", "sorbitol"], ["drug", "calcium polystyrene sulfonate"], ["drug", "sorbitol"], ["route", "the administration"], ["combination drug", "calcium polystyrene sulfonate"], ["combination drug", "sorbitol"], ["effect", "colonic perforation"]]}]}
{"text_id": "17536204_4", "text": "CCBs should be considered in the treatment of 5 - FU or capecitabine - induced headaches .", "tokens": ["CCBs", "should", "be", "considered", "in", "the", "treatment", "of", "5", "-", "FU", "or", "capecitabine", "-", "induced", "headaches", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> CCBs <extra_id_1> <extra_id_0> drug <extra_id_5> CCBs <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> headaches <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [6], "text": "treatment", "args": [{"type": "treatment", "offset": [0], "text": "CCBs"}, {"type": "drug", "offset": [0], "text": "CCBs"}, {"type": "treatment disorder", "offset": [15], "text": "headaches"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "CCBs"], ["drug", "CCBs"], ["treatment disorder", "headaches"]]}]}
{"text_id": "8375752_1", "text": "Although retinoic acid is well tolerated by the majority of patients with this disease , a potentially fatal complication of this kind of treatment has been reported : \" the retinoic acid syndrome \" .", "tokens": ["Although", "retinoic", "acid", "is", "well", "tolerated", "by", "the", "majority", "of", "patients", "with", "this", "disease", ",", "a", "potentially", "fatal", "complication", "of", "this", "kind", "of", "treatment", "has", "been", "reported", ":", "\"", "the", "retinoic", "acid", "syndrome", "\"", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> retinoic acid <extra_id_1> <extra_id_0> drug <extra_id_5> retinoic acid <extra_id_1> <extra_id_0> effect <extra_id_5> fatal complication <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "complication", "args": [{"type": "treatment", "offset": [1, 2], "text": "retinoic acid"}, {"type": "drug", "offset": [1, 2], "text": "retinoic acid"}, {"type": "effect", "offset": [17, 18], "text": "fatal complication"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "retinoic acid"], ["drug", "retinoic acid"], ["effect", "fatal complication"]]}]}
{"text_id": "3195622_1", "text": "A case report of the hypersensitivity syndrome occurring in a patient being treated with dapsone for a brown recluse spider bite is presented .", "tokens": ["A", "case", "report", "of", "the", "hypersensitivity", "syndrome", "occurring", "in", "a", "patient", "being", "treated", "with", "dapsone", "for", "a", "brown", "recluse", "spider", "bite", "is", "presented", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> brown recluse spider bite <extra_id_1> <extra_id_0> treatment <extra_id_5> dapsone <extra_id_1> <extra_id_0> drug <extra_id_5> dapsone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> brown recluse spider bite <extra_id_1> <extra_id_0> effect <extra_id_5> hypersensitivity syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "treated", "args": [{"type": "subject", "offset": [9, 10], "text": "a patient"}, {"type": "subject disorder", "offset": [17, 18, 19, 20], "text": "brown recluse spider bite"}, {"type": "treatment", "offset": [14], "text": "dapsone"}, {"type": "drug", "offset": [14], "text": "dapsone"}, {"type": "treatment disorder", "offset": [17, 18, 19, 20], "text": "brown recluse spider bite"}, {"type": "effect", "offset": [5, 6], "text": "hypersensitivity syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "adverse event", "asoc": [["subject", "a patient"], ["subject disorder", "brown recluse spider bite"], ["treatment", "dapsone"], ["drug", "dapsone"], ["treatment disorder", "brown recluse spider bite"], ["effect", "hypersensitivity syndrome"]]}]}
{"text_id": "9719245_2", "text": "He developed fever , nausea , diarrhea , and malaise and stopped taking on the third day after commencing Pentasa .", "tokens": ["He", "developed", "fever", ",", "nausea", ",", "diarrhea", ",", "and", "malaise", "and", "stopped", "taking", "on", "the", "third", "day", "after", "commencing", "Pentasa", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> He <extra_id_1> <extra_id_0> gender <extra_id_5> He <extra_id_1> <extra_id_0> treatment <extra_id_5> Pentasa <extra_id_1> <extra_id_0> drug <extra_id_5> Pentasa <extra_id_1> <extra_id_0> duration <extra_id_5> third day <extra_id_1> <extra_id_0> time elapsed <extra_id_5> third day <extra_id_1> <extra_id_0> effect <extra_id_5> fever , nausea , diarrhea , and malaise <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "developed", "args": [{"type": "subject", "offset": [0], "text": "He"}, {"type": "gender", "offset": [0], "text": "He"}, {"type": "treatment", "offset": [19], "text": "Pentasa"}, {"type": "drug", "offset": [19], "text": "Pentasa"}, {"type": "duration", "offset": [15, 16], "text": "third day"}, {"type": "time elapsed", "offset": [15, 16], "text": "third day"}, {"type": "effect", "offset": [2, 3, 4, 5, 6, 7, 8, 9], "text": "fever , nausea , diarrhea , and malaise"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "gender", "effect", "subject", "drug", "duration", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "He"], ["gender", "He"], ["treatment", "Pentasa"], ["drug", "Pentasa"], ["duration", "third day"], ["time elapsed", "third day"], ["effect", "fever , nausea , diarrhea , and malaise"]]}]}
{"text_id": "16371793_12", "text": "After intravitreal injection of triamcinolone acetonide , cataract may rapidly develop in eyes that have been intensively treated , topically and systemically , by corticosteroids for several years .", "tokens": ["After", "intravitreal", "injection", "of", "triamcinolone", "acetonide", ",", "cataract", "may", "rapidly", "develop", "in", "eyes", "that", "have", "been", "intensively", "treated", ",", "topically", "and", "systemically", ",", "by", "corticosteroids", "for", "several", "years", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> develop <extra_id_0> treatment <extra_id_5> intravitreal injection of triamcinolone acetonide <extra_id_1> <extra_id_0> drug <extra_id_5> triamcinolone acetonide <extra_id_1> <extra_id_0> route <extra_id_5> intravitreal injection <extra_id_1> <extra_id_0> effect <extra_id_5> cataract <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "develop", "args": [{"type": "treatment", "offset": [1, 2, 3, 4, 5], "text": "intravitreal injection of triamcinolone acetonide"}, {"type": "drug", "offset": [4, 5], "text": "triamcinolone acetonide"}, {"type": "route", "offset": [1, 2], "text": "intravitreal injection"}, {"type": "effect", "offset": [7], "text": "cataract"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "develop", "label": "adverse event", "asoc": [["treatment", "intravitreal injection of triamcinolone acetonide"], ["drug", "triamcinolone acetonide"], ["route", "intravitreal injection"], ["effect", "cataract"]]}]}
{"text_id": "21751542_4", "text": "Angiotensin converting enzyme blockers and their influence on the endothelial dysfunction , but the risk of hyperpotassemia are showed .", "tokens": ["Angiotensin", "converting", "enzyme", "blockers", "and", "their", "influence", "on", "the", "endothelial", "dysfunction", ",", "but", "the", "risk", "of", "hyperpotassemia", "are", "showed", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> showed <extra_id_0> treatment <extra_id_5> Angiotensin converting enzyme blockers <extra_id_1> <extra_id_0> drug <extra_id_5> Angiotensin converting enzyme blockers <extra_id_1> <extra_id_0> effect <extra_id_5> hyperpotassemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "showed", "args": [{"type": "treatment", "offset": [0, 1, 2, 3], "text": "Angiotensin converting enzyme blockers"}, {"type": "drug", "offset": [0, 1, 2, 3], "text": "Angiotensin converting enzyme blockers"}, {"type": "effect", "offset": [16], "text": "hyperpotassemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "showed", "label": "adverse event", "asoc": [["treatment", "Angiotensin converting enzyme blockers"], ["drug", "Angiotensin converting enzyme blockers"], ["effect", "hyperpotassemia"]]}]}
{"text_id": "15373932_10", "text": "This study revealed that ketoconazole affected the disposition of rosiglitazone in humans , probably by the inhibition of CYP2C8 and CYP2C9 , leading to increasing rosiglitazone concentrations that could increase the efficacy of rosiglitazone or its adverse events .", "tokens": ["This", "study", "revealed", "that", "ketoconazole", "affected", "the", "disposition", "of", "rosiglitazone", "in", "humans", ",", "probably", "by", "the", "inhibition", "of", "CYP2C8", "and", "CYP2C9", ",", "leading", "to", "increasing", "rosiglitazone", "concentrations", "that", "could", "increase", "the", "efficacy", "of", "rosiglitazone", "or", "its", "adverse", "events", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> leading to <extra_id_0> subject <extra_id_5> humans <extra_id_1> <extra_id_0> treatment <extra_id_5> ketoconazole <extra_id_1> <extra_id_0> drug <extra_id_5> ketoconazole <extra_id_1> <extra_id_0> effect <extra_id_5> increasing rosiglitazone concentrations that could increase the efficacy of rosiglitazone or its adverse events <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [22, 23], "text": "leading to", "args": [{"type": "subject", "offset": [11], "text": "humans"}, {"type": "treatment", "offset": [4], "text": "ketoconazole"}, {"type": "drug", "offset": [4], "text": "ketoconazole"}, {"type": "effect", "offset": [24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37], "text": "increasing rosiglitazone concentrations that could increase the efficacy of rosiglitazone or its adverse events"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "leading to", "label": "adverse event", "asoc": [["subject", "humans"], ["treatment", "ketoconazole"], ["drug", "ketoconazole"], ["effect", "increasing rosiglitazone concentrations that could increase the efficacy of rosiglitazone or its adverse events"]]}]}
{"text_id": "6987607_1", "text": "However , the amount of prednisone required to maintain normotension resulted in Cushingoid features and has been discontinued .", "tokens": ["However", ",", "the", "amount", "of", "prednisone", "required", "to", "maintain", "normotension", "resulted", "in", "Cushingoid", "features", "and", "has", "been", "discontinued", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resulted in <extra_id_0> treatment <extra_id_5> prednisone <extra_id_1> <extra_id_0> treatment <extra_id_5> to maintain normotension <extra_id_1> <extra_id_0> drug <extra_id_5> prednisone <extra_id_1> <extra_id_0> effect <extra_id_5> Cushingoid features <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10, 11], "text": "resulted in", "args": [{"type": "treatment", "offset": [5], "text": "prednisone"}, {"type": "treatment", "offset": [7, 8, 9], "text": "to maintain normotension"}, {"type": "drug", "offset": [5], "text": "prednisone"}, {"type": "effect", "offset": [12, 13], "text": "Cushingoid features"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "resulted in", "label": "adverse event", "asoc": [["treatment", "prednisone"], ["treatment", "to maintain normotension"], ["drug", "prednisone"], ["effect", "Cushingoid features"]]}]}
{"text_id": "11243427_4", "text": "Ectropion secondary to bolus injection of 5 - fluorouracil .", "tokens": ["Ectropion", "secondary", "to", "bolus", "injection", "of", "5", "-", "fluorouracil", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> secondary <extra_id_0> treatment <extra_id_5> bolus injection of 5 - fluorouracil <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - fluorouracil <extra_id_1> <extra_id_0> route <extra_id_5> bolus injection <extra_id_1> <extra_id_0> effect <extra_id_5> Ectropion <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "secondary", "args": [{"type": "treatment", "offset": [3, 4, 5, 6, 7, 8], "text": "bolus injection of 5 - fluorouracil"}, {"type": "drug", "offset": [6, 7, 8], "text": "5 - fluorouracil"}, {"type": "route", "offset": [3, 4], "text": "bolus injection"}, {"type": "effect", "offset": [0], "text": "Ectropion"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "secondary", "label": "adverse event", "asoc": [["treatment", "bolus injection of 5 - fluorouracil"], ["drug", "5 - fluorouracil"], ["route", "bolus injection"], ["effect", "Ectropion"]]}]}
{"text_id": "9247841_5", "text": "The observation of cutaneous vasculitis during administration of propylthiouracil suggested that clinical awareness of this complication should be of considerable importance .", "tokens": ["The", "observation", "of", "cutaneous", "vasculitis", "during", "administration", "of", "propylthiouracil", "suggested", "that", "clinical", "awareness", "of", "this", "complication", "should", "be", "of", "considerable", "importance", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> propylthiouracil <extra_id_1> <extra_id_0> drug <extra_id_5> propylthiouracil <extra_id_1> <extra_id_0> effect <extra_id_5> cutaneous vasculitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "during", "args": [{"type": "treatment", "offset": [8], "text": "propylthiouracil"}, {"type": "drug", "offset": [8], "text": "propylthiouracil"}, {"type": "effect", "offset": [3, 4], "text": "cutaneous vasculitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "propylthiouracil"], ["drug", "propylthiouracil"], ["effect", "cutaneous vasculitis"]]}]}
{"text_id": "8435665_3", "text": "Thus , the eosinophilia myalgia syndrome can be associated with parenteral tryptophan administration .", "tokens": ["Thus", ",", "the", "eosinophilia", "myalgia", "syndrome", "can", "be", "associated", "with", "parenteral", "tryptophan", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> parenteral tryptophan <extra_id_1> <extra_id_0> drug <extra_id_5> tryptophan <extra_id_1> <extra_id_0> route <extra_id_5> parenteral <extra_id_1> <extra_id_0> effect <extra_id_5> eosinophilia myalgia syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "associated", "args": [{"type": "treatment", "offset": [10, 11], "text": "parenteral tryptophan"}, {"type": "drug", "offset": [11], "text": "tryptophan"}, {"type": "route", "offset": [10], "text": "parenteral"}, {"type": "effect", "offset": [3, 4, 5], "text": "eosinophilia myalgia syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "parenteral tryptophan"], ["drug", "tryptophan"], ["route", "parenteral"], ["effect", "eosinophilia myalgia syndrome"]]}]}
{"text_id": "16641839_2", "text": "Angioedema , a rare side effect of carbamazepine , involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and/or bradykinins .", "tokens": ["Angioedema", ",", "a", "rare", "side", "effect", "of", "carbamazepine", ",", "involves", "vascular", "leakage", "in", "dermis", "and", "subcutis", "mediated", "by", "immunoglobulin", "E", "and/or", "bradykinins", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> of <extra_id_0> treatment <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> effect <extra_id_5> Angioedema <extra_id_1> <extra_id_0> effect <extra_id_5> involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and/or bradykinins <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "of", "args": [{"type": "treatment", "offset": [7], "text": "carbamazepine"}, {"type": "drug", "offset": [7], "text": "carbamazepine"}, {"type": "effect", "offset": [0], "text": "Angioedema"}, {"type": "effect", "offset": [9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21], "text": "involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and/or bradykinins"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "of", "label": "adverse event", "asoc": [["treatment", "carbamazepine"], ["drug", "carbamazepine"], ["effect", "Angioedema"], ["effect", "involves vascular leakage in dermis and subcutis mediated by immunoglobulin E and/or bradykinins"]]}]}
{"text_id": "2940999_1", "text": "Abnormal retinal function associated with isotretinoin therapy for acne .", "tokens": ["Abnormal", "retinal", "function", "associated", "with", "isotretinoin", "therapy", "for", "acne", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> isotretinoin <extra_id_1> <extra_id_0> drug <extra_id_5> isotretinoin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acne <extra_id_1> <extra_id_0> effect <extra_id_5> Abnormal retinal function <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "associated", "args": [{"type": "treatment", "offset": [5], "text": "isotretinoin"}, {"type": "drug", "offset": [5], "text": "isotretinoin"}, {"type": "treatment disorder", "offset": [8], "text": "acne"}, {"type": "effect", "offset": [0, 1, 2], "text": "Abnormal retinal function"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "isotretinoin"], ["drug", "isotretinoin"], ["treatment disorder", "acne"], ["effect", "Abnormal retinal function"]]}]}
{"text_id": "18784429_3", "text": "High - dose methylprednisolone in a pregnant woman with Crohn 's disease and adrenal suppression in her newborn .", "tokens": ["High", "-", "dose", "methylprednisolone", "in", "a", "pregnant", "woman", "with", "Crohn", "'s", "disease", "and", "adrenal", "suppression", "in", "her", "newborn", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> a pregnant woman with Crohn 's disease <extra_id_1> <extra_id_0> age <extra_id_5> pregnant <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> treatment <extra_id_5> High - dose methylprednisolone <extra_id_1> <extra_id_0> drug <extra_id_5> High - dose <extra_id_1> <extra_id_0> drug <extra_id_5> methylprednisolone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> effect <extra_id_5> adrenal suppression in her newborn <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "in", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "a pregnant woman with Crohn 's disease"}, {"type": "age", "offset": [6], "text": "pregnant"}, {"type": "gender", "offset": [7], "text": "woman"}, {"type": "subject disorder", "offset": [9, 10, 11], "text": "Crohn 's disease"}, {"type": "treatment", "offset": [0, 1, 2, 3], "text": "High - dose methylprednisolone"}, {"type": "drug", "offset": [0, 1, 2], "text": "High - dose"}, {"type": "drug", "offset": [3], "text": "methylprednisolone"}, {"type": "treatment disorder", "offset": [9, 10, 11], "text": "Crohn 's disease"}, {"type": "effect", "offset": [13, 14, 15, 16, 17], "text": "adrenal suppression in her newborn"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "a pregnant woman with Crohn 's disease"], ["age", "pregnant"], ["gender", "woman"], ["subject disorder", "Crohn 's disease"], ["treatment", "High - dose methylprednisolone"], ["drug", "High - dose"], ["drug", "methylprednisolone"], ["treatment disorder", "Crohn 's disease"], ["effect", "adrenal suppression in her newborn"]]}]}
{"text_id": "17873198_2", "text": "Pulmonary toxicity associated with erlotinib .", "tokens": ["Pulmonary", "toxicity", "associated", "with", "erlotinib", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> effect <extra_id_5> Pulmonary toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [4], "text": "erlotinib"}, {"type": "drug", "offset": [4], "text": "erlotinib"}, {"type": "effect", "offset": [0, 1], "text": "Pulmonary toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "erlotinib"], ["drug", "erlotinib"], ["effect", "Pulmonary toxicity"]]}]}
{"text_id": "7416268_2", "text": "The authors describe a case of the catatonia syndrome associated with disulfiram therapy .", "tokens": ["The", "authors", "describe", "a", "case", "of", "the", "catatonia", "syndrome", "associated", "with", "disulfiram", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> disulfiram therapy <extra_id_1> <extra_id_0> drug <extra_id_5> disulfiram <extra_id_1> <extra_id_0> effect <extra_id_5> catatonia syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "associated", "args": [{"type": "treatment", "offset": [11, 12], "text": "disulfiram therapy"}, {"type": "drug", "offset": [11], "text": "disulfiram"}, {"type": "effect", "offset": [7, 8], "text": "catatonia syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "disulfiram therapy"], ["drug", "disulfiram"], ["effect", "catatonia syndrome"]]}]}
{"text_id": "18607107_3", "text": "RESULTS : Our patient developed Crohn 's disease while on Copaxone treatment as a consequence of long - term immunosuppression .", "tokens": ["RESULTS", ":", "Our", "patient", "developed", "Crohn", "'s", "disease", "while", "on", "Copaxone", "treatment", "as", "a", "consequence", "of", "long", "-", "term", "immunosuppression", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> patient <extra_id_1> <extra_id_0> treatment <extra_id_5> Copaxone <extra_id_1> <extra_id_0> drug <extra_id_5> Copaxone <extra_id_1> <extra_id_0> effect <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> effect <extra_id_5> long - term immunosuppression <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "developed", "args": [{"type": "subject", "offset": [3], "text": "patient"}, {"type": "treatment", "offset": [10], "text": "Copaxone"}, {"type": "drug", "offset": [10], "text": "Copaxone"}, {"type": "effect", "offset": [5, 6, 7], "text": "Crohn 's disease"}, {"type": "effect", "offset": [16, 17, 18, 19], "text": "long - term immunosuppression"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "patient"], ["treatment", "Copaxone"], ["drug", "Copaxone"], ["effect", "Crohn 's disease"], ["effect", "long - term immunosuppression"]]}]}
{"text_id": "4095247_1", "text": "Cerebral and ocular toxicity induced by desferrioxamine .", "tokens": ["Cerebral", "and", "ocular", "toxicity", "induced", "by", "desferrioxamine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> desferrioxamine <extra_id_1> <extra_id_0> drug <extra_id_5> desferrioxamine <extra_id_1> <extra_id_0> effect <extra_id_5> Cerebral and ocular toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "induced", "args": [{"type": "treatment", "offset": [6], "text": "desferrioxamine"}, {"type": "drug", "offset": [6], "text": "desferrioxamine"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Cerebral and ocular toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "desferrioxamine"], ["drug", "desferrioxamine"], ["effect", "Cerebral and ocular toxicity"]]}]}
{"text_id": "12581772_3", "text": "Rapamycin / sirolimus ( SR ) , trade named Rapammune ( Wyeth - Ayerst , Sydney , Australia ) , is a potent immunosuppressive drug associated with myelosuppression , hypertension , hyperlipidemia , and infection .", "tokens": ["Rapamycin", "/", "sirolimus", "(", "SR", ")", ",", "trade", "named", "Rapammune", "(", "Wyeth", "-", "Ayerst", ",", "Sydney", ",", "Australia", ")", ",", "is", "a", "potent", "immunosuppressive", "drug", "associated", "with", "myelosuppression", ",", "hypertension", ",", "hyperlipidemia", ",", "and", "infection", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Rapamycin / sirolimus ( SR ) , trade named Rapammune ( Wyeth - Ayerst , Sydney , Australia ) <extra_id_1> <extra_id_0> drug <extra_id_5> Rapamycin / sirolimus <extra_id_1> <extra_id_0> effect <extra_id_5> myelosuppression , hypertension , hyperlipidemia , and infection <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [25], "text": "associated", "args": [{"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18], "text": "Rapamycin / sirolimus ( SR ) , trade named Rapammune ( Wyeth - Ayerst , Sydney , Australia )"}, {"type": "drug", "offset": [0, 1, 2], "text": "Rapamycin / sirolimus"}, {"type": "effect", "offset": [27, 28, 29, 30, 31, 32, 33, 34], "text": "myelosuppression , hypertension , hyperlipidemia , and infection"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Rapamycin / sirolimus ( SR ) , trade named Rapammune ( Wyeth - Ayerst , Sydney , Australia )"], ["drug", "Rapamycin / sirolimus"], ["effect", "myelosuppression , hypertension , hyperlipidemia , and infection"]]}]}
{"text_id": "19226083_16", "text": "Linezolid is a popular choice of antibiotic , especially for the treatment of orthopedic - related MRSA infections .", "tokens": ["Linezolid", "is", "a", "popular", "choice", "of", "antibiotic", ",", "especially", "for", "the", "treatment", "of", "orthopedic", "-", "related", "MRSA", "infections", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> Linezolid <extra_id_1> <extra_id_0> drug <extra_id_5> Linezolid <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> orthopedic - related MRSA infections <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [11], "text": "treatment", "args": [{"type": "treatment", "offset": [0], "text": "Linezolid"}, {"type": "drug", "offset": [0], "text": "Linezolid"}, {"type": "treatment disorder", "offset": [13, 14, 15, 16, 17], "text": "orthopedic - related MRSA infections"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "Linezolid"], ["drug", "Linezolid"], ["treatment disorder", "orthopedic - related MRSA infections"]]}]}
{"text_id": "3997294_1", "text": "Pneumonitis with pleural and pericardial effusion and neuropathy during amiodarone therapy .", "tokens": ["Pneumonitis", "with", "pleural", "and", "pericardial", "effusion", "and", "neuropathy", "during", "amiodarone", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> amiodarone therapy <extra_id_1> <extra_id_0> drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> effect <extra_id_5> Pneumonitis with pleural and pericardial effusion and neuropathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "during", "args": [{"type": "treatment", "offset": [9, 10], "text": "amiodarone therapy"}, {"type": "drug", "offset": [9], "text": "amiodarone"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Pneumonitis with pleural and pericardial effusion and neuropathy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "amiodarone therapy"], ["drug", "amiodarone"], ["effect", "Pneumonitis with pleural and pericardial effusion and neuropathy"]]}]}
{"text_id": "19145124_2", "text": "These are the first reported patients to show mfERG abnormalities that correspond to bitemporal visual field defects and add to the growing evidence that ethambutol damages the retina .", "tokens": ["These", "are", "the", "first", "reported", "patients", "to", "show", "mfERG", "abnormalities", "that", "correspond", "to", "bitemporal", "visual", "field", "defects", "and", "add", "to", "the", "growing", "evidence", "that", "ethambutol", "damages", "the", "retina", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> evidence <extra_id_0> treatment <extra_id_5> ethambutol <extra_id_1> <extra_id_0> drug <extra_id_5> ethambutol <extra_id_1> <extra_id_0> effect <extra_id_5> damages the retina <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [22], "text": "evidence", "args": [{"type": "treatment", "offset": [24], "text": "ethambutol"}, {"type": "drug", "offset": [24], "text": "ethambutol"}, {"type": "effect", "offset": [25, 26, 27], "text": "damages the retina"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "evidence", "label": "adverse event", "asoc": [["treatment", "ethambutol"], ["drug", "ethambutol"], ["effect", "damages the retina"]]}]}
{"text_id": "9723127_3", "text": "Decreased plasma cortisol level during alprazolam treatment of panic disorder : a case report .", "tokens": ["Decreased", "plasma", "cortisol", "level", "during", "alprazolam", "treatment", "of", "panic", "disorder", ":", "a", "case", "report", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> alprazolam <extra_id_1> <extra_id_0> drug <extra_id_5> alprazolam <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> panic disorder <extra_id_1> <extra_id_0> effect <extra_id_5> Decreased plasma cortisol level <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "during", "args": [{"type": "treatment", "offset": [5], "text": "alprazolam"}, {"type": "drug", "offset": [5], "text": "alprazolam"}, {"type": "treatment disorder", "offset": [8, 9], "text": "panic disorder"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Decreased plasma cortisol level"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "alprazolam"], ["drug", "alprazolam"], ["treatment disorder", "panic disorder"], ["effect", "Decreased plasma cortisol level"]]}]}
{"text_id": "8903300_2", "text": "Tetany in a child with AIDS receiving intravenous tobramycin .", "tokens": ["Tetany", "in", "a", "child", "with", "AIDS", "receiving", "intravenous", "tobramycin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> a child with AIDS <extra_id_1> <extra_id_0> age <extra_id_5> child <extra_id_1> <extra_id_0> subject disorder <extra_id_5> AIDS <extra_id_1> <extra_id_0> treatment <extra_id_5> intravenous tobramycin <extra_id_1> <extra_id_0> drug <extra_id_5> tobramycin <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> effect <extra_id_5> Tetany <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "in", "args": [{"type": "subject", "offset": [2, 3, 4, 5], "text": "a child with AIDS"}, {"type": "age", "offset": [3], "text": "child"}, {"type": "subject disorder", "offset": [5], "text": "AIDS"}, {"type": "treatment", "offset": [7, 8], "text": "intravenous tobramycin"}, {"type": "drug", "offset": [8], "text": "tobramycin"}, {"type": "route", "offset": [7], "text": "intravenous"}, {"type": "effect", "offset": [0], "text": "Tetany"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "a child with AIDS"], ["age", "child"], ["subject disorder", "AIDS"], ["treatment", "intravenous tobramycin"], ["drug", "tobramycin"], ["route", "intravenous"], ["effect", "Tetany"]]}]}
{"text_id": "16680561_10", "text": "Fewer subjects reported adverse events following treatment with desipramine alone than when receiving desipramine with cinacalcet ( 33 versus 86 % ) , the most frequent of which ( nausea and headache ) have been reported for patients treated with either desipramine or cinacalcet .", "tokens": ["Fewer", "subjects", "reported", "adverse", "events", "following", "treatment", "with", "desipramine", "alone", "than", "when", "receiving", "desipramine", "with", "cinacalcet", "(", "33", "versus", "86", "%", ")", ",", "the", "most", "frequent", "of", "which", "(", "nausea", "and", "headache", ")", "have", "been", "reported", "for", "patients", "treated", "with", "either", "desipramine", "or", "cinacalcet", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> reported <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> treatment <extra_id_5> desipramine or cinacalcet <extra_id_1> <extra_id_0> drug <extra_id_5> desipramine <extra_id_1> <extra_id_0> drug <extra_id_5> cinacalcet <extra_id_1> <extra_id_0> drug <extra_id_5> desipramine <extra_id_1> <extra_id_0> drug <extra_id_5> desipramine <extra_id_1> <extra_id_0> drug <extra_id_5> cinacalcet <extra_id_1> <extra_id_0> combination drug <extra_id_5> desipramine <extra_id_1> <extra_id_0> combination drug <extra_id_5> cinacalcet <extra_id_1> <extra_id_0> effect <extra_id_5> nausea and headache <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [35], "text": "reported", "args": [{"type": "subject", "offset": [37], "text": "patients"}, {"type": "treatment", "offset": [41, 42, 43], "text": "desipramine or cinacalcet"}, {"type": "drug", "offset": [41], "text": "desipramine"}, {"type": "drug", "offset": [43], "text": "cinacalcet"}, {"type": "drug", "offset": [8], "text": "desipramine"}, {"type": "drug", "offset": [13], "text": "desipramine"}, {"type": "drug", "offset": [15], "text": "cinacalcet"}, {"type": "combination drug", "offset": [13], "text": "desipramine"}, {"type": "combination drug", "offset": [15], "text": "cinacalcet"}, {"type": "effect", "offset": [29, 30, 31], "text": "nausea and headache"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "reported", "label": "adverse event", "asoc": [["subject", "patients"], ["treatment", "desipramine or cinacalcet"], ["drug", "desipramine"], ["drug", "cinacalcet"], ["drug", "desipramine"], ["drug", "desipramine"], ["drug", "cinacalcet"], ["combination drug", "desipramine"], ["combination drug", "cinacalcet"], ["effect", "nausea and headache"]]}]}
{"text_id": "582099_1", "text": "A patient with coccidioidal meningitis was treated with intrathecally administered amphotericin B , and an acute toxic delirium with EEG abnormalities developed .", "tokens": ["A", "patient", "with", "coccidioidal", "meningitis", "was", "treated", "with", "intrathecally", "administered", "amphotericin", "B", ",", "and", "an", "acute", "toxic", "delirium", "with", "EEG", "abnormalities", "developed", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated with <extra_id_0> subject <extra_id_5> A patient with coccidioidal meningitis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> coccidioidal meningitis <extra_id_1> <extra_id_0> treatment <extra_id_5> intrathecally administered amphotericin B <extra_id_1> <extra_id_0> drug <extra_id_5> amphotericin B <extra_id_1> <extra_id_0> route <extra_id_5> intrathecally <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> coccidioidal meningitis <extra_id_1> <extra_id_0> effect <extra_id_5> an acute toxic delirium with EEG abnormalities <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6, 7], "text": "treated with", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4], "text": "A patient with coccidioidal meningitis"}, {"type": "subject disorder", "offset": [3, 4], "text": "coccidioidal meningitis"}, {"type": "treatment", "offset": [8, 9, 10, 11], "text": "intrathecally administered amphotericin B"}, {"type": "drug", "offset": [10, 11], "text": "amphotericin B"}, {"type": "route", "offset": [8], "text": "intrathecally"}, {"type": "treatment disorder", "offset": [3, 4], "text": "coccidioidal meningitis"}, {"type": "effect", "offset": [14, 15, 16, 17, 18, 19, 20], "text": "an acute toxic delirium with EEG abnormalities"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treated with", "label": "adverse event", "asoc": [["subject", "A patient with coccidioidal meningitis"], ["subject disorder", "coccidioidal meningitis"], ["treatment", "intrathecally administered amphotericin B"], ["drug", "amphotericin B"], ["route", "intrathecally"], ["treatment disorder", "coccidioidal meningitis"], ["effect", "an acute toxic delirium with EEG abnormalities"]]}]}
{"text_id": "3659584_5", "text": "Although rare , massive pulmonary embolus must be considered to be a major risk of thrombolytic therapy for deep venous thrombosis .", "tokens": ["Although", "rare", ",", "massive", "pulmonary", "embolus", "must", "be", "considered", "to", "be", "a", "major", "risk", "of", "thrombolytic", "therapy", "for", "deep", "venous", "thrombosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> risk <extra_id_0> treatment <extra_id_5> thrombolytic <extra_id_1> <extra_id_0> drug <extra_id_5> thrombolytic <extra_id_1> <extra_id_0> effect <extra_id_5> massive pulmonary embolus <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "risk", "args": [{"type": "treatment", "offset": [15], "text": "thrombolytic"}, {"type": "drug", "offset": [15], "text": "thrombolytic"}, {"type": "effect", "offset": [3, 4, 5], "text": "massive pulmonary embolus"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "risk", "label": "adverse event", "asoc": [["treatment", "thrombolytic"], ["drug", "thrombolytic"], ["effect", "massive pulmonary embolus"]]}]}
{"text_id": "2051906_2", "text": "It is believed that this is the first reported case of reversible azathioprine - induced cholestasis associated with histological evidence of bile duct injury .", "tokens": ["It", "is", "believed", "that", "this", "is", "the", "first", "reported", "case", "of", "reversible", "azathioprine", "-", "induced", "cholestasis", "associated", "with", "histological", "evidence", "of", "bile", "duct", "injury", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> azathioprine <extra_id_1> <extra_id_0> drug <extra_id_5> azathioprine <extra_id_1> <extra_id_0> effect <extra_id_5> cholestasis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "induced", "args": [{"type": "treatment", "offset": [12], "text": "azathioprine"}, {"type": "drug", "offset": [12], "text": "azathioprine"}, {"type": "effect", "offset": [15], "text": "cholestasis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "azathioprine"], ["drug", "azathioprine"], ["effect", "cholestasis"]]}]}
{"text_id": "7962394_4", "text": "The present report describes the first case of acute pancreatitis associated with danazol treatment of endometriosis .", "tokens": ["The", "present", "report", "describes", "the", "first", "case", "of", "acute", "pancreatitis", "associated", "with", "danazol", "treatment", "of", "endometriosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> the first case <extra_id_1> <extra_id_0> subject disorder <extra_id_5> endometriosis <extra_id_1> <extra_id_0> treatment <extra_id_5> danazol treatment of endometriosis <extra_id_1> <extra_id_0> drug <extra_id_5> danazol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> endometriosis <extra_id_1> <extra_id_0> effect <extra_id_5> acute pancreatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "associated", "args": [{"type": "subject", "offset": [4, 5, 6], "text": "the first case"}, {"type": "subject disorder", "offset": [15], "text": "endometriosis"}, {"type": "treatment", "offset": [12, 13, 14, 15], "text": "danazol treatment of endometriosis"}, {"type": "drug", "offset": [12], "text": "danazol"}, {"type": "treatment disorder", "offset": [15], "text": "endometriosis"}, {"type": "effect", "offset": [8, 9], "text": "acute pancreatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "the first case"], ["subject disorder", "endometriosis"], ["treatment", "danazol treatment of endometriosis"], ["drug", "danazol"], ["treatment disorder", "endometriosis"], ["effect", "acute pancreatitis"]]}]}
{"text_id": "7973922_2", "text": "Acyclovir produces neurologic symptoms that resemble extension of viral infection into the central nervous system .", "tokens": ["Acyclovir", "produces", "neurologic", "symptoms", "that", "resemble", "extension", "of", "viral", "infection", "into", "the", "central", "nervous", "system", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> produces <extra_id_0> treatment <extra_id_5> Acyclovir <extra_id_1> <extra_id_0> drug <extra_id_5> Acyclovir <extra_id_1> <extra_id_0> effect <extra_id_5> neurologic symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "produces", "args": [{"type": "treatment", "offset": [0], "text": "Acyclovir"}, {"type": "drug", "offset": [0], "text": "Acyclovir"}, {"type": "effect", "offset": [2, 3], "text": "neurologic symptoms"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "produces", "label": "adverse event", "asoc": [["treatment", "Acyclovir"], ["drug", "Acyclovir"], ["effect", "neurologic symptoms"]]}]}
{"text_id": "1635565_2", "text": "CONCLUSIONS : The administration of prostaglandin E1 to neonates can cause gastric - outlet obstruction due to antral hyperplasia .", "tokens": ["CONCLUSIONS", ":", "The", "administration", "of", "prostaglandin", "E1", "to", "neonates", "can", "cause", "gastric", "-", "outlet", "obstruction", "due", "to", "antral", "hyperplasia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> subject <extra_id_5> neonates <extra_id_1> <extra_id_0> age <extra_id_5> neonates <extra_id_1> <extra_id_0> treatment <extra_id_5> prostaglandin E1 <extra_id_1> <extra_id_0> drug <extra_id_5> prostaglandin E1 <extra_id_1> <extra_id_0> effect <extra_id_5> gastric - outlet obstruction due to antral hyperplasia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "cause", "args": [{"type": "subject", "offset": [8], "text": "neonates"}, {"type": "age", "offset": [8], "text": "neonates"}, {"type": "treatment", "offset": [5, 6], "text": "prostaglandin E1"}, {"type": "drug", "offset": [5, 6], "text": "prostaglandin E1"}, {"type": "effect", "offset": [11, 12, 13, 14, 15, 16, 17, 18], "text": "gastric - outlet obstruction due to antral hyperplasia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["subject", "neonates"], ["age", "neonates"], ["treatment", "prostaglandin E1"], ["drug", "prostaglandin E1"], ["effect", "gastric - outlet obstruction due to antral hyperplasia"]]}]}
{"text_id": "10426918_1", "text": "2 - CdA induces lymphocytopenia , which may explain the improvement in this patient 's psoriasis .", "tokens": ["2", "-", "CdA", "induces", "lymphocytopenia", ",", "which", "may", "explain", "the", "improvement", "in", "this", "patient", "'s", "psoriasis", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> induces <extra_id_0> subject <extra_id_5> patient 's psoriasis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> psoriasis <extra_id_1> <extra_id_0> treatment <extra_id_5> 2 - CdA <extra_id_1> <extra_id_0> drug <extra_id_5> 2 - CdA <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> psoriasis <extra_id_1> <extra_id_0> effect <extra_id_5> lymphocytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [3], "text": "induces", "args": [{"type": "subject", "offset": [13, 14, 15], "text": "patient 's psoriasis"}, {"type": "subject disorder", "offset": [15], "text": "psoriasis"}, {"type": "treatment", "offset": [0, 1, 2], "text": "2 - CdA"}, {"type": "drug", "offset": [0, 1, 2], "text": "2 - CdA"}, {"type": "treatment disorder", "offset": [15], "text": "psoriasis"}, {"type": "effect", "offset": [4], "text": "lymphocytopenia"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induces", "label": "potential therapeutic event", "asoc": [["subject", "patient 's psoriasis"], ["subject disorder", "psoriasis"], ["treatment", "2 - CdA"], ["drug", "2 - CdA"], ["treatment disorder", "psoriasis"], ["effect", "lymphocytopenia"]]}]}
{"text_id": "8979664_3", "text": "Uveitis associated with rifabutin therapy : a clinical alert .", "tokens": ["Uveitis", "associated", "with", "rifabutin", "therapy", ":", "a", "clinical", "alert", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> rifabutin therapy <extra_id_1> <extra_id_0> drug <extra_id_5> rifabutin <extra_id_1> <extra_id_0> effect <extra_id_5> Uveitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "associated", "args": [{"type": "treatment", "offset": [3, 4], "text": "rifabutin therapy"}, {"type": "drug", "offset": [3], "text": "rifabutin"}, {"type": "effect", "offset": [0], "text": "Uveitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "rifabutin therapy"], ["drug", "rifabutin"], ["effect", "Uveitis"]]}]}
{"text_id": "1359782_3", "text": "Sulfasalazine - induced lung disorder is an extremely rare entity which must be considered in all ulcerative colitis patients while on sulfasalazine therapy , despite the absence of pulmonary symptomatology .", "tokens": ["Sulfasalazine", "-", "induced", "lung", "disorder", "is", "an", "extremely", "rare", "entity", "which", "must", "be", "considered", "in", "all", "ulcerative", "colitis", "patients", "while", "on", "sulfasalazine", "therapy", ",", "despite", "the", "absence", "of", "pulmonary", "symptomatology", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Sulfasalazine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Sulfasalazine <extra_id_1> <extra_id_0> effect <extra_id_5> lung disorder <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Sulfasalazine"}, {"type": "treatment disorder", "offset": [0], "text": "Sulfasalazine"}, {"type": "effect", "offset": [3, 4], "text": "lung disorder"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Sulfasalazine"], ["treatment disorder", "Sulfasalazine"], ["effect", "lung disorder"]]}]}
{"text_id": "7226916_2", "text": "Disopyramide - induced heart block .", "tokens": ["Disopyramide", "-", "induced", "heart", "block", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Disopyramide <extra_id_1> <extra_id_0> drug <extra_id_5> Disopyramide <extra_id_1> <extra_id_0> effect <extra_id_5> heart block <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Disopyramide"}, {"type": "drug", "offset": [0], "text": "Disopyramide"}, {"type": "effect", "offset": [3, 4], "text": "heart block"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Disopyramide"], ["drug", "Disopyramide"], ["effect", "heart block"]]}]}
{"text_id": "11243427_3", "text": "DISCUSSION : Patients with 5 - FU - induced ectropion experience tender , red , scaled lids , making contact lens wear difficult .", "tokens": ["DISCUSSION", ":", "Patients", "with", "5", "-", "FU", "-", "induced", "ectropion", "experience", "tender", ",", "red", ",", "scaled", "lids", ",", "making", "contact", "lens", "wear", "difficult", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> Patients with 5 - FU - induced ectropion <extra_id_1> <extra_id_0> treatment <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> effect <extra_id_5> ectropion <extra_id_1> <extra_id_0> effect <extra_id_5> tender , red , scaled lids <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "induced", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7, 8, 9], "text": "Patients with 5 - FU - induced ectropion"}, {"type": "treatment", "offset": [4, 5, 6], "text": "5 - FU"}, {"type": "drug", "offset": [4, 5, 6], "text": "5 - FU"}, {"type": "effect", "offset": [9], "text": "ectropion"}, {"type": "effect", "offset": [11, 12, 13, 14, 15, 16], "text": "tender , red , scaled lids"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "Patients with 5 - FU - induced ectropion"], ["treatment", "5 - FU"], ["drug", "5 - FU"], ["effect", "ectropion"], ["effect", "tender , red , scaled lids"]]}]}
{"text_id": "10723699_2", "text": "We report on a young adolescent with benign intracranial hypertension which we attribute to the use of minocycline for acne .", "tokens": ["We", "report", "on", "a", "young", "adolescent", "with", "benign", "intracranial", "hypertension", "which", "we", "attribute", "to", "the", "use", "of", "minocycline", "for", "acne", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> attribute <extra_id_0> subject <extra_id_5> a young adolescent <extra_id_1> <extra_id_0> age <extra_id_5> young adolescent <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acne <extra_id_1> <extra_id_0> treatment <extra_id_5> minocycline <extra_id_1> <extra_id_0> drug <extra_id_5> minocycline <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acne <extra_id_1> <extra_id_0> effect <extra_id_5> benign intracranial hypertension <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "attribute", "args": [{"type": "subject", "offset": [3, 4, 5], "text": "a young adolescent"}, {"type": "age", "offset": [4, 5], "text": "young adolescent"}, {"type": "subject disorder", "offset": [19], "text": "acne"}, {"type": "treatment", "offset": [17], "text": "minocycline"}, {"type": "drug", "offset": [17], "text": "minocycline"}, {"type": "treatment disorder", "offset": [19], "text": "acne"}, {"type": "effect", "offset": [7, 8, 9], "text": "benign intracranial hypertension"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "attribute", "label": "adverse event", "asoc": [["subject", "a young adolescent"], ["age", "young adolescent"], ["subject disorder", "acne"], ["treatment", "minocycline"], ["drug", "minocycline"], ["treatment disorder", "acne"], ["effect", "benign intracranial hypertension"]]}]}
{"text_id": "1635565_1", "text": "After gastric - outlet obstruction was recognized in several infants who received prostaglandin E1 , we studied the association between the drug and this complication .", "tokens": ["After", "gastric", "-", "outlet", "obstruction", "was", "recognized", "in", "several", "infants", "who", "received", "prostaglandin", "E1", ",", "we", "studied", "the", "association", "between", "the", "drug", "and", "this", "complication", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> received <extra_id_0> subject <extra_id_5> several infants <extra_id_1> <extra_id_0> age <extra_id_5> infants <extra_id_1> <extra_id_0> treatment <extra_id_5> prostaglandin E1 <extra_id_1> <extra_id_0> drug <extra_id_5> prostaglandin E1 <extra_id_1> <extra_id_0> effect <extra_id_5> gastric - outlet obstruction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "received", "args": [{"type": "subject", "offset": [8, 9], "text": "several infants"}, {"type": "age", "offset": [9], "text": "infants"}, {"type": "treatment", "offset": [12, 13], "text": "prostaglandin E1"}, {"type": "drug", "offset": [12, 13], "text": "prostaglandin E1"}, {"type": "effect", "offset": [1, 2, 3, 4], "text": "gastric - outlet obstruction"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "received", "label": "adverse event", "asoc": [["subject", "several infants"], ["age", "infants"], ["treatment", "prostaglandin E1"], ["drug", "prostaglandin E1"], ["effect", "gastric - outlet obstruction"]]}]}
{"text_id": "12923827_1", "text": "Schneiderian first - rank symptoms associated with fluvoxamine treatment : a case report .", "tokens": ["Schneiderian", "first", "-", "rank", "symptoms", "associated", "with", "fluvoxamine", "treatment", ":", "a", "case", "report", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> fluvoxamine <extra_id_1> <extra_id_0> drug <extra_id_5> fluvoxamine <extra_id_1> <extra_id_0> effect <extra_id_5> Schneiderian first - rank symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "associated", "args": [{"type": "treatment", "offset": [7], "text": "fluvoxamine"}, {"type": "drug", "offset": [7], "text": "fluvoxamine"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Schneiderian first - rank symptoms"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "fluvoxamine"], ["drug", "fluvoxamine"], ["effect", "Schneiderian first - rank symptoms"]]}]}
{"text_id": "21045170_9", "text": "When these cells are exposed to nicotinic acid , an exaggerated immune response is produced that may lead to pain , redness , and swelling at the injection site .", "tokens": ["When", "these", "cells", "are", "exposed", "to", "nicotinic", "acid", ",", "an", "exaggerated", "immune", "response", "is", "produced", "that", "may", "lead", "to", "pain", ",", "redness", ",", "and", "swelling", "at", "the", "injection", "site", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> produced <extra_id_0> treatment <extra_id_5> nicotinic acid <extra_id_1> <extra_id_0> drug <extra_id_5> nicotinic acid <extra_id_1> <extra_id_0> effect <extra_id_5> exaggerated immune response <extra_id_1> <extra_id_0> effect <extra_id_5> pain , redness , and swelling at the injection site <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "produced", "args": [{"type": "treatment", "offset": [6, 7], "text": "nicotinic acid"}, {"type": "drug", "offset": [6, 7], "text": "nicotinic acid"}, {"type": "effect", "offset": [10, 11, 12], "text": "exaggerated immune response"}, {"type": "effect", "offset": [19, 20, 21, 22, 23, 24, 25, 26, 27, 28], "text": "pain , redness , and swelling at the injection site"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "produced", "label": "adverse event", "asoc": [["treatment", "nicotinic acid"], ["drug", "nicotinic acid"], ["effect", "exaggerated immune response"], ["effect", "pain , redness , and swelling at the injection site"]]}]}
{"text_id": "18431096_1", "text": "Methylphenidate and dextroamphetamine - induced peripheral vasculopathy .", "tokens": ["Methylphenidate", "and", "dextroamphetamine", "-", "induced", "peripheral", "vasculopathy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Methylphenidate and dextroamphetamine <extra_id_1> <extra_id_0> drug <extra_id_5> dextroamphetamine <extra_id_1> <extra_id_0> drug <extra_id_5> Methylphenidate <extra_id_1> <extra_id_0> effect <extra_id_5> peripheral vasculopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "induced", "args": [{"type": "treatment", "offset": [0, 1, 2], "text": "Methylphenidate and dextroamphetamine"}, {"type": "drug", "offset": [2], "text": "dextroamphetamine"}, {"type": "drug", "offset": [0], "text": "Methylphenidate"}, {"type": "effect", "offset": [5, 6], "text": "peripheral vasculopathy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Methylphenidate and dextroamphetamine"], ["drug", "dextroamphetamine"], ["drug", "Methylphenidate"], ["effect", "peripheral vasculopathy"]]}]}
{"text_id": "10891991_6", "text": "RESULTS : Replacing valproate with lamotrigine resulted in a decrease in serum testosterone concentrations in all 3 women .", "tokens": ["RESULTS", ":", "Replacing", "valproate", "with", "lamotrigine", "resulted", "in", "a", "decrease", "in", "serum", "testosterone", "concentrations", "in", "all", "3", "women", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resulted <extra_id_0> subject <extra_id_5> all 3 women <extra_id_1> <extra_id_0> gender <extra_id_5> women <extra_id_1> <extra_id_0> population <extra_id_5> 3 <extra_id_1> <extra_id_0> treatment <extra_id_5> Replacing valproate with lamotrigine <extra_id_1> <extra_id_0> drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> effect <extra_id_5> a decrease in serum testosterone concentrations <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "resulted", "args": [{"type": "subject", "offset": [15, 16, 17], "text": "all 3 women"}, {"type": "gender", "offset": [17], "text": "women"}, {"type": "population", "offset": [16], "text": "3"}, {"type": "treatment", "offset": [2, 3, 4, 5], "text": "Replacing valproate with lamotrigine"}, {"type": "drug", "offset": [5], "text": "lamotrigine"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13], "text": "a decrease in serum testosterone concentrations"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "gender", "treatment"], "spot_asoc": [{"span": "resulted", "label": "adverse event", "asoc": [["subject", "all 3 women"], ["gender", "women"], ["population", "3"], ["treatment", "Replacing valproate with lamotrigine"], ["drug", "lamotrigine"], ["effect", "a decrease in serum testosterone concentrations"]]}]}
{"text_id": "16371793_11", "text": "CONCLUSIONS : Intravitreal injection of triamcinolone acetonide may be an additional tool in the treatment of therapy - resistant cystoid macular edema after penetrating keratoplasty .", "tokens": ["CONCLUSIONS", ":", "Intravitreal", "injection", "of", "triamcinolone", "acetonide", "may", "be", "an", "additional", "tool", "in", "the", "treatment", "of", "therapy", "-", "resistant", "cystoid", "macular", "edema", "after", "penetrating", "keratoplasty", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> Intravitreal injection of triamcinolone acetonide <extra_id_1> <extra_id_0> drug <extra_id_5> triamcinolone acetonide <extra_id_1> <extra_id_0> route <extra_id_5> Intravitreal injection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> therapy - resistant cystoid macular edema <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [14], "text": "treatment", "args": [{"type": "treatment", "offset": [2, 3, 4, 5, 6], "text": "Intravitreal injection of triamcinolone acetonide"}, {"type": "drug", "offset": [5, 6], "text": "triamcinolone acetonide"}, {"type": "route", "offset": [2, 3], "text": "Intravitreal injection"}, {"type": "treatment disorder", "offset": [16, 17, 18, 19, 20, 21], "text": "therapy - resistant cystoid macular edema"}]}], "spot": ["potential therapeutic event"], "asoc": ["route", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "Intravitreal injection of triamcinolone acetonide"], ["drug", "triamcinolone acetonide"], ["route", "Intravitreal injection"], ["treatment disorder", "therapy - resistant cystoid macular edema"]]}]}
{"text_id": "19299370_1", "text": "According to the Naranjo et al . adverse - reaction probability scale , enoxaparin was the probable cause of hepatotoxicity in this patient .", "tokens": ["According", "to", "the", "Naranjo", "et", "al", ".", "adverse", "-", "reaction", "probability", "scale", ",", "enoxaparin", "was", "the", "probable", "cause", "of", "hepatotoxicity", "in", "this", "patient", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> subject <extra_id_5> this patient <extra_id_1> <extra_id_0> treatment <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> drug <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> effect <extra_id_5> hepatotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "cause", "args": [{"type": "subject", "offset": [21, 22], "text": "this patient"}, {"type": "treatment", "offset": [13], "text": "enoxaparin"}, {"type": "drug", "offset": [13], "text": "enoxaparin"}, {"type": "effect", "offset": [19], "text": "hepatotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["subject", "this patient"], ["treatment", "enoxaparin"], ["drug", "enoxaparin"], ["effect", "hepatotoxicity"]]}]}
{"text_id": "17420198_17", "text": "The patient 's movements resolved following diphenhydramine administration .", "tokens": ["The", "patient", "'s", "movements", "resolved", "following", "diphenhydramine", "administration", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> resolved <extra_id_0> treatment <extra_id_5> diphenhydramine <extra_id_1> <extra_id_0> drug <extra_id_5> diphenhydramine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> movements <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [4], "text": "resolved", "args": [{"type": "treatment", "offset": [6], "text": "diphenhydramine"}, {"type": "drug", "offset": [6], "text": "diphenhydramine"}, {"type": "treatment disorder", "offset": [3], "text": "movements"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "resolved", "label": "potential therapeutic event", "asoc": [["treatment", "diphenhydramine"], ["drug", "diphenhydramine"], ["treatment disorder", "movements"]]}]}
{"text_id": "19116715_3", "text": "Rituximab - based therapy for gemcitabine - induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma : a case report .", "tokens": ["Rituximab", "-", "based", "therapy", "for", "gemcitabine", "-", "induced", "hemolytic", "uremic", "syndrome", "in", "a", "patient", "with", "metastatic", "pancreatic", "adenocarcinoma", ":", "a", "case", "report", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> patient with metastatic pancreatic adenocarcinoma <extra_id_1> <extra_id_0> subject disorder <extra_id_5> metastatic pancreatic adenocarcinoma <extra_id_1> <extra_id_0> treatment <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> metastatic pancreatic adenocarcinoma <extra_id_1> <extra_id_0> effect <extra_id_5> hemolytic uremic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "induced", "args": [{"type": "subject", "offset": [13, 14, 15, 16, 17], "text": "patient with metastatic pancreatic adenocarcinoma"}, {"type": "subject disorder", "offset": [15, 16, 17], "text": "metastatic pancreatic adenocarcinoma"}, {"type": "treatment", "offset": [5], "text": "gemcitabine"}, {"type": "drug", "offset": [5], "text": "gemcitabine"}, {"type": "treatment disorder", "offset": [15, 16, 17], "text": "metastatic pancreatic adenocarcinoma"}, {"type": "effect", "offset": [8, 9, 10], "text": "hemolytic uremic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "patient with metastatic pancreatic adenocarcinoma"], ["subject disorder", "metastatic pancreatic adenocarcinoma"], ["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["treatment disorder", "metastatic pancreatic adenocarcinoma"], ["effect", "hemolytic uremic syndrome"]]}]}
{"text_id": "24477376_7", "text": "Dual antiplatelet therapy with aspirin and a P2Y12 receptor antagonist following placement of coronary stents is critical to prevent stent thrombosis and subsequent myocardial infarction .", "tokens": ["Dual", "antiplatelet", "therapy", "with", "aspirin", "and", "a", "P2Y12", "receptor", "antagonist", "following", "placement", "of", "coronary", "stents", "is", "critical", "to", "prevent", "stent", "thrombosis", "and", "subsequent", "myocardial", "infarction", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> prevent <extra_id_0> treatment <extra_id_5> aspirin and a P2Y12 receptor antagonist following placement of coronary stents <extra_id_1> <extra_id_0> drug <extra_id_5> aspirin <extra_id_1> <extra_id_0> drug <extra_id_5> P2Y12 receptor antagonist <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> stent thrombosis and subsequent myocardial infarction <extra_id_1> <extra_id_0> combination drug <extra_id_5> aspirin <extra_id_1> <extra_id_0> combination drug <extra_id_5> P2Y12 receptor antagonist <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [18], "text": "prevent", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "aspirin and a P2Y12 receptor antagonist following placement of coronary stents"}, {"type": "drug", "offset": [4], "text": "aspirin"}, {"type": "drug", "offset": [7, 8, 9], "text": "P2Y12 receptor antagonist"}, {"type": "treatment disorder", "offset": [19, 20, 21, 22, 23, 24], "text": "stent thrombosis and subsequent myocardial infarction"}, {"type": "combination drug", "offset": [4], "text": "aspirin"}, {"type": "combination drug", "offset": [7, 8, 9], "text": "P2Y12 receptor antagonist"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "combination drug", "drug", "treatment disorder"], "spot_asoc": [{"span": "prevent", "label": "potential therapeutic event", "asoc": [["treatment", "aspirin and a P2Y12 receptor antagonist following placement of coronary stents"], ["drug", "aspirin"], ["drug", "P2Y12 receptor antagonist"], ["treatment disorder", "stent thrombosis and subsequent myocardial infarction"], ["combination drug", "aspirin"], ["combination drug", "P2Y12 receptor antagonist"]]}]}
{"text_id": "6692713_1", "text": "Amiodarone hydrochloride , a new antiarrhythmic agent , has been associated with pulmonary toxicity characterized by cough , dyspnea and diffuse pulmonary infiltrates .", "tokens": ["Amiodarone", "hydrochloride", ",", "a", "new", "antiarrhythmic", "agent", ",", "has", "been", "associated", "with", "pulmonary", "toxicity", "characterized", "by", "cough", ",", "dyspnea", "and", "diffuse", "pulmonary", "infiltrates", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Amiodarone hydrochloride <extra_id_1> <extra_id_0> drug <extra_id_5> Amiodarone hydrochloride <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary toxicity characterized by cough , dyspnea and diffuse pulmonary infiltrates <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "associated", "args": [{"type": "treatment", "offset": [0, 1], "text": "Amiodarone hydrochloride"}, {"type": "drug", "offset": [0, 1], "text": "Amiodarone hydrochloride"}, {"type": "effect", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22], "text": "pulmonary toxicity characterized by cough , dyspnea and diffuse pulmonary infiltrates"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Amiodarone hydrochloride"], ["drug", "Amiodarone hydrochloride"], ["effect", "pulmonary toxicity characterized by cough , dyspnea and diffuse pulmonary infiltrates"]]}]}
{"text_id": "640344_2", "text": "Severe histological osteomalacia developed in a woman with Crohn 's disease 2 years after ileal resection and the start of cholestyramine therapy .", "tokens": ["Severe", "histological", "osteomalacia", "developed", "in", "a", "woman", "with", "Crohn", "'s", "disease", "2", "years", "after", "ileal", "resection", "and", "the", "start", "of", "cholestyramine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a woman with Crohn 's disease <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> treatment <extra_id_5> 2 years after ileal resection and the start of cholestyramine <extra_id_1> <extra_id_0> drug <extra_id_5> cholestyramine <extra_id_1> <extra_id_0> time elapsed <extra_id_5> start <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> effect <extra_id_5> histological osteomalacia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "developed", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10], "text": "a woman with Crohn 's disease"}, {"type": "gender", "offset": [6], "text": "woman"}, {"type": "subject disorder", "offset": [8, 9, 10], "text": "Crohn 's disease"}, {"type": "treatment", "offset": [11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "2 years after ileal resection and the start of cholestyramine"}, {"type": "drug", "offset": [20], "text": "cholestyramine"}, {"type": "time elapsed", "offset": [18], "text": "start"}, {"type": "treatment disorder", "offset": [8, 9, 10], "text": "Crohn 's disease"}, {"type": "effect", "offset": [1, 2], "text": "histological osteomalacia"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a woman with Crohn 's disease"], ["gender", "woman"], ["subject disorder", "Crohn 's disease"], ["treatment", "2 years after ileal resection and the start of cholestyramine"], ["drug", "cholestyramine"], ["time elapsed", "start"], ["treatment disorder", "Crohn 's disease"], ["effect", "histological osteomalacia"]]}]}
{"text_id": "14693027_1", "text": "All patients had taken phenytoin for variable time periods ( range 16 - 80 days ; mean : 40 ) and were on the medication when the skin lesions first appeared .", "tokens": ["All", "patients", "had", "taken", "phenytoin", "for", "variable", "time", "periods", "(", "range", "16", "-", "80", "days", ";", "mean", ":", "40", ")", "and", "were", "on", "the", "medication", "when", "the", "skin", "lesions", "first", "appeared", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> appeared <extra_id_0> subject <extra_id_5> All patients <extra_id_1> <extra_id_0> treatment <extra_id_5> phenytoin for variable time periods ( range 16 - 80 days ; mean : 40 ) <extra_id_1> <extra_id_0> drug <extra_id_5> phenytoin <extra_id_1> <extra_id_0> duration <extra_id_5> 16 - 80 days ; <extra_id_1> <extra_id_0> effect <extra_id_5> skin lesions <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [30], "text": "appeared", "args": [{"type": "subject", "offset": [0, 1], "text": "All patients"}, {"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19], "text": "phenytoin for variable time periods ( range 16 - 80 days ; mean : 40 )"}, {"type": "drug", "offset": [4], "text": "phenytoin"}, {"type": "duration", "offset": [11, 12, 13, 14, 15], "text": "16 - 80 days ;"}, {"type": "effect", "offset": [27, 28], "text": "skin lesions"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "duration", "treatment"], "spot_asoc": [{"span": "appeared", "label": "adverse event", "asoc": [["subject", "All patients"], ["treatment", "phenytoin for variable time periods ( range 16 - 80 days ; mean : 40 )"], ["drug", "phenytoin"], ["duration", "16 - 80 days ;"], ["effect", "skin lesions"]]}]}
{"text_id": "2728526_1", "text": "Rifampin - associated thrombocytopenia secondary to poor compliance .", "tokens": ["Rifampin", "-", "associated", "thrombocytopenia", "secondary", "to", "poor", "compliance", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Rifampin <extra_id_1> <extra_id_0> drug <extra_id_5> Rifampin <extra_id_1> <extra_id_0> effect <extra_id_5> thrombocytopenia secondary to poor compliance <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Rifampin"}, {"type": "drug", "offset": [0], "text": "Rifampin"}, {"type": "effect", "offset": [3, 4, 5, 6, 7], "text": "thrombocytopenia secondary to poor compliance"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Rifampin"], ["drug", "Rifampin"], ["effect", "thrombocytopenia secondary to poor compliance"]]}]}
{"text_id": "18821094_2", "text": "This is an image and brief case report of a 13 - year - old boy who presented with severe rash and systemic symptoms after starting oxcarbazepine .", "tokens": ["This", "is", "an", "image", "and", "brief", "case", "report", "of", "a", "13", "-", "year", "-", "old", "boy", "who", "presented", "with", "severe", "rash", "and", "systemic", "symptoms", "after", "starting", "oxcarbazepine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a 13 - year - old boy <extra_id_1> <extra_id_0> age <extra_id_5> 13 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> boy <extra_id_1> <extra_id_0> treatment <extra_id_5> oxcarbazepine <extra_id_1> <extra_id_0> drug <extra_id_5> oxcarbazepine <extra_id_1> <extra_id_0> effect <extra_id_5> severe rash and systemic symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [24], "text": "after", "args": [{"type": "subject", "offset": [9, 10, 11, 12, 13, 14, 15], "text": "a 13 - year - old boy"}, {"type": "age", "offset": [10, 11, 12, 13, 14], "text": "13 - year - old"}, {"type": "gender", "offset": [15], "text": "boy"}, {"type": "treatment", "offset": [26], "text": "oxcarbazepine"}, {"type": "drug", "offset": [26], "text": "oxcarbazepine"}, {"type": "effect", "offset": [19, 20, 21, 22, 23], "text": "severe rash and systemic symptoms"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a 13 - year - old boy"], ["age", "13 - year - old"], ["gender", "boy"], ["treatment", "oxcarbazepine"], ["drug", "oxcarbazepine"], ["effect", "severe rash and systemic symptoms"]]}]}
{"text_id": "11943900_1", "text": "Pulmonary toxicity secondary to procarbazine .", "tokens": ["Pulmonary", "toxicity", "secondary", "to", "procarbazine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> secondary <extra_id_0> treatment <extra_id_5> procarbazine <extra_id_1> <extra_id_0> drug <extra_id_5> procarbazine <extra_id_1> <extra_id_0> effect <extra_id_5> Pulmonary toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "secondary", "args": [{"type": "treatment", "offset": [4], "text": "procarbazine"}, {"type": "drug", "offset": [4], "text": "procarbazine"}, {"type": "effect", "offset": [0, 1], "text": "Pulmonary toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "secondary", "label": "adverse event", "asoc": [["treatment", "procarbazine"], ["drug", "procarbazine"], ["effect", "Pulmonary toxicity"]]}]}
{"text_id": "15866658_3", "text": "The mean time from starting MMF to the development of neutropenia was 4 months .", "tokens": ["The", "mean", "time", "from", "starting", "MMF", "to", "the", "development", "of", "neutropenia", "was", "4", "months", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> treatment <extra_id_5> MMF <extra_id_1> <extra_id_0> drug <extra_id_5> MMF <extra_id_1> <extra_id_0> effect <extra_id_5> neutropenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "development", "args": [{"type": "treatment", "offset": [5], "text": "MMF"}, {"type": "drug", "offset": [5], "text": "MMF"}, {"type": "effect", "offset": [10], "text": "neutropenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["treatment", "MMF"], ["drug", "MMF"], ["effect", "neutropenia"]]}]}
{"text_id": "11443640_1", "text": "Massive plasmocytosis due to methimazole - induced bone marrow toxicity .", "tokens": ["Massive", "plasmocytosis", "due", "to", "methimazole", "-", "induced", "bone", "marrow", "toxicity", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> methimazole <extra_id_1> <extra_id_0> drug <extra_id_5> methimazole <extra_id_1> <extra_id_0> effect <extra_id_5> bone marrow toxicity <extra_id_1> <extra_id_0> effect <extra_id_5> Massive plasmocytosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "induced", "args": [{"type": "treatment", "offset": [4], "text": "methimazole"}, {"type": "drug", "offset": [4], "text": "methimazole"}, {"type": "effect", "offset": [7, 8, 9], "text": "bone marrow toxicity"}, {"type": "effect", "offset": [0, 1], "text": "Massive plasmocytosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "methimazole"], ["drug", "methimazole"], ["effect", "bone marrow toxicity"], ["effect", "Massive plasmocytosis"]]}]}
{"text_id": "8742573_2", "text": "CONCLUSIONS : Jet - injection devices might constitute a helpful method to treat those patients affected by severe human insulin - induced lipoatrophy .", "tokens": ["CONCLUSIONS", ":", "Jet", "-", "injection", "devices", "might", "constitute", "a", "helpful", "method", "to", "treat", "those", "patients", "affected", "by", "severe", "human", "insulin", "-", "induced", "lipoatrophy", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treat <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> insulin - induced lipoatrophy <extra_id_1> <extra_id_0> treatment <extra_id_5> Jet - injection devices <extra_id_1> <extra_id_0> route <extra_id_5> Jet - injection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> insulin - induced lipoatrophy <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> insulin <extra_id_1> <extra_id_0> drug <extra_id_5> insulin <extra_id_1> <extra_id_0> effect <extra_id_5> lipoatrophy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [12], "text": "treat", "args": [{"type": "subject", "offset": [14], "text": "patients"}, {"type": "subject disorder", "offset": [19, 20, 21, 22], "text": "insulin - induced lipoatrophy"}, {"type": "treatment", "offset": [2, 3, 4, 5], "text": "Jet - injection devices"}, {"type": "route", "offset": [2, 3, 4], "text": "Jet - injection"}, {"type": "treatment disorder", "offset": [19, 20, 21, 22], "text": "insulin - induced lipoatrophy"}]}, {"type": "adverse event", "offset": [21], "text": "induced", "args": [{"type": "treatment", "offset": [19], "text": "insulin"}, {"type": "drug", "offset": [19], "text": "insulin"}, {"type": "effect", "offset": [22], "text": "lipoatrophy"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "route", "subject", "drug", "treatment", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treat", "label": "potential therapeutic event", "asoc": [["subject", "patients"], ["subject disorder", "insulin - induced lipoatrophy"], ["treatment", "Jet - injection devices"], ["route", "Jet - injection"], ["treatment disorder", "insulin - induced lipoatrophy"]]}, {"span": "induced", "label": "adverse event", "asoc": [["treatment", "insulin"], ["drug", "insulin"], ["effect", "lipoatrophy"]]}]}
{"text_id": "3892171_4", "text": "Although adverse reactions to protamine are reported infrequently and are usually mild , we recently observed the first fatal case of type I anaphylaxis resulting from protamine .", "tokens": ["Although", "adverse", "reactions", "to", "protamine", "are", "reported", "infrequently", "and", "are", "usually", "mild", ",", "we", "recently", "observed", "the", "first", "fatal", "case", "of", "type", "I", "anaphylaxis", "resulting", "from", "protamine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resulting <extra_id_0> treatment <extra_id_5> protamine <extra_id_1> <extra_id_0> drug <extra_id_5> protamine <extra_id_1> <extra_id_0> effect <extra_id_5> fatal case of type I anaphylaxis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [24], "text": "resulting", "args": [{"type": "treatment", "offset": [26], "text": "protamine"}, {"type": "drug", "offset": [26], "text": "protamine"}, {"type": "effect", "offset": [18, 19, 20, 21, 22, 23], "text": "fatal case of type I anaphylaxis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "resulting", "label": "adverse event", "asoc": [["treatment", "protamine"], ["drug", "protamine"], ["effect", "fatal case of type I anaphylaxis"]]}]}
{"text_id": "8002140_3", "text": "METHODS : Five cases of contact dermatitis due to budesonide , a nonhalogenated steroid , are described .", "tokens": ["METHODS", ":", "Five", "cases", "of", "contact", "dermatitis", "due", "to", "budesonide", ",", "a", "nonhalogenated", "steroid", ",", "are", "described", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due to <extra_id_0> subject <extra_id_5> Five cases <extra_id_1> <extra_id_0> population <extra_id_5> Five <extra_id_1> <extra_id_0> treatment <extra_id_5> budesonide <extra_id_1> <extra_id_0> drug <extra_id_5> budesonide <extra_id_1> <extra_id_0> effect <extra_id_5> contact dermatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7, 8], "text": "due to", "args": [{"type": "subject", "offset": [2, 3], "text": "Five cases"}, {"type": "population", "offset": [2], "text": "Five"}, {"type": "treatment", "offset": [9], "text": "budesonide"}, {"type": "drug", "offset": [9], "text": "budesonide"}, {"type": "effect", "offset": [5, 6], "text": "contact dermatitis"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "due to", "label": "adverse event", "asoc": [["subject", "Five cases"], ["population", "Five"], ["treatment", "budesonide"], ["drug", "budesonide"], ["effect", "contact dermatitis"]]}]}
{"text_id": "18607107_1", "text": "CONCLUSIONS : Clinicians should be aware that Crohn 's disease is a potential novel adverse drug effect of Copaxone .", "tokens": ["CONCLUSIONS", ":", "Clinicians", "should", "be", "aware", "that", "Crohn", "'s", "disease", "is", "a", "potential", "novel", "adverse", "drug", "effect", "of", "Copaxone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> effect <extra_id_0> treatment <extra_id_5> Copaxone <extra_id_1> <extra_id_0> drug <extra_id_5> Copaxone <extra_id_1> <extra_id_0> effect <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "effect", "args": [{"type": "treatment", "offset": [18], "text": "Copaxone"}, {"type": "drug", "offset": [18], "text": "Copaxone"}, {"type": "effect", "offset": [7, 8, 9], "text": "Crohn 's disease"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "effect", "label": "adverse event", "asoc": [["treatment", "Copaxone"], ["drug", "Copaxone"], ["effect", "Crohn 's disease"]]}]}
{"text_id": "18171260_4", "text": "Serotonin syndrome after concomitant linezolid and meperidine therapy has not been described .", "tokens": ["Serotonin", "syndrome", "after", "concomitant", "linezolid", "and", "meperidine", "therapy", "has", "not", "been", "described", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> linezolid and meperidine <extra_id_1> <extra_id_0> drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> drug <extra_id_5> meperidine <extra_id_1> <extra_id_0> combination drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> combination drug <extra_id_5> meperidine <extra_id_1> <extra_id_0> effect <extra_id_5> Serotonin syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "after", "args": [{"type": "treatment", "offset": [4, 5, 6], "text": "linezolid and meperidine"}, {"type": "drug", "offset": [4], "text": "linezolid"}, {"type": "drug", "offset": [6], "text": "meperidine"}, {"type": "combination drug", "offset": [4], "text": "linezolid"}, {"type": "combination drug", "offset": [6], "text": "meperidine"}, {"type": "effect", "offset": [0, 1], "text": "Serotonin syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "linezolid and meperidine"], ["drug", "linezolid"], ["drug", "meperidine"], ["combination drug", "linezolid"], ["combination drug", "meperidine"], ["effect", "Serotonin syndrome"]]}]}
{"text_id": "8002140_4", "text": "RESULTS : Budesonide use can cause contact dermatitis .", "tokens": ["RESULTS", ":", "Budesonide", "use", "can", "cause", "contact", "dermatitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> Budesonide <extra_id_1> <extra_id_0> drug <extra_id_5> Budesonide <extra_id_1> <extra_id_0> effect <extra_id_5> contact dermatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "cause", "args": [{"type": "treatment", "offset": [2], "text": "Budesonide"}, {"type": "drug", "offset": [2], "text": "Budesonide"}, {"type": "effect", "offset": [6, 7], "text": "contact dermatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "Budesonide"], ["drug", "Budesonide"], ["effect", "contact dermatitis"]]}]}
{"text_id": "10891991_3", "text": "CONCLUSIONS : The 3 cases presented here illustrate the development of reproductive endocrine disorders after the initiation of valproate therapy in women with epilepsy .", "tokens": ["CONCLUSIONS", ":", "The", "3", "cases", "presented", "here", "illustrate", "the", "development", "of", "reproductive", "endocrine", "disorders", "after", "the", "initiation", "of", "valproate", "therapy", "in", "women", "with", "epilepsy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> subject <extra_id_5> The 3 cases <extra_id_1> <extra_id_0> subject <extra_id_5> women with epilepsy <extra_id_1> <extra_id_0> gender <extra_id_5> women <extra_id_1> <extra_id_0> population <extra_id_5> 3 <extra_id_1> <extra_id_0> subject disorder <extra_id_5> epilepsy <extra_id_1> <extra_id_0> treatment <extra_id_5> after the initiation of valproate therapy <extra_id_1> <extra_id_0> drug <extra_id_5> valproate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> epilepsy <extra_id_1> <extra_id_0> effect <extra_id_5> reproductive endocrine disorders <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "development", "args": [{"type": "subject", "offset": [2, 3, 4], "text": "The 3 cases"}, {"type": "subject", "offset": [21, 22, 23], "text": "women with epilepsy"}, {"type": "gender", "offset": [21], "text": "women"}, {"type": "population", "offset": [3], "text": "3"}, {"type": "subject disorder", "offset": [23], "text": "epilepsy"}, {"type": "treatment", "offset": [14, 15, 16, 17, 18, 19], "text": "after the initiation of valproate therapy"}, {"type": "drug", "offset": [18], "text": "valproate"}, {"type": "treatment disorder", "offset": [23], "text": "epilepsy"}, {"type": "effect", "offset": [11, 12, 13], "text": "reproductive endocrine disorders"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "gender", "treatment", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["subject", "The 3 cases"], ["subject", "women with epilepsy"], ["gender", "women"], ["population", "3"], ["subject disorder", "epilepsy"], ["treatment", "after the initiation of valproate therapy"], ["drug", "valproate"], ["treatment disorder", "epilepsy"], ["effect", "reproductive endocrine disorders"]]}]}
{"text_id": "15504988_1", "text": "Severe hypo - alpha - lipoproteinemia during treatment with rosiglitazone .", "tokens": ["Severe", "hypo", "-", "alpha", "-", "lipoproteinemia", "during", "treatment", "with", "rosiglitazone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> rosiglitazone <extra_id_1> <extra_id_0> drug <extra_id_5> rosiglitazone <extra_id_1> <extra_id_0> effect <extra_id_5> hypo - alpha - lipoproteinemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "during", "args": [{"type": "treatment", "offset": [9], "text": "rosiglitazone"}, {"type": "drug", "offset": [9], "text": "rosiglitazone"}, {"type": "effect", "offset": [1, 2, 3, 4, 5], "text": "hypo - alpha - lipoproteinemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "rosiglitazone"], ["drug", "rosiglitazone"], ["effect", "hypo - alpha - lipoproteinemia"]]}]}
{"text_id": "3612639_2", "text": "Pulmonary edema occurred 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy .", "tokens": ["Pulmonary", "edema", "occurred", "24", "hours", "after", "intravenous", "ritodrine", "therapy", "and", "10", "hours", "after", "subcutaneous", "terbutaline", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurred <extra_id_0> treatment <extra_id_5> 24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy <extra_id_1> <extra_id_0> drug <extra_id_5> ritodrine <extra_id_1> <extra_id_0> drug <extra_id_5> terbutaline <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> route <extra_id_5> subcutaneous <extra_id_1> <extra_id_0> duration <extra_id_5> 24 hours <extra_id_1> <extra_id_0> duration <extra_id_5> 10 hours <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 24 hours <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 10 hours <extra_id_1> <extra_id_0> combination drug <extra_id_5> ritodrine <extra_id_1> <extra_id_0> combination drug <extra_id_5> terbutaline <extra_id_1> <extra_id_0> effect <extra_id_5> Pulmonary edema <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "occurred", "args": [{"type": "treatment", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy"}, {"type": "drug", "offset": [7], "text": "ritodrine"}, {"type": "drug", "offset": [14], "text": "terbutaline"}, {"type": "route", "offset": [6], "text": "intravenous"}, {"type": "route", "offset": [13], "text": "subcutaneous"}, {"type": "duration", "offset": [3, 4], "text": "24 hours"}, {"type": "duration", "offset": [10, 11], "text": "10 hours"}, {"type": "time elapsed", "offset": [3, 4], "text": "24 hours"}, {"type": "time elapsed", "offset": [10, 11], "text": "10 hours"}, {"type": "combination drug", "offset": [7], "text": "ritodrine"}, {"type": "combination drug", "offset": [14], "text": "terbutaline"}, {"type": "effect", "offset": [0, 1], "text": "Pulmonary edema"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "route", "drug", "time elapsed", "treatment", "combination drug"], "spot_asoc": [{"span": "occurred", "label": "adverse event", "asoc": [["treatment", "24 hours after intravenous ritodrine therapy and 10 hours after subcutaneous terbutaline therapy"], ["drug", "ritodrine"], ["drug", "terbutaline"], ["route", "intravenous"], ["route", "subcutaneous"], ["duration", "24 hours"], ["duration", "10 hours"], ["time elapsed", "24 hours"], ["time elapsed", "10 hours"], ["combination drug", "ritodrine"], ["combination drug", "terbutaline"], ["effect", "Pulmonary edema"]]}]}
{"text_id": "8396491_2", "text": "The results clearly demonstrate that CPH82 was associated with suppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical hypercortisolism .", "tokens": ["The", "results", "clearly", "demonstrate", "that", "CPH82", "was", "associated", "with", "suppression", "of", "the", "endogeneous", "production", "of", "ACTH", "and", "cortisol", "with", "a", "concomitant", "paradoxical", "picture", "of", "clinical", "hypercortisolism", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> CPH82 <extra_id_1> <extra_id_0> drug <extra_id_5> CPH82 <extra_id_1> <extra_id_0> effect <extra_id_5> suppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical hypercortisolism <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "associated", "args": [{"type": "treatment", "offset": [5], "text": "CPH82"}, {"type": "drug", "offset": [5], "text": "CPH82"}, {"type": "effect", "offset": [9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "suppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical hypercortisolism"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "CPH82"], ["drug", "CPH82"], ["effect", "suppression of the endogeneous production of ACTH and cortisol with a concomitant paradoxical picture of clinical hypercortisolism"]]}]}
{"text_id": "10891991_2", "text": "BACKGROUND : Reproductive endocrine disorders characterized by menstrual disorders , polycystic ovaries , and hyperandrogenism seem to be common among women treated with sodium valproate for epilepsy .", "tokens": ["BACKGROUND", ":", "Reproductive", "endocrine", "disorders", "characterized", "by", "menstrual", "disorders", ",", "polycystic", "ovaries", ",", "and", "hyperandrogenism", "seem", "to", "be", "common", "among", "women", "treated", "with", "sodium", "valproate", "for", "epilepsy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated <extra_id_0> subject <extra_id_5> women <extra_id_1> <extra_id_0> gender <extra_id_5> women <extra_id_1> <extra_id_0> subject disorder <extra_id_5> epilepsy <extra_id_1> <extra_id_0> treatment <extra_id_5> sodium valproate for epilepsy <extra_id_1> <extra_id_0> drug <extra_id_5> sodium valproate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> epilepsy <extra_id_1> <extra_id_0> effect <extra_id_5> Reproductive endocrine disorders characterized by menstrual disorders , polycystic ovaries , and hyperandrogenism <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [21], "text": "treated", "args": [{"type": "subject", "offset": [20], "text": "women"}, {"type": "gender", "offset": [20], "text": "women"}, {"type": "subject disorder", "offset": [26], "text": "epilepsy"}, {"type": "treatment", "offset": [23, 24, 25, 26], "text": "sodium valproate for epilepsy"}, {"type": "drug", "offset": [23, 24], "text": "sodium valproate"}, {"type": "treatment disorder", "offset": [26], "text": "epilepsy"}, {"type": "effect", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "Reproductive endocrine disorders characterized by menstrual disorders , polycystic ovaries , and hyperandrogenism"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "adverse event", "asoc": [["subject", "women"], ["gender", "women"], ["subject disorder", "epilepsy"], ["treatment", "sodium valproate for epilepsy"], ["drug", "sodium valproate"], ["treatment disorder", "epilepsy"], ["effect", "Reproductive endocrine disorders characterized by menstrual disorders , polycystic ovaries , and hyperandrogenism"]]}]}
{"text_id": "267281_1", "text": "A patient with chronic myeloid leukaemia treated with busulphan for 4 - 5 years , developed signs of busulphan toxicity and portal hypertension with ascites , oesophageal varices and jaundice .", "tokens": ["A", "patient", "with", "chronic", "myeloid", "leukaemia", "treated", "with", "busulphan", "for", "4", "-", "5", "years", ",", "developed", "signs", "of", "busulphan", "toxicity", "and", "portal", "hypertension", "with", "ascites", ",", "oesophageal", "varices", "and", "jaundice", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A patient with chronic myeloid leukaemia <extra_id_1> <extra_id_0> subject disorder <extra_id_5> chronic myeloid leukaemia <extra_id_1> <extra_id_0> treatment <extra_id_5> busulphan for 4 - 5 years <extra_id_1> <extra_id_0> drug <extra_id_5> busulphan <extra_id_1> <extra_id_0> duration <extra_id_5> 4 - 5 years <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 4 - 5 years <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic myeloid leukaemia <extra_id_1> <extra_id_0> effect <extra_id_5> busulphan toxicity and portal hypertension with ascites , oesophageal varices and jaundice <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5], "text": "A patient with chronic myeloid leukaemia"}, {"type": "subject disorder", "offset": [3, 4, 5], "text": "chronic myeloid leukaemia"}, {"type": "treatment", "offset": [8, 9, 10, 11, 12, 13], "text": "busulphan for 4 - 5 years"}, {"type": "drug", "offset": [8], "text": "busulphan"}, {"type": "duration", "offset": [10, 11, 12, 13], "text": "4 - 5 years"}, {"type": "time elapsed", "offset": [10, 11, 12, 13], "text": "4 - 5 years"}, {"type": "treatment disorder", "offset": [3, 4, 5], "text": "chronic myeloid leukaemia"}, {"type": "effect", "offset": [18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29], "text": "busulphan toxicity and portal hypertension with ascites , oesophageal varices and jaundice"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "subject", "treatment", "duration", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A patient with chronic myeloid leukaemia"], ["subject disorder", "chronic myeloid leukaemia"], ["treatment", "busulphan for 4 - 5 years"], ["drug", "busulphan"], ["duration", "4 - 5 years"], ["time elapsed", "4 - 5 years"], ["treatment disorder", "chronic myeloid leukaemia"], ["effect", "busulphan toxicity and portal hypertension with ascites , oesophageal varices and jaundice"]]}]}
{"text_id": "3997294_2", "text": "Review of this and previously reported cases indicates the need for early diagnosis of amiodarone pneumonitis , immediate withdrawal of amiodarone , and prompt but continued steroid therapy to ensure full recovery .", "tokens": ["Review", "of", "this", "and", "previously", "reported", "cases", "indicates", "the", "need", "for", "early", "diagnosis", "of", "amiodarone", "pneumonitis", ",", "immediate", "withdrawal", "of", "amiodarone", ",", "and", "prompt", "but", "continued", "steroid", "therapy", "to", "ensure", "full", "recovery", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> of <extra_id_0> treatment <extra_id_5> amiodarone <extra_id_1> <extra_id_0> drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> effect <extra_id_5> pneumonitis <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> recovery <extra_id_0> treatment <extra_id_5> immediate withdrawal of amiodarone , and prompt but continued steroid therapy <extra_id_1> <extra_id_0> drug <extra_id_5> steroid <extra_id_1> <extra_id_0> drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> pneumonitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "of", "args": [{"type": "treatment", "offset": [14], "text": "amiodarone"}, {"type": "drug", "offset": [14], "text": "amiodarone"}, {"type": "effect", "offset": [15], "text": "pneumonitis"}]}, {"type": "potential therapeutic event", "offset": [31], "text": "recovery", "args": [{"type": "treatment", "offset": [17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27], "text": "immediate withdrawal of amiodarone , and prompt but continued steroid therapy"}, {"type": "drug", "offset": [26], "text": "steroid"}, {"type": "drug", "offset": [20], "text": "amiodarone"}, {"type": "treatment disorder", "offset": [15], "text": "pneumonitis"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "of", "label": "adverse event", "asoc": [["treatment", "amiodarone"], ["drug", "amiodarone"], ["effect", "pneumonitis"]]}, {"span": "recovery", "label": "potential therapeutic event", "asoc": [["treatment", "immediate withdrawal of amiodarone , and prompt but continued steroid therapy"], ["drug", "steroid"], ["drug", "amiodarone"], ["treatment disorder", "pneumonitis"]]}]}
{"text_id": "7776854_3", "text": "We report three cases of severe hepatotoxicity related to benzarone , a benzofuran derivative .", "tokens": ["We", "report", "three", "cases", "of", "severe", "hepatotoxicity", "related", "to", "benzarone", ",", "a", "benzofuran", "derivative", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> subject <extra_id_5> three cases <extra_id_1> <extra_id_0> population <extra_id_5> three <extra_id_1> <extra_id_0> treatment <extra_id_5> benzarone <extra_id_1> <extra_id_0> drug <extra_id_5> benzarone <extra_id_1> <extra_id_0> effect <extra_id_5> severe hepatotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "related", "args": [{"type": "subject", "offset": [2, 3], "text": "three cases"}, {"type": "population", "offset": [2], "text": "three"}, {"type": "treatment", "offset": [9], "text": "benzarone"}, {"type": "drug", "offset": [9], "text": "benzarone"}, {"type": "effect", "offset": [5, 6], "text": "severe hepatotoxicity"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["subject", "three cases"], ["population", "three"], ["treatment", "benzarone"], ["drug", "benzarone"], ["effect", "severe hepatotoxicity"]]}]}
{"text_id": "17420198_1", "text": "Potential aripiprazole - mediated extrapyramidal symptoms in an adult with developmental disabilities .", "tokens": ["Potential", "aripiprazole", "-", "mediated", "extrapyramidal", "symptoms", "in", "an", "adult", "with", "developmental", "disabilities", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> mediated <extra_id_0> subject <extra_id_5> an adult with developmental disabilities <extra_id_1> <extra_id_0> age <extra_id_5> adult <extra_id_1> <extra_id_0> subject disorder <extra_id_5> developmental disabilities <extra_id_1> <extra_id_0> treatment <extra_id_5> aripiprazole <extra_id_1> <extra_id_0> drug <extra_id_5> aripiprazole <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> developmental disabilities <extra_id_1> <extra_id_0> effect <extra_id_5> extrapyramidal symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "mediated", "args": [{"type": "subject", "offset": [7, 8, 9, 10, 11], "text": "an adult with developmental disabilities"}, {"type": "age", "offset": [8], "text": "adult"}, {"type": "subject disorder", "offset": [10, 11], "text": "developmental disabilities"}, {"type": "treatment", "offset": [1], "text": "aripiprazole"}, {"type": "drug", "offset": [1], "text": "aripiprazole"}, {"type": "treatment disorder", "offset": [10, 11], "text": "developmental disabilities"}, {"type": "effect", "offset": [4, 5], "text": "extrapyramidal symptoms"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "mediated", "label": "adverse event", "asoc": [["subject", "an adult with developmental disabilities"], ["age", "adult"], ["subject disorder", "developmental disabilities"], ["treatment", "aripiprazole"], ["drug", "aripiprazole"], ["treatment disorder", "developmental disabilities"], ["effect", "extrapyramidal symptoms"]]}]}
{"text_id": "9247841_4", "text": "We report 3 patients who developed cutaneous vasculitis which is a rare and serious side - effect during antithyroid drug therapy .", "tokens": ["We", "report", "3", "patients", "who", "developed", "cutaneous", "vasculitis", "which", "is", "a", "rare", "and", "serious", "side", "-", "effect", "during", "antithyroid", "drug", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> 3 patients <extra_id_1> <extra_id_0> population <extra_id_5> 3 <extra_id_1> <extra_id_0> treatment <extra_id_5> during antithyroid drug therapy <extra_id_1> <extra_id_0> drug <extra_id_5> antithyroid <extra_id_1> <extra_id_0> effect <extra_id_5> cutaneous vasculitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "developed", "args": [{"type": "subject", "offset": [2, 3], "text": "3 patients"}, {"type": "population", "offset": [2], "text": "3"}, {"type": "treatment", "offset": [17, 18, 19, 20], "text": "during antithyroid drug therapy"}, {"type": "drug", "offset": [18], "text": "antithyroid"}, {"type": "effect", "offset": [6, 7], "text": "cutaneous vasculitis"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "3 patients"], ["population", "3"], ["treatment", "during antithyroid drug therapy"], ["drug", "antithyroid"], ["effect", "cutaneous vasculitis"]]}]}
{"text_id": "7653281_2", "text": "Little has been studied of the adverse effects of the exposure of the liver to the interaction of ethanol with its congeners and acetaldehyde , coexisting in the contents of alcoholic beverages .", "tokens": ["Little", "has", "been", "studied", "of", "the", "adverse", "effects", "of", "the", "exposure", "of", "the", "liver", "to", "the", "interaction", "of", "ethanol", "with", "its", "congeners", "and", "acetaldehyde", ",", "coexisting", "in", "the", "contents", "of", "alcoholic", "beverages", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> interaction <extra_id_0> treatment <extra_id_5> ethanol with its congeners and acetaldehyde <extra_id_1> <extra_id_0> drug <extra_id_5> acetaldehyde <extra_id_1> <extra_id_0> drug <extra_id_5> ethanol <extra_id_1> <extra_id_0> combination drug <extra_id_5> ethanol <extra_id_1> <extra_id_0> combination drug <extra_id_5> acetaldehyde <extra_id_1> <extra_id_0> effect <extra_id_5> adverse effects of the exposure of the liver <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "interaction", "args": [{"type": "treatment", "offset": [18, 19, 20, 21, 22, 23], "text": "ethanol with its congeners and acetaldehyde"}, {"type": "drug", "offset": [23], "text": "acetaldehyde"}, {"type": "drug", "offset": [18], "text": "ethanol"}, {"type": "combination drug", "offset": [18], "text": "ethanol"}, {"type": "combination drug", "offset": [23], "text": "acetaldehyde"}, {"type": "effect", "offset": [6, 7, 8, 9, 10, 11, 12, 13], "text": "adverse effects of the exposure of the liver"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "interaction", "label": "adverse event", "asoc": [["treatment", "ethanol with its congeners and acetaldehyde"], ["drug", "acetaldehyde"], ["drug", "ethanol"], ["combination drug", "ethanol"], ["combination drug", "acetaldehyde"], ["effect", "adverse effects of the exposure of the liver"]]}]}
{"text_id": "8730143_2", "text": "Physicians should be aware of the potentially lethal side effects of dapsone .", "tokens": ["Physicians", "should", "be", "aware", "of", "the", "potentially", "lethal", "side", "effects", "of", "dapsone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> of <extra_id_0> treatment <extra_id_5> dapsone <extra_id_1> <extra_id_0> drug <extra_id_5> dapsone <extra_id_1> <extra_id_0> effect <extra_id_5> lethal side effects <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "of", "args": [{"type": "treatment", "offset": [11], "text": "dapsone"}, {"type": "drug", "offset": [11], "text": "dapsone"}, {"type": "effect", "offset": [7, 8, 9], "text": "lethal side effects"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "of", "label": "adverse event", "asoc": [["treatment", "dapsone"], ["drug", "dapsone"], ["effect", "lethal side effects"]]}]}
{"text_id": "8496127_2", "text": "This paper reports on a 6.9 - year - old autistic male who developed repeated episodes of acute dystonic reactions associated with pimozide administration at the doses of 0.096 mg / kg / day and 0.032 mg / kg / day and 32 hours following pimozide withdrawal , as well as during subsequent thioridazine administration .", "tokens": ["This", "paper", "reports", "on", "a", "6.9", "-", "year", "-", "old", "autistic", "male", "who", "developed", "repeated", "episodes", "of", "acute", "dystonic", "reactions", "associated", "with", "pimozide", "administration", "at", "the", "doses", "of", "0.096", "mg", "/", "kg", "/", "day", "and", "0.032", "mg", "/", "kg", "/", "day", "and", "32", "hours", "following", "pimozide", "withdrawal", ",", "as", "well", "as", "during", "subsequent", "thioridazine", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> 6.9 - year - old autistic male <extra_id_1> <extra_id_0> age <extra_id_5> 6.9 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> male <extra_id_1> <extra_id_0> subject disorder <extra_id_5> autistic <extra_id_1> <extra_id_0> treatment <extra_id_5> pimozide administration at the doses of 0.096 mg / kg / day and 0.032 mg / kg / day and 32 hours following pimozide withdrawal , as well as during subsequent thioridazine administration <extra_id_1> <extra_id_0> drug <extra_id_5> pimozide <extra_id_1> <extra_id_0> drug <extra_id_5> pimozide <extra_id_1> <extra_id_0> drug <extra_id_5> thioridazine <extra_id_1> <extra_id_0> dosage <extra_id_5> 0.096 mg / kg <extra_id_1> <extra_id_0> dosage <extra_id_5> 0.032 mg / kg <extra_id_1> <extra_id_0> frequency <extra_id_5> day <extra_id_1> <extra_id_0> frequency <extra_id_5> day <extra_id_1> <extra_id_0> effect <extra_id_5> repeated episodes of acute dystonic reactions <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "associated", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "6.9 - year - old autistic male"}, {"type": "age", "offset": [5, 6, 7, 8, 9], "text": "6.9 - year - old"}, {"type": "gender", "offset": [11], "text": "male"}, {"type": "subject disorder", "offset": [10], "text": "autistic"}, {"type": "treatment", "offset": [22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54], "text": "pimozide administration at the doses of 0.096 mg / kg / day and 0.032 mg / kg / day and 32 hours following pimozide withdrawal , as well as during subsequent thioridazine administration"}, {"type": "drug", "offset": [22], "text": "pimozide"}, {"type": "drug", "offset": [45], "text": "pimozide"}, {"type": "drug", "offset": [53], "text": "thioridazine"}, {"type": "dosage", "offset": [28, 29, 30, 31], "text": "0.096 mg / kg"}, {"type": "dosage", "offset": [35, 36, 37, 38], "text": "0.032 mg / kg"}, {"type": "frequency", "offset": [33], "text": "day"}, {"type": "frequency", "offset": [40], "text": "day"}, {"type": "effect", "offset": [14, 15, 16, 17, 18, 19], "text": "repeated episodes of acute dystonic reactions"}]}], "spot": ["adverse event"], "asoc": ["dosage", "effect", "subject", "drug", "gender", "frequency", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "6.9 - year - old autistic male"], ["age", "6.9 - year - old"], ["gender", "male"], ["subject disorder", "autistic"], ["treatment", "pimozide administration at the doses of 0.096 mg / kg / day and 0.032 mg / kg / day and 32 hours following pimozide withdrawal , as well as during subsequent thioridazine administration"], ["drug", "pimozide"], ["drug", "pimozide"], ["drug", "thioridazine"], ["dosage", "0.096 mg / kg"], ["dosage", "0.032 mg / kg"], ["frequency", "day"], ["frequency", "day"], ["effect", "repeated episodes of acute dystonic reactions"]]}]}
{"text_id": "10923593_1", "text": "Skin manifestations of a case of phenylbutazone - induced serum sickness - like reactions .", "tokens": ["Skin", "manifestations", "of", "a", "case", "of", "phenylbutazone", "-", "induced", "serum", "sickness", "-", "like", "reactions", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> phenylbutazone <extra_id_1> <extra_id_0> drug <extra_id_5> phenylbutazone <extra_id_1> <extra_id_0> effect <extra_id_5> serum sickness - like reactions <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "induced", "args": [{"type": "treatment", "offset": [6], "text": "phenylbutazone"}, {"type": "drug", "offset": [6], "text": "phenylbutazone"}, {"type": "effect", "offset": [9, 10, 11, 12, 13], "text": "serum sickness - like reactions"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "phenylbutazone"], ["drug", "phenylbutazone"], ["effect", "serum sickness - like reactions"]]}]}
{"text_id": "6260900_2", "text": "One of these was clofazimine , an aniline aposafranine derivative known to produce a ceroid - like pigment in the tissues of patients treated with this drug or lepromatous leprosy .", "tokens": ["One", "of", "these", "was", "clofazimine", ",", "an", "aniline", "aposafranine", "derivative", "known", "to", "produce", "a", "ceroid", "-", "like", "pigment", "in", "the", "tissues", "of", "patients", "treated", "with", "this", "drug", "or", "lepromatous", "leprosy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> produce <extra_id_0> subject <extra_id_5> patients treated with this drug or lepromatous leprosy <extra_id_1> <extra_id_0> subject disorder <extra_id_5> lepromatous leprosy <extra_id_1> <extra_id_0> treatment <extra_id_5> clofazimine <extra_id_1> <extra_id_0> drug <extra_id_5> clofazimine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> lepromatous leprosy <extra_id_1> <extra_id_0> effect <extra_id_5> a ceroid - like pigment <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "produce", "args": [{"type": "subject", "offset": [22, 23, 24, 25, 26, 27, 28, 29], "text": "patients treated with this drug or lepromatous leprosy"}, {"type": "subject disorder", "offset": [28, 29], "text": "lepromatous leprosy"}, {"type": "treatment", "offset": [4], "text": "clofazimine"}, {"type": "drug", "offset": [4], "text": "clofazimine"}, {"type": "treatment disorder", "offset": [28, 29], "text": "lepromatous leprosy"}, {"type": "effect", "offset": [13, 14, 15, 16, 17], "text": "a ceroid - like pigment"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "produce", "label": "adverse event", "asoc": [["subject", "patients treated with this drug or lepromatous leprosy"], ["subject disorder", "lepromatous leprosy"], ["treatment", "clofazimine"], ["drug", "clofazimine"], ["treatment disorder", "lepromatous leprosy"], ["effect", "a ceroid - like pigment"]]}]}
{"text_id": "10203437_8", "text": "CONCLUSIONS : Reversible lupus - like syndrome appears to be a rare but significant side effect of 5 - ASA compounds .", "tokens": ["CONCLUSIONS", ":", "Reversible", "lupus", "-", "like", "syndrome", "appears", "to", "be", "a", "rare", "but", "significant", "side", "effect", "of", "5", "-", "ASA", "compounds", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> side effect <extra_id_0> treatment <extra_id_5> 5 - ASA <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - ASA <extra_id_1> <extra_id_0> effect <extra_id_5> Reversible lupus - like syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14, 15], "text": "side effect", "args": [{"type": "treatment", "offset": [17, 18, 19], "text": "5 - ASA"}, {"type": "drug", "offset": [17, 18, 19], "text": "5 - ASA"}, {"type": "effect", "offset": [2, 3, 4, 5, 6], "text": "Reversible lupus - like syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "side effect", "label": "adverse event", "asoc": [["treatment", "5 - ASA"], ["drug", "5 - ASA"], ["effect", "Reversible lupus - like syndrome"]]}]}
{"text_id": "8742573_1", "text": "CASE : We report a case of a woman with severe human insulin - induced lipoatrophy who has been treated exclusively with recombinant DNA human insulin since the onset of IDDM .", "tokens": ["CASE", ":", "We", "report", "a", "case", "of", "a", "woman", "with", "severe", "human", "insulin", "-", "induced", "lipoatrophy", "who", "has", "been", "treated", "exclusively", "with", "recombinant", "DNA", "human", "insulin", "since", "the", "onset", "of", "IDDM", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated <extra_id_0> subject <extra_id_5> woman <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> treatment <extra_id_5> recombinant DNA human insulin <extra_id_1> <extra_id_0> drug <extra_id_5> recombinant DNA human insulin <extra_id_1> <extra_id_0> effect <extra_id_5> severe human insulin - induced lipoatrophy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "treated", "args": [{"type": "subject", "offset": [8], "text": "woman"}, {"type": "gender", "offset": [8], "text": "woman"}, {"type": "treatment", "offset": [22, 23, 24, 25], "text": "recombinant DNA human insulin"}, {"type": "drug", "offset": [22, 23, 24, 25], "text": "recombinant DNA human insulin"}, {"type": "effect", "offset": [10, 11, 12, 13, 14, 15], "text": "severe human insulin - induced lipoatrophy"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "gender", "treatment"], "spot_asoc": [{"span": "treated", "label": "adverse event", "asoc": [["subject", "woman"], ["gender", "woman"], ["treatment", "recombinant DNA human insulin"], ["drug", "recombinant DNA human insulin"], ["effect", "severe human insulin - induced lipoatrophy"]]}]}
{"text_id": "8604715_2", "text": "No cases of renal acidosis , and only one case of nephrogenic diabetes insipidus , has been previously reported as a complication of foscarnet treatment .", "tokens": ["No", "cases", "of", "renal", "acidosis", ",", "and", "only", "one", "case", "of", "nephrogenic", "diabetes", "insipidus", ",", "has", "been", "previously", "reported", "as", "a", "complication", "of", "foscarnet", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> reported <extra_id_0> treatment <extra_id_5> foscarnet treatment <extra_id_1> <extra_id_0> drug <extra_id_5> foscarnet <extra_id_1> <extra_id_0> effect <extra_id_5> nephrogenic diabetes insipidus <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "reported", "args": [{"type": "treatment", "offset": [23, 24], "text": "foscarnet treatment"}, {"type": "drug", "offset": [23], "text": "foscarnet"}, {"type": "effect", "offset": [11, 12, 13], "text": "nephrogenic diabetes insipidus"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "reported", "label": "adverse event", "asoc": [["treatment", "foscarnet treatment"], ["drug", "foscarnet"], ["effect", "nephrogenic diabetes insipidus"]]}]}
{"text_id": "7779233_1", "text": "Case study : a modified topical treatment regimen for sodium warfarin - induced necrotizing fasciitis .", "tokens": ["Case", "study", ":", "a", "modified", "topical", "treatment", "regimen", "for", "sodium", "warfarin", "-", "induced", "necrotizing", "fasciitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> sodium warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> sodium warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> necrotizing fasciitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "induced", "args": [{"type": "treatment", "offset": [9, 10], "text": "sodium warfarin"}, {"type": "drug", "offset": [9, 10], "text": "sodium warfarin"}, {"type": "effect", "offset": [13, 14], "text": "necrotizing fasciitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "sodium warfarin"], ["drug", "sodium warfarin"], ["effect", "necrotizing fasciitis"]]}]}
{"text_id": "12135176_2", "text": "Verapamil is widely used for the termination of paroxysmal supraventricular tachycardia ( PSVT ) with little proarrhythmic effect .", "tokens": ["Verapamil", "is", "widely", "used", "for", "the", "termination", "of", "paroxysmal", "supraventricular", "tachycardia", "(", "PSVT", ")", "with", "little", "proarrhythmic", "effect", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> with <extra_id_0> treatment <extra_id_5> Verapamil <extra_id_1> <extra_id_0> drug <extra_id_5> Verapamil <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> paroxysmal supraventricular tachycardia <extra_id_1> <extra_id_0> effect <extra_id_5> proarrhythmic effect <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "with", "args": [{"type": "treatment", "offset": [0], "text": "Verapamil"}, {"type": "drug", "offset": [0], "text": "Verapamil"}, {"type": "treatment disorder", "offset": [8, 9, 10], "text": "paroxysmal supraventricular tachycardia"}, {"type": "effect", "offset": [16, 17], "text": "proarrhythmic effect"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "with", "label": "adverse event", "asoc": [["treatment", "Verapamil"], ["drug", "Verapamil"], ["treatment disorder", "paroxysmal supraventricular tachycardia"], ["effect", "proarrhythmic effect"]]}]}
{"text_id": "8485005_1", "text": "Complete regression of iatrogenic Kaposi 's sarcoma due to corticosteroid treatment in a patient with tubercular pericarditis .", "tokens": ["Complete", "regression", "of", "iatrogenic", "Kaposi", "'s", "sarcoma", "due", "to", "corticosteroid", "treatment", "in", "a", "patient", "with", "tubercular", "pericarditis", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> regression <extra_id_0> subject <extra_id_5> a patient with tubercular pericarditis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> tubercular pericarditis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Kaposi 's sarcoma <extra_id_1> <extra_id_0> treatment <extra_id_5> corticosteroid <extra_id_1> <extra_id_0> drug <extra_id_5> corticosteroid <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Kaposi 's sarcoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [1], "text": "regression", "args": [{"type": "subject", "offset": [12, 13, 14, 15, 16], "text": "a patient with tubercular pericarditis"}, {"type": "subject disorder", "offset": [15, 16], "text": "tubercular pericarditis"}, {"type": "subject disorder", "offset": [4, 5, 6], "text": "Kaposi 's sarcoma"}, {"type": "treatment", "offset": [9], "text": "corticosteroid"}, {"type": "drug", "offset": [9], "text": "corticosteroid"}, {"type": "treatment disorder", "offset": [4, 5, 6], "text": "Kaposi 's sarcoma"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "regression", "label": "potential therapeutic event", "asoc": [["subject", "a patient with tubercular pericarditis"], ["subject disorder", "tubercular pericarditis"], ["subject disorder", "Kaposi 's sarcoma"], ["treatment", "corticosteroid"], ["drug", "corticosteroid"], ["treatment disorder", "Kaposi 's sarcoma"]]}]}
{"text_id": "19995222_3", "text": "However , several case reports have suggested that clozapine could also cause TD .", "tokens": ["However", ",", "several", "case", "reports", "have", "suggested", "that", "clozapine", "could", "also", "cause", "TD", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> effect <extra_id_5> TD <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "cause", "args": [{"type": "treatment", "offset": [8], "text": "clozapine"}, {"type": "drug", "offset": [8], "text": "clozapine"}, {"type": "effect", "offset": [12], "text": "TD"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "clozapine"], ["drug", "clozapine"], ["effect", "TD"]]}]}
{"text_id": "2442958_1", "text": "Multicentric hepatocellular carcinoma following phosphate diethylstilbestrol therapy for prostatic cancer .", "tokens": ["Multicentric", "hepatocellular", "carcinoma", "following", "phosphate", "diethylstilbestrol", "therapy", "for", "prostatic", "cancer", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> phosphate diethylstilbestrol <extra_id_1> <extra_id_0> drug <extra_id_5> phosphate diethylstilbestrol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> prostatic cancer <extra_id_1> <extra_id_0> effect <extra_id_5> Multicentric hepatocellular carcinoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "following", "args": [{"type": "treatment", "offset": [4, 5], "text": "phosphate diethylstilbestrol"}, {"type": "drug", "offset": [4, 5], "text": "phosphate diethylstilbestrol"}, {"type": "treatment disorder", "offset": [8, 9], "text": "prostatic cancer"}, {"type": "effect", "offset": [0, 1, 2], "text": "Multicentric hepatocellular carcinoma"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "phosphate diethylstilbestrol"], ["drug", "phosphate diethylstilbestrol"], ["treatment disorder", "prostatic cancer"], ["effect", "Multicentric hepatocellular carcinoma"]]}]}
{"text_id": "19892516_4", "text": "In one patient the vasculitis resolved after termination of the ciprofloxacin therapy ; in the other patient the ciprofloxacin - induced hemorrhagic vasculitis was superimposed on a severe forefoot infection , leading to progressive gangrene and a below - knee amputation .", "tokens": ["In", "one", "patient", "the", "vasculitis", "resolved", "after", "termination", "of", "the", "ciprofloxacin", "therapy", ";", "in", "the", "other", "patient", "the", "ciprofloxacin", "-", "induced", "hemorrhagic", "vasculitis", "was", "superimposed", "on", "a", "severe", "forefoot", "infection", ",", "leading", "to", "progressive", "gangrene", "and", "a", "below", "-", "knee", "amputation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> patient <extra_id_1> <extra_id_0> treatment <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> hemorrhagic vasculitis was superimposed on a severe forefoot infection , leading to progressive gangrene and a below - knee amputation <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> resolved <extra_id_0> subject <extra_id_5> one patient the vasculitis <extra_id_1> <extra_id_0> population <extra_id_5> one <extra_id_1> <extra_id_0> subject disorder <extra_id_5> vasculitis <extra_id_1> <extra_id_0> treatment <extra_id_5> termination of the ciprofloxacin therapy <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> vasculitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "induced", "args": [{"type": "subject", "offset": [16], "text": "patient"}, {"type": "treatment", "offset": [18], "text": "ciprofloxacin"}, {"type": "drug", "offset": [18], "text": "ciprofloxacin"}, {"type": "effect", "offset": [21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40], "text": "hemorrhagic vasculitis was superimposed on a severe forefoot infection , leading to progressive gangrene and a below - knee amputation"}]}, {"type": "potential therapeutic event", "offset": [5], "text": "resolved", "args": [{"type": "subject", "offset": [1, 2, 3, 4], "text": "one patient the vasculitis"}, {"type": "population", "offset": [1], "text": "one"}, {"type": "subject disorder", "offset": [4], "text": "vasculitis"}, {"type": "treatment", "offset": [7, 8, 9, 10, 11], "text": "termination of the ciprofloxacin therapy"}, {"type": "drug", "offset": [10], "text": "ciprofloxacin"}, {"type": "treatment disorder", "offset": [4], "text": "vasculitis"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "patient"], ["treatment", "ciprofloxacin"], ["drug", "ciprofloxacin"], ["effect", "hemorrhagic vasculitis was superimposed on a severe forefoot infection , leading to progressive gangrene and a below - knee amputation"]]}, {"span": "resolved", "label": "potential therapeutic event", "asoc": [["subject", "one patient the vasculitis"], ["population", "one"], ["subject disorder", "vasculitis"], ["treatment", "termination of the ciprofloxacin therapy"], ["drug", "ciprofloxacin"], ["treatment disorder", "vasculitis"]]}]}
{"text_id": "9161656_14", "text": "Although dyspnea associated with verapamil administration has been reported , this is the first report of an elderly asymptomatic asthmatic patient with hypertension who developed an acute asthma attack following sustained - release verapamil administration .", "tokens": ["Although", "dyspnea", "associated", "with", "verapamil", "administration", "has", "been", "reported", ",", "this", "is", "the", "first", "report", "of", "an", "elderly", "asymptomatic", "asthmatic", "patient", "with", "hypertension", "who", "developed", "an", "acute", "asthma", "attack", "following", "sustained", "-", "release", "verapamil", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> an elderly asymptomatic asthmatic patient with hypertension <extra_id_1> <extra_id_0> age <extra_id_5> elderly <extra_id_1> <extra_id_0> subject disorder <extra_id_5> asymptomatic asthmatic <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hypertension <extra_id_1> <extra_id_0> treatment <extra_id_5> sustained - release verapamil administration <extra_id_1> <extra_id_0> drug <extra_id_5> sustained - release verapamil <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hypertension <extra_id_1> <extra_id_0> effect <extra_id_5> an acute asthma attack <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [24], "text": "developed", "args": [{"type": "subject", "offset": [16, 17, 18, 19, 20, 21, 22], "text": "an elderly asymptomatic asthmatic patient with hypertension"}, {"type": "age", "offset": [17], "text": "elderly"}, {"type": "subject disorder", "offset": [18, 19], "text": "asymptomatic asthmatic"}, {"type": "subject disorder", "offset": [22], "text": "hypertension"}, {"type": "treatment", "offset": [30, 31, 32, 33, 34], "text": "sustained - release verapamil administration"}, {"type": "drug", "offset": [30, 31, 32, 33], "text": "sustained - release verapamil"}, {"type": "treatment disorder", "offset": [22], "text": "hypertension"}, {"type": "effect", "offset": [25, 26, 27, 28], "text": "an acute asthma attack"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "an elderly asymptomatic asthmatic patient with hypertension"], ["age", "elderly"], ["subject disorder", "asymptomatic asthmatic"], ["subject disorder", "hypertension"], ["treatment", "sustained - release verapamil administration"], ["drug", "sustained - release verapamil"], ["treatment disorder", "hypertension"], ["effect", "an acute asthma attack"]]}]}
{"text_id": "11033734_1", "text": "Eighty - two patients with various malignancies who received imipenem / cilastatin 143 times for neutropenic fever between March 1994 and October 1999 in Department of Pediatric Oncology , Gazi University , were identified .", "tokens": ["Eighty", "-", "two", "patients", "with", "various", "malignancies", "who", "received", "imipenem", "/", "cilastatin", "143", "times", "for", "neutropenic", "fever", "between", "March", "1994", "and", "October", "1999", "in", "Department", "of", "Pediatric", "Oncology", ",", "Gazi", "University", ",", "were", "identified", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> received <extra_id_0> subject <extra_id_5> Eighty - two patients with various malignancies <extra_id_1> <extra_id_0> population <extra_id_5> Eighty - two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> various malignancies <extra_id_1> <extra_id_0> subject disorder <extra_id_5> neutropenic fever <extra_id_1> <extra_id_0> treatment <extra_id_5> imipenem / cilastatin 143 times for neutropenic fever <extra_id_1> <extra_id_0> drug <extra_id_5> imipenem <extra_id_1> <extra_id_0> drug <extra_id_5> cilastatin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> neutropenic fever <extra_id_1> <extra_id_0> combination drug <extra_id_5> imipenem <extra_id_1> <extra_id_0> combination drug <extra_id_5> cilastatin <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [8], "text": "received", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Eighty - two patients with various malignancies"}, {"type": "population", "offset": [0, 1, 2], "text": "Eighty - two"}, {"type": "subject disorder", "offset": [5, 6], "text": "various malignancies"}, {"type": "subject disorder", "offset": [15, 16], "text": "neutropenic fever"}, {"type": "treatment", "offset": [9, 10, 11, 12, 13, 14, 15, 16], "text": "imipenem / cilastatin 143 times for neutropenic fever"}, {"type": "drug", "offset": [9], "text": "imipenem"}, {"type": "drug", "offset": [11], "text": "cilastatin"}, {"type": "treatment disorder", "offset": [15, 16], "text": "neutropenic fever"}, {"type": "combination drug", "offset": [9], "text": "imipenem"}, {"type": "combination drug", "offset": [11], "text": "cilastatin"}]}], "spot": ["potential therapeutic event"], "asoc": ["population", "subject", "treatment", "drug", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "received", "label": "potential therapeutic event", "asoc": [["subject", "Eighty - two patients with various malignancies"], ["population", "Eighty - two"], ["subject disorder", "various malignancies"], ["subject disorder", "neutropenic fever"], ["treatment", "imipenem / cilastatin 143 times for neutropenic fever"], ["drug", "imipenem"], ["drug", "cilastatin"], ["treatment disorder", "neutropenic fever"], ["combination drug", "imipenem"], ["combination drug", "cilastatin"]]}]}
{"text_id": "17873198_1", "text": "Interstitial lung disease ( ILD ) related to therapy with the drug gefitinib has been well reported .", "tokens": ["Interstitial", "lung", "disease", "(", "ILD", ")", "related", "to", "therapy", "with", "the", "drug", "gefitinib", "has", "been", "well", "reported", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> treatment <extra_id_5> therapy with the drug gefitinib <extra_id_1> <extra_id_0> drug <extra_id_5> gefitinib <extra_id_1> <extra_id_0> effect <extra_id_5> Interstitial lung disease ( ILD ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "related", "args": [{"type": "treatment", "offset": [8, 9, 10, 11, 12], "text": "therapy with the drug gefitinib"}, {"type": "drug", "offset": [12], "text": "gefitinib"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "Interstitial lung disease ( ILD )"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["treatment", "therapy with the drug gefitinib"], ["drug", "gefitinib"], ["effect", "Interstitial lung disease ( ILD )"]]}]}
{"text_id": "21751542_5", "text": "The risk of gastrointestinal bleeding during the treatment with antiagregants and anticoagulants , the risk of bradycardia in beta - blockade , possible interactions with other medications lowering the heart rate are discussed .", "tokens": ["The", "risk", "of", "gastrointestinal", "bleeding", "during", "the", "treatment", "with", "antiagregants", "and", "anticoagulants", ",", "the", "risk", "of", "bradycardia", "in", "beta", "-", "blockade", ",", "possible", "interactions", "with", "other", "medications", "lowering", "the", "heart", "rate", "are", "discussed", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> antiagregants and anticoagulants <extra_id_1> <extra_id_0> drug <extra_id_5> antiagregants <extra_id_1> <extra_id_0> drug <extra_id_5> anticoagulants <extra_id_1> <extra_id_0> combination drug <extra_id_5> antiagregants <extra_id_1> <extra_id_0> combination drug <extra_id_5> anticoagulants <extra_id_1> <extra_id_0> effect <extra_id_5> gastrointestinal bleeding <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> treatment <extra_id_5> beta - blockade <extra_id_1> <extra_id_0> drug <extra_id_5> beta - blockade <extra_id_1> <extra_id_0> effect <extra_id_5> bradycardia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "during", "args": [{"type": "treatment", "offset": [9, 10, 11], "text": "antiagregants and anticoagulants"}, {"type": "drug", "offset": [9], "text": "antiagregants"}, {"type": "drug", "offset": [11], "text": "anticoagulants"}, {"type": "combination drug", "offset": [9], "text": "antiagregants"}, {"type": "combination drug", "offset": [11], "text": "anticoagulants"}, {"type": "effect", "offset": [3, 4], "text": "gastrointestinal bleeding"}]}, {"type": "adverse event", "offset": [17], "text": "in", "args": [{"type": "treatment", "offset": [18, 19, 20], "text": "beta - blockade"}, {"type": "drug", "offset": [18, 19, 20], "text": "beta - blockade"}, {"type": "effect", "offset": [16], "text": "bradycardia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "antiagregants and anticoagulants"], ["drug", "antiagregants"], ["drug", "anticoagulants"], ["combination drug", "antiagregants"], ["combination drug", "anticoagulants"], ["effect", "gastrointestinal bleeding"]]}, {"span": "in", "label": "adverse event", "asoc": [["treatment", "beta - blockade"], ["drug", "beta - blockade"], ["effect", "bradycardia"]]}]}
{"text_id": "7594371_2", "text": "Both PAN and methotrexate have been independently demonstrated to cause sensorineural hearing loss .", "tokens": ["Both", "PAN", "and", "methotrexate", "have", "been", "independently", "demonstrated", "to", "cause", "sensorineural", "hearing", "loss", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> PAN and methotrexate <extra_id_1> <extra_id_0> drug <extra_id_5> PAN <extra_id_1> <extra_id_0> drug <extra_id_5> methotrexate <extra_id_1> <extra_id_0> combination drug <extra_id_5> PAN <extra_id_1> <extra_id_0> combination drug <extra_id_5> methotrexate <extra_id_1> <extra_id_0> effect <extra_id_5> sensorineural hearing loss <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "cause", "args": [{"type": "treatment", "offset": [1, 2, 3], "text": "PAN and methotrexate"}, {"type": "drug", "offset": [1], "text": "PAN"}, {"type": "drug", "offset": [3], "text": "methotrexate"}, {"type": "combination drug", "offset": [1], "text": "PAN"}, {"type": "combination drug", "offset": [3], "text": "methotrexate"}, {"type": "effect", "offset": [10, 11, 12], "text": "sensorineural hearing loss"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "PAN and methotrexate"], ["drug", "PAN"], ["drug", "methotrexate"], ["combination drug", "PAN"], ["combination drug", "methotrexate"], ["effect", "sensorineural hearing loss"]]}]}
{"text_id": "7295427_1", "text": "Fatal ventricular fibrillation after treatment with digoxin in a 27 - year - old man with mitral leaflet prolapse syndrome .", "tokens": ["Fatal", "ventricular", "fibrillation", "after", "treatment", "with", "digoxin", "in", "a", "27", "-", "year", "-", "old", "man", "with", "mitral", "leaflet", "prolapse", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a 27 - year - old man with mitral leaflet prolapse syndrome <extra_id_1> <extra_id_0> age <extra_id_5> 27 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> mitral leaflet prolapse syndrome <extra_id_1> <extra_id_0> treatment <extra_id_5> digoxin <extra_id_1> <extra_id_0> drug <extra_id_5> digoxin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> mitral leaflet prolapse syndrome <extra_id_1> <extra_id_0> effect <extra_id_5> Fatal ventricular fibrillation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "after", "args": [{"type": "subject", "offset": [8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19], "text": "a 27 - year - old man with mitral leaflet prolapse syndrome"}, {"type": "age", "offset": [9, 10, 11, 12, 13], "text": "27 - year - old"}, {"type": "gender", "offset": [14], "text": "man"}, {"type": "subject disorder", "offset": [16, 17, 18, 19], "text": "mitral leaflet prolapse syndrome"}, {"type": "treatment", "offset": [6], "text": "digoxin"}, {"type": "drug", "offset": [6], "text": "digoxin"}, {"type": "treatment disorder", "offset": [16, 17, 18, 19], "text": "mitral leaflet prolapse syndrome"}, {"type": "effect", "offset": [0, 1, 2], "text": "Fatal ventricular fibrillation"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a 27 - year - old man with mitral leaflet prolapse syndrome"], ["age", "27 - year - old"], ["gender", "man"], ["subject disorder", "mitral leaflet prolapse syndrome"], ["treatment", "digoxin"], ["drug", "digoxin"], ["treatment disorder", "mitral leaflet prolapse syndrome"], ["effect", "Fatal ventricular fibrillation"]]}]}
{"text_id": "19116715_2", "text": "METHODS : A retrospective report of the first case of gemcitabine - related HUS , in a patient with metastatic pancreatic adenocarcinoma , treated with a variety of standard therapies in addition to rituximab is presented .", "tokens": ["METHODS", ":", "A", "retrospective", "report", "of", "the", "first", "case", "of", "gemcitabine", "-", "related", "HUS", ",", "in", "a", "patient", "with", "metastatic", "pancreatic", "adenocarcinoma", ",", "treated", "with", "a", "variety", "of", "standard", "therapies", "in", "addition", "to", "rituximab", "is", "presented", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> subject <extra_id_5> a patient with metastatic pancreatic adenocarcinoma <extra_id_1> <extra_id_0> subject disorder <extra_id_5> metastatic pancreatic adenocarcinoma , <extra_id_1> <extra_id_0> treatment <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> metastatic pancreatic adenocarcinoma , <extra_id_1> <extra_id_0> effect <extra_id_5> HUS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "related", "args": [{"type": "subject", "offset": [16, 17, 18, 19, 20, 21], "text": "a patient with metastatic pancreatic adenocarcinoma"}, {"type": "subject disorder", "offset": [19, 20, 21, 22], "text": "metastatic pancreatic adenocarcinoma ,"}, {"type": "treatment", "offset": [10], "text": "gemcitabine"}, {"type": "drug", "offset": [10], "text": "gemcitabine"}, {"type": "treatment disorder", "offset": [19, 20, 21, 22], "text": "metastatic pancreatic adenocarcinoma ,"}, {"type": "effect", "offset": [13], "text": "HUS"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["subject", "a patient with metastatic pancreatic adenocarcinoma"], ["subject disorder", "metastatic pancreatic adenocarcinoma ,"], ["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["treatment disorder", "metastatic pancreatic adenocarcinoma ,"], ["effect", "HUS"]]}]}
{"text_id": "24477376_5", "text": "While the patient was receiving both drugs , platelet aggregation studies revealed less platelet inhibition than would be expected in a patient not taking a concomitant inducer of ticagrelor metabolism .", "tokens": ["While", "the", "patient", "was", "receiving", "both", "drugs", ",", "platelet", "aggregation", "studies", "revealed", "less", "platelet", "inhibition", "than", "would", "be", "expected", "in", "a", "patient", "not", "taking", "a", "concomitant", "inducer", "of", "ticagrelor", "metabolism", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> revealed <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> taking a concomitant inducer of ticagrelor metabolism . <extra_id_1> <extra_id_0> drug <extra_id_5> ticagrelor <extra_id_1> <extra_id_0> drug <extra_id_5> inducer of ticagrelor metabolism <extra_id_1> <extra_id_0> combination drug <extra_id_5> inducer of ticagrelor metabolism <extra_id_1> <extra_id_0> combination drug <extra_id_5> ticagrelor <extra_id_1> <extra_id_0> effect <extra_id_5> less platelet inhibition than would be expected <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "revealed", "args": [{"type": "subject", "offset": [20, 21], "text": "a patient"}, {"type": "treatment", "offset": [23, 24, 25, 26, 27, 28, 29, 30], "text": "taking a concomitant inducer of ticagrelor metabolism ."}, {"type": "drug", "offset": [28], "text": "ticagrelor"}, {"type": "drug", "offset": [26, 27, 28, 29], "text": "inducer of ticagrelor metabolism"}, {"type": "combination drug", "offset": [26, 27, 28, 29], "text": "inducer of ticagrelor metabolism"}, {"type": "combination drug", "offset": [28], "text": "ticagrelor"}, {"type": "effect", "offset": [12, 13, 14, 15, 16, 17, 18], "text": "less platelet inhibition than would be expected"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "revealed", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "taking a concomitant inducer of ticagrelor metabolism ."], ["drug", "ticagrelor"], ["drug", "inducer of ticagrelor metabolism"], ["combination drug", "inducer of ticagrelor metabolism"], ["combination drug", "ticagrelor"], ["effect", "less platelet inhibition than would be expected"]]}]}
{"text_id": "10755579_1", "text": "Fluoxetine - related death in a child with cytochrome P - 450 2D6 genetic deficiency .", "tokens": ["Fluoxetine", "-", "related", "death", "in", "a", "child", "with", "cytochrome", "P", "-", "450", "2D6", "genetic", "deficiency", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> subject <extra_id_5> child with cytochrome P - 450 2D6 genetic deficiency <extra_id_1> <extra_id_0> age <extra_id_5> child <extra_id_1> <extra_id_0> subject disorder <extra_id_5> cytochrome P - 450 2D6 genetic deficiency <extra_id_1> <extra_id_0> treatment <extra_id_5> Fluoxetine <extra_id_1> <extra_id_0> drug <extra_id_5> Fluoxetine <extra_id_1> <extra_id_0> effect <extra_id_5> death <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "related", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "child with cytochrome P - 450 2D6 genetic deficiency"}, {"type": "age", "offset": [6], "text": "child"}, {"type": "subject disorder", "offset": [8, 9, 10, 11, 12, 13, 14], "text": "cytochrome P - 450 2D6 genetic deficiency"}, {"type": "treatment", "offset": [0], "text": "Fluoxetine"}, {"type": "drug", "offset": [0], "text": "Fluoxetine"}, {"type": "effect", "offset": [3], "text": "death"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["subject", "child with cytochrome P - 450 2D6 genetic deficiency"], ["age", "child"], ["subject disorder", "cytochrome P - 450 2D6 genetic deficiency"], ["treatment", "Fluoxetine"], ["drug", "Fluoxetine"], ["effect", "death"]]}]}
{"text_id": "7673653_1", "text": "Beneficial effect of low - dose mianserin on fluvoxamine - induced akathisia in an obsessive - compulsive patient .", "tokens": ["Beneficial", "effect", "of", "low", "-", "dose", "mianserin", "on", "fluvoxamine", "-", "induced", "akathisia", "in", "an", "obsessive", "-", "compulsive", "patient", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> obsessive - compulsive patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> obsessive - compulsive <extra_id_1> <extra_id_0> treatment <extra_id_5> fluvoxamine <extra_id_1> <extra_id_0> drug <extra_id_5> fluvoxamine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> obsessive - compulsive <extra_id_1> <extra_id_0> effect <extra_id_5> akathisia <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> Beneficial <extra_id_0> subject <extra_id_5> obsessive - compulsive patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> fluvoxamine - induced akathisia <extra_id_1> <extra_id_0> treatment <extra_id_5> low - dose mianserin <extra_id_1> <extra_id_0> drug <extra_id_5> mianserin <extra_id_1> <extra_id_0> dosage <extra_id_5> low - dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> fluvoxamine - induced akathisia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "induced", "args": [{"type": "subject", "offset": [14, 15, 16, 17], "text": "obsessive - compulsive patient"}, {"type": "subject disorder", "offset": [14, 15, 16], "text": "obsessive - compulsive"}, {"type": "treatment", "offset": [8], "text": "fluvoxamine"}, {"type": "drug", "offset": [8], "text": "fluvoxamine"}, {"type": "treatment disorder", "offset": [14, 15, 16], "text": "obsessive - compulsive"}, {"type": "effect", "offset": [11], "text": "akathisia"}]}, {"type": "potential therapeutic event", "offset": [0], "text": "Beneficial", "args": [{"type": "subject", "offset": [14, 15, 16, 17], "text": "obsessive - compulsive patient"}, {"type": "subject disorder", "offset": [8, 9, 10, 11], "text": "fluvoxamine - induced akathisia"}, {"type": "treatment", "offset": [3, 4, 5, 6], "text": "low - dose mianserin"}, {"type": "drug", "offset": [6], "text": "mianserin"}, {"type": "dosage", "offset": [3, 4, 5], "text": "low - dose"}, {"type": "treatment disorder", "offset": [8, 9, 10, 11], "text": "fluvoxamine - induced akathisia"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["dosage", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "obsessive - compulsive patient"], ["subject disorder", "obsessive - compulsive"], ["treatment", "fluvoxamine"], ["drug", "fluvoxamine"], ["treatment disorder", "obsessive - compulsive"], ["effect", "akathisia"]]}, {"span": "Beneficial", "label": "potential therapeutic event", "asoc": [["subject", "obsessive - compulsive patient"], ["subject disorder", "fluvoxamine - induced akathisia"], ["treatment", "low - dose mianserin"], ["drug", "mianserin"], ["dosage", "low - dose"], ["treatment disorder", "fluvoxamine - induced akathisia"]]}]}
{"text_id": "1261772_1", "text": "Fulminant hepatic failure developed in a 24 - year - old black woman who had been treated with propylthiouracil and propranolol for hyperthyroidism .", "tokens": ["Fulminant", "hepatic", "failure", "developed", "in", "a", "24", "-", "year", "-", "old", "black", "woman", "who", "had", "been", "treated", "with", "propylthiouracil", "and", "propranolol", "for", "hyperthyroidism", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a 24 - year - old black woman <extra_id_1> <extra_id_0> age <extra_id_5> 24 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> race <extra_id_5> black <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hyperthyroidism <extra_id_1> <extra_id_0> treatment <extra_id_5> propylthiouracil and propranolol <extra_id_1> <extra_id_0> drug <extra_id_5> propylthiouracil <extra_id_1> <extra_id_0> drug <extra_id_5> propranolol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hyperthyroidism <extra_id_1> <extra_id_0> combination drug <extra_id_5> propranolol <extra_id_1> <extra_id_0> combination drug <extra_id_5> propylthiouracil <extra_id_1> <extra_id_0> effect <extra_id_5> Fulminant hepatic failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "developed", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11, 12], "text": "a 24 - year - old black woman"}, {"type": "age", "offset": [6, 7, 8, 9, 10], "text": "24 - year - old"}, {"type": "gender", "offset": [12], "text": "woman"}, {"type": "race", "offset": [11], "text": "black"}, {"type": "subject disorder", "offset": [22], "text": "hyperthyroidism"}, {"type": "treatment", "offset": [18, 19, 20], "text": "propylthiouracil and propranolol"}, {"type": "drug", "offset": [18], "text": "propylthiouracil"}, {"type": "drug", "offset": [20], "text": "propranolol"}, {"type": "treatment disorder", "offset": [22], "text": "hyperthyroidism"}, {"type": "combination drug", "offset": [20], "text": "propranolol"}, {"type": "combination drug", "offset": [18], "text": "propylthiouracil"}, {"type": "effect", "offset": [0, 1, 2], "text": "Fulminant hepatic failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "combination drug", "age", "subject disorder", "race"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a 24 - year - old black woman"], ["age", "24 - year - old"], ["gender", "woman"], ["race", "black"], ["subject disorder", "hyperthyroidism"], ["treatment", "propylthiouracil and propranolol"], ["drug", "propylthiouracil"], ["drug", "propranolol"], ["treatment disorder", "hyperthyroidism"], ["combination drug", "propranolol"], ["combination drug", "propylthiouracil"], ["effect", "Fulminant hepatic failure"]]}]}
{"text_id": "11424102_1", "text": "Cutaneous seeding after ultrasound - guided percutaneous ethanol injection for treatment of hepatocellular carcinoma .", "tokens": ["Cutaneous", "seeding", "after", "ultrasound", "-", "guided", "percutaneous", "ethanol", "injection", "for", "treatment", "of", "hepatocellular", "carcinoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> ultrasound - guided percutaneous ethanol injection <extra_id_1> <extra_id_0> drug <extra_id_5> ethanol <extra_id_1> <extra_id_0> route <extra_id_5> injection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hepatocellular carcinoma <extra_id_1> <extra_id_0> effect <extra_id_5> Cutaneous seeding <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "after", "args": [{"type": "treatment", "offset": [3, 4, 5, 6, 7, 8], "text": "ultrasound - guided percutaneous ethanol injection"}, {"type": "drug", "offset": [7], "text": "ethanol"}, {"type": "route", "offset": [8], "text": "injection"}, {"type": "treatment disorder", "offset": [12, 13], "text": "hepatocellular carcinoma"}, {"type": "effect", "offset": [0, 1], "text": "Cutaneous seeding"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "treatment", "treatment disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "ultrasound - guided percutaneous ethanol injection"], ["drug", "ethanol"], ["route", "injection"], ["treatment disorder", "hepatocellular carcinoma"], ["effect", "Cutaneous seeding"]]}]}
{"text_id": "15266150_3", "text": "Trichiasis associated with prostaglandin analog use .", "tokens": ["Trichiasis", "associated", "with", "prostaglandin", "analog", "use", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> prostaglandin analog <extra_id_1> <extra_id_0> drug <extra_id_5> prostaglandin analog <extra_id_1> <extra_id_0> effect <extra_id_5> Trichiasis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "associated", "args": [{"type": "treatment", "offset": [3, 4], "text": "prostaglandin analog"}, {"type": "drug", "offset": [3, 4], "text": "prostaglandin analog"}, {"type": "effect", "offset": [0], "text": "Trichiasis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "prostaglandin analog"], ["drug", "prostaglandin analog"], ["effect", "Trichiasis"]]}]}
{"text_id": "12944250_3", "text": "Thrombocytosis under ciprofloxacin and tazobactam / piperacillin .", "tokens": ["Thrombocytosis", "under", "ciprofloxacin", "and", "tazobactam", "/", "piperacillin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> under <extra_id_0> treatment <extra_id_5> ciprofloxacin and tazobactam / piperacillin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> tazobactam <extra_id_1> <extra_id_0> drug <extra_id_5> piperacillin <extra_id_1> <extra_id_0> combination drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> combination drug <extra_id_5> tazobactam <extra_id_1> <extra_id_0> combination drug <extra_id_5> piperacillin <extra_id_1> <extra_id_0> effect <extra_id_5> Thrombocytosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "under", "args": [{"type": "treatment", "offset": [2, 3, 4, 5, 6], "text": "ciprofloxacin and tazobactam / piperacillin"}, {"type": "drug", "offset": [2], "text": "ciprofloxacin"}, {"type": "drug", "offset": [4], "text": "tazobactam"}, {"type": "drug", "offset": [6], "text": "piperacillin"}, {"type": "combination drug", "offset": [2], "text": "ciprofloxacin"}, {"type": "combination drug", "offset": [4], "text": "tazobactam"}, {"type": "combination drug", "offset": [6], "text": "piperacillin"}, {"type": "effect", "offset": [0], "text": "Thrombocytosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "under", "label": "adverse event", "asoc": [["treatment", "ciprofloxacin and tazobactam / piperacillin"], ["drug", "ciprofloxacin"], ["drug", "tazobactam"], ["drug", "piperacillin"], ["combination drug", "ciprofloxacin"], ["combination drug", "tazobactam"], ["combination drug", "piperacillin"], ["effect", "Thrombocytosis"]]}]}
{"text_id": "18648015_1", "text": "Cephalosporin - induced leukopenia following rechallenge with cefoxitin .", "tokens": ["Cephalosporin", "-", "induced", "leukopenia", "following", "rechallenge", "with", "cefoxitin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> cefoxitin <extra_id_1> <extra_id_0> treatment <extra_id_5> Cephalosporin <extra_id_1> <extra_id_0> drug <extra_id_5> Cephalosporin <extra_id_1> <extra_id_0> drug <extra_id_5> cefoxitin <extra_id_1> <extra_id_0> effect <extra_id_5> leukopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [7], "text": "cefoxitin"}, {"type": "treatment", "offset": [0], "text": "Cephalosporin"}, {"type": "drug", "offset": [0], "text": "Cephalosporin"}, {"type": "drug", "offset": [7], "text": "cefoxitin"}, {"type": "effect", "offset": [3], "text": "leukopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "cefoxitin"], ["treatment", "Cephalosporin"], ["drug", "Cephalosporin"], ["drug", "cefoxitin"], ["effect", "leukopenia"]]}]}
{"text_id": "417679_1", "text": "Four cases of fat embolism are described in infants receiving prolonged intravenous infusion of fat ( Intralipid 20 % ) .", "tokens": ["Four", "cases", "of", "fat", "embolism", "are", "described", "in", "infants", "receiving", "prolonged", "intravenous", "infusion", "of", "fat", "(", "Intralipid", "20", "%", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> receiving <extra_id_0> subject <extra_id_5> Four cases <extra_id_1> <extra_id_0> subject <extra_id_5> infants <extra_id_1> <extra_id_0> age <extra_id_5> infants <extra_id_1> <extra_id_0> age <extra_id_5> Four <extra_id_1> <extra_id_0> treatment <extra_id_5> prolonged intravenous infusion of fat ( Intralipid 20 % ) <extra_id_1> <extra_id_0> drug <extra_id_5> Intralipid <extra_id_1> <extra_id_0> route <extra_id_5> intravenous infusion <extra_id_1> <extra_id_0> effect <extra_id_5> fat embolism <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "receiving", "args": [{"type": "subject", "offset": [0, 1], "text": "Four cases"}, {"type": "subject", "offset": [8], "text": "infants"}, {"type": "age", "offset": [8], "text": "infants"}, {"type": "age", "offset": [0], "text": "Four"}, {"type": "treatment", "offset": [10, 11, 12, 13, 14, 15, 16, 17, 18, 19], "text": "prolonged intravenous infusion of fat ( Intralipid 20 % )"}, {"type": "drug", "offset": [16], "text": "Intralipid"}, {"type": "route", "offset": [11, 12], "text": "intravenous infusion"}, {"type": "effect", "offset": [3, 4], "text": "fat embolism"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "receiving", "label": "adverse event", "asoc": [["subject", "Four cases"], ["subject", "infants"], ["age", "infants"], ["age", "Four"], ["treatment", "prolonged intravenous infusion of fat ( Intralipid 20 % )"], ["drug", "Intralipid"], ["route", "intravenous infusion"], ["effect", "fat embolism"]]}]}
{"text_id": "961329_1", "text": "A case of prolonged suxamethonium apnoea successfully terminated by the infusion of a commercial preparation of serumcholinesterase is reported .", "tokens": ["A", "case", "of", "prolonged", "suxamethonium", "apnoea", "successfully", "terminated", "by", "the", "infusion", "of", "a", "commercial", "preparation", "of", "serumcholinesterase", "is", "reported", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> terminated <extra_id_0> treatment <extra_id_5> the infusion of a commercial preparation of serumcholinesterase <extra_id_1> <extra_id_0> drug <extra_id_5> suxamethonium <extra_id_1> <extra_id_0> drug <extra_id_5> serumcholinesterase <extra_id_1> <extra_id_0> route <extra_id_5> infusion <extra_id_1> <extra_id_0> effect <extra_id_5> prolonged suxamethonium apnoea <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [7], "text": "terminated", "args": [{"type": "treatment", "offset": [9, 10, 11, 12, 13, 14, 15, 16], "text": "the infusion of a commercial preparation of serumcholinesterase"}, {"type": "drug", "offset": [4], "text": "suxamethonium"}, {"type": "drug", "offset": [16], "text": "serumcholinesterase"}, {"type": "route", "offset": [10], "text": "infusion"}, {"type": "effect", "offset": [3, 4, 5], "text": "prolonged suxamethonium apnoea"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "terminated", "label": "potential therapeutic event", "asoc": [["treatment", "the infusion of a commercial preparation of serumcholinesterase"], ["drug", "suxamethonium"], ["drug", "serumcholinesterase"], ["route", "infusion"], ["effect", "prolonged suxamethonium apnoea"]]}]}
{"text_id": "1393348_2", "text": "Although both the spontaneous occurrence of SLE and the psychosis as a sign of CNS involvement of SLE can not be excluded , SLE could be considered as an adverse effect of carbamazepine .", "tokens": ["Although", "both", "the", "spontaneous", "occurrence", "of", "SLE", "and", "the", "psychosis", "as", "a", "sign", "of", "CNS", "involvement", "of", "SLE", "can", "not", "be", "excluded", ",", "SLE", "could", "be", "considered", "as", "an", "adverse", "effect", "of", "carbamazepine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> considered <extra_id_0> treatment <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> effect <extra_id_5> SLE <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [26], "text": "considered", "args": [{"type": "treatment", "offset": [32], "text": "carbamazepine"}, {"type": "drug", "offset": [32], "text": "carbamazepine"}, {"type": "effect", "offset": [23], "text": "SLE"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "considered", "label": "adverse event", "asoc": [["treatment", "carbamazepine"], ["drug", "carbamazepine"], ["effect", "SLE"]]}]}
{"text_id": "1477441_3", "text": "Fixed drug eruption of the scrotum due to methylphenidate .", "tokens": ["Fixed", "drug", "eruption", "of", "the", "scrotum", "due", "to", "methylphenidate", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> treatment <extra_id_5> methylphenidate <extra_id_1> <extra_id_0> drug <extra_id_5> methylphenidate <extra_id_1> <extra_id_0> effect <extra_id_5> Fixed drug eruption of the scrotum <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "due", "args": [{"type": "treatment", "offset": [8], "text": "methylphenidate"}, {"type": "drug", "offset": [8], "text": "methylphenidate"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "Fixed drug eruption of the scrotum"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["treatment", "methylphenidate"], ["drug", "methylphenidate"], ["effect", "Fixed drug eruption of the scrotum"]]}]}
{"text_id": "9824032_1", "text": "Dental and gingival pain as side effects of niacin therapy .", "tokens": ["Dental", "and", "gingival", "pain", "as", "side", "effects", "of", "niacin", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> side effects <extra_id_0> treatment <extra_id_5> niacin <extra_id_1> <extra_id_0> drug <extra_id_5> niacin <extra_id_1> <extra_id_0> effect <extra_id_5> Dental and gingival pain <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5, 6], "text": "side effects", "args": [{"type": "treatment", "offset": [8], "text": "niacin"}, {"type": "drug", "offset": [8], "text": "niacin"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Dental and gingival pain"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "side effects", "label": "adverse event", "asoc": [["treatment", "niacin"], ["drug", "niacin"], ["effect", "Dental and gingival pain"]]}]}
{"text_id": "8024670_1", "text": "Four patients who manifested symptoms of the antiepileptic drug ( AED ) hypersensitivity syndrome during therapy with carbamazepine are reported .", "tokens": ["Four", "patients", "who", "manifested", "symptoms", "of", "the", "antiepileptic", "drug", "(", "AED", ")", "hypersensitivity", "syndrome", "during", "therapy", "with", "carbamazepine", "are", "reported", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> symptoms of <extra_id_0> subject <extra_id_5> Four patients <extra_id_1> <extra_id_0> population <extra_id_5> Four <extra_id_1> <extra_id_0> treatment <extra_id_5> antiepileptic drug ( AED ) <extra_id_1> <extra_id_0> treatment <extra_id_5> during therapy with carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> antiepileptic drug ( AED ) <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> effect <extra_id_5> hypersensitivity syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4, 5], "text": "symptoms of", "args": [{"type": "subject", "offset": [0, 1], "text": "Four patients"}, {"type": "population", "offset": [0], "text": "Four"}, {"type": "treatment", "offset": [7, 8, 9, 10, 11], "text": "antiepileptic drug ( AED )"}, {"type": "treatment", "offset": [14, 15, 16, 17], "text": "during therapy with carbamazepine"}, {"type": "drug", "offset": [7, 8, 9, 10, 11], "text": "antiepileptic drug ( AED )"}, {"type": "drug", "offset": [17], "text": "carbamazepine"}, {"type": "effect", "offset": [12, 13], "text": "hypersensitivity syndrome"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "symptoms of", "label": "adverse event", "asoc": [["subject", "Four patients"], ["population", "Four"], ["treatment", "antiepileptic drug ( AED )"], ["treatment", "during therapy with carbamazepine"], ["drug", "antiepileptic drug ( AED )"], ["drug", "carbamazepine"], ["effect", "hypersensitivity syndrome"]]}]}
{"text_id": "16116136_2", "text": "Despite minimal short - term side effects and apparent efficacy , chronic treatment of MG with MM may be associated with increased risk of lymphoproliferative disorders .", "tokens": ["Despite", "minimal", "short", "-", "term", "side", "effects", "and", "apparent", "efficacy", ",", "chronic", "treatment", "of", "MG", "with", "MM", "may", "be", "associated", "with", "increased", "risk", "of", "lymphoproliferative", "disorders", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> MG with MM <extra_id_1> <extra_id_0> drug <extra_id_5> MM <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> MG <extra_id_1> <extra_id_0> effect <extra_id_5> increased risk of lymphoproliferative <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "associated", "args": [{"type": "treatment", "offset": [14, 15, 16], "text": "MG with MM"}, {"type": "drug", "offset": [16], "text": "MM"}, {"type": "treatment disorder", "offset": [14], "text": "MG"}, {"type": "effect", "offset": [21, 22, 23, 24], "text": "increased risk of lymphoproliferative"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "MG with MM"], ["drug", "MM"], ["treatment disorder", "MG"], ["effect", "increased risk of lymphoproliferative"]]}]}
{"text_id": "6484655_2", "text": "Ampicillin - associated seizures .", "tokens": ["Ampicillin", "-", "associated", "seizures", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Ampicillin <extra_id_1> <extra_id_0> drug <extra_id_5> Ampicillin <extra_id_1> <extra_id_0> effect <extra_id_5> seizures <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Ampicillin"}, {"type": "drug", "offset": [0], "text": "Ampicillin"}, {"type": "effect", "offset": [3], "text": "seizures"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Ampicillin"], ["drug", "Ampicillin"], ["effect", "seizures"]]}]}
{"text_id": "6484655_3", "text": "Two patients had ampicillin - associated seizures .", "tokens": ["Two", "patients", "had", "ampicillin", "-", "associated", "seizures", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> ampicillin <extra_id_1> <extra_id_0> drug <extra_id_5> ampicillin <extra_id_1> <extra_id_0> effect <extra_id_5> seizures <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "associated", "args": [{"type": "treatment", "offset": [3], "text": "ampicillin"}, {"type": "drug", "offset": [3], "text": "ampicillin"}, {"type": "effect", "offset": [6], "text": "seizures"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "ampicillin"], ["drug", "ampicillin"], ["effect", "seizures"]]}]}
{"text_id": "15239684_2", "text": "The findings were judged to be consistent with soft - tissue injury associated with intravenous administration of phenytoin , also termed purple glove syndrome .", "tokens": ["The", "findings", "were", "judged", "to", "be", "consistent", "with", "soft", "-", "tissue", "injury", "associated", "with", "intravenous", "administration", "of", "phenytoin", ",", "also", "termed", "purple", "glove", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> intravenous administration of phenytoin <extra_id_1> <extra_id_0> drug <extra_id_5> phenytoin <extra_id_1> <extra_id_0> route <extra_id_5> intravenous administration <extra_id_1> <extra_id_0> effect <extra_id_5> soft - tissue injury <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "associated", "args": [{"type": "treatment", "offset": [14, 15, 16, 17], "text": "intravenous administration of phenytoin"}, {"type": "drug", "offset": [17], "text": "phenytoin"}, {"type": "route", "offset": [14, 15], "text": "intravenous administration"}, {"type": "effect", "offset": [8, 9, 10, 11], "text": "soft - tissue injury"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "intravenous administration of phenytoin"], ["drug", "phenytoin"], ["route", "intravenous administration"], ["effect", "soft - tissue injury"]]}]}
{"text_id": "8313300_6", "text": "A severe form of exophthalmos resulting from lithium therapy has not been described in the literature .", "tokens": ["A", "severe", "form", "of", "exophthalmos", "resulting", "from", "lithium", "therapy", "has", "not", "been", "described", "in", "the", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resulting <extra_id_0> treatment <extra_id_5> lithium <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> effect <extra_id_5> exophthalmos <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "resulting", "args": [{"type": "treatment", "offset": [7], "text": "lithium"}, {"type": "drug", "offset": [7], "text": "lithium"}, {"type": "effect", "offset": [4], "text": "exophthalmos"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "resulting", "label": "adverse event", "asoc": [["treatment", "lithium"], ["drug", "lithium"], ["effect", "exophthalmos"]]}]}
{"text_id": "22233409_4", "text": "We report the case of a patient with chronic hepatitis C infection who developed severe anaemia during antiviral treatment with peginterferon alfa / ribavirin when oseltamivir was added to treat influenza .", "tokens": ["We", "report", "the", "case", "of", "a", "patient", "with", "chronic", "hepatitis", "C", "infection", "who", "developed", "severe", "anaemia", "during", "antiviral", "treatment", "with", "peginterferon", "alfa", "/", "ribavirin", "when", "oseltamivir", "was", "added", "to", "treat", "influenza", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a patient with chronic hepatitis C infection <extra_id_1> <extra_id_0> subject disorder <extra_id_5> chronic hepatitis C infection <extra_id_1> <extra_id_0> subject disorder <extra_id_5> influenza <extra_id_1> <extra_id_0> treatment <extra_id_5> peginterferon alfa / ribavirin <extra_id_1> <extra_id_0> treatment <extra_id_5> oseltamivir <extra_id_1> <extra_id_0> drug <extra_id_5> peginterferon alfa <extra_id_1> <extra_id_0> drug <extra_id_5> ribavirin <extra_id_1> <extra_id_0> drug <extra_id_5> oseltamivir <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic hepatitis C infection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> influenza <extra_id_1> <extra_id_0> combination drug <extra_id_5> peginterferon alfa <extra_id_1> <extra_id_0> combination drug <extra_id_5> ribavirin <extra_id_1> <extra_id_0> combination drug <extra_id_5> oseltamivir <extra_id_1> <extra_id_0> effect <extra_id_5> severe anaemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "developed", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "a patient with chronic hepatitis C infection"}, {"type": "subject disorder", "offset": [8, 9, 10, 11], "text": "chronic hepatitis C infection"}, {"type": "subject disorder", "offset": [30], "text": "influenza"}, {"type": "treatment", "offset": [20, 21, 22, 23], "text": "peginterferon alfa / ribavirin"}, {"type": "treatment", "offset": [25], "text": "oseltamivir"}, {"type": "drug", "offset": [20, 21], "text": "peginterferon alfa"}, {"type": "drug", "offset": [23], "text": "ribavirin"}, {"type": "drug", "offset": [25], "text": "oseltamivir"}, {"type": "treatment disorder", "offset": [8, 9, 10, 11], "text": "chronic hepatitis C infection"}, {"type": "treatment disorder", "offset": [30], "text": "influenza"}, {"type": "combination drug", "offset": [20, 21], "text": "peginterferon alfa"}, {"type": "combination drug", "offset": [23], "text": "ribavirin"}, {"type": "combination drug", "offset": [25], "text": "oseltamivir"}, {"type": "effect", "offset": [14, 15], "text": "severe anaemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a patient with chronic hepatitis C infection"], ["subject disorder", "chronic hepatitis C infection"], ["subject disorder", "influenza"], ["treatment", "peginterferon alfa / ribavirin"], ["treatment", "oseltamivir"], ["drug", "peginterferon alfa"], ["drug", "ribavirin"], ["drug", "oseltamivir"], ["treatment disorder", "chronic hepatitis C infection"], ["treatment disorder", "influenza"], ["combination drug", "peginterferon alfa"], ["combination drug", "ribavirin"], ["combination drug", "oseltamivir"], ["effect", "severe anaemia"]]}]}
{"text_id": "9366852_1", "text": "Skin necrosis secondary to low - molecular weight heparin in a patient with antiphospholipid antibody syndrome .", "tokens": ["Skin", "necrosis", "secondary", "to", "low", "-", "molecular", "weight", "heparin", "in", "a", "patient", "with", "antiphospholipid", "antibody", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> secondary to <extra_id_0> subject <extra_id_5> a patient with antiphospholipid antibody syndrome <extra_id_1> <extra_id_0> subject disorder <extra_id_5> antiphospholipid antibody syndrome <extra_id_1> <extra_id_0> treatment <extra_id_5> low - molecular weight heparin <extra_id_1> <extra_id_0> drug <extra_id_5> low - molecular weight heparin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> antiphospholipid antibody syndrome <extra_id_1> <extra_id_0> effect <extra_id_5> Skin necrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2, 3], "text": "secondary to", "args": [{"type": "subject", "offset": [10, 11, 12, 13, 14, 15], "text": "a patient with antiphospholipid antibody syndrome"}, {"type": "subject disorder", "offset": [13, 14, 15], "text": "antiphospholipid antibody syndrome"}, {"type": "treatment", "offset": [4, 5, 6, 7, 8], "text": "low - molecular weight heparin"}, {"type": "drug", "offset": [4, 5, 6, 7, 8], "text": "low - molecular weight heparin"}, {"type": "treatment disorder", "offset": [13, 14, 15], "text": "antiphospholipid antibody syndrome"}, {"type": "effect", "offset": [0, 1], "text": "Skin necrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "secondary to", "label": "adverse event", "asoc": [["subject", "a patient with antiphospholipid antibody syndrome"], ["subject disorder", "antiphospholipid antibody syndrome"], ["treatment", "low - molecular weight heparin"], ["drug", "low - molecular weight heparin"], ["treatment disorder", "antiphospholipid antibody syndrome"], ["effect", "Skin necrosis"]]}]}
{"text_id": "6692713_3", "text": "To our knowledge , this recurrence of amiodarone pulmonary toxicity has not been reported previously .", "tokens": ["To", "our", "knowledge", ",", "this", "recurrence", "of", "amiodarone", "pulmonary", "toxicity", "has", "not", "been", "reported", "previously", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> toxicity <extra_id_0> treatment <extra_id_5> amiodarone <extra_id_1> <extra_id_0> drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "toxicity", "args": [{"type": "treatment", "offset": [7], "text": "amiodarone"}, {"type": "drug", "offset": [7], "text": "amiodarone"}, {"type": "effect", "offset": [8, 9], "text": "pulmonary toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "toxicity", "label": "adverse event", "asoc": [["treatment", "amiodarone"], ["drug", "amiodarone"], ["effect", "pulmonary toxicity"]]}]}
{"text_id": "9876812_2", "text": "CONCLUSIONS : Because of its structural similarity to the other vinca alkaloids , vinorelbine is believed to be responsible for SIADH in our patient .", "tokens": ["CONCLUSIONS", ":", "Because", "of", "its", "structural", "similarity", "to", "the", "other", "vinca", "alkaloids", ",", "vinorelbine", "is", "believed", "to", "be", "responsible", "for", "SIADH", "in", "our", "patient", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> responsible <extra_id_0> treatment <extra_id_5> vinorelbine <extra_id_1> <extra_id_0> drug <extra_id_5> vinorelbine <extra_id_1> <extra_id_0> effect <extra_id_5> SIADH <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "responsible", "args": [{"type": "treatment", "offset": [13], "text": "vinorelbine"}, {"type": "drug", "offset": [13], "text": "vinorelbine"}, {"type": "effect", "offset": [20], "text": "SIADH"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "responsible", "label": "adverse event", "asoc": [["treatment", "vinorelbine"], ["drug", "vinorelbine"], ["effect", "SIADH"]]}]}
{"text_id": "8435665_2", "text": "Fatal eosinophilia myalgia syndrome in a marrow transplant patient attributed to total parenteral nutrition with a solution containing tryptophan .", "tokens": ["Fatal", "eosinophilia", "myalgia", "syndrome", "in", "a", "marrow", "transplant", "patient", "attributed", "to", "total", "parenteral", "nutrition", "with", "a", "solution", "containing", "tryptophan", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> attributed <extra_id_0> subject <extra_id_5> marrow transplant patient <extra_id_1> <extra_id_0> treatment <extra_id_5> total parenteral nutrition with a solution containing tryptophan <extra_id_1> <extra_id_0> drug <extra_id_5> tryptophan <extra_id_1> <extra_id_0> route <extra_id_5> parenteral <extra_id_1> <extra_id_0> effect <extra_id_5> Fatal eosinophilia myalgia syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "attributed", "args": [{"type": "subject", "offset": [6, 7, 8], "text": "marrow transplant patient"}, {"type": "treatment", "offset": [11, 12, 13, 14, 15, 16, 17, 18], "text": "total parenteral nutrition with a solution containing tryptophan"}, {"type": "drug", "offset": [18], "text": "tryptophan"}, {"type": "route", "offset": [12], "text": "parenteral"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Fatal eosinophilia myalgia syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "treatment"], "spot_asoc": [{"span": "attributed", "label": "adverse event", "asoc": [["subject", "marrow transplant patient"], ["treatment", "total parenteral nutrition with a solution containing tryptophan"], ["drug", "tryptophan"], ["route", "parenteral"], ["effect", "Fatal eosinophilia myalgia syndrome"]]}]}
{"text_id": "2937155_2", "text": "The possible development of a drug - induced vasculitis or lupus - like syndrome should be added to the list of rare toxic effects of vancomycin .", "tokens": ["The", "possible", "development", "of", "a", "drug", "-", "induced", "vasculitis", "or", "lupus", "-", "like", "syndrome", "should", "be", "added", "to", "the", "list", "of", "rare", "toxic", "effects", "of", "vancomycin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> treatment <extra_id_5> vancomycin <extra_id_1> <extra_id_0> drug <extra_id_5> vancomycin <extra_id_1> <extra_id_0> effect <extra_id_5> drug - induced vasculitis or lupus - like syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "development", "args": [{"type": "treatment", "offset": [25], "text": "vancomycin"}, {"type": "drug", "offset": [25], "text": "vancomycin"}, {"type": "effect", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13], "text": "drug - induced vasculitis or lupus - like syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["treatment", "vancomycin"], ["drug", "vancomycin"], ["effect", "drug - induced vasculitis or lupus - like syndrome"]]}]}
{"text_id": "2369419_1", "text": "A patient with seropositive rheumatoid arthritis developed ascites while taking weekly doses of methotrexate ( MTX ) .", "tokens": ["A", "patient", "with", "seropositive", "rheumatoid", "arthritis", "developed", "ascites", "while", "taking", "weekly", "doses", "of", "methotrexate", "(", "MTX", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A patient with seropositive rheumatoid arthritis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> seropositive rheumatoid arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> taking weekly doses of methotrexate ( MTX ) <extra_id_1> <extra_id_0> drug <extra_id_5> methotrexate <extra_id_1> <extra_id_0> frequency <extra_id_5> weekly <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> seropositive rheumatoid arthritis <extra_id_1> <extra_id_0> effect <extra_id_5> ascites <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5], "text": "A patient with seropositive rheumatoid arthritis"}, {"type": "subject disorder", "offset": [3, 4, 5], "text": "seropositive rheumatoid arthritis"}, {"type": "treatment", "offset": [9, 10, 11, 12, 13, 14, 15, 16], "text": "taking weekly doses of methotrexate ( MTX )"}, {"type": "drug", "offset": [13], "text": "methotrexate"}, {"type": "frequency", "offset": [10], "text": "weekly"}, {"type": "treatment disorder", "offset": [3, 4, 5], "text": "seropositive rheumatoid arthritis"}, {"type": "effect", "offset": [7], "text": "ascites"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "frequency", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A patient with seropositive rheumatoid arthritis"], ["subject disorder", "seropositive rheumatoid arthritis"], ["treatment", "taking weekly doses of methotrexate ( MTX )"], ["drug", "methotrexate"], ["frequency", "weekly"], ["treatment disorder", "seropositive rheumatoid arthritis"], ["effect", "ascites"]]}]}
{"text_id": "15239684_1", "text": "Purple glove syndrome , named for its distinctive purple discoloration and swelling of the hands in the distribution of a glove , is an uncommon complication of intravenous phenytoin administration through small dorsal veins of the hands .", "tokens": ["Purple", "glove", "syndrome", ",", "named", "for", "its", "distinctive", "purple", "discoloration", "and", "swelling", "of", "the", "hands", "in", "the", "distribution", "of", "a", "glove", ",", "is", "an", "uncommon", "complication", "of", "intravenous", "phenytoin", "administration", "through", "small", "dorsal", "veins", "of", "the", "hands", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> intravenous phenytoin administration through small dorsal veins of the hands <extra_id_1> <extra_id_0> drug <extra_id_5> phenytoin <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> effect <extra_id_5> Purple glove syndrome <extra_id_1> <extra_id_0> effect <extra_id_5> purple discoloration and swelling of the hands in the distribution of a glove <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [25], "text": "complication", "args": [{"type": "treatment", "offset": [27, 28, 29, 30, 31, 32, 33, 34, 35, 36], "text": "intravenous phenytoin administration through small dorsal veins of the hands"}, {"type": "drug", "offset": [28], "text": "phenytoin"}, {"type": "route", "offset": [27], "text": "intravenous"}, {"type": "effect", "offset": [0, 1, 2], "text": "Purple glove syndrome"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "purple discoloration and swelling of the hands in the distribution of a glove"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "intravenous phenytoin administration through small dorsal veins of the hands"], ["drug", "phenytoin"], ["route", "intravenous"], ["effect", "Purple glove syndrome"], ["effect", "purple discoloration and swelling of the hands in the distribution of a glove"]]}]}
{"text_id": "6311654_5", "text": "There was a good correlation between the total dose of ACTH and the percentage decrease of brain parenchyma .", "tokens": ["There", "was", "a", "good", "correlation", "between", "the", "total", "dose", "of", "ACTH", "and", "the", "percentage", "decrease", "of", "brain", "parenchyma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> correlation <extra_id_0> treatment <extra_id_5> total dose of ACTH <extra_id_1> <extra_id_0> drug <extra_id_5> ACTH <extra_id_1> <extra_id_0> effect <extra_id_5> percentage decrease of brain parenchyma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "correlation", "args": [{"type": "treatment", "offset": [7, 8, 9, 10], "text": "total dose of ACTH"}, {"type": "drug", "offset": [10], "text": "ACTH"}, {"type": "effect", "offset": [13, 14, 15, 16, 17], "text": "percentage decrease of brain parenchyma"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "correlation", "label": "adverse event", "asoc": [["treatment", "total dose of ACTH"], ["drug", "ACTH"], ["effect", "percentage decrease of brain parenchyma"]]}]}
{"text_id": "10473079_2", "text": "We now report the first known cancer patient who developed life - threatening complications after treatment with topical 5 - FU and was shown subsequently to have profound DPD deficiency .", "tokens": ["We", "now", "report", "the", "first", "known", "cancer", "patient", "who", "developed", "life", "-", "threatening", "complications", "after", "treatment", "with", "topical", "5", "-", "FU", "and", "was", "shown", "subsequently", "to", "have", "profound", "DPD", "deficiency", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> cancer patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> topical 5 - FU <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> route <extra_id_5> topical <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> cancer <extra_id_1> <extra_id_0> effect <extra_id_5> life - threatening complications <extra_id_1> <extra_id_0> effect <extra_id_5> have profound DPD deficiency <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "developed", "args": [{"type": "subject", "offset": [6, 7], "text": "cancer patient"}, {"type": "subject disorder", "offset": [6], "text": "cancer"}, {"type": "treatment", "offset": [17, 18, 19, 20], "text": "topical 5 - FU"}, {"type": "drug", "offset": [18, 19, 20], "text": "5 - FU"}, {"type": "route", "offset": [17], "text": "topical"}, {"type": "treatment disorder", "offset": [6], "text": "cancer"}, {"type": "effect", "offset": [10, 11, 12, 13], "text": "life - threatening complications"}, {"type": "effect", "offset": [26, 27, 28, 29], "text": "have profound DPD deficiency"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "cancer patient"], ["subject disorder", "cancer"], ["treatment", "topical 5 - FU"], ["drug", "5 - FU"], ["route", "topical"], ["treatment disorder", "cancer"], ["effect", "life - threatening complications"], ["effect", "have profound DPD deficiency"]]}]}
{"text_id": "2554727_2", "text": "High - dose cytosine arabinoside may benefit patients with refractory acute leukemia .", "tokens": ["High", "-", "dose", "cytosine", "arabinoside", "may", "benefit", "patients", "with", "refractory", "acute", "leukemia", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> benefit <extra_id_0> subject <extra_id_5> patients with refractory acute leukemia <extra_id_1> <extra_id_0> subject disorder <extra_id_5> refractory acute leukemia <extra_id_1> <extra_id_0> treatment <extra_id_5> High - dose cytosine arabinoside <extra_id_1> <extra_id_0> drug <extra_id_5> cytosine arabinoside <extra_id_1> <extra_id_0> dosage <extra_id_5> High - dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> refractory acute leukemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [6], "text": "benefit", "args": [{"type": "subject", "offset": [7, 8, 9, 10, 11], "text": "patients with refractory acute leukemia"}, {"type": "subject disorder", "offset": [9, 10, 11], "text": "refractory acute leukemia"}, {"type": "treatment", "offset": [0, 1, 2, 3, 4], "text": "High - dose cytosine arabinoside"}, {"type": "drug", "offset": [3, 4], "text": "cytosine arabinoside"}, {"type": "dosage", "offset": [0, 1, 2], "text": "High - dose"}, {"type": "treatment disorder", "offset": [9, 10, 11], "text": "refractory acute leukemia"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "drug", "treatment", "dosage", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "benefit", "label": "potential therapeutic event", "asoc": [["subject", "patients with refractory acute leukemia"], ["subject disorder", "refractory acute leukemia"], ["treatment", "High - dose cytosine arabinoside"], ["drug", "cytosine arabinoside"], ["dosage", "High - dose"], ["treatment disorder", "refractory acute leukemia"]]}]}
{"text_id": "12013364_1", "text": "A 53 - year - old man developed NMS without rigidity while taking olanzapine .", "tokens": ["A", "53", "-", "year", "-", "old", "man", "developed", "NMS", "without", "rigidity", "while", "taking", "olanzapine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 53 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 53 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> olanzapine <extra_id_1> <extra_id_0> drug <extra_id_5> olanzapine <extra_id_1> <extra_id_0> effect <extra_id_5> NMS without rigidity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "A 53 - year - old man"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "53 - year - old"}, {"type": "gender", "offset": [6], "text": "man"}, {"type": "treatment", "offset": [13], "text": "olanzapine"}, {"type": "drug", "offset": [13], "text": "olanzapine"}, {"type": "effect", "offset": [8, 9, 10], "text": "NMS without rigidity"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 53 - year - old man"], ["age", "53 - year - old"], ["gender", "man"], ["treatment", "olanzapine"], ["drug", "olanzapine"], ["effect", "NMS without rigidity"]]}]}
{"text_id": "20190474_4", "text": "This is the first report of acute kidney injury due to zonisamide - induced DRESS / DIHS .", "tokens": ["This", "is", "the", "first", "report", "of", "acute", "kidney", "injury", "due", "to", "zonisamide", "-", "induced", "DRESS", "/", "DIHS", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> zonisamide <extra_id_1> <extra_id_0> drug <extra_id_5> zonisamide <extra_id_1> <extra_id_0> effect <extra_id_5> acute kidney injury due to <extra_id_1> <extra_id_0> effect <extra_id_5> DRESS / DIHS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "induced", "args": [{"type": "treatment", "offset": [11], "text": "zonisamide"}, {"type": "drug", "offset": [11], "text": "zonisamide"}, {"type": "effect", "offset": [6, 7, 8, 9, 10], "text": "acute kidney injury due to"}, {"type": "effect", "offset": [14, 15, 16], "text": "DRESS / DIHS"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "zonisamide"], ["drug", "zonisamide"], ["effect", "acute kidney injury due to"], ["effect", "DRESS / DIHS"]]}]}
{"text_id": "6683487_1", "text": "Thrombotic thrombocytopenic purpura during penicillamine therapy in rheumatoid arthritis .", "tokens": ["Thrombotic", "thrombocytopenic", "purpura", "during", "penicillamine", "therapy", "in", "rheumatoid", "arthritis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> penicillamine <extra_id_1> <extra_id_0> drug <extra_id_5> penicillamine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> effect <extra_id_5> Thrombotic thrombocytopenic purpura <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "during", "args": [{"type": "treatment", "offset": [4], "text": "penicillamine"}, {"type": "drug", "offset": [4], "text": "penicillamine"}, {"type": "treatment disorder", "offset": [7, 8], "text": "rheumatoid arthritis"}, {"type": "effect", "offset": [0, 1, 2], "text": "Thrombotic thrombocytopenic purpura"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "penicillamine"], ["drug", "penicillamine"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "Thrombotic thrombocytopenic purpura"]]}]}
{"text_id": "17536204_1", "text": "A cause - effect relationship to capecitabine was suggested due to resolution of headache with capecitabine withdrawal and reappearance with capecitabine rechallenge .", "tokens": ["A", "cause", "-", "effect", "relationship", "to", "capecitabine", "was", "suggested", "due", "to", "resolution", "of", "headache", "with", "capecitabine", "withdrawal", "and", "reappearance", "with", "capecitabine", "rechallenge", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> relationship to <extra_id_0> treatment <extra_id_5> capecitabine <extra_id_1> <extra_id_0> drug <extra_id_5> capecitabine <extra_id_1> <extra_id_0> effect <extra_id_5> headache <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4, 5], "text": "relationship to", "args": [{"type": "treatment", "offset": [6], "text": "capecitabine"}, {"type": "drug", "offset": [6], "text": "capecitabine"}, {"type": "effect", "offset": [13], "text": "headache"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "relationship to", "label": "adverse event", "asoc": [["treatment", "capecitabine"], ["drug", "capecitabine"], ["effect", "headache"]]}]}
{"text_id": "20190474_2", "text": "Hypersensitivity to zonisamide was confirmed by the skin patch test .", "tokens": ["Hypersensitivity", "to", "zonisamide", "was", "confirmed", "by", "the", "skin", "patch", "test", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> to <extra_id_0> treatment <extra_id_5> zonisamide <extra_id_1> <extra_id_0> drug <extra_id_5> zonisamide <extra_id_1> <extra_id_0> effect <extra_id_5> Hypersensitivity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "to", "args": [{"type": "treatment", "offset": [2], "text": "zonisamide"}, {"type": "drug", "offset": [2], "text": "zonisamide"}, {"type": "effect", "offset": [0], "text": "Hypersensitivity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "to", "label": "adverse event", "asoc": [["treatment", "zonisamide"], ["drug", "zonisamide"], ["effect", "Hypersensitivity"]]}]}
{"text_id": "1536494_2", "text": "We present a case of ethylenediamine - induced delayed hypersensitivity reaction in a 46 - year - old woman who received parenteral aminophylline for an acute asthma exacerbation .", "tokens": ["We", "present", "a", "case", "of", "ethylenediamine", "-", "induced", "delayed", "hypersensitivity", "reaction", "in", "a", "46", "-", "year", "-", "old", "woman", "who", "received", "parenteral", "aminophylline", "for", "an", "acute", "asthma", "exacerbation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a 46 - year - old woman <extra_id_1> <extra_id_0> age <extra_id_5> 46 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> treatment <extra_id_5> ethylenediamine <extra_id_1> <extra_id_0> drug <extra_id_5> ethylenediamine <extra_id_1> <extra_id_0> effect <extra_id_5> delayed hypersensitivity reaction <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> received <extra_id_0> subject <extra_id_5> a 46 - year - old woman <extra_id_1> <extra_id_0> age <extra_id_5> 46 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute asthma exacerbation <extra_id_1> <extra_id_0> treatment <extra_id_5> parenteral aminophylline <extra_id_1> <extra_id_0> drug <extra_id_5> aminophylline <extra_id_1> <extra_id_0> route <extra_id_5> parenteral <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute asthma exacerbation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "induced", "args": [{"type": "subject", "offset": [12, 13, 14, 15, 16, 17, 18], "text": "a 46 - year - old woman"}, {"type": "age", "offset": [13, 14, 15, 16, 17], "text": "46 - year - old"}, {"type": "gender", "offset": [18], "text": "woman"}, {"type": "treatment", "offset": [5], "text": "ethylenediamine"}, {"type": "drug", "offset": [5], "text": "ethylenediamine"}, {"type": "effect", "offset": [8, 9, 10], "text": "delayed hypersensitivity reaction"}]}, {"type": "potential therapeutic event", "offset": [20], "text": "received", "args": [{"type": "subject", "offset": [12, 13, 14, 15, 16, 17, 18], "text": "a 46 - year - old woman"}, {"type": "age", "offset": [13, 14, 15, 16, 17], "text": "46 - year - old"}, {"type": "gender", "offset": [18], "text": "woman"}, {"type": "subject disorder", "offset": [25, 26, 27], "text": "acute asthma exacerbation"}, {"type": "treatment", "offset": [21, 22], "text": "parenteral aminophylline"}, {"type": "drug", "offset": [22], "text": "aminophylline"}, {"type": "route", "offset": [21], "text": "parenteral"}, {"type": "treatment disorder", "offset": [25, 26, 27], "text": "acute asthma exacerbation"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["subject disorder", "effect", "route", "subject", "treatment disorder", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a 46 - year - old woman"], ["age", "46 - year - old"], ["gender", "woman"], ["treatment", "ethylenediamine"], ["drug", "ethylenediamine"], ["effect", "delayed hypersensitivity reaction"]]}, {"span": "received", "label": "potential therapeutic event", "asoc": [["subject", "a 46 - year - old woman"], ["age", "46 - year - old"], ["gender", "woman"], ["subject disorder", "acute asthma exacerbation"], ["treatment", "parenteral aminophylline"], ["drug", "aminophylline"], ["route", "parenteral"], ["treatment disorder", "acute asthma exacerbation"]]}]}
{"text_id": "1467295_1", "text": "We describe a patient who developed NEH on three separate occasions provoked by two different chemotherapeutic agents -- cytarabine and mitoxantrone .", "tokens": ["We", "describe", "a", "patient", "who", "developed", "NEH", "on", "three", "separate", "occasions", "provoked", "by", "two", "different", "chemotherapeutic", "agents", "--", "cytarabine", "and", "mitoxantrone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> provoked <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> cytarabine and mitoxantrone <extra_id_1> <extra_id_0> drug <extra_id_5> cytarabine <extra_id_1> <extra_id_0> drug <extra_id_5> mitoxantrone <extra_id_1> <extra_id_0> combination drug <extra_id_5> cytarabine <extra_id_1> <extra_id_0> combination drug <extra_id_5> mitoxantrone <extra_id_1> <extra_id_0> effect <extra_id_5> NEH <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "provoked", "args": [{"type": "subject", "offset": [2, 3], "text": "a patient"}, {"type": "treatment", "offset": [18, 19, 20], "text": "cytarabine and mitoxantrone"}, {"type": "drug", "offset": [18], "text": "cytarabine"}, {"type": "drug", "offset": [20], "text": "mitoxantrone"}, {"type": "combination drug", "offset": [18], "text": "cytarabine"}, {"type": "combination drug", "offset": [20], "text": "mitoxantrone"}, {"type": "effect", "offset": [6], "text": "NEH"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "provoked", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "cytarabine and mitoxantrone"], ["drug", "cytarabine"], ["drug", "mitoxantrone"], ["combination drug", "cytarabine"], ["combination drug", "mitoxantrone"], ["effect", "NEH"]]}]}
{"text_id": "812008_1", "text": "Diphenylhydantoin apparently adversely affected both the clinical and biochemical parameters of the acute intermittent porphyria .", "tokens": ["Diphenylhydantoin", "apparently", "adversely", "affected", "both", "the", "clinical", "and", "biochemical", "parameters", "of", "the", "acute", "intermittent", "porphyria", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> affected <extra_id_0> treatment <extra_id_5> Diphenylhydantoin <extra_id_1> <extra_id_0> drug <extra_id_5> Diphenylhydantoin <extra_id_1> <extra_id_0> effect <extra_id_5> adversely affected both the clinical and biochemical parameters of the acute intermittent porphyria <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "affected", "args": [{"type": "treatment", "offset": [0], "text": "Diphenylhydantoin"}, {"type": "drug", "offset": [0], "text": "Diphenylhydantoin"}, {"type": "effect", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "adversely affected both the clinical and biochemical parameters of the acute intermittent porphyria"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "affected", "label": "adverse event", "asoc": [["treatment", "Diphenylhydantoin"], ["drug", "Diphenylhydantoin"], ["effect", "adversely affected both the clinical and biochemical parameters of the acute intermittent porphyria"]]}]}
{"text_id": "2621382_3", "text": "Two cases of lepromatous leprosy with erythema nodosum leprosum who were on high doses of clofazimine , showed discoloration of nail plate , subungual hyperkeratosis and onycholysis .", "tokens": ["Two", "cases", "of", "lepromatous", "leprosy", "with", "erythema", "nodosum", "leprosum", "who", "were", "on", "high", "doses", "of", "clofazimine", ",", "showed", "discoloration", "of", "nail", "plate", ",", "subungual", "hyperkeratosis", "and", "onycholysis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> showed <extra_id_0> subject <extra_id_5> Two cases of lepromatous leprosy with erythema nodosum leprosum <extra_id_1> <extra_id_0> population <extra_id_5> Two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> lepromatous leprosy with erythema nodosum leprosum <extra_id_1> <extra_id_0> treatment <extra_id_5> high doses of clofazimine <extra_id_1> <extra_id_0> drug <extra_id_5> clofazimine <extra_id_1> <extra_id_0> dosage <extra_id_5> high doses <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> lepromatous leprosy with erythema nodosum leprosum <extra_id_1> <extra_id_0> effect <extra_id_5> discoloration of nail plate , subungual hyperkeratosis and onycholysis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "showed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8], "text": "Two cases of lepromatous leprosy with erythema nodosum leprosum"}, {"type": "population", "offset": [0], "text": "Two"}, {"type": "subject disorder", "offset": [3, 4, 5, 6, 7, 8], "text": "lepromatous leprosy with erythema nodosum leprosum"}, {"type": "treatment", "offset": [12, 13, 14, 15], "text": "high doses of clofazimine"}, {"type": "drug", "offset": [15], "text": "clofazimine"}, {"type": "dosage", "offset": [12, 13], "text": "high doses"}, {"type": "treatment disorder", "offset": [3, 4, 5, 6, 7, 8], "text": "lepromatous leprosy with erythema nodosum leprosum"}, {"type": "effect", "offset": [18, 19, 20, 21, 22, 23, 24, 25, 26], "text": "discoloration of nail plate , subungual hyperkeratosis and onycholysis"}]}], "spot": ["adverse event"], "asoc": ["dosage", "population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "showed", "label": "adverse event", "asoc": [["subject", "Two cases of lepromatous leprosy with erythema nodosum leprosum"], ["population", "Two"], ["subject disorder", "lepromatous leprosy with erythema nodosum leprosum"], ["treatment", "high doses of clofazimine"], ["drug", "clofazimine"], ["dosage", "high doses"], ["treatment disorder", "lepromatous leprosy with erythema nodosum leprosum"], ["effect", "discoloration of nail plate , subungual hyperkeratosis and onycholysis"]]}]}
{"text_id": "889156_4", "text": "A more serious development of adrenal insufficiency may occur upon the improper replacement of systemic steroids .", "tokens": ["A", "more", "serious", "development", "of", "adrenal", "insufficiency", "may", "occur", "upon", "the", "improper", "replacement", "of", "systemic", "steroids", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> replacement <extra_id_0> treatment <extra_id_5> systemic steroids <extra_id_1> <extra_id_0> drug <extra_id_5> steroids <extra_id_1> <extra_id_0> effect <extra_id_5> development of adrenal insufficiency <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "replacement", "args": [{"type": "treatment", "offset": [14, 15], "text": "systemic steroids"}, {"type": "drug", "offset": [15], "text": "steroids"}, {"type": "effect", "offset": [3, 4, 5, 6], "text": "development of adrenal insufficiency"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "replacement", "label": "adverse event", "asoc": [["treatment", "systemic steroids"], ["drug", "steroids"], ["effect", "development of adrenal insufficiency"]]}]}
{"text_id": "1775411_2", "text": "Pulmonary fibrosis associated with nabumetone .", "tokens": ["Pulmonary", "fibrosis", "associated", "with", "nabumetone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> nabumetone <extra_id_1> <extra_id_0> drug <extra_id_5> nabumetone <extra_id_1> <extra_id_0> effect <extra_id_5> Pulmonary fibrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [4], "text": "nabumetone"}, {"type": "drug", "offset": [4], "text": "nabumetone"}, {"type": "effect", "offset": [0, 1], "text": "Pulmonary fibrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "nabumetone"], ["drug", "nabumetone"], ["effect", "Pulmonary fibrosis"]]}]}
{"text_id": "15289139_2", "text": "METHODS : A 76 - year - old woman with primary open - angle glaucoma and no history of ocular surgery developed a choroidal detachment 12 hours after initiation of therapy with dorzolamide eye drops .", "tokens": ["METHODS", ":", "A", "76", "-", "year", "-", "old", "woman", "with", "primary", "open", "-", "angle", "glaucoma", "and", "no", "history", "of", "ocular", "surgery", "developed", "a", "choroidal", "detachment", "12", "hours", "after", "initiation", "of", "therapy", "with", "dorzolamide", "eye", "drops", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 76 - year - old woman with primary open - angle glaucoma and no history of ocular surgery <extra_id_1> <extra_id_0> age <extra_id_5> 76 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> open - angle glaucoma <extra_id_1> <extra_id_0> treatment <extra_id_5> 12 hours after initiation of therapy with dorzolamide eye drops <extra_id_1> <extra_id_0> drug <extra_id_5> dorzolamide <extra_id_1> <extra_id_0> route <extra_id_5> eye drops <extra_id_1> <extra_id_0> duration <extra_id_5> 12 hours <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 12 hours <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> open - angle glaucoma <extra_id_1> <extra_id_0> effect <extra_id_5> choroidal detachment <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [21], "text": "developed", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "A 76 - year - old woman with primary open - angle glaucoma and no history of ocular surgery"}, {"type": "age", "offset": [3, 4, 5, 6, 7], "text": "76 - year - old"}, {"type": "gender", "offset": [8], "text": "woman"}, {"type": "subject disorder", "offset": [11, 12, 13, 14], "text": "open - angle glaucoma"}, {"type": "treatment", "offset": [25, 26, 27, 28, 29, 30, 31, 32, 33, 34], "text": "12 hours after initiation of therapy with dorzolamide eye drops"}, {"type": "drug", "offset": [32], "text": "dorzolamide"}, {"type": "route", "offset": [33, 34], "text": "eye drops"}, {"type": "duration", "offset": [25, 26], "text": "12 hours"}, {"type": "time elapsed", "offset": [25, 26], "text": "12 hours"}, {"type": "treatment disorder", "offset": [11, 12, 13, 14], "text": "open - angle glaucoma"}, {"type": "effect", "offset": [23, 24], "text": "choroidal detachment"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "duration", "effect", "route", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 76 - year - old woman with primary open - angle glaucoma and no history of ocular surgery"], ["age", "76 - year - old"], ["gender", "woman"], ["subject disorder", "open - angle glaucoma"], ["treatment", "12 hours after initiation of therapy with dorzolamide eye drops"], ["drug", "dorzolamide"], ["route", "eye drops"], ["duration", "12 hours"], ["time elapsed", "12 hours"], ["treatment disorder", "open - angle glaucoma"], ["effect", "choroidal detachment"]]}]}
{"text_id": "19826099_2", "text": "Severe apnea in an infant exposed to lamotrigine in breast milk .", "tokens": ["Severe", "apnea", "in", "an", "infant", "exposed", "to", "lamotrigine", "in", "breast", "milk", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> an infant <extra_id_1> <extra_id_0> age <extra_id_5> infant <extra_id_1> <extra_id_0> treatment <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> route <extra_id_5> breast milk <extra_id_1> <extra_id_0> effect <extra_id_5> apnea <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "in", "args": [{"type": "subject", "offset": [3, 4], "text": "an infant"}, {"type": "age", "offset": [4], "text": "infant"}, {"type": "treatment", "offset": [7], "text": "lamotrigine"}, {"type": "drug", "offset": [7], "text": "lamotrigine"}, {"type": "route", "offset": [9, 10], "text": "breast milk"}, {"type": "effect", "offset": [1], "text": "apnea"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "an infant"], ["age", "infant"], ["treatment", "lamotrigine"], ["drug", "lamotrigine"], ["route", "breast milk"], ["effect", "apnea"]]}]}
{"text_id": "9719245_1", "text": "Excluding other causes , Pentasa - associated pancytopenia was considered .", "tokens": ["Excluding", "other", "causes", ",", "Pentasa", "-", "associated", "pancytopenia", "was", "considered", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Pentasa <extra_id_1> <extra_id_0> drug <extra_id_5> Pentasa <extra_id_1> <extra_id_0> effect <extra_id_5> pancytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "associated", "args": [{"type": "treatment", "offset": [4], "text": "Pentasa"}, {"type": "drug", "offset": [4], "text": "Pentasa"}, {"type": "effect", "offset": [7], "text": "pancytopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Pentasa"], ["drug", "Pentasa"], ["effect", "pancytopenia"]]}]}
{"text_id": "10904571_1", "text": "A 60 year - old woman with chronic renal failure developed acute proximal muscle weakness after receiving a regular dosage of colchicine .", "tokens": ["A", "60", "year", "-", "old", "woman", "with", "chronic", "renal", "failure", "developed", "acute", "proximal", "muscle", "weakness", "after", "receiving", "a", "regular", "dosage", "of", "colchicine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 60 year - old woman with chronic renal failure <extra_id_1> <extra_id_0> age <extra_id_5> 60 year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> chronic renal failure <extra_id_1> <extra_id_0> treatment <extra_id_5> regular dosage of colchicine <extra_id_1> <extra_id_0> drug <extra_id_5> colchicine <extra_id_1> <extra_id_0> dosage <extra_id_5> regular dosage <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic renal failure <extra_id_1> <extra_id_0> effect <extra_id_5> acute proximal muscle weakness <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9], "text": "A 60 year - old woman with chronic renal failure"}, {"type": "age", "offset": [1, 2, 3, 4], "text": "60 year - old"}, {"type": "gender", "offset": [5], "text": "woman"}, {"type": "subject disorder", "offset": [7, 8, 9], "text": "chronic renal failure"}, {"type": "treatment", "offset": [18, 19, 20, 21], "text": "regular dosage of colchicine"}, {"type": "drug", "offset": [21], "text": "colchicine"}, {"type": "dosage", "offset": [18, 19], "text": "regular dosage"}, {"type": "treatment disorder", "offset": [7, 8, 9], "text": "chronic renal failure"}, {"type": "effect", "offset": [11, 12, 13, 14], "text": "acute proximal muscle weakness"}]}], "spot": ["adverse event"], "asoc": ["dosage", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 60 year - old woman with chronic renal failure"], ["age", "60 year - old"], ["gender", "woman"], ["subject disorder", "chronic renal failure"], ["treatment", "regular dosage of colchicine"], ["drug", "colchicine"], ["dosage", "regular dosage"], ["treatment disorder", "chronic renal failure"], ["effect", "acute proximal muscle weakness"]]}]}
{"text_id": "1993143_1", "text": "Of 371 patients treated with 8MOP , three ( 0.8 % ) developed an acute dermatitis in the PUVA - treated areas .", "tokens": ["Of", "371", "patients", "treated", "with", "8MOP", ",", "three", "(", "0.8", "%", ")", "developed", "an", "acute", "dermatitis", "in", "the", "PUVA", "-", "treated", "areas", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> Of 371 patients <extra_id_1> <extra_id_0> subject <extra_id_5> three ( 0.8 % ) <extra_id_1> <extra_id_0> population <extra_id_5> 371 <extra_id_1> <extra_id_0> population <extra_id_5> three ( 0.8 % ) <extra_id_1> <extra_id_0> treatment <extra_id_5> treated with 8MOP <extra_id_1> <extra_id_0> drug <extra_id_5> 8MOP <extra_id_1> <extra_id_0> effect <extra_id_5> acute dermatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2], "text": "Of 371 patients"}, {"type": "subject", "offset": [7, 8, 9, 10, 11], "text": "three ( 0.8 % )"}, {"type": "population", "offset": [1], "text": "371"}, {"type": "population", "offset": [7, 8, 9, 10, 11], "text": "three ( 0.8 % )"}, {"type": "treatment", "offset": [3, 4, 5], "text": "treated with 8MOP"}, {"type": "drug", "offset": [5], "text": "8MOP"}, {"type": "effect", "offset": [14, 15], "text": "acute dermatitis"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "Of 371 patients"], ["subject", "three ( 0.8 % )"], ["population", "371"], ["population", "three ( 0.8 % )"], ["treatment", "treated with 8MOP"], ["drug", "8MOP"], ["effect", "acute dermatitis"]]}]}
{"text_id": "8485005_3", "text": "We report a case of drug - induced Kaposi 's sarcoma ( KS ) on the sole of the right foot in a 71 - year - old man , treated for 6 months with corticosteroid therapy ( prednisolone 25 mg / day ) for pericardial effusion .", "tokens": ["We", "report", "a", "case", "of", "drug", "-", "induced", "Kaposi", "'s", "sarcoma", "(", "KS", ")", "on", "the", "sole", "of", "the", "right", "foot", "in", "a", "71", "-", "year", "-", "old", "man", ",", "treated", "for", "6", "months", "with", "corticosteroid", "therapy", "(", "prednisolone", "25", "mg", "/", "day", ")", "for", "pericardial", "effusion", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a case of <extra_id_1> <extra_id_0> subject <extra_id_5> a 71 - year - old man <extra_id_1> <extra_id_0> subject <extra_id_5> for pericardial effusion <extra_id_1> <extra_id_0> age <extra_id_5> 71 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> pericardial effusion <extra_id_1> <extra_id_0> treatment <extra_id_5> 6 months with corticosteroid therapy ( prednisolone 25 mg / day ) <extra_id_1> <extra_id_0> drug <extra_id_5> prednisolone <extra_id_1> <extra_id_0> dosage <extra_id_5> 25 mg / day <extra_id_1> <extra_id_0> duration <extra_id_5> 6 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 6 months <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> pericardial effusion <extra_id_1> <extra_id_0> effect <extra_id_5> Kaposi 's sarcoma ( KS ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "induced", "args": [{"type": "subject", "offset": [2, 3, 4], "text": "a case of"}, {"type": "subject", "offset": [22, 23, 24, 25, 26, 27, 28], "text": "a 71 - year - old man"}, {"type": "subject", "offset": [44, 45, 46], "text": "for pericardial effusion"}, {"type": "age", "offset": [23, 24, 25, 26, 27], "text": "71 - year - old"}, {"type": "gender", "offset": [28], "text": "man"}, {"type": "subject disorder", "offset": [45, 46], "text": "pericardial effusion"}, {"type": "treatment", "offset": [32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43], "text": "6 months with corticosteroid therapy ( prednisolone 25 mg / day )"}, {"type": "drug", "offset": [38], "text": "prednisolone"}, {"type": "dosage", "offset": [39, 40, 41, 42], "text": "25 mg / day"}, {"type": "duration", "offset": [32, 33], "text": "6 months"}, {"type": "time elapsed", "offset": [32, 33], "text": "6 months"}, {"type": "treatment disorder", "offset": [45, 46], "text": "pericardial effusion"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13], "text": "Kaposi 's sarcoma ( KS )"}]}], "spot": ["adverse event"], "asoc": ["dosage", "time elapsed", "duration", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a case of"], ["subject", "a 71 - year - old man"], ["subject", "for pericardial effusion"], ["age", "71 - year - old"], ["gender", "man"], ["subject disorder", "pericardial effusion"], ["treatment", "6 months with corticosteroid therapy ( prednisolone 25 mg / day )"], ["drug", "prednisolone"], ["dosage", "25 mg / day"], ["duration", "6 months"], ["time elapsed", "6 months"], ["treatment disorder", "pericardial effusion"], ["effect", "Kaposi 's sarcoma ( KS )"]]}]}
{"text_id": "8255797_3", "text": "We report two cases of neutropenia following captopril use in cardiac patients with trisomy 21 .", "tokens": ["We", "report", "two", "cases", "of", "neutropenia", "following", "captopril", "use", "in", "cardiac", "patients", "with", "trisomy", "21", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> subject <extra_id_5> two cases of <extra_id_1> <extra_id_0> subject <extra_id_5> cardiac patients with trisomy 21 <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> cardiac <extra_id_1> <extra_id_0> subject disorder <extra_id_5> trisomy 21 <extra_id_1> <extra_id_0> treatment <extra_id_5> captopril use <extra_id_1> <extra_id_0> drug <extra_id_5> captopril <extra_id_1> <extra_id_0> effect <extra_id_5> neutropenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "following", "args": [{"type": "subject", "offset": [2, 3, 4], "text": "two cases of"}, {"type": "subject", "offset": [10, 11, 12, 13, 14], "text": "cardiac patients with trisomy 21"}, {"type": "population", "offset": [2], "text": "two"}, {"type": "subject disorder", "offset": [10], "text": "cardiac"}, {"type": "subject disorder", "offset": [13, 14], "text": "trisomy 21"}, {"type": "treatment", "offset": [7, 8], "text": "captopril use"}, {"type": "drug", "offset": [7], "text": "captopril"}, {"type": "effect", "offset": [5], "text": "neutropenia"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["subject", "two cases of"], ["subject", "cardiac patients with trisomy 21"], ["population", "two"], ["subject disorder", "cardiac"], ["subject disorder", "trisomy 21"], ["treatment", "captopril use"], ["drug", "captopril"], ["effect", "neutropenia"]]}]}
{"text_id": "16225183_6", "text": "CASE REPORT : We present a case of a 28 - yr - old male who developed a severe case of nephrotic syndrome while being treated for relapsing / remitting Multiple Sclerosis ( RRMS ) with weekly injections of interferon beta 1a .", "tokens": ["CASE", "REPORT", ":", "We", "present", "a", "case", "of", "a", "28", "-", "yr", "-", "old", "male", "who", "developed", "a", "severe", "case", "of", "nephrotic", "syndrome", "while", "being", "treated", "for", "relapsing", "/", "remitting", "Multiple", "Sclerosis", "(", "RRMS", ")", "with", "weekly", "injections", "of", "interferon", "beta", "1a", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> 28 - yr - old male <extra_id_1> <extra_id_0> subject <extra_id_5> relapsing / remitting Multiple Sclerosis ( RRMS ) <extra_id_1> <extra_id_0> age <extra_id_5> 28 - yr - old <extra_id_1> <extra_id_0> gender <extra_id_5> male <extra_id_1> <extra_id_0> subject disorder <extra_id_5> relapsing / remitting Multiple Sclerosis <extra_id_1> <extra_id_0> treatment <extra_id_5> weekly injections of interferon beta 1a <extra_id_1> <extra_id_0> drug <extra_id_5> interferon beta 1a <extra_id_1> <extra_id_0> frequency <extra_id_5> weekly <extra_id_1> <extra_id_0> route <extra_id_5> injections <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> relapsing / remitting Multiple Sclerosis <extra_id_1> <extra_id_0> effect <extra_id_5> nephrotic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "developed", "args": [{"type": "subject", "offset": [9, 10, 11, 12, 13, 14], "text": "28 - yr - old male"}, {"type": "subject", "offset": [27, 28, 29, 30, 31, 32, 33, 34], "text": "relapsing / remitting Multiple Sclerosis ( RRMS )"}, {"type": "age", "offset": [9, 10, 11, 12, 13], "text": "28 - yr - old"}, {"type": "gender", "offset": [14], "text": "male"}, {"type": "subject disorder", "offset": [27, 28, 29, 30, 31], "text": "relapsing / remitting Multiple Sclerosis"}, {"type": "treatment", "offset": [36, 37, 38, 39, 40, 41], "text": "weekly injections of interferon beta 1a"}, {"type": "drug", "offset": [39, 40, 41], "text": "interferon beta 1a"}, {"type": "frequency", "offset": [36], "text": "weekly"}, {"type": "route", "offset": [37], "text": "injections"}, {"type": "treatment disorder", "offset": [27, 28, 29, 30, 31], "text": "relapsing / remitting Multiple Sclerosis"}, {"type": "effect", "offset": [21, 22], "text": "nephrotic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment disorder", "drug", "gender", "frequency", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "28 - yr - old male"], ["subject", "relapsing / remitting Multiple Sclerosis ( RRMS )"], ["age", "28 - yr - old"], ["gender", "male"], ["subject disorder", "relapsing / remitting Multiple Sclerosis"], ["treatment", "weekly injections of interferon beta 1a"], ["drug", "interferon beta 1a"], ["frequency", "weekly"], ["route", "injections"], ["treatment disorder", "relapsing / remitting Multiple Sclerosis"], ["effect", "nephrotic syndrome"]]}]}
{"text_id": "12944250_2", "text": "Since the thrombocyte count started to increase immediately after initiation and dropped immediately after discontinuation of ciprofloxacin and tazobactam / piperacillin and all other drugs were discontinued already before or were started after the nadir of the thrombocyte count , these two antibiotics were regarded causative .", "tokens": ["Since", "the", "thrombocyte", "count", "started", "to", "increase", "immediately", "after", "initiation", "and", "dropped", "immediately", "after", "discontinuation", "of", "ciprofloxacin", "and", "tazobactam", "/", "piperacillin", "and", "all", "other", "drugs", "were", "discontinued", "already", "before", "or", "were", "started", "after", "the", "nadir", "of", "the", "thrombocyte", "count", ",", "these", "two", "antibiotics", "were", "regarded", "causative", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> Since <extra_id_0> treatment <extra_id_5> discontinuation of ciprofloxacin and tazobactam / piperacillin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> tazobactam / piperacillin <extra_id_1> <extra_id_0> dosage <extra_id_5> discontinuation <extra_id_1> <extra_id_0> combination drug <extra_id_5> tazobactam / piperacillin <extra_id_1> <extra_id_0> combination drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> the thrombocyte count started to increase immediately after initiation and dropped immediately <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [0], "text": "Since", "args": [{"type": "treatment", "offset": [14, 15, 16, 17, 18, 19, 20], "text": "discontinuation of ciprofloxacin and tazobactam / piperacillin"}, {"type": "drug", "offset": [16], "text": "ciprofloxacin"}, {"type": "drug", "offset": [18, 19, 20], "text": "tazobactam / piperacillin"}, {"type": "dosage", "offset": [14], "text": "discontinuation"}, {"type": "combination drug", "offset": [18, 19, 20], "text": "tazobactam / piperacillin"}, {"type": "combination drug", "offset": [16], "text": "ciprofloxacin"}, {"type": "effect", "offset": [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12], "text": "the thrombocyte count started to increase immediately after initiation and dropped immediately"}]}], "spot": ["adverse event"], "asoc": ["effect", "drug", "dosage", "combination drug", "treatment"], "spot_asoc": [{"span": "Since", "label": "adverse event", "asoc": [["treatment", "discontinuation of ciprofloxacin and tazobactam / piperacillin"], ["drug", "ciprofloxacin"], ["drug", "tazobactam / piperacillin"], ["dosage", "discontinuation"], ["combination drug", "tazobactam / piperacillin"], ["combination drug", "ciprofloxacin"], ["effect", "the thrombocyte count started to increase immediately after initiation and dropped immediately"]]}]}
{"text_id": "3346128_1", "text": "A 43 - year - old white man developed a shallow erosion of a psoriatic plaque after chronic administration of methotrexate .", "tokens": ["A", "43", "-", "year", "-", "old", "white", "man", "developed", "a", "shallow", "erosion", "of", "a", "psoriatic", "plaque", "after", "chronic", "administration", "of", "methotrexate", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> A 43 - year - old white man <extra_id_1> <extra_id_0> age <extra_id_5> 43 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> race <extra_id_5> white <extra_id_1> <extra_id_0> subject disorder <extra_id_5> psoriatic plaque <extra_id_1> <extra_id_0> treatment <extra_id_5> chronic administration of methotrexate <extra_id_1> <extra_id_0> drug <extra_id_5> methotrexate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> psoriatic plaque <extra_id_1> <extra_id_0> effect <extra_id_5> shallow erosion of a psoriatic plaque <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "after", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "A 43 - year - old white man"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "43 - year - old"}, {"type": "gender", "offset": [7], "text": "man"}, {"type": "race", "offset": [6], "text": "white"}, {"type": "subject disorder", "offset": [14, 15], "text": "psoriatic plaque"}, {"type": "treatment", "offset": [17, 18, 19, 20], "text": "chronic administration of methotrexate"}, {"type": "drug", "offset": [20], "text": "methotrexate"}, {"type": "treatment disorder", "offset": [14, 15], "text": "psoriatic plaque"}, {"type": "effect", "offset": [10, 11, 12, 13, 14, 15], "text": "shallow erosion of a psoriatic plaque"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder", "race"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "A 43 - year - old white man"], ["age", "43 - year - old"], ["gender", "man"], ["race", "white"], ["subject disorder", "psoriatic plaque"], ["treatment", "chronic administration of methotrexate"], ["drug", "methotrexate"], ["treatment disorder", "psoriatic plaque"], ["effect", "shallow erosion of a psoriatic plaque"]]}]}
{"text_id": "17285101_2", "text": "The authors presented a case of pulmonary hypertension during lithium therapy , while she has been on lithium for 6 years .", "tokens": ["The", "authors", "presented", "a", "case", "of", "pulmonary", "hypertension", "during", "lithium", "therapy", ",", "while", "she", "has", "been", "on", "lithium", "for", "6", "years", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> subject <extra_id_5> she <extra_id_1> <extra_id_0> gender <extra_id_5> she <extra_id_1> <extra_id_0> treatment <extra_id_5> lithium therapy <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> duration <extra_id_5> 6 years <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary hypertension <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "during", "args": [{"type": "subject", "offset": [13], "text": "she"}, {"type": "gender", "offset": [13], "text": "she"}, {"type": "treatment", "offset": [9, 10], "text": "lithium therapy"}, {"type": "drug", "offset": [9], "text": "lithium"}, {"type": "duration", "offset": [19, 20], "text": "6 years"}, {"type": "effect", "offset": [6, 7], "text": "pulmonary hypertension"}]}], "spot": ["adverse event"], "asoc": ["gender", "effect", "subject", "drug", "duration", "treatment"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["subject", "she"], ["gender", "she"], ["treatment", "lithium therapy"], ["drug", "lithium"], ["duration", "6 years"], ["effect", "pulmonary hypertension"]]}]}
{"text_id": "21881031_5", "text": "Granisetron hydrochloride ( 3 mg on days 1 , 8 , and 15 ) and dexamethasone ( 13.2 mg on day 1 and 6.6 mg on days 2 , 3 , 8 , and 15 ) were used prior to irinotecan administration in both patients .", "tokens": ["Granisetron", "hydrochloride", "(", "3", "mg", "on", "days", "1", ",", "8", ",", "and", "15", ")", "and", "dexamethasone", "(", "13.2", "mg", "on", "day", "1", "and", "6.6", "mg", "on", "days", "2", ",", "3", ",", "8", ",", "and", "15", ")", "were", "used", "prior", "to", "irinotecan", "administration", "in", "both", "patients", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> used <extra_id_0> subject <extra_id_5> both patients <extra_id_1> <extra_id_0> treatment <extra_id_5> Granisetron hydrochloride ( 3 mg on days 1 , 8 , and 15 ) and dexamethasone ( 13.2 mg on day 1 and 6.6 mg on days 2 , 3 , 8 , and 15 ) <extra_id_1> <extra_id_0> treatment <extra_id_5> irinotecan <extra_id_1> <extra_id_0> drug <extra_id_5> Granisetron hydrochloride <extra_id_1> <extra_id_0> drug <extra_id_5> dexamethasone <extra_id_1> <extra_id_0> dosage <extra_id_5> 3 mg <extra_id_1> <extra_id_0> dosage <extra_id_5> 13.2 mg <extra_id_1> <extra_id_0> dosage <extra_id_5> 6.6 mg <extra_id_1> <extra_id_0> frequency <extra_id_5> on day 1 <extra_id_1> <extra_id_0> frequency <extra_id_5> on days 1 , 8 , and 15 <extra_id_1> <extra_id_0> frequency <extra_id_5> on days 2 , 3 , 8 , and 15 <extra_id_1> <extra_id_0> combination drug <extra_id_5> dexamethasone <extra_id_1> <extra_id_0> combination drug <extra_id_5> Granisetron hydrochloride <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [37], "text": "used", "args": [{"type": "subject", "offset": [43, 44], "text": "both patients"}, {"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35], "text": "Granisetron hydrochloride ( 3 mg on days 1 , 8 , and 15 ) and dexamethasone ( 13.2 mg on day 1 and 6.6 mg on days 2 , 3 , 8 , and 15 )"}, {"type": "treatment", "offset": [40], "text": "irinotecan"}, {"type": "drug", "offset": [0, 1], "text": "Granisetron hydrochloride"}, {"type": "drug", "offset": [15], "text": "dexamethasone"}, {"type": "dosage", "offset": [3, 4], "text": "3 mg"}, {"type": "dosage", "offset": [17, 18], "text": "13.2 mg"}, {"type": "dosage", "offset": [23, 24], "text": "6.6 mg"}, {"type": "frequency", "offset": [19, 20, 21], "text": "on day 1"}, {"type": "frequency", "offset": [5, 6, 7, 8, 9, 10, 11, 12], "text": "on days 1 , 8 , and 15"}, {"type": "frequency", "offset": [25, 26, 27, 28, 29, 30, 31, 32, 33, 34], "text": "on days 2 , 3 , 8 , and 15"}, {"type": "combination drug", "offset": [15], "text": "dexamethasone"}, {"type": "combination drug", "offset": [0, 1], "text": "Granisetron hydrochloride"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "drug", "frequency", "dosage", "combination drug", "treatment"], "spot_asoc": [{"span": "used", "label": "potential therapeutic event", "asoc": [["subject", "both patients"], ["treatment", "Granisetron hydrochloride ( 3 mg on days 1 , 8 , and 15 ) and dexamethasone ( 13.2 mg on day 1 and 6.6 mg on days 2 , 3 , 8 , and 15 )"], ["treatment", "irinotecan"], ["drug", "Granisetron hydrochloride"], ["drug", "dexamethasone"], ["dosage", "3 mg"], ["dosage", "13.2 mg"], ["dosage", "6.6 mg"], ["frequency", "on day 1"], ["frequency", "on days 1 , 8 , and 15"], ["frequency", "on days 2 , 3 , 8 , and 15"], ["combination drug", "dexamethasone"], ["combination drug", "Granisetron hydrochloride"]]}]}
{"text_id": "18171260_2", "text": "Serotonin syndrome has been reported with administration of linezolid and serotonin reuptake inhibitors .", "tokens": ["Serotonin", "syndrome", "has", "been", "reported", "with", "administration", "of", "linezolid", "and", "serotonin", "reuptake", "inhibitors", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> reported with <extra_id_0> treatment <extra_id_5> administration of linezolid and serotonin reuptake inhibitors <extra_id_1> <extra_id_0> drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> drug <extra_id_5> serotonin reuptake inhibitors <extra_id_1> <extra_id_0> combination drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> combination drug <extra_id_5> serotonin reuptake inhibitors <extra_id_1> <extra_id_0> effect <extra_id_5> Serotonin syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4, 5], "text": "reported with", "args": [{"type": "treatment", "offset": [6, 7, 8, 9, 10, 11, 12], "text": "administration of linezolid and serotonin reuptake inhibitors"}, {"type": "drug", "offset": [8], "text": "linezolid"}, {"type": "drug", "offset": [10, 11, 12], "text": "serotonin reuptake inhibitors"}, {"type": "combination drug", "offset": [8], "text": "linezolid"}, {"type": "combination drug", "offset": [10, 11, 12], "text": "serotonin reuptake inhibitors"}, {"type": "effect", "offset": [0, 1], "text": "Serotonin syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "reported with", "label": "adverse event", "asoc": [["treatment", "administration of linezolid and serotonin reuptake inhibitors"], ["drug", "linezolid"], ["drug", "serotonin reuptake inhibitors"], ["combination drug", "linezolid"], ["combination drug", "serotonin reuptake inhibitors"], ["effect", "Serotonin syndrome"]]}]}
{"text_id": "7439122_1", "text": "Clofibrate - induced myopathy in patients with diabetes insipidus .", "tokens": ["Clofibrate", "-", "induced", "myopathy", "in", "patients", "with", "diabetes", "insipidus", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> patients with diabetes insipidus <extra_id_1> <extra_id_0> subject disorder <extra_id_5> diabetes insipidus <extra_id_1> <extra_id_0> treatment <extra_id_5> Clofibrate <extra_id_1> <extra_id_0> drug <extra_id_5> Clofibrate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> diabetes insipidus <extra_id_1> <extra_id_0> effect <extra_id_5> myopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "subject", "offset": [5, 6, 7, 8], "text": "patients with diabetes insipidus"}, {"type": "subject disorder", "offset": [7, 8], "text": "diabetes insipidus"}, {"type": "treatment", "offset": [0], "text": "Clofibrate"}, {"type": "drug", "offset": [0], "text": "Clofibrate"}, {"type": "treatment disorder", "offset": [7, 8], "text": "diabetes insipidus"}, {"type": "effect", "offset": [3], "text": "myopathy"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "patients with diabetes insipidus"], ["subject disorder", "diabetes insipidus"], ["treatment", "Clofibrate"], ["drug", "Clofibrate"], ["treatment disorder", "diabetes insipidus"], ["effect", "myopathy"]]}]}
{"text_id": "6860059_2", "text": "We report a case of fatal fulminant hepatitis caused by the use of disulfiram in a man with previously normal hepatocellular function .", "tokens": ["We", "report", "a", "case", "of", "fatal", "fulminant", "hepatitis", "caused", "by", "the", "use", "of", "disulfiram", "in", "a", "man", "with", "previously", "normal", "hepatocellular", "function", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> subject <extra_id_5> a man <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> disulfiram <extra_id_1> <extra_id_0> drug <extra_id_5> disulfiram <extra_id_1> <extra_id_0> effect <extra_id_5> fatal fulminant hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "caused", "args": [{"type": "subject", "offset": [15, 16], "text": "a man"}, {"type": "gender", "offset": [16], "text": "man"}, {"type": "treatment", "offset": [13], "text": "disulfiram"}, {"type": "drug", "offset": [13], "text": "disulfiram"}, {"type": "effect", "offset": [5, 6, 7], "text": "fatal fulminant hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "gender", "treatment"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["subject", "a man"], ["gender", "man"], ["treatment", "disulfiram"], ["drug", "disulfiram"], ["effect", "fatal fulminant hepatitis"]]}]}
{"text_id": "8604715_1", "text": "Nephrogenic diabetes insipidus and renal tubular acidosis secondary to foscarnet therapy .", "tokens": ["Nephrogenic", "diabetes", "insipidus", "and", "renal", "tubular", "acidosis", "secondary", "to", "foscarnet", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> secondary <extra_id_0> treatment <extra_id_5> foscarnet <extra_id_1> <extra_id_0> drug <extra_id_5> foscarnet <extra_id_1> <extra_id_0> effect <extra_id_5> Nephrogenic diabetes insipidus and renal tubular acidosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "secondary", "args": [{"type": "treatment", "offset": [9], "text": "foscarnet"}, {"type": "drug", "offset": [9], "text": "foscarnet"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Nephrogenic diabetes insipidus and renal tubular acidosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "secondary", "label": "adverse event", "asoc": [["treatment", "foscarnet"], ["drug", "foscarnet"], ["effect", "Nephrogenic diabetes insipidus and renal tubular acidosis"]]}]}
{"text_id": "11837564_1", "text": "A 62 - year - old Caucasian man with atrial fibrillation who was taking warfarin reported an episode of hematochezia ; his international normalized ratio ( INR ) was 1.74 .", "tokens": ["A", "62", "-", "year", "-", "old", "Caucasian", "man", "with", "atrial", "fibrillation", "who", "was", "taking", "warfarin", "reported", "an", "episode", "of", "hematochezia", ";", "his", "international", "normalized", "ratio", "(", "INR", ")", "was", "1.74", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> episode <extra_id_0> subject <extra_id_5> A 62 - year - old Caucasian man with atrial fibrillation <extra_id_1> <extra_id_0> age <extra_id_5> 62 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> race <extra_id_5> Caucasian <extra_id_1> <extra_id_0> subject disorder <extra_id_5> atrial fibrillation <extra_id_1> <extra_id_0> treatment <extra_id_5> warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> atrial fibrillation <extra_id_1> <extra_id_0> effect <extra_id_5> hematochezia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "episode", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10], "text": "A 62 - year - old Caucasian man with atrial fibrillation"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "62 - year - old"}, {"type": "gender", "offset": [7], "text": "man"}, {"type": "race", "offset": [6], "text": "Caucasian"}, {"type": "subject disorder", "offset": [9, 10], "text": "atrial fibrillation"}, {"type": "treatment", "offset": [14], "text": "warfarin"}, {"type": "drug", "offset": [14], "text": "warfarin"}, {"type": "treatment disorder", "offset": [9, 10], "text": "atrial fibrillation"}, {"type": "effect", "offset": [19], "text": "hematochezia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder", "race"], "spot_asoc": [{"span": "episode", "label": "adverse event", "asoc": [["subject", "A 62 - year - old Caucasian man with atrial fibrillation"], ["age", "62 - year - old"], ["gender", "man"], ["race", "Caucasian"], ["subject disorder", "atrial fibrillation"], ["treatment", "warfarin"], ["drug", "warfarin"], ["treatment disorder", "atrial fibrillation"], ["effect", "hematochezia"]]}]}
{"text_id": "16116136_1", "text": "A patient with generalized MG was effectively managed with MM but developed CNS lymphoma after 3 years of treatment .", "tokens": ["A", "patient", "with", "generalized", "MG", "was", "effectively", "managed", "with", "MM", "but", "developed", "CNS", "lymphoma", "after", "3", "years", "of", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A patient with generalized MG <extra_id_1> <extra_id_0> subject disorder <extra_id_5> generalized MG <extra_id_1> <extra_id_0> treatment <extra_id_5> MM <extra_id_1> <extra_id_0> drug <extra_id_5> MM <extra_id_1> <extra_id_0> duration <extra_id_5> 3 years <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 3 years <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> generalized MG <extra_id_1> <extra_id_0> effect <extra_id_5> CNS lymphoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4], "text": "A patient with generalized MG"}, {"type": "subject disorder", "offset": [3, 4], "text": "generalized MG"}, {"type": "treatment", "offset": [9], "text": "MM"}, {"type": "drug", "offset": [9], "text": "MM"}, {"type": "duration", "offset": [15, 16], "text": "3 years"}, {"type": "time elapsed", "offset": [15, 16], "text": "3 years"}, {"type": "treatment disorder", "offset": [3, 4], "text": "generalized MG"}, {"type": "effect", "offset": [12, 13], "text": "CNS lymphoma"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "subject", "treatment", "duration", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A patient with generalized MG"], ["subject disorder", "generalized MG"], ["treatment", "MM"], ["drug", "MM"], ["duration", "3 years"], ["time elapsed", "3 years"], ["treatment disorder", "generalized MG"], ["effect", "CNS lymphoma"]]}]}
{"text_id": "19995222_4", "text": "OBJECTIVE : Clozapine causes few extrapyramidal symptoms and is recommended as a treatment drug for severe tardive dyskinesia ( TD ) .", "tokens": ["OBJECTIVE", ":", "Clozapine", "causes", "few", "extrapyramidal", "symptoms", "and", "is", "recommended", "as", "a", "treatment", "drug", "for", "severe", "tardive", "dyskinesia", "(", "TD", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> causes <extra_id_0> treatment <extra_id_5> Clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> Clozapine <extra_id_1> <extra_id_0> effect <extra_id_5> few extrapyramidal symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "causes", "args": [{"type": "treatment", "offset": [2], "text": "Clozapine"}, {"type": "drug", "offset": [2], "text": "Clozapine"}, {"type": "effect", "offset": [4, 5, 6], "text": "few extrapyramidal symptoms"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "causes", "label": "adverse event", "asoc": [["treatment", "Clozapine"], ["drug", "Clozapine"], ["effect", "few extrapyramidal symptoms"]]}]}
{"text_id": "7019786_2", "text": "The other woman had rheumatoid arthritis and developed acute tubular necrosis after treatment with gentamicin and cefoxitin .", "tokens": ["The", "other", "woman", "had", "rheumatoid", "arthritis", "and", "developed", "acute", "tubular", "necrosis", "after", "treatment", "with", "gentamicin", "and", "cefoxitin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> The other woman had rheumatoid arthritis <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> gentamicin and cefoxitin <extra_id_1> <extra_id_0> drug <extra_id_5> gentamicin <extra_id_1> <extra_id_0> drug <extra_id_5> cefoxitin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> combination drug <extra_id_5> gentamicin <extra_id_1> <extra_id_0> combination drug <extra_id_5> cefoxitin <extra_id_1> <extra_id_0> effect <extra_id_5> acute tubular necrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5], "text": "The other woman had rheumatoid arthritis"}, {"type": "gender", "offset": [2], "text": "woman"}, {"type": "subject disorder", "offset": [4, 5], "text": "rheumatoid arthritis"}, {"type": "treatment", "offset": [14, 15, 16], "text": "gentamicin and cefoxitin"}, {"type": "drug", "offset": [14], "text": "gentamicin"}, {"type": "drug", "offset": [16], "text": "cefoxitin"}, {"type": "treatment disorder", "offset": [4, 5], "text": "rheumatoid arthritis"}, {"type": "combination drug", "offset": [14], "text": "gentamicin"}, {"type": "combination drug", "offset": [16], "text": "cefoxitin"}, {"type": "effect", "offset": [8, 9, 10], "text": "acute tubular necrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "gender", "drug", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "The other woman had rheumatoid arthritis"], ["gender", "woman"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "gentamicin and cefoxitin"], ["drug", "gentamicin"], ["drug", "cefoxitin"], ["treatment disorder", "rheumatoid arthritis"], ["combination drug", "gentamicin"], ["combination drug", "cefoxitin"], ["effect", "acute tubular necrosis"]]}]}
{"text_id": "19995690_2", "text": "Acetaminophen is a widely used analgesic that can cause acute liver failure when consumed above a maximum daily dose .", "tokens": ["Acetaminophen", "is", "a", "widely", "used", "analgesic", "that", "can", "cause", "acute", "liver", "failure", "when", "consumed", "above", "a", "maximum", "daily", "dose", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> Acetaminophen <extra_id_1> <extra_id_0> drug <extra_id_5> Acetaminophen <extra_id_1> <extra_id_0> effect <extra_id_5> acute liver failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "cause", "args": [{"type": "treatment", "offset": [0], "text": "Acetaminophen"}, {"type": "drug", "offset": [0], "text": "Acetaminophen"}, {"type": "effect", "offset": [9, 10, 11], "text": "acute liver failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "Acetaminophen"], ["drug", "Acetaminophen"], ["effect", "acute liver failure"]]}]}
{"text_id": "12875956_1", "text": "Acute psychosis associated with levetiracetam .", "tokens": ["Acute", "psychosis", "associated", "with", "levetiracetam", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> levetiracetam <extra_id_1> <extra_id_0> drug <extra_id_5> levetiracetam <extra_id_1> <extra_id_0> effect <extra_id_5> Acute psychosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [4], "text": "levetiracetam"}, {"type": "drug", "offset": [4], "text": "levetiracetam"}, {"type": "effect", "offset": [0, 1], "text": "Acute psychosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "levetiracetam"], ["drug", "levetiracetam"], ["effect", "Acute psychosis"]]}]}
{"text_id": "11886466_2", "text": "Porcine factor VIII ( pFVIII ) , which is used to control bleeding in patients with congenital or acquired haemophilia who have high - titre neutralizing antibodies to human FVIII , is not known to increase the risk of arterial or venous thrombosis .", "tokens": ["Porcine", "factor", "VIII", "(", "pFVIII", ")", ",", "which", "is", "used", "to", "control", "bleeding", "in", "patients", "with", "congenital", "or", "acquired", "haemophilia", "who", "have", "high", "-", "titre", "neutralizing", "antibodies", "to", "human", "FVIII", ",", "is", "not", "known", "to", "increase", "the", "risk", "of", "arterial", "or", "venous", "thrombosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> increase <extra_id_0> subject <extra_id_5> patients with congenital or acquired haemophilia who have high - titre neutralizing antibodies to human FVIII <extra_id_1> <extra_id_0> subject disorder <extra_id_5> high - titre neutralizing antibodies to human FVIII <extra_id_1> <extra_id_0> subject disorder <extra_id_5> bleeding <extra_id_1> <extra_id_0> subject disorder <extra_id_5> congenital or acquired haemophilia <extra_id_1> <extra_id_0> treatment <extra_id_5> Porcine factor VIII ( pFVIII ) <extra_id_1> <extra_id_0> drug <extra_id_5> Porcine factor VIII <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> high - titre neutralizing antibodies to human FVIII <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> bleeding <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> congenital or acquired haemophilia <extra_id_1> <extra_id_0> effect <extra_id_5> risk of arterial or venous thrombosis . <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [35], "text": "increase", "args": [{"type": "subject", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29], "text": "patients with congenital or acquired haemophilia who have high - titre neutralizing antibodies to human FVIII"}, {"type": "subject disorder", "offset": [22, 23, 24, 25, 26, 27, 28, 29], "text": "high - titre neutralizing antibodies to human FVIII"}, {"type": "subject disorder", "offset": [12], "text": "bleeding"}, {"type": "subject disorder", "offset": [16, 17, 18, 19], "text": "congenital or acquired haemophilia"}, {"type": "treatment", "offset": [0, 1, 2, 3, 4, 5], "text": "Porcine factor VIII ( pFVIII )"}, {"type": "drug", "offset": [0, 1, 2], "text": "Porcine factor VIII"}, {"type": "treatment disorder", "offset": [22, 23, 24, 25, 26, 27, 28, 29], "text": "high - titre neutralizing antibodies to human FVIII"}, {"type": "treatment disorder", "offset": [12], "text": "bleeding"}, {"type": "treatment disorder", "offset": [16, 17, 18, 19], "text": "congenital or acquired haemophilia"}, {"type": "effect", "offset": [37, 38, 39, 40, 41, 42, 43], "text": "risk of arterial or venous thrombosis ."}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "increase", "label": "adverse event", "asoc": [["subject", "patients with congenital or acquired haemophilia who have high - titre neutralizing antibodies to human FVIII"], ["subject disorder", "high - titre neutralizing antibodies to human FVIII"], ["subject disorder", "bleeding"], ["subject disorder", "congenital or acquired haemophilia"], ["treatment", "Porcine factor VIII ( pFVIII )"], ["drug", "Porcine factor VIII"], ["treatment disorder", "high - titre neutralizing antibodies to human FVIII"], ["treatment disorder", "bleeding"], ["treatment disorder", "congenital or acquired haemophilia"], ["effect", "risk of arterial or venous thrombosis ."]]}]}
{"text_id": "15752306_1", "text": "Livedo reticularis associated with interferon alpha therapy in two melanoma patients .", "tokens": ["Livedo", "reticularis", "associated", "with", "interferon", "alpha", "therapy", "in", "two", "melanoma", "patients", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> two melanoma patients <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> melanoma <extra_id_1> <extra_id_0> treatment <extra_id_5> interferon alpha therapy <extra_id_1> <extra_id_0> drug <extra_id_5> interferon alpha <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> melanoma <extra_id_1> <extra_id_0> effect <extra_id_5> Livedo reticularis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "subject", "offset": [8, 9, 10], "text": "two melanoma patients"}, {"type": "population", "offset": [8], "text": "two"}, {"type": "subject disorder", "offset": [9], "text": "melanoma"}, {"type": "treatment", "offset": [4, 5, 6], "text": "interferon alpha therapy"}, {"type": "drug", "offset": [4, 5], "text": "interferon alpha"}, {"type": "treatment disorder", "offset": [9], "text": "melanoma"}, {"type": "effect", "offset": [0, 1], "text": "Livedo reticularis"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "two melanoma patients"], ["population", "two"], ["subject disorder", "melanoma"], ["treatment", "interferon alpha therapy"], ["drug", "interferon alpha"], ["treatment disorder", "melanoma"], ["effect", "Livedo reticularis"]]}]}
{"text_id": "12221670_1", "text": "The first case concerns a 70 - year - old man who developed severe aplastic anemia 7 weeks after treatment with 500 mg of ticlopidine daily .", "tokens": ["The", "first", "case", "concerns", "a", "70", "-", "year", "-", "old", "man", "who", "developed", "severe", "aplastic", "anemia", "7", "weeks", "after", "treatment", "with", "500", "mg", "of", "ticlopidine", "daily", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> 70 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 70 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> 7 weeks after treatment with 500 mg of ticlopidine daily <extra_id_1> <extra_id_0> drug <extra_id_5> ticlopidine <extra_id_1> <extra_id_0> dosage <extra_id_5> 500 mg <extra_id_1> <extra_id_0> frequency <extra_id_5> daily <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 7 weeks <extra_id_1> <extra_id_0> effect <extra_id_5> severe aplastic anemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "developed", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10], "text": "70 - year - old man"}, {"type": "age", "offset": [5, 6, 7, 8, 9], "text": "70 - year - old"}, {"type": "gender", "offset": [10], "text": "man"}, {"type": "treatment", "offset": [16, 17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "7 weeks after treatment with 500 mg of ticlopidine daily"}, {"type": "drug", "offset": [24], "text": "ticlopidine"}, {"type": "dosage", "offset": [21, 22], "text": "500 mg"}, {"type": "frequency", "offset": [25], "text": "daily"}, {"type": "time elapsed", "offset": [16, 17], "text": "7 weeks"}, {"type": "effect", "offset": [13, 14, 15], "text": "severe aplastic anemia"}]}], "spot": ["adverse event"], "asoc": ["dosage", "time elapsed", "effect", "subject", "gender", "frequency", "drug", "age", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "70 - year - old man"], ["age", "70 - year - old"], ["gender", "man"], ["treatment", "7 weeks after treatment with 500 mg of ticlopidine daily"], ["drug", "ticlopidine"], ["dosage", "500 mg"], ["frequency", "daily"], ["time elapsed", "7 weeks"], ["effect", "severe aplastic anemia"]]}]}
{"text_id": "17509184_1", "text": "A 40 - year - old man with advanced HIV infection and Mycobacterium avium complex infection experienced rapid cognitive decline after commencement of ethambutol , and symptoms fully resolved with cessation .", "tokens": ["A", "40", "-", "year", "-", "old", "man", "with", "advanced", "HIV", "infection", "and", "Mycobacterium", "avium", "complex", "infection", "experienced", "rapid", "cognitive", "decline", "after", "commencement", "of", "ethambutol", ",", "and", "symptoms", "fully", "resolved", "with", "cessation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> 40 - year - old man with advanced HIV infection and Mycobacterium avium complex infection <extra_id_1> <extra_id_0> age <extra_id_5> 40 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> ethambutol <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Mycobacterium avium complex infection <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HIV infection <extra_id_1> <extra_id_0> treatment <extra_id_5> commencement of ethambutol <extra_id_1> <extra_id_0> drug <extra_id_5> ethambutol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> ethambutol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Mycobacterium avium complex infection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HIV infection <extra_id_1> <extra_id_0> effect <extra_id_5> rapid cognitive decline <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "after", "args": [{"type": "subject", "offset": [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "40 - year - old man with advanced HIV infection and Mycobacterium avium complex infection"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "40 - year - old"}, {"type": "gender", "offset": [6], "text": "man"}, {"type": "subject disorder", "offset": [23], "text": "ethambutol"}, {"type": "subject disorder", "offset": [12, 13, 14, 15], "text": "Mycobacterium avium complex infection"}, {"type": "subject disorder", "offset": [9, 10], "text": "HIV infection"}, {"type": "treatment", "offset": [21, 22, 23], "text": "commencement of ethambutol"}, {"type": "drug", "offset": [23], "text": "ethambutol"}, {"type": "treatment disorder", "offset": [23], "text": "ethambutol"}, {"type": "treatment disorder", "offset": [12, 13, 14, 15], "text": "Mycobacterium avium complex infection"}, {"type": "treatment disorder", "offset": [9, 10], "text": "HIV infection"}, {"type": "effect", "offset": [17, 18, 19], "text": "rapid cognitive decline"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "40 - year - old man with advanced HIV infection and Mycobacterium avium complex infection"], ["age", "40 - year - old"], ["gender", "man"], ["subject disorder", "ethambutol"], ["subject disorder", "Mycobacterium avium complex infection"], ["subject disorder", "HIV infection"], ["treatment", "commencement of ethambutol"], ["drug", "ethambutol"], ["treatment disorder", "ethambutol"], ["treatment disorder", "Mycobacterium avium complex infection"], ["treatment disorder", "HIV infection"], ["effect", "rapid cognitive decline"]]}]}
{"text_id": "12951892_1", "text": "Lethargy in a newborn : lithium toxicity or lab error ?", "tokens": ["Lethargy", "in", "a", "newborn", ":", "lithium", "toxicity", "or", "lab", "error", "?"], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> toxicity <extra_id_0> subject <extra_id_5> a newborn <extra_id_1> <extra_id_0> age <extra_id_5> newborn <extra_id_1> <extra_id_0> treatment <extra_id_5> lithium <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> effect <extra_id_5> Lethargy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "toxicity", "args": [{"type": "subject", "offset": [2, 3], "text": "a newborn"}, {"type": "age", "offset": [3], "text": "newborn"}, {"type": "treatment", "offset": [5], "text": "lithium"}, {"type": "drug", "offset": [5], "text": "lithium"}, {"type": "effect", "offset": [0], "text": "Lethargy"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "toxicity", "label": "adverse event", "asoc": [["subject", "a newborn"], ["age", "newborn"], ["treatment", "lithium"], ["drug", "lithium"], ["effect", "Lethargy"]]}]}
{"text_id": "1393348_1", "text": "A 21 - year - old woman suffering from bipolar affective disorder developed systemic lupus erythematosus ( SLE ) with characteristic laboratory findings , 18 months after starting carbamazepine maintenance treatment .", "tokens": ["A", "21", "-", "year", "-", "old", "woman", "suffering", "from", "bipolar", "affective", "disorder", "developed", "systemic", "lupus", "erythematosus", "(", "SLE", ")", "with", "characteristic", "laboratory", "findings", ",", "18", "months", "after", "starting", "carbamazepine", "maintenance", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 21 - year - old woman suffering from bipolar affective disorder <extra_id_1> <extra_id_0> age <extra_id_5> 21 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> bipolar affective disorder <extra_id_1> <extra_id_0> treatment <extra_id_5> 18 months after starting carbamazepine maintenance treatment <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> duration <extra_id_5> 18 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 18 months <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> bipolar affective disorder <extra_id_1> <extra_id_0> effect <extra_id_5> systemic lupus erythematosus ( SLE ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11], "text": "A 21 - year - old woman suffering from bipolar affective disorder"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "21 - year - old"}, {"type": "gender", "offset": [6], "text": "woman"}, {"type": "subject disorder", "offset": [9, 10, 11], "text": "bipolar affective disorder"}, {"type": "treatment", "offset": [24, 25, 26, 27, 28, 29, 30], "text": "18 months after starting carbamazepine maintenance treatment"}, {"type": "drug", "offset": [28], "text": "carbamazepine"}, {"type": "duration", "offset": [24, 25], "text": "18 months"}, {"type": "time elapsed", "offset": [24, 25], "text": "18 months"}, {"type": "treatment disorder", "offset": [9, 10, 11], "text": "bipolar affective disorder"}, {"type": "effect", "offset": [13, 14, 15, 16, 17, 18], "text": "systemic lupus erythematosus ( SLE )"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "duration", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 21 - year - old woman suffering from bipolar affective disorder"], ["age", "21 - year - old"], ["gender", "woman"], ["subject disorder", "bipolar affective disorder"], ["treatment", "18 months after starting carbamazepine maintenance treatment"], ["drug", "carbamazepine"], ["duration", "18 months"], ["time elapsed", "18 months"], ["treatment disorder", "bipolar affective disorder"], ["effect", "systemic lupus erythematosus ( SLE )"]]}]}
{"text_id": "1477441_4", "text": "OBJECTIVE : To report two cases of fixed drug eruption induced by methylphenidate .", "tokens": ["OBJECTIVE", ":", "To", "report", "two", "cases", "of", "fixed", "drug", "eruption", "induced", "by", "methylphenidate", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> two cases <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> treatment <extra_id_5> methylphenidate <extra_id_1> <extra_id_0> drug <extra_id_5> methylphenidate <extra_id_1> <extra_id_0> effect <extra_id_5> fixed drug eruption <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "induced", "args": [{"type": "subject", "offset": [4, 5], "text": "two cases"}, {"type": "population", "offset": [4], "text": "two"}, {"type": "treatment", "offset": [12], "text": "methylphenidate"}, {"type": "drug", "offset": [12], "text": "methylphenidate"}, {"type": "effect", "offset": [7, 8, 9], "text": "fixed drug eruption"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "two cases"], ["population", "two"], ["treatment", "methylphenidate"], ["drug", "methylphenidate"], ["effect", "fixed drug eruption"]]}]}
{"text_id": "15977922_3", "text": "We describe the development of ischemic colitis in a woman who was treated with tegaserod and review the relationship among ischemic colitis , tegaserod use , and irritable bowel syndrome .", "tokens": ["We", "describe", "the", "development", "of", "ischemic", "colitis", "in", "a", "woman", "who", "was", "treated", "with", "tegaserod", "and", "review", "the", "relationship", "among", "ischemic", "colitis", ",", "tegaserod", "use", ",", "and", "irritable", "bowel", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> subject <extra_id_5> woman <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> treatment <extra_id_5> tegaserod <extra_id_1> <extra_id_0> drug <extra_id_5> tegaserod <extra_id_1> <extra_id_0> effect <extra_id_5> ischemic colitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "development", "args": [{"type": "subject", "offset": [9], "text": "woman"}, {"type": "gender", "offset": [9], "text": "woman"}, {"type": "treatment", "offset": [14], "text": "tegaserod"}, {"type": "drug", "offset": [14], "text": "tegaserod"}, {"type": "effect", "offset": [5, 6], "text": "ischemic colitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "gender", "treatment"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["subject", "woman"], ["gender", "woman"], ["treatment", "tegaserod"], ["drug", "tegaserod"], ["effect", "ischemic colitis"]]}]}
{"text_id": "9796135_3", "text": "In a postural challenge test after administration of isosorbide dinitrate ( 5 mg ) , blood pressure decreased from 120/67 to 65/35 mmHg , followed by syncope with a sudden decrease in pulse rate from 85 to 60 beats / min .", "tokens": ["In", "a", "postural", "challenge", "test", "after", "administration", "of", "isosorbide", "dinitrate", "(", "5", "mg", ")", ",", "blood", "pressure", "decreased", "from", "120/67", "to", "65/35", "mmHg", ",", "followed", "by", "syncope", "with", "a", "sudden", "decrease", "in", "pulse", "rate", "from", "85", "to", "60", "beats", "/", "min", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> administration of isosorbide dinitrate ( 5 mg ) <extra_id_1> <extra_id_0> drug <extra_id_5> isosorbide dinitrate <extra_id_1> <extra_id_0> dosage <extra_id_5> 5 mg <extra_id_1> <extra_id_0> effect <extra_id_5> blood pressure decreased <extra_id_1> <extra_id_0> effect <extra_id_5> syncope <extra_id_1> <extra_id_0> effect <extra_id_5> a sudden decrease in pulse rate <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "after", "args": [{"type": "treatment", "offset": [6, 7, 8, 9, 10, 11, 12, 13], "text": "administration of isosorbide dinitrate ( 5 mg )"}, {"type": "drug", "offset": [8, 9], "text": "isosorbide dinitrate"}, {"type": "dosage", "offset": [11, 12], "text": "5 mg"}, {"type": "effect", "offset": [15, 16, 17], "text": "blood pressure decreased"}, {"type": "effect", "offset": [26], "text": "syncope"}, {"type": "effect", "offset": [28, 29, 30, 31, 32, 33], "text": "a sudden decrease in pulse rate"}]}], "spot": ["adverse event"], "asoc": ["dosage", "treatment", "drug", "effect"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "administration of isosorbide dinitrate ( 5 mg )"], ["drug", "isosorbide dinitrate"], ["dosage", "5 mg"], ["effect", "blood pressure decreased"], ["effect", "syncope"], ["effect", "a sudden decrease in pulse rate"]]}]}
{"text_id": "18676387_2", "text": "To report a case of serotonin toxicity , presenting in the postoperative period , caused by an interaction between paroxetine ( a selective serotonin reuptake inhibitor , SSRI ) and fentanyl ( a phenylpiperidine opioid ) .", "tokens": ["To", "report", "a", "case", "of", "serotonin", "toxicity", ",", "presenting", "in", "the", "postoperative", "period", ",", "caused", "by", "an", "interaction", "between", "paroxetine", "(", "a", "selective", "serotonin", "reuptake", "inhibitor", ",", "SSRI", ")", "and", "fentanyl", "(", "a", "phenylpiperidine", "opioid", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> paroxetine <extra_id_1> <extra_id_0> treatment <extra_id_5> fentanyl <extra_id_1> <extra_id_0> drug <extra_id_5> paroxetine <extra_id_1> <extra_id_0> drug <extra_id_5> fentanyl <extra_id_1> <extra_id_0> combination drug <extra_id_5> paroxetine <extra_id_1> <extra_id_0> combination drug <extra_id_5> fentanyl <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "caused", "args": [{"type": "treatment", "offset": [19], "text": "paroxetine"}, {"type": "treatment", "offset": [30], "text": "fentanyl"}, {"type": "drug", "offset": [19], "text": "paroxetine"}, {"type": "drug", "offset": [30], "text": "fentanyl"}, {"type": "combination drug", "offset": [19], "text": "paroxetine"}, {"type": "combination drug", "offset": [30], "text": "fentanyl"}, {"type": "effect", "offset": [5, 6], "text": "serotonin toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "paroxetine"], ["treatment", "fentanyl"], ["drug", "paroxetine"], ["drug", "fentanyl"], ["combination drug", "paroxetine"], ["combination drug", "fentanyl"], ["effect", "serotonin toxicity"]]}]}
{"text_id": "24801976_1", "text": "Pain management discussion forum : serious interaction among frequently used drugs for chronic pain .", "tokens": ["Pain", "management", "discussion", "forum", ":", "serious", "interaction", "among", "frequently", "used", "drugs", "for", "chronic", "pain", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> among <extra_id_0> treatment <extra_id_5> frequently used drugs <extra_id_1> <extra_id_0> drug <extra_id_5> drugs <extra_id_1> <extra_id_0> frequency <extra_id_5> frequently <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic pain <extra_id_1> <extra_id_0> effect <extra_id_5> serious interaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "among", "args": [{"type": "treatment", "offset": [8, 9, 10], "text": "frequently used drugs"}, {"type": "drug", "offset": [10], "text": "drugs"}, {"type": "frequency", "offset": [8], "text": "frequently"}, {"type": "treatment disorder", "offset": [12, 13], "text": "chronic pain"}, {"type": "effect", "offset": [5, 6], "text": "serious interaction"}]}], "spot": ["adverse event"], "asoc": ["effect", "drug", "frequency", "treatment", "treatment disorder"], "spot_asoc": [{"span": "among", "label": "adverse event", "asoc": [["treatment", "frequently used drugs"], ["drug", "drugs"], ["frequency", "frequently"], ["treatment disorder", "chronic pain"], ["effect", "serious interaction"]]}]}
{"text_id": "11886466_1", "text": "Thrombotic stroke associated with the use of porcine factor VIII in a patient with acquired haemophilia .", "tokens": ["Thrombotic", "stroke", "associated", "with", "the", "use", "of", "porcine", "factor", "VIII", "in", "a", "patient", "with", "acquired", "haemophilia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> patient with acquired haemophilia <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acquired haemophilia <extra_id_1> <extra_id_0> treatment <extra_id_5> porcine factor VIII <extra_id_1> <extra_id_0> drug <extra_id_5> porcine factor VIII <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acquired haemophilia <extra_id_1> <extra_id_0> effect <extra_id_5> Thrombotic stroke <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "subject", "offset": [12, 13, 14, 15], "text": "patient with acquired haemophilia"}, {"type": "subject disorder", "offset": [14, 15], "text": "acquired haemophilia"}, {"type": "treatment", "offset": [7, 8, 9], "text": "porcine factor VIII"}, {"type": "drug", "offset": [7, 8, 9], "text": "porcine factor VIII"}, {"type": "treatment disorder", "offset": [14, 15], "text": "acquired haemophilia"}, {"type": "effect", "offset": [0, 1], "text": "Thrombotic stroke"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "patient with acquired haemophilia"], ["subject disorder", "acquired haemophilia"], ["treatment", "porcine factor VIII"], ["drug", "porcine factor VIII"], ["treatment disorder", "acquired haemophilia"], ["effect", "Thrombotic stroke"]]}]}
{"text_id": "20367573_1", "text": "However , to our knowledge , in newborns there have been no reported cases to date of thrombocytosis induced by enoxaparin .", "tokens": ["However", ",", "to", "our", "knowledge", ",", "in", "newborns", "there", "have", "been", "no", "reported", "cases", "to", "date", "of", "thrombocytosis", "induced", "by", "enoxaparin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> newborns <extra_id_1> <extra_id_0> age <extra_id_5> newborns <extra_id_1> <extra_id_0> treatment <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> drug <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> effect <extra_id_5> thrombocytosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "induced", "args": [{"type": "subject", "offset": [7], "text": "newborns"}, {"type": "age", "offset": [7], "text": "newborns"}, {"type": "treatment", "offset": [20], "text": "enoxaparin"}, {"type": "drug", "offset": [20], "text": "enoxaparin"}, {"type": "effect", "offset": [17], "text": "thrombocytosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "newborns"], ["age", "newborns"], ["treatment", "enoxaparin"], ["drug", "enoxaparin"], ["effect", "thrombocytosis"]]}]}
{"text_id": "16960880_3", "text": "Native arterial thrombosis , though recognized as a severe complication of thrombin injection , has not been well described in the literature .", "tokens": ["Native", "arterial", "thrombosis", ",", "though", "recognized", "as", "a", "severe", "complication", "of", "thrombin", "injection", ",", "has", "not", "been", "well", "described", "in", "the", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> thrombin injection <extra_id_1> <extra_id_0> drug <extra_id_5> thrombin <extra_id_1> <extra_id_0> route <extra_id_5> injection <extra_id_1> <extra_id_0> effect <extra_id_5> Native arterial thrombosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "complication", "args": [{"type": "treatment", "offset": [11, 12], "text": "thrombin injection"}, {"type": "drug", "offset": [11], "text": "thrombin"}, {"type": "route", "offset": [12], "text": "injection"}, {"type": "effect", "offset": [0, 1, 2], "text": "Native arterial thrombosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "thrombin injection"], ["drug", "thrombin"], ["route", "injection"], ["effect", "Native arterial thrombosis"]]}]}
{"text_id": "19995222_1", "text": "Clozapine - induced tardive dyskinesia in schizophrenic patients taking clozapine as a first - line antipsychotic drug .", "tokens": ["Clozapine", "-", "induced", "tardive", "dyskinesia", "in", "schizophrenic", "patients", "taking", "clozapine", "as", "a", "first", "-", "line", "antipsychotic", "drug", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> schizophrenic patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> schizophrenic <extra_id_1> <extra_id_0> treatment <extra_id_5> Clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> Clozapine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> schizophrenic <extra_id_1> <extra_id_0> effect <extra_id_5> tardive dyskinesia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "subject", "offset": [6, 7], "text": "schizophrenic patients"}, {"type": "subject disorder", "offset": [6], "text": "schizophrenic"}, {"type": "treatment", "offset": [0], "text": "Clozapine"}, {"type": "drug", "offset": [0], "text": "Clozapine"}, {"type": "treatment disorder", "offset": [6], "text": "schizophrenic"}, {"type": "effect", "offset": [3, 4], "text": "tardive dyskinesia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "schizophrenic patients"], ["subject disorder", "schizophrenic"], ["treatment", "Clozapine"], ["drug", "Clozapine"], ["treatment disorder", "schizophrenic"], ["effect", "tardive dyskinesia"]]}]}
{"text_id": "15920338_1", "text": "A case of high - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth , in a woman with a history of breast cancer who was treated with adjuvant tamoxifen .", "tokens": ["A", "case", "of", "high", "-", "grade", "endometrial", "stromal", "sarcoma", ",", "confined", "into", "an", "intrauterine", "polypoid", "growth", ",", "in", "a", "woman", "with", "a", "history", "of", "breast", "cancer", "who", "was", "treated", "with", "adjuvant", "tamoxifen", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treated <extra_id_0> subject <extra_id_5> A case of high - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth , in a woman with a history of breast cancer <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> population <extra_id_5> A <extra_id_1> <extra_id_0> subject disorder <extra_id_5> breast cancer <extra_id_1> <extra_id_0> subject disorder <extra_id_5> high - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth <extra_id_1> <extra_id_0> treatment <extra_id_5> adjuvant tamoxifen <extra_id_1> <extra_id_0> drug <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> high - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [28], "text": "treated", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "A case of high - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth , in a woman with a history of breast cancer"}, {"type": "gender", "offset": [19], "text": "woman"}, {"type": "population", "offset": [0], "text": "A"}, {"type": "subject disorder", "offset": [24, 25], "text": "breast cancer"}, {"type": "subject disorder", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "high - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth"}, {"type": "treatment", "offset": [30, 31], "text": "adjuvant tamoxifen"}, {"type": "drug", "offset": [31], "text": "tamoxifen"}, {"type": "treatment disorder", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "high - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth"}]}], "spot": ["potential therapeutic event"], "asoc": ["population", "subject", "drug", "gender", "treatment", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "potential therapeutic event", "asoc": [["subject", "A case of high - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth , in a woman with a history of breast cancer"], ["gender", "woman"], ["population", "A"], ["subject disorder", "breast cancer"], ["subject disorder", "high - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth"], ["treatment", "adjuvant tamoxifen"], ["drug", "tamoxifen"], ["treatment disorder", "high - grade endometrial stromal sarcoma , confined into an intrauterine polypoid growth"]]}]}
{"text_id": "1109248_9", "text": "It is concluded that chloral hydrate and methaqualone may be administered safely without additional caution in prothrombin test monitoring during oral anticoagulant therapy .", "tokens": ["It", "is", "concluded", "that", "chloral", "hydrate", "and", "methaqualone", "may", "be", "administered", "safely", "without", "additional", "caution", "in", "prothrombin", "test", "monitoring", "during", "oral", "anticoagulant", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caution <extra_id_0> treatment <extra_id_5> chloral hydrate and methaqualone <extra_id_1> <extra_id_0> treatment <extra_id_5> during oral anticoagulant therapy <extra_id_1> <extra_id_0> drug <extra_id_5> chloral hydrate <extra_id_1> <extra_id_0> drug <extra_id_5> methaqualone <extra_id_1> <extra_id_0> drug <extra_id_5> anticoagulant <extra_id_1> <extra_id_0> route <extra_id_5> oral <extra_id_1> <extra_id_0> combination drug <extra_id_5> chloral hydrate <extra_id_1> <extra_id_0> combination drug <extra_id_5> methaqualone <extra_id_1> <extra_id_0> combination drug <extra_id_5> anticoagulant <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "caution", "args": [{"type": "treatment", "offset": [4, 5, 6, 7], "text": "chloral hydrate and methaqualone"}, {"type": "treatment", "offset": [19, 20, 21, 22], "text": "during oral anticoagulant therapy"}, {"type": "drug", "offset": [4, 5], "text": "chloral hydrate"}, {"type": "drug", "offset": [7], "text": "methaqualone"}, {"type": "drug", "offset": [21], "text": "anticoagulant"}, {"type": "route", "offset": [20], "text": "oral"}, {"type": "combination drug", "offset": [4, 5], "text": "chloral hydrate"}, {"type": "combination drug", "offset": [7], "text": "methaqualone"}, {"type": "combination drug", "offset": [21], "text": "anticoagulant"}]}], "spot": ["adverse event"], "asoc": ["route", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "caution", "label": "adverse event", "asoc": [["treatment", "chloral hydrate and methaqualone"], ["treatment", "during oral anticoagulant therapy"], ["drug", "chloral hydrate"], ["drug", "methaqualone"], ["drug", "anticoagulant"], ["route", "oral"], ["combination drug", "chloral hydrate"], ["combination drug", "methaqualone"], ["combination drug", "anticoagulant"]]}]}
{"text_id": "12921505_4", "text": "OBJECTIVE : To report a case of significant hepatic and renal failure with the use of argatroban in a patient with heparin - induced thrombocytopenia ( HIT ) requiring continuous veno - veno hemodialysis ( CVVHD ) .", "tokens": ["OBJECTIVE", ":", "To", "report", "a", "case", "of", "significant", "hepatic", "and", "renal", "failure", "with", "the", "use", "of", "argatroban", "in", "a", "patient", "with", "heparin", "-", "induced", "thrombocytopenia", "(", "HIT", ")", "requiring", "continuous", "veno", "-", "veno", "hemodialysis", "(", "CVVHD", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> use <extra_id_0> subject <extra_id_5> a patient with heparin - induced thrombocytopenia ( HIT ) requiring continuous veno - veno hemodialysis ( CVVHD ) <extra_id_1> <extra_id_0> subject disorder <extra_id_5> heparin - induced thrombocytopenia ( HIT ) <extra_id_1> <extra_id_0> treatment <extra_id_5> argatroban <extra_id_1> <extra_id_0> drug <extra_id_5> argatroban <extra_id_1> <extra_id_0> effect <extra_id_5> significant hepatic and renal failure <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> heparin <extra_id_1> <extra_id_0> drug <extra_id_5> heparin <extra_id_1> <extra_id_0> effect <extra_id_5> thrombocytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "use", "args": [{"type": "subject", "offset": [18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36], "text": "a patient with heparin - induced thrombocytopenia ( HIT ) requiring continuous veno - veno hemodialysis ( CVVHD )"}, {"type": "subject disorder", "offset": [21, 22, 23, 24, 25, 26, 27], "text": "heparin - induced thrombocytopenia ( HIT )"}, {"type": "treatment", "offset": [16], "text": "argatroban"}, {"type": "drug", "offset": [16], "text": "argatroban"}, {"type": "effect", "offset": [7, 8, 9, 10, 11], "text": "significant hepatic and renal failure"}]}, {"type": "adverse event", "offset": [23], "text": "induced", "args": [{"type": "treatment", "offset": [21], "text": "heparin"}, {"type": "drug", "offset": [21], "text": "heparin"}, {"type": "effect", "offset": [24], "text": "thrombocytopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "use", "label": "adverse event", "asoc": [["subject", "a patient with heparin - induced thrombocytopenia ( HIT ) requiring continuous veno - veno hemodialysis ( CVVHD )"], ["subject disorder", "heparin - induced thrombocytopenia ( HIT )"], ["treatment", "argatroban"], ["drug", "argatroban"], ["effect", "significant hepatic and renal failure"]]}, {"span": "induced", "label": "adverse event", "asoc": [["treatment", "heparin"], ["drug", "heparin"], ["effect", "thrombocytopenia"]]}]}
{"text_id": "8979664_1", "text": "METHODS / RESULTS : This paper presents a new case of rifabutin uveitis and a review of the various published reports to date .", "tokens": ["METHODS", "/", "RESULTS", ":", "This", "paper", "presents", "a", "new", "case", "of", "rifabutin", "uveitis", "and", "a", "review", "of", "the", "various", "published", "reports", "to", "date", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> presents <extra_id_0> subject <extra_id_5> new case <extra_id_1> <extra_id_0> treatment <extra_id_5> rifabutin <extra_id_1> <extra_id_0> drug <extra_id_5> rifabutin <extra_id_1> <extra_id_0> effect <extra_id_5> uveitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "presents", "args": [{"type": "subject", "offset": [8, 9], "text": "new case"}, {"type": "treatment", "offset": [11], "text": "rifabutin"}, {"type": "drug", "offset": [11], "text": "rifabutin"}, {"type": "effect", "offset": [12], "text": "uveitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "presents", "label": "adverse event", "asoc": [["subject", "new case"], ["treatment", "rifabutin"], ["drug", "rifabutin"], ["effect", "uveitis"]]}]}
{"text_id": "20185472_2", "text": "Tremor : a newly described adverse event with long - term itraconazole therapy .", "tokens": ["Tremor", ":", "a", "newly", "described", "adverse", "event", "with", "long", "-", "term", "itraconazole", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> with <extra_id_0> treatment <extra_id_5> long - term itraconazole therapy <extra_id_1> <extra_id_0> drug <extra_id_5> itraconazole <extra_id_1> <extra_id_0> effect <extra_id_5> Tremor <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "with", "args": [{"type": "treatment", "offset": [8, 9, 10, 11, 12], "text": "long - term itraconazole therapy"}, {"type": "drug", "offset": [11], "text": "itraconazole"}, {"type": "effect", "offset": [0], "text": "Tremor"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "with", "label": "adverse event", "asoc": [["treatment", "long - term itraconazole therapy"], ["drug", "itraconazole"], ["effect", "Tremor"]]}]}
{"text_id": "21712512_5", "text": "Seven weeks after the initiation of inhaled fluticasone , she developed vaginal candidiasis and was prescribed fluconazole 100 mg / day , a CYP3A4 inhibitor .", "tokens": ["Seven", "weeks", "after", "the", "initiation", "of", "inhaled", "fluticasone", ",", "she", "developed", "vaginal", "candidiasis", "and", "was", "prescribed", "fluconazole", "100", "mg", "/", "day", ",", "a", "CYP3A4", "inhibitor", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> treatment <extra_id_5> Seven weeks after the initiation of inhaled fluticasone <extra_id_1> <extra_id_0> drug <extra_id_5> fluticasone <extra_id_1> <extra_id_0> route <extra_id_5> inhaled <extra_id_1> <extra_id_0> time elapsed <extra_id_5> Seven weeks <extra_id_1> <extra_id_0> effect <extra_id_5> vaginal candidiasis <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> prescribed <extra_id_0> treatment <extra_id_5> fluconazole 100 mg / day , a CYP3A4 inhibitor <extra_id_1> <extra_id_0> drug <extra_id_5> fluconazole <extra_id_1> <extra_id_0> dosage <extra_id_5> 100 mg / day <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> vaginal candidiasis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "developed", "args": [{"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Seven weeks after the initiation of inhaled fluticasone"}, {"type": "drug", "offset": [7], "text": "fluticasone"}, {"type": "route", "offset": [6], "text": "inhaled"}, {"type": "time elapsed", "offset": [0, 1], "text": "Seven weeks"}, {"type": "effect", "offset": [11, 12], "text": "vaginal candidiasis"}]}, {"type": "potential therapeutic event", "offset": [15], "text": "prescribed", "args": [{"type": "treatment", "offset": [16, 17, 18, 19, 20, 21, 22, 23, 24], "text": "fluconazole 100 mg / day , a CYP3A4 inhibitor"}, {"type": "drug", "offset": [16], "text": "fluconazole"}, {"type": "dosage", "offset": [17, 18, 19, 20], "text": "100 mg / day"}, {"type": "treatment disorder", "offset": [11, 12], "text": "vaginal candidiasis"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["dosage", "effect", "route", "drug", "time elapsed", "treatment", "treatment disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["treatment", "Seven weeks after the initiation of inhaled fluticasone"], ["drug", "fluticasone"], ["route", "inhaled"], ["time elapsed", "Seven weeks"], ["effect", "vaginal candidiasis"]]}, {"span": "prescribed", "label": "potential therapeutic event", "asoc": [["treatment", "fluconazole 100 mg / day , a CYP3A4 inhibitor"], ["drug", "fluconazole"], ["dosage", "100 mg / day"], ["treatment disorder", "vaginal candidiasis"]]}]}
{"text_id": "11215836_4", "text": "The day after clozapine was stopped , while he was still receiving clomipramine 150 mg / d , he began behaving oddly , started sweating profusely , shivering , and became tremulous , agitated , and confused .", "tokens": ["The", "day", "after", "clozapine", "was", "stopped", ",", "while", "he", "was", "still", "receiving", "clomipramine", "150", "mg", "/", "d", ",", "he", "began", "behaving", "oddly", ",", "started", "sweating", "profusely", ",", "shivering", ",", "and", "became", "tremulous", ",", "agitated", ",", "and", "confused", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> stopped <extra_id_0> subject <extra_id_5> he <extra_id_1> <extra_id_0> gender <extra_id_5> he <extra_id_1> <extra_id_0> treatment <extra_id_5> day after clozapine was stopped , while he was still receiving clomipramine 150 mg / d <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clomipramine <extra_id_1> <extra_id_0> dosage <extra_id_5> 150 mg / d <extra_id_1> <extra_id_0> effect <extra_id_5> behaving oddly , started sweating profusely , shivering , and became tremulous , agitated , and confused <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "stopped", "args": [{"type": "subject", "offset": [18], "text": "he"}, {"type": "gender", "offset": [18], "text": "he"}, {"type": "treatment", "offset": [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16], "text": "day after clozapine was stopped , while he was still receiving clomipramine 150 mg / d"}, {"type": "drug", "offset": [3], "text": "clozapine"}, {"type": "drug", "offset": [12], "text": "clomipramine"}, {"type": "dosage", "offset": [13, 14, 15, 16], "text": "150 mg / d"}, {"type": "effect", "offset": [20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36], "text": "behaving oddly , started sweating profusely , shivering , and became tremulous , agitated , and confused"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "gender", "dosage", "treatment"], "spot_asoc": [{"span": "stopped", "label": "adverse event", "asoc": [["subject", "he"], ["gender", "he"], ["treatment", "day after clozapine was stopped , while he was still receiving clomipramine 150 mg / d"], ["drug", "clozapine"], ["drug", "clomipramine"], ["dosage", "150 mg / d"], ["effect", "behaving oddly , started sweating profusely , shivering , and became tremulous , agitated , and confused"]]}]}
{"text_id": "17968817_2", "text": "We report ( to our knowledge , for the first time in a child ) the emergence of psychosis in a 12 - year old white girl with an increased efavirenz concentration and heterozygous gene polymorphism of the CYP2B6 - G516T.", "tokens": ["We", "report", "(", "to", "our", "knowledge", ",", "for", "the", "first", "time", "in", "a", "child", ")", "the", "emergence", "of", "psychosis", "in", "a", "12", "-", "year", "old", "white", "girl", "with", "an", "increased", "efavirenz", "concentration", "and", "heterozygous", "gene", "polymorphism", "of", "the", "CYP2B6", "-", "G516T."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> emergence <extra_id_0> subject <extra_id_5> a 12 - year old white girl <extra_id_1> <extra_id_0> subject <extra_id_5> heterozygous gene polymorphism of the CYP2B6 - G516T. <extra_id_1> <extra_id_0> age <extra_id_5> 12 - year old <extra_id_1> <extra_id_0> gender <extra_id_5> girl <extra_id_1> <extra_id_0> race <extra_id_5> white <extra_id_1> <extra_id_0> treatment <extra_id_5> increased efavirenz concentration <extra_id_1> <extra_id_0> drug <extra_id_5> efavirenz <extra_id_1> <extra_id_0> effect <extra_id_5> psychosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "emergence", "args": [{"type": "subject", "offset": [20, 21, 22, 23, 24, 25, 26], "text": "a 12 - year old white girl"}, {"type": "subject", "offset": [33, 34, 35, 36, 37, 38, 39, 40], "text": "heterozygous gene polymorphism of the CYP2B6 - G516T."}, {"type": "age", "offset": [21, 22, 23, 24], "text": "12 - year old"}, {"type": "gender", "offset": [26], "text": "girl"}, {"type": "race", "offset": [25], "text": "white"}, {"type": "treatment", "offset": [29, 30, 31], "text": "increased efavirenz concentration"}, {"type": "drug", "offset": [30], "text": "efavirenz"}, {"type": "effect", "offset": [18], "text": "psychosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "gender", "treatment", "age", "race"], "spot_asoc": [{"span": "emergence", "label": "adverse event", "asoc": [["subject", "a 12 - year old white girl"], ["subject", "heterozygous gene polymorphism of the CYP2B6 - G516T."], ["age", "12 - year old"], ["gender", "girl"], ["race", "white"], ["treatment", "increased efavirenz concentration"], ["drug", "efavirenz"], ["effect", "psychosis"]]}]}
{"text_id": "18585545_5", "text": "RESULTS : A previously healthy 42 - year - old woman presented with acute - onset delirium with psychotic features as a consequence of levofloxacin therapy .", "tokens": ["RESULTS", ":", "A", "previously", "healthy", "42", "-", "year", "-", "old", "woman", "presented", "with", "acute", "-", "onset", "delirium", "with", "psychotic", "features", "as", "a", "consequence", "of", "levofloxacin", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> as a consequence of <extra_id_0> subject <extra_id_5> A previously healthy 42 - year - old woman <extra_id_1> <extra_id_0> age <extra_id_5> 42 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> treatment <extra_id_5> levofloxacin therapy <extra_id_1> <extra_id_0> drug <extra_id_5> levofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> acute - onset delirium with psychotic features <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20, 21, 22, 23], "text": "as a consequence of", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10], "text": "A previously healthy 42 - year - old woman"}, {"type": "age", "offset": [5, 6, 7, 8, 9], "text": "42 - year - old"}, {"type": "gender", "offset": [10], "text": "woman"}, {"type": "treatment", "offset": [24, 25], "text": "levofloxacin therapy"}, {"type": "drug", "offset": [24], "text": "levofloxacin"}, {"type": "effect", "offset": [13, 14, 15, 16, 17, 18, 19], "text": "acute - onset delirium with psychotic features"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "as a consequence of", "label": "adverse event", "asoc": [["subject", "A previously healthy 42 - year - old woman"], ["age", "42 - year - old"], ["gender", "woman"], ["treatment", "levofloxacin therapy"], ["drug", "levofloxacin"], ["effect", "acute - onset delirium with psychotic features"]]}]}
{"text_id": "6833205_1", "text": "A case of SIADH associated with desipramine treatment in an elderly depressed woman is described .", "tokens": ["A", "case", "of", "SIADH", "associated", "with", "desipramine", "treatment", "in", "an", "elderly", "depressed", "woman", "is", "described", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> an elderly depressed woman <extra_id_1> <extra_id_0> age <extra_id_5> elderly <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> depressed <extra_id_1> <extra_id_0> treatment <extra_id_5> desipramine treatment <extra_id_1> <extra_id_0> drug <extra_id_5> desipramine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> depressed <extra_id_1> <extra_id_0> effect <extra_id_5> SIADH <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "associated", "args": [{"type": "subject", "offset": [9, 10, 11, 12], "text": "an elderly depressed woman"}, {"type": "age", "offset": [10], "text": "elderly"}, {"type": "gender", "offset": [12], "text": "woman"}, {"type": "subject disorder", "offset": [11], "text": "depressed"}, {"type": "treatment", "offset": [6, 7], "text": "desipramine treatment"}, {"type": "drug", "offset": [6], "text": "desipramine"}, {"type": "treatment disorder", "offset": [11], "text": "depressed"}, {"type": "effect", "offset": [3], "text": "SIADH"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "an elderly depressed woman"], ["age", "elderly"], ["gender", "woman"], ["subject disorder", "depressed"], ["treatment", "desipramine treatment"], ["drug", "desipramine"], ["treatment disorder", "depressed"], ["effect", "SIADH"]]}]}
{"text_id": "8496127_1", "text": "Acute dystonic reaction with low - dose pimozide .", "tokens": ["Acute", "dystonic", "reaction", "with", "low", "-", "dose", "pimozide", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> with <extra_id_0> treatment <extra_id_5> low - dose pimozide <extra_id_1> <extra_id_0> drug <extra_id_5> pimozide <extra_id_1> <extra_id_0> dosage <extra_id_5> low - dose <extra_id_1> <extra_id_0> effect <extra_id_5> Acute dystonic reaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "with", "args": [{"type": "treatment", "offset": [4, 5, 6, 7], "text": "low - dose pimozide"}, {"type": "drug", "offset": [7], "text": "pimozide"}, {"type": "dosage", "offset": [4, 5, 6], "text": "low - dose"}, {"type": "effect", "offset": [0, 1, 2], "text": "Acute dystonic reaction"}]}], "spot": ["adverse event"], "asoc": ["dosage", "treatment", "drug", "effect"], "spot_asoc": [{"span": "with", "label": "adverse event", "asoc": [["treatment", "low - dose pimozide"], ["drug", "pimozide"], ["dosage", "low - dose"], ["effect", "Acute dystonic reaction"]]}]}
{"text_id": "19775485_1", "text": "Are nasal decongestants safer than rhinitis ? A case of oxymetazoline - induced syncope .", "tokens": ["Are", "nasal", "decongestants", "safer", "than", "rhinitis", "?", "A", "case", "of", "oxymetazoline", "-", "induced", "syncope", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> oxymetazoline <extra_id_1> <extra_id_0> drug <extra_id_5> oxymetazoline <extra_id_1> <extra_id_0> effect <extra_id_5> syncope <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "induced", "args": [{"type": "treatment", "offset": [10], "text": "oxymetazoline"}, {"type": "drug", "offset": [10], "text": "oxymetazoline"}, {"type": "effect", "offset": [13], "text": "syncope"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "oxymetazoline"], ["drug", "oxymetazoline"], ["effect", "syncope"]]}]}
{"text_id": "16196187_1", "text": "Acute myocardial ischemia following accidental intravenous administration of epinephrine in high concentration .", "tokens": ["Acute", "myocardial", "ischemia", "following", "accidental", "intravenous", "administration", "of", "epinephrine", "in", "high", "concentration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> accidental intravenous administration of epinephrine in high concentration <extra_id_1> <extra_id_0> drug <extra_id_5> epinephrine <extra_id_1> <extra_id_0> dosage <extra_id_5> high concentration <extra_id_1> <extra_id_0> route <extra_id_5> intravenous administration <extra_id_1> <extra_id_0> effect <extra_id_5> Acute myocardial ischemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "following", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10, 11], "text": "accidental intravenous administration of epinephrine in high concentration"}, {"type": "drug", "offset": [8], "text": "epinephrine"}, {"type": "dosage", "offset": [10, 11], "text": "high concentration"}, {"type": "route", "offset": [5, 6], "text": "intravenous administration"}, {"type": "effect", "offset": [0, 1, 2], "text": "Acute myocardial ischemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "dosage", "treatment"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "accidental intravenous administration of epinephrine in high concentration"], ["drug", "epinephrine"], ["dosage", "high concentration"], ["route", "intravenous administration"], ["effect", "Acute myocardial ischemia"]]}]}
{"text_id": "10458196_4", "text": "CONCLUSIONS : Topical brimonidine may be associated with central nervous system depression in infants .", "tokens": ["CONCLUSIONS", ":", "Topical", "brimonidine", "may", "be", "associated", "with", "central", "nervous", "system", "depression", "in", "infants", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> infants <extra_id_1> <extra_id_0> age <extra_id_5> infants <extra_id_1> <extra_id_0> treatment <extra_id_5> Topical brimonidine <extra_id_1> <extra_id_0> drug <extra_id_5> brimonidine <extra_id_1> <extra_id_0> route <extra_id_5> Topical <extra_id_1> <extra_id_0> effect <extra_id_5> central nervous system depression <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "associated", "args": [{"type": "subject", "offset": [13], "text": "infants"}, {"type": "age", "offset": [13], "text": "infants"}, {"type": "treatment", "offset": [2, 3], "text": "Topical brimonidine"}, {"type": "drug", "offset": [3], "text": "brimonidine"}, {"type": "route", "offset": [2], "text": "Topical"}, {"type": "effect", "offset": [8, 9, 10, 11], "text": "central nervous system depression"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "infants"], ["age", "infants"], ["treatment", "Topical brimonidine"], ["drug", "brimonidine"], ["route", "Topical"], ["effect", "central nervous system depression"]]}]}
{"text_id": "19390192_1", "text": "Leukopenia due to parvovirus B19 in a Crohn 's disease patient using azathioprine .", "tokens": ["Leukopenia", "due", "to", "parvovirus", "B19", "in", "a", "Crohn", "'s", "disease", "patient", "using", "azathioprine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> subject <extra_id_5> parvovirus B19 in a Crohn 's disease patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> parvovirus B19 <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> treatment <extra_id_5> azathioprine <extra_id_1> <extra_id_0> drug <extra_id_5> azathioprine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> effect <extra_id_5> Leukopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "due", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8, 9, 10], "text": "parvovirus B19 in a Crohn 's disease patient"}, {"type": "subject disorder", "offset": [3, 4], "text": "parvovirus B19"}, {"type": "subject disorder", "offset": [7, 8, 9], "text": "Crohn 's disease"}, {"type": "treatment", "offset": [12], "text": "azathioprine"}, {"type": "drug", "offset": [12], "text": "azathioprine"}, {"type": "treatment disorder", "offset": [7, 8, 9], "text": "Crohn 's disease"}, {"type": "effect", "offset": [0], "text": "Leukopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["subject", "parvovirus B19 in a Crohn 's disease patient"], ["subject disorder", "parvovirus B19"], ["subject disorder", "Crohn 's disease"], ["treatment", "azathioprine"], ["drug", "azathioprine"], ["treatment disorder", "Crohn 's disease"], ["effect", "Leukopenia"]]}]}
{"text_id": "16167682_1", "text": "She died within six weeks of developing congestive heart failure coupled with liver failure due to haemosiderosis despite regular use of desferrioxamine .", "tokens": ["She", "died", "within", "six", "weeks", "of", "developing", "congestive", "heart", "failure", "coupled", "with", "liver", "failure", "due", "to", "haemosiderosis", "despite", "regular", "use", "of", "desferrioxamine", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> despite <extra_id_0> treatment <extra_id_5> regular use of desferrioxamine <extra_id_1> <extra_id_0> drug <extra_id_5> desferrioxamine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> haemosiderosis <extra_id_1> <extra_id_0> effect <extra_id_5> died within six weeks of developing congestive heart failure coupled with liver failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [17], "text": "despite", "args": [{"type": "treatment", "offset": [18, 19, 20, 21], "text": "regular use of desferrioxamine"}, {"type": "drug", "offset": [21], "text": "desferrioxamine"}, {"type": "treatment disorder", "offset": [16], "text": "haemosiderosis"}, {"type": "effect", "offset": [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13], "text": "died within six weeks of developing congestive heart failure coupled with liver failure"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "despite", "label": "potential therapeutic event", "asoc": [["treatment", "regular use of desferrioxamine"], ["drug", "desferrioxamine"], ["treatment disorder", "haemosiderosis"], ["effect", "died within six weeks of developing congestive heart failure coupled with liver failure"]]}]}
{"text_id": "9128433_1", "text": "Its overall toxicity is considerably less compared to standard induction chemotherapy ; however , it is associated with a high incidence of a potentially fatal symptom complex referred to as \" retinoic acid syndrome . \" This report describes a patient with APL who developed the syndrome a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis .", "tokens": ["Its", "overall", "toxicity", "is", "considerably", "less", "compared", "to", "standard", "induction", "chemotherapy", ";", "however", ",", "it", "is", "associated", "with", "a", "high", "incidence", "of", "a", "potentially", "fatal", "symptom", "complex", "referred", "to", "as", "\"", "retinoic", "acid", "syndrome", ".", "\"", "This", "report", "describes", "a", "patient", "with", "APL", "who", "developed", "the", "syndrome", "a", "few", "weeks", "after", "initiating", "induction", "therapy", "with", "ATRA", "despite", "being", "treated", "for", "hyperleukocytosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a patient with APL <extra_id_1> <extra_id_0> subject disorder <extra_id_5> APL <extra_id_1> <extra_id_0> treatment <extra_id_5> a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis <extra_id_1> <extra_id_0> drug <extra_id_5> ATRA <extra_id_1> <extra_id_0> time elapsed <extra_id_5> a few weeks <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> APL <extra_id_1> <extra_id_0> effect <extra_id_5> symptom complex referred to as \" retinoic acid syndrome . \" <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [44], "text": "developed", "args": [{"type": "subject", "offset": [39, 40, 41, 42], "text": "a patient with APL"}, {"type": "subject disorder", "offset": [42], "text": "APL"}, {"type": "treatment", "offset": [47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60], "text": "a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis"}, {"type": "drug", "offset": [55], "text": "ATRA"}, {"type": "time elapsed", "offset": [47, 48, 49], "text": "a few weeks"}, {"type": "treatment disorder", "offset": [42], "text": "APL"}, {"type": "effect", "offset": [25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35], "text": "symptom complex referred to as \" retinoic acid syndrome . \""}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "time elapsed", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a patient with APL"], ["subject disorder", "APL"], ["treatment", "a few weeks after initiating induction therapy with ATRA despite being treated for hyperleukocytosis"], ["drug", "ATRA"], ["time elapsed", "a few weeks"], ["treatment disorder", "APL"], ["effect", "symptom complex referred to as \" retinoic acid syndrome . \""]]}]}
{"text_id": "12135176_1", "text": "Two cases of polymorphic ventricular tachycardia induced by the administration of verapamil against paroxysmal supraventricular tachycardia .", "tokens": ["Two", "cases", "of", "polymorphic", "ventricular", "tachycardia", "induced", "by", "the", "administration", "of", "verapamil", "against", "paroxysmal", "supraventricular", "tachycardia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> verapamil <extra_id_1> <extra_id_0> drug <extra_id_5> verapamil <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> paroxysmal supraventricular tachycardia <extra_id_1> <extra_id_0> effect <extra_id_5> polymorphic ventricular tachycardia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "induced", "args": [{"type": "treatment", "offset": [11], "text": "verapamil"}, {"type": "drug", "offset": [11], "text": "verapamil"}, {"type": "treatment disorder", "offset": [13, 14, 15], "text": "paroxysmal supraventricular tachycardia"}, {"type": "effect", "offset": [3, 4, 5], "text": "polymorphic ventricular tachycardia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "verapamil"], ["drug", "verapamil"], ["treatment disorder", "paroxysmal supraventricular tachycardia"], ["effect", "polymorphic ventricular tachycardia"]]}]}
{"text_id": "18176653_12", "text": "Although HAART is very important in the treatment of HIV , its side effects are responsible for patients ' non - adherence to medications .", "tokens": ["Although", "HAART", "is", "very", "important", "in", "the", "treatment", "of", "HIV", ",", "its", "side", "effects", "are", "responsible", "for", "patients", "'", "non", "-", "adherence", "to", "medications", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> side effects <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> treatment <extra_id_5> HAART <extra_id_1> <extra_id_0> drug <extra_id_5> HAART <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> effect <extra_id_5> non - adherence to medications <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12, 13], "text": "side effects", "args": [{"type": "subject", "offset": [17], "text": "patients"}, {"type": "subject disorder", "offset": [9], "text": "HIV"}, {"type": "treatment", "offset": [1], "text": "HAART"}, {"type": "drug", "offset": [1], "text": "HAART"}, {"type": "treatment disorder", "offset": [9], "text": "HIV"}, {"type": "effect", "offset": [19, 20, 21, 22, 23], "text": "non - adherence to medications"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "side effects", "label": "adverse event", "asoc": [["subject", "patients"], ["subject disorder", "HIV"], ["treatment", "HAART"], ["drug", "HAART"], ["treatment disorder", "HIV"], ["effect", "non - adherence to medications"]]}]}
{"text_id": "1504404_3", "text": "DATA SYNTHESIS : A 49 - year - old man developed symptoms of severe psychosis concomitant with ciprofloxacin ( 250 mg bid ) treatment .", "tokens": ["DATA", "SYNTHESIS", ":", "A", "49", "-", "year", "-", "old", "man", "developed", "symptoms", "of", "severe", "psychosis", "concomitant", "with", "ciprofloxacin", "(", "250", "mg", "bid", ")", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 49 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 49 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> dosage <extra_id_5> 250 mg bid <extra_id_1> <extra_id_0> effect <extra_id_5> psychosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8, 9], "text": "A 49 - year - old man"}, {"type": "age", "offset": [4, 5, 6, 7, 8], "text": "49 - year - old"}, {"type": "gender", "offset": [9], "text": "man"}, {"type": "treatment", "offset": [17], "text": "ciprofloxacin"}, {"type": "drug", "offset": [17], "text": "ciprofloxacin"}, {"type": "dosage", "offset": [19, 20, 21], "text": "250 mg bid"}, {"type": "effect", "offset": [14], "text": "psychosis"}]}], "spot": ["adverse event"], "asoc": ["dosage", "effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 49 - year - old man"], ["age", "49 - year - old"], ["gender", "man"], ["treatment", "ciprofloxacin"], ["drug", "ciprofloxacin"], ["dosage", "250 mg bid"], ["effect", "psychosis"]]}]}
{"text_id": "20367573_2", "text": "Thrombocytosis associated with enoxaparin : A very rare cause in newborns .", "tokens": ["Thrombocytosis", "associated", "with", "enoxaparin", ":", "A", "very", "rare", "cause", "in", "newborns", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> newborns <extra_id_1> <extra_id_0> age <extra_id_5> newborns <extra_id_1> <extra_id_0> treatment <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> drug <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> effect <extra_id_5> Thrombocytosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "associated", "args": [{"type": "subject", "offset": [10], "text": "newborns"}, {"type": "age", "offset": [10], "text": "newborns"}, {"type": "treatment", "offset": [3], "text": "enoxaparin"}, {"type": "drug", "offset": [3], "text": "enoxaparin"}, {"type": "effect", "offset": [0], "text": "Thrombocytosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "newborns"], ["age", "newborns"], ["treatment", "enoxaparin"], ["drug", "enoxaparin"], ["effect", "Thrombocytosis"]]}]}
{"text_id": "16298824_4", "text": "Dyspnea , hypoxemia , and pleuritic chest pain occurred within 24 hours of rituximab administration , and there was no other apparent explanation .", "tokens": ["Dyspnea", ",", "hypoxemia", ",", "and", "pleuritic", "chest", "pain", "occurred", "within", "24", "hours", "of", "rituximab", "administration", ",", "and", "there", "was", "no", "other", "apparent", "explanation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurred <extra_id_0> treatment <extra_id_5> rituximab administration <extra_id_1> <extra_id_0> drug <extra_id_5> rituximab <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 24 hours <extra_id_1> <extra_id_0> effect <extra_id_5> Dyspnea , hypoxemia , and pleuritic chest pain <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "occurred", "args": [{"type": "treatment", "offset": [13, 14], "text": "rituximab administration"}, {"type": "drug", "offset": [13], "text": "rituximab"}, {"type": "time elapsed", "offset": [10, 11], "text": "24 hours"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Dyspnea , hypoxemia , and pleuritic chest pain"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "time elapsed"], "spot_asoc": [{"span": "occurred", "label": "adverse event", "asoc": [["treatment", "rituximab administration"], ["drug", "rituximab"], ["time elapsed", "24 hours"], ["effect", "Dyspnea , hypoxemia , and pleuritic chest pain"]]}]}
{"text_id": "10458196_2", "text": "An 11 - day - old infant became lethargic and apneic after a single drop of brimonidine .", "tokens": ["An", "11", "-", "day", "-", "old", "infant", "became", "lethargic", "and", "apneic", "after", "a", "single", "drop", "of", "brimonidine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> became <extra_id_0> subject <extra_id_5> An 11 - day - old infant <extra_id_1> <extra_id_0> age <extra_id_5> 11 - day - old <extra_id_1> <extra_id_0> age <extra_id_5> infant <extra_id_1> <extra_id_0> treatment <extra_id_5> a single drop of brimonidine <extra_id_1> <extra_id_0> drug <extra_id_5> brimonidine <extra_id_1> <extra_id_0> dosage <extra_id_5> single drop <extra_id_1> <extra_id_0> effect <extra_id_5> lethargic and apneic <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "became", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "An 11 - day - old infant"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "11 - day - old"}, {"type": "age", "offset": [6], "text": "infant"}, {"type": "treatment", "offset": [12, 13, 14, 15, 16], "text": "a single drop of brimonidine"}, {"type": "drug", "offset": [16], "text": "brimonidine"}, {"type": "dosage", "offset": [13, 14], "text": "single drop"}, {"type": "effect", "offset": [8, 9, 10], "text": "lethargic and apneic"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "dosage", "age", "treatment"], "spot_asoc": [{"span": "became", "label": "adverse event", "asoc": [["subject", "An 11 - day - old infant"], ["age", "11 - day - old"], ["age", "infant"], ["treatment", "a single drop of brimonidine"], ["drug", "brimonidine"], ["dosage", "single drop"], ["effect", "lethargic and apneic"]]}]}
{"text_id": "6837655_2", "text": "The spectrum of renal lesions occurring during antituberculous therapy , particularly in association with rifampin , may be wider than previously suspected .", "tokens": ["The", "spectrum", "of", "renal", "lesions", "occurring", "during", "antituberculous", "therapy", ",", "particularly", "in", "association", "with", "rifampin", ",", "may", "be", "wider", "than", "previously", "suspected", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> antituberculous therapy , particularly in association with rifampin <extra_id_1> <extra_id_0> drug <extra_id_5> rifampin <extra_id_1> <extra_id_0> drug <extra_id_5> antituberculous therapy <extra_id_1> <extra_id_0> combination drug <extra_id_5> rifampin <extra_id_1> <extra_id_0> combination drug <extra_id_5> antituberculous therapy <extra_id_1> <extra_id_0> effect <extra_id_5> The spectrum of renal lesions occurring <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "during", "args": [{"type": "treatment", "offset": [7, 8, 9, 10, 11, 12, 13, 14], "text": "antituberculous therapy , particularly in association with rifampin"}, {"type": "drug", "offset": [14], "text": "rifampin"}, {"type": "drug", "offset": [7, 8], "text": "antituberculous therapy"}, {"type": "combination drug", "offset": [14], "text": "rifampin"}, {"type": "combination drug", "offset": [7, 8], "text": "antituberculous therapy"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "The spectrum of renal lesions occurring"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "antituberculous therapy , particularly in association with rifampin"], ["drug", "rifampin"], ["drug", "antituberculous therapy"], ["combination drug", "rifampin"], ["combination drug", "antituberculous therapy"], ["effect", "The spectrum of renal lesions occurring"]]}]}
{"text_id": "19299370_2", "text": "CONCLUSION : A woman receiving enoxaparin every 12 hours developed signs and symptoms of hepatotoxicity after the second dose .", "tokens": ["CONCLUSION", ":", "A", "woman", "receiving", "enoxaparin", "every", "12", "hours", "developed", "signs", "and", "symptoms", "of", "hepatotoxicity", "after", "the", "second", "dose", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A woman <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> treatment <extra_id_5> enoxaparin every 12 hours <extra_id_1> <extra_id_0> treatment <extra_id_5> after the second dose <extra_id_1> <extra_id_0> drug <extra_id_5> enoxaparin <extra_id_1> <extra_id_0> dosage <extra_id_5> the second dose . <extra_id_1> <extra_id_0> frequency <extra_id_5> every 12 hours <extra_id_1> <extra_id_0> effect <extra_id_5> signs and symptoms of hepatotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "developed", "args": [{"type": "subject", "offset": [2, 3], "text": "A woman"}, {"type": "gender", "offset": [3], "text": "woman"}, {"type": "treatment", "offset": [5, 6, 7, 8], "text": "enoxaparin every 12 hours"}, {"type": "treatment", "offset": [15, 16, 17, 18], "text": "after the second dose"}, {"type": "drug", "offset": [5], "text": "enoxaparin"}, {"type": "dosage", "offset": [16, 17, 18, 19], "text": "the second dose ."}, {"type": "frequency", "offset": [6, 7, 8], "text": "every 12 hours"}, {"type": "effect", "offset": [10, 11, 12, 13, 14], "text": "signs and symptoms of hepatotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "gender", "frequency", "dosage", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A woman"], ["gender", "woman"], ["treatment", "enoxaparin every 12 hours"], ["treatment", "after the second dose"], ["drug", "enoxaparin"], ["dosage", "the second dose ."], ["frequency", "every 12 hours"], ["effect", "signs and symptoms of hepatotoxicity"]]}]}
{"text_id": "11886466_3", "text": "We have recently encountered a patient with acquired haemophilia who developed a thrombotic left middle cerebral artery distribution stroke while being treated with pFVIII .", "tokens": ["We", "have", "recently", "encountered", "a", "patient", "with", "acquired", "haemophilia", "who", "developed", "a", "thrombotic", "left", "middle", "cerebral", "artery", "distribution", "stroke", "while", "being", "treated", "with", "pFVIII", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated <extra_id_0> subject <extra_id_5> patient with acquired haemophilia who developed a thrombotic left middle cerebral artery distribution stroke <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acquired haemophilia <extra_id_1> <extra_id_0> treatment <extra_id_5> pFVIII <extra_id_1> <extra_id_0> drug <extra_id_5> pFVIII <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acquired haemophilia <extra_id_1> <extra_id_0> effect <extra_id_5> thrombotic left middle cerebral artery distribution stroke <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [21], "text": "treated", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18], "text": "patient with acquired haemophilia who developed a thrombotic left middle cerebral artery distribution stroke"}, {"type": "subject disorder", "offset": [7, 8], "text": "acquired haemophilia"}, {"type": "treatment", "offset": [23], "text": "pFVIII"}, {"type": "drug", "offset": [23], "text": "pFVIII"}, {"type": "treatment disorder", "offset": [7, 8], "text": "acquired haemophilia"}, {"type": "effect", "offset": [12, 13, 14, 15, 16, 17, 18], "text": "thrombotic left middle cerebral artery distribution stroke"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "adverse event", "asoc": [["subject", "patient with acquired haemophilia who developed a thrombotic left middle cerebral artery distribution stroke"], ["subject disorder", "acquired haemophilia"], ["treatment", "pFVIII"], ["drug", "pFVIII"], ["treatment disorder", "acquired haemophilia"], ["effect", "thrombotic left middle cerebral artery distribution stroke"]]}]}
{"text_id": "458006_2", "text": "We report the development of squamous - cell carcinoma within a basal - cell epithelioma that was treated with intralesional injections of 5 - FU .", "tokens": ["We", "report", "the", "development", "of", "squamous", "-", "cell", "carcinoma", "within", "a", "basal", "-", "cell", "epithelioma", "that", "was", "treated", "with", "intralesional", "injections", "of", "5", "-", "FU", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treated <extra_id_0> treatment <extra_id_5> intralesional injections of 5 - FU <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> route <extra_id_5> intralesional injections <extra_id_1> <extra_id_0> effect <extra_id_5> squamous - cell carcinoma within a basal - cell epithelioma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [17], "text": "treated", "args": [{"type": "treatment", "offset": [19, 20, 21, 22, 23, 24], "text": "intralesional injections of 5 - FU"}, {"type": "drug", "offset": [22, 23, 24], "text": "5 - FU"}, {"type": "route", "offset": [19, 20], "text": "intralesional injections"}, {"type": "effect", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "squamous - cell carcinoma within a basal - cell epithelioma"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "treated", "label": "potential therapeutic event", "asoc": [["treatment", "intralesional injections of 5 - FU"], ["drug", "5 - FU"], ["route", "intralesional injections"], ["effect", "squamous - cell carcinoma within a basal - cell epithelioma"]]}]}
{"text_id": "15806568_2", "text": "To date , there have been few reports of visual disturbances associated with BTX - B use .", "tokens": ["To", "date", ",", "there", "have", "been", "few", "reports", "of", "visual", "disturbances", "associated", "with", "BTX", "-", "B", "use", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> BTX - B <extra_id_1> <extra_id_0> drug <extra_id_5> BTX - B <extra_id_1> <extra_id_0> effect <extra_id_5> visual disturbances <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "associated", "args": [{"type": "treatment", "offset": [13, 14, 15], "text": "BTX - B"}, {"type": "drug", "offset": [13, 14, 15], "text": "BTX - B"}, {"type": "effect", "offset": [9, 10], "text": "visual disturbances"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "BTX - B"], ["drug", "BTX - B"], ["effect", "visual disturbances"]]}]}
{"text_id": "21728158_4", "text": "Drug resistant tuberculosis requires more complex and longer treatment with alternative substances .", "tokens": ["Drug", "resistant", "tuberculosis", "requires", "more", "complex", "and", "longer", "treatment", "with", "alternative", "substances", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> requires <extra_id_0> treatment <extra_id_5> complex and longer treatment with alternative substances <extra_id_1> <extra_id_0> drug <extra_id_5> substances <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Drug resistant tuberculosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [3], "text": "requires", "args": [{"type": "treatment", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "complex and longer treatment with alternative substances"}, {"type": "drug", "offset": [11], "text": "substances"}, {"type": "treatment disorder", "offset": [0, 1, 2], "text": "Drug resistant tuberculosis"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "requires", "label": "potential therapeutic event", "asoc": [["treatment", "complex and longer treatment with alternative substances"], ["drug", "substances"], ["treatment disorder", "Drug resistant tuberculosis"]]}]}
{"text_id": "19892516_2", "text": "Ciprofloxacin - induced hemorrhagic vasculitis is a rare side effect .", "tokens": ["Ciprofloxacin", "-", "induced", "hemorrhagic", "vasculitis", "is", "a", "rare", "side", "effect", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> Ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> hemorrhagic vasculitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Ciprofloxacin"}, {"type": "drug", "offset": [0], "text": "Ciprofloxacin"}, {"type": "effect", "offset": [3, 4], "text": "hemorrhagic vasculitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Ciprofloxacin"], ["drug", "Ciprofloxacin"], ["effect", "hemorrhagic vasculitis"]]}]}
{"text_id": "1673494_1", "text": "Amphotericin B ( AmB ) is effective , but its use is limited by toxicity : renal impairment , anaemia , fever , malaise , and hypokalaemia are common .", "tokens": ["Amphotericin", "B", "(", "AmB", ")", "is", "effective", ",", "but", "its", "use", "is", "limited", "by", "toxicity", ":", "renal", "impairment", ",", "anaemia", ",", "fever", ",", "malaise", ",", "and", "hypokalaemia", "are", "common", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> by <extra_id_0> treatment <extra_id_5> Amphotericin B ( AmB ) <extra_id_1> <extra_id_0> drug <extra_id_5> Amphotericin B <extra_id_1> <extra_id_0> effect <extra_id_5> toxicity : renal impairment , anaemia , fever , malaise , and hypokalaemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "by", "args": [{"type": "treatment", "offset": [0, 1, 2, 3, 4], "text": "Amphotericin B ( AmB )"}, {"type": "drug", "offset": [0, 1], "text": "Amphotericin B"}, {"type": "effect", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26], "text": "toxicity : renal impairment , anaemia , fever , malaise , and hypokalaemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "by", "label": "adverse event", "asoc": [["treatment", "Amphotericin B ( AmB )"], ["drug", "Amphotericin B"], ["effect", "toxicity : renal impairment , anaemia , fever , malaise , and hypokalaemia"]]}]}
{"text_id": "15307435_2", "text": "In this report , we present a case of hypoglycaemic coma associated with SP , an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of SP increases .", "tokens": ["In", "this", "report", ",", "we", "present", "a", "case", "of", "hypoglycaemic", "coma", "associated", "with", "SP", ",", "an", "adverse", "reaction", "that", "is", "likely", "to", "be", "underreported", "and", "expected", "to", "occur", "with", "greater", "frequency", "as", "the", "use", "of", "SP", "increases", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> SP <extra_id_1> <extra_id_0> drug <extra_id_5> SP <extra_id_1> <extra_id_0> effect <extra_id_5> hypoglycaemic coma <extra_id_1> <extra_id_0> effect <extra_id_5> an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of SP increases <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "associated", "args": [{"type": "treatment", "offset": [13], "text": "SP"}, {"type": "drug", "offset": [13], "text": "SP"}, {"type": "effect", "offset": [9, 10], "text": "hypoglycaemic coma"}, {"type": "effect", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36], "text": "an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of SP increases"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "SP"], ["drug", "SP"], ["effect", "hypoglycaemic coma"], ["effect", "an adverse reaction that is likely to be underreported and expected to occur with greater frequency as the use of SP increases"]]}]}
{"text_id": "11576059_2", "text": "We present the case of a 5 - year - old girl who developed bilateral vocal cord paralysis following preoperative peritonsillar bupivacaine infiltration .", "tokens": ["We", "present", "the", "case", "of", "a", "5", "-", "year", "-", "old", "girl", "who", "developed", "bilateral", "vocal", "cord", "paralysis", "following", "preoperative", "peritonsillar", "bupivacaine", "infiltration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> subject <extra_id_5> a 5 - year - old girl <extra_id_1> <extra_id_0> age <extra_id_5> 5 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> girl <extra_id_1> <extra_id_0> treatment <extra_id_5> preoperative peritonsillar bupivacaine infiltration <extra_id_1> <extra_id_0> drug <extra_id_5> bupivacaine <extra_id_1> <extra_id_0> route <extra_id_5> peritonsillar <extra_id_1> <extra_id_0> route <extra_id_5> infiltration <extra_id_1> <extra_id_0> effect <extra_id_5> bilateral vocal cord paralysis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "following", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "a 5 - year - old girl"}, {"type": "age", "offset": [6, 7, 8, 9, 10], "text": "5 - year - old"}, {"type": "gender", "offset": [11], "text": "girl"}, {"type": "treatment", "offset": [19, 20, 21, 22], "text": "preoperative peritonsillar bupivacaine infiltration"}, {"type": "drug", "offset": [21], "text": "bupivacaine"}, {"type": "route", "offset": [20], "text": "peritonsillar"}, {"type": "route", "offset": [22], "text": "infiltration"}, {"type": "effect", "offset": [14, 15, 16, 17], "text": "bilateral vocal cord paralysis"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["subject", "a 5 - year - old girl"], ["age", "5 - year - old"], ["gender", "girl"], ["treatment", "preoperative peritonsillar bupivacaine infiltration"], ["drug", "bupivacaine"], ["route", "peritonsillar"], ["route", "infiltration"], ["effect", "bilateral vocal cord paralysis"]]}]}
{"text_id": "17852449_3", "text": "Treatment of APL in pregnancy is controversial as the use of ATRA has been questioned due to the teratogenic effect of retinoids .", "tokens": ["Treatment", "of", "APL", "in", "pregnancy", "is", "controversial", "as", "the", "use", "of", "ATRA", "has", "been", "questioned", "due", "to", "the", "teratogenic", "effect", "of", "retinoids", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> treatment <extra_id_5> retinoids <extra_id_1> <extra_id_0> drug <extra_id_5> retinoids <extra_id_1> <extra_id_0> effect <extra_id_5> teratogenic effect <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "due", "args": [{"type": "treatment", "offset": [21], "text": "retinoids"}, {"type": "drug", "offset": [21], "text": "retinoids"}, {"type": "effect", "offset": [18, 19], "text": "teratogenic effect"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["treatment", "retinoids"], ["drug", "retinoids"], ["effect", "teratogenic effect"]]}]}
{"text_id": "10891991_4", "text": "OBJECTIVE : To describe the development of valproate - related reproductive endocrine disorders in women with epilepsy .", "tokens": ["OBJECTIVE", ":", "To", "describe", "the", "development", "of", "valproate", "-", "related", "reproductive", "endocrine", "disorders", "in", "women", "with", "epilepsy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> subject <extra_id_5> women with epilepsy <extra_id_1> <extra_id_0> gender <extra_id_5> women <extra_id_1> <extra_id_0> subject disorder <extra_id_5> epilepsy <extra_id_1> <extra_id_0> treatment <extra_id_5> valproate <extra_id_1> <extra_id_0> drug <extra_id_5> valproate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> epilepsy <extra_id_1> <extra_id_0> effect <extra_id_5> reproductive endocrine disorders <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "related", "args": [{"type": "subject", "offset": [14, 15, 16], "text": "women with epilepsy"}, {"type": "gender", "offset": [14], "text": "women"}, {"type": "subject disorder", "offset": [16], "text": "epilepsy"}, {"type": "treatment", "offset": [7], "text": "valproate"}, {"type": "drug", "offset": [7], "text": "valproate"}, {"type": "treatment disorder", "offset": [16], "text": "epilepsy"}, {"type": "effect", "offset": [10, 11, 12], "text": "reproductive endocrine disorders"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["subject", "women with epilepsy"], ["gender", "women"], ["subject disorder", "epilepsy"], ["treatment", "valproate"], ["drug", "valproate"], ["treatment disorder", "epilepsy"], ["effect", "reproductive endocrine disorders"]]}]}
{"text_id": "7249424_3", "text": "Two patients on long - term lithium therapy developed the nephrotic syndrome .", "tokens": ["Two", "patients", "on", "long", "-", "term", "lithium", "therapy", "developed", "the", "nephrotic", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> Two patients <extra_id_1> <extra_id_0> population <extra_id_5> Two <extra_id_1> <extra_id_0> treatment <extra_id_5> long - term lithium therapy <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> effect <extra_id_5> nephrotic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "developed", "args": [{"type": "subject", "offset": [0, 1], "text": "Two patients"}, {"type": "population", "offset": [0], "text": "Two"}, {"type": "treatment", "offset": [3, 4, 5, 6, 7], "text": "long - term lithium therapy"}, {"type": "drug", "offset": [6], "text": "lithium"}, {"type": "effect", "offset": [10, 11], "text": "nephrotic syndrome"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "Two patients"], ["population", "Two"], ["treatment", "long - term lithium therapy"], ["drug", "lithium"], ["effect", "nephrotic syndrome"]]}]}
{"text_id": "9366852_2", "text": "Skin necrosis is a rare complication of subcutaneous heparin therapy that usually occurs at injection sites .", "tokens": ["Skin", "necrosis", "is", "a", "rare", "complication", "of", "subcutaneous", "heparin", "therapy", "that", "usually", "occurs", "at", "injection", "sites", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> subcutaneous heparin therapy <extra_id_1> <extra_id_0> drug <extra_id_5> heparin <extra_id_1> <extra_id_0> route <extra_id_5> subcutaneous <extra_id_1> <extra_id_0> effect <extra_id_5> Skin necrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "complication", "args": [{"type": "treatment", "offset": [7, 8, 9], "text": "subcutaneous heparin therapy"}, {"type": "drug", "offset": [8], "text": "heparin"}, {"type": "route", "offset": [7], "text": "subcutaneous"}, {"type": "effect", "offset": [0, 1], "text": "Skin necrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "subcutaneous heparin therapy"], ["drug", "heparin"], ["route", "subcutaneous"], ["effect", "Skin necrosis"]]}]}
{"text_id": "19904536_3", "text": "In this report , we describe a fatal gemcitabine - induced pulmonary toxicity in a patient with gallbladder metastatic adenocarcinoma .", "tokens": ["In", "this", "report", ",", "we", "describe", "a", "fatal", "gemcitabine", "-", "induced", "pulmonary", "toxicity", "in", "a", "patient", "with", "gallbladder", "metastatic", "adenocarcinoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a patient with gallbladder metastatic adenocarcinoma <extra_id_1> <extra_id_0> subject disorder <extra_id_5> gallbladder metastatic adenocarcinoma <extra_id_1> <extra_id_0> treatment <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> gallbladder metastatic adenocarcinoma <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "induced", "args": [{"type": "subject", "offset": [14, 15, 16, 17, 18, 19], "text": "a patient with gallbladder metastatic adenocarcinoma"}, {"type": "subject disorder", "offset": [17, 18, 19], "text": "gallbladder metastatic adenocarcinoma"}, {"type": "treatment", "offset": [8], "text": "gemcitabine"}, {"type": "drug", "offset": [8], "text": "gemcitabine"}, {"type": "treatment disorder", "offset": [17, 18, 19], "text": "gallbladder metastatic adenocarcinoma"}, {"type": "effect", "offset": [11, 12], "text": "pulmonary toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a patient with gallbladder metastatic adenocarcinoma"], ["subject disorder", "gallbladder metastatic adenocarcinoma"], ["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["treatment disorder", "gallbladder metastatic adenocarcinoma"], ["effect", "pulmonary toxicity"]]}]}
{"text_id": "19857154_1", "text": "Clinically significant adverse events from a drug interaction between quetiapine and atazanavir - ritonavir in two patients .", "tokens": ["Clinically", "significant", "adverse", "events", "from", "a", "drug", "interaction", "between", "quetiapine", "and", "atazanavir", "-", "ritonavir", "in", "two", "patients", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> adverse events <extra_id_0> subject <extra_id_5> two patients <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> treatment <extra_id_5> interaction between quetiapine and atazanavir - ritonavir <extra_id_1> <extra_id_0> drug <extra_id_5> quetiapine <extra_id_1> <extra_id_0> drug <extra_id_5> atazanavir - ritonavir <extra_id_1> <extra_id_0> combination drug <extra_id_5> quetiapine <extra_id_1> <extra_id_0> combination drug <extra_id_5> atazanavir - ritonavir <extra_id_1> <extra_id_0> effect <extra_id_5> Clinically significant <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2, 3], "text": "adverse events", "args": [{"type": "subject", "offset": [15, 16], "text": "two patients"}, {"type": "population", "offset": [15], "text": "two"}, {"type": "treatment", "offset": [7, 8, 9, 10, 11, 12, 13], "text": "interaction between quetiapine and atazanavir - ritonavir"}, {"type": "drug", "offset": [9], "text": "quetiapine"}, {"type": "drug", "offset": [11, 12, 13], "text": "atazanavir - ritonavir"}, {"type": "combination drug", "offset": [9], "text": "quetiapine"}, {"type": "combination drug", "offset": [11, 12, 13], "text": "atazanavir - ritonavir"}, {"type": "effect", "offset": [0, 1], "text": "Clinically significant"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "adverse events", "label": "adverse event", "asoc": [["subject", "two patients"], ["population", "two"], ["treatment", "interaction between quetiapine and atazanavir - ritonavir"], ["drug", "quetiapine"], ["drug", "atazanavir - ritonavir"], ["combination drug", "quetiapine"], ["combination drug", "atazanavir - ritonavir"], ["effect", "Clinically significant"]]}]}
{"text_id": "15157248_2", "text": "CASE REPORT : We report a patient who developed a DAT - positive hemolytic episode after a red cell ( RBC ) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin .", "tokens": ["CASE", "REPORT", ":", "We", "report", "a", "patient", "who", "developed", "a", "DAT", "-", "positive", "hemolytic", "episode", "after", "a", "red", "cell", "(", "RBC", ")", "transfusion", "was", "delivered", "during", "the", "infusion", "of", "her", "17th", "cycle", "of", "oxaliplatin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> a red cell ( RBC ) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin <extra_id_1> <extra_id_0> drug <extra_id_5> oxaliplatin <extra_id_1> <extra_id_0> drug <extra_id_5> a red cell <extra_id_1> <extra_id_0> route <extra_id_5> infusion <extra_id_1> <extra_id_0> route <extra_id_5> transfusion <extra_id_1> <extra_id_0> duration <extra_id_5> 17th cycle <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 17th cycle <extra_id_1> <extra_id_0> combination drug <extra_id_5> oxaliplatin <extra_id_1> <extra_id_0> combination drug <extra_id_5> a red cell <extra_id_1> <extra_id_0> effect <extra_id_5> developed a DAT - positive hemolytic episode <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "after", "args": [{"type": "subject", "offset": [5, 6], "text": "a patient"}, {"type": "treatment", "offset": [16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33], "text": "a red cell ( RBC ) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin"}, {"type": "drug", "offset": [33], "text": "oxaliplatin"}, {"type": "drug", "offset": [16, 17, 18], "text": "a red cell"}, {"type": "route", "offset": [27], "text": "infusion"}, {"type": "route", "offset": [22], "text": "transfusion"}, {"type": "duration", "offset": [30, 31], "text": "17th cycle"}, {"type": "time elapsed", "offset": [30, 31], "text": "17th cycle"}, {"type": "combination drug", "offset": [33], "text": "oxaliplatin"}, {"type": "combination drug", "offset": [16, 17, 18], "text": "a red cell"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13, 14], "text": "developed a DAT - positive hemolytic episode"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "route", "subject", "drug", "duration", "treatment", "combination drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "a red cell ( RBC ) transfusion was delivered during the infusion of her 17th cycle of oxaliplatin"], ["drug", "oxaliplatin"], ["drug", "a red cell"], ["route", "infusion"], ["route", "transfusion"], ["duration", "17th cycle"], ["time elapsed", "17th cycle"], ["combination drug", "oxaliplatin"], ["combination drug", "a red cell"], ["effect", "developed a DAT - positive hemolytic episode"]]}]}
{"text_id": "122410_1", "text": "A patient who had been treated with large doses of thyroid hormone for several years developed features of secondary hypothyroidism after thyroid hormone withdrawal .", "tokens": ["A", "patient", "who", "had", "been", "treated", "with", "large", "doses", "of", "thyroid", "hormone", "for", "several", "years", "developed", "features", "of", "secondary", "hypothyroidism", "after", "thyroid", "hormone", "withdrawal", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A patient <extra_id_1> <extra_id_0> treatment <extra_id_5> thyroid hormone withdrawal <extra_id_1> <extra_id_0> drug <extra_id_5> thyroid hormone <extra_id_1> <extra_id_0> effect <extra_id_5> secondary hypothyroidism <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "developed", "args": [{"type": "subject", "offset": [0, 1], "text": "A patient"}, {"type": "treatment", "offset": [21, 22, 23], "text": "thyroid hormone withdrawal"}, {"type": "drug", "offset": [21, 22], "text": "thyroid hormone"}, {"type": "effect", "offset": [18, 19], "text": "secondary hypothyroidism"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A patient"], ["treatment", "thyroid hormone withdrawal"], ["drug", "thyroid hormone"], ["effect", "secondary hypothyroidism"]]}]}
{"text_id": "7439122_2", "text": "However , we have recently had four cases of clofibrate - induced myopathy in patients with diabetes insipidus due to hypothalamic lesions .", "tokens": ["However", ",", "we", "have", "recently", "had", "four", "cases", "of", "clofibrate", "-", "induced", "myopathy", "in", "patients", "with", "diabetes", "insipidus", "due", "to", "hypothalamic", "lesions", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> four cases <extra_id_1> <extra_id_0> subject <extra_id_5> diabetes insipidus due to hypothalamic lesions <extra_id_1> <extra_id_0> population <extra_id_5> four <extra_id_1> <extra_id_0> subject disorder <extra_id_5> diabetes insipidus <extra_id_1> <extra_id_0> treatment <extra_id_5> clofibrate <extra_id_1> <extra_id_0> drug <extra_id_5> clofibrate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> diabetes insipidus <extra_id_1> <extra_id_0> effect <extra_id_5> myopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "induced", "args": [{"type": "subject", "offset": [6, 7], "text": "four cases"}, {"type": "subject", "offset": [16, 17, 18, 19, 20, 21], "text": "diabetes insipidus due to hypothalamic lesions"}, {"type": "population", "offset": [6], "text": "four"}, {"type": "subject disorder", "offset": [16, 17], "text": "diabetes insipidus"}, {"type": "treatment", "offset": [9], "text": "clofibrate"}, {"type": "drug", "offset": [9], "text": "clofibrate"}, {"type": "treatment disorder", "offset": [16, 17], "text": "diabetes insipidus"}, {"type": "effect", "offset": [12], "text": "myopathy"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "four cases"], ["subject", "diabetes insipidus due to hypothalamic lesions"], ["population", "four"], ["subject disorder", "diabetes insipidus"], ["treatment", "clofibrate"], ["drug", "clofibrate"], ["treatment disorder", "diabetes insipidus"], ["effect", "myopathy"]]}]}
{"text_id": "1849334_2", "text": "We report on 7 patients ( 2 women , 5 men ) with chronic renal failure , who developed under a high dosage of the new diuretic muzolimine ( range 240 to 1440 mg per day ) fatal neuromyeloencephalopathy .", "tokens": ["We", "report", "on", "7", "patients", "(", "2", "women", ",", "5", "men", ")", "with", "chronic", "renal", "failure", ",", "who", "developed", "under", "a", "high", "dosage", "of", "the", "new", "diuretic", "muzolimine", "(", "range", "240", "to", "1440", "mg", "per", "day", ")", "fatal", "neuromyeloencephalopathy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> 7 patients ( 2 women , 5 men ) with chronic renal failure <extra_id_1> <extra_id_0> population <extra_id_5> 7 <extra_id_1> <extra_id_0> subject disorder <extra_id_5> chronic renal failure <extra_id_1> <extra_id_0> treatment <extra_id_5> a high dosage of the new diuretic muzolimine ( range 240 to 1440 mg per day ) <extra_id_1> <extra_id_0> drug <extra_id_5> diuretic muzolimine <extra_id_1> <extra_id_0> dosage <extra_id_5> range 240 to 1440 mg <extra_id_1> <extra_id_0> frequency <extra_id_5> per day <extra_id_1> <extra_id_0> effect <extra_id_5> fatal neuromyeloencephalopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "7 patients ( 2 women , 5 men ) with chronic renal failure"}, {"type": "population", "offset": [3], "text": "7"}, {"type": "subject disorder", "offset": [13, 14, 15], "text": "chronic renal failure"}, {"type": "treatment", "offset": [20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36], "text": "a high dosage of the new diuretic muzolimine ( range 240 to 1440 mg per day )"}, {"type": "drug", "offset": [26, 27], "text": "diuretic muzolimine"}, {"type": "dosage", "offset": [29, 30, 31, 32, 33], "text": "range 240 to 1440 mg"}, {"type": "frequency", "offset": [34, 35], "text": "per day"}, {"type": "effect", "offset": [37, 38], "text": "fatal neuromyeloencephalopathy"}]}], "spot": ["adverse event"], "asoc": ["dosage", "population", "effect", "subject", "treatment", "frequency", "drug", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "7 patients ( 2 women , 5 men ) with chronic renal failure"], ["population", "7"], ["subject disorder", "chronic renal failure"], ["treatment", "a high dosage of the new diuretic muzolimine ( range 240 to 1440 mg per day )"], ["drug", "diuretic muzolimine"], ["dosage", "range 240 to 1440 mg"], ["frequency", "per day"], ["effect", "fatal neuromyeloencephalopathy"]]}]}
{"text_id": "12523465_1", "text": "Although visual hallucinations have not been reported as an adverse effect of this agent , we describe three patients who experienced complex visual hallucinations and altered mental status after zonisamide treatment was begun or its dosage increased .", "tokens": ["Although", "visual", "hallucinations", "have", "not", "been", "reported", "as", "an", "adverse", "effect", "of", "this", "agent", ",", "we", "describe", "three", "patients", "who", "experienced", "complex", "visual", "hallucinations", "and", "altered", "mental", "status", "after", "zonisamide", "treatment", "was", "begun", "or", "its", "dosage", "increased", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> zonisamide <extra_id_1> <extra_id_0> drug <extra_id_5> zonisamide <extra_id_1> <extra_id_0> effect <extra_id_5> complex visual hallucinations and altered mental status <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [28], "text": "after", "args": [{"type": "treatment", "offset": [29], "text": "zonisamide"}, {"type": "drug", "offset": [29], "text": "zonisamide"}, {"type": "effect", "offset": [21, 22, 23, 24, 25, 26, 27], "text": "complex visual hallucinations and altered mental status"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "zonisamide"], ["drug", "zonisamide"], ["effect", "complex visual hallucinations and altered mental status"]]}]}
{"text_id": "8530331_6", "text": "Two of the five patients who worsened motorically also developed encephalopathy during risperidone treatment ; the encephalopathy resolved when the patients were switched to clozapine treatment .", "tokens": ["Two", "of", "the", "five", "patients", "who", "worsened", "motorically", "also", "developed", "encephalopathy", "during", "risperidone", "treatment", ";", "the", "encephalopathy", "resolved", "when", "the", "patients", "were", "switched", "to", "clozapine", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> Two of the five patients who worsened motorically <extra_id_1> <extra_id_0> population <extra_id_5> Two of the five <extra_id_1> <extra_id_0> subject disorder <extra_id_5> worsened motorically <extra_id_1> <extra_id_0> treatment <extra_id_5> risperidone treatment <extra_id_1> <extra_id_0> drug <extra_id_5> risperidone <extra_id_1> <extra_id_0> effect <extra_id_5> encephalopathy <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> resolved <extra_id_0> subject <extra_id_5> Two of the five patients who worsened motorically <extra_id_1> <extra_id_0> population <extra_id_5> Two of the five <extra_id_1> <extra_id_0> subject disorder <extra_id_5> worsened motorically <extra_id_1> <extra_id_0> subject disorder <extra_id_5> encephalopathy <extra_id_1> <extra_id_0> treatment <extra_id_5> switched to clozapine treatment <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> encephalopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Two of the five patients who worsened motorically"}, {"type": "population", "offset": [0, 1, 2, 3], "text": "Two of the five"}, {"type": "subject disorder", "offset": [6, 7], "text": "worsened motorically"}, {"type": "treatment", "offset": [12, 13], "text": "risperidone treatment"}, {"type": "drug", "offset": [12], "text": "risperidone"}, {"type": "effect", "offset": [10], "text": "encephalopathy"}]}, {"type": "potential therapeutic event", "offset": [17], "text": "resolved", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Two of the five patients who worsened motorically"}, {"type": "population", "offset": [0, 1, 2, 3], "text": "Two of the five"}, {"type": "subject disorder", "offset": [6, 7], "text": "worsened motorically"}, {"type": "subject disorder", "offset": [16], "text": "encephalopathy"}, {"type": "treatment", "offset": [22, 23, 24, 25], "text": "switched to clozapine treatment"}, {"type": "drug", "offset": [24], "text": "clozapine"}, {"type": "treatment disorder", "offset": [16], "text": "encephalopathy"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "Two of the five patients who worsened motorically"], ["population", "Two of the five"], ["subject disorder", "worsened motorically"], ["treatment", "risperidone treatment"], ["drug", "risperidone"], ["effect", "encephalopathy"]]}, {"span": "resolved", "label": "potential therapeutic event", "asoc": [["subject", "Two of the five patients who worsened motorically"], ["population", "Two of the five"], ["subject disorder", "worsened motorically"], ["subject disorder", "encephalopathy"], ["treatment", "switched to clozapine treatment"], ["drug", "clozapine"], ["treatment disorder", "encephalopathy"]]}]}
{"text_id": "19857154_7", "text": "The second patient was a 32 - year - old woman with HIV , anxiety disorder , and a history of intravenous drug abuse who developed increased sedation and mental confusion when an atazanavir - ritonavir - based antiretroviral regimen was added to her stable antianxiety drug regimen , which included quetiapine .", "tokens": ["The", "second", "patient", "was", "a", "32", "-", "year", "-", "old", "woman", "with", "HIV", ",", "anxiety", "disorder", ",", "and", "a", "history", "of", "intravenous", "drug", "abuse", "who", "developed", "increased", "sedation", "and", "mental", "confusion", "when", "an", "atazanavir", "-", "ritonavir", "-", "based", "antiretroviral", "regimen", "was", "added", "to", "her", "stable", "antianxiety", "drug", "regimen", ",", "which", "included", "quetiapine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a 32 - year - old woman with HIV , anxiety disorder , and a history of intravenous drug abuse <extra_id_1> <extra_id_0> age <extra_id_5> 32 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> intravenous drug abuse <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> subject disorder <extra_id_5> anxiety disorder <extra_id_1> <extra_id_0> treatment <extra_id_5> atazanavir - ritonavir - based antiretroviral regimen was added to her stable antianxiety drug regimen , which included quetiapine <extra_id_1> <extra_id_0> drug <extra_id_5> quetiapine <extra_id_1> <extra_id_0> drug <extra_id_5> atazanavir <extra_id_1> <extra_id_0> drug <extra_id_5> ritonavir <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> anxiety disorder <extra_id_1> <extra_id_0> combination drug <extra_id_5> ritonavir <extra_id_1> <extra_id_0> combination drug <extra_id_5> atazanavir <extra_id_1> <extra_id_0> combination drug <extra_id_5> quetiapine <extra_id_1> <extra_id_0> effect <extra_id_5> increased sedation and mental confusion <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [25], "text": "developed", "args": [{"type": "subject", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23], "text": "a 32 - year - old woman with HIV , anxiety disorder , and a history of intravenous drug abuse"}, {"type": "age", "offset": [5, 6, 7, 8, 9], "text": "32 - year - old"}, {"type": "gender", "offset": [10], "text": "woman"}, {"type": "subject disorder", "offset": [21, 22, 23], "text": "intravenous drug abuse"}, {"type": "subject disorder", "offset": [12], "text": "HIV"}, {"type": "subject disorder", "offset": [14, 15], "text": "anxiety disorder"}, {"type": "treatment", "offset": [33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51], "text": "atazanavir - ritonavir - based antiretroviral regimen was added to her stable antianxiety drug regimen , which included quetiapine"}, {"type": "drug", "offset": [51], "text": "quetiapine"}, {"type": "drug", "offset": [33], "text": "atazanavir"}, {"type": "drug", "offset": [35], "text": "ritonavir"}, {"type": "treatment disorder", "offset": [12], "text": "HIV"}, {"type": "treatment disorder", "offset": [14, 15], "text": "anxiety disorder"}, {"type": "combination drug", "offset": [35], "text": "ritonavir"}, {"type": "combination drug", "offset": [33], "text": "atazanavir"}, {"type": "combination drug", "offset": [51], "text": "quetiapine"}, {"type": "effect", "offset": [26, 27, 28, 29, 30], "text": "increased sedation and mental confusion"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a 32 - year - old woman with HIV , anxiety disorder , and a history of intravenous drug abuse"], ["age", "32 - year - old"], ["gender", "woman"], ["subject disorder", "intravenous drug abuse"], ["subject disorder", "HIV"], ["subject disorder", "anxiety disorder"], ["treatment", "atazanavir - ritonavir - based antiretroviral regimen was added to her stable antianxiety drug regimen , which included quetiapine"], ["drug", "quetiapine"], ["drug", "atazanavir"], ["drug", "ritonavir"], ["treatment disorder", "HIV"], ["treatment disorder", "anxiety disorder"], ["combination drug", "ritonavir"], ["combination drug", "atazanavir"], ["combination drug", "quetiapine"], ["effect", "increased sedation and mental confusion"]]}]}
{"text_id": "19789166_1", "text": "Given that discontinuation of nitrofurantoin and introduction of methylprednisolon therapy significantly lowered liver enzyme levels , restoring most of them to normal , we concluded that this was probably the case of toxic liver damage caused by nitrofurantoin .", "tokens": ["Given", "that", "discontinuation", "of", "nitrofurantoin", "and", "introduction", "of", "methylprednisolon", "therapy", "significantly", "lowered", "liver", "enzyme", "levels", ",", "restoring", "most", "of", "them", "to", "normal", ",", "we", "concluded", "that", "this", "was", "probably", "the", "case", "of", "toxic", "liver", "damage", "caused", "by", "nitrofurantoin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> nitrofurantoin <extra_id_1> <extra_id_0> drug <extra_id_5> nitrofurantoin <extra_id_1> <extra_id_0> effect <extra_id_5> toxic liver damage <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [35], "text": "caused", "args": [{"type": "treatment", "offset": [37], "text": "nitrofurantoin"}, {"type": "drug", "offset": [37], "text": "nitrofurantoin"}, {"type": "effect", "offset": [32, 33, 34], "text": "toxic liver damage"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "nitrofurantoin"], ["drug", "nitrofurantoin"], ["effect", "toxic liver damage"]]}]}
{"text_id": "2979256_2", "text": "Gastro - oesophageal reflux associated with nifedipine .", "tokens": ["Gastro", "-", "oesophageal", "reflux", "associated", "with", "nifedipine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> nifedipine <extra_id_1> <extra_id_0> drug <extra_id_5> nifedipine <extra_id_1> <extra_id_0> effect <extra_id_5> Gastro - oesophageal reflux <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "associated", "args": [{"type": "treatment", "offset": [6], "text": "nifedipine"}, {"type": "drug", "offset": [6], "text": "nifedipine"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Gastro - oesophageal reflux"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "nifedipine"], ["drug", "nifedipine"], ["effect", "Gastro - oesophageal reflux"]]}]}
{"text_id": "2887555_1", "text": "Soon after its introduction in 1952 , chlorpromazine was noted to induce symptoms resembling Parkinson 's disease .", "tokens": ["Soon", "after", "its", "introduction", "in", "1952", ",", "chlorpromazine", "was", "noted", "to", "induce", "symptoms", "resembling", "Parkinson", "'s", "disease", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induce <extra_id_0> treatment <extra_id_5> chlorpromazine <extra_id_1> <extra_id_0> drug <extra_id_5> chlorpromazine <extra_id_1> <extra_id_0> effect <extra_id_5> symptoms resembling Parkinson 's disease <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "induce", "args": [{"type": "treatment", "offset": [7], "text": "chlorpromazine"}, {"type": "drug", "offset": [7], "text": "chlorpromazine"}, {"type": "effect", "offset": [12, 13, 14, 15, 16], "text": "symptoms resembling Parkinson 's disease"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induce", "label": "adverse event", "asoc": [["treatment", "chlorpromazine"], ["drug", "chlorpromazine"], ["effect", "symptoms resembling Parkinson 's disease"]]}]}
{"text_id": "2327115_4", "text": "This article describes a patient with suspected ciprofloxacin - induced interstitial nephritis .", "tokens": ["This", "article", "describes", "a", "patient", "with", "suspected", "ciprofloxacin", "-", "induced", "interstitial", "nephritis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> interstitial nephritis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "induced", "args": [{"type": "subject", "offset": [3, 4], "text": "a patient"}, {"type": "treatment", "offset": [7], "text": "ciprofloxacin"}, {"type": "drug", "offset": [7], "text": "ciprofloxacin"}, {"type": "effect", "offset": [10, 11], "text": "interstitial nephritis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "ciprofloxacin"], ["drug", "ciprofloxacin"], ["effect", "interstitial nephritis"]]}]}
{"text_id": "12656748_1", "text": "A 58 - yr - old male patient with essential thrombocythaemia ( ET ) developed chronic myeloid leukaemia ( CML ) after continuous uneventful treatment with hydroxyurea for 18 yr .", "tokens": ["A", "58", "-", "yr", "-", "old", "male", "patient", "with", "essential", "thrombocythaemia", "(", "ET", ")", "developed", "chronic", "myeloid", "leukaemia", "(", "CML", ")", "after", "continuous", "uneventful", "treatment", "with", "hydroxyurea", "for", "18", "yr", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 58 - yr - old male patient with essential thrombocythaemia ( ET ) <extra_id_1> <extra_id_0> age <extra_id_5> 58 - yr - old <extra_id_1> <extra_id_0> gender <extra_id_5> male <extra_id_1> <extra_id_0> subject disorder <extra_id_5> essential thrombocythaemia ( ET ) <extra_id_1> <extra_id_0> treatment <extra_id_5> continuous uneventful treatment with hydroxyurea for 18 yr <extra_id_1> <extra_id_0> drug <extra_id_5> hydroxyurea <extra_id_1> <extra_id_0> duration <extra_id_5> 18 yr <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 18 yr <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> essential thrombocythaemia ( ET ) <extra_id_1> <extra_id_0> effect <extra_id_5> chronic myeloid leukaemia ( CML ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13], "text": "A 58 - yr - old male patient with essential thrombocythaemia ( ET )"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "58 - yr - old"}, {"type": "gender", "offset": [6], "text": "male"}, {"type": "subject disorder", "offset": [9, 10, 11, 12, 13], "text": "essential thrombocythaemia ( ET )"}, {"type": "treatment", "offset": [22, 23, 24, 25, 26, 27, 28, 29], "text": "continuous uneventful treatment with hydroxyurea for 18 yr"}, {"type": "drug", "offset": [26], "text": "hydroxyurea"}, {"type": "duration", "offset": [28, 29], "text": "18 yr"}, {"type": "time elapsed", "offset": [28, 29], "text": "18 yr"}, {"type": "treatment disorder", "offset": [9, 10, 11, 12, 13], "text": "essential thrombocythaemia ( ET )"}, {"type": "effect", "offset": [15, 16, 17, 18, 19, 20], "text": "chronic myeloid leukaemia ( CML )"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "duration", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 58 - yr - old male patient with essential thrombocythaemia ( ET )"], ["age", "58 - yr - old"], ["gender", "male"], ["subject disorder", "essential thrombocythaemia ( ET )"], ["treatment", "continuous uneventful treatment with hydroxyurea for 18 yr"], ["drug", "hydroxyurea"], ["duration", "18 yr"], ["time elapsed", "18 yr"], ["treatment disorder", "essential thrombocythaemia ( ET )"], ["effect", "chronic myeloid leukaemia ( CML )"]]}]}
{"text_id": "11424102_3", "text": "We describe a case of needle - track cutaneous seeding of hepatocellular carcinoma ( HCC ) after sonographically guided percutaneous ethanol injection ( PEI ) .", "tokens": ["We", "describe", "a", "case", "of", "needle", "-", "track", "cutaneous", "seeding", "of", "hepatocellular", "carcinoma", "(", "HCC", ")", "after", "sonographically", "guided", "percutaneous", "ethanol", "injection", "(", "PEI", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> sonographically guided percutaneous ethanol injection <extra_id_1> <extra_id_0> drug <extra_id_5> ethanol <extra_id_1> <extra_id_0> route <extra_id_5> injection <extra_id_1> <extra_id_0> effect <extra_id_5> needle - track cutaneous seeding of hepatocellular carcinoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "after", "args": [{"type": "treatment", "offset": [17, 18, 19, 20, 21], "text": "sonographically guided percutaneous ethanol injection"}, {"type": "drug", "offset": [20], "text": "ethanol"}, {"type": "route", "offset": [21], "text": "injection"}, {"type": "effect", "offset": [5, 6, 7, 8, 9, 10, 11, 12], "text": "needle - track cutaneous seeding of hepatocellular carcinoma"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "sonographically guided percutaneous ethanol injection"], ["drug", "ethanol"], ["route", "injection"], ["effect", "needle - track cutaneous seeding of hepatocellular carcinoma"]]}]}
{"text_id": "10755579_2", "text": "The medical examiner 's report indicated death caused by fluoxetine toxicity .", "tokens": ["The", "medical", "examiner", "'s", "report", "indicated", "death", "caused", "by", "fluoxetine", "toxicity", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> fluoxetine toxicity <extra_id_1> <extra_id_0> drug <extra_id_5> fluoxetine <extra_id_1> <extra_id_0> effect <extra_id_5> death <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "caused", "args": [{"type": "treatment", "offset": [9, 10], "text": "fluoxetine toxicity"}, {"type": "drug", "offset": [9], "text": "fluoxetine"}, {"type": "effect", "offset": [6], "text": "death"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "fluoxetine toxicity"], ["drug", "fluoxetine"], ["effect", "death"]]}]}
{"text_id": "16649344_3", "text": "Sirolimus works differently from the immunosuppressants currently available , and except for increased lipid levels , the adverse reaction profile of sirolimus does not appear to overlap to any great extent with that associated with cyclosporine or tacrolimus .", "tokens": ["Sirolimus", "works", "differently", "from", "the", "immunosuppressants", "currently", "available", ",", "and", "except", "for", "increased", "lipid", "levels", ",", "the", "adverse", "reaction", "profile", "of", "sirolimus", "does", "not", "appear", "to", "overlap", "to", "any", "great", "extent", "with", "that", "associated", "with", "cyclosporine", "or", "tacrolimus", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> for <extra_id_0> treatment <extra_id_5> Sirolimus works differently from the immunosuppressants currently available <extra_id_1> <extra_id_0> drug <extra_id_5> Sirolimus <extra_id_1> <extra_id_0> drug <extra_id_5> immunosuppressants <extra_id_1> <extra_id_0> drug <extra_id_5> sirolimus <extra_id_1> <extra_id_0> drug <extra_id_5> cyclosporine <extra_id_1> <extra_id_0> drug <extra_id_5> tacrolimus <extra_id_1> <extra_id_0> effect <extra_id_5> increased lipid levels <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "for", "args": [{"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Sirolimus works differently from the immunosuppressants currently available"}, {"type": "drug", "offset": [0], "text": "Sirolimus"}, {"type": "drug", "offset": [5], "text": "immunosuppressants"}, {"type": "drug", "offset": [21], "text": "sirolimus"}, {"type": "drug", "offset": [35], "text": "cyclosporine"}, {"type": "drug", "offset": [37], "text": "tacrolimus"}, {"type": "effect", "offset": [12, 13, 14], "text": "increased lipid levels"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "for", "label": "adverse event", "asoc": [["treatment", "Sirolimus works differently from the immunosuppressants currently available"], ["drug", "Sirolimus"], ["drug", "immunosuppressants"], ["drug", "sirolimus"], ["drug", "cyclosporine"], ["drug", "tacrolimus"], ["effect", "increased lipid levels"]]}]}
{"text_id": "15266150_2", "text": "Increased lash length , thickness , and pigmentation are well - documented side effects of prostaglandin analog glaucoma drops .", "tokens": ["Increased", "lash", "length", ",", "thickness", ",", "and", "pigmentation", "are", "well", "-", "documented", "side", "effects", "of", "prostaglandin", "analog", "glaucoma", "drops", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> are <extra_id_0> treatment <extra_id_5> prostaglandin analog glaucoma drops <extra_id_1> <extra_id_0> drug <extra_id_5> prostaglandin analog <extra_id_1> <extra_id_0> route <extra_id_5> drops <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> glaucoma <extra_id_1> <extra_id_0> effect <extra_id_5> Increased lash length , thickness , and pigmentation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "are", "args": [{"type": "treatment", "offset": [15, 16, 17, 18], "text": "prostaglandin analog glaucoma drops"}, {"type": "drug", "offset": [15, 16], "text": "prostaglandin analog"}, {"type": "route", "offset": [18], "text": "drops"}, {"type": "treatment disorder", "offset": [17], "text": "glaucoma"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Increased lash length , thickness , and pigmentation"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "treatment", "treatment disorder"], "spot_asoc": [{"span": "are", "label": "adverse event", "asoc": [["treatment", "prostaglandin analog glaucoma drops"], ["drug", "prostaglandin analog"], ["route", "drops"], ["treatment disorder", "glaucoma"], ["effect", "Increased lash length , thickness , and pigmentation"]]}]}
{"text_id": "11174414_1", "text": "Stevens - Johnson syndrome caused by the antiretroviral drug nevirapine .", "tokens": ["Stevens", "-", "Johnson", "syndrome", "caused", "by", "the", "antiretroviral", "drug", "nevirapine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused by <extra_id_0> treatment <extra_id_5> antiretroviral drug nevirapine <extra_id_1> <extra_id_0> drug <extra_id_5> nevirapine <extra_id_1> <extra_id_0> effect <extra_id_5> Stevens - Johnson syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4, 5], "text": "caused by", "args": [{"type": "treatment", "offset": [7, 8, 9], "text": "antiretroviral drug nevirapine"}, {"type": "drug", "offset": [9], "text": "nevirapine"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Stevens - Johnson syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "caused by", "label": "adverse event", "asoc": [["treatment", "antiretroviral drug nevirapine"], ["drug", "nevirapine"], ["effect", "Stevens - Johnson syndrome"]]}]}
{"text_id": "21751666_4", "text": "Post - exposure prophylaxis of H1N1 with oseltamivir was safe , effective and well tolerated to prevent H1N1 influenza A virus infection in newly transplanted renal allograft recipient receiving triple immunosuppression without any interaction with tacrolimus level .", "tokens": ["Post", "-", "exposure", "prophylaxis", "of", "H1N1", "with", "oseltamivir", "was", "safe", ",", "effective", "and", "well", "tolerated", "to", "prevent", "H1N1", "influenza", "A", "virus", "infection", "in", "newly", "transplanted", "renal", "allograft", "recipient", "receiving", "triple", "immunosuppression", "without", "any", "interaction", "with", "tacrolimus", "level", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> prophylaxis <extra_id_0> subject <extra_id_5> newly transplanted renal allograft recipient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> transplanted renal allograft <extra_id_1> <extra_id_0> subject disorder <extra_id_5> H1N1 <extra_id_1> <extra_id_0> treatment <extra_id_5> oseltamivir <extra_id_1> <extra_id_0> treatment <extra_id_5> without any interaction with tacrolimus level <extra_id_1> <extra_id_0> drug <extra_id_5> oseltamivir <extra_id_1> <extra_id_0> drug <extra_id_5> tacrolimus <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> H1N1 <extra_id_1> <extra_id_0> combination drug <extra_id_5> tacrolimus <extra_id_1> <extra_id_0> combination drug <extra_id_5> oseltamivir <extra_id_1> <extra_id_0> effect <extra_id_5> safe , effective and well tolerated to prevent H1N1 influenza A virus infection <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [3], "text": "prophylaxis", "args": [{"type": "subject", "offset": [23, 24, 25, 26, 27], "text": "newly transplanted renal allograft recipient"}, {"type": "subject disorder", "offset": [24, 25, 26], "text": "transplanted renal allograft"}, {"type": "subject disorder", "offset": [5], "text": "H1N1"}, {"type": "treatment", "offset": [7], "text": "oseltamivir"}, {"type": "treatment", "offset": [31, 32, 33, 34, 35, 36], "text": "without any interaction with tacrolimus level"}, {"type": "drug", "offset": [7], "text": "oseltamivir"}, {"type": "drug", "offset": [35], "text": "tacrolimus"}, {"type": "treatment disorder", "offset": [5], "text": "H1N1"}, {"type": "combination drug", "offset": [35], "text": "tacrolimus"}, {"type": "combination drug", "offset": [7], "text": "oseltamivir"}, {"type": "effect", "offset": [9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21], "text": "safe , effective and well tolerated to prevent H1N1 influenza A virus infection"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "subject", "treatment", "drug", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "prophylaxis", "label": "potential therapeutic event", "asoc": [["subject", "newly transplanted renal allograft recipient"], ["subject disorder", "transplanted renal allograft"], ["subject disorder", "H1N1"], ["treatment", "oseltamivir"], ["treatment", "without any interaction with tacrolimus level"], ["drug", "oseltamivir"], ["drug", "tacrolimus"], ["treatment disorder", "H1N1"], ["combination drug", "tacrolimus"], ["combination drug", "oseltamivir"], ["effect", "safe , effective and well tolerated to prevent H1N1 influenza A virus infection"]]}]}
{"text_id": "15866658_4", "text": "The side effects of MMF , such as bone marrow toxicity , have been reported .", "tokens": ["The", "side", "effects", "of", "MMF", ",", "such", "as", "bone", "marrow", "toxicity", ",", "have", "been", "reported", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> reported <extra_id_0> treatment <extra_id_5> MMF <extra_id_1> <extra_id_0> drug <extra_id_5> MMF <extra_id_1> <extra_id_0> effect <extra_id_5> bone marrow toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "reported", "args": [{"type": "treatment", "offset": [4], "text": "MMF"}, {"type": "drug", "offset": [4], "text": "MMF"}, {"type": "effect", "offset": [8, 9, 10], "text": "bone marrow toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "reported", "label": "adverse event", "asoc": [["treatment", "MMF"], ["drug", "MMF"], ["effect", "bone marrow toxicity"]]}]}
{"text_id": "19707032_4", "text": "CONCLUSIONS : Patients receiving intravitreal injections of bevacizumab should be evaluated for potential systemic risk factors such as carotid insufficiency , coagulopathy and poorly controlled diabetes mellitus .", "tokens": ["CONCLUSIONS", ":", "Patients", "receiving", "intravitreal", "injections", "of", "bevacizumab", "should", "be", "evaluated", "for", "potential", "systemic", "risk", "factors", "such", "as", "carotid", "insufficiency", ",", "coagulopathy", "and", "poorly", "controlled", "diabetes", "mellitus", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> risk <extra_id_0> treatment <extra_id_5> intravitreal injections of bevacizumab <extra_id_1> <extra_id_0> drug <extra_id_5> bevacizumab <extra_id_1> <extra_id_0> route <extra_id_5> intravitreal injections <extra_id_1> <extra_id_0> effect <extra_id_5> carotid insufficiency , coagulopathy and poorly controlled diabetes mellitus <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "risk", "args": [{"type": "treatment", "offset": [4, 5, 6, 7], "text": "intravitreal injections of bevacizumab"}, {"type": "drug", "offset": [7], "text": "bevacizumab"}, {"type": "route", "offset": [4, 5], "text": "intravitreal injections"}, {"type": "effect", "offset": [18, 19, 20, 21, 22, 23, 24, 25, 26], "text": "carotid insufficiency , coagulopathy and poorly controlled diabetes mellitus"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "risk", "label": "adverse event", "asoc": [["treatment", "intravitreal injections of bevacizumab"], ["drug", "bevacizumab"], ["route", "intravitreal injections"], ["effect", "carotid insufficiency , coagulopathy and poorly controlled diabetes mellitus"]]}]}
{"text_id": "7661076_1", "text": "Evidence is shown in this report that adenosine was associated with dangerous worsening of arrhythmia in patients with atrial flutter .", "tokens": ["Evidence", "is", "shown", "in", "this", "report", "that", "adenosine", "was", "associated", "with", "dangerous", "worsening", "of", "arrhythmia", "in", "patients", "with", "atrial", "flutter", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> patients with atrial flutter <extra_id_1> <extra_id_0> subject disorder <extra_id_5> atrial flutter . <extra_id_1> <extra_id_0> treatment <extra_id_5> adenosine <extra_id_1> <extra_id_0> drug <extra_id_5> adenosine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> atrial flutter . <extra_id_1> <extra_id_0> effect <extra_id_5> dangerous worsening of arrhythmia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "associated", "args": [{"type": "subject", "offset": [16, 17, 18, 19], "text": "patients with atrial flutter"}, {"type": "subject disorder", "offset": [18, 19, 20], "text": "atrial flutter ."}, {"type": "treatment", "offset": [7], "text": "adenosine"}, {"type": "drug", "offset": [7], "text": "adenosine"}, {"type": "treatment disorder", "offset": [18, 19, 20], "text": "atrial flutter ."}, {"type": "effect", "offset": [11, 12, 13, 14], "text": "dangerous worsening of arrhythmia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "patients with atrial flutter"], ["subject disorder", "atrial flutter ."], ["treatment", "adenosine"], ["drug", "adenosine"], ["treatment disorder", "atrial flutter ."], ["effect", "dangerous worsening of arrhythmia"]]}]}
{"text_id": "15920338_2", "text": "High - grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer .", "tokens": ["High", "-", "grade", "endometrial", "stromal", "sarcoma", "after", "tamoxifen", "therapy", "for", "breast", "cancer", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> drug <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> breast cancer <extra_id_1> <extra_id_0> effect <extra_id_5> High - grade endometrial stromal sarcoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "after", "args": [{"type": "treatment", "offset": [7], "text": "tamoxifen"}, {"type": "drug", "offset": [7], "text": "tamoxifen"}, {"type": "treatment disorder", "offset": [10, 11], "text": "breast cancer"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "High - grade endometrial stromal sarcoma"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "tamoxifen"], ["drug", "tamoxifen"], ["treatment disorder", "breast cancer"], ["effect", "High - grade endometrial stromal sarcoma"]]}]}
{"text_id": "1642627_1", "text": "A combination of behavioural and cognitive adverse effects is illustrated in this case report of a recurrent triazolam - induced eating disorder .", "tokens": ["A", "combination", "of", "behavioural", "and", "cognitive", "adverse", "effects", "is", "illustrated", "in", "this", "case", "report", "of", "a", "recurrent", "triazolam", "-", "induced", "eating", "disorder", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> triazolam <extra_id_1> <extra_id_0> drug <extra_id_5> triazolam <extra_id_1> <extra_id_0> effect <extra_id_5> eating disorder <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "induced", "args": [{"type": "treatment", "offset": [17], "text": "triazolam"}, {"type": "drug", "offset": [17], "text": "triazolam"}, {"type": "effect", "offset": [20, 21], "text": "eating disorder"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "triazolam"], ["drug", "triazolam"], ["effect", "eating disorder"]]}]}
{"text_id": "17228132_6", "text": "CONCLUSIONS : Acute severe hepatitis though rare is occasionally observed with EGFR inhibitors gefitinib or erlotinib .", "tokens": ["CONCLUSIONS", ":", "Acute", "severe", "hepatitis", "though", "rare", "is", "occasionally", "observed", "with", "EGFR", "inhibitors", "gefitinib", "or", "erlotinib", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> observed <extra_id_0> treatment <extra_id_5> EGFR inhibitors gefitinib or erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> gefitinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> effect <extra_id_5> Acute severe hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "observed", "args": [{"type": "treatment", "offset": [11, 12, 13, 14, 15], "text": "EGFR inhibitors gefitinib or erlotinib"}, {"type": "drug", "offset": [13], "text": "gefitinib"}, {"type": "drug", "offset": [15], "text": "erlotinib"}, {"type": "effect", "offset": [2, 3, 4], "text": "Acute severe hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "observed", "label": "adverse event", "asoc": [["treatment", "EGFR inhibitors gefitinib or erlotinib"], ["drug", "gefitinib"], ["drug", "erlotinib"], ["effect", "Acute severe hepatitis"]]}]}
{"text_id": "17420198_9", "text": "Aripiprazole , 5 mg daily , was initiated in November 2004 as an augmentation strategy for the diagnosis of OCD .", "tokens": ["Aripiprazole", ",", "5", "mg", "daily", ",", "was", "initiated", "in", "November", "2004", "as", "an", "augmentation", "strategy", "for", "the", "diagnosis", "of", "OCD", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> augmentation <extra_id_0> treatment <extra_id_5> Aripiprazole <extra_id_1> <extra_id_0> treatment <extra_id_5> 5 mg daily <extra_id_1> <extra_id_0> drug <extra_id_5> Aripiprazole <extra_id_1> <extra_id_0> dosage <extra_id_5> 5 mg <extra_id_1> <extra_id_0> frequency <extra_id_5> daily <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> OCD <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [13], "text": "augmentation", "args": [{"type": "treatment", "offset": [0], "text": "Aripiprazole"}, {"type": "treatment", "offset": [2, 3, 4], "text": "5 mg daily"}, {"type": "drug", "offset": [0], "text": "Aripiprazole"}, {"type": "dosage", "offset": [2, 3], "text": "5 mg"}, {"type": "frequency", "offset": [4], "text": "daily"}, {"type": "treatment disorder", "offset": [19], "text": "OCD"}]}], "spot": ["potential therapeutic event"], "asoc": ["drug", "frequency", "dosage", "treatment disorder", "treatment"], "spot_asoc": [{"span": "augmentation", "label": "potential therapeutic event", "asoc": [["treatment", "Aripiprazole"], ["treatment", "5 mg daily"], ["drug", "Aripiprazole"], ["dosage", "5 mg"], ["frequency", "daily"], ["treatment disorder", "OCD"]]}]}
{"text_id": "16641839_3", "text": "Cutaneous eruptions occur in 3 % of individuals administered carbamazepine .", "tokens": ["Cutaneous", "eruptions", "occur", "in", "3", "%", "of", "individuals", "administered", "carbamazepine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occur <extra_id_0> treatment <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> effect <extra_id_5> Cutaneous eruptions <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "occur", "args": [{"type": "treatment", "offset": [9], "text": "carbamazepine"}, {"type": "drug", "offset": [9], "text": "carbamazepine"}, {"type": "effect", "offset": [0, 1], "text": "Cutaneous eruptions"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "occur", "label": "adverse event", "asoc": [["treatment", "carbamazepine"], ["drug", "carbamazepine"], ["effect", "Cutaneous eruptions"]]}]}
{"text_id": "12126225_1", "text": "A 53 - year - old man developed lower leg edema 4 weeks after rosiglitazone was increased from 4 mg once / day to 4 mg twice / day .", "tokens": ["A", "53", "-", "year", "-", "old", "man", "developed", "lower", "leg", "edema", "4", "weeks", "after", "rosiglitazone", "was", "increased", "from", "4", "mg", "once", "/", "day", "to", "4", "mg", "twice", "/", "day", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> A 53 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 53 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> 4 weeks after rosiglitazone was increased from 4 mg once / day to 4 mg twice / day <extra_id_1> <extra_id_0> drug <extra_id_5> rosiglitazone <extra_id_1> <extra_id_0> dosage <extra_id_5> 4 mg <extra_id_1> <extra_id_0> frequency <extra_id_5> twice / day <extra_id_1> <extra_id_0> duration <extra_id_5> 4 weeks <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 4 weeks <extra_id_1> <extra_id_0> effect <extra_id_5> lower leg edema <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "after", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "A 53 - year - old man"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "53 - year - old"}, {"type": "gender", "offset": [6], "text": "man"}, {"type": "treatment", "offset": [11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28], "text": "4 weeks after rosiglitazone was increased from 4 mg once / day to 4 mg twice / day"}, {"type": "drug", "offset": [14], "text": "rosiglitazone"}, {"type": "dosage", "offset": [24, 25], "text": "4 mg"}, {"type": "frequency", "offset": [26, 27, 28], "text": "twice / day"}, {"type": "duration", "offset": [11, 12], "text": "4 weeks"}, {"type": "time elapsed", "offset": [11, 12], "text": "4 weeks"}, {"type": "effect", "offset": [8, 9, 10], "text": "lower leg edema"}]}], "spot": ["adverse event"], "asoc": ["dosage", "time elapsed", "duration", "effect", "subject", "gender", "frequency", "drug", "age", "treatment"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "A 53 - year - old man"], ["age", "53 - year - old"], ["gender", "man"], ["treatment", "4 weeks after rosiglitazone was increased from 4 mg once / day to 4 mg twice / day"], ["drug", "rosiglitazone"], ["dosage", "4 mg"], ["frequency", "twice / day"], ["duration", "4 weeks"], ["time elapsed", "4 weeks"], ["effect", "lower leg edema"]]}]}
{"text_id": "16863495_1", "text": "Olanzapine - associated neuroleptic malignant syndrome .", "tokens": ["Olanzapine", "-", "associated", "neuroleptic", "malignant", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Olanzapine <extra_id_1> <extra_id_0> drug <extra_id_5> Olanzapine <extra_id_1> <extra_id_0> effect <extra_id_5> neuroleptic malignant syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Olanzapine"}, {"type": "drug", "offset": [0], "text": "Olanzapine"}, {"type": "effect", "offset": [3, 4, 5], "text": "neuroleptic malignant syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Olanzapine"], ["drug", "Olanzapine"], ["effect", "neuroleptic malignant syndrome"]]}]}
{"text_id": "18717612_2", "text": "FDE from cephalosporins has been rarely reported , and to the best of our knowledge there is no published report of ceftriaxone - induced FDE in the literature .", "tokens": ["FDE", "from", "cephalosporins", "has", "been", "rarely", "reported", ",", "and", "to", "the", "best", "of", "our", "knowledge", "there", "is", "no", "published", "report", "of", "ceftriaxone", "-", "induced", "FDE", "in", "the", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> from <extra_id_0> treatment <extra_id_5> cephalosporins <extra_id_1> <extra_id_0> drug <extra_id_5> cephalosporins <extra_id_1> <extra_id_0> effect <extra_id_5> FDE <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> ceftriaxone <extra_id_1> <extra_id_0> drug <extra_id_5> ceftriaxone <extra_id_1> <extra_id_0> effect <extra_id_5> FDE <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "from", "args": [{"type": "treatment", "offset": [2], "text": "cephalosporins"}, {"type": "drug", "offset": [2], "text": "cephalosporins"}, {"type": "effect", "offset": [0], "text": "FDE"}]}, {"type": "adverse event", "offset": [23], "text": "induced", "args": [{"type": "treatment", "offset": [21], "text": "ceftriaxone"}, {"type": "drug", "offset": [21], "text": "ceftriaxone"}, {"type": "effect", "offset": [24], "text": "FDE"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "from", "label": "adverse event", "asoc": [["treatment", "cephalosporins"], ["drug", "cephalosporins"], ["effect", "FDE"]]}, {"span": "induced", "label": "adverse event", "asoc": [["treatment", "ceftriaxone"], ["drug", "ceftriaxone"], ["effect", "FDE"]]}]}
{"text_id": "18020545_2", "text": "Tardive oculogyric crisis during treatment with clozapine : report of three cases .", "tokens": ["Tardive", "oculogyric", "crisis", "during", "treatment", "with", "clozapine", ":", "report", "of", "three", "cases", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> with <extra_id_0> subject <extra_id_5> three cases <extra_id_1> <extra_id_0> population <extra_id_5> three <extra_id_1> <extra_id_0> treatment <extra_id_5> clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> effect <extra_id_5> Tardive oculogyric crisis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "with", "args": [{"type": "subject", "offset": [10, 11], "text": "three cases"}, {"type": "population", "offset": [10], "text": "three"}, {"type": "treatment", "offset": [6], "text": "clozapine"}, {"type": "drug", "offset": [6], "text": "clozapine"}, {"type": "effect", "offset": [0, 1, 2], "text": "Tardive oculogyric crisis"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "with", "label": "adverse event", "asoc": [["subject", "three cases"], ["population", "three"], ["treatment", "clozapine"], ["drug", "clozapine"], ["effect", "Tardive oculogyric crisis"]]}]}
{"text_id": "8530331_1", "text": "Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson 's disease and other akinetic - rigid syndromes .", "tokens": ["Risperidone", "versus", "clozapine", "in", "the", "treatment", "of", "psychosis", "in", "six", "patients", "with", "Parkinson", "'s", "disease", "and", "other", "akinetic", "-", "rigid", "syndromes", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> subject <extra_id_5> six patients with Parkinson 's disease and other akinetic - rigid syndromes <extra_id_1> <extra_id_0> population <extra_id_5> six <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Parkinson 's disease <extra_id_1> <extra_id_0> subject disorder <extra_id_5> akinetic - rigid syndromes <extra_id_1> <extra_id_0> subject disorder <extra_id_5> psychosis <extra_id_1> <extra_id_0> treatment <extra_id_5> Risperidone versus clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> Risperidone <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> psychosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [5], "text": "treatment", "args": [{"type": "subject", "offset": [9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "six patients with Parkinson 's disease and other akinetic - rigid syndromes"}, {"type": "population", "offset": [9], "text": "six"}, {"type": "subject disorder", "offset": [12, 13, 14], "text": "Parkinson 's disease"}, {"type": "subject disorder", "offset": [17, 18, 19, 20], "text": "akinetic - rigid syndromes"}, {"type": "subject disorder", "offset": [7], "text": "psychosis"}, {"type": "treatment", "offset": [0, 1, 2], "text": "Risperidone versus clozapine"}, {"type": "drug", "offset": [0], "text": "Risperidone"}, {"type": "drug", "offset": [2], "text": "clozapine"}, {"type": "treatment disorder", "offset": [7], "text": "psychosis"}]}], "spot": ["potential therapeutic event"], "asoc": ["population", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["subject", "six patients with Parkinson 's disease and other akinetic - rigid syndromes"], ["population", "six"], ["subject disorder", "Parkinson 's disease"], ["subject disorder", "akinetic - rigid syndromes"], ["subject disorder", "psychosis"], ["treatment", "Risperidone versus clozapine"], ["drug", "Risperidone"], ["drug", "clozapine"], ["treatment disorder", "psychosis"]]}]}
{"text_id": "21712512_6", "text": "Three days after starting fluconazole , she developed polyuria and polydipsia and was found to have severe hyperglycemia , which led to the diagnosis of Cushing syndrome .", "tokens": ["Three", "days", "after", "starting", "fluconazole", ",", "she", "developed", "polyuria", "and", "polydipsia", "and", "was", "found", "to", "have", "severe", "hyperglycemia", ",", "which", "led", "to", "the", "diagnosis", "of", "Cushing", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> treatment <extra_id_5> Three days after starting fluconazole <extra_id_1> <extra_id_0> drug <extra_id_5> fluconazole <extra_id_1> <extra_id_0> duration <extra_id_5> Three days <extra_id_1> <extra_id_0> time elapsed <extra_id_5> Three days <extra_id_1> <extra_id_0> effect <extra_id_5> polyuria and polydipsia and was found to have severe hyperglycemia , which led to the diagnosis of Cushing syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "developed", "args": [{"type": "treatment", "offset": [0, 1, 2, 3, 4], "text": "Three days after starting fluconazole"}, {"type": "drug", "offset": [4], "text": "fluconazole"}, {"type": "duration", "offset": [0, 1], "text": "Three days"}, {"type": "time elapsed", "offset": [0, 1], "text": "Three days"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26], "text": "polyuria and polydipsia and was found to have severe hyperglycemia , which led to the diagnosis of Cushing syndrome"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "drug", "time elapsed", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["treatment", "Three days after starting fluconazole"], ["drug", "fluconazole"], ["duration", "Three days"], ["time elapsed", "Three days"], ["effect", "polyuria and polydipsia and was found to have severe hyperglycemia , which led to the diagnosis of Cushing syndrome"]]}]}
{"text_id": "8979664_2", "text": "over the past 3 years there have been several reports of uveitis associated with rifabutin therapy .", "tokens": ["over", "the", "past", "3", "years", "there", "have", "been", "several", "reports", "of", "uveitis", "associated", "with", "rifabutin", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> rifabutin therapy <extra_id_1> <extra_id_0> drug <extra_id_5> rifabutin <extra_id_1> <extra_id_0> effect <extra_id_5> uveitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "associated", "args": [{"type": "treatment", "offset": [14, 15], "text": "rifabutin therapy"}, {"type": "drug", "offset": [14], "text": "rifabutin"}, {"type": "effect", "offset": [11], "text": "uveitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "rifabutin therapy"], ["drug", "rifabutin"], ["effect", "uveitis"]]}]}
{"text_id": "9796135_2", "text": "Elderly patients for whom nitrate has been prescribed should be warned of the occurrence of hypotension , leading to unconsciousness .", "tokens": ["Elderly", "patients", "for", "whom", "nitrate", "has", "been", "prescribed", "should", "be", "warned", "of", "the", "occurrence", "of", "hypotension", ",", "leading", "to", "unconsciousness", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurrence <extra_id_0> subject <extra_id_5> Elderly patients <extra_id_1> <extra_id_0> age <extra_id_5> Elderly <extra_id_1> <extra_id_0> treatment <extra_id_5> nitrate <extra_id_1> <extra_id_0> drug <extra_id_5> nitrate <extra_id_1> <extra_id_0> effect <extra_id_5> hypotension <extra_id_1> <extra_id_0> effect <extra_id_5> unconsciousness <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "occurrence", "args": [{"type": "subject", "offset": [0, 1], "text": "Elderly patients"}, {"type": "age", "offset": [0], "text": "Elderly"}, {"type": "treatment", "offset": [4], "text": "nitrate"}, {"type": "drug", "offset": [4], "text": "nitrate"}, {"type": "effect", "offset": [15], "text": "hypotension"}, {"type": "effect", "offset": [19], "text": "unconsciousness"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "occurrence", "label": "adverse event", "asoc": [["subject", "Elderly patients"], ["age", "Elderly"], ["treatment", "nitrate"], ["drug", "nitrate"], ["effect", "hypotension"], ["effect", "unconsciousness"]]}]}
{"text_id": "6860059_1", "text": "Fulminant hepatitis associated with disulfiram .", "tokens": ["Fulminant", "hepatitis", "associated", "with", "disulfiram", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> disulfiram <extra_id_1> <extra_id_0> drug <extra_id_5> disulfiram <extra_id_1> <extra_id_0> effect <extra_id_5> Fulminant hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [4], "text": "disulfiram"}, {"type": "drug", "offset": [4], "text": "disulfiram"}, {"type": "effect", "offset": [0, 1], "text": "Fulminant hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "disulfiram"], ["drug", "disulfiram"], ["effect", "Fulminant hepatitis"]]}]}
{"text_id": "19725909_1", "text": "Favorable outcome of de novo hepatitis B infection after liver transplantation with lamivudine and adefovir therapy .", "tokens": ["Favorable", "outcome", "of", "de", "novo", "hepatitis", "B", "infection", "after", "liver", "transplantation", "with", "lamivudine", "and", "adefovir", "therapy", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> outcome <extra_id_0> treatment <extra_id_5> after liver transplantation with lamivudine and adefovir therapy <extra_id_1> <extra_id_0> drug <extra_id_5> lamivudine <extra_id_1> <extra_id_0> drug <extra_id_5> adefovir <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hepatitis B infection <extra_id_1> <extra_id_0> combination drug <extra_id_5> lamivudine <extra_id_1> <extra_id_0> combination drug <extra_id_5> adefovir <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [1], "text": "outcome", "args": [{"type": "treatment", "offset": [8, 9, 10, 11, 12, 13, 14, 15], "text": "after liver transplantation with lamivudine and adefovir therapy"}, {"type": "drug", "offset": [12], "text": "lamivudine"}, {"type": "drug", "offset": [14], "text": "adefovir"}, {"type": "treatment disorder", "offset": [5, 6, 7], "text": "hepatitis B infection"}, {"type": "combination drug", "offset": [12], "text": "lamivudine"}, {"type": "combination drug", "offset": [14], "text": "adefovir"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "combination drug", "drug", "treatment disorder"], "spot_asoc": [{"span": "outcome", "label": "potential therapeutic event", "asoc": [["treatment", "after liver transplantation with lamivudine and adefovir therapy"], ["drug", "lamivudine"], ["drug", "adefovir"], ["treatment disorder", "hepatitis B infection"], ["combination drug", "lamivudine"], ["combination drug", "adefovir"]]}]}
{"text_id": "12135176_3", "text": "We describe two cases of PSVT that changed to non - sustained polymorphic ventricular tachycardia after administration of verapamil .", "tokens": ["We", "describe", "two", "cases", "of", "PSVT", "that", "changed", "to", "non", "-", "sustained", "polymorphic", "ventricular", "tachycardia", "after", "administration", "of", "verapamil", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> changed <extra_id_0> subject <extra_id_5> two cases of PSVT <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> PSVT <extra_id_1> <extra_id_0> treatment <extra_id_5> administration of verapamil . <extra_id_1> <extra_id_0> drug <extra_id_5> verapamil <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> PSVT <extra_id_1> <extra_id_0> effect <extra_id_5> non - sustained polymorphic ventricular tachycardia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "changed", "args": [{"type": "subject", "offset": [2, 3, 4, 5], "text": "two cases of PSVT"}, {"type": "population", "offset": [2], "text": "two"}, {"type": "subject disorder", "offset": [5], "text": "PSVT"}, {"type": "treatment", "offset": [16, 17, 18, 19], "text": "administration of verapamil ."}, {"type": "drug", "offset": [18], "text": "verapamil"}, {"type": "treatment disorder", "offset": [5], "text": "PSVT"}, {"type": "effect", "offset": [9, 10, 11, 12, 13, 14], "text": "non - sustained polymorphic ventricular tachycardia"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "changed", "label": "adverse event", "asoc": [["subject", "two cases of PSVT"], ["population", "two"], ["subject disorder", "PSVT"], ["treatment", "administration of verapamil ."], ["drug", "verapamil"], ["treatment disorder", "PSVT"], ["effect", "non - sustained polymorphic ventricular tachycardia"]]}]}
{"text_id": "24791374_2", "text": "We describe a rare case of severe drug - drug interaction between propafenone and mirtazapine leading to propafenone toxicity .", "tokens": ["We", "describe", "a", "rare", "case", "of", "severe", "drug", "-", "drug", "interaction", "between", "propafenone", "and", "mirtazapine", "leading", "to", "propafenone", "toxicity", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> leading <extra_id_0> subject <extra_id_5> a rare case <extra_id_1> <extra_id_0> treatment <extra_id_5> propafenone and mirtazapine <extra_id_1> <extra_id_0> drug <extra_id_5> propafenone <extra_id_1> <extra_id_0> drug <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> combination drug <extra_id_5> propafenone <extra_id_1> <extra_id_0> combination drug <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> effect <extra_id_5> propafenone toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "leading", "args": [{"type": "subject", "offset": [2, 3, 4], "text": "a rare case"}, {"type": "treatment", "offset": [12, 13, 14], "text": "propafenone and mirtazapine"}, {"type": "drug", "offset": [12], "text": "propafenone"}, {"type": "drug", "offset": [14], "text": "mirtazapine"}, {"type": "combination drug", "offset": [12], "text": "propafenone"}, {"type": "combination drug", "offset": [14], "text": "mirtazapine"}, {"type": "effect", "offset": [17, 18], "text": "propafenone toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "leading", "label": "adverse event", "asoc": [["subject", "a rare case"], ["treatment", "propafenone and mirtazapine"], ["drug", "propafenone"], ["drug", "mirtazapine"], ["combination drug", "propafenone"], ["combination drug", "mirtazapine"], ["effect", "propafenone toxicity"]]}]}
{"text_id": "10084639_1", "text": "BACKGROUND : How to best treat psychotic patients who have had past clozapine - induced agranulocytosis or granulocytopenia remains a problem .", "tokens": ["BACKGROUND", ":", "How", "to", "best", "treat", "psychotic", "patients", "who", "have", "had", "past", "clozapine", "-", "induced", "agranulocytosis", "or", "granulocytopenia", "remains", "a", "problem", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> psychotic patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> psychotic <extra_id_1> <extra_id_0> treatment <extra_id_5> clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> psychotic <extra_id_1> <extra_id_0> effect <extra_id_5> agranulocytosis or granulocytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "induced", "args": [{"type": "subject", "offset": [6, 7], "text": "psychotic patients"}, {"type": "subject disorder", "offset": [6], "text": "psychotic"}, {"type": "treatment", "offset": [12], "text": "clozapine"}, {"type": "drug", "offset": [12], "text": "clozapine"}, {"type": "treatment disorder", "offset": [6], "text": "psychotic"}, {"type": "effect", "offset": [15, 16, 17], "text": "agranulocytosis or granulocytopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "psychotic patients"], ["subject disorder", "psychotic"], ["treatment", "clozapine"], ["drug", "clozapine"], ["treatment disorder", "psychotic"], ["effect", "agranulocytosis or granulocytopenia"]]}]}
{"text_id": "19382926_6", "text": "A drug interaction between the alpha(2) - adrenergic agonist medetomidine and lignocaine is suspected and highlights the potential for seizures following the subcutaneous administration of relatively large doses of lignocaine under medetomidine sedation .", "tokens": ["A", "drug", "interaction", "between", "the", "alpha(2)", "-", "adrenergic", "agonist", "medetomidine", "and", "lignocaine", "is", "suspected", "and", "highlights", "the", "potential", "for", "seizures", "following", "the", "subcutaneous", "administration", "of", "relatively", "large", "doses", "of", "lignocaine", "under", "medetomidine", "sedation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> subcutaneous administration of relatively large doses of lignocaine under medetomidine sedation <extra_id_1> <extra_id_0> drug <extra_id_5> lignocaine <extra_id_1> <extra_id_0> drug <extra_id_5> medetomidine <extra_id_1> <extra_id_0> route <extra_id_5> subcutaneous <extra_id_1> <extra_id_0> combination drug <extra_id_5> medetomidine <extra_id_1> <extra_id_0> combination drug <extra_id_5> lignocaine <extra_id_1> <extra_id_0> effect <extra_id_5> seizures <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "following", "args": [{"type": "treatment", "offset": [22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32], "text": "subcutaneous administration of relatively large doses of lignocaine under medetomidine sedation"}, {"type": "drug", "offset": [29], "text": "lignocaine"}, {"type": "drug", "offset": [31], "text": "medetomidine"}, {"type": "route", "offset": [22], "text": "subcutaneous"}, {"type": "combination drug", "offset": [31], "text": "medetomidine"}, {"type": "combination drug", "offset": [29], "text": "lignocaine"}, {"type": "effect", "offset": [19], "text": "seizures"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "subcutaneous administration of relatively large doses of lignocaine under medetomidine sedation"], ["drug", "lignocaine"], ["drug", "medetomidine"], ["route", "subcutaneous"], ["combination drug", "medetomidine"], ["combination drug", "lignocaine"], ["effect", "seizures"]]}]}
{"text_id": "17122225_4", "text": "We report two cases of severe serotonin syndrome induced by the administration of cyclobenzaprine in postoperative patients already receiving another proserotoninergic drug ( phenelzine in one case and duloxetine in the other ) .", "tokens": ["We", "report", "two", "cases", "of", "severe", "serotonin", "syndrome", "induced", "by", "the", "administration", "of", "cyclobenzaprine", "in", "postoperative", "patients", "already", "receiving", "another", "proserotoninergic", "drug", "(", "phenelzine", "in", "one", "case", "and", "duloxetine", "in", "the", "other", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> postoperative patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> postoperative <extra_id_1> <extra_id_0> treatment <extra_id_5> cyclobenzaprine <extra_id_1> <extra_id_0> treatment <extra_id_5> duloxetine <extra_id_1> <extra_id_0> drug <extra_id_5> duloxetine <extra_id_1> <extra_id_0> combination drug <extra_id_5> cyclobenzaprine <extra_id_1> <extra_id_0> combination drug <extra_id_5> duloxetine <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin syndrome <extra_id_1> <extra_id_0> subject <extra_id_5> postoperative patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> postoperative <extra_id_1> <extra_id_0> treatment <extra_id_5> cyclobenzaprine <extra_id_1> <extra_id_0> treatment <extra_id_5> phenelzine <extra_id_1> <extra_id_0> drug <extra_id_5> cyclobenzaprine <extra_id_1> <extra_id_0> drug <extra_id_5> phenelzine <extra_id_1> <extra_id_0> combination drug <extra_id_5> cyclobenzaprine <extra_id_1> <extra_id_0> combination drug <extra_id_5> phenelzine <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "induced", "args": [{"type": "subject", "offset": [15, 16], "text": "postoperative patients"}, {"type": "subject disorder", "offset": [15], "text": "postoperative"}, {"type": "treatment", "offset": [13], "text": "cyclobenzaprine"}, {"type": "treatment", "offset": [28], "text": "duloxetine"}, {"type": "drug", "offset": [28], "text": "duloxetine"}, {"type": "combination drug", "offset": [13], "text": "cyclobenzaprine"}, {"type": "combination drug", "offset": [28], "text": "duloxetine"}, {"type": "effect", "offset": [6, 7], "text": "serotonin syndrome"}]}, {"type": "adverse event", "offset": [8], "text": "induced", "args": [{"type": "subject", "offset": [15, 16], "text": "postoperative patients"}, {"type": "subject disorder", "offset": [15], "text": "postoperative"}, {"type": "treatment", "offset": [13], "text": "cyclobenzaprine"}, {"type": "treatment", "offset": [23], "text": "phenelzine"}, {"type": "drug", "offset": [13], "text": "cyclobenzaprine"}, {"type": "drug", "offset": [23], "text": "phenelzine"}, {"type": "combination drug", "offset": [13], "text": "cyclobenzaprine"}, {"type": "combination drug", "offset": [23], "text": "phenelzine"}, {"type": "effect", "offset": [6, 7], "text": "serotonin syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "combination drug", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "postoperative patients"], ["subject disorder", "postoperative"], ["treatment", "cyclobenzaprine"], ["treatment", "duloxetine"], ["drug", "duloxetine"], ["combination drug", "cyclobenzaprine"], ["combination drug", "duloxetine"], ["effect", "serotonin syndrome"], ["subject", "postoperative patients"], ["subject disorder", "postoperative"], ["treatment", "cyclobenzaprine"], ["treatment", "phenelzine"], ["drug", "cyclobenzaprine"], ["drug", "phenelzine"], ["combination drug", "cyclobenzaprine"], ["combination drug", "phenelzine"], ["effect", "serotonin syndrome"]]}]}
{"text_id": "19995222_2", "text": "CONCLUSIONS : These results suggest that clozapine may cause TD ; however , the prevalence is low and the severity is relatively mild , with no or mild self - reported discomfort .", "tokens": ["CONCLUSIONS", ":", "These", "results", "suggest", "that", "clozapine", "may", "cause", "TD", ";", "however", ",", "the", "prevalence", "is", "low", "and", "the", "severity", "is", "relatively", "mild", ",", "with", "no", "or", "mild", "self", "-", "reported", "discomfort", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> effect <extra_id_5> TD <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "cause", "args": [{"type": "treatment", "offset": [6], "text": "clozapine"}, {"type": "drug", "offset": [6], "text": "clozapine"}, {"type": "effect", "offset": [9], "text": "TD"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "clozapine"], ["drug", "clozapine"], ["effect", "TD"]]}]}
{"text_id": "18176653_4", "text": "CASE REPORT : A 29 - year - old black man , HIV - infected since 1996 , began highly active antiretroviral therapy ( HAART ) with zidovudine , lamivudine , and indinavir .", "tokens": ["CASE", "REPORT", ":", "A", "29", "-", "year", "-", "old", "black", "man", ",", "HIV", "-", "infected", "since", "1996", ",", "began", "highly", "active", "antiretroviral", "therapy", "(", "HAART", ")", "with", "zidovudine", ",", "lamivudine", ",", "and", "indinavir", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> began <extra_id_0> subject <extra_id_5> A 29 - year - old black man , HIV - infected since 1996 <extra_id_1> <extra_id_0> age <extra_id_5> 29 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> race <extra_id_5> black <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> treatment <extra_id_5> highly active antiretroviral therapy ( HAART ) with zidovudine , lamivudine , and indinavir <extra_id_1> <extra_id_0> drug <extra_id_5> zidovudine <extra_id_1> <extra_id_0> drug <extra_id_5> lamivudine <extra_id_1> <extra_id_0> drug <extra_id_5> indinavir <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> combination drug <extra_id_5> zidovudine <extra_id_1> <extra_id_0> combination drug <extra_id_5> lamivudine <extra_id_1> <extra_id_0> combination drug <extra_id_5> indinavir <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [18], "text": "began", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16], "text": "A 29 - year - old black man , HIV - infected since 1996"}, {"type": "age", "offset": [4, 5, 6, 7, 8], "text": "29 - year - old"}, {"type": "gender", "offset": [10], "text": "man"}, {"type": "race", "offset": [9], "text": "black"}, {"type": "subject disorder", "offset": [12], "text": "HIV"}, {"type": "treatment", "offset": [19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32], "text": "highly active antiretroviral therapy ( HAART ) with zidovudine , lamivudine , and indinavir"}, {"type": "drug", "offset": [27], "text": "zidovudine"}, {"type": "drug", "offset": [29], "text": "lamivudine"}, {"type": "drug", "offset": [32], "text": "indinavir"}, {"type": "treatment disorder", "offset": [12], "text": "HIV"}, {"type": "combination drug", "offset": [27], "text": "zidovudine"}, {"type": "combination drug", "offset": [29], "text": "lamivudine"}, {"type": "combination drug", "offset": [32], "text": "indinavir"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment disorder", "drug", "gender", "treatment", "combination drug", "age", "subject disorder", "race"], "spot_asoc": [{"span": "began", "label": "potential therapeutic event", "asoc": [["subject", "A 29 - year - old black man , HIV - infected since 1996"], ["age", "29 - year - old"], ["gender", "man"], ["race", "black"], ["subject disorder", "HIV"], ["treatment", "highly active antiretroviral therapy ( HAART ) with zidovudine , lamivudine , and indinavir"], ["drug", "zidovudine"], ["drug", "lamivudine"], ["drug", "indinavir"], ["treatment disorder", "HIV"], ["combination drug", "zidovudine"], ["combination drug", "lamivudine"], ["combination drug", "indinavir"]]}]}
{"text_id": "3195622_2", "text": "A dapsone hypersensitivity syndrome , consisting of fever , headache , nausea , vomiting , lymphadenopathy , hepatitis , hemolysis , leukopenia , and mononucleosis , has been described in patients treated with the drug for leprosy .", "tokens": ["A", "dapsone", "hypersensitivity", "syndrome", ",", "consisting", "of", "fever", ",", "headache", ",", "nausea", ",", "vomiting", ",", "lymphadenopathy", ",", "hepatitis", ",", "hemolysis", ",", "leukopenia", ",", "and", "mononucleosis", ",", "has", "been", "described", "in", "patients", "treated", "with", "the", "drug", "for", "leprosy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> leprosy <extra_id_1> <extra_id_0> treatment <extra_id_5> dapsone <extra_id_1> <extra_id_0> drug <extra_id_5> dapsone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> leprosy <extra_id_1> <extra_id_0> effect <extra_id_5> hypersensitivity syndrome , consisting of fever , headache , nausea , vomiting , lymphadenopathy , hepatitis , hemolysis , leukopenia , and mononucleosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [31], "text": "treated", "args": [{"type": "subject", "offset": [30], "text": "patients"}, {"type": "subject disorder", "offset": [36], "text": "leprosy"}, {"type": "treatment", "offset": [1], "text": "dapsone"}, {"type": "drug", "offset": [1], "text": "dapsone"}, {"type": "treatment disorder", "offset": [36], "text": "leprosy"}, {"type": "effect", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24], "text": "hypersensitivity syndrome , consisting of fever , headache , nausea , vomiting , lymphadenopathy , hepatitis , hemolysis , leukopenia , and mononucleosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "adverse event", "asoc": [["subject", "patients"], ["subject disorder", "leprosy"], ["treatment", "dapsone"], ["drug", "dapsone"], ["treatment disorder", "leprosy"], ["effect", "hypersensitivity syndrome , consisting of fever , headache , nausea , vomiting , lymphadenopathy , hepatitis , hemolysis , leukopenia , and mononucleosis"]]}]}
{"text_id": "15977922_2", "text": "Tegaserod - associated ischemic colitis .", "tokens": ["Tegaserod", "-", "associated", "ischemic", "colitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Tegaserod <extra_id_1> <extra_id_0> drug <extra_id_5> Tegaserod <extra_id_1> <extra_id_0> effect <extra_id_5> ischemic colitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Tegaserod"}, {"type": "drug", "offset": [0], "text": "Tegaserod"}, {"type": "effect", "offset": [3, 4], "text": "ischemic colitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Tegaserod"], ["drug", "Tegaserod"], ["effect", "ischemic colitis"]]}]}
{"text_id": "9545161_1", "text": "A 54 - year - old man developed TEN 4 weeks after beginning lamotrigine for complex partial seizures related to a glioblastoma multiforme brain tumor .", "tokens": ["A", "54", "-", "year", "-", "old", "man", "developed", "TEN", "4", "weeks", "after", "beginning", "lamotrigine", "for", "complex", "partial", "seizures", "related", "to", "a", "glioblastoma", "multiforme", "brain", "tumor", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 54 - year - old man <extra_id_1> <extra_id_0> subject <extra_id_5> complex partial seizures related to a glioblastoma multiforme brain tumor <extra_id_1> <extra_id_0> age <extra_id_5> 54 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> glioblastoma multiforme brain tumor <extra_id_1> <extra_id_0> subject disorder <extra_id_5> complex partial seizures <extra_id_1> <extra_id_0> treatment <extra_id_5> 4 weeks after beginning lamotrigine <extra_id_1> <extra_id_0> drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> duration <extra_id_5> 4 weeks <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 4 weeks <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> complex partial seizures <extra_id_1> <extra_id_0> effect <extra_id_5> TEN <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "A 54 - year - old man"}, {"type": "subject", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23, 24], "text": "complex partial seizures related to a glioblastoma multiforme brain tumor"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "54 - year - old"}, {"type": "gender", "offset": [6], "text": "man"}, {"type": "subject disorder", "offset": [21, 22, 23, 24], "text": "glioblastoma multiforme brain tumor"}, {"type": "subject disorder", "offset": [15, 16, 17], "text": "complex partial seizures"}, {"type": "treatment", "offset": [9, 10, 11, 12, 13], "text": "4 weeks after beginning lamotrigine"}, {"type": "drug", "offset": [13], "text": "lamotrigine"}, {"type": "duration", "offset": [9, 10], "text": "4 weeks"}, {"type": "time elapsed", "offset": [9, 10], "text": "4 weeks"}, {"type": "treatment disorder", "offset": [15, 16, 17], "text": "complex partial seizures"}, {"type": "effect", "offset": [8], "text": "TEN"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "duration", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 54 - year - old man"], ["subject", "complex partial seizures related to a glioblastoma multiforme brain tumor"], ["age", "54 - year - old"], ["gender", "man"], ["subject disorder", "glioblastoma multiforme brain tumor"], ["subject disorder", "complex partial seizures"], ["treatment", "4 weeks after beginning lamotrigine"], ["drug", "lamotrigine"], ["duration", "4 weeks"], ["time elapsed", "4 weeks"], ["treatment disorder", "complex partial seizures"], ["effect", "TEN"]]}]}
{"text_id": "12196666_1", "text": "The authors describe three families in whom the occurrence of FVS in all the siblings strongly suggests hereditary susceptibility to valproic acid - induced adverse outcome .", "tokens": ["The", "authors", "describe", "three", "families", "in", "whom", "the", "occurrence", "of", "FVS", "in", "all", "the", "siblings", "strongly", "suggests", "hereditary", "susceptibility", "to", "valproic", "acid", "-", "induced", "adverse", "outcome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> susceptibility <extra_id_0> subject <extra_id_5> three families <extra_id_1> <extra_id_0> subject <extra_id_5> all the siblings <extra_id_1> <extra_id_0> population <extra_id_5> three <extra_id_1> <extra_id_0> treatment <extra_id_5> valproic acid - induced <extra_id_1> <extra_id_0> drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> effect <extra_id_5> FVS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "susceptibility", "args": [{"type": "subject", "offset": [3, 4], "text": "three families"}, {"type": "subject", "offset": [12, 13, 14], "text": "all the siblings"}, {"type": "population", "offset": [3], "text": "three"}, {"type": "treatment", "offset": [20, 21, 22, 23], "text": "valproic acid - induced"}, {"type": "drug", "offset": [20, 21], "text": "valproic acid"}, {"type": "effect", "offset": [10], "text": "FVS"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "susceptibility", "label": "adverse event", "asoc": [["subject", "three families"], ["subject", "all the siblings"], ["population", "three"], ["treatment", "valproic acid - induced"], ["drug", "valproic acid"], ["effect", "FVS"]]}]}
{"text_id": "998323_1", "text": "Lithium treatment was terminated in 1975 because of lithium intoxication with a diabetes insipidus - like syndrome .", "tokens": ["Lithium", "treatment", "was", "terminated", "in", "1975", "because", "of", "lithium", "intoxication", "with", "a", "diabetes", "insipidus", "-", "like", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> because <extra_id_0> treatment <extra_id_5> Lithium treatment <extra_id_1> <extra_id_0> drug <extra_id_5> Lithium <extra_id_1> <extra_id_0> effect <extra_id_5> lithium intoxication with a diabetes insipidus - like syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "because", "args": [{"type": "treatment", "offset": [0, 1], "text": "Lithium treatment"}, {"type": "drug", "offset": [0], "text": "Lithium"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13, 14, 15, 16], "text": "lithium intoxication with a diabetes insipidus - like syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "because", "label": "adverse event", "asoc": [["treatment", "Lithium treatment"], ["drug", "Lithium"], ["effect", "lithium intoxication with a diabetes insipidus - like syndrome"]]}]}
{"text_id": "20298401_2", "text": "INTRODUCTION : Although gefitinib used for the treatment of non - small - cell lung cancer is a well - known cause of interstitial lung disease ( ILD ) , few case reports on erlotinib - induced ILD have been issued .", "tokens": ["INTRODUCTION", ":", "Although", "gefitinib", "used", "for", "the", "treatment", "of", "non", "-", "small", "-", "cell", "lung", "cancer", "is", "a", "well", "-", "known", "cause", "of", "interstitial", "lung", "disease", "(", "ILD", ")", ",", "few", "case", "reports", "on", "erlotinib", "-", "induced", "ILD", "have", "been", "issued", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> gefitinib <extra_id_1> <extra_id_0> drug <extra_id_5> gefitinib <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> non - small - cell lung cancer <extra_id_1> <extra_id_0> effect <extra_id_5> interstitial lung disease ( ILD ) <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> effect <extra_id_5> ILD <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [21], "text": "cause", "args": [{"type": "treatment", "offset": [3], "text": "gefitinib"}, {"type": "drug", "offset": [3], "text": "gefitinib"}, {"type": "treatment disorder", "offset": [9, 10, 11, 12, 13, 14, 15], "text": "non - small - cell lung cancer"}, {"type": "effect", "offset": [23, 24, 25, 26, 27, 28], "text": "interstitial lung disease ( ILD )"}]}, {"type": "adverse event", "offset": [36], "text": "induced", "args": [{"type": "treatment", "offset": [34], "text": "erlotinib"}, {"type": "drug", "offset": [34], "text": "erlotinib"}, {"type": "effect", "offset": [37], "text": "ILD"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "gefitinib"], ["drug", "gefitinib"], ["treatment disorder", "non - small - cell lung cancer"], ["effect", "interstitial lung disease ( ILD )"]]}, {"span": "induced", "label": "adverse event", "asoc": [["treatment", "erlotinib"], ["drug", "erlotinib"], ["effect", "ILD"]]}]}
{"text_id": "8140860_3", "text": "Seven days after the introduction of amoxycillin ( 500 mg/8 h ) for a probable respiratory infection , the patient developed spontaneous bruising , with an INR of 7.1 .", "tokens": ["Seven", "days", "after", "the", "introduction", "of", "amoxycillin", "(", "500", "mg/8", "h", ")", "for", "a", "probable", "respiratory", "infection", ",", "the", "patient", "developed", "spontaneous", "bruising", ",", "with", "an", "INR", "of", "7.1", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> the patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> a probable respiratory infection <extra_id_1> <extra_id_0> treatment <extra_id_5> Seven days after the introduction of amoxycillin ( 500 mg/8 h ) <extra_id_1> <extra_id_0> drug <extra_id_5> amoxycillin <extra_id_1> <extra_id_0> dosage <extra_id_5> 500 mg/8 h <extra_id_1> <extra_id_0> duration <extra_id_5> Seven days <extra_id_1> <extra_id_0> time elapsed <extra_id_5> Seven days after <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> a probable respiratory infection <extra_id_1> <extra_id_0> effect <extra_id_5> spontaneous bruising , with an INR of 7.1 <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "developed", "args": [{"type": "subject", "offset": [18, 19], "text": "the patient"}, {"type": "subject disorder", "offset": [13, 14, 15, 16], "text": "a probable respiratory infection"}, {"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11], "text": "Seven days after the introduction of amoxycillin ( 500 mg/8 h )"}, {"type": "drug", "offset": [6], "text": "amoxycillin"}, {"type": "dosage", "offset": [8, 9, 10], "text": "500 mg/8 h"}, {"type": "duration", "offset": [0, 1], "text": "Seven days"}, {"type": "time elapsed", "offset": [0, 1, 2], "text": "Seven days after"}, {"type": "treatment disorder", "offset": [13, 14, 15, 16], "text": "a probable respiratory infection"}, {"type": "effect", "offset": [21, 22, 23, 24, 25, 26, 27, 28], "text": "spontaneous bruising , with an INR of 7.1"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "subject", "drug", "treatment", "duration", "dosage", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "the patient"], ["subject disorder", "a probable respiratory infection"], ["treatment", "Seven days after the introduction of amoxycillin ( 500 mg/8 h )"], ["drug", "amoxycillin"], ["dosage", "500 mg/8 h"], ["duration", "Seven days"], ["time elapsed", "Seven days after"], ["treatment disorder", "a probable respiratory infection"], ["effect", "spontaneous bruising , with an INR of 7.1"]]}]}
{"text_id": "8435665_1", "text": "A 16 - year - old white male with acute biphenotypic leukemia developed evidence of the eosinophilia myalgia syndrome associated with total parenteral nutritional support with solutions containing tryptophan , which were given during his initial induction chemotherapy and also after autologous marrow transplantation .", "tokens": ["A", "16", "-", "year", "-", "old", "white", "male", "with", "acute", "biphenotypic", "leukemia", "developed", "evidence", "of", "the", "eosinophilia", "myalgia", "syndrome", "associated", "with", "total", "parenteral", "nutritional", "support", "with", "solutions", "containing", "tryptophan", ",", "which", "were", "given", "during", "his", "initial", "induction", "chemotherapy", "and", "also", "after", "autologous", "marrow", "transplantation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 16 - year - old white male with acute biphenotypic leukemia <extra_id_1> <extra_id_0> age <extra_id_5> 16 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> male <extra_id_1> <extra_id_0> race <extra_id_5> white <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute biphenotypic leukemia <extra_id_1> <extra_id_0> treatment <extra_id_5> total parenteral nutritional support with solutions containing tryptophan , which were given during his initial induction chemotherapy and also after autologous marrow transplantation <extra_id_1> <extra_id_0> drug <extra_id_5> tryptophan <extra_id_1> <extra_id_0> route <extra_id_5> parenteral <extra_id_1> <extra_id_0> effect <extra_id_5> eosinophilia myalgia syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11], "text": "A 16 - year - old white male with acute biphenotypic leukemia"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "16 - year - old"}, {"type": "gender", "offset": [7], "text": "male"}, {"type": "race", "offset": [6], "text": "white"}, {"type": "subject disorder", "offset": [9, 10, 11], "text": "acute biphenotypic leukemia"}, {"type": "treatment", "offset": [21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43], "text": "total parenteral nutritional support with solutions containing tryptophan , which were given during his initial induction chemotherapy and also after autologous marrow transplantation"}, {"type": "drug", "offset": [28], "text": "tryptophan"}, {"type": "route", "offset": [22], "text": "parenteral"}, {"type": "effect", "offset": [16, 17, 18], "text": "eosinophilia myalgia syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "gender", "treatment", "age", "subject disorder", "race"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 16 - year - old white male with acute biphenotypic leukemia"], ["age", "16 - year - old"], ["gender", "male"], ["race", "white"], ["subject disorder", "acute biphenotypic leukemia"], ["treatment", "total parenteral nutritional support with solutions containing tryptophan , which were given during his initial induction chemotherapy and also after autologous marrow transplantation"], ["drug", "tryptophan"], ["route", "parenteral"], ["effect", "eosinophilia myalgia syndrome"]]}]}
{"text_id": "8742573_3", "text": "Human insulin - induced lipoatrophy .", "tokens": ["Human", "insulin", "-", "induced", "lipoatrophy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Human insulin <extra_id_1> <extra_id_0> drug <extra_id_5> Human insulin <extra_id_1> <extra_id_0> effect <extra_id_5> lipoatrophy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "induced", "args": [{"type": "treatment", "offset": [0, 1], "text": "Human insulin"}, {"type": "drug", "offset": [0, 1], "text": "Human insulin"}, {"type": "effect", "offset": [4], "text": "lipoatrophy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Human insulin"], ["drug", "Human insulin"], ["effect", "lipoatrophy"]]}]}
{"text_id": "17522786_1", "text": "INTRODUCTION : We describe the neurointensive care ( NIC ) management of a patient with severe cerebral swelling and raised intracranial pressure ( ICP ) after severe sodium valproic acid ( VPA ) intoxication .", "tokens": ["INTRODUCTION", ":", "We", "describe", "the", "neurointensive", "care", "(", "NIC", ")", "management", "of", "a", "patient", "with", "severe", "cerebral", "swelling", "and", "raised", "intracranial", "pressure", "(", "ICP", ")", "after", "severe", "sodium", "valproic", "acid", "(", "VPA", ")", "intoxication", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> patient <extra_id_1> <extra_id_0> treatment <extra_id_5> sodium valproic acid ( VPA ) <extra_id_1> <extra_id_0> drug <extra_id_5> sodium valproic acid <extra_id_1> <extra_id_0> effect <extra_id_5> severe cerebral swelling and raised intracranial pressure ( ICP ) <extra_id_1> <extra_id_0> effect <extra_id_5> intoxication <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [25], "text": "after", "args": [{"type": "subject", "offset": [13], "text": "patient"}, {"type": "treatment", "offset": [27, 28, 29, 30, 31, 32], "text": "sodium valproic acid ( VPA )"}, {"type": "drug", "offset": [27, 28, 29], "text": "sodium valproic acid"}, {"type": "effect", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23, 24], "text": "severe cerebral swelling and raised intracranial pressure ( ICP )"}, {"type": "effect", "offset": [33], "text": "intoxication"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "patient"], ["treatment", "sodium valproic acid ( VPA )"], ["drug", "sodium valproic acid"], ["effect", "severe cerebral swelling and raised intracranial pressure ( ICP )"], ["effect", "intoxication"]]}]}
{"text_id": "15482394_2", "text": "Based on the clinical status of the patient , it was suspected that several conditions contributed to the abnormal hypersensitivity to warfarin .", "tokens": ["Based", "on", "the", "clinical", "status", "of", "the", "patient", ",", "it", "was", "suspected", "that", "several", "conditions", "contributed", "to", "the", "abnormal", "hypersensitivity", "to", "warfarin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> to <extra_id_0> subject <extra_id_5> the patient <extra_id_1> <extra_id_0> treatment <extra_id_5> warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> abnormal hypersensitivity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "to", "args": [{"type": "subject", "offset": [6, 7], "text": "the patient"}, {"type": "treatment", "offset": [21], "text": "warfarin"}, {"type": "drug", "offset": [21], "text": "warfarin"}, {"type": "effect", "offset": [18, 19], "text": "abnormal hypersensitivity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "to", "label": "adverse event", "asoc": [["subject", "the patient"], ["treatment", "warfarin"], ["drug", "warfarin"], ["effect", "abnormal hypersensitivity"]]}]}
{"text_id": "10897389_1", "text": "However , recurrent staphylococcus aureus sepsis developed during CyA therapy .", "tokens": ["However", ",", "recurrent", "staphylococcus", "aureus", "sepsis", "developed", "during", "CyA", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> treatment <extra_id_5> CyA therapy <extra_id_1> <extra_id_0> drug <extra_id_5> CyA <extra_id_1> <extra_id_0> effect <extra_id_5> staphylococcus aureus sepsis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "developed", "args": [{"type": "treatment", "offset": [8, 9], "text": "CyA therapy"}, {"type": "drug", "offset": [8], "text": "CyA"}, {"type": "effect", "offset": [3, 4, 5], "text": "staphylococcus aureus sepsis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["treatment", "CyA therapy"], ["drug", "CyA"], ["effect", "staphylococcus aureus sepsis"]]}]}
{"text_id": "11424102_5", "text": "Despite the risk of needle - track seeding , PEI remains useful in the treatment of HCC .", "tokens": ["Despite", "the", "risk", "of", "needle", "-", "track", "seeding", ",", "PEI", "remains", "useful", "in", "the", "treatment", "of", "HCC", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> remains <extra_id_0> treatment <extra_id_5> PEI <extra_id_1> <extra_id_0> drug <extra_id_5> PEI <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HCC <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [10], "text": "remains", "args": [{"type": "treatment", "offset": [9], "text": "PEI"}, {"type": "drug", "offset": [9], "text": "PEI"}, {"type": "treatment disorder", "offset": [16], "text": "HCC"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "remains", "label": "potential therapeutic event", "asoc": [["treatment", "PEI"], ["drug", "PEI"], ["treatment disorder", "HCC"]]}]}
{"text_id": "812008_2", "text": "Significant clinical improvement of the porphyria followed withdrawal of the diphenylhydantoin .", "tokens": ["Significant", "clinical", "improvement", "of", "the", "porphyria", "followed", "withdrawal", "of", "the", "diphenylhydantoin", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> improvement <extra_id_0> treatment <extra_id_5> withdrawal of the diphenylhydantoin <extra_id_1> <extra_id_0> drug <extra_id_5> diphenylhydantoin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> porphyria <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [2], "text": "improvement", "args": [{"type": "treatment", "offset": [7, 8, 9, 10], "text": "withdrawal of the diphenylhydantoin"}, {"type": "drug", "offset": [10], "text": "diphenylhydantoin"}, {"type": "treatment disorder", "offset": [5], "text": "porphyria"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "improvement", "label": "potential therapeutic event", "asoc": [["treatment", "withdrawal of the diphenylhydantoin"], ["drug", "diphenylhydantoin"], ["treatment disorder", "porphyria"]]}]}
{"text_id": "8792511_2", "text": "Methemoglobinemia is another common finding among patients receiving dapsone therapy , but rarely does it result in prominent symptoms other than transient pallor .", "tokens": ["Methemoglobinemia", "is", "another", "common", "finding", "among", "patients", "receiving", "dapsone", "therapy", ",", "but", "rarely", "does", "it", "result", "in", "prominent", "symptoms", "other", "than", "transient", "pallor", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> receiving <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> treatment <extra_id_5> dapsone therapy <extra_id_1> <extra_id_0> drug <extra_id_5> dapsone <extra_id_1> <extra_id_0> effect <extra_id_5> Methemoglobinemia <extra_id_1> <extra_id_0> effect <extra_id_5> transient pallor <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "receiving", "args": [{"type": "subject", "offset": [6], "text": "patients"}, {"type": "treatment", "offset": [8, 9], "text": "dapsone therapy"}, {"type": "drug", "offset": [8], "text": "dapsone"}, {"type": "effect", "offset": [0], "text": "Methemoglobinemia"}, {"type": "effect", "offset": [21, 22], "text": "transient pallor"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "receiving", "label": "adverse event", "asoc": [["subject", "patients"], ["treatment", "dapsone therapy"], ["drug", "dapsone"], ["effect", "Methemoglobinemia"], ["effect", "transient pallor"]]}]}
{"text_id": "18676387_1", "text": "Serotonin toxicity caused by an interaction between fentanyl and paroxetine .", "tokens": ["Serotonin", "toxicity", "caused", "by", "an", "interaction", "between", "fentanyl", "and", "paroxetine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> an interaction between fentanyl and paroxetine <extra_id_1> <extra_id_0> drug <extra_id_5> fentanyl <extra_id_1> <extra_id_0> drug <extra_id_5> paroxetine <extra_id_1> <extra_id_0> combination drug <extra_id_5> fentanyl <extra_id_1> <extra_id_0> combination drug <extra_id_5> paroxetine <extra_id_1> <extra_id_0> effect <extra_id_5> Serotonin toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "caused", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9], "text": "an interaction between fentanyl and paroxetine"}, {"type": "drug", "offset": [7], "text": "fentanyl"}, {"type": "drug", "offset": [9], "text": "paroxetine"}, {"type": "combination drug", "offset": [7], "text": "fentanyl"}, {"type": "combination drug", "offset": [9], "text": "paroxetine"}, {"type": "effect", "offset": [0, 1], "text": "Serotonin toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "an interaction between fentanyl and paroxetine"], ["drug", "fentanyl"], ["drug", "paroxetine"], ["combination drug", "fentanyl"], ["combination drug", "paroxetine"], ["effect", "Serotonin toxicity"]]}]}
{"text_id": "12078977_2", "text": "Posterior leukoencephalopathy following cisplatin , bleomycin and vinblastine therapy for germ cell tumor of the ovary .", "tokens": ["Posterior", "leukoencephalopathy", "following", "cisplatin", ",", "bleomycin", "and", "vinblastine", "therapy", "for", "germ", "cell", "tumor", "of", "the", "ovary", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> cisplatin , bleomycin and vinblastine therapy for germ cell tumor of the ovary <extra_id_1> <extra_id_0> drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> drug <extra_id_5> bleomycin <extra_id_1> <extra_id_0> drug <extra_id_5> vinblastine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> germ cell tumor of the ovary <extra_id_1> <extra_id_0> combination drug <extra_id_5> vinblastine <extra_id_1> <extra_id_0> combination drug <extra_id_5> bleomycin <extra_id_1> <extra_id_0> combination drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> effect <extra_id_5> Posterior leukoencephalopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "following", "args": [{"type": "treatment", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "cisplatin , bleomycin and vinblastine therapy for germ cell tumor of the ovary"}, {"type": "drug", "offset": [3], "text": "cisplatin"}, {"type": "drug", "offset": [5], "text": "bleomycin"}, {"type": "drug", "offset": [7], "text": "vinblastine"}, {"type": "treatment disorder", "offset": [10, 11, 12, 13, 14, 15], "text": "germ cell tumor of the ovary"}, {"type": "combination drug", "offset": [7], "text": "vinblastine"}, {"type": "combination drug", "offset": [5], "text": "bleomycin"}, {"type": "combination drug", "offset": [3], "text": "cisplatin"}, {"type": "effect", "offset": [0, 1], "text": "Posterior leukoencephalopathy"}]}], "spot": ["adverse event"], "asoc": ["effect", "drug", "treatment", "combination drug", "treatment disorder"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "cisplatin , bleomycin and vinblastine therapy for germ cell tumor of the ovary"], ["drug", "cisplatin"], ["drug", "bleomycin"], ["drug", "vinblastine"], ["treatment disorder", "germ cell tumor of the ovary"], ["combination drug", "vinblastine"], ["combination drug", "bleomycin"], ["combination drug", "cisplatin"], ["effect", "Posterior leukoencephalopathy"]]}]}
{"text_id": "15907341_2", "text": "Six patients developed peripheral neuropathy and five patients bone marrow depression , blood transfusions were given to three patients and in all five patients bone marrow function normalized after cessation of linezolid .", "tokens": ["Six", "patients", "developed", "peripheral", "neuropathy", "and", "five", "patients", "bone", "marrow", "depression", ",", "blood", "transfusions", "were", "given", "to", "three", "patients", "and", "in", "all", "five", "patients", "bone", "marrow", "function", "normalized", "after", "cessation", "of", "linezolid", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> normalized <extra_id_0> subject <extra_id_5> all five patients <extra_id_1> <extra_id_0> population <extra_id_5> five <extra_id_1> <extra_id_0> subject disorder <extra_id_5> bone marrow depression <extra_id_1> <extra_id_0> treatment <extra_id_5> cessation of linezolid <extra_id_1> <extra_id_0> drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> bone marrow depression <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> Six patients <extra_id_1> <extra_id_0> population <extra_id_5> Six <extra_id_1> <extra_id_0> treatment <extra_id_5> linezolid <extra_id_1> <extra_id_0> drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> effect <extra_id_5> peripheral neuropathy <extra_id_1> <extra_id_0> subject <extra_id_5> five patients <extra_id_1> <extra_id_0> population <extra_id_5> five <extra_id_1> <extra_id_0> treatment <extra_id_5> linezolid <extra_id_1> <extra_id_0> drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> effect <extra_id_5> bone marrow depression <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> given <extra_id_0> subject <extra_id_5> three patients <extra_id_1> <extra_id_0> population <extra_id_5> three <extra_id_1> <extra_id_0> treatment <extra_id_5> blood transfusions <extra_id_1> <extra_id_0> treatment <extra_id_5> cessation of linezolid <extra_id_1> <extra_id_0> drug <extra_id_5> linezolid <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [27], "text": "normalized", "args": [{"type": "subject", "offset": [21, 22, 23], "text": "all five patients"}, {"type": "population", "offset": [22], "text": "five"}, {"type": "subject disorder", "offset": [8, 9, 10], "text": "bone marrow depression"}, {"type": "treatment", "offset": [29, 30, 31], "text": "cessation of linezolid"}, {"type": "drug", "offset": [31], "text": "linezolid"}, {"type": "treatment disorder", "offset": [8, 9, 10], "text": "bone marrow depression"}]}, {"type": "adverse event", "offset": [2], "text": "developed", "args": [{"type": "subject", "offset": [0, 1], "text": "Six patients"}, {"type": "population", "offset": [0], "text": "Six"}, {"type": "treatment", "offset": [31], "text": "linezolid"}, {"type": "drug", "offset": [31], "text": "linezolid"}, {"type": "effect", "offset": [3, 4], "text": "peripheral neuropathy"}]}, {"type": "adverse event", "offset": [2], "text": "developed", "args": [{"type": "subject", "offset": [6, 7], "text": "five patients"}, {"type": "population", "offset": [6], "text": "five"}, {"type": "treatment", "offset": [31], "text": "linezolid"}, {"type": "drug", "offset": [31], "text": "linezolid"}, {"type": "effect", "offset": [8, 9, 10], "text": "bone marrow depression"}]}, {"type": "potential therapeutic event", "offset": [15], "text": "given", "args": [{"type": "subject", "offset": [17, 18], "text": "three patients"}, {"type": "population", "offset": [17], "text": "three"}, {"type": "treatment", "offset": [12, 13], "text": "blood transfusions"}, {"type": "treatment", "offset": [29, 30, 31], "text": "cessation of linezolid"}, {"type": "drug", "offset": [31], "text": "linezolid"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "normalized", "label": "potential therapeutic event", "asoc": [["subject", "all five patients"], ["population", "five"], ["subject disorder", "bone marrow depression"], ["treatment", "cessation of linezolid"], ["drug", "linezolid"], ["treatment disorder", "bone marrow depression"]]}, {"span": "developed", "label": "adverse event", "asoc": [["subject", "Six patients"], ["population", "Six"], ["treatment", "linezolid"], ["drug", "linezolid"], ["effect", "peripheral neuropathy"], ["subject", "five patients"], ["population", "five"], ["treatment", "linezolid"], ["drug", "linezolid"], ["effect", "bone marrow depression"]]}, {"span": "given", "label": "potential therapeutic event", "asoc": [["subject", "three patients"], ["population", "three"], ["treatment", "blood transfusions"], ["treatment", "cessation of linezolid"], ["drug", "linezolid"]]}]}
{"text_id": "8832451_3", "text": "We also describe a new , noninvasive method to assess magnesium - induced neuromuscular block when curariform muscle relaxant was given simultaneously .", "tokens": ["We", "also", "describe", "a", "new", ",", "noninvasive", "method", "to", "assess", "magnesium", "-", "induced", "neuromuscular", "block", "when", "curariform", "muscle", "relaxant", "was", "given", "simultaneously", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> curariform muscle relaxant was given simultaneously <extra_id_1> <extra_id_0> drug <extra_id_5> magnesium <extra_id_1> <extra_id_0> drug <extra_id_5> curariform muscle relaxant <extra_id_1> <extra_id_0> combination drug <extra_id_5> magnesium <extra_id_1> <extra_id_0> combination drug <extra_id_5> curariform muscle relaxant <extra_id_1> <extra_id_0> effect <extra_id_5> neuromuscular block <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "induced", "args": [{"type": "treatment", "offset": [16, 17, 18, 19, 20, 21], "text": "curariform muscle relaxant was given simultaneously"}, {"type": "drug", "offset": [10], "text": "magnesium"}, {"type": "drug", "offset": [16, 17, 18], "text": "curariform muscle relaxant"}, {"type": "combination drug", "offset": [10], "text": "magnesium"}, {"type": "combination drug", "offset": [16, 17, 18], "text": "curariform muscle relaxant"}, {"type": "effect", "offset": [13, 14], "text": "neuromuscular block"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "curariform muscle relaxant was given simultaneously"], ["drug", "magnesium"], ["drug", "curariform muscle relaxant"], ["combination drug", "magnesium"], ["combination drug", "curariform muscle relaxant"], ["effect", "neuromuscular block"]]}]}
{"text_id": "18810448_2", "text": "Thymic enlargement in a patient with juvenile idiopathic arthritis during etanercept therapy .", "tokens": ["Thymic", "enlargement", "in", "a", "patient", "with", "juvenile", "idiopathic", "arthritis", "during", "etanercept", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> subject <extra_id_5> a patient with juvenile idiopathic arthritis <extra_id_1> <extra_id_0> age <extra_id_5> juvenile <extra_id_1> <extra_id_0> subject disorder <extra_id_5> idiopathic arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> etanercept <extra_id_1> <extra_id_0> drug <extra_id_5> etanercept <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> idiopathic arthritis <extra_id_1> <extra_id_0> effect <extra_id_5> Thymic enlargement <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "during", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8], "text": "a patient with juvenile idiopathic arthritis"}, {"type": "age", "offset": [6], "text": "juvenile"}, {"type": "subject disorder", "offset": [7, 8], "text": "idiopathic arthritis"}, {"type": "treatment", "offset": [10], "text": "etanercept"}, {"type": "drug", "offset": [10], "text": "etanercept"}, {"type": "treatment disorder", "offset": [7, 8], "text": "idiopathic arthritis"}, {"type": "effect", "offset": [0, 1], "text": "Thymic enlargement"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["subject", "a patient with juvenile idiopathic arthritis"], ["age", "juvenile"], ["subject disorder", "idiopathic arthritis"], ["treatment", "etanercept"], ["drug", "etanercept"], ["treatment disorder", "idiopathic arthritis"], ["effect", "Thymic enlargement"]]}]}
{"text_id": "12656748_3", "text": "There are no previous reports in the literature about the emergence of CML during treatment with hydroxyurea .", "tokens": ["There", "are", "no", "previous", "reports", "in", "the", "literature", "about", "the", "emergence", "of", "CML", "during", "treatment", "with", "hydroxyurea", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> treatment with hydroxyurea <extra_id_1> <extra_id_0> drug <extra_id_5> hydroxyurea <extra_id_1> <extra_id_0> effect <extra_id_5> CML <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "during", "args": [{"type": "treatment", "offset": [14, 15, 16], "text": "treatment with hydroxyurea"}, {"type": "drug", "offset": [16], "text": "hydroxyurea"}, {"type": "effect", "offset": [12], "text": "CML"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "treatment with hydroxyurea"], ["drug", "hydroxyurea"], ["effect", "CML"]]}]}
{"text_id": "19904536_1", "text": "Fatal gemcitabine - induced pulmonary toxicity in metastatic gallbladder adenocarcinoma .", "tokens": ["Fatal", "gemcitabine", "-", "induced", "pulmonary", "toxicity", "in", "metastatic", "gallbladder", "adenocarcinoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> metastatic gallbladder adenocarcinoma <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "induced", "args": [{"type": "treatment", "offset": [1], "text": "gemcitabine"}, {"type": "drug", "offset": [1], "text": "gemcitabine"}, {"type": "treatment disorder", "offset": [7, 8, 9], "text": "metastatic gallbladder adenocarcinoma"}, {"type": "effect", "offset": [4, 5], "text": "pulmonary toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["treatment disorder", "metastatic gallbladder adenocarcinoma"], ["effect", "pulmonary toxicity"]]}]}
{"text_id": "16225183_2", "text": "BACKGROUND : Interferon beta has become standard therapy for reducing relapse frequency in relapsing / remitting Multiple Sclerosis ( RRMS ) .", "tokens": ["BACKGROUND", ":", "Interferon", "beta", "has", "become", "standard", "therapy", "for", "reducing", "relapse", "frequency", "in", "relapsing", "/", "remitting", "Multiple", "Sclerosis", "(", "RRMS", ")", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> standard therapy <extra_id_0> treatment <extra_id_5> Interferon beta <extra_id_1> <extra_id_0> drug <extra_id_5> Interferon beta <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> relapsing / remitting Multiple Sclerosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [6, 7], "text": "standard therapy", "args": [{"type": "treatment", "offset": [2, 3], "text": "Interferon beta"}, {"type": "drug", "offset": [2, 3], "text": "Interferon beta"}, {"type": "treatment disorder", "offset": [13, 14, 15, 16, 17], "text": "relapsing / remitting Multiple Sclerosis"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "standard therapy", "label": "potential therapeutic event", "asoc": [["treatment", "Interferon beta"], ["drug", "Interferon beta"], ["treatment disorder", "relapsing / remitting Multiple Sclerosis"]]}]}
{"text_id": "12187348_8", "text": "Retrospectively , bucillamine was believed to be the cause of the giant hypertrophy because of its structural similarity to D - penicillamine , which was the subject of an abundance of reports of mammary hyperplasia .", "tokens": ["Retrospectively", ",", "bucillamine", "was", "believed", "to", "be", "the", "cause", "of", "the", "giant", "hypertrophy", "because", "of", "its", "structural", "similarity", "to", "D", "-", "penicillamine", ",", "which", "was", "the", "subject", "of", "an", "abundance", "of", "reports", "of", "mammary", "hyperplasia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause of <extra_id_0> treatment <extra_id_5> bucillamine <extra_id_1> <extra_id_0> drug <extra_id_5> bucillamine <extra_id_1> <extra_id_0> drug <extra_id_5> D - penicillamine <extra_id_1> <extra_id_0> effect <extra_id_5> giant hypertrophy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8, 9], "text": "cause of", "args": [{"type": "treatment", "offset": [2], "text": "bucillamine"}, {"type": "drug", "offset": [2], "text": "bucillamine"}, {"type": "drug", "offset": [19, 20, 21], "text": "D - penicillamine"}, {"type": "effect", "offset": [11, 12], "text": "giant hypertrophy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause of", "label": "adverse event", "asoc": [["treatment", "bucillamine"], ["drug", "bucillamine"], ["drug", "D - penicillamine"], ["effect", "giant hypertrophy"]]}]}
{"text_id": "8255797_1", "text": "Captopril - induced bone marrow suppression in two cardiac patients with trisomy 21 .", "tokens": ["Captopril", "-", "induced", "bone", "marrow", "suppression", "in", "two", "cardiac", "patients", "with", "trisomy", "21", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> two cardiac patients with trisomy 21 <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> cardiac <extra_id_1> <extra_id_0> subject disorder <extra_id_5> trisomy 21 <extra_id_1> <extra_id_0> treatment <extra_id_5> Captopril <extra_id_1> <extra_id_0> drug <extra_id_5> Captopril <extra_id_1> <extra_id_0> effect <extra_id_5> bone marrow suppression <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "subject", "offset": [7, 8, 9, 10, 11, 12], "text": "two cardiac patients with trisomy 21"}, {"type": "population", "offset": [7], "text": "two"}, {"type": "subject disorder", "offset": [8], "text": "cardiac"}, {"type": "subject disorder", "offset": [11, 12], "text": "trisomy 21"}, {"type": "treatment", "offset": [0], "text": "Captopril"}, {"type": "drug", "offset": [0], "text": "Captopril"}, {"type": "effect", "offset": [3, 4, 5], "text": "bone marrow suppression"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "two cardiac patients with trisomy 21"], ["population", "two"], ["subject disorder", "cardiac"], ["subject disorder", "trisomy 21"], ["treatment", "Captopril"], ["drug", "Captopril"], ["effect", "bone marrow suppression"]]}]}
{"text_id": "17536204_3", "text": "Capecitabine - induced headache responding to diltiazem .", "tokens": ["Capecitabine", "-", "induced", "headache", "responding", "to", "diltiazem", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Capecitabine <extra_id_1> <extra_id_0> drug <extra_id_5> Capecitabine <extra_id_1> <extra_id_0> effect <extra_id_5> headache <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Capecitabine"}, {"type": "drug", "offset": [0], "text": "Capecitabine"}, {"type": "effect", "offset": [3], "text": "headache"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Capecitabine"], ["drug", "Capecitabine"], ["effect", "headache"]]}]}
{"text_id": "16641839_1", "text": "Angioedema and maculopapular eruptions associated with carbamazepine administration .", "tokens": ["Angioedema", "and", "maculopapular", "eruptions", "associated", "with", "carbamazepine", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> carbamazepine administration . <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> effect <extra_id_5> Angioedema and maculopapular eruptions <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "associated", "args": [{"type": "treatment", "offset": [6, 7, 8], "text": "carbamazepine administration ."}, {"type": "drug", "offset": [6], "text": "carbamazepine"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Angioedema and maculopapular eruptions"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "carbamazepine administration ."], ["drug", "carbamazepine"], ["effect", "Angioedema and maculopapular eruptions"]]}]}
{"text_id": "16649344_2", "text": "Current immunosuppressive therapies are effective but can be associated with significant adverse reactions .", "tokens": ["Current", "immunosuppressive", "therapies", "are", "effective", "but", "can", "be", "associated", "with", "significant", "adverse", "reactions", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Current immunosuppressive therapies <extra_id_1> <extra_id_0> drug <extra_id_5> immunosuppressive <extra_id_1> <extra_id_0> effect <extra_id_5> significant adverse reactions . <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "associated", "args": [{"type": "treatment", "offset": [0, 1, 2], "text": "Current immunosuppressive therapies"}, {"type": "drug", "offset": [1], "text": "immunosuppressive"}, {"type": "effect", "offset": [10, 11, 12, 13], "text": "significant adverse reactions ."}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Current immunosuppressive therapies"], ["drug", "immunosuppressive"], ["effect", "significant adverse reactions ."]]}]}
{"text_id": "8651254_5", "text": "We describe a patient with acute myeloblastic leukemia ( AML ) who developed nephrotic syndrome after receiving several courses of chemotherapy , including macrophage - colony - stimulating factor ( M - CSF ) .", "tokens": ["We", "describe", "a", "patient", "with", "acute", "myeloblastic", "leukemia", "(", "AML", ")", "who", "developed", "nephrotic", "syndrome", "after", "receiving", "several", "courses", "of", "chemotherapy", ",", "including", "macrophage", "-", "colony", "-", "stimulating", "factor", "(", "M", "-", "CSF", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a patient with acute myeloblastic leukemia ( AML ) <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute myeloblastic leukemia <extra_id_1> <extra_id_0> treatment <extra_id_5> several courses of chemotherapy , including macrophage - colony - stimulating factor ( M - CSF ) <extra_id_1> <extra_id_0> drug <extra_id_5> macrophage - colony - stimulating factor <extra_id_1> <extra_id_0> route <extra_id_5> chemotherapy <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute myeloblastic leukemia <extra_id_1> <extra_id_0> effect <extra_id_5> nephrotic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "after", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10], "text": "a patient with acute myeloblastic leukemia ( AML )"}, {"type": "subject disorder", "offset": [5, 6, 7], "text": "acute myeloblastic leukemia"}, {"type": "treatment", "offset": [17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33], "text": "several courses of chemotherapy , including macrophage - colony - stimulating factor ( M - CSF )"}, {"type": "drug", "offset": [23, 24, 25, 26, 27, 28], "text": "macrophage - colony - stimulating factor"}, {"type": "route", "offset": [20], "text": "chemotherapy"}, {"type": "treatment disorder", "offset": [5, 6, 7], "text": "acute myeloblastic leukemia"}, {"type": "effect", "offset": [13, 14], "text": "nephrotic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a patient with acute myeloblastic leukemia ( AML )"], ["subject disorder", "acute myeloblastic leukemia"], ["treatment", "several courses of chemotherapy , including macrophage - colony - stimulating factor ( M - CSF )"], ["drug", "macrophage - colony - stimulating factor"], ["route", "chemotherapy"], ["treatment disorder", "acute myeloblastic leukemia"], ["effect", "nephrotic syndrome"]]}]}
{"text_id": "10473079_1", "text": "We conclude that the presence of this metabolic defect combined with topical 5 - FU ( a drug demonstrating a narrow therapeutic index ) results in the unusual presentation of life - threatening toxicity after treatment with a topical drug .", "tokens": ["We", "conclude", "that", "the", "presence", "of", "this", "metabolic", "defect", "combined", "with", "topical", "5", "-", "FU", "(", "a", "drug", "demonstrating", "a", "narrow", "therapeutic", "index", ")", "results", "in", "the", "unusual", "presentation", "of", "life", "-", "threatening", "toxicity", "after", "treatment", "with", "a", "topical", "drug", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> results in <extra_id_0> subject <extra_id_5> this metabolic defect <extra_id_1> <extra_id_0> subject disorder <extra_id_5> metabolic defect <extra_id_1> <extra_id_0> treatment <extra_id_5> topical 5 - FU ( a drug demonstrating a narrow therapeutic index ) <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> route <extra_id_5> topical <extra_id_1> <extra_id_0> effect <extra_id_5> unusual presentation of life - threatening toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [24, 25], "text": "results in", "args": [{"type": "subject", "offset": [6, 7, 8], "text": "this metabolic defect"}, {"type": "subject disorder", "offset": [7, 8], "text": "metabolic defect"}, {"type": "treatment", "offset": [11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23], "text": "topical 5 - FU ( a drug demonstrating a narrow therapeutic index )"}, {"type": "drug", "offset": [12, 13, 14], "text": "5 - FU"}, {"type": "route", "offset": [11], "text": "topical"}, {"type": "effect", "offset": [27, 28, 29, 30, 31, 32, 33], "text": "unusual presentation of life - threatening toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "results in", "label": "adverse event", "asoc": [["subject", "this metabolic defect"], ["subject disorder", "metabolic defect"], ["treatment", "topical 5 - FU ( a drug demonstrating a narrow therapeutic index )"], ["drug", "5 - FU"], ["route", "topical"], ["effect", "unusual presentation of life - threatening toxicity"]]}]}
{"text_id": "17536204_6", "text": "We hypothesize that capecitabine - induced headache is vascular in nature .", "tokens": ["We", "hypothesize", "that", "capecitabine", "-", "induced", "headache", "is", "vascular", "in", "nature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> capecitabine <extra_id_1> <extra_id_0> drug <extra_id_5> capecitabine <extra_id_1> <extra_id_0> effect <extra_id_5> headache <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "induced", "args": [{"type": "treatment", "offset": [3], "text": "capecitabine"}, {"type": "drug", "offset": [3], "text": "capecitabine"}, {"type": "effect", "offset": [6], "text": "headache"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "capecitabine"], ["drug", "capecitabine"], ["effect", "headache"]]}]}
{"text_id": "8530331_7", "text": "Only one patient , the youngest , did well on risperidone therapy .", "tokens": ["Only", "one", "patient", ",", "the", "youngest", ",", "did", "well", "on", "risperidone", "therapy", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> did well <extra_id_0> subject <extra_id_5> the youngest <extra_id_1> <extra_id_0> treatment <extra_id_5> risperidone <extra_id_1> <extra_id_0> drug <extra_id_5> risperidone <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [7, 8], "text": "did well", "args": [{"type": "subject", "offset": [4, 5], "text": "the youngest"}, {"type": "treatment", "offset": [10], "text": "risperidone"}, {"type": "drug", "offset": [10], "text": "risperidone"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "subject"], "spot_asoc": [{"span": "did well", "label": "potential therapeutic event", "asoc": [["subject", "the youngest"], ["treatment", "risperidone"], ["drug", "risperidone"]]}]}
{"text_id": "17965530_2", "text": "We concluded that the colonic ulcer and the sigmoidovesical fistula had been caused by the administration of calcium polystyrene sulfonate and sorbitol .", "tokens": ["We", "concluded", "that", "the", "colonic", "ulcer", "and", "the", "sigmoidovesical", "fistula", "had", "been", "caused", "by", "the", "administration", "of", "calcium", "polystyrene", "sulfonate", "and", "sorbitol", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> calcium polystyrene sulfonate and sorbitol <extra_id_1> <extra_id_0> drug <extra_id_5> calcium polystyrene sulfonate <extra_id_1> <extra_id_0> drug <extra_id_5> sorbitol <extra_id_1> <extra_id_0> combination drug <extra_id_5> sorbitol <extra_id_1> <extra_id_0> combination drug <extra_id_5> calcium polystyrene sulfonate <extra_id_1> <extra_id_0> effect <extra_id_5> colonic ulcer and the sigmoidovesical fistula <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "caused", "args": [{"type": "treatment", "offset": [17, 18, 19, 20, 21], "text": "calcium polystyrene sulfonate and sorbitol"}, {"type": "drug", "offset": [17, 18, 19], "text": "calcium polystyrene sulfonate"}, {"type": "drug", "offset": [21], "text": "sorbitol"}, {"type": "combination drug", "offset": [21], "text": "sorbitol"}, {"type": "combination drug", "offset": [17, 18, 19], "text": "calcium polystyrene sulfonate"}, {"type": "effect", "offset": [4, 5, 6, 7, 8, 9], "text": "colonic ulcer and the sigmoidovesical fistula"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "calcium polystyrene sulfonate and sorbitol"], ["drug", "calcium polystyrene sulfonate"], ["drug", "sorbitol"], ["combination drug", "sorbitol"], ["combination drug", "calcium polystyrene sulfonate"], ["effect", "colonic ulcer and the sigmoidovesical fistula"]]}]}
{"text_id": "8530331_8", "text": "CONCLUSION : We believe that risperidone is not a substitute for clozapine in treating psychosis in parkinsonian patients and should be used with caution .", "tokens": ["CONCLUSION", ":", "We", "believe", "that", "risperidone", "is", "not", "a", "substitute", "for", "clozapine", "in", "treating", "psychosis", "in", "parkinsonian", "patients", "and", "should", "be", "used", "with", "caution", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treating <extra_id_0> subject <extra_id_5> parkinsonian patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> parkinsonian <extra_id_1> <extra_id_0> subject disorder <extra_id_5> psychosis <extra_id_1> <extra_id_0> treatment <extra_id_5> risperidone <extra_id_1> <extra_id_0> drug <extra_id_5> risperidone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> psychosis <extra_id_1> <extra_id_0> subject <extra_id_5> parkinsonian patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> parkinsonian <extra_id_1> <extra_id_0> treatment <extra_id_5> clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [13], "text": "treating", "args": [{"type": "subject", "offset": [16, 17], "text": "parkinsonian patients"}, {"type": "subject disorder", "offset": [16], "text": "parkinsonian"}, {"type": "subject disorder", "offset": [14], "text": "psychosis"}, {"type": "treatment", "offset": [5], "text": "risperidone"}, {"type": "drug", "offset": [5], "text": "risperidone"}, {"type": "treatment disorder", "offset": [14], "text": "psychosis"}]}, {"type": "potential therapeutic event", "offset": [13], "text": "treating", "args": [{"type": "subject", "offset": [16, 17], "text": "parkinsonian patients"}, {"type": "subject disorder", "offset": [16], "text": "parkinsonian"}, {"type": "treatment", "offset": [11], "text": "clozapine"}, {"type": "drug", "offset": [11], "text": "clozapine"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treating", "label": "potential therapeutic event", "asoc": [["subject", "parkinsonian patients"], ["subject disorder", "parkinsonian"], ["subject disorder", "psychosis"], ["treatment", "risperidone"], ["drug", "risperidone"], ["treatment disorder", "psychosis"], ["subject", "parkinsonian patients"], ["subject disorder", "parkinsonian"], ["treatment", "clozapine"], ["drug", "clozapine"]]}]}
{"text_id": "21751666_5", "text": "Oseltamivir was effective for post - exposure prophylaxis of H1N1 in close contact .", "tokens": ["Oseltamivir", "was", "effective", "for", "post", "-", "exposure", "prophylaxis", "of", "H1N1", "in", "close", "contact", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> post - exposure prophylaxis <extra_id_0> treatment <extra_id_5> Oseltamivir <extra_id_1> <extra_id_0> drug <extra_id_5> Oseltamivir <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> H1N1 <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [4, 5, 6, 7], "text": "post - exposure prophylaxis", "args": [{"type": "treatment", "offset": [0], "text": "Oseltamivir"}, {"type": "drug", "offset": [0], "text": "Oseltamivir"}, {"type": "treatment disorder", "offset": [9], "text": "H1N1"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "post - exposure prophylaxis", "label": "potential therapeutic event", "asoc": [["treatment", "Oseltamivir"], ["drug", "Oseltamivir"], ["treatment disorder", "H1N1"]]}]}
{"text_id": "11576059_1", "text": "Vocal cord paralysis as a consequence of peritonsillar infiltration with bupivacaine .", "tokens": ["Vocal", "cord", "paralysis", "as", "a", "consequence", "of", "peritonsillar", "infiltration", "with", "bupivacaine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> consequence <extra_id_0> treatment <extra_id_5> peritonsillar infiltration with bupivacaine <extra_id_1> <extra_id_0> drug <extra_id_5> bupivacaine <extra_id_1> <extra_id_0> route <extra_id_5> peritonsillar infiltration <extra_id_1> <extra_id_0> effect <extra_id_5> Vocal cord paralysis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "consequence", "args": [{"type": "treatment", "offset": [7, 8, 9, 10], "text": "peritonsillar infiltration with bupivacaine"}, {"type": "drug", "offset": [10], "text": "bupivacaine"}, {"type": "route", "offset": [7, 8], "text": "peritonsillar infiltration"}, {"type": "effect", "offset": [0, 1, 2], "text": "Vocal cord paralysis"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "consequence", "label": "adverse event", "asoc": [["treatment", "peritonsillar infiltration with bupivacaine"], ["drug", "bupivacaine"], ["route", "peritonsillar infiltration"], ["effect", "Vocal cord paralysis"]]}]}
{"text_id": "17228132_8", "text": "Hepatotoxicity resolved once erlotinib was discontinued and serum transaminases returned to baseline normal values .", "tokens": ["Hepatotoxicity", "resolved", "once", "erlotinib", "was", "discontinued", "and", "serum", "transaminases", "returned", "to", "baseline", "normal", "values", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> discontinued <extra_id_0> treatment <extra_id_5> erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Hepatotoxicity <extra_id_1> <extra_id_0> effect <extra_id_5> Hepatotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [5], "text": "discontinued", "args": [{"type": "treatment", "offset": [3], "text": "erlotinib"}, {"type": "drug", "offset": [3], "text": "erlotinib"}, {"type": "treatment disorder", "offset": [0], "text": "Hepatotoxicity"}, {"type": "effect", "offset": [0], "text": "Hepatotoxicity"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "discontinued", "label": "potential therapeutic event", "asoc": [["treatment", "erlotinib"], ["drug", "erlotinib"], ["treatment disorder", "Hepatotoxicity"], ["effect", "Hepatotoxicity"]]}]}
{"text_id": "8926752_1", "text": "Zolpidem ( Ambien ) , a relatively new nonbenzodiazepine sedative - hypnotic , was involved in the death of a 39 - year - old obese male who was being treated for depression and insomnia .", "tokens": ["Zolpidem", "(", "Ambien", ")", ",", "a", "relatively", "new", "nonbenzodiazepine", "sedative", "-", "hypnotic", ",", "was", "involved", "in", "the", "death", "of", "a", "39", "-", "year", "-", "old", "obese", "male", "who", "was", "being", "treated", "for", "depression", "and", "insomnia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> involved <extra_id_0> subject <extra_id_5> a 39 - year - old obese male <extra_id_1> <extra_id_0> age <extra_id_5> 39 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> male <extra_id_1> <extra_id_0> subject disorder <extra_id_5> obese <extra_id_1> <extra_id_0> subject disorder <extra_id_5> depression and insomnia <extra_id_1> <extra_id_0> treatment <extra_id_5> Zolpidem ( Ambien ) <extra_id_1> <extra_id_0> drug <extra_id_5> Zolpidem <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> depression and insomnia <extra_id_1> <extra_id_0> effect <extra_id_5> death <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "involved", "args": [{"type": "subject", "offset": [19, 20, 21, 22, 23, 24, 25, 26], "text": "a 39 - year - old obese male"}, {"type": "age", "offset": [20, 21, 22, 23, 24], "text": "39 - year - old"}, {"type": "gender", "offset": [26], "text": "male"}, {"type": "subject disorder", "offset": [25], "text": "obese"}, {"type": "subject disorder", "offset": [32, 33, 34], "text": "depression and insomnia"}, {"type": "treatment", "offset": [0, 1, 2, 3], "text": "Zolpidem ( Ambien )"}, {"type": "drug", "offset": [0], "text": "Zolpidem"}, {"type": "treatment disorder", "offset": [32, 33, 34], "text": "depression and insomnia"}, {"type": "effect", "offset": [17], "text": "death"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "involved", "label": "adverse event", "asoc": [["subject", "a 39 - year - old obese male"], ["age", "39 - year - old"], ["gender", "male"], ["subject disorder", "obese"], ["subject disorder", "depression and insomnia"], ["treatment", "Zolpidem ( Ambien )"], ["drug", "Zolpidem"], ["treatment disorder", "depression and insomnia"], ["effect", "death"]]}]}
{"text_id": "9804082_2", "text": "We observed 3 diabetic patients with intolerable dizziness followed by nausea and vomiting immediately after an initial administration of the alpha - glucosidase inhibitor , voglibose .", "tokens": ["We", "observed", "3", "diabetic", "patients", "with", "intolerable", "dizziness", "followed", "by", "nausea", "and", "vomiting", "immediately", "after", "an", "initial", "administration", "of", "the", "alpha", "-", "glucosidase", "inhibitor", ",", "voglibose", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> 3 diabetic patients <extra_id_1> <extra_id_0> population <extra_id_5> 3 <extra_id_1> <extra_id_0> subject disorder <extra_id_5> diabetic <extra_id_1> <extra_id_0> treatment <extra_id_5> an initial administration of the alpha - glucosidase inhibitor , voglibose <extra_id_1> <extra_id_0> drug <extra_id_5> voglibose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> diabetic <extra_id_1> <extra_id_0> effect <extra_id_5> intolerable dizziness followed by nausea and vomiting <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "after", "args": [{"type": "subject", "offset": [2, 3, 4], "text": "3 diabetic patients"}, {"type": "population", "offset": [2], "text": "3"}, {"type": "subject disorder", "offset": [3], "text": "diabetic"}, {"type": "treatment", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "an initial administration of the alpha - glucosidase inhibitor , voglibose"}, {"type": "drug", "offset": [25], "text": "voglibose"}, {"type": "treatment disorder", "offset": [3], "text": "diabetic"}, {"type": "effect", "offset": [6, 7, 8, 9, 10, 11, 12], "text": "intolerable dizziness followed by nausea and vomiting"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "3 diabetic patients"], ["population", "3"], ["subject disorder", "diabetic"], ["treatment", "an initial administration of the alpha - glucosidase inhibitor , voglibose"], ["drug", "voglibose"], ["treatment disorder", "diabetic"], ["effect", "intolerable dizziness followed by nausea and vomiting"]]}]}
{"text_id": "115078_1", "text": "A patient with rheumatoid arthritis developed an acute intrahepatic cholestasis after 100 mg of sodium aurothiomalate .", "tokens": ["A", "patient", "with", "rheumatoid", "arthritis", "developed", "an", "acute", "intrahepatic", "cholestasis", "after", "100", "mg", "of", "sodium", "aurothiomalate", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A patient with rheumatoid arthritis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> 100 mg of sodium aurothiomalate <extra_id_1> <extra_id_0> drug <extra_id_5> sodium aurothiomalate <extra_id_1> <extra_id_0> dosage <extra_id_5> 100 mg <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> effect <extra_id_5> acute intrahepatic cholestasis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4], "text": "A patient with rheumatoid arthritis"}, {"type": "subject disorder", "offset": [3, 4], "text": "rheumatoid arthritis"}, {"type": "treatment", "offset": [11, 12, 13, 14, 15], "text": "100 mg of sodium aurothiomalate"}, {"type": "drug", "offset": [14, 15], "text": "sodium aurothiomalate"}, {"type": "dosage", "offset": [11, 12], "text": "100 mg"}, {"type": "treatment disorder", "offset": [3, 4], "text": "rheumatoid arthritis"}, {"type": "effect", "offset": [7, 8, 9], "text": "acute intrahepatic cholestasis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "dosage", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A patient with rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "100 mg of sodium aurothiomalate"], ["drug", "sodium aurothiomalate"], ["dosage", "100 mg"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "acute intrahepatic cholestasis"]]}]}
{"text_id": "19423610_4", "text": "We offered several tentative explanations for this event , including an adverse interaction between paroxetine and other agent(s ) used in the course of the anaesthesia .", "tokens": ["We", "offered", "several", "tentative", "explanations", "for", "this", "event", ",", "including", "an", "adverse", "interaction", "between", "paroxetine", "and", "other", "agent(s", ")", "used", "in", "the", "course", "of", "the", "anaesthesia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> between <extra_id_0> treatment <extra_id_5> paroxetine and other agent(s ) <extra_id_1> <extra_id_0> drug <extra_id_5> paroxetine <extra_id_1> <extra_id_0> drug <extra_id_5> anaesthesia <extra_id_1> <extra_id_0> combination drug <extra_id_5> anaesthesia <extra_id_1> <extra_id_0> combination drug <extra_id_5> paroxetine <extra_id_1> <extra_id_0> effect <extra_id_5> adverse interaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "between", "args": [{"type": "treatment", "offset": [14, 15, 16, 17, 18], "text": "paroxetine and other agent(s )"}, {"type": "drug", "offset": [14], "text": "paroxetine"}, {"type": "drug", "offset": [25], "text": "anaesthesia"}, {"type": "combination drug", "offset": [25], "text": "anaesthesia"}, {"type": "combination drug", "offset": [14], "text": "paroxetine"}, {"type": "effect", "offset": [11, 12], "text": "adverse interaction"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "between", "label": "adverse event", "asoc": [["treatment", "paroxetine and other agent(s )"], ["drug", "paroxetine"], ["drug", "anaesthesia"], ["combination drug", "anaesthesia"], ["combination drug", "paroxetine"], ["effect", "adverse interaction"]]}]}
{"text_id": "6292681_1", "text": "Severe neurotoxicity with methyl G : CALGB experience .", "tokens": ["Severe", "neurotoxicity", "with", "methyl", "G", ":", "CALGB", "experience", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> with <extra_id_0> treatment <extra_id_5> methyl G <extra_id_1> <extra_id_0> drug <extra_id_5> methyl G <extra_id_1> <extra_id_0> effect <extra_id_5> neurotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "with", "args": [{"type": "treatment", "offset": [3, 4], "text": "methyl G"}, {"type": "drug", "offset": [3, 4], "text": "methyl G"}, {"type": "effect", "offset": [1], "text": "neurotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "with", "label": "adverse event", "asoc": [["treatment", "methyl G"], ["drug", "methyl G"], ["effect", "neurotoxicity"]]}]}
{"text_id": "8828999_1", "text": "a 67 - year - old man with bipolar disorder developed a Creutzfeldt - Jakob like syndrome during lithium carbonate treatment .", "tokens": ["a", "67", "-", "year", "-", "old", "man", "with", "bipolar", "disorder", "developed", "a", "Creutzfeldt", "-", "Jakob", "like", "syndrome", "during", "lithium", "carbonate", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> subject <extra_id_5> a 67 - year - old man with bipolar disorder <extra_id_1> <extra_id_0> age <extra_id_5> 67 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> bipolar disorder <extra_id_1> <extra_id_0> treatment <extra_id_5> lithium carbonate <extra_id_1> <extra_id_0> drug <extra_id_5> lithium carbonate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> bipolar disorder <extra_id_1> <extra_id_0> effect <extra_id_5> Creutzfeldt - Jakob like syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "during", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9], "text": "a 67 - year - old man with bipolar disorder"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "67 - year - old"}, {"type": "gender", "offset": [6], "text": "man"}, {"type": "subject disorder", "offset": [8, 9], "text": "bipolar disorder"}, {"type": "treatment", "offset": [18, 19], "text": "lithium carbonate"}, {"type": "drug", "offset": [18, 19], "text": "lithium carbonate"}, {"type": "treatment disorder", "offset": [8, 9], "text": "bipolar disorder"}, {"type": "effect", "offset": [12, 13, 14, 15, 16], "text": "Creutzfeldt - Jakob like syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["subject", "a 67 - year - old man with bipolar disorder"], ["age", "67 - year - old"], ["gender", "man"], ["subject disorder", "bipolar disorder"], ["treatment", "lithium carbonate"], ["drug", "lithium carbonate"], ["treatment disorder", "bipolar disorder"], ["effect", "Creutzfeldt - Jakob like syndrome"]]}]}
{"text_id": "4054170_2", "text": "Chlorambucil central nervous toxicity : a significant side effect of chlorambucil therapy in childhood nephrotic syndrome .", "tokens": ["Chlorambucil", "central", "nervous", "toxicity", ":", "a", "significant", "side", "effect", "of", "chlorambucil", "therapy", "in", "childhood", "nephrotic", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> side effect <extra_id_0> treatment <extra_id_5> Chlorambucil <extra_id_1> <extra_id_0> drug <extra_id_5> Chlorambucil <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> childhood nephrotic syndrome <extra_id_1> <extra_id_0> effect <extra_id_5> central nervous toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7, 8], "text": "side effect", "args": [{"type": "treatment", "offset": [0], "text": "Chlorambucil"}, {"type": "drug", "offset": [0], "text": "Chlorambucil"}, {"type": "treatment disorder", "offset": [13, 14, 15], "text": "childhood nephrotic syndrome"}, {"type": "effect", "offset": [1, 2, 3], "text": "central nervous toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "side effect", "label": "adverse event", "asoc": [["treatment", "Chlorambucil"], ["drug", "Chlorambucil"], ["treatment disorder", "childhood nephrotic syndrome"], ["effect", "central nervous toxicity"]]}]}
{"text_id": "12875956_3", "text": "The psychotic behavior resolved completely soon after the discontinuation of levetiracetam .", "tokens": ["The", "psychotic", "behavior", "resolved", "completely", "soon", "after", "the", "discontinuation", "of", "levetiracetam", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> resolved <extra_id_0> treatment <extra_id_5> discontinuation of levetiracetam <extra_id_1> <extra_id_0> drug <extra_id_5> levetiracetam <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> psychotic behavior <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [3], "text": "resolved", "args": [{"type": "treatment", "offset": [8, 9, 10], "text": "discontinuation of levetiracetam"}, {"type": "drug", "offset": [10], "text": "levetiracetam"}, {"type": "treatment disorder", "offset": [1, 2], "text": "psychotic behavior"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "resolved", "label": "potential therapeutic event", "asoc": [["treatment", "discontinuation of levetiracetam"], ["drug", "levetiracetam"], ["treatment disorder", "psychotic behavior"]]}]}
{"text_id": "8651254_1", "text": "Development of nephrotic syndrome in a patient with acute myeloblastic leukemia after treatment with macrophage - colony - stimulating factor .", "tokens": ["Development", "of", "nephrotic", "syndrome", "in", "a", "patient", "with", "acute", "myeloblastic", "leukemia", "after", "treatment", "with", "macrophage", "-", "colony", "-", "stimulating", "factor", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a patient with acute myeloblastic leukemia <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute myeloblastic leukemia <extra_id_1> <extra_id_0> treatment <extra_id_5> macrophage - colony - stimulating factor <extra_id_1> <extra_id_0> drug <extra_id_5> macrophage - colony - stimulating factor <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute myeloblastic leukemia <extra_id_1> <extra_id_0> effect <extra_id_5> nephrotic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "after", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10], "text": "a patient with acute myeloblastic leukemia"}, {"type": "subject disorder", "offset": [8, 9, 10], "text": "acute myeloblastic leukemia"}, {"type": "treatment", "offset": [14, 15, 16, 17, 18, 19], "text": "macrophage - colony - stimulating factor"}, {"type": "drug", "offset": [14, 15, 16, 17, 18, 19], "text": "macrophage - colony - stimulating factor"}, {"type": "treatment disorder", "offset": [8, 9, 10], "text": "acute myeloblastic leukemia"}, {"type": "effect", "offset": [2, 3], "text": "nephrotic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a patient with acute myeloblastic leukemia"], ["subject disorder", "acute myeloblastic leukemia"], ["treatment", "macrophage - colony - stimulating factor"], ["drug", "macrophage - colony - stimulating factor"], ["treatment disorder", "acute myeloblastic leukemia"], ["effect", "nephrotic syndrome"]]}]}
{"text_id": "19775485_2", "text": "We report here a case of cardiovascular and neurological depression induced by oxymetalzoline in a toddler .", "tokens": ["We", "report", "here", "a", "case", "of", "cardiovascular", "and", "neurological", "depression", "induced", "by", "oxymetalzoline", "in", "a", "toddler", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a toddler <extra_id_1> <extra_id_0> age <extra_id_5> toddler <extra_id_1> <extra_id_0> treatment <extra_id_5> oxymetalzoline <extra_id_1> <extra_id_0> drug <extra_id_5> oxymetalzoline <extra_id_1> <extra_id_0> effect <extra_id_5> cardiovascular and neurological depression <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "induced", "args": [{"type": "subject", "offset": [14, 15], "text": "a toddler"}, {"type": "age", "offset": [15], "text": "toddler"}, {"type": "treatment", "offset": [12], "text": "oxymetalzoline"}, {"type": "drug", "offset": [12], "text": "oxymetalzoline"}, {"type": "effect", "offset": [6, 7, 8, 9], "text": "cardiovascular and neurological depression"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a toddler"], ["age", "toddler"], ["treatment", "oxymetalzoline"], ["drug", "oxymetalzoline"], ["effect", "cardiovascular and neurological depression"]]}]}
{"text_id": "7787496_1", "text": "Sotalol - induced bradycardia reversed by glucagon .", "tokens": ["Sotalol", "-", "induced", "bradycardia", "reversed", "by", "glucagon", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> reversed <extra_id_0> treatment <extra_id_5> glucagon <extra_id_1> <extra_id_0> drug <extra_id_5> glucagon <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Sotalol - induced bradycardia <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Sotalol <extra_id_1> <extra_id_0> drug <extra_id_5> Sotalol <extra_id_1> <extra_id_0> effect <extra_id_5> bradycardia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [4], "text": "reversed", "args": [{"type": "treatment", "offset": [6], "text": "glucagon"}, {"type": "drug", "offset": [6], "text": "glucagon"}, {"type": "treatment disorder", "offset": [0, 1, 2, 3], "text": "Sotalol - induced bradycardia"}]}, {"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Sotalol"}, {"type": "drug", "offset": [0], "text": "Sotalol"}, {"type": "effect", "offset": [3], "text": "bradycardia"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "reversed", "label": "potential therapeutic event", "asoc": [["treatment", "glucagon"], ["drug", "glucagon"], ["treatment disorder", "Sotalol - induced bradycardia"]]}, {"span": "induced", "label": "adverse event", "asoc": [["treatment", "Sotalol"], ["drug", "Sotalol"], ["effect", "bradycardia"]]}]}
{"text_id": "9161656_5", "text": "Antiasthmatic medications were prescribed , but the asthma symptoms did not improve .", "tokens": ["Antiasthmatic", "medications", "were", "prescribed", ",", "but", "the", "asthma", "symptoms", "did", "not", "improve", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> improve <extra_id_0> treatment <extra_id_5> Antiasthmatic medications were prescribed <extra_id_1> <extra_id_0> drug <extra_id_5> Antiasthmatic medications <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> asthma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [11], "text": "improve", "args": [{"type": "treatment", "offset": [0, 1, 2, 3], "text": "Antiasthmatic medications were prescribed"}, {"type": "drug", "offset": [0, 1], "text": "Antiasthmatic medications"}, {"type": "treatment disorder", "offset": [7], "text": "asthma"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "improve", "label": "potential therapeutic event", "asoc": [["treatment", "Antiasthmatic medications were prescribed"], ["drug", "Antiasthmatic medications"], ["treatment disorder", "asthma"]]}]}
{"text_id": "17624096_1", "text": "5 - Fluorouracil cardiotoxicity complicating treatment of stage IIB cervical cancer -- case report .", "tokens": ["5", "-", "Fluorouracil", "cardiotoxicity", "complicating", "treatment", "of", "stage", "IIB", "cervical", "cancer", "--", "case", "report", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complicating <extra_id_0> treatment <extra_id_5> 5 - Fluorouracil <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - Fluorouracil <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> cervical cancer <extra_id_1> <extra_id_0> effect <extra_id_5> cardiotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "complicating", "args": [{"type": "treatment", "offset": [0, 1, 2], "text": "5 - Fluorouracil"}, {"type": "drug", "offset": [0, 1, 2], "text": "5 - Fluorouracil"}, {"type": "treatment disorder", "offset": [9, 10], "text": "cervical cancer"}, {"type": "effect", "offset": [3], "text": "cardiotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "complicating", "label": "adverse event", "asoc": [["treatment", "5 - Fluorouracil"], ["drug", "5 - Fluorouracil"], ["treatment disorder", "cervical cancer"], ["effect", "cardiotoxicity"]]}]}
{"text_id": "16463436_1", "text": "Some patients develop hypersensitivity rash in response to HCQ .", "tokens": ["Some", "patients", "develop", "hypersensitivity", "rash", "in", "response", "to", "HCQ", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> develop <extra_id_0> subject <extra_id_5> Some patients <extra_id_1> <extra_id_0> population <extra_id_5> Some <extra_id_1> <extra_id_0> treatment <extra_id_5> HCQ <extra_id_1> <extra_id_0> drug <extra_id_5> HCQ <extra_id_1> <extra_id_0> effect <extra_id_5> hypersensitivity rash <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "develop", "args": [{"type": "subject", "offset": [0, 1], "text": "Some patients"}, {"type": "population", "offset": [0], "text": "Some"}, {"type": "treatment", "offset": [8], "text": "HCQ"}, {"type": "drug", "offset": [8], "text": "HCQ"}, {"type": "effect", "offset": [3, 4], "text": "hypersensitivity rash"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "develop", "label": "adverse event", "asoc": [["subject", "Some patients"], ["population", "Some"], ["treatment", "HCQ"], ["drug", "HCQ"], ["effect", "hypersensitivity rash"]]}]}
{"text_id": "15866658_2", "text": "Mycophenolate mofetil - induced neutropenia in liver transplantation .", "tokens": ["Mycophenolate", "mofetil", "-", "induced", "neutropenia", "in", "liver", "transplantation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Mycophenolate mofetil <extra_id_1> <extra_id_0> drug <extra_id_5> Mycophenolate mofetil <extra_id_1> <extra_id_0> effect <extra_id_5> neutropenia in liver transplantation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "induced", "args": [{"type": "treatment", "offset": [0, 1], "text": "Mycophenolate mofetil"}, {"type": "drug", "offset": [0, 1], "text": "Mycophenolate mofetil"}, {"type": "effect", "offset": [4, 5, 6, 7], "text": "neutropenia in liver transplantation"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Mycophenolate mofetil"], ["drug", "Mycophenolate mofetil"], ["effect", "neutropenia in liver transplantation"]]}]}
{"text_id": "8530331_2", "text": "BACKGROUND : We report six cases of psychosis in patients with akinetic - rigid syndromes who were treated with risperidone .", "tokens": ["BACKGROUND", ":", "We", "report", "six", "cases", "of", "psychosis", "in", "patients", "with", "akinetic", "-", "rigid", "syndromes", "who", "were", "treated", "with", "risperidone", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treated <extra_id_0> subject <extra_id_5> six cases <extra_id_1> <extra_id_0> subject <extra_id_5> patients with akinetic - rigid syndromes <extra_id_1> <extra_id_0> population <extra_id_5> six <extra_id_1> <extra_id_0> subject disorder <extra_id_5> akinetic - rigid syndromes <extra_id_1> <extra_id_0> subject disorder <extra_id_5> psychosis <extra_id_1> <extra_id_0> treatment <extra_id_5> risperidone <extra_id_1> <extra_id_0> drug <extra_id_5> risperidone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> psychosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [17], "text": "treated", "args": [{"type": "subject", "offset": [4, 5], "text": "six cases"}, {"type": "subject", "offset": [9, 10, 11, 12, 13, 14], "text": "patients with akinetic - rigid syndromes"}, {"type": "population", "offset": [4], "text": "six"}, {"type": "subject disorder", "offset": [11, 12, 13, 14], "text": "akinetic - rigid syndromes"}, {"type": "subject disorder", "offset": [7], "text": "psychosis"}, {"type": "treatment", "offset": [19], "text": "risperidone"}, {"type": "drug", "offset": [19], "text": "risperidone"}, {"type": "treatment disorder", "offset": [7], "text": "psychosis"}]}], "spot": ["potential therapeutic event"], "asoc": ["population", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "potential therapeutic event", "asoc": [["subject", "six cases"], ["subject", "patients with akinetic - rigid syndromes"], ["population", "six"], ["subject disorder", "akinetic - rigid syndromes"], ["subject disorder", "psychosis"], ["treatment", "risperidone"], ["drug", "risperidone"], ["treatment disorder", "psychosis"]]}]}
{"text_id": "15482394_4", "text": "In view of our experience in the present case , it should be stressed that close monitoring of coagulation capacity is necessary in critically ill patients in order to avoid fatal haemorrhage after initiating warfarin therapy regardless of the dosage .", "tokens": ["In", "view", "of", "our", "experience", "in", "the", "present", "case", ",", "it", "should", "be", "stressed", "that", "close", "monitoring", "of", "coagulation", "capacity", "is", "necessary", "in", "critically", "ill", "patients", "in", "order", "to", "avoid", "fatal", "haemorrhage", "after", "initiating", "warfarin", "therapy", "regardless", "of", "the", "dosage", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> initiating warfarin therapy regardless of the dosage <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> haemorrhage <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [32], "text": "after", "args": [{"type": "treatment", "offset": [33, 34, 35, 36, 37, 38, 39], "text": "initiating warfarin therapy regardless of the dosage"}, {"type": "drug", "offset": [34], "text": "warfarin"}, {"type": "effect", "offset": [31], "text": "haemorrhage"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "initiating warfarin therapy regardless of the dosage"], ["drug", "warfarin"], ["effect", "haemorrhage"]]}]}
{"text_id": "18446030_1", "text": "Disseminated eruptive giant mollusca contagiosa in an adult psoriasis patient during efalizumab therapy .", "tokens": ["Disseminated", "eruptive", "giant", "mollusca", "contagiosa", "in", "an", "adult", "psoriasis", "patient", "during", "efalizumab", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> subject <extra_id_5> an adult psoriasis patient <extra_id_1> <extra_id_0> age <extra_id_5> adult <extra_id_1> <extra_id_0> subject disorder <extra_id_5> psoriasis <extra_id_1> <extra_id_0> treatment <extra_id_5> efalizumab therapy <extra_id_1> <extra_id_0> drug <extra_id_5> efalizumab <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> psoriasis <extra_id_1> <extra_id_0> effect <extra_id_5> Disseminated eruptive giant mollusca contagiosa <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "during", "args": [{"type": "subject", "offset": [6, 7, 8, 9], "text": "an adult psoriasis patient"}, {"type": "age", "offset": [7], "text": "adult"}, {"type": "subject disorder", "offset": [8], "text": "psoriasis"}, {"type": "treatment", "offset": [11, 12], "text": "efalizumab therapy"}, {"type": "drug", "offset": [11], "text": "efalizumab"}, {"type": "treatment disorder", "offset": [8], "text": "psoriasis"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Disseminated eruptive giant mollusca contagiosa"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["subject", "an adult psoriasis patient"], ["age", "adult"], ["subject disorder", "psoriasis"], ["treatment", "efalizumab therapy"], ["drug", "efalizumab"], ["treatment disorder", "psoriasis"], ["effect", "Disseminated eruptive giant mollusca contagiosa"]]}]}
{"text_id": "11876387_2", "text": "Since tamoxifen therapy can induce endometrial disorders , surveillance schemes of women taking tamoxifen have been recommended .", "tokens": ["Since", "tamoxifen", "therapy", "can", "induce", "endometrial", "disorders", ",", "surveillance", "schemes", "of", "women", "taking", "tamoxifen", "have", "been", "recommended", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induce <extra_id_0> subject <extra_id_5> women <extra_id_1> <extra_id_0> gender <extra_id_5> women <extra_id_1> <extra_id_0> treatment <extra_id_5> tamoxifen therapy <extra_id_1> <extra_id_0> drug <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> effect <extra_id_5> endometrial disorders <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "induce", "args": [{"type": "subject", "offset": [11], "text": "women"}, {"type": "gender", "offset": [11], "text": "women"}, {"type": "treatment", "offset": [1, 2], "text": "tamoxifen therapy"}, {"type": "drug", "offset": [1], "text": "tamoxifen"}, {"type": "effect", "offset": [5, 6], "text": "endometrial disorders"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "gender", "treatment"], "spot_asoc": [{"span": "induce", "label": "adverse event", "asoc": [["subject", "women"], ["gender", "women"], ["treatment", "tamoxifen therapy"], ["drug", "tamoxifen"], ["effect", "endometrial disorders"]]}]}
{"text_id": "9876812_4", "text": "Syndrome of inappropriate antidiuretic hormone associated with vinorelbine therapy .", "tokens": ["Syndrome", "of", "inappropriate", "antidiuretic", "hormone", "associated", "with", "vinorelbine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> vinorelbine <extra_id_1> <extra_id_0> drug <extra_id_5> vinorelbine <extra_id_1> <extra_id_0> effect <extra_id_5> Syndrome of inappropriate antidiuretic hormone <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "associated", "args": [{"type": "treatment", "offset": [7], "text": "vinorelbine"}, {"type": "drug", "offset": [7], "text": "vinorelbine"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Syndrome of inappropriate antidiuretic hormone"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "vinorelbine"], ["drug", "vinorelbine"], ["effect", "Syndrome of inappropriate antidiuretic hormone"]]}]}
{"text_id": "2006943_1", "text": "Type I second - degree AV block ( Mobitz type I , Wenckebach AV block ) during ritodrine therapy for preterm labor .", "tokens": ["Type", "I", "second", "-", "degree", "AV", "block", "(", "Mobitz", "type", "I", ",", "Wenckebach", "AV", "block", ")", "during", "ritodrine", "therapy", "for", "preterm", "labor", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> ritodrine <extra_id_1> <extra_id_0> drug <extra_id_5> ritodrine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> preterm labor <extra_id_1> <extra_id_0> effect <extra_id_5> Type I second - degree AV block ( Mobitz type I , Wenckebach AV block ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "during", "args": [{"type": "treatment", "offset": [17], "text": "ritodrine"}, {"type": "drug", "offset": [17], "text": "ritodrine"}, {"type": "treatment disorder", "offset": [20, 21], "text": "preterm labor"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "Type I second - degree AV block ( Mobitz type I , Wenckebach AV block )"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "ritodrine"], ["drug", "ritodrine"], ["treatment disorder", "preterm labor"], ["effect", "Type I second - degree AV block ( Mobitz type I , Wenckebach AV block )"]]}]}
{"text_id": "17873198_3", "text": "Similar to reports in patients receiving gefitinib , those with pathologic findings of UIP on resected lung specimens or known pulmonary fibrosis may be at particular risk for erlotinib pulmonary toxicity .", "tokens": ["Similar", "to", "reports", "in", "patients", "receiving", "gefitinib", ",", "those", "with", "pathologic", "findings", "of", "UIP", "on", "resected", "lung", "specimens", "or", "known", "pulmonary", "fibrosis", "may", "be", "at", "particular", "risk", "for", "erlotinib", "pulmonary", "toxicity", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> receiving <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> treatment <extra_id_5> gefitinib <extra_id_1> <extra_id_0> drug <extra_id_5> gefitinib <extra_id_1> <extra_id_0> effect <extra_id_5> erlotinib pulmonary toxicity . <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "receiving", "args": [{"type": "subject", "offset": [4], "text": "patients"}, {"type": "treatment", "offset": [6], "text": "gefitinib"}, {"type": "drug", "offset": [6], "text": "gefitinib"}, {"type": "effect", "offset": [28, 29, 30, 31], "text": "erlotinib pulmonary toxicity ."}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "receiving", "label": "adverse event", "asoc": [["subject", "patients"], ["treatment", "gefitinib"], ["drug", "gefitinib"], ["effect", "erlotinib pulmonary toxicity ."]]}]}
{"text_id": "19423610_1", "text": "Risk of severe serotonin toxicity following co - administration of methylene blue and serotonin reuptake inhibitors : an update on a case report of post - operative delirium .", "tokens": ["Risk", "of", "severe", "serotonin", "toxicity", "following", "co", "-", "administration", "of", "methylene", "blue", "and", "serotonin", "reuptake", "inhibitors", ":", "an", "update", "on", "a", "case", "report", "of", "post", "-", "operative", "delirium", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> co - administration of methylene blue and serotonin reuptake inhibitors <extra_id_1> <extra_id_0> drug <extra_id_5> methylene blue <extra_id_1> <extra_id_0> drug <extra_id_5> serotonin reuptake inhibitors <extra_id_1> <extra_id_0> combination drug <extra_id_5> methylene blue <extra_id_1> <extra_id_0> combination drug <extra_id_5> serotonin reuptake inhibitors <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin toxicity <extra_id_1> <extra_id_0> effect <extra_id_5> post - operative delirium <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "following", "args": [{"type": "treatment", "offset": [6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "co - administration of methylene blue and serotonin reuptake inhibitors"}, {"type": "drug", "offset": [10, 11], "text": "methylene blue"}, {"type": "drug", "offset": [13, 14, 15], "text": "serotonin reuptake inhibitors"}, {"type": "combination drug", "offset": [10, 11], "text": "methylene blue"}, {"type": "combination drug", "offset": [13, 14, 15], "text": "serotonin reuptake inhibitors"}, {"type": "effect", "offset": [3, 4], "text": "serotonin toxicity"}, {"type": "effect", "offset": [24, 25, 26, 27], "text": "post - operative delirium"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "co - administration of methylene blue and serotonin reuptake inhibitors"], ["drug", "methylene blue"], ["drug", "serotonin reuptake inhibitors"], ["combination drug", "methylene blue"], ["combination drug", "serotonin reuptake inhibitors"], ["effect", "serotonin toxicity"], ["effect", "post - operative delirium"]]}]}
{"text_id": "17420198_2", "text": "A case of extrapyramidal symptoms ( EPS ) following administration of aripiprazole to a man with developmental disabilities who had never received antipsychotic medications and had no history of movement disorders is presented .", "tokens": ["A", "case", "of", "extrapyramidal", "symptoms", "(", "EPS", ")", "following", "administration", "of", "aripiprazole", "to", "a", "man", "with", "developmental", "disabilities", "who", "had", "never", "received", "antipsychotic", "medications", "and", "had", "no", "history", "of", "movement", "disorders", "is", "presented", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> subject <extra_id_5> a man with developmental disabilities who had never received antipsychotic medications and had no history of movement disorders is presented <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> developmental disabilities <extra_id_1> <extra_id_0> treatment <extra_id_5> aripiprazole <extra_id_1> <extra_id_0> drug <extra_id_5> aripiprazole <extra_id_1> <extra_id_0> effect <extra_id_5> extrapyramidal symptoms ( EPS ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "following", "args": [{"type": "subject", "offset": [13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32], "text": "a man with developmental disabilities who had never received antipsychotic medications and had no history of movement disorders is presented"}, {"type": "gender", "offset": [14], "text": "man"}, {"type": "subject disorder", "offset": [16, 17], "text": "developmental disabilities"}, {"type": "treatment", "offset": [11], "text": "aripiprazole"}, {"type": "drug", "offset": [11], "text": "aripiprazole"}, {"type": "effect", "offset": [3, 4, 5, 6, 7], "text": "extrapyramidal symptoms ( EPS )"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "gender", "drug", "subject disorder"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["subject", "a man with developmental disabilities who had never received antipsychotic medications and had no history of movement disorders is presented"], ["gender", "man"], ["subject disorder", "developmental disabilities"], ["treatment", "aripiprazole"], ["drug", "aripiprazole"], ["effect", "extrapyramidal symptoms ( EPS )"]]}]}
{"text_id": "11868077_2", "text": "We describe a case of subcutaneous metastasis along the needle track after percutaneous ethanol injection ( PEI ) for treatment of hepatocellular carcinoma .", "tokens": ["We", "describe", "a", "case", "of", "subcutaneous", "metastasis", "along", "the", "needle", "track", "after", "percutaneous", "ethanol", "injection", "(", "PEI", ")", "for", "treatment", "of", "hepatocellular", "carcinoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a case <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hepatocellular carcinoma <extra_id_1> <extra_id_0> treatment <extra_id_5> percutaneous ethanol injection ( PEI ) <extra_id_1> <extra_id_0> drug <extra_id_5> ethanol <extra_id_1> <extra_id_0> route <extra_id_5> injection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hepatocellular carcinoma <extra_id_1> <extra_id_0> effect <extra_id_5> subcutaneous metastasis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "after", "args": [{"type": "subject", "offset": [2, 3], "text": "a case"}, {"type": "subject disorder", "offset": [21, 22], "text": "hepatocellular carcinoma"}, {"type": "treatment", "offset": [12, 13, 14, 15, 16, 17], "text": "percutaneous ethanol injection ( PEI )"}, {"type": "drug", "offset": [13], "text": "ethanol"}, {"type": "route", "offset": [14], "text": "injection"}, {"type": "treatment disorder", "offset": [21, 22], "text": "hepatocellular carcinoma"}, {"type": "effect", "offset": [5, 6], "text": "subcutaneous metastasis"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a case"], ["subject disorder", "hepatocellular carcinoma"], ["treatment", "percutaneous ethanol injection ( PEI )"], ["drug", "ethanol"], ["route", "injection"], ["treatment disorder", "hepatocellular carcinoma"], ["effect", "subcutaneous metastasis"]]}]}
{"text_id": "20185472_1", "text": "The authors report five cases of tremor related to itraconazole therapy , which occurred within 1 - 12 months of initiating treatment and resolved gradually following itraconazole withdrawal .", "tokens": ["The", "authors", "report", "five", "cases", "of", "tremor", "related", "to", "itraconazole", "therapy", ",", "which", "occurred", "within", "1", "-", "12", "months", "of", "initiating", "treatment", "and", "resolved", "gradually", "following", "itraconazole", "withdrawal", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> treatment <extra_id_5> itraconazole therapy , <extra_id_1> <extra_id_0> drug <extra_id_5> itraconazole <extra_id_1> <extra_id_0> duration <extra_id_5> within 1 - 12 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> within 1 - 12 months <extra_id_1> <extra_id_0> effect <extra_id_5> tremor <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "related", "args": [{"type": "treatment", "offset": [9, 10, 11], "text": "itraconazole therapy ,"}, {"type": "drug", "offset": [9], "text": "itraconazole"}, {"type": "duration", "offset": [14, 15, 16, 17, 18], "text": "within 1 - 12 months"}, {"type": "time elapsed", "offset": [14, 15, 16, 17, 18], "text": "within 1 - 12 months"}, {"type": "effect", "offset": [6], "text": "tremor"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "drug", "time elapsed", "treatment"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["treatment", "itraconazole therapy ,"], ["drug", "itraconazole"], ["duration", "within 1 - 12 months"], ["time elapsed", "within 1 - 12 months"], ["effect", "tremor"]]}]}
{"text_id": "12581772_1", "text": "Interstitial pneumonitis associated with sirolimus : a dilemma for lung transplantation .", "tokens": ["Interstitial", "pneumonitis", "associated", "with", "sirolimus", ":", "a", "dilemma", "for", "lung", "transplantation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> sirolimus <extra_id_1> <extra_id_0> drug <extra_id_5> sirolimus <extra_id_1> <extra_id_0> effect <extra_id_5> Interstitial pneumonitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [4], "text": "sirolimus"}, {"type": "drug", "offset": [4], "text": "sirolimus"}, {"type": "effect", "offset": [0, 1], "text": "Interstitial pneumonitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "sirolimus"], ["drug", "sirolimus"], ["effect", "Interstitial pneumonitis"]]}]}
{"text_id": "12324937_2", "text": "CONCLUSION : There are only a few confirmed cases of gemcitabine - associated HUS despite the widespread use of the drug .", "tokens": ["CONCLUSION", ":", "There", "are", "only", "a", "few", "confirmed", "cases", "of", "gemcitabine", "-", "associated", "HUS", "despite", "the", "widespread", "use", "of", "the", "drug", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> effect <extra_id_5> HUS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "associated", "args": [{"type": "treatment", "offset": [10], "text": "gemcitabine"}, {"type": "drug", "offset": [10], "text": "gemcitabine"}, {"type": "effect", "offset": [13], "text": "HUS"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["effect", "HUS"]]}]}
{"text_id": "6830388_1", "text": "Since early symptoms of the toxic effects of theophylline can mimic peptic ulcer disease , cimetidine might be prescribed for the gastrointestinal symptoms with subsequent worsening of theophylline poisoning .", "tokens": ["Since", "early", "symptoms", "of", "the", "toxic", "effects", "of", "theophylline", "can", "mimic", "peptic", "ulcer", "disease", ",", "cimetidine", "might", "be", "prescribed", "for", "the", "gastrointestinal", "symptoms", "with", "subsequent", "worsening", "of", "theophylline", "poisoning", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> prescribed <extra_id_0> treatment <extra_id_5> cimetidine <extra_id_1> <extra_id_0> drug <extra_id_5> cimetidine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> gastrointestinal symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [18], "text": "prescribed", "args": [{"type": "treatment", "offset": [15], "text": "cimetidine"}, {"type": "drug", "offset": [15], "text": "cimetidine"}, {"type": "treatment disorder", "offset": [21, 22], "text": "gastrointestinal symptoms"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "prescribed", "label": "potential therapeutic event", "asoc": [["treatment", "cimetidine"], ["drug", "cimetidine"], ["treatment disorder", "gastrointestinal symptoms"]]}]}
{"text_id": "16960880_2", "text": "Lower extremity arterial thrombosis following sonographically guided thrombin injection of a femoral pseudoaneurysm .", "tokens": ["Lower", "extremity", "arterial", "thrombosis", "following", "sonographically", "guided", "thrombin", "injection", "of", "a", "femoral", "pseudoaneurysm", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> thrombin injection of a femoral pseudoaneurysm <extra_id_1> <extra_id_0> drug <extra_id_5> thrombin <extra_id_1> <extra_id_0> route <extra_id_5> injection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> femoral pseudoaneurysm <extra_id_1> <extra_id_0> effect <extra_id_5> Lower extremity arterial thrombosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "following", "args": [{"type": "treatment", "offset": [7, 8, 9, 10, 11, 12], "text": "thrombin injection of a femoral pseudoaneurysm"}, {"type": "drug", "offset": [7], "text": "thrombin"}, {"type": "route", "offset": [8], "text": "injection"}, {"type": "treatment disorder", "offset": [11, 12], "text": "femoral pseudoaneurysm"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Lower extremity arterial thrombosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "treatment", "treatment disorder"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "thrombin injection of a femoral pseudoaneurysm"], ["drug", "thrombin"], ["route", "injection"], ["treatment disorder", "femoral pseudoaneurysm"], ["effect", "Lower extremity arterial thrombosis"]]}]}
{"text_id": "7594371_1", "text": "Acute sensorineural hearing loss following intravenous ketoralac administration .", "tokens": ["Acute", "sensorineural", "hearing", "loss", "following", "intravenous", "ketoralac", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> intravenous ketoralac <extra_id_1> <extra_id_0> drug <extra_id_5> ketoralac <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> effect <extra_id_5> Acute sensorineural hearing loss <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "following", "args": [{"type": "treatment", "offset": [5, 6], "text": "intravenous ketoralac"}, {"type": "drug", "offset": [6], "text": "ketoralac"}, {"type": "route", "offset": [5], "text": "intravenous"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Acute sensorineural hearing loss"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "intravenous ketoralac"], ["drug", "ketoralac"], ["route", "intravenous"], ["effect", "Acute sensorineural hearing loss"]]}]}
{"text_id": "15543388_3", "text": "PATIENT AND METHOD : A 34 - year - old woman with chronic hepatitis C , genotype 3 , receiving pegylated interferon alpha - 2a and ribavirin for 6 months , developed progressive malaise and anemia 6 months after the end of treatment .", "tokens": ["PATIENT", "AND", "METHOD", ":", "A", "34", "-", "year", "-", "old", "woman", "with", "chronic", "hepatitis", "C", ",", "genotype", "3", ",", "receiving", "pegylated", "interferon", "alpha", "-", "2a", "and", "ribavirin", "for", "6", "months", ",", "developed", "progressive", "malaise", "and", "anemia", "6", "months", "after", "the", "end", "of", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 34 - year - old woman with chronic hepatitis C , genotype 3 <extra_id_1> <extra_id_0> age <extra_id_5> 34 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> genotype 3 <extra_id_1> <extra_id_0> subject disorder <extra_id_5> chronic hepatitis C <extra_id_1> <extra_id_0> treatment <extra_id_5> pegylated interferon alpha - 2a and ribavirin for 6 months <extra_id_1> <extra_id_0> drug <extra_id_5> pegylated interferon alpha - 2a <extra_id_1> <extra_id_0> drug <extra_id_5> ribavirin <extra_id_1> <extra_id_0> duration <extra_id_5> 6 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 6 months <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic hepatitis C <extra_id_1> <extra_id_0> combination drug <extra_id_5> ribavirin <extra_id_1> <extra_id_0> combination drug <extra_id_5> pegylated interferon alpha - 2a <extra_id_1> <extra_id_0> effect <extra_id_5> progressive malaise and anemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [31], "text": "developed", "args": [{"type": "subject", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17], "text": "A 34 - year - old woman with chronic hepatitis C , genotype 3"}, {"type": "age", "offset": [5, 6, 7, 8, 9], "text": "34 - year - old"}, {"type": "gender", "offset": [10], "text": "woman"}, {"type": "subject disorder", "offset": [16, 17], "text": "genotype 3"}, {"type": "subject disorder", "offset": [12, 13, 14], "text": "chronic hepatitis C"}, {"type": "treatment", "offset": [20, 21, 22, 23, 24, 25, 26, 27, 28, 29], "text": "pegylated interferon alpha - 2a and ribavirin for 6 months"}, {"type": "drug", "offset": [20, 21, 22, 23, 24], "text": "pegylated interferon alpha - 2a"}, {"type": "drug", "offset": [26], "text": "ribavirin"}, {"type": "duration", "offset": [28, 29], "text": "6 months"}, {"type": "time elapsed", "offset": [36, 37], "text": "6 months"}, {"type": "treatment disorder", "offset": [12, 13, 14], "text": "chronic hepatitis C"}, {"type": "combination drug", "offset": [26], "text": "ribavirin"}, {"type": "combination drug", "offset": [20, 21, 22, 23, 24], "text": "pegylated interferon alpha - 2a"}, {"type": "effect", "offset": [32, 33, 34, 35], "text": "progressive malaise and anemia"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "duration", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 34 - year - old woman with chronic hepatitis C , genotype 3"], ["age", "34 - year - old"], ["gender", "woman"], ["subject disorder", "genotype 3"], ["subject disorder", "chronic hepatitis C"], ["treatment", "pegylated interferon alpha - 2a and ribavirin for 6 months"], ["drug", "pegylated interferon alpha - 2a"], ["drug", "ribavirin"], ["duration", "6 months"], ["time elapsed", "6 months"], ["treatment disorder", "chronic hepatitis C"], ["combination drug", "ribavirin"], ["combination drug", "pegylated interferon alpha - 2a"], ["effect", "progressive malaise and anemia"]]}]}
{"text_id": "3310776_2", "text": "Captopril - related ( and -induced ? ) asthma .", "tokens": ["Captopril", "-", "related", "(", "and", "-induced", "?", ")", "asthma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> treatment <extra_id_5> Captopril <extra_id_1> <extra_id_0> drug <extra_id_5> Captopril <extra_id_1> <extra_id_0> effect <extra_id_5> asthma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "related", "args": [{"type": "treatment", "offset": [0], "text": "Captopril"}, {"type": "drug", "offset": [0], "text": "Captopril"}, {"type": "effect", "offset": [8], "text": "asthma"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["treatment", "Captopril"], ["drug", "Captopril"], ["effect", "asthma"]]}]}
{"text_id": "21751692_3", "text": "We retrospectively reviewed the records of 7 pediatric oncology patients who received low - dose ketamine in conjunction with propofol for total intravenous anesthesia ( TIVA ) repeatedly for radiation therapy .", "tokens": ["We", "retrospectively", "reviewed", "the", "records", "of", "7", "pediatric", "oncology", "patients", "who", "received", "low", "-", "dose", "ketamine", "in", "conjunction", "with", "propofol", "for", "total", "intravenous", "anesthesia", "(", "TIVA", ")", "repeatedly", "for", "radiation", "therapy", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> received <extra_id_0> subject <extra_id_5> 7 pediatric oncology patients <extra_id_1> <extra_id_0> age <extra_id_5> pediatric <extra_id_1> <extra_id_0> population <extra_id_5> 7 <extra_id_1> <extra_id_0> subject disorder <extra_id_5> oncology <extra_id_1> <extra_id_0> treatment <extra_id_5> low - dose ketamine in conjunction with propofol for total intravenous anesthesia ( TIVA ) repeatedly for radiation therapy <extra_id_1> <extra_id_0> drug <extra_id_5> propofol <extra_id_1> <extra_id_0> drug <extra_id_5> ketamine <extra_id_1> <extra_id_0> dosage <extra_id_5> low - dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> oncology <extra_id_1> <extra_id_0> combination drug <extra_id_5> propofol <extra_id_1> <extra_id_0> combination drug <extra_id_5> ketamine <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [11], "text": "received", "args": [{"type": "subject", "offset": [6, 7, 8, 9], "text": "7 pediatric oncology patients"}, {"type": "age", "offset": [7], "text": "pediatric"}, {"type": "population", "offset": [6], "text": "7"}, {"type": "subject disorder", "offset": [8], "text": "oncology"}, {"type": "treatment", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30], "text": "low - dose ketamine in conjunction with propofol for total intravenous anesthesia ( TIVA ) repeatedly for radiation therapy"}, {"type": "drug", "offset": [19], "text": "propofol"}, {"type": "drug", "offset": [15], "text": "ketamine"}, {"type": "dosage", "offset": [12, 13, 14], "text": "low - dose"}, {"type": "treatment disorder", "offset": [8], "text": "oncology"}, {"type": "combination drug", "offset": [19], "text": "propofol"}, {"type": "combination drug", "offset": [15], "text": "ketamine"}]}], "spot": ["potential therapeutic event"], "asoc": ["dosage", "population", "subject", "treatment disorder", "drug", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "received", "label": "potential therapeutic event", "asoc": [["subject", "7 pediatric oncology patients"], ["age", "pediatric"], ["population", "7"], ["subject disorder", "oncology"], ["treatment", "low - dose ketamine in conjunction with propofol for total intravenous anesthesia ( TIVA ) repeatedly for radiation therapy"], ["drug", "propofol"], ["drug", "ketamine"], ["dosage", "low - dose"], ["treatment disorder", "oncology"], ["combination drug", "propofol"], ["combination drug", "ketamine"]]}]}
{"text_id": "4095247_2", "text": "Subsequent in vivo / vitro studies clearly demonstrated that the neurological effects were due to a synergistic action of desferrioxamine and prochlorperazine , probably resulting in exceptional fluxes of intra / extra cellular iron / copper disturbing noradrenergic and serotonergic systems .", "tokens": ["Subsequent", "in", "vivo", "/", "vitro", "studies", "clearly", "demonstrated", "that", "the", "neurological", "effects", "were", "due", "to", "a", "synergistic", "action", "of", "desferrioxamine", "and", "prochlorperazine", ",", "probably", "resulting", "in", "exceptional", "fluxes", "of", "intra", "/", "extra", "cellular", "iron", "/", "copper", "disturbing", "noradrenergic", "and", "serotonergic", "systems", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> treatment <extra_id_5> desferrioxamine and prochlorperazine <extra_id_1> <extra_id_0> drug <extra_id_5> desferrioxamine <extra_id_1> <extra_id_0> drug <extra_id_5> prochlorperazine <extra_id_1> <extra_id_0> combination drug <extra_id_5> desferrioxamine <extra_id_1> <extra_id_0> combination drug <extra_id_5> prochlorperazine <extra_id_1> <extra_id_0> effect <extra_id_5> neurological effects <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "due", "args": [{"type": "treatment", "offset": [19, 20, 21], "text": "desferrioxamine and prochlorperazine"}, {"type": "drug", "offset": [19], "text": "desferrioxamine"}, {"type": "drug", "offset": [21], "text": "prochlorperazine"}, {"type": "combination drug", "offset": [19], "text": "desferrioxamine"}, {"type": "combination drug", "offset": [21], "text": "prochlorperazine"}, {"type": "effect", "offset": [10, 11], "text": "neurological effects"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["treatment", "desferrioxamine and prochlorperazine"], ["drug", "desferrioxamine"], ["drug", "prochlorperazine"], ["combination drug", "desferrioxamine"], ["combination drug", "prochlorperazine"], ["effect", "neurological effects"]]}]}
{"text_id": "8503421_1", "text": "Although there is one case report of cholesterol crystal embolization following t - PA therapy with only extrarenal manifestations ( N Engl J Med 321:1270 , 1989 ) , this is the first reported case of atheroembolic acute renal failure following t - PA therapy .", "tokens": ["Although", "there", "is", "one", "case", "report", "of", "cholesterol", "crystal", "embolization", "following", "t", "-", "PA", "therapy", "with", "only", "extrarenal", "manifestations", "(", "N", "Engl", "J", "Med", "321:1270", ",", "1989", ")", ",", "this", "is", "the", "first", "reported", "case", "of", "atheroembolic", "acute", "renal", "failure", "following", "t", "-", "PA", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> t - PA therapy <extra_id_1> <extra_id_0> drug <extra_id_5> t - PA <extra_id_1> <extra_id_0> effect <extra_id_5> atheroembolic acute renal failure <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> t - PA <extra_id_1> <extra_id_0> drug <extra_id_5> t - PA <extra_id_1> <extra_id_0> effect <extra_id_5> cholesterol crystal embolization <extra_id_1> <extra_id_0> effect <extra_id_5> with only extrarenal manifestations <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [40], "text": "following", "args": [{"type": "treatment", "offset": [41, 42, 43, 44], "text": "t - PA therapy"}, {"type": "drug", "offset": [41, 42, 43], "text": "t - PA"}, {"type": "effect", "offset": [36, 37, 38, 39], "text": "atheroembolic acute renal failure"}]}, {"type": "adverse event", "offset": [10], "text": "following", "args": [{"type": "treatment", "offset": [11, 12, 13], "text": "t - PA"}, {"type": "drug", "offset": [11, 12, 13], "text": "t - PA"}, {"type": "effect", "offset": [7, 8, 9], "text": "cholesterol crystal embolization"}, {"type": "effect", "offset": [15, 16, 17, 18], "text": "with only extrarenal manifestations"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "t - PA therapy"], ["drug", "t - PA"], ["effect", "atheroembolic acute renal failure"]]}, {"span": "following", "label": "adverse event", "asoc": [["treatment", "t - PA"], ["drug", "t - PA"], ["effect", "cholesterol crystal embolization"], ["effect", "with only extrarenal manifestations"]]}]}
{"text_id": "7663030_1", "text": "Probable propafenone - induced transient global amnesia .", "tokens": ["Probable", "propafenone", "-", "induced", "transient", "global", "amnesia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> propafenone <extra_id_1> <extra_id_0> drug <extra_id_5> propafenone <extra_id_1> <extra_id_0> effect <extra_id_5> transient global amnesia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "induced", "args": [{"type": "treatment", "offset": [1], "text": "propafenone"}, {"type": "drug", "offset": [1], "text": "propafenone"}, {"type": "effect", "offset": [4, 5, 6], "text": "transient global amnesia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "propafenone"], ["drug", "propafenone"], ["effect", "transient global amnesia"]]}]}
{"text_id": "20378385_1", "text": "OBJECTIVE : 1 ) To describe a patient with rheumatoid arthritis receiving adalimumab who developed fever , pancytopenia , splenomegaly , and extreme hyperferritinemia .", "tokens": ["OBJECTIVE", ":", "1", ")", "To", "describe", "a", "patient", "with", "rheumatoid", "arthritis", "receiving", "adalimumab", "who", "developed", "fever", ",", "pancytopenia", ",", "splenomegaly", ",", "and", "extreme", "hyperferritinemia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a patient with rheumatoid arthritis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> adalimumab <extra_id_1> <extra_id_0> drug <extra_id_5> adalimumab <extra_id_1> <extra_id_0> effect <extra_id_5> fever , pancytopenia , splenomegaly , and extreme hyperferritinemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "developed", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10], "text": "a patient with rheumatoid arthritis"}, {"type": "subject disorder", "offset": [9, 10], "text": "rheumatoid arthritis"}, {"type": "treatment", "offset": [12], "text": "adalimumab"}, {"type": "drug", "offset": [12], "text": "adalimumab"}, {"type": "effect", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23], "text": "fever , pancytopenia , splenomegaly , and extreme hyperferritinemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a patient with rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "adalimumab"], ["drug", "adalimumab"], ["effect", "fever , pancytopenia , splenomegaly , and extreme hyperferritinemia"]]}]}
{"text_id": "7854541_3", "text": "Observations in our patient suggest that the leukoencephalopathy that developed in previously reported patients who received 5 - fluorouracil and levamisole may have been caused at least partly by levamisole .", "tokens": ["Observations", "in", "our", "patient", "suggest", "that", "the", "leukoencephalopathy", "that", "developed", "in", "previously", "reported", "patients", "who", "received", "5", "-", "fluorouracil", "and", "levamisole", "may", "have", "been", "caused", "at", "least", "partly", "by", "levamisole", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> treatment <extra_id_5> levamisole <extra_id_1> <extra_id_0> drug <extra_id_5> levamisole <extra_id_1> <extra_id_0> effect <extra_id_5> leukoencephalopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [24], "text": "caused", "args": [{"type": "subject", "offset": [13], "text": "patients"}, {"type": "treatment", "offset": [29], "text": "levamisole"}, {"type": "drug", "offset": [29], "text": "levamisole"}, {"type": "effect", "offset": [7], "text": "leukoencephalopathy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["subject", "patients"], ["treatment", "levamisole"], ["drug", "levamisole"], ["effect", "leukoencephalopathy"]]}]}
{"text_id": "6093724_1", "text": "A healthy , 30 - year - old man , exposed to sulindac on two separate occasions , had an incapacitating isolated idential sensory neuropathy .", "tokens": ["A", "healthy", ",", "30", "-", "year", "-", "old", "man", ",", "exposed", "to", "sulindac", "on", "two", "separate", "occasions", ",", "had", "an", "incapacitating", "isolated", "idential", "sensory", "neuropathy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> exposed <extra_id_0> subject <extra_id_5> A healthy , 30 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 30 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> sulindac <extra_id_1> <extra_id_0> drug <extra_id_5> sulindac <extra_id_1> <extra_id_0> effect <extra_id_5> incapacitating isolated idential sensory neuropathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "exposed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8], "text": "A healthy , 30 - year - old man"}, {"type": "age", "offset": [3, 4, 5, 6, 7], "text": "30 - year - old"}, {"type": "gender", "offset": [8], "text": "man"}, {"type": "treatment", "offset": [12], "text": "sulindac"}, {"type": "drug", "offset": [12], "text": "sulindac"}, {"type": "effect", "offset": [20, 21, 22, 23, 24], "text": "incapacitating isolated idential sensory neuropathy"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "exposed", "label": "adverse event", "asoc": [["subject", "A healthy , 30 - year - old man"], ["age", "30 - year - old"], ["gender", "man"], ["treatment", "sulindac"], ["drug", "sulindac"], ["effect", "incapacitating isolated idential sensory neuropathy"]]}]}
{"text_id": "12923827_3", "text": "This communication describes a patient who developed Schneiderian first - rank symptoms in the course of treatment with fluvoxamine .", "tokens": ["This", "communication", "describes", "a", "patient", "who", "developed", "Schneiderian", "first", "-", "rank", "symptoms", "in", "the", "course", "of", "treatment", "with", "fluvoxamine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> fluvoxamine <extra_id_1> <extra_id_0> drug <extra_id_5> fluvoxamine <extra_id_1> <extra_id_0> effect <extra_id_5> Schneiderian first - rank symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "developed", "args": [{"type": "subject", "offset": [3, 4], "text": "a patient"}, {"type": "treatment", "offset": [18], "text": "fluvoxamine"}, {"type": "drug", "offset": [18], "text": "fluvoxamine"}, {"type": "effect", "offset": [7, 8, 9, 10, 11], "text": "Schneiderian first - rank symptoms"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "fluvoxamine"], ["drug", "fluvoxamine"], ["effect", "Schneiderian first - rank symptoms"]]}]}
{"text_id": "6093724_3", "text": "To our knowledge , we describe the first reported case of isolated paresthesia and peripheral neuropathy , without systemic involvement , secondary to sulindac administration .", "tokens": ["To", "our", "knowledge", ",", "we", "describe", "the", "first", "reported", "case", "of", "isolated", "paresthesia", "and", "peripheral", "neuropathy", ",", "without", "systemic", "involvement", ",", "secondary", "to", "sulindac", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> secondary <extra_id_0> treatment <extra_id_5> sulindac administration <extra_id_1> <extra_id_0> drug <extra_id_5> sulindac <extra_id_1> <extra_id_0> effect <extra_id_5> isolated paresthesia and peripheral neuropathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [21], "text": "secondary", "args": [{"type": "treatment", "offset": [23, 24], "text": "sulindac administration"}, {"type": "drug", "offset": [23], "text": "sulindac"}, {"type": "effect", "offset": [11, 12, 13, 14, 15], "text": "isolated paresthesia and peripheral neuropathy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "secondary", "label": "adverse event", "asoc": [["treatment", "sulindac administration"], ["drug", "sulindac"], ["effect", "isolated paresthesia and peripheral neuropathy"]]}]}
{"text_id": "12621956_1", "text": "The diagnosis of hypothermia was delayed until it was apparent for several days but resolved with the discontinuation of risperidone and continuation of clozapine .", "tokens": ["The", "diagnosis", "of", "hypothermia", "was", "delayed", "until", "it", "was", "apparent", "for", "several", "days", "but", "resolved", "with", "the", "discontinuation", "of", "risperidone", "and", "continuation", "of", "clozapine", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> resolved <extra_id_0> treatment <extra_id_5> discontinuation of risperidone and continuation of clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> risperidone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hypothermia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [14], "text": "resolved", "args": [{"type": "treatment", "offset": [17, 18, 19, 20, 21, 22, 23], "text": "discontinuation of risperidone and continuation of clozapine"}, {"type": "drug", "offset": [23], "text": "clozapine"}, {"type": "drug", "offset": [19], "text": "risperidone"}, {"type": "treatment disorder", "offset": [3], "text": "hypothermia"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "resolved", "label": "potential therapeutic event", "asoc": [["treatment", "discontinuation of risperidone and continuation of clozapine"], ["drug", "clozapine"], ["drug", "risperidone"], ["treatment disorder", "hypothermia"]]}]}
{"text_id": "15752306_2", "text": "We report two patients who developed intense livedo reticularis clearly related to the administration of interferon alpha 2b as an adjuvant therapy for melanoma .", "tokens": ["We", "report", "two", "patients", "who", "developed", "intense", "livedo", "reticularis", "clearly", "related", "to", "the", "administration", "of", "interferon", "alpha", "2b", "as", "an", "adjuvant", "therapy", "for", "melanoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> subject <extra_id_5> two patients <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> melanoma <extra_id_1> <extra_id_0> treatment <extra_id_5> interferon alpha 2b as an adjuvant therapy for melanoma <extra_id_1> <extra_id_0> drug <extra_id_5> interferon alpha 2b <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> melanoma <extra_id_1> <extra_id_0> effect <extra_id_5> intense livedo reticularis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "related", "args": [{"type": "subject", "offset": [2, 3], "text": "two patients"}, {"type": "population", "offset": [2], "text": "two"}, {"type": "subject disorder", "offset": [23], "text": "melanoma"}, {"type": "treatment", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23], "text": "interferon alpha 2b as an adjuvant therapy for melanoma"}, {"type": "drug", "offset": [15, 16, 17], "text": "interferon alpha 2b"}, {"type": "treatment disorder", "offset": [23], "text": "melanoma"}, {"type": "effect", "offset": [6, 7, 8], "text": "intense livedo reticularis"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["subject", "two patients"], ["population", "two"], ["subject disorder", "melanoma"], ["treatment", "interferon alpha 2b as an adjuvant therapy for melanoma"], ["drug", "interferon alpha 2b"], ["treatment disorder", "melanoma"], ["effect", "intense livedo reticularis"]]}]}
{"text_id": "14514135_1", "text": "Neutrophilic eccrine hidradenitis mimicking cutaneous vasculitis in a lupus patient : a complication of cyclophosphamide .", "tokens": ["Neutrophilic", "eccrine", "hidradenitis", "mimicking", "cutaneous", "vasculitis", "in", "a", "lupus", "patient", ":", "a", "complication", "of", "cyclophosphamide", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> subject <extra_id_5> a lupus patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> lupus <extra_id_1> <extra_id_0> treatment <extra_id_5> cyclophosphamide <extra_id_1> <extra_id_0> drug <extra_id_5> cyclophosphamide <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> lupus <extra_id_1> <extra_id_0> effect <extra_id_5> Neutrophilic eccrine hidradenitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "complication", "args": [{"type": "subject", "offset": [7, 8, 9], "text": "a lupus patient"}, {"type": "subject disorder", "offset": [8], "text": "lupus"}, {"type": "treatment", "offset": [14], "text": "cyclophosphamide"}, {"type": "drug", "offset": [14], "text": "cyclophosphamide"}, {"type": "treatment disorder", "offset": [8], "text": "lupus"}, {"type": "effect", "offset": [0, 1, 2], "text": "Neutrophilic eccrine hidradenitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["subject", "a lupus patient"], ["subject disorder", "lupus"], ["treatment", "cyclophosphamide"], ["drug", "cyclophosphamide"], ["treatment disorder", "lupus"], ["effect", "Neutrophilic eccrine hidradenitis"]]}]}
{"text_id": "15806568_3", "text": "Visual system side effects caused by parasympathetic dysfunction after botulinum toxin type B injections .", "tokens": ["Visual", "system", "side", "effects", "caused", "by", "parasympathetic", "dysfunction", "after", "botulinum", "toxin", "type", "B", "injections", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> botulinum toxin type B injections <extra_id_1> <extra_id_0> drug <extra_id_5> botulinum toxin type B <extra_id_1> <extra_id_0> route <extra_id_5> injections <extra_id_1> <extra_id_0> effect <extra_id_5> Visual system side effects caused by parasympathetic dysfunction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "after", "args": [{"type": "treatment", "offset": [9, 10, 11, 12, 13], "text": "botulinum toxin type B injections"}, {"type": "drug", "offset": [9, 10, 11, 12], "text": "botulinum toxin type B"}, {"type": "route", "offset": [13], "text": "injections"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Visual system side effects caused by parasympathetic dysfunction"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "botulinum toxin type B injections"], ["drug", "botulinum toxin type B"], ["route", "injections"], ["effect", "Visual system side effects caused by parasympathetic dysfunction"]]}]}
{"text_id": "20203465_3", "text": "We report the case of an 87 - year - old white woman with myasthenia gravis who presented with nausea , shortness of breath , azotemia , and hyperkalemia shortly after completing a course of intravenous immunoglobulin ( IVIG ) .", "tokens": ["We", "report", "the", "case", "of", "an", "87", "-", "year", "-", "old", "white", "woman", "with", "myasthenia", "gravis", "who", "presented", "with", "nausea", ",", "shortness", "of", "breath", ",", "azotemia", ",", "and", "hyperkalemia", "shortly", "after", "completing", "a", "course", "of", "intravenous", "immunoglobulin", "(", "IVIG", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> presented <extra_id_0> subject <extra_id_5> an 87 - year - old white woman with myasthenia gravis <extra_id_1> <extra_id_0> age <extra_id_5> 87 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> race <extra_id_5> white <extra_id_1> <extra_id_0> subject disorder <extra_id_5> myasthenia gravis <extra_id_1> <extra_id_0> treatment <extra_id_5> intravenous immunoglobulin <extra_id_1> <extra_id_0> drug <extra_id_5> immunoglobulin <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> myasthenia gravis <extra_id_1> <extra_id_0> effect <extra_id_5> nausea , shortness of breath , azotemia , and hyperkalemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "presented", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "an 87 - year - old white woman with myasthenia gravis"}, {"type": "age", "offset": [6, 7, 8, 9, 10], "text": "87 - year - old"}, {"type": "gender", "offset": [12], "text": "woman"}, {"type": "race", "offset": [11], "text": "white"}, {"type": "subject disorder", "offset": [14, 15], "text": "myasthenia gravis"}, {"type": "treatment", "offset": [35, 36], "text": "intravenous immunoglobulin"}, {"type": "drug", "offset": [36], "text": "immunoglobulin"}, {"type": "route", "offset": [35], "text": "intravenous"}, {"type": "treatment disorder", "offset": [14, 15], "text": "myasthenia gravis"}, {"type": "effect", "offset": [19, 20, 21, 22, 23, 24, 25, 26, 27, 28], "text": "nausea , shortness of breath , azotemia , and hyperkalemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder", "race"], "spot_asoc": [{"span": "presented", "label": "adverse event", "asoc": [["subject", "an 87 - year - old white woman with myasthenia gravis"], ["age", "87 - year - old"], ["gender", "woman"], ["race", "white"], ["subject disorder", "myasthenia gravis"], ["treatment", "intravenous immunoglobulin"], ["drug", "immunoglobulin"], ["route", "intravenous"], ["treatment disorder", "myasthenia gravis"], ["effect", "nausea , shortness of breath , azotemia , and hyperkalemia"]]}]}
{"text_id": "8604715_4", "text": "We present a patient with human immunodeficiency virus infection under treatment with foscarnet for CMV retinitis who complained of thirst and polyuria .", "tokens": ["We", "present", "a", "patient", "with", "human", "immunodeficiency", "virus", "infection", "under", "treatment", "with", "foscarnet", "for", "CMV", "retinitis", "who", "complained", "of", "thirst", "and", "polyuria", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complained <extra_id_0> subject <extra_id_5> a patient with human immunodeficiency virus infection <extra_id_1> <extra_id_0> subject disorder <extra_id_5> human immunodeficiency virus infection <extra_id_1> <extra_id_0> subject disorder <extra_id_5> CMV retinitis <extra_id_1> <extra_id_0> treatment <extra_id_5> foscarnet <extra_id_1> <extra_id_0> drug <extra_id_5> foscarnet <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> CMV retinitis <extra_id_1> <extra_id_0> effect <extra_id_5> thirst and polyuria <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "complained", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7, 8], "text": "a patient with human immunodeficiency virus infection"}, {"type": "subject disorder", "offset": [5, 6, 7, 8], "text": "human immunodeficiency virus infection"}, {"type": "subject disorder", "offset": [14, 15], "text": "CMV retinitis"}, {"type": "treatment", "offset": [12], "text": "foscarnet"}, {"type": "drug", "offset": [12], "text": "foscarnet"}, {"type": "treatment disorder", "offset": [14, 15], "text": "CMV retinitis"}, {"type": "effect", "offset": [19, 20, 21], "text": "thirst and polyuria"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "complained", "label": "adverse event", "asoc": [["subject", "a patient with human immunodeficiency virus infection"], ["subject disorder", "human immunodeficiency virus infection"], ["subject disorder", "CMV retinitis"], ["treatment", "foscarnet"], ["drug", "foscarnet"], ["treatment disorder", "CMV retinitis"], ["effect", "thirst and polyuria"]]}]}
{"text_id": "17285101_1", "text": "Pulmonary hypertension during lithium therapy : clinical case study .", "tokens": ["Pulmonary", "hypertension", "during", "lithium", "therapy", ":", "clinical", "case", "study", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> lithium therapy <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> effect <extra_id_5> Pulmonary hypertension <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "during", "args": [{"type": "treatment", "offset": [3, 4], "text": "lithium therapy"}, {"type": "drug", "offset": [3], "text": "lithium"}, {"type": "effect", "offset": [0, 1], "text": "Pulmonary hypertension"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "lithium therapy"], ["drug", "lithium"], ["effect", "Pulmonary hypertension"]]}]}
{"text_id": "2442958_2", "text": "This is a unique autopsy case of hepatocellular carcinoma closely related to diethylstilbestrol ( DES ) therapy for prostatic cancer .", "tokens": ["This", "is", "a", "unique", "autopsy", "case", "of", "hepatocellular", "carcinoma", "closely", "related", "to", "diethylstilbestrol", "(", "DES", ")", "therapy", "for", "prostatic", "cancer", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> subject <extra_id_5> a unique autopsy case <extra_id_1> <extra_id_0> subject disorder <extra_id_5> prostatic cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> diethylstilbestrol ( DES ) <extra_id_1> <extra_id_0> drug <extra_id_5> diethylstilbestrol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> prostatic cancer <extra_id_1> <extra_id_0> effect <extra_id_5> hepatocellular carcinoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "related", "args": [{"type": "subject", "offset": [2, 3, 4, 5], "text": "a unique autopsy case"}, {"type": "subject disorder", "offset": [18, 19], "text": "prostatic cancer"}, {"type": "treatment", "offset": [12, 13, 14, 15], "text": "diethylstilbestrol ( DES )"}, {"type": "drug", "offset": [12], "text": "diethylstilbestrol"}, {"type": "treatment disorder", "offset": [18, 19], "text": "prostatic cancer"}, {"type": "effect", "offset": [7, 8], "text": "hepatocellular carcinoma"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["subject", "a unique autopsy case"], ["subject disorder", "prostatic cancer"], ["treatment", "diethylstilbestrol ( DES )"], ["drug", "diethylstilbestrol"], ["treatment disorder", "prostatic cancer"], ["effect", "hepatocellular carcinoma"]]}]}
{"text_id": "2554727_3", "text": "Peripheral nervous system disturbances caused by cytosine arabinoside have rarely been reported .", "tokens": ["Peripheral", "nervous", "system", "disturbances", "caused", "by", "cytosine", "arabinoside", "have", "rarely", "been", "reported", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> cytosine arabinoside <extra_id_1> <extra_id_0> drug <extra_id_5> cytosine arabinoside <extra_id_1> <extra_id_0> effect <extra_id_5> Peripheral nervous system disturbances <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "caused", "args": [{"type": "treatment", "offset": [6, 7], "text": "cytosine arabinoside"}, {"type": "drug", "offset": [6, 7], "text": "cytosine arabinoside"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Peripheral nervous system disturbances"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "cytosine arabinoside"], ["drug", "cytosine arabinoside"], ["effect", "Peripheral nervous system disturbances"]]}]}
{"text_id": "17873198_5", "text": "We report a case of fatal pulmonary toxicity in a patient with advanced non - small cell lung cancer who received erlotinib .", "tokens": ["We", "report", "a", "case", "of", "fatal", "pulmonary", "toxicity", "in", "a", "patient", "with", "advanced", "non", "-", "small", "cell", "lung", "cancer", "who", "received", "erlotinib", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> received <extra_id_0> subject <extra_id_5> a patient with advanced non - small cell lung cancer <extra_id_1> <extra_id_0> subject disorder <extra_id_5> advanced non - small cell lung cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> advanced non - small cell lung cancer <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "received", "args": [{"type": "subject", "offset": [9, 10, 11, 12, 13, 14, 15, 16, 17, 18], "text": "a patient with advanced non - small cell lung cancer"}, {"type": "subject disorder", "offset": [12, 13, 14, 15, 16, 17, 18], "text": "advanced non - small cell lung cancer"}, {"type": "treatment", "offset": [21], "text": "erlotinib"}, {"type": "drug", "offset": [21], "text": "erlotinib"}, {"type": "treatment disorder", "offset": [12, 13, 14, 15, 16, 17, 18], "text": "advanced non - small cell lung cancer"}, {"type": "effect", "offset": [6, 7], "text": "pulmonary toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "received", "label": "adverse event", "asoc": [["subject", "a patient with advanced non - small cell lung cancer"], ["subject disorder", "advanced non - small cell lung cancer"], ["treatment", "erlotinib"], ["drug", "erlotinib"], ["treatment disorder", "advanced non - small cell lung cancer"], ["effect", "pulmonary toxicity"]]}]}
{"text_id": "16225183_10", "text": "This latest ( third ) report suggests that the safety profile should be reexamined and at least raises the question of potential renal toxicity of interferons in MS.", "tokens": ["This", "latest", "(", "third", ")", "report", "suggests", "that", "the", "safety", "profile", "should", "be", "reexamined", "and", "at", "least", "raises", "the", "question", "of", "potential", "renal", "toxicity", "of", "interferons", "in", "MS."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> raises <extra_id_0> treatment <extra_id_5> interferons <extra_id_1> <extra_id_0> drug <extra_id_5> interferons <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> MS. <extra_id_1> <extra_id_0> effect <extra_id_5> potential renal toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "raises", "args": [{"type": "treatment", "offset": [25], "text": "interferons"}, {"type": "drug", "offset": [25], "text": "interferons"}, {"type": "treatment disorder", "offset": [27], "text": "MS."}, {"type": "effect", "offset": [21, 22, 23], "text": "potential renal toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "raises", "label": "adverse event", "asoc": [["treatment", "interferons"], ["drug", "interferons"], ["treatment disorder", "MS."], ["effect", "potential renal toxicity"]]}]}
{"text_id": "12951892_2", "text": "The newborn manifested a four day course of lethargy with unexplained high lithium levels in the adult toxic range .", "tokens": ["The", "newborn", "manifested", "a", "four", "day", "course", "of", "lethargy", "with", "unexplained", "high", "lithium", "levels", "in", "the", "adult", "toxic", "range", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> manifested <extra_id_0> subject <extra_id_5> newborn <extra_id_1> <extra_id_0> age <extra_id_5> newborn <extra_id_1> <extra_id_0> treatment <extra_id_5> lithium <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> effect <extra_id_5> four day course of lethargy with unexplained high lithium levels <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "manifested", "args": [{"type": "subject", "offset": [1], "text": "newborn"}, {"type": "age", "offset": [1], "text": "newborn"}, {"type": "treatment", "offset": [12], "text": "lithium"}, {"type": "drug", "offset": [12], "text": "lithium"}, {"type": "effect", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12, 13], "text": "four day course of lethargy with unexplained high lithium levels"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "manifested", "label": "adverse event", "asoc": [["subject", "newborn"], ["age", "newborn"], ["treatment", "lithium"], ["drug", "lithium"], ["effect", "four day course of lethargy with unexplained high lithium levels"]]}]}
{"text_id": "2147700_1", "text": "One patient with systemic lupus erythematosus developed erythema multiforme after taking griseofulvin .", "tokens": ["One", "patient", "with", "systemic", "lupus", "erythematosus", "developed", "erythema", "multiforme", "after", "taking", "griseofulvin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> One patient with systemic lupus erythematosus <extra_id_1> <extra_id_0> population <extra_id_5> One <extra_id_1> <extra_id_0> subject disorder <extra_id_5> systemic lupus erythematosus <extra_id_1> <extra_id_0> treatment <extra_id_5> griseofulvin <extra_id_1> <extra_id_0> drug <extra_id_5> griseofulvin <extra_id_1> <extra_id_0> effect <extra_id_5> erythema multiforme <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "after", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5], "text": "One patient with systemic lupus erythematosus"}, {"type": "population", "offset": [0], "text": "One"}, {"type": "subject disorder", "offset": [3, 4, 5], "text": "systemic lupus erythematosus"}, {"type": "treatment", "offset": [11], "text": "griseofulvin"}, {"type": "drug", "offset": [11], "text": "griseofulvin"}, {"type": "effect", "offset": [7, 8], "text": "erythema multiforme"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "One patient with systemic lupus erythematosus"], ["population", "One"], ["subject disorder", "systemic lupus erythematosus"], ["treatment", "griseofulvin"], ["drug", "griseofulvin"], ["effect", "erythema multiforme"]]}]}
{"text_id": "12923827_4", "text": "This finding suggests that fluvoxamine can precipitate Schneiderian first - rank symptoms in some susceptible patients .", "tokens": ["This", "finding", "suggests", "that", "fluvoxamine", "can", "precipitate", "Schneiderian", "first", "-", "rank", "symptoms", "in", "some", "susceptible", "patients", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> precipitate <extra_id_0> subject <extra_id_5> some susceptible patients <extra_id_1> <extra_id_0> treatment <extra_id_5> fluvoxamine <extra_id_1> <extra_id_0> drug <extra_id_5> fluvoxamine <extra_id_1> <extra_id_0> effect <extra_id_5> Schneiderian first - rank symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "precipitate", "args": [{"type": "subject", "offset": [13, 14, 15], "text": "some susceptible patients"}, {"type": "treatment", "offset": [4], "text": "fluvoxamine"}, {"type": "drug", "offset": [4], "text": "fluvoxamine"}, {"type": "effect", "offset": [7, 8, 9, 10, 11], "text": "Schneiderian first - rank symptoms"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "precipitate", "label": "adverse event", "asoc": [["subject", "some susceptible patients"], ["treatment", "fluvoxamine"], ["drug", "fluvoxamine"], ["effect", "Schneiderian first - rank symptoms"]]}]}
{"text_id": "11215836_3", "text": "Possible serotonin syndrome associated with clomipramine after withdrawal of clozapine .", "tokens": ["Possible", "serotonin", "syndrome", "associated", "with", "clomipramine", "after", "withdrawal", "of", "clozapine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> withdrawal of clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clomipramine <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin syndrome associated with clomipramine <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "after", "args": [{"type": "treatment", "offset": [7, 8, 9], "text": "withdrawal of clozapine"}, {"type": "drug", "offset": [9], "text": "clozapine"}, {"type": "drug", "offset": [5], "text": "clomipramine"}, {"type": "effect", "offset": [1, 2, 3, 4, 5], "text": "serotonin syndrome associated with clomipramine"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "withdrawal of clozapine"], ["drug", "clozapine"], ["drug", "clomipramine"], ["effect", "serotonin syndrome associated with clomipramine"]]}]}
{"text_id": "9215418_1", "text": "Clinical signs of hypermagnesemia are an uncommon complication following oral administration of magnesium sulfate .", "tokens": ["Clinical", "signs", "of", "hypermagnesemia", "are", "an", "uncommon", "complication", "following", "oral", "administration", "of", "magnesium", "sulfate", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> oral administration of magnesium sulfate <extra_id_1> <extra_id_0> drug <extra_id_5> magnesium sulfate <extra_id_1> <extra_id_0> route <extra_id_5> oral <extra_id_1> <extra_id_0> effect <extra_id_5> hypermagnesemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "complication", "args": [{"type": "treatment", "offset": [9, 10, 11, 12, 13], "text": "oral administration of magnesium sulfate"}, {"type": "drug", "offset": [12, 13], "text": "magnesium sulfate"}, {"type": "route", "offset": [9], "text": "oral"}, {"type": "effect", "offset": [3], "text": "hypermagnesemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "oral administration of magnesium sulfate"], ["drug", "magnesium sulfate"], ["route", "oral"], ["effect", "hypermagnesemia"]]}]}
{"text_id": "4095247_3", "text": "Two of these patients , who also received the anti - emetic prochlorperazine , lost consciousness for 48 - 72 h and then fully recovered .", "tokens": ["Two", "of", "these", "patients", ",", "who", "also", "received", "the", "anti", "-", "emetic", "prochlorperazine", ",", "lost", "consciousness", "for", "48", "-", "72", "h", "and", "then", "fully", "recovered", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> lost <extra_id_0> subject <extra_id_5> Two of these patients <extra_id_1> <extra_id_0> population <extra_id_5> Two <extra_id_1> <extra_id_0> treatment <extra_id_5> anti - emetic prochlorperazine <extra_id_1> <extra_id_0> drug <extra_id_5> prochlorperazine <extra_id_1> <extra_id_0> effect <extra_id_5> lost consciousness for 48 - 72 h and then fully recovered <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "lost", "args": [{"type": "subject", "offset": [0, 1, 2, 3], "text": "Two of these patients"}, {"type": "population", "offset": [0], "text": "Two"}, {"type": "treatment", "offset": [9, 10, 11, 12], "text": "anti - emetic prochlorperazine"}, {"type": "drug", "offset": [12], "text": "prochlorperazine"}, {"type": "effect", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24], "text": "lost consciousness for 48 - 72 h and then fully recovered"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "lost", "label": "adverse event", "asoc": [["subject", "Two of these patients"], ["population", "Two"], ["treatment", "anti - emetic prochlorperazine"], ["drug", "prochlorperazine"], ["effect", "lost consciousness for 48 - 72 h and then fully recovered"]]}]}
{"text_id": "11918514_4", "text": "Severe serotonin syndrome induced by mirtazapine monotherapy .", "tokens": ["Severe", "serotonin", "syndrome", "induced", "by", "mirtazapine", "monotherapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced by <extra_id_0> treatment <extra_id_5> mirtazapine monotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3, 4], "text": "induced by", "args": [{"type": "treatment", "offset": [5, 6], "text": "mirtazapine monotherapy"}, {"type": "drug", "offset": [5], "text": "mirtazapine"}, {"type": "effect", "offset": [1, 2], "text": "serotonin syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced by", "label": "adverse event", "asoc": [["treatment", "mirtazapine monotherapy"], ["drug", "mirtazapine"], ["effect", "serotonin syndrome"]]}]}
{"text_id": "7375145_1", "text": "Diagnosis : practolol induced sclerosing peritonitis .", "tokens": ["Diagnosis", ":", "practolol", "induced", "sclerosing", "peritonitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> practolol <extra_id_1> <extra_id_0> drug <extra_id_5> practolol <extra_id_1> <extra_id_0> effect <extra_id_5> sclerosing peritonitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "induced", "args": [{"type": "treatment", "offset": [2], "text": "practolol"}, {"type": "drug", "offset": [2], "text": "practolol"}, {"type": "effect", "offset": [4, 5], "text": "sclerosing peritonitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "practolol"], ["drug", "practolol"], ["effect", "sclerosing peritonitis"]]}]}
{"text_id": "1477441_1", "text": "CASE SUMMARY : Two children with attention deficit disorder treated with methylphenidate as a simple drug developed fixed drug eruption of the scrotum .", "tokens": ["CASE", "SUMMARY", ":", "Two", "children", "with", "attention", "deficit", "disorder", "treated", "with", "methylphenidate", "as", "a", "simple", "drug", "developed", "fixed", "drug", "eruption", "of", "the", "scrotum", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> Two children with attention deficit disorder <extra_id_1> <extra_id_0> age <extra_id_5> children <extra_id_1> <extra_id_0> population <extra_id_5> Two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> attention deficit disorder <extra_id_1> <extra_id_0> treatment <extra_id_5> methylphenidate as a simple drug <extra_id_1> <extra_id_0> drug <extra_id_5> methylphenidate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> attention deficit disorder <extra_id_1> <extra_id_0> effect <extra_id_5> fixed drug eruption of the scrotum <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8], "text": "Two children with attention deficit disorder"}, {"type": "age", "offset": [4], "text": "children"}, {"type": "population", "offset": [3], "text": "Two"}, {"type": "subject disorder", "offset": [6, 7, 8], "text": "attention deficit disorder"}, {"type": "treatment", "offset": [11, 12, 13, 14, 15], "text": "methylphenidate as a simple drug"}, {"type": "drug", "offset": [11], "text": "methylphenidate"}, {"type": "treatment disorder", "offset": [6, 7, 8], "text": "attention deficit disorder"}, {"type": "effect", "offset": [17, 18, 19, 20, 21, 22], "text": "fixed drug eruption of the scrotum"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment disorder", "drug", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "Two children with attention deficit disorder"], ["age", "children"], ["population", "Two"], ["subject disorder", "attention deficit disorder"], ["treatment", "methylphenidate as a simple drug"], ["drug", "methylphenidate"], ["treatment disorder", "attention deficit disorder"], ["effect", "fixed drug eruption of the scrotum"]]}]}
{"text_id": "19226083_4", "text": "There are several documented case reports of serotonin toxicity when used with selective serotonin reuptake inhibitors .", "tokens": ["There", "are", "several", "documented", "case", "reports", "of", "serotonin", "toxicity", "when", "used", "with", "selective", "serotonin", "reuptake", "inhibitors", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> reports <extra_id_0> subject <extra_id_5> several documented case <extra_id_1> <extra_id_0> population <extra_id_5> several <extra_id_1> <extra_id_0> treatment <extra_id_5> selective serotonin reuptake inhibitors <extra_id_1> <extra_id_0> drug <extra_id_5> selective serotonin reuptake inhibitors <extra_id_1> <extra_id_0> drug <extra_id_5> serotonin <extra_id_1> <extra_id_0> combination drug <extra_id_5> selective serotonin reuptake inhibitors <extra_id_1> <extra_id_0> combination drug <extra_id_5> serotonin <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "reports", "args": [{"type": "subject", "offset": [2, 3, 4], "text": "several documented case"}, {"type": "population", "offset": [2], "text": "several"}, {"type": "treatment", "offset": [12, 13, 14, 15], "text": "selective serotonin reuptake inhibitors"}, {"type": "drug", "offset": [12, 13, 14, 15], "text": "selective serotonin reuptake inhibitors"}, {"type": "drug", "offset": [7], "text": "serotonin"}, {"type": "combination drug", "offset": [12, 13, 14, 15], "text": "selective serotonin reuptake inhibitors"}, {"type": "combination drug", "offset": [7], "text": "serotonin"}, {"type": "effect", "offset": [7, 8], "text": "serotonin toxicity"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "reports", "label": "adverse event", "asoc": [["subject", "several documented case"], ["population", "several"], ["treatment", "selective serotonin reuptake inhibitors"], ["drug", "selective serotonin reuptake inhibitors"], ["drug", "serotonin"], ["combination drug", "selective serotonin reuptake inhibitors"], ["combination drug", "serotonin"], ["effect", "serotonin toxicity"]]}]}
{"text_id": "12141409_1", "text": "Epsilon - aminocaproic acid and renal complications : case report and review of the literature .", "tokens": ["Epsilon", "-", "aminocaproic", "acid", "and", "renal", "complications", ":", "case", "report", "and", "review", "of", "the", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complications <extra_id_0> treatment <extra_id_5> Epsilon - aminocaproic acid <extra_id_1> <extra_id_0> drug <extra_id_5> Epsilon - aminocaproic acid <extra_id_1> <extra_id_0> effect <extra_id_5> renal complications <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "complications", "args": [{"type": "treatment", "offset": [0, 1, 2, 3], "text": "Epsilon - aminocaproic acid"}, {"type": "drug", "offset": [0, 1, 2, 3], "text": "Epsilon - aminocaproic acid"}, {"type": "effect", "offset": [5, 6], "text": "renal complications"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "complications", "label": "adverse event", "asoc": [["treatment", "Epsilon - aminocaproic acid"], ["drug", "Epsilon - aminocaproic acid"], ["effect", "renal complications"]]}]}
{"text_id": "15289139_1", "text": "Dorzolamide - induced choroidal detachment in a surgically untreated eye .", "tokens": ["Dorzolamide", "-", "induced", "choroidal", "detachment", "in", "a", "surgically", "untreated", "eye", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a surgically untreated eye <extra_id_1> <extra_id_0> treatment <extra_id_5> Dorzolamide <extra_id_1> <extra_id_0> drug <extra_id_5> Dorzolamide <extra_id_1> <extra_id_0> effect <extra_id_5> choroidal detachment <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "subject", "offset": [6, 7, 8, 9], "text": "a surgically untreated eye"}, {"type": "treatment", "offset": [0], "text": "Dorzolamide"}, {"type": "drug", "offset": [0], "text": "Dorzolamide"}, {"type": "effect", "offset": [3, 4], "text": "choroidal detachment"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a surgically untreated eye"], ["treatment", "Dorzolamide"], ["drug", "Dorzolamide"], ["effect", "choroidal detachment"]]}]}
{"text_id": "17122225_1", "text": "Serotonin syndrome from the interaction of cyclobenzaprine with other serotoninergic drugs .", "tokens": ["Serotonin", "syndrome", "from", "the", "interaction", "of", "cyclobenzaprine", "with", "other", "serotoninergic", "drugs", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> from <extra_id_0> treatment <extra_id_5> interaction of cyclobenzaprine with other serotoninergic drugs <extra_id_1> <extra_id_0> drug <extra_id_5> cyclobenzaprine <extra_id_1> <extra_id_0> drug <extra_id_5> serotoninergic drugs <extra_id_1> <extra_id_0> effect <extra_id_5> Serotonin syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "from", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10], "text": "interaction of cyclobenzaprine with other serotoninergic drugs"}, {"type": "drug", "offset": [6], "text": "cyclobenzaprine"}, {"type": "drug", "offset": [9, 10], "text": "serotoninergic drugs"}, {"type": "effect", "offset": [0, 1], "text": "Serotonin syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "from", "label": "adverse event", "asoc": [["treatment", "interaction of cyclobenzaprine with other serotoninergic drugs"], ["drug", "cyclobenzaprine"], ["drug", "serotoninergic drugs"], ["effect", "Serotonin syndrome"]]}]}
{"text_id": "10575189_2", "text": "Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy .", "tokens": ["Thrombotic", "microangiopathy", "with", "renal", "failure", "in", "two", "patients", "undergoing", "gemcitabine", "chemotherapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> undergoing <extra_id_0> subject <extra_id_5> two patients <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> treatment <extra_id_5> gemcitabine chemotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> route <extra_id_5> chemotherapy <extra_id_1> <extra_id_0> effect <extra_id_5> Thrombotic microangiopathy with renal failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "undergoing", "args": [{"type": "subject", "offset": [6, 7], "text": "two patients"}, {"type": "population", "offset": [6], "text": "two"}, {"type": "treatment", "offset": [9, 10], "text": "gemcitabine chemotherapy"}, {"type": "drug", "offset": [9], "text": "gemcitabine"}, {"type": "route", "offset": [10], "text": "chemotherapy"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Thrombotic microangiopathy with renal failure"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "route", "subject", "drug", "treatment"], "spot_asoc": [{"span": "undergoing", "label": "adverse event", "asoc": [["subject", "two patients"], ["population", "two"], ["treatment", "gemcitabine chemotherapy"], ["drug", "gemcitabine"], ["route", "chemotherapy"], ["effect", "Thrombotic microangiopathy with renal failure"]]}]}
{"text_id": "889156_7", "text": "While a lower systemic steroid dosage may have been the provoking factor , we feel that an adverse reaction to oleic acid , a dispersing agent in the aerosol freon vehicle , is a strong possibility .", "tokens": ["While", "a", "lower", "systemic", "steroid", "dosage", "may", "have", "been", "the", "provoking", "factor", ",", "we", "feel", "that", "an", "adverse", "reaction", "to", "oleic", "acid", ",", "a", "dispersing", "agent", "in", "the", "aerosol", "freon", "vehicle", ",", "is", "a", "strong", "possibility", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> to <extra_id_0> treatment <extra_id_5> oleic acid <extra_id_1> <extra_id_0> drug <extra_id_5> oleic acid <extra_id_1> <extra_id_0> effect <extra_id_5> adverse reaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "to", "args": [{"type": "treatment", "offset": [20, 21], "text": "oleic acid"}, {"type": "drug", "offset": [20, 21], "text": "oleic acid"}, {"type": "effect", "offset": [17, 18], "text": "adverse reaction"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "to", "label": "adverse event", "asoc": [["treatment", "oleic acid"], ["drug", "oleic acid"], ["effect", "adverse reaction"]]}]}
{"text_id": "9366852_4", "text": "We describe a patient with the antiphospholipid syndrome who had skin necrosis develop from low - molecular weight heparin therapy at sites distant from injection sites .", "tokens": ["We", "describe", "a", "patient", "with", "the", "antiphospholipid", "syndrome", "who", "had", "skin", "necrosis", "develop", "from", "low", "-", "molecular", "weight", "heparin", "therapy", "at", "sites", "distant", "from", "injection", "sites", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> develop <extra_id_0> subject <extra_id_5> a patient with the antiphospholipid syndrome <extra_id_1> <extra_id_0> subject disorder <extra_id_5> antiphospholipid syndrome <extra_id_1> <extra_id_0> treatment <extra_id_5> low - molecular weight heparin therapy at sites distant from injection sites <extra_id_1> <extra_id_0> drug <extra_id_5> low - molecular weight heparin <extra_id_1> <extra_id_0> route <extra_id_5> injection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> antiphospholipid syndrome <extra_id_1> <extra_id_0> effect <extra_id_5> skin necrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "develop", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7], "text": "a patient with the antiphospholipid syndrome"}, {"type": "subject disorder", "offset": [6, 7], "text": "antiphospholipid syndrome"}, {"type": "treatment", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "low - molecular weight heparin therapy at sites distant from injection sites"}, {"type": "drug", "offset": [14, 15, 16, 17, 18], "text": "low - molecular weight heparin"}, {"type": "route", "offset": [24], "text": "injection"}, {"type": "treatment disorder", "offset": [6, 7], "text": "antiphospholipid syndrome"}, {"type": "effect", "offset": [10, 11], "text": "skin necrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "develop", "label": "adverse event", "asoc": [["subject", "a patient with the antiphospholipid syndrome"], ["subject disorder", "antiphospholipid syndrome"], ["treatment", "low - molecular weight heparin therapy at sites distant from injection sites"], ["drug", "low - molecular weight heparin"], ["route", "injection"], ["treatment disorder", "antiphospholipid syndrome"], ["effect", "skin necrosis"]]}]}
{"text_id": "18801826_3", "text": "We report a case of a 35 - year old female who developed new onset type II diabetes mellitus with hyperosmolar hyperglycaemic coma and acute renal failure following treatment with a SGA for a first manic episode .", "tokens": ["We", "report", "a", "case", "of", "a", "35", "-", "year", "old", "female", "who", "developed", "new", "onset", "type", "II", "diabetes", "mellitus", "with", "hyperosmolar", "hyperglycaemic", "coma", "and", "acute", "renal", "failure", "following", "treatment", "with", "a", "SGA", "for", "a", "first", "manic", "episode", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> 35 - year old female <extra_id_1> <extra_id_0> age <extra_id_5> 35 - year old <extra_id_1> <extra_id_0> gender <extra_id_5> female <extra_id_1> <extra_id_0> treatment <extra_id_5> treatment with a SGA <extra_id_1> <extra_id_0> drug <extra_id_5> SGA <extra_id_1> <extra_id_0> effect <extra_id_5> type II diabetes mellitus with hyperosmolar hyperglycaemic coma and acute renal failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "developed", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10], "text": "35 - year old female"}, {"type": "age", "offset": [6, 7, 8, 9], "text": "35 - year old"}, {"type": "gender", "offset": [10], "text": "female"}, {"type": "treatment", "offset": [28, 29, 30, 31], "text": "treatment with a SGA"}, {"type": "drug", "offset": [31], "text": "SGA"}, {"type": "effect", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26], "text": "type II diabetes mellitus with hyperosmolar hyperglycaemic coma and acute renal failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "35 - year old female"], ["age", "35 - year old"], ["gender", "female"], ["treatment", "treatment with a SGA"], ["drug", "SGA"], ["effect", "type II diabetes mellitus with hyperosmolar hyperglycaemic coma and acute renal failure"]]}]}
{"text_id": "10410183_9", "text": "For those patients with a history of NMS , or even of isolated serum CK elevation during antipsychotic therapy , follow - up should be stricter .", "tokens": ["For", "those", "patients", "with", "a", "history", "of", "NMS", ",", "or", "even", "of", "isolated", "serum", "CK", "elevation", "during", "antipsychotic", "therapy", ",", "follow", "-", "up", "should", "be", "stricter", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> subject <extra_id_5> patients with a history of NMS <extra_id_1> <extra_id_0> subject disorder <extra_id_5> a history of NMS <extra_id_1> <extra_id_0> treatment <extra_id_5> antipsychotic therapy <extra_id_1> <extra_id_0> effect <extra_id_5> isolated serum CK elevation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "during", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7], "text": "patients with a history of NMS"}, {"type": "subject disorder", "offset": [4, 5, 6, 7], "text": "a history of NMS"}, {"type": "treatment", "offset": [17, 18], "text": "antipsychotic therapy"}, {"type": "effect", "offset": [12, 13, 14, 15], "text": "isolated serum CK elevation"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject disorder", "subject", "treatment"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["subject", "patients with a history of NMS"], ["subject disorder", "a history of NMS"], ["treatment", "antipsychotic therapy"], ["effect", "isolated serum CK elevation"]]}]}
{"text_id": "12324937_5", "text": "METHODS : A case is presented of a 45 - year - old woman on prolonged gemcitabine treatment for ovarian cancer who developed HUS and recovered after drug discontinuation .", "tokens": ["METHODS", ":", "A", "case", "is", "presented", "of", "a", "45", "-", "year", "-", "old", "woman", "on", "prolonged", "gemcitabine", "treatment", "for", "ovarian", "cancer", "who", "developed", "HUS", "and", "recovered", "after", "drug", "discontinuation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a 45 - year - old woman <extra_id_1> <extra_id_0> age <extra_id_5> 45 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> ovarian cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> prolonged gemcitabine treatment <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> ovarian cancer <extra_id_1> <extra_id_0> effect <extra_id_5> HUS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [22], "text": "developed", "args": [{"type": "subject", "offset": [7, 8, 9, 10, 11, 12, 13], "text": "a 45 - year - old woman"}, {"type": "age", "offset": [8, 9, 10, 11, 12], "text": "45 - year - old"}, {"type": "gender", "offset": [13], "text": "woman"}, {"type": "subject disorder", "offset": [19, 20], "text": "ovarian cancer"}, {"type": "treatment", "offset": [15, 16, 17], "text": "prolonged gemcitabine treatment"}, {"type": "drug", "offset": [16], "text": "gemcitabine"}, {"type": "treatment disorder", "offset": [19, 20], "text": "ovarian cancer"}, {"type": "effect", "offset": [23], "text": "HUS"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a 45 - year - old woman"], ["age", "45 - year - old"], ["gender", "woman"], ["subject disorder", "ovarian cancer"], ["treatment", "prolonged gemcitabine treatment"], ["drug", "gemcitabine"], ["treatment disorder", "ovarian cancer"], ["effect", "HUS"]]}]}
{"text_id": "19789166_2", "text": "Nitrofurantoin - induced acute liver damage in pregnancy .", "tokens": ["Nitrofurantoin", "-", "induced", "acute", "liver", "damage", "in", "pregnancy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> pregnancy <extra_id_1> <extra_id_0> treatment <extra_id_5> Nitrofurantoin <extra_id_1> <extra_id_0> drug <extra_id_5> Nitrofurantoin <extra_id_1> <extra_id_0> effect <extra_id_5> acute liver damage <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "subject", "offset": [7], "text": "pregnancy"}, {"type": "treatment", "offset": [0], "text": "Nitrofurantoin"}, {"type": "drug", "offset": [0], "text": "Nitrofurantoin"}, {"type": "effect", "offset": [3, 4, 5], "text": "acute liver damage"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "pregnancy"], ["treatment", "Nitrofurantoin"], ["drug", "Nitrofurantoin"], ["effect", "acute liver damage"]]}]}
{"text_id": "633424_1", "text": "Acute leukopenia associated with silver sulfadiazine therapy .", "tokens": ["Acute", "leukopenia", "associated", "with", "silver", "sulfadiazine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> silver sulfadiazine <extra_id_1> <extra_id_0> drug <extra_id_5> silver sulfadiazine <extra_id_1> <extra_id_0> effect <extra_id_5> Acute leukopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [4, 5], "text": "silver sulfadiazine"}, {"type": "drug", "offset": [4, 5], "text": "silver sulfadiazine"}, {"type": "effect", "offset": [0, 1], "text": "Acute leukopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "silver sulfadiazine"], ["drug", "silver sulfadiazine"], ["effect", "Acute leukopenia"]]}]}
{"text_id": "12944250_1", "text": "It is concluded that simultaneous administration of ciprofloxacin and tazobactam / piperacillin may cause marked thrombocytosis .", "tokens": ["It", "is", "concluded", "that", "simultaneous", "administration", "of", "ciprofloxacin", "and", "tazobactam", "/", "piperacillin", "may", "cause", "marked", "thrombocytosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> simultaneous administration of ciprofloxacin and tazobactam / piperacillin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> tazobactam / piperacillin <extra_id_1> <extra_id_0> combination drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> combination drug <extra_id_5> tazobactam / piperacillin <extra_id_1> <extra_id_0> effect <extra_id_5> marked thrombocytosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "cause", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10, 11], "text": "simultaneous administration of ciprofloxacin and tazobactam / piperacillin"}, {"type": "drug", "offset": [7], "text": "ciprofloxacin"}, {"type": "drug", "offset": [9, 10, 11], "text": "tazobactam / piperacillin"}, {"type": "combination drug", "offset": [7], "text": "ciprofloxacin"}, {"type": "combination drug", "offset": [9, 10, 11], "text": "tazobactam / piperacillin"}, {"type": "effect", "offset": [14, 15], "text": "marked thrombocytosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "simultaneous administration of ciprofloxacin and tazobactam / piperacillin"], ["drug", "ciprofloxacin"], ["drug", "tazobactam / piperacillin"], ["combination drug", "ciprofloxacin"], ["combination drug", "tazobactam / piperacillin"], ["effect", "marked thrombocytosis"]]}]}
{"text_id": "2369419_3", "text": "This is the third report of reversible hepatic decompensation associated with prolonged MTX therapy in patients with rheumatoid arthritis .", "tokens": ["This", "is", "the", "third", "report", "of", "reversible", "hepatic", "decompensation", "associated", "with", "prolonged", "MTX", "therapy", "in", "patients", "with", "rheumatoid", "arthritis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> patients with rheumatoid arthritis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> MTX <extra_id_1> <extra_id_0> drug <extra_id_5> MTX <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> effect <extra_id_5> reversible hepatic decompensation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "associated", "args": [{"type": "subject", "offset": [15, 16, 17, 18], "text": "patients with rheumatoid arthritis"}, {"type": "subject disorder", "offset": [17, 18], "text": "rheumatoid arthritis"}, {"type": "treatment", "offset": [12], "text": "MTX"}, {"type": "drug", "offset": [12], "text": "MTX"}, {"type": "treatment disorder", "offset": [17, 18], "text": "rheumatoid arthritis"}, {"type": "effect", "offset": [6, 7, 8], "text": "reversible hepatic decompensation"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "patients with rheumatoid arthritis"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "MTX"], ["drug", "MTX"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "reversible hepatic decompensation"]]}]}
{"text_id": "9804082_1", "text": "Three diabetic cases of acute dizziness due to initial administration of voglibose .", "tokens": ["Three", "diabetic", "cases", "of", "acute", "dizziness", "due", "to", "initial", "administration", "of", "voglibose", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> subject <extra_id_5> Three diabetic cases <extra_id_1> <extra_id_0> population <extra_id_5> Three <extra_id_1> <extra_id_0> subject disorder <extra_id_5> diabetic <extra_id_1> <extra_id_0> treatment <extra_id_5> initial administration of voglibose <extra_id_1> <extra_id_0> drug <extra_id_5> voglibose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> diabetic <extra_id_1> <extra_id_0> effect <extra_id_5> acute dizziness <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "due", "args": [{"type": "subject", "offset": [0, 1, 2], "text": "Three diabetic cases"}, {"type": "population", "offset": [0], "text": "Three"}, {"type": "subject disorder", "offset": [1], "text": "diabetic"}, {"type": "treatment", "offset": [8, 9, 10, 11], "text": "initial administration of voglibose"}, {"type": "drug", "offset": [11], "text": "voglibose"}, {"type": "treatment disorder", "offset": [1], "text": "diabetic"}, {"type": "effect", "offset": [4, 5], "text": "acute dizziness"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["subject", "Three diabetic cases"], ["population", "Three"], ["subject disorder", "diabetic"], ["treatment", "initial administration of voglibose"], ["drug", "voglibose"], ["treatment disorder", "diabetic"], ["effect", "acute dizziness"]]}]}
{"text_id": "426502_2", "text": "Inappropriate antidiuretic hormone following adenine arabinoside administration .", "tokens": ["Inappropriate", "antidiuretic", "hormone", "following", "adenine", "arabinoside", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> adenine arabinoside <extra_id_1> <extra_id_0> drug <extra_id_5> adenine arabinoside <extra_id_1> <extra_id_0> effect <extra_id_5> Inappropriate antidiuretic hormone <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "following", "args": [{"type": "treatment", "offset": [4, 5], "text": "adenine arabinoside"}, {"type": "drug", "offset": [4, 5], "text": "adenine arabinoside"}, {"type": "effect", "offset": [0, 1, 2], "text": "Inappropriate antidiuretic hormone"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "adenine arabinoside"], ["drug", "adenine arabinoside"], ["effect", "Inappropriate antidiuretic hormone"]]}]}
{"text_id": "1977935_1", "text": "Torsades de pointes occurring in association with terfenadine use .", "tokens": ["Torsades", "de", "pointes", "occurring", "in", "association", "with", "terfenadine", "use", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> association <extra_id_0> treatment <extra_id_5> terfenadine <extra_id_1> <extra_id_0> drug <extra_id_5> terfenadine <extra_id_1> <extra_id_0> effect <extra_id_5> Torsades de pointes <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "association", "args": [{"type": "treatment", "offset": [7], "text": "terfenadine"}, {"type": "drug", "offset": [7], "text": "terfenadine"}, {"type": "effect", "offset": [0, 1, 2], "text": "Torsades de pointes"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "association", "label": "adverse event", "asoc": [["treatment", "terfenadine"], ["drug", "terfenadine"], ["effect", "Torsades de pointes"]]}]}
{"text_id": "9247841_3", "text": "Generalized maculopapular and papular purpuric eruptions are perhaps the most common thionamide - induced reactions .", "tokens": ["Generalized", "maculopapular", "and", "papular", "purpuric", "eruptions", "are", "perhaps", "the", "most", "common", "thionamide", "-", "induced", "reactions", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> thionamide <extra_id_1> <extra_id_0> drug <extra_id_5> thionamide <extra_id_1> <extra_id_0> effect <extra_id_5> Generalized maculopapular and papular purpuric eruptions <extra_id_1> <extra_id_0> effect <extra_id_5> reactions <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "induced", "args": [{"type": "treatment", "offset": [11], "text": "thionamide"}, {"type": "drug", "offset": [11], "text": "thionamide"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "Generalized maculopapular and papular purpuric eruptions"}, {"type": "effect", "offset": [14], "text": "reactions"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "thionamide"], ["drug", "thionamide"], ["effect", "Generalized maculopapular and papular purpuric eruptions"], ["effect", "reactions"]]}]}
{"text_id": "21712512_10", "text": "Iatrogenic Cushing syndrome has been reported in patients with CF treated concomitantly , and for extended duration , with inhaled corticosteroids and CYP3A4 inhibitors .", "tokens": ["Iatrogenic", "Cushing", "syndrome", "has", "been", "reported", "in", "patients", "with", "CF", "treated", "concomitantly", ",", "and", "for", "extended", "duration", ",", "with", "inhaled", "corticosteroids", "and", "CYP3A4", "inhibitors", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> reported <extra_id_0> subject <extra_id_5> patients with CF <extra_id_1> <extra_id_0> subject disorder <extra_id_5> CF <extra_id_1> <extra_id_0> treatment <extra_id_5> inhaled corticosteroids and CYP3A4 inhibitors <extra_id_1> <extra_id_0> drug <extra_id_5> corticosteroids <extra_id_1> <extra_id_0> drug <extra_id_5> CYP3A4 inhibitors <extra_id_1> <extra_id_0> route <extra_id_5> inhaled <extra_id_1> <extra_id_0> combination drug <extra_id_5> corticosteroids <extra_id_1> <extra_id_0> combination drug <extra_id_5> CYP3A4 inhibitors <extra_id_1> <extra_id_0> effect <extra_id_5> Iatrogenic Cushing syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "reported", "args": [{"type": "subject", "offset": [7, 8, 9], "text": "patients with CF"}, {"type": "subject disorder", "offset": [9], "text": "CF"}, {"type": "treatment", "offset": [19, 20, 21, 22, 23], "text": "inhaled corticosteroids and CYP3A4 inhibitors"}, {"type": "drug", "offset": [20], "text": "corticosteroids"}, {"type": "drug", "offset": [22, 23], "text": "CYP3A4 inhibitors"}, {"type": "route", "offset": [19], "text": "inhaled"}, {"type": "combination drug", "offset": [20], "text": "corticosteroids"}, {"type": "combination drug", "offset": [22, 23], "text": "CYP3A4 inhibitors"}, {"type": "effect", "offset": [0, 1, 2], "text": "Iatrogenic Cushing syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "combination drug", "subject disorder"], "spot_asoc": [{"span": "reported", "label": "adverse event", "asoc": [["subject", "patients with CF"], ["subject disorder", "CF"], ["treatment", "inhaled corticosteroids and CYP3A4 inhibitors"], ["drug", "corticosteroids"], ["drug", "CYP3A4 inhibitors"], ["route", "inhaled"], ["combination drug", "corticosteroids"], ["combination drug", "CYP3A4 inhibitors"], ["effect", "Iatrogenic Cushing syndrome"]]}]}
{"text_id": "11675845_4", "text": "Ropinirole was added to his current therapy for Parkinson disease , with a corresponding decrease in the dose of levodopa / carbidopa to allow levodopa sparing .", "tokens": ["Ropinirole", "was", "added", "to", "his", "current", "therapy", "for", "Parkinson", "disease", ",", "with", "a", "corresponding", "decrease", "in", "the", "dose", "of", "levodopa", "/", "carbidopa", "to", "allow", "levodopa", "sparing", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> added <extra_id_0> treatment <extra_id_5> Ropinirole <extra_id_1> <extra_id_0> treatment <extra_id_5> a corresponding decrease in the dose of levodopa / carbidopa to allow levodopa sparing <extra_id_1> <extra_id_0> drug <extra_id_5> Ropinirole <extra_id_1> <extra_id_0> drug <extra_id_5> levodopa <extra_id_1> <extra_id_0> drug <extra_id_5> carbidopa <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Parkinson disease <extra_id_1> <extra_id_0> combination drug <extra_id_5> Ropinirole <extra_id_1> <extra_id_0> combination drug <extra_id_5> levodopa <extra_id_1> <extra_id_0> combination drug <extra_id_5> carbidopa <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [2], "text": "added", "args": [{"type": "treatment", "offset": [0], "text": "Ropinirole"}, {"type": "treatment", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "a corresponding decrease in the dose of levodopa / carbidopa to allow levodopa sparing"}, {"type": "drug", "offset": [0], "text": "Ropinirole"}, {"type": "drug", "offset": [19], "text": "levodopa"}, {"type": "drug", "offset": [21], "text": "carbidopa"}, {"type": "treatment disorder", "offset": [8, 9], "text": "Parkinson disease"}, {"type": "combination drug", "offset": [0], "text": "Ropinirole"}, {"type": "combination drug", "offset": [19], "text": "levodopa"}, {"type": "combination drug", "offset": [21], "text": "carbidopa"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "combination drug", "drug", "treatment disorder"], "spot_asoc": [{"span": "added", "label": "potential therapeutic event", "asoc": [["treatment", "Ropinirole"], ["treatment", "a corresponding decrease in the dose of levodopa / carbidopa to allow levodopa sparing"], ["drug", "Ropinirole"], ["drug", "levodopa"], ["drug", "carbidopa"], ["treatment disorder", "Parkinson disease"], ["combination drug", "Ropinirole"], ["combination drug", "levodopa"], ["combination drug", "carbidopa"]]}]}
{"text_id": "11443640_2", "text": "To our knowledge this is the first report of pancytopenia due to MMI , where the usual hypoplasia found is replaced by massive plasmocytosis .", "tokens": ["To", "our", "knowledge", "this", "is", "the", "first", "report", "of", "pancytopenia", "due", "to", "MMI", ",", "where", "the", "usual", "hypoplasia", "found", "is", "replaced", "by", "massive", "plasmocytosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> treatment <extra_id_5> MMI <extra_id_1> <extra_id_0> drug <extra_id_5> MMI <extra_id_1> <extra_id_0> effect <extra_id_5> pancytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "due", "args": [{"type": "treatment", "offset": [12], "text": "MMI"}, {"type": "drug", "offset": [12], "text": "MMI"}, {"type": "effect", "offset": [9], "text": "pancytopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["treatment", "MMI"], ["drug", "MMI"], ["effect", "pancytopenia"]]}]}
{"text_id": "18343993_3", "text": "Life - threatening interstitial lung disease associated with trastuzumab : case report .", "tokens": ["Life", "-", "threatening", "interstitial", "lung", "disease", "associated", "with", "trastuzumab", ":", "case", "report", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> case <extra_id_1> <extra_id_0> treatment <extra_id_5> trastuzumab <extra_id_1> <extra_id_0> drug <extra_id_5> trastuzumab <extra_id_1> <extra_id_0> effect <extra_id_5> Life - threatening interstitial lung disease <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "associated", "args": [{"type": "subject", "offset": [10], "text": "case"}, {"type": "treatment", "offset": [8], "text": "trastuzumab"}, {"type": "drug", "offset": [8], "text": "trastuzumab"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "Life - threatening interstitial lung disease"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "case"], ["treatment", "trastuzumab"], ["drug", "trastuzumab"], ["effect", "Life - threatening interstitial lung disease"]]}]}
{"text_id": "15482394_5", "text": "Unusual hypersensitivity to warfarin in a critically ill patient .", "tokens": ["Unusual", "hypersensitivity", "to", "warfarin", "in", "a", "critically", "ill", "patient", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> to <extra_id_0> subject <extra_id_5> a critically ill patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> critically ill <extra_id_1> <extra_id_0> treatment <extra_id_5> warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> Unusual hypersensitivity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "to", "args": [{"type": "subject", "offset": [5, 6, 7, 8], "text": "a critically ill patient"}, {"type": "subject disorder", "offset": [6, 7], "text": "critically ill"}, {"type": "treatment", "offset": [3], "text": "warfarin"}, {"type": "drug", "offset": [3], "text": "warfarin"}, {"type": "effect", "offset": [0, 1], "text": "Unusual hypersensitivity"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "to", "label": "adverse event", "asoc": [["subject", "a critically ill patient"], ["subject disorder", "critically ill"], ["treatment", "warfarin"], ["drug", "warfarin"], ["effect", "Unusual hypersensitivity"]]}]}
{"text_id": "12187348_2", "text": "Drug - induced mammary hyperplasias have been reported as rare complications of D - penicillamine and Neothetazone .", "tokens": ["Drug", "-", "induced", "mammary", "hyperplasias", "have", "been", "reported", "as", "rare", "complications", "of", "D", "-", "penicillamine", "and", "Neothetazone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Drug <extra_id_1> <extra_id_0> treatment <extra_id_5> D - penicillamine and Neothetazone <extra_id_1> <extra_id_0> drug <extra_id_5> Drug <extra_id_1> <extra_id_0> drug <extra_id_5> Neothetazone <extra_id_1> <extra_id_0> drug <extra_id_5> D - penicillamine <extra_id_1> <extra_id_0> combination drug <extra_id_5> D - penicillamine <extra_id_1> <extra_id_0> combination drug <extra_id_5> Neothetazone <extra_id_1> <extra_id_0> effect <extra_id_5> mammary hyperplasias <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Drug"}, {"type": "treatment", "offset": [12, 13, 14, 15, 16], "text": "D - penicillamine and Neothetazone"}, {"type": "drug", "offset": [0], "text": "Drug"}, {"type": "drug", "offset": [16], "text": "Neothetazone"}, {"type": "drug", "offset": [12, 13, 14], "text": "D - penicillamine"}, {"type": "combination drug", "offset": [12, 13, 14], "text": "D - penicillamine"}, {"type": "combination drug", "offset": [16], "text": "Neothetazone"}, {"type": "effect", "offset": [3, 4], "text": "mammary hyperplasias"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Drug"], ["treatment", "D - penicillamine and Neothetazone"], ["drug", "Drug"], ["drug", "Neothetazone"], ["drug", "D - penicillamine"], ["combination drug", "D - penicillamine"], ["combination drug", "Neothetazone"], ["effect", "mammary hyperplasias"]]}]}
{"text_id": "9161656_16", "text": "She continued taking verapamil for 6 months , then , on her own , stopped all medications including the sustained - release verapamil , and her asthma symptoms disappeared .", "tokens": ["She", "continued", "taking", "verapamil", "for", "6", "months", ",", "then", ",", "on", "her", "own", ",", "stopped", "all", "medications", "including", "the", "sustained", "-", "release", "verapamil", ",", "and", "her", "asthma", "symptoms", "disappeared", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> disappeared <extra_id_0> subject <extra_id_5> She <extra_id_1> <extra_id_0> gender <extra_id_5> She <extra_id_1> <extra_id_0> subject disorder <extra_id_5> asthma <extra_id_1> <extra_id_0> treatment <extra_id_5> continued taking verapamil for 6 months , then , on her own , stopped all medications including the sustained - release verapamil <extra_id_1> <extra_id_0> drug <extra_id_5> verapamil <extra_id_1> <extra_id_0> duration <extra_id_5> for 6 months <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> asthma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [28], "text": "disappeared", "args": [{"type": "subject", "offset": [0], "text": "She"}, {"type": "gender", "offset": [0], "text": "She"}, {"type": "subject disorder", "offset": [26], "text": "asthma"}, {"type": "treatment", "offset": [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22], "text": "continued taking verapamil for 6 months , then , on her own , stopped all medications including the sustained - release verapamil"}, {"type": "drug", "offset": [3], "text": "verapamil"}, {"type": "duration", "offset": [4, 5, 6], "text": "for 6 months"}, {"type": "treatment disorder", "offset": [26], "text": "asthma"}]}], "spot": ["potential therapeutic event"], "asoc": ["duration", "subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "disappeared", "label": "potential therapeutic event", "asoc": [["subject", "She"], ["gender", "She"], ["subject disorder", "asthma"], ["treatment", "continued taking verapamil for 6 months , then , on her own , stopped all medications including the sustained - release verapamil"], ["drug", "verapamil"], ["duration", "for 6 months"], ["treatment disorder", "asthma"]]}]}
{"text_id": "18446030_2", "text": "We report a 45 - year - old psoriasis patient who developed eruptive mollusca contagiosa during an antipsoriatic treatment with efalizumab .", "tokens": ["We", "report", "a", "45", "-", "year", "-", "old", "psoriasis", "patient", "who", "developed", "eruptive", "mollusca", "contagiosa", "during", "an", "antipsoriatic", "treatment", "with", "efalizumab", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> 45 - year - old psoriasis patient <extra_id_1> <extra_id_0> age <extra_id_5> 45 - year - old <extra_id_1> <extra_id_0> subject disorder <extra_id_5> psoriasis <extra_id_1> <extra_id_0> treatment <extra_id_5> antipsoriatic treatment with efalizumab <extra_id_1> <extra_id_0> drug <extra_id_5> efalizumab <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> psoriasis <extra_id_1> <extra_id_0> effect <extra_id_5> eruptive mollusca contagiosa <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8, 9], "text": "45 - year - old psoriasis patient"}, {"type": "age", "offset": [3, 4, 5, 6, 7], "text": "45 - year - old"}, {"type": "subject disorder", "offset": [8], "text": "psoriasis"}, {"type": "treatment", "offset": [17, 18, 19, 20], "text": "antipsoriatic treatment with efalizumab"}, {"type": "drug", "offset": [20], "text": "efalizumab"}, {"type": "treatment disorder", "offset": [8], "text": "psoriasis"}, {"type": "effect", "offset": [12, 13, 14], "text": "eruptive mollusca contagiosa"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "45 - year - old psoriasis patient"], ["age", "45 - year - old"], ["subject disorder", "psoriasis"], ["treatment", "antipsoriatic treatment with efalizumab"], ["drug", "efalizumab"], ["treatment disorder", "psoriasis"], ["effect", "eruptive mollusca contagiosa"]]}]}
{"text_id": "17494808_1", "text": "Hypersensitivity pneumonitis - like syndrome associated with the use of lenalidomide .", "tokens": ["Hypersensitivity", "pneumonitis", "-", "like", "syndrome", "associated", "with", "the", "use", "of", "lenalidomide", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> lenalidomide <extra_id_1> <extra_id_0> drug <extra_id_5> lenalidomide <extra_id_1> <extra_id_0> effect <extra_id_5> Hypersensitivity pneumonitis - like syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "associated", "args": [{"type": "treatment", "offset": [10], "text": "lenalidomide"}, {"type": "drug", "offset": [10], "text": "lenalidomide"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Hypersensitivity pneumonitis - like syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "lenalidomide"], ["drug", "lenalidomide"], ["effect", "Hypersensitivity pneumonitis - like syndrome"]]}]}
{"text_id": "21045170_3", "text": "A 47 - year - old HIV - infected man with dilated cardiomyopathy and prolonged QT syndrome with an automatic implantable cardiovascular defibrillator device was prescribed subcutaneous enfuvirtide 90 mg twice daily as part of his antiretroviral regimen and oral extended - release niacin 500 mg / day for a high - density lipoprotein level of 8 mg / dL. After 1 week of concomitant therapy , the patient began experiencing extreme redness , edema , and swelling at the injection site that corresponded with the flushing sensation due to niacin .", "tokens": ["A", "47", "-", "year", "-", "old", "HIV", "-", "infected", "man", "with", "dilated", "cardiomyopathy", "and", "prolonged", "QT", "syndrome", "with", "an", "automatic", "implantable", "cardiovascular", "defibrillator", "device", "was", "prescribed", "subcutaneous", "enfuvirtide", "90", "mg", "twice", "daily", "as", "part", "of", "his", "antiretroviral", "regimen", "and", "oral", "extended", "-", "release", "niacin", "500", "mg", "/", "day", "for", "a", "high", "-", "density", "lipoprotein", "level", "of", "8", "mg", "/", "dL.", "After", "1", "week", "of", "concomitant", "therapy", ",", "the", "patient", "began", "experiencing", "extreme", "redness", ",", "edema", ",", "and", "swelling", "at", "the", "injection", "site", "that", "corresponded", "with", "the", "flushing", "sensation", "due", "to", "niacin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> experiencing <extra_id_0> subject <extra_id_5> A 47 - year - old HIV - infected man with dilated cardiomyopathy and prolonged QT syndrome with an automatic implantable cardiovascular defibrillator device <extra_id_1> <extra_id_0> age <extra_id_5> 47 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> dilated cardiomyopathy <extra_id_1> <extra_id_0> subject disorder <extra_id_5> prolonged QT syndrome <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HIV - infected <extra_id_1> <extra_id_0> treatment <extra_id_5> subcutaneous enfuvirtide 90 mg twice daily as part of his antiretroviral regimen and oral extended - release niacin 500 mg / day for a high - density lipoprotein level of 8 mg / dL. <extra_id_1> <extra_id_0> drug <extra_id_5> enfuvirtide <extra_id_1> <extra_id_0> drug <extra_id_5> niacin <extra_id_1> <extra_id_0> dosage <extra_id_5> 90 mg <extra_id_1> <extra_id_0> dosage <extra_id_5> 500 mg <extra_id_1> <extra_id_0> frequency <extra_id_5> twice daily <extra_id_1> <extra_id_0> frequency <extra_id_5> day <extra_id_1> <extra_id_0> route <extra_id_5> subcutaneous <extra_id_1> <extra_id_0> route <extra_id_5> oral <extra_id_1> <extra_id_0> duration <extra_id_5> 1 week <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 1 week <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HIV - infected <extra_id_1> <extra_id_0> combination drug <extra_id_5> niacin <extra_id_1> <extra_id_0> combination drug <extra_id_5> enfuvirtide <extra_id_1> <extra_id_0> effect <extra_id_5> extreme redness , edema , and swelling at the injection site that corresponded with the flushing sensation due to niacin <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [70], "text": "experiencing", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23], "text": "A 47 - year - old HIV - infected man with dilated cardiomyopathy and prolonged QT syndrome with an automatic implantable cardiovascular defibrillator device"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "47 - year - old"}, {"type": "gender", "offset": [9], "text": "man"}, {"type": "subject disorder", "offset": [11, 12], "text": "dilated cardiomyopathy"}, {"type": "subject disorder", "offset": [14, 15, 16], "text": "prolonged QT syndrome"}, {"type": "subject disorder", "offset": [6, 7, 8], "text": "HIV - infected"}, {"type": "treatment", "offset": [26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59], "text": "subcutaneous enfuvirtide 90 mg twice daily as part of his antiretroviral regimen and oral extended - release niacin 500 mg / day for a high - density lipoprotein level of 8 mg / dL."}, {"type": "drug", "offset": [27], "text": "enfuvirtide"}, {"type": "drug", "offset": [43], "text": "niacin"}, {"type": "dosage", "offset": [28, 29], "text": "90 mg"}, {"type": "dosage", "offset": [44, 45], "text": "500 mg"}, {"type": "frequency", "offset": [30, 31], "text": "twice daily"}, {"type": "frequency", "offset": [47], "text": "day"}, {"type": "route", "offset": [26], "text": "subcutaneous"}, {"type": "route", "offset": [39], "text": "oral"}, {"type": "duration", "offset": [61, 62], "text": "1 week"}, {"type": "time elapsed", "offset": [61, 62], "text": "1 week"}, {"type": "treatment disorder", "offset": [6, 7, 8], "text": "HIV - infected"}, {"type": "combination drug", "offset": [43], "text": "niacin"}, {"type": "combination drug", "offset": [27], "text": "enfuvirtide"}, {"type": "effect", "offset": [71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90], "text": "extreme redness , edema , and swelling at the injection site that corresponded with the flushing sensation due to niacin"}]}], "spot": ["adverse event"], "asoc": ["dosage", "time elapsed", "duration", "effect", "route", "subject", "treatment disorder", "drug", "gender", "frequency", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "experiencing", "label": "adverse event", "asoc": [["subject", "A 47 - year - old HIV - infected man with dilated cardiomyopathy and prolonged QT syndrome with an automatic implantable cardiovascular defibrillator device"], ["age", "47 - year - old"], ["gender", "man"], ["subject disorder", "dilated cardiomyopathy"], ["subject disorder", "prolonged QT syndrome"], ["subject disorder", "HIV - infected"], ["treatment", "subcutaneous enfuvirtide 90 mg twice daily as part of his antiretroviral regimen and oral extended - release niacin 500 mg / day for a high - density lipoprotein level of 8 mg / dL."], ["drug", "enfuvirtide"], ["drug", "niacin"], ["dosage", "90 mg"], ["dosage", "500 mg"], ["frequency", "twice daily"], ["frequency", "day"], ["route", "subcutaneous"], ["route", "oral"], ["duration", "1 week"], ["time elapsed", "1 week"], ["treatment disorder", "HIV - infected"], ["combination drug", "niacin"], ["combination drug", "enfuvirtide"], ["effect", "extreme redness , edema , and swelling at the injection site that corresponded with the flushing sensation due to niacin"]]}]}
{"text_id": "16527771_3", "text": "We report a 78 - year - old man who had acute unilateral total visual loss after retrogasserian phenol injection for the treatment of trigeminal neuralgia .", "tokens": ["We", "report", "a", "78", "-", "year", "-", "old", "man", "who", "had", "acute", "unilateral", "total", "visual", "loss", "after", "retrogasserian", "phenol", "injection", "for", "the", "treatment", "of", "trigeminal", "neuralgia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a 78 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 78 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> trigeminal neuralgia <extra_id_1> <extra_id_0> treatment <extra_id_5> retrogasserian phenol injection <extra_id_1> <extra_id_0> drug <extra_id_5> phenol <extra_id_1> <extra_id_0> route <extra_id_5> injection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> trigeminal neuralgia <extra_id_1> <extra_id_0> effect <extra_id_5> acute unilateral total visual loss <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "after", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7, 8], "text": "a 78 - year - old man"}, {"type": "age", "offset": [3, 4, 5, 6, 7], "text": "78 - year - old"}, {"type": "gender", "offset": [8], "text": "man"}, {"type": "subject disorder", "offset": [24, 25], "text": "trigeminal neuralgia"}, {"type": "treatment", "offset": [17, 18, 19], "text": "retrogasserian phenol injection"}, {"type": "drug", "offset": [18], "text": "phenol"}, {"type": "route", "offset": [19], "text": "injection"}, {"type": "treatment disorder", "offset": [24, 25], "text": "trigeminal neuralgia"}, {"type": "effect", "offset": [11, 12, 13, 14, 15], "text": "acute unilateral total visual loss"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a 78 - year - old man"], ["age", "78 - year - old"], ["gender", "man"], ["subject disorder", "trigeminal neuralgia"], ["treatment", "retrogasserian phenol injection"], ["drug", "phenol"], ["route", "injection"], ["treatment disorder", "trigeminal neuralgia"], ["effect", "acute unilateral total visual loss"]]}]}
{"text_id": "8903300_1", "text": "She had just finished a 3 - week course of intravenous tobramycin for bronchiectasis and had an elevated serum tobramycin trough level 1 week before the onset of tetany .", "tokens": ["She", "had", "just", "finished", "a", "3", "-", "week", "course", "of", "intravenous", "tobramycin", "for", "bronchiectasis", "and", "had", "an", "elevated", "serum", "tobramycin", "trough", "level", "1", "week", "before", "the", "onset", "of", "tetany", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> had <extra_id_0> treatment <extra_id_5> a 3 - week course of intravenous tobramycin <extra_id_1> <extra_id_0> drug <extra_id_5> tobramycin <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> duration <extra_id_5> 3 - week course <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 3 - week course <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> bronchiectasis <extra_id_1> <extra_id_0> effect <extra_id_5> elevated serum tobramycin trough level 1 week before the onset of tetany <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "had", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10, 11], "text": "a 3 - week course of intravenous tobramycin"}, {"type": "drug", "offset": [11], "text": "tobramycin"}, {"type": "route", "offset": [10], "text": "intravenous"}, {"type": "duration", "offset": [5, 6, 7, 8], "text": "3 - week course"}, {"type": "time elapsed", "offset": [5, 6, 7, 8], "text": "3 - week course"}, {"type": "treatment disorder", "offset": [13], "text": "bronchiectasis"}, {"type": "effect", "offset": [17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28], "text": "elevated serum tobramycin trough level 1 week before the onset of tetany"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "route", "drug", "time elapsed", "treatment", "treatment disorder"], "spot_asoc": [{"span": "had", "label": "adverse event", "asoc": [["treatment", "a 3 - week course of intravenous tobramycin"], ["drug", "tobramycin"], ["route", "intravenous"], ["duration", "3 - week course"], ["time elapsed", "3 - week course"], ["treatment disorder", "bronchiectasis"], ["effect", "elevated serum tobramycin trough level 1 week before the onset of tetany"]]}]}
{"text_id": "20298401_11", "text": "This case had radiation fibrosis , so we suggest that radiation fibrosis may be another contributor of the occurrence of ILD in patients taking erlotinib .", "tokens": ["This", "case", "had", "radiation", "fibrosis", ",", "so", "we", "suggest", "that", "radiation", "fibrosis", "may", "be", "another", "contributor", "of", "the", "occurrence", "of", "ILD", "in", "patients", "taking", "erlotinib", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> of <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> treatment <extra_id_5> taking erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> effect <extra_id_5> occurrence of ILD <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "of", "args": [{"type": "subject", "offset": [22], "text": "patients"}, {"type": "treatment", "offset": [23, 24], "text": "taking erlotinib"}, {"type": "drug", "offset": [24], "text": "erlotinib"}, {"type": "effect", "offset": [18, 19, 20], "text": "occurrence of ILD"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "of", "label": "adverse event", "asoc": [["subject", "patients"], ["treatment", "taking erlotinib"], ["drug", "erlotinib"], ["effect", "occurrence of ILD"]]}]}
{"text_id": "16641839_4", "text": "Cutaneous rashes and eruptions can be caused by many medications , including carbamazepine .", "tokens": ["Cutaneous", "rashes", "and", "eruptions", "can", "be", "caused", "by", "many", "medications", ",", "including", "carbamazepine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> effect <extra_id_5> Cutaneous rashes and eruptions <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "caused", "args": [{"type": "treatment", "offset": [12], "text": "carbamazepine"}, {"type": "drug", "offset": [12], "text": "carbamazepine"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Cutaneous rashes and eruptions"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "carbamazepine"], ["drug", "carbamazepine"], ["effect", "Cutaneous rashes and eruptions"]]}]}
{"text_id": "11918514_3", "text": "OBJECTIVE : To document a case of serotonin syndrome ( SS ) associated with mirtazapine monotherapy , review the previously reported cases of SS associated with this tetracyclic antidepressant , and discuss the possible pathogenic mechanisms leading to this serious adverse drug reaction .", "tokens": ["OBJECTIVE", ":", "To", "document", "a", "case", "of", "serotonin", "syndrome", "(", "SS", ")", "associated", "with", "mirtazapine", "monotherapy", ",", "review", "the", "previously", "reported", "cases", "of", "SS", "associated", "with", "this", "tetracyclic", "antidepressant", ",", "and", "discuss", "the", "possible", "pathogenic", "mechanisms", "leading", "to", "this", "serious", "adverse", "drug", "reaction", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> a case <extra_id_1> <extra_id_0> treatment <extra_id_5> mirtazapine monotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin syndrome ( SS ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "associated", "args": [{"type": "subject", "offset": [4, 5], "text": "a case"}, {"type": "treatment", "offset": [14, 15], "text": "mirtazapine monotherapy"}, {"type": "drug", "offset": [14], "text": "mirtazapine"}, {"type": "effect", "offset": [7, 8, 9, 10, 11], "text": "serotonin syndrome ( SS )"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "a case"], ["treatment", "mirtazapine monotherapy"], ["drug", "mirtazapine"], ["effect", "serotonin syndrome ( SS )"]]}]}
{"text_id": "17122225_5", "text": "In both cases , symptoms of autonomic instability and severe agitation started within hours of initiation of cyclobenzaprine and fully resolved within 3 days after discontinuing the proserotoninergic drugs .", "tokens": ["In", "both", "cases", ",", "symptoms", "of", "autonomic", "instability", "and", "severe", "agitation", "started", "within", "hours", "of", "initiation", "of", "cyclobenzaprine", "and", "fully", "resolved", "within", "3", "days", "after", "discontinuing", "the", "proserotoninergic", "drugs", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> started <extra_id_0> treatment <extra_id_5> within hours of initiation of cyclobenzaprine <extra_id_1> <extra_id_0> drug <extra_id_5> cyclobenzaprine <extra_id_1> <extra_id_0> duration <extra_id_5> hours <extra_id_1> <extra_id_0> time elapsed <extra_id_5> within hours <extra_id_1> <extra_id_0> effect <extra_id_5> symptoms of autonomic instability and severe agitation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "started", "args": [{"type": "treatment", "offset": [12, 13, 14, 15, 16, 17], "text": "within hours of initiation of cyclobenzaprine"}, {"type": "drug", "offset": [17], "text": "cyclobenzaprine"}, {"type": "duration", "offset": [13], "text": "hours"}, {"type": "time elapsed", "offset": [12, 13], "text": "within hours"}, {"type": "effect", "offset": [4, 5, 6, 7, 8, 9, 10], "text": "symptoms of autonomic instability and severe agitation"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "drug", "time elapsed", "treatment"], "spot_asoc": [{"span": "started", "label": "adverse event", "asoc": [["treatment", "within hours of initiation of cyclobenzaprine"], ["drug", "cyclobenzaprine"], ["duration", "hours"], ["time elapsed", "within hours"], ["effect", "symptoms of autonomic instability and severe agitation"]]}]}
{"text_id": "18585545_1", "text": "Acute delirium resulting from levofloxacin therapy is an exceedingly rare complication that has been thought to occur more commonly in elderly patients .", "tokens": ["Acute", "delirium", "resulting", "from", "levofloxacin", "therapy", "is", "an", "exceedingly", "rare", "complication", "that", "has", "been", "thought", "to", "occur", "more", "commonly", "in", "elderly", "patients", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resulting <extra_id_0> subject <extra_id_5> elderly patients <extra_id_1> <extra_id_0> age <extra_id_5> elderly <extra_id_1> <extra_id_0> treatment <extra_id_5> levofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> levofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> Acute delirium <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "resulting", "args": [{"type": "subject", "offset": [20, 21], "text": "elderly patients"}, {"type": "age", "offset": [20], "text": "elderly"}, {"type": "treatment", "offset": [4], "text": "levofloxacin"}, {"type": "drug", "offset": [4], "text": "levofloxacin"}, {"type": "effect", "offset": [0, 1], "text": "Acute delirium"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "resulting", "label": "adverse event", "asoc": [["subject", "elderly patients"], ["age", "elderly"], ["treatment", "levofloxacin"], ["drug", "levofloxacin"], ["effect", "Acute delirium"]]}]}
{"text_id": "15190230_3", "text": "Therapy with IFN - alpha may be associated with a number of neuropsychiatric symptoms , such as Parkinsonism , akathisia , seizure , and depressive disorders .", "tokens": ["Therapy", "with", "IFN", "-", "alpha", "may", "be", "associated", "with", "a", "number", "of", "neuropsychiatric", "symptoms", ",", "such", "as", "Parkinsonism", ",", "akathisia", ",", "seizure", ",", "and", "depressive", "disorders", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated with <extra_id_0> treatment <extra_id_5> Therapy with IFN - alpha <extra_id_1> <extra_id_0> drug <extra_id_5> IFN - alpha <extra_id_1> <extra_id_0> effect <extra_id_5> neuropsychiatric symptoms , such as Parkinsonism , akathisia , seizure , and depressive disorders <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7, 8], "text": "associated with", "args": [{"type": "treatment", "offset": [0, 1, 2, 3, 4], "text": "Therapy with IFN - alpha"}, {"type": "drug", "offset": [2, 3, 4], "text": "IFN - alpha"}, {"type": "effect", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "neuropsychiatric symptoms , such as Parkinsonism , akathisia , seizure , and depressive disorders"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated with", "label": "adverse event", "asoc": [["treatment", "Therapy with IFN - alpha"], ["drug", "IFN - alpha"], ["effect", "neuropsychiatric symptoms , such as Parkinsonism , akathisia , seizure , and depressive disorders"]]}]}
{"text_id": "19915794_1", "text": "He had hypokalemia ( K 2.3 mmol / L ) induced by licorice and also had received disopyramide for arrhythmia , bicalutamide for prostate cancer , and silodosin for prostate hypertrophy .", "tokens": ["He", "had", "hypokalemia", "(", "K", "2.3", "mmol", "/", "L", ")", "induced", "by", "licorice", "and", "also", "had", "received", "disopyramide", "for", "arrhythmia", ",", "bicalutamide", "for", "prostate", "cancer", ",", "and", "silodosin", "for", "prostate", "hypertrophy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> licorice and also had received disopyramide for arrhythmia , bicalutamide for prostate cancer , and silodosin for prostate hypertrophy <extra_id_1> <extra_id_0> drug <extra_id_5> licorice <extra_id_1> <extra_id_0> drug <extra_id_5> disopyramide <extra_id_1> <extra_id_0> drug <extra_id_5> bicalutamide <extra_id_1> <extra_id_0> drug <extra_id_5> silodosin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> prostate hypertrophy <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> prostate cancer <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> arrhythmia <extra_id_1> <extra_id_0> combination drug <extra_id_5> disopyramide <extra_id_1> <extra_id_0> combination drug <extra_id_5> bicalutamide <extra_id_1> <extra_id_0> combination drug <extra_id_5> silodosin <extra_id_1> <extra_id_0> combination drug <extra_id_5> licorice <extra_id_1> <extra_id_0> effect <extra_id_5> hypokalemia ( K 2.3 mmol / L ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "induced", "args": [{"type": "treatment", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30], "text": "licorice and also had received disopyramide for arrhythmia , bicalutamide for prostate cancer , and silodosin for prostate hypertrophy"}, {"type": "drug", "offset": [12], "text": "licorice"}, {"type": "drug", "offset": [17], "text": "disopyramide"}, {"type": "drug", "offset": [21], "text": "bicalutamide"}, {"type": "drug", "offset": [27], "text": "silodosin"}, {"type": "treatment disorder", "offset": [29, 30], "text": "prostate hypertrophy"}, {"type": "treatment disorder", "offset": [23, 24], "text": "prostate cancer"}, {"type": "treatment disorder", "offset": [19], "text": "arrhythmia"}, {"type": "combination drug", "offset": [17], "text": "disopyramide"}, {"type": "combination drug", "offset": [21], "text": "bicalutamide"}, {"type": "combination drug", "offset": [27], "text": "silodosin"}, {"type": "combination drug", "offset": [12], "text": "licorice"}, {"type": "effect", "offset": [2, 3, 4, 5, 6, 7, 8, 9], "text": "hypokalemia ( K 2.3 mmol / L )"}]}], "spot": ["adverse event"], "asoc": ["effect", "drug", "treatment", "combination drug", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "licorice and also had received disopyramide for arrhythmia , bicalutamide for prostate cancer , and silodosin for prostate hypertrophy"], ["drug", "licorice"], ["drug", "disopyramide"], ["drug", "bicalutamide"], ["drug", "silodosin"], ["treatment disorder", "prostate hypertrophy"], ["treatment disorder", "prostate cancer"], ["treatment disorder", "arrhythmia"], ["combination drug", "disopyramide"], ["combination drug", "bicalutamide"], ["combination drug", "silodosin"], ["combination drug", "licorice"], ["effect", "hypokalemia ( K 2.3 mmol / L )"]]}]}
{"text_id": "9545161_5", "text": "To date , eight cases of TEN and one of SJS related to lamotrigine administration have been reported in the literature .", "tokens": ["To", "date", ",", "eight", "cases", "of", "TEN", "and", "one", "of", "SJS", "related", "to", "lamotrigine", "administration", "have", "been", "reported", "in", "the", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> treatment <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> effect <extra_id_5> TEN <extra_id_1> <extra_id_0> effect <extra_id_5> SJS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "related", "args": [{"type": "treatment", "offset": [13], "text": "lamotrigine"}, {"type": "drug", "offset": [13], "text": "lamotrigine"}, {"type": "effect", "offset": [6], "text": "TEN"}, {"type": "effect", "offset": [10], "text": "SJS"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["treatment", "lamotrigine"], ["drug", "lamotrigine"], ["effect", "TEN"], ["effect", "SJS"]]}]}
{"text_id": "8503421_2", "text": "Cholesterol crystal embolization - associated renal failure after therapy with recombinant tissue - type plasminogen activator .", "tokens": ["Cholesterol", "crystal", "embolization", "-", "associated", "renal", "failure", "after", "therapy", "with", "recombinant", "tissue", "-", "type", "plasminogen", "activator", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> therapy with recombinant tissue - type plasminogen activator <extra_id_1> <extra_id_0> drug <extra_id_5> plasminogen activator <extra_id_1> <extra_id_0> effect <extra_id_5> Cholesterol crystal embolization - associated renal failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "after", "args": [{"type": "treatment", "offset": [8, 9, 10, 11, 12, 13, 14, 15], "text": "therapy with recombinant tissue - type plasminogen activator"}, {"type": "drug", "offset": [14, 15], "text": "plasminogen activator"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Cholesterol crystal embolization - associated renal failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "therapy with recombinant tissue - type plasminogen activator"], ["drug", "plasminogen activator"], ["effect", "Cholesterol crystal embolization - associated renal failure"]]}]}
{"text_id": "19995690_4", "text": "We report a case of a 34 - year - old man on carbamazepine for complex partial seizures who developed acute liver and renal failure on less than 2.5 grams a day of acetaminophen .", "tokens": ["We", "report", "a", "case", "of", "a", "34", "-", "year", "-", "old", "man", "on", "carbamazepine", "for", "complex", "partial", "seizures", "who", "developed", "acute", "liver", "and", "renal", "failure", "on", "less", "than", "2.5", "grams", "a", "day", "of", "acetaminophen", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> on <extra_id_0> subject <extra_id_5> a 34 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 34 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> complex partial seizures <extra_id_1> <extra_id_0> treatment <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> treatment <extra_id_5> less than 2.5 grams a day of acetaminophen <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> acetaminophen <extra_id_1> <extra_id_0> dosage <extra_id_5> less than 2.5 grams <extra_id_1> <extra_id_0> frequency <extra_id_5> a day <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> complex partial seizures <extra_id_1> <extra_id_0> combination drug <extra_id_5> acetaminophen <extra_id_1> <extra_id_0> combination drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> effect <extra_id_5> acute liver and renal failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "on", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "a 34 - year - old man"}, {"type": "age", "offset": [6, 7, 8, 9, 10], "text": "34 - year - old"}, {"type": "gender", "offset": [11], "text": "man"}, {"type": "subject disorder", "offset": [15, 16, 17], "text": "complex partial seizures"}, {"type": "treatment", "offset": [13], "text": "carbamazepine"}, {"type": "treatment", "offset": [26, 27, 28, 29, 30, 31, 32, 33], "text": "less than 2.5 grams a day of acetaminophen"}, {"type": "drug", "offset": [13], "text": "carbamazepine"}, {"type": "drug", "offset": [33], "text": "acetaminophen"}, {"type": "dosage", "offset": [26, 27, 28, 29], "text": "less than 2.5 grams"}, {"type": "frequency", "offset": [30, 31], "text": "a day"}, {"type": "treatment disorder", "offset": [15, 16, 17], "text": "complex partial seizures"}, {"type": "combination drug", "offset": [33], "text": "acetaminophen"}, {"type": "combination drug", "offset": [13], "text": "carbamazepine"}, {"type": "effect", "offset": [20, 21, 22, 23, 24], "text": "acute liver and renal failure"}]}], "spot": ["adverse event"], "asoc": ["dosage", "effect", "subject", "treatment disorder", "drug", "gender", "frequency", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "on", "label": "adverse event", "asoc": [["subject", "a 34 - year - old man"], ["age", "34 - year - old"], ["gender", "man"], ["subject disorder", "complex partial seizures"], ["treatment", "carbamazepine"], ["treatment", "less than 2.5 grams a day of acetaminophen"], ["drug", "carbamazepine"], ["drug", "acetaminophen"], ["dosage", "less than 2.5 grams"], ["frequency", "a day"], ["treatment disorder", "complex partial seizures"], ["combination drug", "acetaminophen"], ["combination drug", "carbamazepine"], ["effect", "acute liver and renal failure"]]}]}
{"text_id": "17188061_2", "text": "PURPOSE : To describe transient structured visual hallucinations in a patient with vascular age - related macular degeneration ( AMD ) , following an intravitreal Avastin - injection .", "tokens": ["PURPOSE", ":", "To", "describe", "transient", "structured", "visual", "hallucinations", "in", "a", "patient", "with", "vascular", "age", "-", "related", "macular", "degeneration", "(", "AMD", ")", ",", "following", "an", "intravitreal", "Avastin", "-", "injection", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> subject <extra_id_5> a patient with vascular age - related macular degeneration ( AMD ) <extra_id_1> <extra_id_0> subject disorder <extra_id_5> vascular age - related macular degeneration ( AMD ) <extra_id_1> <extra_id_0> treatment <extra_id_5> an intravitreal Avastin - injection <extra_id_1> <extra_id_0> drug <extra_id_5> Avastin <extra_id_1> <extra_id_0> route <extra_id_5> intravitreal <extra_id_1> <extra_id_0> route <extra_id_5> injection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> vascular age - related macular degeneration ( AMD ) <extra_id_1> <extra_id_0> effect <extra_id_5> transient structured visual hallucinations <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [22], "text": "following", "args": [{"type": "subject", "offset": [9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "a patient with vascular age - related macular degeneration ( AMD )"}, {"type": "subject disorder", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "vascular age - related macular degeneration ( AMD )"}, {"type": "treatment", "offset": [23, 24, 25, 26, 27], "text": "an intravitreal Avastin - injection"}, {"type": "drug", "offset": [25], "text": "Avastin"}, {"type": "route", "offset": [24], "text": "intravitreal"}, {"type": "route", "offset": [27], "text": "injection"}, {"type": "treatment disorder", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "vascular age - related macular degeneration ( AMD )"}, {"type": "effect", "offset": [4, 5, 6, 7], "text": "transient structured visual hallucinations"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["subject", "a patient with vascular age - related macular degeneration ( AMD )"], ["subject disorder", "vascular age - related macular degeneration ( AMD )"], ["treatment", "an intravitreal Avastin - injection"], ["drug", "Avastin"], ["route", "intravitreal"], ["route", "injection"], ["treatment disorder", "vascular age - related macular degeneration ( AMD )"], ["effect", "transient structured visual hallucinations"]]}]}
{"text_id": "24477376_4", "text": "The patient was previously on phenytoin and was initiated on ticagrelor for antiplatelet therapy following stent placement .", "tokens": ["The", "patient", "was", "previously", "on", "phenytoin", "and", "was", "initiated", "on", "ticagrelor", "for", "antiplatelet", "therapy", "following", "stent", "placement", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> for <extra_id_0> subject <extra_id_5> The patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> antiplatelet therapy <extra_id_1> <extra_id_0> treatment <extra_id_5> previously on phenytoin <extra_id_1> <extra_id_0> treatment <extra_id_5> initiated on ticagrelor <extra_id_1> <extra_id_0> treatment <extra_id_5> following stent placement <extra_id_1> <extra_id_0> drug <extra_id_5> phenytoin <extra_id_1> <extra_id_0> drug <extra_id_5> ticagrelor <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> antiplatelet therapy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [11], "text": "for", "args": [{"type": "subject", "offset": [0, 1], "text": "The patient"}, {"type": "subject disorder", "offset": [12, 13], "text": "antiplatelet therapy"}, {"type": "treatment", "offset": [3, 4, 5], "text": "previously on phenytoin"}, {"type": "treatment", "offset": [8, 9, 10], "text": "initiated on ticagrelor"}, {"type": "treatment", "offset": [14, 15, 16], "text": "following stent placement"}, {"type": "drug", "offset": [5], "text": "phenytoin"}, {"type": "drug", "offset": [10], "text": "ticagrelor"}, {"type": "treatment disorder", "offset": [12, 13], "text": "antiplatelet therapy"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "for", "label": "potential therapeutic event", "asoc": [["subject", "The patient"], ["subject disorder", "antiplatelet therapy"], ["treatment", "previously on phenytoin"], ["treatment", "initiated on ticagrelor"], ["treatment", "following stent placement"], ["drug", "phenytoin"], ["drug", "ticagrelor"], ["treatment disorder", "antiplatelet therapy"]]}]}
{"text_id": "19707032_3", "text": "AIM : To report a patient with diabetic rubeosis who suffered from acute retinal ischemic change and stroke after intravitreal injection of bevacizumab .", "tokens": ["AIM", ":", "To", "report", "a", "patient", "with", "diabetic", "rubeosis", "who", "suffered", "from", "acute", "retinal", "ischemic", "change", "and", "stroke", "after", "intravitreal", "injection", "of", "bevacizumab", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> suffered <extra_id_0> subject <extra_id_5> patient with diabetic rubeosis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> diabetic rubeosis <extra_id_1> <extra_id_0> treatment <extra_id_5> intravitreal injection of bevacizumab <extra_id_1> <extra_id_0> drug <extra_id_5> bevacizumab <extra_id_1> <extra_id_0> route <extra_id_5> intravitreal injection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> diabetic rubeosis <extra_id_1> <extra_id_0> effect <extra_id_5> acute retinal ischemic change and stroke <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "suffered", "args": [{"type": "subject", "offset": [5, 6, 7, 8], "text": "patient with diabetic rubeosis"}, {"type": "subject disorder", "offset": [7, 8], "text": "diabetic rubeosis"}, {"type": "treatment", "offset": [19, 20, 21, 22], "text": "intravitreal injection of bevacizumab"}, {"type": "drug", "offset": [22], "text": "bevacizumab"}, {"type": "route", "offset": [19, 20], "text": "intravitreal injection"}, {"type": "treatment disorder", "offset": [7, 8], "text": "diabetic rubeosis"}, {"type": "effect", "offset": [12, 13, 14, 15, 16, 17], "text": "acute retinal ischemic change and stroke"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "suffered", "label": "adverse event", "asoc": [["subject", "patient with diabetic rubeosis"], ["subject disorder", "diabetic rubeosis"], ["treatment", "intravitreal injection of bevacizumab"], ["drug", "bevacizumab"], ["route", "intravitreal injection"], ["treatment disorder", "diabetic rubeosis"], ["effect", "acute retinal ischemic change and stroke"]]}]}
{"text_id": "2979256_1", "text": "A 57 - year - old woman presented with a 3 - week history of dysphagia for solids , 6 months after starting treatment with nifedipine .", "tokens": ["A", "57", "-", "year", "-", "old", "woman", "presented", "with", "a", "3", "-", "week", "history", "of", "dysphagia", "for", "solids", ",", "6", "months", "after", "starting", "treatment", "with", "nifedipine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> presented <extra_id_0> subject <extra_id_5> A 57 - year - old woman <extra_id_1> <extra_id_0> age <extra_id_5> 57 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> treatment <extra_id_5> nifedipine <extra_id_1> <extra_id_0> drug <extra_id_5> nifedipine <extra_id_1> <extra_id_0> duration <extra_id_5> 6 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 6 months <extra_id_1> <extra_id_0> effect <extra_id_5> dysphagia for solids <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "presented", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "A 57 - year - old woman"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "57 - year - old"}, {"type": "gender", "offset": [6], "text": "woman"}, {"type": "treatment", "offset": [25], "text": "nifedipine"}, {"type": "drug", "offset": [25], "text": "nifedipine"}, {"type": "duration", "offset": [19, 20], "text": "6 months"}, {"type": "time elapsed", "offset": [19, 20], "text": "6 months"}, {"type": "effect", "offset": [15, 16, 17], "text": "dysphagia for solids"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "duration", "effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "presented", "label": "adverse event", "asoc": [["subject", "A 57 - year - old woman"], ["age", "57 - year - old"], ["gender", "woman"], ["treatment", "nifedipine"], ["drug", "nifedipine"], ["duration", "6 months"], ["time elapsed", "6 months"], ["effect", "dysphagia for solids"]]}]}
{"text_id": "17509184_2", "text": "Ethambutol toxicity manifesting as acute onset psychosis .", "tokens": ["Ethambutol", "toxicity", "manifesting", "as", "acute", "onset", "psychosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> toxicity <extra_id_0> treatment <extra_id_5> Ethambutol <extra_id_1> <extra_id_0> drug <extra_id_5> Ethambutol <extra_id_1> <extra_id_0> effect <extra_id_5> acute onset psychosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "toxicity", "args": [{"type": "treatment", "offset": [0], "text": "Ethambutol"}, {"type": "drug", "offset": [0], "text": "Ethambutol"}, {"type": "effect", "offset": [4, 5, 6], "text": "acute onset psychosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "toxicity", "label": "adverse event", "asoc": [["treatment", "Ethambutol"], ["drug", "Ethambutol"], ["effect", "acute onset psychosis"]]}]}
{"text_id": "7416268_1", "text": "Disulfiram encephalopathy as a cause of the catatonia syndrome .", "tokens": ["Disulfiram", "encephalopathy", "as", "a", "cause", "of", "the", "catatonia", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> Disulfiram <extra_id_1> <extra_id_0> drug <extra_id_5> Disulfiram <extra_id_1> <extra_id_0> effect <extra_id_5> catatonia syndrome <extra_id_1> <extra_id_0> effect <extra_id_5> encephalopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "cause", "args": [{"type": "treatment", "offset": [0], "text": "Disulfiram"}, {"type": "drug", "offset": [0], "text": "Disulfiram"}, {"type": "effect", "offset": [7, 8], "text": "catatonia syndrome"}, {"type": "effect", "offset": [1], "text": "encephalopathy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "Disulfiram"], ["drug", "Disulfiram"], ["effect", "catatonia syndrome"], ["effect", "encephalopathy"]]}]}
{"text_id": "18344455_2", "text": "It is rare to develop simultaneous toxicities while on anticonvulsants .", "tokens": ["It", "is", "rare", "to", "develop", "simultaneous", "toxicities", "while", "on", "anticonvulsants", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> develop <extra_id_0> treatment <extra_id_5> anticonvulsants <extra_id_1> <extra_id_0> drug <extra_id_5> anticonvulsants <extra_id_1> <extra_id_0> effect <extra_id_5> toxicities <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "develop", "args": [{"type": "treatment", "offset": [9], "text": "anticonvulsants"}, {"type": "drug", "offset": [9], "text": "anticonvulsants"}, {"type": "effect", "offset": [6], "text": "toxicities"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "develop", "label": "adverse event", "asoc": [["treatment", "anticonvulsants"], ["drug", "anticonvulsants"], ["effect", "toxicities"]]}]}
{"text_id": "1642627_2", "text": "Triazolam - induced nocturnal bingeing with amnesia .", "tokens": ["Triazolam", "-", "induced", "nocturnal", "bingeing", "with", "amnesia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Triazolam <extra_id_1> <extra_id_0> drug <extra_id_5> Triazolam <extra_id_1> <extra_id_0> effect <extra_id_5> nocturnal bingeing with amnesia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Triazolam"}, {"type": "drug", "offset": [0], "text": "Triazolam"}, {"type": "effect", "offset": [3, 4, 5, 6], "text": "nocturnal bingeing with amnesia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Triazolam"], ["drug", "Triazolam"], ["effect", "nocturnal bingeing with amnesia"]]}]}
{"text_id": "16371793_2", "text": "PURPOSE : The intravitreal application of triamcinolone acetonide as treatment of long - standing , therapy - resistant cystoid macular edema after penetrating keratoplasty is reported .", "tokens": ["PURPOSE", ":", "The", "intravitreal", "application", "of", "triamcinolone", "acetonide", "as", "treatment", "of", "long", "-", "standing", ",", "therapy", "-", "resistant", "cystoid", "macular", "edema", "after", "penetrating", "keratoplasty", "is", "reported", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> The intravitreal application of triamcinolone acetonide <extra_id_1> <extra_id_0> drug <extra_id_5> triamcinolone acetonide <extra_id_1> <extra_id_0> route <extra_id_5> intravitreal <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> cystoid macular edema <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [9], "text": "treatment", "args": [{"type": "treatment", "offset": [2, 3, 4, 5, 6, 7], "text": "The intravitreal application of triamcinolone acetonide"}, {"type": "drug", "offset": [6, 7], "text": "triamcinolone acetonide"}, {"type": "route", "offset": [3], "text": "intravitreal"}, {"type": "treatment disorder", "offset": [18, 19, 20], "text": "cystoid macular edema"}]}], "spot": ["potential therapeutic event"], "asoc": ["route", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "The intravitreal application of triamcinolone acetonide"], ["drug", "triamcinolone acetonide"], ["route", "intravitreal"], ["treatment disorder", "cystoid macular edema"]]}]}
{"text_id": "2320800_1", "text": "Lethal anuria complicating high dose ifosfamide chemotherapy in a breast cancer patient with an impaired renal function .", "tokens": ["Lethal", "anuria", "complicating", "high", "dose", "ifosfamide", "chemotherapy", "in", "a", "breast", "cancer", "patient", "with", "an", "impaired", "renal", "function", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complicating <extra_id_0> subject <extra_id_5> a breast cancer patient with an impaired renal function <extra_id_1> <extra_id_0> subject disorder <extra_id_5> an impaired renal function <extra_id_1> <extra_id_0> subject disorder <extra_id_5> breast cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> high dose ifosfamide chemotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> ifosfamide <extra_id_1> <extra_id_0> dosage <extra_id_5> high dose <extra_id_1> <extra_id_0> route <extra_id_5> chemotherapy <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> breast cancer <extra_id_1> <extra_id_0> effect <extra_id_5> anuria <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "complicating", "args": [{"type": "subject", "offset": [8, 9, 10, 11, 12, 13, 14, 15, 16], "text": "a breast cancer patient with an impaired renal function"}, {"type": "subject disorder", "offset": [13, 14, 15, 16], "text": "an impaired renal function"}, {"type": "subject disorder", "offset": [9, 10], "text": "breast cancer"}, {"type": "treatment", "offset": [3, 4, 5, 6], "text": "high dose ifosfamide chemotherapy"}, {"type": "drug", "offset": [5], "text": "ifosfamide"}, {"type": "dosage", "offset": [3, 4], "text": "high dose"}, {"type": "route", "offset": [6], "text": "chemotherapy"}, {"type": "treatment disorder", "offset": [9, 10], "text": "breast cancer"}, {"type": "effect", "offset": [1], "text": "anuria"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "treatment", "dosage", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "complicating", "label": "adverse event", "asoc": [["subject", "a breast cancer patient with an impaired renal function"], ["subject disorder", "an impaired renal function"], ["subject disorder", "breast cancer"], ["treatment", "high dose ifosfamide chemotherapy"], ["drug", "ifosfamide"], ["dosage", "high dose"], ["route", "chemotherapy"], ["treatment disorder", "breast cancer"], ["effect", "anuria"]]}]}
{"text_id": "8828999_3", "text": "Lithium neurotoxicity should be considered in Creutzfeldt - Jakob disease differential diagnosis , serial electroencephalograms being the most valuable .", "tokens": ["Lithium", "neurotoxicity", "should", "be", "considered", "in", "Creutzfeldt", "-", "Jakob", "disease", "differential", "diagnosis", ",", "serial", "electroencephalograms", "being", "the", "most", "valuable", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> considered <extra_id_0> treatment <extra_id_5> Lithium <extra_id_1> <extra_id_0> drug <extra_id_5> Lithium <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Creutzfeldt - Jakob disease <extra_id_1> <extra_id_0> effect <extra_id_5> Lithium neurotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "considered", "args": [{"type": "treatment", "offset": [0], "text": "Lithium"}, {"type": "drug", "offset": [0], "text": "Lithium"}, {"type": "treatment disorder", "offset": [6, 7, 8, 9], "text": "Creutzfeldt - Jakob disease"}, {"type": "effect", "offset": [0, 1], "text": "Lithium neurotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "considered", "label": "adverse event", "asoc": [["treatment", "Lithium"], ["drug", "Lithium"], ["treatment disorder", "Creutzfeldt - Jakob disease"], ["effect", "Lithium neurotoxicity"]]}]}
{"text_id": "10891991_5", "text": "PATIENTS : Three patients developed a reproductive endocrine disorder during treatment with valproate .", "tokens": ["PATIENTS", ":", "Three", "patients", "developed", "a", "reproductive", "endocrine", "disorder", "during", "treatment", "with", "valproate", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> Three patients <extra_id_1> <extra_id_0> population <extra_id_5> Three <extra_id_1> <extra_id_0> treatment <extra_id_5> valproate <extra_id_1> <extra_id_0> drug <extra_id_5> valproate <extra_id_1> <extra_id_0> effect <extra_id_5> reproductive endocrine disorder <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "developed", "args": [{"type": "subject", "offset": [2, 3], "text": "Three patients"}, {"type": "population", "offset": [2], "text": "Three"}, {"type": "treatment", "offset": [12], "text": "valproate"}, {"type": "drug", "offset": [12], "text": "valproate"}, {"type": "effect", "offset": [6, 7, 8], "text": "reproductive endocrine disorder"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "Three patients"], ["population", "Three"], ["treatment", "valproate"], ["drug", "valproate"], ["effect", "reproductive endocrine disorder"]]}]}
{"text_id": "11122162_3", "text": "We have safely used recombinant factor VIIa to treat bleeding in the immediate and long - term period following PCC - related MI .", "tokens": ["We", "have", "safely", "used", "recombinant", "factor", "VIIa", "to", "treat", "bleeding", "in", "the", "immediate", "and", "long", "-", "term", "period", "following", "PCC", "-", "related", "MI", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treat <extra_id_0> subject <extra_id_5> PCC - related MI <extra_id_1> <extra_id_0> subject disorder <extra_id_5> PCC - related MI <extra_id_1> <extra_id_0> subject disorder <extra_id_5> bleeding <extra_id_1> <extra_id_0> treatment <extra_id_5> recombinant factor VIIa <extra_id_1> <extra_id_0> drug <extra_id_5> recombinant factor VIIa <extra_id_1> <extra_id_0> time elapsed <extra_id_5> immediate and long - term period <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> bleeding <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> treatment <extra_id_5> PCC <extra_id_1> <extra_id_0> drug <extra_id_5> PCC <extra_id_1> <extra_id_0> effect <extra_id_5> MI <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [8], "text": "treat", "args": [{"type": "subject", "offset": [19, 20, 21, 22], "text": "PCC - related MI"}, {"type": "subject disorder", "offset": [19, 20, 21, 22], "text": "PCC - related MI"}, {"type": "subject disorder", "offset": [9], "text": "bleeding"}, {"type": "treatment", "offset": [4, 5, 6], "text": "recombinant factor VIIa"}, {"type": "drug", "offset": [4, 5, 6], "text": "recombinant factor VIIa"}, {"type": "time elapsed", "offset": [12, 13, 14, 15, 16, 17], "text": "immediate and long - term period"}, {"type": "treatment disorder", "offset": [9], "text": "bleeding"}]}, {"type": "adverse event", "offset": [21], "text": "related", "args": [{"type": "treatment", "offset": [19], "text": "PCC"}, {"type": "drug", "offset": [19], "text": "PCC"}, {"type": "effect", "offset": [22], "text": "MI"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "subject", "treatment", "time elapsed", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treat", "label": "potential therapeutic event", "asoc": [["subject", "PCC - related MI"], ["subject disorder", "PCC - related MI"], ["subject disorder", "bleeding"], ["treatment", "recombinant factor VIIa"], ["drug", "recombinant factor VIIa"], ["time elapsed", "immediate and long - term period"], ["treatment disorder", "bleeding"]]}, {"span": "related", "label": "adverse event", "asoc": [["treatment", "PCC"], ["drug", "PCC"], ["effect", "MI"]]}]}
{"text_id": "8098286_2", "text": "Inadvertent subsequent rechallenge with celiprolol led to recurrence of the pneumonitis , 10 weeks after drug readministration .", "tokens": ["Inadvertent", "subsequent", "rechallenge", "with", "celiprolol", "led", "to", "recurrence", "of", "the", "pneumonitis", ",", "10", "weeks", "after", "drug", "readministration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> led to <extra_id_0> treatment <extra_id_5> Inadvertent subsequent rechallenge with celiprolol <extra_id_1> <extra_id_0> treatment <extra_id_5> 10 weeks after drug readministration <extra_id_1> <extra_id_0> drug <extra_id_5> celiprolol <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 10 weeks <extra_id_1> <extra_id_0> effect <extra_id_5> recurrence of the pneumonitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5, 6], "text": "led to", "args": [{"type": "treatment", "offset": [0, 1, 2, 3, 4], "text": "Inadvertent subsequent rechallenge with celiprolol"}, {"type": "treatment", "offset": [12, 13, 14, 15, 16], "text": "10 weeks after drug readministration"}, {"type": "drug", "offset": [4], "text": "celiprolol"}, {"type": "time elapsed", "offset": [12, 13], "text": "10 weeks"}, {"type": "effect", "offset": [7, 8, 9, 10], "text": "recurrence of the pneumonitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "time elapsed"], "spot_asoc": [{"span": "led to", "label": "adverse event", "asoc": [["treatment", "Inadvertent subsequent rechallenge with celiprolol"], ["treatment", "10 weeks after drug readministration"], ["drug", "celiprolol"], ["time elapsed", "10 weeks"], ["effect", "recurrence of the pneumonitis"]]}]}
{"text_id": "3405528_2", "text": "Halothane hepatitis and prompt resolution with methionine therapy : case report .", "tokens": ["Halothane", "hepatitis", "and", "prompt", "resolution", "with", "methionine", "therapy", ":", "case", "report", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> resolution <extra_id_0> subject <extra_id_5> case <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Halothane hepatitis <extra_id_1> <extra_id_0> treatment <extra_id_5> methionine <extra_id_1> <extra_id_0> drug <extra_id_5> methionine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Halothane hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [4], "text": "resolution", "args": [{"type": "subject", "offset": [9], "text": "case"}, {"type": "subject disorder", "offset": [0, 1], "text": "Halothane hepatitis"}, {"type": "treatment", "offset": [6], "text": "methionine"}, {"type": "drug", "offset": [6], "text": "methionine"}, {"type": "treatment disorder", "offset": [0, 1], "text": "Halothane hepatitis"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "resolution", "label": "potential therapeutic event", "asoc": [["subject", "case"], ["subject disorder", "Halothane hepatitis"], ["treatment", "methionine"], ["drug", "methionine"], ["treatment disorder", "Halothane hepatitis"]]}]}
{"text_id": "2320800_2", "text": "A sixty - year - old woman with advanced breast cancer , previously treated with cisplatin , developed an irreversible lethal renal failure with anuria , the day after 5 g / m2 bolus ifosfamide .", "tokens": ["A", "sixty", "-", "year", "-", "old", "woman", "with", "advanced", "breast", "cancer", ",", "previously", "treated", "with", "cisplatin", ",", "developed", "an", "irreversible", "lethal", "renal", "failure", "with", "anuria", ",", "the", "day", "after", "5", "g", "/", "m2", "bolus", "ifosfamide", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A sixty - year - old woman with advanced breast cancer , previously treated with cisplatin <extra_id_1> <extra_id_0> age <extra_id_5> sixty - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> advanced breast cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> the day after 5 g / m2 bolus ifosfamide <extra_id_1> <extra_id_0> drug <extra_id_5> ifosfamide <extra_id_1> <extra_id_0> dosage <extra_id_5> 5 g / m2 <extra_id_1> <extra_id_0> time elapsed <extra_id_5> the day after <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> advanced breast cancer <extra_id_1> <extra_id_0> effect <extra_id_5> an irreversible lethal renal failure with anuria <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "A sixty - year - old woman with advanced breast cancer , previously treated with cisplatin"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "sixty - year - old"}, {"type": "gender", "offset": [6], "text": "woman"}, {"type": "subject disorder", "offset": [8, 9, 10], "text": "advanced breast cancer"}, {"type": "treatment", "offset": [26, 27, 28, 29, 30, 31, 32, 33, 34], "text": "the day after 5 g / m2 bolus ifosfamide"}, {"type": "drug", "offset": [34], "text": "ifosfamide"}, {"type": "dosage", "offset": [29, 30, 31, 32], "text": "5 g / m2"}, {"type": "time elapsed", "offset": [26, 27, 28], "text": "the day after"}, {"type": "treatment disorder", "offset": [8, 9, 10], "text": "advanced breast cancer"}, {"type": "effect", "offset": [18, 19, 20, 21, 22, 23, 24], "text": "an irreversible lethal renal failure with anuria"}]}], "spot": ["adverse event"], "asoc": ["dosage", "time elapsed", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A sixty - year - old woman with advanced breast cancer , previously treated with cisplatin"], ["age", "sixty - year - old"], ["gender", "woman"], ["subject disorder", "advanced breast cancer"], ["treatment", "the day after 5 g / m2 bolus ifosfamide"], ["drug", "ifosfamide"], ["dosage", "5 g / m2"], ["time elapsed", "the day after"], ["treatment disorder", "advanced breast cancer"], ["effect", "an irreversible lethal renal failure with anuria"]]}]}
{"text_id": "21751666_3", "text": "Prevention of infection by immunization , together with early recognition and prompt antiviral treatment are critical .", "tokens": ["Prevention", "of", "infection", "by", "immunization", ",", "together", "with", "early", "recognition", "and", "prompt", "antiviral", "treatment", "are", "critical", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> Prevention <extra_id_0> treatment <extra_id_5> immunization , together with early recognition and prompt antiviral treatment <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> infection <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [0], "text": "Prevention", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12, 13], "text": "immunization , together with early recognition and prompt antiviral treatment"}, {"type": "treatment disorder", "offset": [2], "text": "infection"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "treatment disorder"], "spot_asoc": [{"span": "Prevention", "label": "potential therapeutic event", "asoc": [["treatment", "immunization , together with early recognition and prompt antiviral treatment"], ["treatment disorder", "infection"]]}]}
{"text_id": "18344455_4", "text": "These toxicities resolved after the cessation of anticonvulsants , and her seizures were managed acutely with scheduled lorazepam .", "tokens": ["These", "toxicities", "resolved", "after", "the", "cessation", "of", "anticonvulsants", ",", "and", "her", "seizures", "were", "managed", "acutely", "with", "scheduled", "lorazepam", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> managed <extra_id_0> treatment <extra_id_5> lorazepam <extra_id_1> <extra_id_0> drug <extra_id_5> lorazepam <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> seizures <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [13], "text": "managed", "args": [{"type": "treatment", "offset": [17], "text": "lorazepam"}, {"type": "drug", "offset": [17], "text": "lorazepam"}, {"type": "treatment disorder", "offset": [11], "text": "seizures"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "managed", "label": "potential therapeutic event", "asoc": [["treatment", "lorazepam"], ["drug", "lorazepam"], ["treatment disorder", "seizures"]]}]}
{"text_id": "189279_3", "text": "The role of Adriamycin in the production of cardiotoxicity is reviewed .", "tokens": ["The", "role", "of", "Adriamycin", "in", "the", "production", "of", "cardiotoxicity", "is", "reviewed", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> production <extra_id_0> treatment <extra_id_5> Adriamycin <extra_id_1> <extra_id_0> drug <extra_id_5> Adriamycin <extra_id_1> <extra_id_0> effect <extra_id_5> cardiotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "production", "args": [{"type": "treatment", "offset": [3], "text": "Adriamycin"}, {"type": "drug", "offset": [3], "text": "Adriamycin"}, {"type": "effect", "offset": [8], "text": "cardiotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "production", "label": "adverse event", "asoc": [["treatment", "Adriamycin"], ["drug", "Adriamycin"], ["effect", "cardiotoxicity"]]}]}
{"text_id": "15300114_1", "text": "Deepening of lid sulcus from topical bimatoprost therapy .", "tokens": ["Deepening", "of", "lid", "sulcus", "from", "topical", "bimatoprost", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> from <extra_id_0> treatment <extra_id_5> bimatoprost <extra_id_1> <extra_id_0> drug <extra_id_5> bimatoprost <extra_id_1> <extra_id_0> effect <extra_id_5> Deepening of lid sulcus <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "from", "args": [{"type": "treatment", "offset": [6], "text": "bimatoprost"}, {"type": "drug", "offset": [6], "text": "bimatoprost"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Deepening of lid sulcus"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "from", "label": "adverse event", "asoc": [["treatment", "bimatoprost"], ["drug", "bimatoprost"], ["effect", "Deepening of lid sulcus"]]}]}
{"text_id": "9111724_1", "text": "Discontinuation of the itraconazole caused resolution of the drug eruption .", "tokens": ["Discontinuation", "of", "the", "itraconazole", "caused", "resolution", "of", "the", "drug", "eruption", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> itraconazole <extra_id_1> <extra_id_0> drug <extra_id_5> itraconazole <extra_id_1> <extra_id_0> effect <extra_id_5> drug eruption <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "caused", "args": [{"type": "treatment", "offset": [3], "text": "itraconazole"}, {"type": "drug", "offset": [3], "text": "itraconazole"}, {"type": "effect", "offset": [8, 9], "text": "drug eruption"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "itraconazole"], ["drug", "itraconazole"], ["effect", "drug eruption"]]}]}
{"text_id": "17044380_1", "text": "Herein is reported an unusual case of coexistent warfarin - induced skin necrosis and heparin - induced thrombocytopenia following mitral valve replacement for thromboembolic phenomena associated with marantic endocarditis and bronchial adenocarcinoma .", "tokens": ["Herein", "is", "reported", "an", "unusual", "case", "of", "coexistent", "warfarin", "-", "induced", "skin", "necrosis", "and", "heparin", "-", "induced", "thrombocytopenia", "following", "mitral", "valve", "replacement", "for", "thromboembolic", "phenomena", "associated", "with", "marantic", "endocarditis", "and", "bronchial", "adenocarcinoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> skin necrosis <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> heparin <extra_id_1> <extra_id_0> drug <extra_id_5> heparin <extra_id_1> <extra_id_0> effect <extra_id_5> thrombocytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "induced", "args": [{"type": "treatment", "offset": [8], "text": "warfarin"}, {"type": "drug", "offset": [8], "text": "warfarin"}, {"type": "effect", "offset": [11, 12], "text": "skin necrosis"}]}, {"type": "adverse event", "offset": [16], "text": "induced", "args": [{"type": "treatment", "offset": [14], "text": "heparin"}, {"type": "drug", "offset": [14], "text": "heparin"}, {"type": "effect", "offset": [17], "text": "thrombocytopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "warfarin"], ["drug", "warfarin"], ["effect", "skin necrosis"]]}, {"span": "induced", "label": "adverse event", "asoc": [["treatment", "heparin"], ["drug", "heparin"], ["effect", "thrombocytopenia"]]}]}
{"text_id": "16176119_2", "text": "Gefitinib ( IRESSA , ZD1839 ) , an epidermal growth factor receptor tyrosine kinase inhibitor , has been approved in several countries for the treatment of advanced non - small - cell lung cancer .", "tokens": ["Gefitinib", "(", "IRESSA", ",", "ZD1839", ")", ",", "an", "epidermal", "growth", "factor", "receptor", "tyrosine", "kinase", "inhibitor", ",", "has", "been", "approved", "in", "several", "countries", "for", "the", "treatment", "of", "advanced", "non", "-", "small", "-", "cell", "lung", "cancer", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> Gefitinib <extra_id_1> <extra_id_0> drug <extra_id_5> Gefitinib <extra_id_1> <extra_id_0> drug <extra_id_5> IRESSA <extra_id_1> <extra_id_0> drug <extra_id_5> ZD1839 <extra_id_1> <extra_id_0> drug <extra_id_5> epidermal growth factor receptor tyrosine kinase inhibitor <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> advanced non - small - cell lung cancer <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [24], "text": "treatment", "args": [{"type": "treatment", "offset": [0], "text": "Gefitinib"}, {"type": "drug", "offset": [0], "text": "Gefitinib"}, {"type": "drug", "offset": [2], "text": "IRESSA"}, {"type": "drug", "offset": [4], "text": "ZD1839"}, {"type": "drug", "offset": [8, 9, 10, 11, 12, 13, 14], "text": "epidermal growth factor receptor tyrosine kinase inhibitor"}, {"type": "treatment disorder", "offset": [26, 27, 28, 29, 30, 31, 32, 33], "text": "advanced non - small - cell lung cancer"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "Gefitinib"], ["drug", "Gefitinib"], ["drug", "IRESSA"], ["drug", "ZD1839"], ["drug", "epidermal growth factor receptor tyrosine kinase inhibitor"], ["treatment disorder", "advanced non - small - cell lung cancer"]]}]}
{"text_id": "20178709_3", "text": "We report here a rare case of pleuropericarditis due to methotrexate .", "tokens": ["We", "report", "here", "a", "rare", "case", "of", "pleuropericarditis", "due", "to", "methotrexate", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> subject <extra_id_5> a rare case <extra_id_1> <extra_id_0> treatment <extra_id_5> methotrexate <extra_id_1> <extra_id_0> drug <extra_id_5> methotrexate <extra_id_1> <extra_id_0> effect <extra_id_5> pleuropericarditis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "due", "args": [{"type": "subject", "offset": [3, 4, 5], "text": "a rare case"}, {"type": "treatment", "offset": [10], "text": "methotrexate"}, {"type": "drug", "offset": [10], "text": "methotrexate"}, {"type": "effect", "offset": [7], "text": "pleuropericarditis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["subject", "a rare case"], ["treatment", "methotrexate"], ["drug", "methotrexate"], ["effect", "pleuropericarditis"]]}]}
{"text_id": "8313300_7", "text": "Lithium therapy was discontinued because of poor compliance to the medication and intolerable polyuria .", "tokens": ["Lithium", "therapy", "was", "discontinued", "because", "of", "poor", "compliance", "to", "the", "medication", "and", "intolerable", "polyuria", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> because <extra_id_0> treatment <extra_id_5> Lithium <extra_id_1> <extra_id_0> effect <extra_id_5> polyuria <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "because", "args": [{"type": "treatment", "offset": [0], "text": "Lithium"}, {"type": "effect", "offset": [13], "text": "polyuria"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment"], "spot_asoc": [{"span": "because", "label": "adverse event", "asoc": [["treatment", "Lithium"], ["effect", "polyuria"]]}]}
{"text_id": "9177620_1", "text": "A possible case of carbamazepine induced pancreatitis .", "tokens": ["A", "possible", "case", "of", "carbamazepine", "induced", "pancreatitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> A possible case <extra_id_1> <extra_id_0> treatment <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> effect <extra_id_5> pancreatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "induced", "args": [{"type": "subject", "offset": [0, 1, 2], "text": "A possible case"}, {"type": "treatment", "offset": [4], "text": "carbamazepine"}, {"type": "drug", "offset": [4], "text": "carbamazepine"}, {"type": "effect", "offset": [6], "text": "pancreatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "A possible case"], ["treatment", "carbamazepine"], ["drug", "carbamazepine"], ["effect", "pancreatitis"]]}]}
{"text_id": "9232614_1", "text": "Acute leukaemia during tamoxifen therapy .", "tokens": ["Acute", "leukaemia", "during", "tamoxifen", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> tamoxifen therapy <extra_id_1> <extra_id_0> drug <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> effect <extra_id_5> Acute leukaemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "during", "args": [{"type": "treatment", "offset": [3, 4], "text": "tamoxifen therapy"}, {"type": "drug", "offset": [3], "text": "tamoxifen"}, {"type": "effect", "offset": [0, 1], "text": "Acute leukaemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "tamoxifen therapy"], ["drug", "tamoxifen"], ["effect", "Acute leukaemia"]]}]}
{"text_id": "2006943_2", "text": "A patient , while on intravenous ritodrine therapy for preterm labor , experienced an episode of acute chest pain .", "tokens": ["A", "patient", ",", "while", "on", "intravenous", "ritodrine", "therapy", "for", "preterm", "labor", ",", "experienced", "an", "episode", "of", "acute", "chest", "pain", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> on <extra_id_0> subject <extra_id_5> A patient <extra_id_1> <extra_id_0> treatment <extra_id_5> intravenous ritodrine therapy <extra_id_1> <extra_id_0> drug <extra_id_5> ritodrine <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> effect <extra_id_5> an episode of acute chest pain <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "on", "args": [{"type": "subject", "offset": [0, 1], "text": "A patient"}, {"type": "treatment", "offset": [5, 6, 7], "text": "intravenous ritodrine therapy"}, {"type": "drug", "offset": [6], "text": "ritodrine"}, {"type": "route", "offset": [5], "text": "intravenous"}, {"type": "effect", "offset": [13, 14, 15, 16, 17, 18], "text": "an episode of acute chest pain"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "treatment"], "spot_asoc": [{"span": "on", "label": "adverse event", "asoc": [["subject", "A patient"], ["treatment", "intravenous ritodrine therapy"], ["drug", "ritodrine"], ["route", "intravenous"], ["effect", "an episode of acute chest pain"]]}]}
{"text_id": "10723699_1", "text": "Tetracycline - induced benign intracranial hypertension .", "tokens": ["Tetracycline", "-", "induced", "benign", "intracranial", "hypertension", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Tetracycline <extra_id_1> <extra_id_0> drug <extra_id_5> Tetracycline <extra_id_1> <extra_id_0> effect <extra_id_5> benign intracranial hypertension <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Tetracycline"}, {"type": "drug", "offset": [0], "text": "Tetracycline"}, {"type": "effect", "offset": [3, 4, 5], "text": "benign intracranial hypertension"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Tetracycline"], ["drug", "Tetracycline"], ["effect", "benign intracranial hypertension"]]}]}
{"text_id": "14585456_1", "text": "We present a case of a 20 - year - old woman who ingested 900 mg of glyburide causing refractory hypoglycemia resistant to treatment with intravenous dextrose , glucagon , and diazoxide .", "tokens": ["We", "present", "a", "case", "of", "a", "20", "-", "year", "-", "old", "woman", "who", "ingested", "900", "mg", "of", "glyburide", "causing", "refractory", "hypoglycemia", "resistant", "to", "treatment", "with", "intravenous", "dextrose", ",", "glucagon", ",", "and", "diazoxide", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> ingested <extra_id_0> subject <extra_id_5> a 20 - year - old woman <extra_id_1> <extra_id_0> age <extra_id_5> 20 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> treatment <extra_id_5> 900 mg of glyburide <extra_id_1> <extra_id_0> drug <extra_id_5> glyburide <extra_id_1> <extra_id_0> dosage <extra_id_5> 900 mg <extra_id_1> <extra_id_0> effect <extra_id_5> refractory hypoglycemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "ingested", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "a 20 - year - old woman"}, {"type": "age", "offset": [6, 7, 8, 9, 10], "text": "20 - year - old"}, {"type": "gender", "offset": [11], "text": "woman"}, {"type": "treatment", "offset": [14, 15, 16, 17], "text": "900 mg of glyburide"}, {"type": "drug", "offset": [17], "text": "glyburide"}, {"type": "dosage", "offset": [14, 15], "text": "900 mg"}, {"type": "effect", "offset": [19, 20], "text": "refractory hypoglycemia"}]}], "spot": ["adverse event"], "asoc": ["dosage", "effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "ingested", "label": "adverse event", "asoc": [["subject", "a 20 - year - old woman"], ["age", "20 - year - old"], ["gender", "woman"], ["treatment", "900 mg of glyburide"], ["drug", "glyburide"], ["dosage", "900 mg"], ["effect", "refractory hypoglycemia"]]}]}
{"text_id": "12114387_1", "text": "Epoprostenol may be associated rarely with severe erythroderma .", "tokens": ["Epoprostenol", "may", "be", "associated", "rarely", "with", "severe", "erythroderma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Epoprostenol <extra_id_1> <extra_id_0> drug <extra_id_5> Epoprostenol <extra_id_1> <extra_id_0> effect <extra_id_5> severe erythroderma . <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Epoprostenol"}, {"type": "drug", "offset": [0], "text": "Epoprostenol"}, {"type": "effect", "offset": [6, 7, 8], "text": "severe erythroderma ."}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Epoprostenol"], ["drug", "Epoprostenol"], ["effect", "severe erythroderma ."]]}]}
{"text_id": "19017039_2", "text": "Syringotropic hypersensitivity reaction associated with infliximab and leflunomide combination therapy in a child with psoriatic arthritis .", "tokens": ["Syringotropic", "hypersensitivity", "reaction", "associated", "with", "infliximab", "and", "leflunomide", "combination", "therapy", "in", "a", "child", "with", "psoriatic", "arthritis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> a child with psoriatic arthritis <extra_id_1> <extra_id_0> age <extra_id_5> child <extra_id_1> <extra_id_0> subject disorder <extra_id_5> psoriatic arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> infliximab and leflunomide combination therapy <extra_id_1> <extra_id_0> drug <extra_id_5> infliximab <extra_id_1> <extra_id_0> drug <extra_id_5> leflunomide <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> psoriatic arthritis <extra_id_1> <extra_id_0> combination drug <extra_id_5> leflunomide <extra_id_1> <extra_id_0> combination drug <extra_id_5> infliximab <extra_id_1> <extra_id_0> effect <extra_id_5> Syringotropic hypersensitivity reaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "associated", "args": [{"type": "subject", "offset": [11, 12, 13, 14, 15], "text": "a child with psoriatic arthritis"}, {"type": "age", "offset": [12], "text": "child"}, {"type": "subject disorder", "offset": [14, 15], "text": "psoriatic arthritis"}, {"type": "treatment", "offset": [5, 6, 7, 8, 9], "text": "infliximab and leflunomide combination therapy"}, {"type": "drug", "offset": [5], "text": "infliximab"}, {"type": "drug", "offset": [7], "text": "leflunomide"}, {"type": "treatment disorder", "offset": [14, 15], "text": "psoriatic arthritis"}, {"type": "combination drug", "offset": [7], "text": "leflunomide"}, {"type": "combination drug", "offset": [5], "text": "infliximab"}, {"type": "effect", "offset": [0, 1, 2], "text": "Syringotropic hypersensitivity reaction"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "a child with psoriatic arthritis"], ["age", "child"], ["subject disorder", "psoriatic arthritis"], ["treatment", "infliximab and leflunomide combination therapy"], ["drug", "infliximab"], ["drug", "leflunomide"], ["treatment disorder", "psoriatic arthritis"], ["combination drug", "leflunomide"], ["combination drug", "infliximab"], ["effect", "Syringotropic hypersensitivity reaction"]]}]}
{"text_id": "17188061_1", "text": "CONCLUSIONS : We report a typical symptoms of Charles - Bonnet syndrome ( CBS ) in patients with severe AMD after intravitreal Avastin - injections .", "tokens": ["CONCLUSIONS", ":", "We", "report", "a", "typical", "symptoms", "of", "Charles", "-", "Bonnet", "syndrome", "(", "CBS", ")", "in", "patients", "with", "severe", "AMD", "after", "intravitreal", "Avastin", "-", "injections", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> patients with severe AMD <extra_id_1> <extra_id_0> subject disorder <extra_id_5> AMD <extra_id_1> <extra_id_0> treatment <extra_id_5> intravitreal Avastin - injections <extra_id_1> <extra_id_0> drug <extra_id_5> Avastin <extra_id_1> <extra_id_0> route <extra_id_5> intravitreal <extra_id_1> <extra_id_0> route <extra_id_5> injections <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> AMD <extra_id_1> <extra_id_0> effect <extra_id_5> typical symptoms of Charles - Bonnet syndrome ( CBS ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "after", "args": [{"type": "subject", "offset": [16, 17, 18, 19], "text": "patients with severe AMD"}, {"type": "subject disorder", "offset": [19], "text": "AMD"}, {"type": "treatment", "offset": [21, 22, 23, 24], "text": "intravitreal Avastin - injections"}, {"type": "drug", "offset": [22], "text": "Avastin"}, {"type": "route", "offset": [21], "text": "intravitreal"}, {"type": "route", "offset": [24], "text": "injections"}, {"type": "treatment disorder", "offset": [19], "text": "AMD"}, {"type": "effect", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "typical symptoms of Charles - Bonnet syndrome ( CBS )"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "patients with severe AMD"], ["subject disorder", "AMD"], ["treatment", "intravitreal Avastin - injections"], ["drug", "Avastin"], ["route", "intravitreal"], ["route", "injections"], ["treatment disorder", "AMD"], ["effect", "typical symptoms of Charles - Bonnet syndrome ( CBS )"]]}]}
{"text_id": "11033734_3", "text": "Proconvulsive tendency of imipenem / cilastatin is one of its well - known side effects .", "tokens": ["Proconvulsive", "tendency", "of", "imipenem", "/", "cilastatin", "is", "one", "of", "its", "well", "-", "known", "side", "effects", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> side effects <extra_id_0> treatment <extra_id_5> imipenem / cilastatin <extra_id_1> <extra_id_0> drug <extra_id_5> cilastatin <extra_id_1> <extra_id_0> drug <extra_id_5> imipenem <extra_id_1> <extra_id_0> combination drug <extra_id_5> imipenem <extra_id_1> <extra_id_0> combination drug <extra_id_5> cilastatin <extra_id_1> <extra_id_0> effect <extra_id_5> Proconvulsive tendency <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13, 14], "text": "side effects", "args": [{"type": "treatment", "offset": [3, 4, 5], "text": "imipenem / cilastatin"}, {"type": "drug", "offset": [5], "text": "cilastatin"}, {"type": "drug", "offset": [3], "text": "imipenem"}, {"type": "combination drug", "offset": [3], "text": "imipenem"}, {"type": "combination drug", "offset": [5], "text": "cilastatin"}, {"type": "effect", "offset": [0, 1], "text": "Proconvulsive tendency"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "side effects", "label": "adverse event", "asoc": [["treatment", "imipenem / cilastatin"], ["drug", "cilastatin"], ["drug", "imipenem"], ["combination drug", "imipenem"], ["combination drug", "cilastatin"], ["effect", "Proconvulsive tendency"]]}]}
{"text_id": "18504683_2", "text": "The purpose of this article is to present the first case - series of posterior reversible encephalopathy syndrome ( PRES ) associated with L - asparaginase treatment .", "tokens": ["The", "purpose", "of", "this", "article", "is", "to", "present", "the", "first", "case", "-", "series", "of", "posterior", "reversible", "encephalopathy", "syndrome", "(", "PRES", ")", "associated", "with", "L", "-", "asparaginase", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> L - asparaginase treatment <extra_id_1> <extra_id_0> drug <extra_id_5> L - asparaginase <extra_id_1> <extra_id_0> effect <extra_id_5> posterior reversible encephalopathy syndrome ( PRES ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [21], "text": "associated", "args": [{"type": "treatment", "offset": [23, 24, 25, 26], "text": "L - asparaginase treatment"}, {"type": "drug", "offset": [23, 24, 25], "text": "L - asparaginase"}, {"type": "effect", "offset": [14, 15, 16, 17, 18, 19, 20], "text": "posterior reversible encephalopathy syndrome ( PRES )"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "L - asparaginase treatment"], ["drug", "L - asparaginase"], ["effect", "posterior reversible encephalopathy syndrome ( PRES )"]]}]}
{"text_id": "15379082_2", "text": "Fulminant hepatic failure is a rare complication of disulfiram treatment for alcoholism .", "tokens": ["Fulminant", "hepatic", "failure", "is", "a", "rare", "complication", "of", "disulfiram", "treatment", "for", "alcoholism", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> disulfiram <extra_id_1> <extra_id_0> drug <extra_id_5> disulfiram <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> alcoholism <extra_id_1> <extra_id_0> effect <extra_id_5> Fulminant hepatic failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "complication", "args": [{"type": "treatment", "offset": [8], "text": "disulfiram"}, {"type": "drug", "offset": [8], "text": "disulfiram"}, {"type": "treatment disorder", "offset": [11], "text": "alcoholism"}, {"type": "effect", "offset": [0, 1, 2], "text": "Fulminant hepatic failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "disulfiram"], ["drug", "disulfiram"], ["treatment disorder", "alcoholism"], ["effect", "Fulminant hepatic failure"]]}]}
{"text_id": "9315405_1", "text": "We report an unusually short lived and asymptomatic episode of severe cisplatin - induced renal tubular salt wasting in a fit 41 - year - old patient with malignant teratoma .", "tokens": ["We", "report", "an", "unusually", "short", "lived", "and", "asymptomatic", "episode", "of", "severe", "cisplatin", "-", "induced", "renal", "tubular", "salt", "wasting", "in", "a", "fit", "41", "-", "year", "-", "old", "patient", "with", "malignant", "teratoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a fit 41 - year - old patient with malignant teratoma <extra_id_1> <extra_id_0> age <extra_id_5> 41 - year - old <extra_id_1> <extra_id_0> subject disorder <extra_id_5> malignant teratoma <extra_id_1> <extra_id_0> treatment <extra_id_5> cisplatin <extra_id_1> <extra_id_0> drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> malignant teratoma <extra_id_1> <extra_id_0> effect <extra_id_5> renal tubular salt wasting <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "induced", "args": [{"type": "subject", "offset": [19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29], "text": "a fit 41 - year - old patient with malignant teratoma"}, {"type": "age", "offset": [21, 22, 23, 24, 25], "text": "41 - year - old"}, {"type": "subject disorder", "offset": [28, 29], "text": "malignant teratoma"}, {"type": "treatment", "offset": [11], "text": "cisplatin"}, {"type": "drug", "offset": [11], "text": "cisplatin"}, {"type": "treatment disorder", "offset": [28, 29], "text": "malignant teratoma"}, {"type": "effect", "offset": [14, 15, 16, 17], "text": "renal tubular salt wasting"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a fit 41 - year - old patient with malignant teratoma"], ["age", "41 - year - old"], ["subject disorder", "malignant teratoma"], ["treatment", "cisplatin"], ["drug", "cisplatin"], ["treatment disorder", "malignant teratoma"], ["effect", "renal tubular salt wasting"]]}]}
{"text_id": "17536204_5", "text": "The patient developed grade 3 capecitabine - induced headache .", "tokens": ["The", "patient", "developed", "grade", "3", "capecitabine", "-", "induced", "headache", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> capecitabine <extra_id_1> <extra_id_0> drug <extra_id_5> capecitabine <extra_id_1> <extra_id_0> effect <extra_id_5> headache <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "induced", "args": [{"type": "treatment", "offset": [5], "text": "capecitabine"}, {"type": "drug", "offset": [5], "text": "capecitabine"}, {"type": "effect", "offset": [8], "text": "headache"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "capecitabine"], ["drug", "capecitabine"], ["effect", "headache"]]}]}
{"text_id": "11749112_2", "text": "This case report describes the development of asymptomatic visual field defects ( VFDs ) in a psychiatric patient with bipolar disorder receiving adjunctive tiagabine treatment .", "tokens": ["This", "case", "report", "describes", "the", "development", "of", "asymptomatic", "visual", "field", "defects", "(", "VFDs", ")", "in", "a", "psychiatric", "patient", "with", "bipolar", "disorder", "receiving", "adjunctive", "tiagabine", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> subject <extra_id_5> patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> bipolar disorder <extra_id_1> <extra_id_0> treatment <extra_id_5> tiagabine <extra_id_1> <extra_id_0> drug <extra_id_5> tiagabine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> bipolar disorder <extra_id_1> <extra_id_0> effect <extra_id_5> asymptomatic visual field defects <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "development", "args": [{"type": "subject", "offset": [17], "text": "patient"}, {"type": "subject disorder", "offset": [19, 20], "text": "bipolar disorder"}, {"type": "treatment", "offset": [23], "text": "tiagabine"}, {"type": "drug", "offset": [23], "text": "tiagabine"}, {"type": "treatment disorder", "offset": [19, 20], "text": "bipolar disorder"}, {"type": "effect", "offset": [7, 8, 9, 10], "text": "asymptomatic visual field defects"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["subject", "patient"], ["subject disorder", "bipolar disorder"], ["treatment", "tiagabine"], ["drug", "tiagabine"], ["treatment disorder", "bipolar disorder"], ["effect", "asymptomatic visual field defects"]]}]}
{"text_id": "9161656_8", "text": "The asthma resolved within 24 hours following three albuterol inhalations .", "tokens": ["The", "asthma", "resolved", "within", "24", "hours", "following", "three", "albuterol", "inhalations", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> resolved <extra_id_0> treatment <extra_id_5> three albuterol inhalations <extra_id_1> <extra_id_0> drug <extra_id_5> albuterol <extra_id_1> <extra_id_0> dosage <extra_id_5> three <extra_id_1> <extra_id_0> route <extra_id_5> inhalations <extra_id_1> <extra_id_0> time elapsed <extra_id_5> within 24 hours <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> asthma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [2], "text": "resolved", "args": [{"type": "treatment", "offset": [7, 8, 9], "text": "three albuterol inhalations"}, {"type": "drug", "offset": [8], "text": "albuterol"}, {"type": "dosage", "offset": [7], "text": "three"}, {"type": "route", "offset": [9], "text": "inhalations"}, {"type": "time elapsed", "offset": [3, 4, 5], "text": "within 24 hours"}, {"type": "treatment disorder", "offset": [1], "text": "asthma"}]}], "spot": ["potential therapeutic event"], "asoc": ["route", "drug", "time elapsed", "dosage", "treatment disorder", "treatment"], "spot_asoc": [{"span": "resolved", "label": "potential therapeutic event", "asoc": [["treatment", "three albuterol inhalations"], ["drug", "albuterol"], ["dosage", "three"], ["route", "inhalations"], ["time elapsed", "within 24 hours"], ["treatment disorder", "asthma"]]}]}
{"text_id": "2728526_2", "text": "Rifampin can be associated with severe adverse effects such as hepatitis , acute renal failure , hemolytic anemia , and thrombocytopenia .", "tokens": ["Rifampin", "can", "be", "associated", "with", "severe", "adverse", "effects", "such", "as", "hepatitis", ",", "acute", "renal", "failure", ",", "hemolytic", "anemia", ",", "and", "thrombocytopenia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Rifampin <extra_id_1> <extra_id_0> drug <extra_id_5> Rifampin <extra_id_1> <extra_id_0> effect <extra_id_5> hepatitis , acute renal failure , hemolytic anemia , and thrombocytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Rifampin"}, {"type": "drug", "offset": [0], "text": "Rifampin"}, {"type": "effect", "offset": [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "hepatitis , acute renal failure , hemolytic anemia , and thrombocytopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Rifampin"], ["drug", "Rifampin"], ["effect", "hepatitis , acute renal failure , hemolytic anemia , and thrombocytopenia"]]}]}
{"text_id": "961329_2", "text": "Suxamethonium apnoea terminated with commercial serumcholinesterase .", "tokens": ["Suxamethonium", "apnoea", "terminated", "with", "commercial", "serumcholinesterase", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> terminated <extra_id_0> treatment <extra_id_5> commercial serumcholinesterase <extra_id_1> <extra_id_0> drug <extra_id_5> commercial serumcholinesterase <extra_id_1> <extra_id_0> effect <extra_id_5> Suxamethonium apnoea <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [2], "text": "terminated", "args": [{"type": "treatment", "offset": [4, 5], "text": "commercial serumcholinesterase"}, {"type": "drug", "offset": [4, 5], "text": "commercial serumcholinesterase"}, {"type": "effect", "offset": [0, 1], "text": "Suxamethonium apnoea"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "terminated", "label": "potential therapeutic event", "asoc": [["treatment", "commercial serumcholinesterase"], ["drug", "commercial serumcholinesterase"], ["effect", "Suxamethonium apnoea"]]}]}
{"text_id": "11837564_3", "text": "Warfarin - associated bleeding generally is considered deleterious ; however , in our patient it unmasked an early stage of colon cancer and thus may have saved the patient 's life .", "tokens": ["Warfarin", "-", "associated", "bleeding", "generally", "is", "considered", "deleterious", ";", "however", ",", "in", "our", "patient", "it", "unmasked", "an", "early", "stage", "of", "colon", "cancer", "and", "thus", "may", "have", "saved", "the", "patient", "'s", "life", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> Warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> bleeding <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Warfarin"}, {"type": "drug", "offset": [0], "text": "Warfarin"}, {"type": "effect", "offset": [3], "text": "bleeding"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Warfarin"], ["drug", "Warfarin"], ["effect", "bleeding"]]}]}
{"text_id": "3365032_1", "text": "A patient is presented with typical hyperthyroidism , who developed a severe proximal muscle weakness and a raised creatine phosphokinase after treatment for hyperthyroidism with propylthiouracil ( 100 mg orally , three times a day ) .", "tokens": ["A", "patient", "is", "presented", "with", "typical", "hyperthyroidism", ",", "who", "developed", "a", "severe", "proximal", "muscle", "weakness", "and", "a", "raised", "creatine", "phosphokinase", "after", "treatment", "for", "hyperthyroidism", "with", "propylthiouracil", "(", "100", "mg", "orally", ",", "three", "times", "a", "day", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> A patient is presented with typical hyperthyroidism <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hyperthyroidism <extra_id_1> <extra_id_0> subject disorder <extra_id_5> typical hyperthyroidism <extra_id_1> <extra_id_0> treatment <extra_id_5> treatment for hyperthyroidism with propylthiouracil ( 100 mg orally , three times a day ) <extra_id_1> <extra_id_0> drug <extra_id_5> propylthiouracil <extra_id_1> <extra_id_0> dosage <extra_id_5> 100 mg <extra_id_1> <extra_id_0> frequency <extra_id_5> three times a day <extra_id_1> <extra_id_0> route <extra_id_5> orally <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hyperthyroidism <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> typical hyperthyroidism <extra_id_1> <extra_id_0> effect <extra_id_5> severe proximal muscle weakness and a raised creatine phosphokinase <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "after", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "A patient is presented with typical hyperthyroidism"}, {"type": "subject disorder", "offset": [23], "text": "hyperthyroidism"}, {"type": "subject disorder", "offset": [5, 6], "text": "typical hyperthyroidism"}, {"type": "treatment", "offset": [21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35], "text": "treatment for hyperthyroidism with propylthiouracil ( 100 mg orally , three times a day )"}, {"type": "drug", "offset": [25], "text": "propylthiouracil"}, {"type": "dosage", "offset": [27, 28], "text": "100 mg"}, {"type": "frequency", "offset": [31, 32, 33, 34], "text": "three times a day"}, {"type": "route", "offset": [29], "text": "orally"}, {"type": "treatment disorder", "offset": [23], "text": "hyperthyroidism"}, {"type": "treatment disorder", "offset": [5, 6], "text": "typical hyperthyroidism"}, {"type": "effect", "offset": [11, 12, 13, 14, 15, 16, 17, 18, 19], "text": "severe proximal muscle weakness and a raised creatine phosphokinase"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "treatment", "frequency", "dosage", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "A patient is presented with typical hyperthyroidism"], ["subject disorder", "hyperthyroidism"], ["subject disorder", "typical hyperthyroidism"], ["treatment", "treatment for hyperthyroidism with propylthiouracil ( 100 mg orally , three times a day )"], ["drug", "propylthiouracil"], ["dosage", "100 mg"], ["frequency", "three times a day"], ["route", "orally"], ["treatment disorder", "hyperthyroidism"], ["treatment disorder", "typical hyperthyroidism"], ["effect", "severe proximal muscle weakness and a raised creatine phosphokinase"]]}]}
{"text_id": "3926849_1", "text": "Administration of intravenous nitroglycerin in a patient with idiopathic pulmonary hypertension resulted in an increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance .", "tokens": ["Administration", "of", "intravenous", "nitroglycerin", "in", "a", "patient", "with", "idiopathic", "pulmonary", "hypertension", "resulted", "in", "an", "increase", "in", "pulmonary", "artery", "pressure", "associated", "with", "a", "decrease", "in", "blood", "flow", "that", "is", "best", "explained", "by", "an", "increase", "in", "pulmonary", "vascular", "resistance", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> Administration <extra_id_0> subject <extra_id_5> a patient with idiopathic pulmonary hypertension <extra_id_1> <extra_id_0> subject disorder <extra_id_5> idiopathic pulmonary hypertension <extra_id_1> <extra_id_0> treatment <extra_id_5> intravenous nitroglycerin <extra_id_1> <extra_id_0> drug <extra_id_5> nitroglycerin <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> idiopathic pulmonary hypertension <extra_id_1> <extra_id_0> effect <extra_id_5> increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [0], "text": "Administration", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10], "text": "a patient with idiopathic pulmonary hypertension"}, {"type": "subject disorder", "offset": [8, 9, 10], "text": "idiopathic pulmonary hypertension"}, {"type": "treatment", "offset": [2, 3], "text": "intravenous nitroglycerin"}, {"type": "drug", "offset": [3], "text": "nitroglycerin"}, {"type": "route", "offset": [2], "text": "intravenous"}, {"type": "treatment disorder", "offset": [8, 9, 10], "text": "idiopathic pulmonary hypertension"}, {"type": "effect", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36], "text": "increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "Administration", "label": "adverse event", "asoc": [["subject", "a patient with idiopathic pulmonary hypertension"], ["subject disorder", "idiopathic pulmonary hypertension"], ["treatment", "intravenous nitroglycerin"], ["drug", "nitroglycerin"], ["route", "intravenous"], ["treatment disorder", "idiopathic pulmonary hypertension"], ["effect", "increase in pulmonary artery pressure associated with a decrease in blood flow that is best explained by an increase in pulmonary vascular resistance"]]}]}
{"text_id": "15977922_1", "text": "Potential mechanisms involved in the occurrence of ischemic colitis in patients receiving tegaserod are also discussed .", "tokens": ["Potential", "mechanisms", "involved", "in", "the", "occurrence", "of", "ischemic", "colitis", "in", "patients", "receiving", "tegaserod", "are", "also", "discussed", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurrence <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> treatment <extra_id_5> tegaserod <extra_id_1> <extra_id_0> drug <extra_id_5> tegaserod <extra_id_1> <extra_id_0> effect <extra_id_5> ischemic colitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "occurrence", "args": [{"type": "subject", "offset": [10], "text": "patients"}, {"type": "treatment", "offset": [12], "text": "tegaserod"}, {"type": "drug", "offset": [12], "text": "tegaserod"}, {"type": "effect", "offset": [7, 8], "text": "ischemic colitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "occurrence", "label": "adverse event", "asoc": [["subject", "patients"], ["treatment", "tegaserod"], ["drug", "tegaserod"], ["effect", "ischemic colitis"]]}]}
{"text_id": "6692713_4", "text": "We describe a case of fibrosing alveolitis , diagnosed by lung biopsy , in a patient receiving amiodarone which responded to corticosteroid therapy .", "tokens": ["We", "describe", "a", "case", "of", "fibrosing", "alveolitis", ",", "diagnosed", "by", "lung", "biopsy", ",", "in", "a", "patient", "receiving", "amiodarone", "which", "responded", "to", "corticosteroid", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> receiving <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> amiodarone which responded to corticosteroid therapy <extra_id_1> <extra_id_0> drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> drug <extra_id_5> corticosteroid <extra_id_1> <extra_id_0> combination drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> combination drug <extra_id_5> corticosteroid <extra_id_1> <extra_id_0> effect <extra_id_5> fibrosing alveolitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "receiving", "args": [{"type": "subject", "offset": [14, 15], "text": "a patient"}, {"type": "treatment", "offset": [17, 18, 19, 20, 21, 22], "text": "amiodarone which responded to corticosteroid therapy"}, {"type": "drug", "offset": [17], "text": "amiodarone"}, {"type": "drug", "offset": [21], "text": "corticosteroid"}, {"type": "combination drug", "offset": [17], "text": "amiodarone"}, {"type": "combination drug", "offset": [21], "text": "corticosteroid"}, {"type": "effect", "offset": [5, 6], "text": "fibrosing alveolitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "receiving", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "amiodarone which responded to corticosteroid therapy"], ["drug", "amiodarone"], ["drug", "corticosteroid"], ["combination drug", "amiodarone"], ["combination drug", "corticosteroid"], ["effect", "fibrosing alveolitis"]]}]}
{"text_id": "9892272_1", "text": "Massive subfascial hematoma after alteplase therapy for acute myocardial infarction .", "tokens": ["Massive", "subfascial", "hematoma", "after", "alteplase", "therapy", "for", "acute", "myocardial", "infarction", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> alteplase therapy <extra_id_1> <extra_id_0> drug <extra_id_5> alteplase <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute myocardial infarction <extra_id_1> <extra_id_0> effect <extra_id_5> Massive subfascial hematoma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "after", "args": [{"type": "treatment", "offset": [4, 5], "text": "alteplase therapy"}, {"type": "drug", "offset": [4], "text": "alteplase"}, {"type": "treatment disorder", "offset": [7, 8, 9], "text": "acute myocardial infarction"}, {"type": "effect", "offset": [0, 1, 2], "text": "Massive subfascial hematoma"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "alteplase therapy"], ["drug", "alteplase"], ["treatment disorder", "acute myocardial infarction"], ["effect", "Massive subfascial hematoma"]]}]}
{"text_id": "8002140_2", "text": "Contact dermatitis due to budesonide : report of five cases and review of the Japanese literature .", "tokens": ["Contact", "dermatitis", "due", "to", "budesonide", ":", "report", "of", "five", "cases", "and", "review", "of", "the", "Japanese", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> treatment <extra_id_5> budesonide <extra_id_1> <extra_id_0> drug <extra_id_5> budesonide <extra_id_1> <extra_id_0> effect <extra_id_5> Contact dermatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "due", "args": [{"type": "treatment", "offset": [4], "text": "budesonide"}, {"type": "drug", "offset": [4], "text": "budesonide"}, {"type": "effect", "offset": [0, 1], "text": "Contact dermatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["treatment", "budesonide"], ["drug", "budesonide"], ["effect", "Contact dermatitis"]]}]}
{"text_id": "17852449_6", "text": "Review of all reported cases of the use of ATRA in pregnancy revealed no serious adverse outcomes or congenital anomalies although only very few cases had exposure in the first trimester .", "tokens": ["Review", "of", "all", "reported", "cases", "of", "the", "use", "of", "ATRA", "in", "pregnancy", "revealed", "no", "serious", "adverse", "outcomes", "or", "congenital", "anomalies", "although", "only", "very", "few", "cases", "had", "exposure", "in", "the", "first", "trimester", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> revealed <extra_id_0> subject <extra_id_5> in pregnancy <extra_id_1> <extra_id_0> subject disorder <extra_id_5> pregnancy <extra_id_1> <extra_id_0> treatment <extra_id_5> ATRA <extra_id_1> <extra_id_0> drug <extra_id_5> ATRA <extra_id_1> <extra_id_0> effect <extra_id_5> adverse outcomes or congenital anomalies <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "revealed", "args": [{"type": "subject", "offset": [10, 11], "text": "in pregnancy"}, {"type": "subject disorder", "offset": [11], "text": "pregnancy"}, {"type": "treatment", "offset": [9], "text": "ATRA"}, {"type": "drug", "offset": [9], "text": "ATRA"}, {"type": "effect", "offset": [15, 16, 17, 18, 19], "text": "adverse outcomes or congenital anomalies"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "revealed", "label": "adverse event", "asoc": [["subject", "in pregnancy"], ["subject disorder", "pregnancy"], ["treatment", "ATRA"], ["drug", "ATRA"], ["effect", "adverse outcomes or congenital anomalies"]]}]}
{"text_id": "6692713_2", "text": "Possible recurrence of amiodarone pulmonary toxicity following corticosteroid therapy .", "tokens": ["Possible", "recurrence", "of", "amiodarone", "pulmonary", "toxicity", "following", "corticosteroid", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> corticosteroid <extra_id_1> <extra_id_0> drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> drug <extra_id_5> corticosteroid <extra_id_1> <extra_id_0> effect <extra_id_5> amiodarone pulmonary toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "following", "args": [{"type": "treatment", "offset": [7], "text": "corticosteroid"}, {"type": "drug", "offset": [3], "text": "amiodarone"}, {"type": "drug", "offset": [7], "text": "corticosteroid"}, {"type": "effect", "offset": [3, 4, 5], "text": "amiodarone pulmonary toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "corticosteroid"], ["drug", "amiodarone"], ["drug", "corticosteroid"], ["effect", "amiodarone pulmonary toxicity"]]}]}
{"text_id": "18717612_1", "text": "Ceftriaxone - induced fixed drug eruption : first report .", "tokens": ["Ceftriaxone", "-", "induced", "fixed", "drug", "eruption", ":", "first", "report", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Ceftriaxone <extra_id_1> <extra_id_0> drug <extra_id_5> Ceftriaxone <extra_id_1> <extra_id_0> effect <extra_id_5> fixed drug eruption <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Ceftriaxone"}, {"type": "drug", "offset": [0], "text": "Ceftriaxone"}, {"type": "effect", "offset": [3, 4, 5], "text": "fixed drug eruption"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Ceftriaxone"], ["drug", "Ceftriaxone"], ["effect", "fixed drug eruption"]]}]}
{"text_id": "24755135_3", "text": "Study 202 was an open - label , add - on study in patients with partial or generalized epilepsy treated with valproic acid ( VPA ) , carbamazepine ( CBZ ) , phenytoin ( PHT ) , or topiramate ( TPM ) as monotherapy .", "tokens": ["Study", "202", "was", "an", "open", "-", "label", ",", "add", "-", "on", "study", "in", "patients", "with", "partial", "or", "generalized", "epilepsy", "treated", "with", "valproic", "acid", "(", "VPA", ")", ",", "carbamazepine", "(", "CBZ", ")", ",", "phenytoin", "(", "PHT", ")", ",", "or", "topiramate", "(", "TPM", ")", "as", "monotherapy", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treated <extra_id_0> subject <extra_id_5> patients with partial or generalized epilepsy <extra_id_1> <extra_id_0> treatment <extra_id_5> valproic acid ( VPA ) , carbamazepine ( CBZ ) , phenytoin ( PHT ) , or topiramate ( TPM ) as monotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> phenytoin <extra_id_1> <extra_id_0> drug <extra_id_5> topiramate <extra_id_1> <extra_id_0> combination drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> combination drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> combination drug <extra_id_5> phenytoin <extra_id_1> <extra_id_0> combination drug <extra_id_5> topiramate <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [19], "text": "treated", "args": [{"type": "subject", "offset": [13, 14, 15, 16, 17, 18], "text": "patients with partial or generalized epilepsy"}, {"type": "treatment", "offset": [21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43], "text": "valproic acid ( VPA ) , carbamazepine ( CBZ ) , phenytoin ( PHT ) , or topiramate ( TPM ) as monotherapy"}, {"type": "drug", "offset": [21, 22], "text": "valproic acid"}, {"type": "drug", "offset": [27], "text": "carbamazepine"}, {"type": "drug", "offset": [32], "text": "phenytoin"}, {"type": "drug", "offset": [38], "text": "topiramate"}, {"type": "combination drug", "offset": [21, 22], "text": "valproic acid"}, {"type": "combination drug", "offset": [27], "text": "carbamazepine"}, {"type": "combination drug", "offset": [32], "text": "phenytoin"}, {"type": "combination drug", "offset": [38], "text": "topiramate"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "combination drug", "drug", "subject"], "spot_asoc": [{"span": "treated", "label": "potential therapeutic event", "asoc": [["subject", "patients with partial or generalized epilepsy"], ["treatment", "valproic acid ( VPA ) , carbamazepine ( CBZ ) , phenytoin ( PHT ) , or topiramate ( TPM ) as monotherapy"], ["drug", "valproic acid"], ["drug", "carbamazepine"], ["drug", "phenytoin"], ["drug", "topiramate"], ["combination drug", "valproic acid"], ["combination drug", "carbamazepine"], ["combination drug", "phenytoin"], ["combination drug", "topiramate"]]}]}
{"text_id": "1401493_1", "text": "We report a case of acne fulminans occurring during treatment with 13 - cis - retinoic acid for cystic acne .", "tokens": ["We", "report", "a", "case", "of", "acne", "fulminans", "occurring", "during", "treatment", "with", "13", "-", "cis", "-", "retinoic", "acid", "for", "cystic", "acne", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurring <extra_id_0> subject <extra_id_5> a case <extra_id_1> <extra_id_0> subject disorder <extra_id_5> cystic acne <extra_id_1> <extra_id_0> treatment <extra_id_5> 13 - cis - retinoic acid <extra_id_1> <extra_id_0> drug <extra_id_5> 13 - cis - retinoic acid <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> cystic acne <extra_id_1> <extra_id_0> effect <extra_id_5> acne fulminans <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "occurring", "args": [{"type": "subject", "offset": [2, 3], "text": "a case"}, {"type": "subject disorder", "offset": [18, 19], "text": "cystic acne"}, {"type": "treatment", "offset": [11, 12, 13, 14, 15, 16], "text": "13 - cis - retinoic acid"}, {"type": "drug", "offset": [11, 12, 13, 14, 15, 16], "text": "13 - cis - retinoic acid"}, {"type": "treatment disorder", "offset": [18, 19], "text": "cystic acne"}, {"type": "effect", "offset": [5, 6], "text": "acne fulminans"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "occurring", "label": "adverse event", "asoc": [["subject", "a case"], ["subject disorder", "cystic acne"], ["treatment", "13 - cis - retinoic acid"], ["drug", "13 - cis - retinoic acid"], ["treatment disorder", "cystic acne"], ["effect", "acne fulminans"]]}]}
{"text_id": "20178709_2", "text": "Methotrexate may rarely provoke serositis , even with low doses and after just a few weeks of therapy .", "tokens": ["Methotrexate", "may", "rarely", "provoke", "serositis", ",", "even", "with", "low", "doses", "and", "after", "just", "a", "few", "weeks", "of", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> provoke <extra_id_0> treatment <extra_id_5> Methotrexate <extra_id_1> <extra_id_0> drug <extra_id_5> Methotrexate <extra_id_1> <extra_id_0> effect <extra_id_5> serositis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "provoke", "args": [{"type": "treatment", "offset": [0], "text": "Methotrexate"}, {"type": "drug", "offset": [0], "text": "Methotrexate"}, {"type": "effect", "offset": [4], "text": "serositis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "provoke", "label": "adverse event", "asoc": [["treatment", "Methotrexate"], ["drug", "Methotrexate"], ["effect", "serositis"]]}]}
{"text_id": "19540093_5", "text": "We recommend that clinicians monitor patients for signs and symptoms of pancreatitis , including abdominal pain , during treatment with tigecycline .", "tokens": ["We", "recommend", "that", "clinicians", "monitor", "patients", "for", "signs", "and", "symptoms", "of", "pancreatitis", ",", "including", "abdominal", "pain", ",", "during", "treatment", "with", "tigecycline", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> tigecycline <extra_id_1> <extra_id_0> drug <extra_id_5> tigecycline <extra_id_1> <extra_id_0> effect <extra_id_5> pancreatitis , including abdominal pain <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [18], "text": "treatment", "args": [{"type": "treatment", "offset": [20], "text": "tigecycline"}, {"type": "drug", "offset": [20], "text": "tigecycline"}, {"type": "effect", "offset": [11, 12, 13, 14, 15], "text": "pancreatitis , including abdominal pain"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "tigecycline"], ["drug", "tigecycline"], ["effect", "pancreatitis , including abdominal pain"]]}]}
{"text_id": "19423610_7", "text": "Methylene blue has been found to be a potent inhibitor of monoamine oxidase ( MAO ) , and several cases of serotonin toxicity have been reported recently following its administration .", "tokens": ["Methylene", "blue", "has", "been", "found", "to", "be", "a", "potent", "inhibitor", "of", "monoamine", "oxidase", "(", "MAO", ")", ",", "and", "several", "cases", "of", "serotonin", "toxicity", "have", "been", "reported", "recently", "following", "its", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> subject <extra_id_5> several cases <extra_id_1> <extra_id_0> treatment <extra_id_5> Methylene blue <extra_id_1> <extra_id_0> drug <extra_id_5> Methylene blue <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [27], "text": "following", "args": [{"type": "subject", "offset": [18, 19], "text": "several cases"}, {"type": "treatment", "offset": [0, 1], "text": "Methylene blue"}, {"type": "drug", "offset": [0, 1], "text": "Methylene blue"}, {"type": "effect", "offset": [21, 22], "text": "serotonin toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["subject", "several cases"], ["treatment", "Methylene blue"], ["drug", "Methylene blue"], ["effect", "serotonin toxicity"]]}]}
{"text_id": "9876812_1", "text": "Clinicians should be aware of the possibility that vinorelbine may cause SIADH and possibly hypokalemia .", "tokens": ["Clinicians", "should", "be", "aware", "of", "the", "possibility", "that", "vinorelbine", "may", "cause", "SIADH", "and", "possibly", "hypokalemia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> vinorelbine <extra_id_1> <extra_id_0> drug <extra_id_5> vinorelbine <extra_id_1> <extra_id_0> effect <extra_id_5> SIADH and possibly hypokalemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "cause", "args": [{"type": "treatment", "offset": [8], "text": "vinorelbine"}, {"type": "drug", "offset": [8], "text": "vinorelbine"}, {"type": "effect", "offset": [11, 12, 13, 14], "text": "SIADH and possibly hypokalemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "vinorelbine"], ["drug", "vinorelbine"], ["effect", "SIADH and possibly hypokalemia"]]}]}
{"text_id": "3558331_2", "text": "Two patients are described in whom subtle cognitive impairments are associated with therapeutic doses of amoxapine .", "tokens": ["Two", "patients", "are", "described", "in", "whom", "subtle", "cognitive", "impairments", "are", "associated", "with", "therapeutic", "doses", "of", "amoxapine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> Two patients <extra_id_1> <extra_id_0> population <extra_id_5> Two <extra_id_1> <extra_id_0> treatment <extra_id_5> therapeutic doses of amoxapine <extra_id_1> <extra_id_0> drug <extra_id_5> amoxapine <extra_id_1> <extra_id_0> dosage <extra_id_5> therapeutic doses <extra_id_1> <extra_id_0> effect <extra_id_5> subtle cognitive impairments <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "associated", "args": [{"type": "subject", "offset": [0, 1], "text": "Two patients"}, {"type": "population", "offset": [0], "text": "Two"}, {"type": "treatment", "offset": [12, 13, 14, 15], "text": "therapeutic doses of amoxapine"}, {"type": "drug", "offset": [15], "text": "amoxapine"}, {"type": "dosage", "offset": [12, 13], "text": "therapeutic doses"}, {"type": "effect", "offset": [6, 7, 8], "text": "subtle cognitive impairments"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "dosage", "treatment"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "Two patients"], ["population", "Two"], ["treatment", "therapeutic doses of amoxapine"], ["drug", "amoxapine"], ["dosage", "therapeutic doses"], ["effect", "subtle cognitive impairments"]]}]}
{"text_id": "17420198_8", "text": "Baclofen and oxazepam were prescribed secondary to right - sided hemiparesis contractures .", "tokens": ["Baclofen", "and", "oxazepam", "were", "prescribed", "secondary", "to", "right", "-", "sided", "hemiparesis", "contractures", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> prescribed <extra_id_0> treatment <extra_id_5> oxazepam <extra_id_1> <extra_id_0> treatment <extra_id_5> Baclofen <extra_id_1> <extra_id_0> drug <extra_id_5> Baclofen <extra_id_1> <extra_id_0> drug <extra_id_5> oxazepam <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> right - sided hemiparesis contractures <extra_id_1> <extra_id_0> combination drug <extra_id_5> oxazepam <extra_id_1> <extra_id_0> combination drug <extra_id_5> Baclofen <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [4], "text": "prescribed", "args": [{"type": "treatment", "offset": [2], "text": "oxazepam"}, {"type": "treatment", "offset": [0], "text": "Baclofen"}, {"type": "drug", "offset": [0], "text": "Baclofen"}, {"type": "drug", "offset": [2], "text": "oxazepam"}, {"type": "treatment disorder", "offset": [7, 8, 9, 10, 11], "text": "right - sided hemiparesis contractures"}, {"type": "combination drug", "offset": [2], "text": "oxazepam"}, {"type": "combination drug", "offset": [0], "text": "Baclofen"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "combination drug", "drug", "treatment disorder"], "spot_asoc": [{"span": "prescribed", "label": "potential therapeutic event", "asoc": [["treatment", "oxazepam"], ["treatment", "Baclofen"], ["drug", "Baclofen"], ["drug", "oxazepam"], ["treatment disorder", "right - sided hemiparesis contractures"], ["combination drug", "oxazepam"], ["combination drug", "Baclofen"]]}]}
{"text_id": "11483161_2", "text": "The bleeding resolved on discontinuation of APV .", "tokens": ["The", "bleeding", "resolved", "on", "discontinuation", "of", "APV", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> resolved <extra_id_0> treatment <extra_id_5> discontinuation of APV <extra_id_1> <extra_id_0> drug <extra_id_5> APV <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> The bleeding <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [2], "text": "resolved", "args": [{"type": "treatment", "offset": [4, 5, 6], "text": "discontinuation of APV"}, {"type": "drug", "offset": [6], "text": "APV"}, {"type": "treatment disorder", "offset": [0, 1], "text": "The bleeding"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "resolved", "label": "potential therapeutic event", "asoc": [["treatment", "discontinuation of APV"], ["drug", "APV"], ["treatment disorder", "The bleeding"]]}]}
{"text_id": "10458196_1", "text": "A 5 - month - old infant became lethargic and poorly responsive after receiving 1 drop of brimonidine in each eye .", "tokens": ["A", "5", "-", "month", "-", "old", "infant", "became", "lethargic", "and", "poorly", "responsive", "after", "receiving", "1", "drop", "of", "brimonidine", "in", "each", "eye", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> became <extra_id_0> subject <extra_id_5> A 5 - month - old infant <extra_id_1> <extra_id_0> age <extra_id_5> 5 - month - old <extra_id_1> <extra_id_0> age <extra_id_5> infant <extra_id_1> <extra_id_0> treatment <extra_id_5> receiving 1 drop of brimonidine in each eye <extra_id_1> <extra_id_0> drug <extra_id_5> brimonidine <extra_id_1> <extra_id_0> dosage <extra_id_5> 1 drop <extra_id_1> <extra_id_0> route <extra_id_5> in each eye <extra_id_1> <extra_id_0> effect <extra_id_5> lethargic and poorly responsive <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "became", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "A 5 - month - old infant"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "5 - month - old"}, {"type": "age", "offset": [6], "text": "infant"}, {"type": "treatment", "offset": [13, 14, 15, 16, 17, 18, 19, 20], "text": "receiving 1 drop of brimonidine in each eye"}, {"type": "drug", "offset": [17], "text": "brimonidine"}, {"type": "dosage", "offset": [14, 15], "text": "1 drop"}, {"type": "route", "offset": [18, 19, 20], "text": "in each eye"}, {"type": "effect", "offset": [8, 9, 10, 11], "text": "lethargic and poorly responsive"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "dosage", "age", "treatment"], "spot_asoc": [{"span": "became", "label": "adverse event", "asoc": [["subject", "A 5 - month - old infant"], ["age", "5 - month - old"], ["age", "infant"], ["treatment", "receiving 1 drop of brimonidine in each eye"], ["drug", "brimonidine"], ["dosage", "1 drop"], ["route", "in each eye"], ["effect", "lethargic and poorly responsive"]]}]}
{"text_id": "18682542_1", "text": "CONCLUSIONS : Clinicians should be aware of this adverse reaction when facing similar complex neurologic symptoms in patients who are receiving the antibiotic treatment described here , especially vancomycin .", "tokens": ["CONCLUSIONS", ":", "Clinicians", "should", "be", "aware", "of", "this", "adverse", "reaction", "when", "facing", "similar", "complex", "neurologic", "symptoms", "in", "patients", "who", "are", "receiving", "the", "antibiotic", "treatment", "described", "here", ",", "especially", "vancomycin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> adverse reaction <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> treatment <extra_id_5> vancomycin <extra_id_1> <extra_id_0> drug <extra_id_5> vancomycin <extra_id_1> <extra_id_0> effect <extra_id_5> neurologic symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8, 9], "text": "adverse reaction", "args": [{"type": "subject", "offset": [17], "text": "patients"}, {"type": "treatment", "offset": [28], "text": "vancomycin"}, {"type": "drug", "offset": [28], "text": "vancomycin"}, {"type": "effect", "offset": [14, 15], "text": "neurologic symptoms"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "adverse reaction", "label": "adverse event", "asoc": [["subject", "patients"], ["treatment", "vancomycin"], ["drug", "vancomycin"], ["effect", "neurologic symptoms"]]}]}
{"text_id": "10650865_1", "text": "Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding -- successful thrombolysis under heparin therapy .", "tokens": ["Portal", "vein", "thrombosis", "in", "a", "patient", "with", "severe", "haemophilia", "A", "and", "F", "V", "G1691A", "mutation", "during", "continuous", "infusion", "of", "F", "VIII", "after", "intramural", "jejunal", "bleeding", "--", "successful", "thrombolysis", "under", "heparin", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> subject <extra_id_5> a patient with severe haemophilia A and F V G1691A mutation <extra_id_1> <extra_id_0> subject disorder <extra_id_5> haemophilia A and F V G1691A mutation <extra_id_1> <extra_id_0> subject disorder <extra_id_5> intramural jejunal bleeding <extra_id_1> <extra_id_0> treatment <extra_id_5> continuous infusion of F VIII <extra_id_1> <extra_id_0> drug <extra_id_5> F VIII <extra_id_1> <extra_id_0> route <extra_id_5> continuous infusion <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> intramural jejunal bleeding <extra_id_1> <extra_id_0> effect <extra_id_5> Portal vein thrombosis <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> therapy <extra_id_0> treatment <extra_id_5> heparin <extra_id_1> <extra_id_0> drug <extra_id_5> heparin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Portal vein thrombosis <extra_id_1> <extra_id_0> effect <extra_id_5> successful thrombolysis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "during", "args": [{"type": "subject", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "a patient with severe haemophilia A and F V G1691A mutation"}, {"type": "subject disorder", "offset": [8, 9, 10, 11, 12, 13, 14], "text": "haemophilia A and F V G1691A mutation"}, {"type": "subject disorder", "offset": [22, 23, 24], "text": "intramural jejunal bleeding"}, {"type": "treatment", "offset": [16, 17, 18, 19, 20], "text": "continuous infusion of F VIII"}, {"type": "drug", "offset": [19, 20], "text": "F VIII"}, {"type": "route", "offset": [16, 17], "text": "continuous infusion"}, {"type": "treatment disorder", "offset": [22, 23, 24], "text": "intramural jejunal bleeding"}, {"type": "effect", "offset": [0, 1, 2], "text": "Portal vein thrombosis"}]}, {"type": "potential therapeutic event", "offset": [30], "text": "therapy", "args": [{"type": "treatment", "offset": [29], "text": "heparin"}, {"type": "drug", "offset": [29], "text": "heparin"}, {"type": "treatment disorder", "offset": [0, 1, 2], "text": "Portal vein thrombosis"}, {"type": "effect", "offset": [26, 27], "text": "successful thrombolysis"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["subject", "a patient with severe haemophilia A and F V G1691A mutation"], ["subject disorder", "haemophilia A and F V G1691A mutation"], ["subject disorder", "intramural jejunal bleeding"], ["treatment", "continuous infusion of F VIII"], ["drug", "F VIII"], ["route", "continuous infusion"], ["treatment disorder", "intramural jejunal bleeding"], ["effect", "Portal vein thrombosis"]]}, {"span": "therapy", "label": "potential therapeutic event", "asoc": [["treatment", "heparin"], ["drug", "heparin"], ["treatment disorder", "Portal vein thrombosis"], ["effect", "successful thrombolysis"]]}]}
{"text_id": "15190230_2", "text": "In this case report , we present clinical and laboratory findings of a case with chronic hepatitis B that developed acute dystonia soon after the first dose of pegylated interferon alpha .", "tokens": ["In", "this", "case", "report", ",", "we", "present", "clinical", "and", "laboratory", "findings", "of", "a", "case", "with", "chronic", "hepatitis", "B", "that", "developed", "acute", "dystonia", "soon", "after", "the", "first", "dose", "of", "pegylated", "interferon", "alpha", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a case with chronic hepatitis B <extra_id_1> <extra_id_0> population <extra_id_5> a <extra_id_1> <extra_id_0> subject disorder <extra_id_5> chronic hepatitis B <extra_id_1> <extra_id_0> treatment <extra_id_5> the first dose of pegylated interferon alpha . <extra_id_1> <extra_id_0> drug <extra_id_5> pegylated interferon alpha <extra_id_1> <extra_id_0> dosage <extra_id_5> first dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic hepatitis B <extra_id_1> <extra_id_0> effect <extra_id_5> acute dystonia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [23], "text": "after", "args": [{"type": "subject", "offset": [12, 13, 14, 15, 16, 17], "text": "a case with chronic hepatitis B"}, {"type": "population", "offset": [12], "text": "a"}, {"type": "subject disorder", "offset": [15, 16, 17], "text": "chronic hepatitis B"}, {"type": "treatment", "offset": [24, 25, 26, 27, 28, 29, 30, 31], "text": "the first dose of pegylated interferon alpha ."}, {"type": "drug", "offset": [28, 29, 30], "text": "pegylated interferon alpha"}, {"type": "dosage", "offset": [25, 26], "text": "first dose"}, {"type": "treatment disorder", "offset": [15, 16, 17], "text": "chronic hepatitis B"}, {"type": "effect", "offset": [20, 21], "text": "acute dystonia"}]}], "spot": ["adverse event"], "asoc": ["dosage", "population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a case with chronic hepatitis B"], ["population", "a"], ["subject disorder", "chronic hepatitis B"], ["treatment", "the first dose of pegylated interferon alpha ."], ["drug", "pegylated interferon alpha"], ["dosage", "first dose"], ["treatment disorder", "chronic hepatitis B"], ["effect", "acute dystonia"]]}]}
{"text_id": "17324248_1", "text": "AIMS : To present a case of piloerection after replacing fluvoxamine maleate with milnacipran hydrochloride , and to analyse this effect based on receptor occupancy theory .", "tokens": ["AIMS", ":", "To", "present", "a", "case", "of", "piloerection", "after", "replacing", "fluvoxamine", "maleate", "with", "milnacipran", "hydrochloride", ",", "and", "to", "analyse", "this", "effect", "based", "on", "receptor", "occupancy", "theory", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> fluvoxamine maleate <extra_id_1> <extra_id_0> drug <extra_id_5> fluvoxamine maleate <extra_id_1> <extra_id_0> drug <extra_id_5> milnacipran hydrochloride <extra_id_1> <extra_id_0> effect <extra_id_5> piloerection <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "after", "args": [{"type": "treatment", "offset": [10, 11], "text": "fluvoxamine maleate"}, {"type": "drug", "offset": [10, 11], "text": "fluvoxamine maleate"}, {"type": "drug", "offset": [13, 14], "text": "milnacipran hydrochloride"}, {"type": "effect", "offset": [7], "text": "piloerection"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "fluvoxamine maleate"], ["drug", "fluvoxamine maleate"], ["drug", "milnacipran hydrochloride"], ["effect", "piloerection"]]}]}
{"text_id": "15311565_1", "text": "Initial treatment with heparin was substituted with thrombolysis , which resulted in clinical improvement and dissolution of right heart thrombus but was followed by fatal intracerebral haemorrhage .", "tokens": ["Initial", "treatment", "with", "heparin", "was", "substituted", "with", "thrombolysis", ",", "which", "resulted", "in", "clinical", "improvement", "and", "dissolution", "of", "right", "heart", "thrombus", "but", "was", "followed", "by", "fatal", "intracerebral", "haemorrhage", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resulted <extra_id_0> treatment <extra_id_5> thrombolysis <extra_id_1> <extra_id_0> drug <extra_id_5> thrombolysis <extra_id_1> <extra_id_0> effect <extra_id_5> fatal intracerebral haemorrhage <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "resulted", "args": [{"type": "treatment", "offset": [7], "text": "thrombolysis"}, {"type": "drug", "offset": [7], "text": "thrombolysis"}, {"type": "effect", "offset": [24, 25, 26], "text": "fatal intracerebral haemorrhage"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "resulted", "label": "adverse event", "asoc": [["treatment", "thrombolysis"], ["drug", "thrombolysis"], ["effect", "fatal intracerebral haemorrhage"]]}]}
{"text_id": "20298401_9", "text": "The patient died of respiratory failure after 8 days of steroid infusion and erlotinib discontinuation .", "tokens": ["The", "patient", "died", "of", "respiratory", "failure", "after", "8", "days", "of", "steroid", "infusion", "and", "erlotinib", "discontinuation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> The patient <extra_id_1> <extra_id_0> subject <extra_id_5> The <extra_id_1> <extra_id_0> treatment <extra_id_5> 8 days of steroid infusion and erlotinib discontinuation . <extra_id_1> <extra_id_0> drug <extra_id_5> steroid <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> route <extra_id_5> infusion <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 8 days <extra_id_1> <extra_id_0> effect <extra_id_5> died of respiratory failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "after", "args": [{"type": "subject", "offset": [0, 1], "text": "The patient"}, {"type": "subject", "offset": [0], "text": "The"}, {"type": "treatment", "offset": [7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "8 days of steroid infusion and erlotinib discontinuation ."}, {"type": "drug", "offset": [10], "text": "steroid"}, {"type": "drug", "offset": [13], "text": "erlotinib"}, {"type": "route", "offset": [11], "text": "infusion"}, {"type": "time elapsed", "offset": [7, 8], "text": "8 days"}, {"type": "effect", "offset": [2, 3, 4, 5], "text": "died of respiratory failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "time elapsed", "treatment"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "The patient"], ["subject", "The"], ["treatment", "8 days of steroid infusion and erlotinib discontinuation ."], ["drug", "steroid"], ["drug", "erlotinib"], ["route", "infusion"], ["time elapsed", "8 days"], ["effect", "died of respiratory failure"]]}]}
{"text_id": "19904536_10", "text": "A helicoidal CT scan showed diffuse and severe interstitial pneumonitis , and lung biopsy confirmed accelerated usual interstitial pneumonia consistent with drug - induced toxicity .", "tokens": ["A", "helicoidal", "CT", "scan", "showed", "diffuse", "and", "severe", "interstitial", "pneumonitis", ",", "and", "lung", "biopsy", "confirmed", "accelerated", "usual", "interstitial", "pneumonia", "consistent", "with", "drug", "-", "induced", "toxicity", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> drug <extra_id_1> <extra_id_0> drug <extra_id_5> drug <extra_id_1> <extra_id_0> effect <extra_id_5> diffuse and severe interstitial pneumonitis <extra_id_1> <extra_id_0> effect <extra_id_5> accelerated usual interstitial pneumonia <extra_id_1> <extra_id_0> effect <extra_id_5> toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [23], "text": "induced", "args": [{"type": "treatment", "offset": [21], "text": "drug"}, {"type": "drug", "offset": [21], "text": "drug"}, {"type": "effect", "offset": [5, 6, 7, 8, 9], "text": "diffuse and severe interstitial pneumonitis"}, {"type": "effect", "offset": [15, 16, 17, 18], "text": "accelerated usual interstitial pneumonia"}, {"type": "effect", "offset": [24], "text": "toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "drug"], ["drug", "drug"], ["effect", "diffuse and severe interstitial pneumonitis"], ["effect", "accelerated usual interstitial pneumonia"], ["effect", "toxicity"]]}]}
{"text_id": "19116715_1", "text": "Gemcitabine is a known risk factor for hemolytic uremic syndrome ( HUS ) , which can often have a rapidly fatal clinical course despite intervention with steroids , plasmapheresis and hemodialysis .", "tokens": ["Gemcitabine", "is", "a", "known", "risk", "factor", "for", "hemolytic", "uremic", "syndrome", "(", "HUS", ")", ",", "which", "can", "often", "have", "a", "rapidly", "fatal", "clinical", "course", "despite", "intervention", "with", "steroids", ",", "plasmapheresis", "and", "hemodialysis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> risk <extra_id_0> treatment <extra_id_5> Gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> Gemcitabine <extra_id_1> <extra_id_0> effect <extra_id_5> hemolytic uremic syndrome <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> intervention <extra_id_0> treatment <extra_id_5> with steroids , plasmapheresis and hemodialysis <extra_id_1> <extra_id_0> drug <extra_id_5> steroids <extra_id_1> <extra_id_0> drug <extra_id_5> plasmapheresis <extra_id_1> <extra_id_0> drug <extra_id_5> hemodialysis <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> a rapidly fatal <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "risk", "args": [{"type": "treatment", "offset": [0], "text": "Gemcitabine"}, {"type": "drug", "offset": [0], "text": "Gemcitabine"}, {"type": "effect", "offset": [7, 8, 9], "text": "hemolytic uremic syndrome"}]}, {"type": "potential therapeutic event", "offset": [24], "text": "intervention", "args": [{"type": "treatment", "offset": [25, 26, 27, 28, 29, 30], "text": "with steroids , plasmapheresis and hemodialysis"}, {"type": "drug", "offset": [26], "text": "steroids"}, {"type": "drug", "offset": [28], "text": "plasmapheresis"}, {"type": "drug", "offset": [30], "text": "hemodialysis"}, {"type": "treatment disorder", "offset": [18, 19, 20], "text": "a rapidly fatal"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "risk", "label": "adverse event", "asoc": [["treatment", "Gemcitabine"], ["drug", "Gemcitabine"], ["effect", "hemolytic uremic syndrome"]]}, {"span": "intervention", "label": "potential therapeutic event", "asoc": [["treatment", "with steroids , plasmapheresis and hemodialysis"], ["drug", "steroids"], ["drug", "plasmapheresis"], ["drug", "hemodialysis"], ["treatment disorder", "a rapidly fatal"]]}]}
{"text_id": "6311654_3", "text": "In six cases CT scans did not return to their original state after ACTH therapy .", "tokens": ["In", "six", "cases", "CT", "scans", "did", "not", "return", "to", "their", "original", "state", "after", "ACTH", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> six cases <extra_id_1> <extra_id_0> population <extra_id_5> six <extra_id_1> <extra_id_0> treatment <extra_id_5> ACTH <extra_id_1> <extra_id_0> drug <extra_id_5> ACTH <extra_id_1> <extra_id_0> effect <extra_id_5> CT scans did not return to their original state <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "after", "args": [{"type": "subject", "offset": [1, 2], "text": "six cases"}, {"type": "population", "offset": [1], "text": "six"}, {"type": "treatment", "offset": [13], "text": "ACTH"}, {"type": "drug", "offset": [13], "text": "ACTH"}, {"type": "effect", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11], "text": "CT scans did not return to their original state"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "six cases"], ["population", "six"], ["treatment", "ACTH"], ["drug", "ACTH"], ["effect", "CT scans did not return to their original state"]]}]}
{"text_id": "18676387_3", "text": "Serotonin toxicity precipitated by fentanyl is unusual and has not previously been described in combination with SSRIs in the perioperative setting .", "tokens": ["Serotonin", "toxicity", "precipitated", "by", "fentanyl", "is", "unusual", "and", "has", "not", "previously", "been", "described", "in", "combination", "with", "SSRIs", "in", "the", "perioperative", "setting", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> precipitated <extra_id_0> treatment <extra_id_5> fentanyl <extra_id_1> <extra_id_0> drug <extra_id_5> fentanyl <extra_id_1> <extra_id_0> drug <extra_id_5> SSRIs <extra_id_1> <extra_id_0> combination drug <extra_id_5> fentanyl <extra_id_1> <extra_id_0> combination drug <extra_id_5> SSRIs <extra_id_1> <extra_id_0> effect <extra_id_5> Serotonin toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "precipitated", "args": [{"type": "treatment", "offset": [4], "text": "fentanyl"}, {"type": "drug", "offset": [4], "text": "fentanyl"}, {"type": "drug", "offset": [16], "text": "SSRIs"}, {"type": "combination drug", "offset": [4], "text": "fentanyl"}, {"type": "combination drug", "offset": [16], "text": "SSRIs"}, {"type": "effect", "offset": [0, 1], "text": "Serotonin toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "precipitated", "label": "adverse event", "asoc": [["treatment", "fentanyl"], ["drug", "fentanyl"], ["drug", "SSRIs"], ["combination drug", "fentanyl"], ["combination drug", "SSRIs"], ["effect", "Serotonin toxicity"]]}]}
{"text_id": "8903300_3", "text": "This pattern is suggestive of renal toxicity due to tobramycin .", "tokens": ["This", "pattern", "is", "suggestive", "of", "renal", "toxicity", "due", "to", "tobramycin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due to <extra_id_0> treatment <extra_id_5> tobramycin <extra_id_1> <extra_id_0> drug <extra_id_5> tobramycin <extra_id_1> <extra_id_0> effect <extra_id_5> renal toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7, 8], "text": "due to", "args": [{"type": "treatment", "offset": [9], "text": "tobramycin"}, {"type": "drug", "offset": [9], "text": "tobramycin"}, {"type": "effect", "offset": [5, 6], "text": "renal toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "due to", "label": "adverse event", "asoc": [["treatment", "tobramycin"], ["drug", "tobramycin"], ["effect", "renal toxicity"]]}]}
{"text_id": "18648015_3", "text": "OBJECTIVE : To describe a case of cefazolin - induced leukopenia in a critically ill patient who developed this adverse reaction upon rechallenge with cefoxitin .", "tokens": ["OBJECTIVE", ":", "To", "describe", "a", "case", "of", "cefazolin", "-", "induced", "leukopenia", "in", "a", "critically", "ill", "patient", "who", "developed", "this", "adverse", "reaction", "upon", "rechallenge", "with", "cefoxitin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a critically ill patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> critically ill <extra_id_1> <extra_id_0> treatment <extra_id_5> cefazolin <extra_id_1> <extra_id_0> drug <extra_id_5> cefazolin <extra_id_1> <extra_id_0> effect <extra_id_5> leukopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "induced", "args": [{"type": "subject", "offset": [12, 13, 14, 15], "text": "a critically ill patient"}, {"type": "subject disorder", "offset": [13, 14], "text": "critically ill"}, {"type": "treatment", "offset": [7], "text": "cefazolin"}, {"type": "drug", "offset": [7], "text": "cefazolin"}, {"type": "effect", "offset": [10], "text": "leukopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a critically ill patient"], ["subject disorder", "critically ill"], ["treatment", "cefazolin"], ["drug", "cefazolin"], ["effect", "leukopenia"]]}]}
{"text_id": "12187348_1", "text": "Gigantomastia induced by bucillamine .", "tokens": ["Gigantomastia", "induced", "by", "bucillamine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> bucillamine <extra_id_1> <extra_id_0> drug <extra_id_5> bucillamine <extra_id_1> <extra_id_0> effect <extra_id_5> Gigantomastia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "induced", "args": [{"type": "treatment", "offset": [3], "text": "bucillamine"}, {"type": "drug", "offset": [3], "text": "bucillamine"}, {"type": "effect", "offset": [0], "text": "Gigantomastia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "bucillamine"], ["drug", "bucillamine"], ["effect", "Gigantomastia"]]}]}
{"text_id": "11483161_1", "text": "Possible linkage of amprenavir with intracranial bleeding in an HIV - infected hemophiliac .", "tokens": ["Possible", "linkage", "of", "amprenavir", "with", "intracranial", "bleeding", "in", "an", "HIV", "-", "infected", "hemophiliac", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> linkage <extra_id_0> subject <extra_id_5> an HIV - infected hemophiliac <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> treatment <extra_id_5> amprenavir <extra_id_1> <extra_id_0> drug <extra_id_5> amprenavir <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> effect <extra_id_5> intracranial bleeding <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "linkage", "args": [{"type": "subject", "offset": [8, 9, 10, 11, 12], "text": "an HIV - infected hemophiliac"}, {"type": "subject disorder", "offset": [9], "text": "HIV"}, {"type": "treatment", "offset": [3], "text": "amprenavir"}, {"type": "drug", "offset": [3], "text": "amprenavir"}, {"type": "treatment disorder", "offset": [9], "text": "HIV"}, {"type": "effect", "offset": [5, 6], "text": "intracranial bleeding"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "linkage", "label": "adverse event", "asoc": [["subject", "an HIV - infected hemophiliac"], ["subject disorder", "HIV"], ["treatment", "amprenavir"], ["drug", "amprenavir"], ["treatment disorder", "HIV"], ["effect", "intracranial bleeding"]]}]}
{"text_id": "20118434_2", "text": "Interferon - induced psychosis as a \" psychiatric contraindication \" to hepatitis C treatment : a review and case - based discussion .", "tokens": ["Interferon", "-", "induced", "psychosis", "as", "a", "\"", "psychiatric", "contraindication", "\"", "to", "hepatitis", "C", "treatment", ":", "a", "review", "and", "case", "-", "based", "discussion", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Interferon <extra_id_1> <extra_id_0> drug <extra_id_5> Interferon <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hepatitis C <extra_id_1> <extra_id_0> effect <extra_id_5> psychosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Interferon"}, {"type": "drug", "offset": [0], "text": "Interferon"}, {"type": "treatment disorder", "offset": [11, 12], "text": "hepatitis C"}, {"type": "effect", "offset": [3], "text": "psychosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Interferon"], ["drug", "Interferon"], ["treatment disorder", "hepatitis C"], ["effect", "psychosis"]]}]}
{"text_id": "19949685_2", "text": "Colonic necrosis is known as a rare complication following the administration of Kayexalate ( sodium polystryrene sulfonate ) in sorbitol .", "tokens": ["Colonic", "necrosis", "is", "known", "as", "a", "rare", "complication", "following", "the", "administration", "of", "Kayexalate", "(", "sodium", "polystryrene", "sulfonate", ")", "in", "sorbitol", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> Kayexalate ( sodium polystryrene sulfonate ) in sorbitol <extra_id_1> <extra_id_0> drug <extra_id_5> Kayexalate <extra_id_1> <extra_id_0> drug <extra_id_5> sorbitol <extra_id_1> <extra_id_0> combination drug <extra_id_5> sorbitol <extra_id_1> <extra_id_0> combination drug <extra_id_5> Kayexalate <extra_id_1> <extra_id_0> effect <extra_id_5> Colonic necrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "following", "args": [{"type": "treatment", "offset": [12, 13, 14, 15, 16, 17, 18, 19], "text": "Kayexalate ( sodium polystryrene sulfonate ) in sorbitol"}, {"type": "drug", "offset": [12], "text": "Kayexalate"}, {"type": "drug", "offset": [19], "text": "sorbitol"}, {"type": "combination drug", "offset": [19], "text": "sorbitol"}, {"type": "combination drug", "offset": [12], "text": "Kayexalate"}, {"type": "effect", "offset": [0, 1], "text": "Colonic necrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "Kayexalate ( sodium polystryrene sulfonate ) in sorbitol"], ["drug", "Kayexalate"], ["drug", "sorbitol"], ["combination drug", "sorbitol"], ["combination drug", "Kayexalate"], ["effect", "Colonic necrosis"]]}]}
{"text_id": "3926849_2", "text": "Paradoxical pulmonary vasoconstriction induced by nitroglycerin in idiopathic pulmonary hypertension .", "tokens": ["Paradoxical", "pulmonary", "vasoconstriction", "induced", "by", "nitroglycerin", "in", "idiopathic", "pulmonary", "hypertension", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> nitroglycerin <extra_id_1> <extra_id_0> drug <extra_id_5> nitroglycerin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> idiopathic pulmonary hypertension <extra_id_1> <extra_id_0> effect <extra_id_5> Paradoxical pulmonary vasoconstriction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "induced", "args": [{"type": "treatment", "offset": [5], "text": "nitroglycerin"}, {"type": "drug", "offset": [5], "text": "nitroglycerin"}, {"type": "treatment disorder", "offset": [7, 8, 9], "text": "idiopathic pulmonary hypertension"}, {"type": "effect", "offset": [0, 1, 2], "text": "Paradoxical pulmonary vasoconstriction"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "nitroglycerin"], ["drug", "nitroglycerin"], ["treatment disorder", "idiopathic pulmonary hypertension"], ["effect", "Paradoxical pulmonary vasoconstriction"]]}]}
{"text_id": "12221670_3", "text": "Ticlopidine - induced aplastic anemia ( TIAA ) is considered very uncommon .", "tokens": ["Ticlopidine", "-", "induced", "aplastic", "anemia", "(", "TIAA", ")", "is", "considered", "very", "uncommon", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Ticlopidine <extra_id_1> <extra_id_0> drug <extra_id_5> Ticlopidine <extra_id_1> <extra_id_0> effect <extra_id_5> aplastic anemia ( TIAA ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Ticlopidine"}, {"type": "drug", "offset": [0], "text": "Ticlopidine"}, {"type": "effect", "offset": [3, 4, 5, 6, 7], "text": "aplastic anemia ( TIAA )"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Ticlopidine"], ["drug", "Ticlopidine"], ["effect", "aplastic anemia ( TIAA )"]]}]}
{"text_id": "1977935_4", "text": "This report describes the first association ( exclusive of drug overdose ) of symptomatic torsades de pointes occurring with the use of terfenadine in a patient who was taking the recommended prescribed dose of this drug in addition to cefaclor , ketoconazole , and medroxyprogesterone .", "tokens": ["This", "report", "describes", "the", "first", "association", "(", "exclusive", "of", "drug", "overdose", ")", "of", "symptomatic", "torsades", "de", "pointes", "occurring", "with", "the", "use", "of", "terfenadine", "in", "a", "patient", "who", "was", "taking", "the", "recommended", "prescribed", "dose", "of", "this", "drug", "in", "addition", "to", "cefaclor", ",", "ketoconazole", ",", "and", "medroxyprogesterone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurring <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> terfenadine <extra_id_1> <extra_id_0> treatment <extra_id_5> taking the recommended prescribed dose of this drug in addition to cefaclor , ketoconazole , and medroxyprogesterone <extra_id_1> <extra_id_0> drug <extra_id_5> cefaclor <extra_id_1> <extra_id_0> drug <extra_id_5> ketoconazole <extra_id_1> <extra_id_0> drug <extra_id_5> medroxyprogesterone <extra_id_1> <extra_id_0> drug <extra_id_5> terfenadine <extra_id_1> <extra_id_0> combination drug <extra_id_5> terfenadine <extra_id_1> <extra_id_0> combination drug <extra_id_5> cefaclor <extra_id_1> <extra_id_0> combination drug <extra_id_5> ketoconazole <extra_id_1> <extra_id_0> combination drug <extra_id_5> medroxyprogesterone <extra_id_1> <extra_id_0> effect <extra_id_5> symptomatic torsades de pointes <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "occurring", "args": [{"type": "subject", "offset": [24, 25], "text": "a patient"}, {"type": "treatment", "offset": [22], "text": "terfenadine"}, {"type": "treatment", "offset": [28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44], "text": "taking the recommended prescribed dose of this drug in addition to cefaclor , ketoconazole , and medroxyprogesterone"}, {"type": "drug", "offset": [39], "text": "cefaclor"}, {"type": "drug", "offset": [41], "text": "ketoconazole"}, {"type": "drug", "offset": [44], "text": "medroxyprogesterone"}, {"type": "drug", "offset": [22], "text": "terfenadine"}, {"type": "combination drug", "offset": [22], "text": "terfenadine"}, {"type": "combination drug", "offset": [39], "text": "cefaclor"}, {"type": "combination drug", "offset": [41], "text": "ketoconazole"}, {"type": "combination drug", "offset": [44], "text": "medroxyprogesterone"}, {"type": "effect", "offset": [13, 14, 15, 16], "text": "symptomatic torsades de pointes"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "occurring", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "terfenadine"], ["treatment", "taking the recommended prescribed dose of this drug in addition to cefaclor , ketoconazole , and medroxyprogesterone"], ["drug", "cefaclor"], ["drug", "ketoconazole"], ["drug", "medroxyprogesterone"], ["drug", "terfenadine"], ["combination drug", "terfenadine"], ["combination drug", "cefaclor"], ["combination drug", "ketoconazole"], ["combination drug", "medroxyprogesterone"], ["effect", "symptomatic torsades de pointes"]]}]}
{"text_id": "12630660_6", "text": "After reviewing the literature we suggest the CPM was a complication of lithium toxicity which affected the lateral geniculate nucleus which produced blindness .", "tokens": ["After", "reviewing", "the", "literature", "we", "suggest", "the", "CPM", "was", "a", "complication", "of", "lithium", "toxicity", "which", "affected", "the", "lateral", "geniculate", "nucleus", "which", "produced", "blindness", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> lithium <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> effect <extra_id_5> CPM <extra_id_1> <extra_id_0> effect <extra_id_5> lithium toxicity <extra_id_1> <extra_id_0> effect <extra_id_5> blindness <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "complication", "args": [{"type": "treatment", "offset": [12], "text": "lithium"}, {"type": "drug", "offset": [12], "text": "lithium"}, {"type": "effect", "offset": [7], "text": "CPM"}, {"type": "effect", "offset": [12, 13], "text": "lithium toxicity"}, {"type": "effect", "offset": [22], "text": "blindness"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "lithium"], ["drug", "lithium"], ["effect", "CPM"], ["effect", "lithium toxicity"], ["effect", "blindness"]]}]}
{"text_id": "16960880_1", "text": "Despite a very low complication rate , several severe arterial thrombotic events have been reported following thrombin injection of pseudoaneurysms .", "tokens": ["Despite", "a", "very", "low", "complication", "rate", ",", "several", "severe", "arterial", "thrombotic", "events", "have", "been", "reported", "following", "thrombin", "injection", "of", "pseudoaneurysms", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> thrombin injection <extra_id_1> <extra_id_0> drug <extra_id_5> thrombin <extra_id_1> <extra_id_0> route <extra_id_5> injection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> pseudoaneurysms <extra_id_1> <extra_id_0> effect <extra_id_5> arterial thrombotic <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "following", "args": [{"type": "treatment", "offset": [16, 17], "text": "thrombin injection"}, {"type": "drug", "offset": [16], "text": "thrombin"}, {"type": "route", "offset": [17], "text": "injection"}, {"type": "treatment disorder", "offset": [19], "text": "pseudoaneurysms"}, {"type": "effect", "offset": [9, 10], "text": "arterial thrombotic"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "treatment", "treatment disorder"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "thrombin injection"], ["drug", "thrombin"], ["route", "injection"], ["treatment disorder", "pseudoaneurysms"], ["effect", "arterial thrombotic"]]}]}
{"text_id": "7663030_14", "text": "Comparable adverse effects , such as disorientation and temporary amnesia , have been reported in patients in the analogous agent , propranolol .", "tokens": ["Comparable", "adverse", "effects", ",", "such", "as", "disorientation", "and", "temporary", "amnesia", ",", "have", "been", "reported", "in", "patients", "in", "the", "analogous", "agent", ",", "propranolol", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> been reported <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> treatment <extra_id_5> propranolol <extra_id_1> <extra_id_0> drug <extra_id_5> propranolol <extra_id_1> <extra_id_0> effect <extra_id_5> disorientation and temporary amnesia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12, 13], "text": "been reported", "args": [{"type": "subject", "offset": [15], "text": "patients"}, {"type": "treatment", "offset": [21], "text": "propranolol"}, {"type": "drug", "offset": [21], "text": "propranolol"}, {"type": "effect", "offset": [6, 7, 8, 9], "text": "disorientation and temporary amnesia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "been reported", "label": "adverse event", "asoc": [["subject", "patients"], ["treatment", "propranolol"], ["drug", "propranolol"], ["effect", "disorientation and temporary amnesia"]]}]}
{"text_id": "11243427_5", "text": "Exacerbation of 5 - FU dermatologic toxicities in patients with preexisting conditions suggests the importance of aggressive ocular prophylaxis , using frequent ocular lubrication and topical steroid preparations with concurrent medical management of pre - existing dermatologic conditions .", "tokens": ["Exacerbation", "of", "5", "-", "FU", "dermatologic", "toxicities", "in", "patients", "with", "preexisting", "conditions", "suggests", "the", "importance", "of", "aggressive", "ocular", "prophylaxis", ",", "using", "frequent", "ocular", "lubrication", "and", "topical", "steroid", "preparations", "with", "concurrent", "medical", "management", "of", "pre", "-", "existing", "dermatologic", "conditions", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> toxicities <extra_id_0> treatment <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> effect <extra_id_5> dermatologic toxicities <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "toxicities", "args": [{"type": "treatment", "offset": [2, 3, 4], "text": "5 - FU"}, {"type": "drug", "offset": [2, 3, 4], "text": "5 - FU"}, {"type": "effect", "offset": [5, 6], "text": "dermatologic toxicities"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "toxicities", "label": "adverse event", "asoc": [["treatment", "5 - FU"], ["drug", "5 - FU"], ["effect", "dermatologic toxicities"]]}]}
{"text_id": "19904536_13", "text": "Gemcitabine - induced pulmonary toxicity is usually a dramatic condition .", "tokens": ["Gemcitabine", "-", "induced", "pulmonary", "toxicity", "is", "usually", "a", "dramatic", "condition", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> Gemcitabine <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Gemcitabine"}, {"type": "drug", "offset": [0], "text": "Gemcitabine"}, {"type": "effect", "offset": [3, 4], "text": "pulmonary toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Gemcitabine"], ["drug", "Gemcitabine"], ["effect", "pulmonary toxicity"]]}]}
{"text_id": "15224368_1", "text": "Sweet 's syndrome associated with sargramostim ( granulocyte - macrophage colony stimulating factor ) treatment .", "tokens": ["Sweet", "'s", "syndrome", "associated", "with", "sargramostim", "(", "granulocyte", "-", "macrophage", "colony", "stimulating", "factor", ")", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> sargramostim ( granulocyte - macrophage colony stimulating factor ) treatment <extra_id_1> <extra_id_0> drug <extra_id_5> sargramostim <extra_id_1> <extra_id_0> effect <extra_id_5> Sweet 's syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "associated", "args": [{"type": "treatment", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "sargramostim ( granulocyte - macrophage colony stimulating factor ) treatment"}, {"type": "drug", "offset": [5], "text": "sargramostim"}, {"type": "effect", "offset": [0, 1, 2], "text": "Sweet 's syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "sargramostim ( granulocyte - macrophage colony stimulating factor ) treatment"], ["drug", "sargramostim"], ["effect", "Sweet 's syndrome"]]}]}
{"text_id": "12621956_2", "text": "This is a case report of subtle , mild hypothermia in a 54 - year old female patient receiving risperidone for schizophrenia .", "tokens": ["This", "is", "a", "case", "report", "of", "subtle", ",", "mild", "hypothermia", "in", "a", "54", "-", "year", "old", "female", "patient", "receiving", "risperidone", "for", "schizophrenia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> receiving <extra_id_0> subject <extra_id_5> a 54 - year old female patient <extra_id_1> <extra_id_0> age <extra_id_5> 54 - year old <extra_id_1> <extra_id_0> gender <extra_id_5> female <extra_id_1> <extra_id_0> subject disorder <extra_id_5> schizophrenia <extra_id_1> <extra_id_0> treatment <extra_id_5> risperidone <extra_id_1> <extra_id_0> drug <extra_id_5> risperidone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> schizophrenia <extra_id_1> <extra_id_0> effect <extra_id_5> mild hypothermia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "receiving", "args": [{"type": "subject", "offset": [11, 12, 13, 14, 15, 16, 17], "text": "a 54 - year old female patient"}, {"type": "age", "offset": [12, 13, 14, 15], "text": "54 - year old"}, {"type": "gender", "offset": [16], "text": "female"}, {"type": "subject disorder", "offset": [21], "text": "schizophrenia"}, {"type": "treatment", "offset": [19], "text": "risperidone"}, {"type": "drug", "offset": [19], "text": "risperidone"}, {"type": "treatment disorder", "offset": [21], "text": "schizophrenia"}, {"type": "effect", "offset": [8, 9], "text": "mild hypothermia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "receiving", "label": "adverse event", "asoc": [["subject", "a 54 - year old female patient"], ["age", "54 - year old"], ["gender", "female"], ["subject disorder", "schizophrenia"], ["treatment", "risperidone"], ["drug", "risperidone"], ["treatment disorder", "schizophrenia"], ["effect", "mild hypothermia"]]}]}
{"text_id": "2937155_1", "text": "A patient receiving vancomycin for a serious staphylococcal infection had a lupus - like syndrome characterized by a malar rash , pain and erythema of the cartilage of both ears , and tender erythematous and hemorrhagic lesions of the finger tips .", "tokens": ["A", "patient", "receiving", "vancomycin", "for", "a", "serious", "staphylococcal", "infection", "had", "a", "lupus", "-", "like", "syndrome", "characterized", "by", "a", "malar", "rash", ",", "pain", "and", "erythema", "of", "the", "cartilage", "of", "both", "ears", ",", "and", "tender", "erythematous", "and", "hemorrhagic", "lesions", "of", "the", "finger", "tips", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> had <extra_id_0> treatment <extra_id_5> vancomycin <extra_id_1> <extra_id_0> drug <extra_id_5> vancomycin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> serious staphylococcal infection <extra_id_1> <extra_id_0> effect <extra_id_5> a lupus - like syndrome characterized by a malar rash , pain and erythema of the cartilage of both ears , and tender erythematous and hemorrhagic lesions of the finger tips <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "had", "args": [{"type": "treatment", "offset": [3], "text": "vancomycin"}, {"type": "drug", "offset": [3], "text": "vancomycin"}, {"type": "treatment disorder", "offset": [6, 7, 8], "text": "serious staphylococcal infection"}, {"type": "effect", "offset": [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40], "text": "a lupus - like syndrome characterized by a malar rash , pain and erythema of the cartilage of both ears , and tender erythematous and hemorrhagic lesions of the finger tips"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "had", "label": "adverse event", "asoc": [["treatment", "vancomycin"], ["drug", "vancomycin"], ["treatment disorder", "serious staphylococcal infection"], ["effect", "a lupus - like syndrome characterized by a malar rash , pain and erythema of the cartilage of both ears , and tender erythematous and hemorrhagic lesions of the finger tips"]]}]}
{"text_id": "15203443_2", "text": "We describe a heroin abuser in whom clinical and laboratory manifestations of acute hepatitis B and C appeared a few days after the insertion of a subcutaneous naltrexone implant .", "tokens": ["We", "describe", "a", "heroin", "abuser", "in", "whom", "clinical", "and", "laboratory", "manifestations", "of", "acute", "hepatitis", "B", "and", "C", "appeared", "a", "few", "days", "after", "the", "insertion", "of", "a", "subcutaneous", "naltrexone", "implant", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a heroin abuser <extra_id_1> <extra_id_0> subject disorder <extra_id_5> heroin abuser <extra_id_1> <extra_id_0> treatment <extra_id_5> subcutaneous naltrexone implant <extra_id_1> <extra_id_0> drug <extra_id_5> naltrexone <extra_id_1> <extra_id_0> route <extra_id_5> subcutaneous <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> heroin abuser <extra_id_1> <extra_id_0> effect <extra_id_5> acute hepatitis B and C <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [21], "text": "after", "args": [{"type": "subject", "offset": [2, 3, 4], "text": "a heroin abuser"}, {"type": "subject disorder", "offset": [3, 4], "text": "heroin abuser"}, {"type": "treatment", "offset": [26, 27, 28], "text": "subcutaneous naltrexone implant"}, {"type": "drug", "offset": [27], "text": "naltrexone"}, {"type": "route", "offset": [26], "text": "subcutaneous"}, {"type": "treatment disorder", "offset": [3, 4], "text": "heroin abuser"}, {"type": "effect", "offset": [12, 13, 14, 15, 16], "text": "acute hepatitis B and C"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a heroin abuser"], ["subject disorder", "heroin abuser"], ["treatment", "subcutaneous naltrexone implant"], ["drug", "naltrexone"], ["route", "subcutaneous"], ["treatment disorder", "heroin abuser"], ["effect", "acute hepatitis B and C"]]}]}
{"text_id": "10575189_1", "text": "Described here are 2 patients who developed thrombotic microangiopathy of the kidneys after receiving high cumulative doses of the new anticancer drug gemcitabine .", "tokens": ["Described", "here", "are", "2", "patients", "who", "developed", "thrombotic", "microangiopathy", "of", "the", "kidneys", "after", "receiving", "high", "cumulative", "doses", "of", "the", "new", "anticancer", "drug", "gemcitabine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> receiving <extra_id_0> subject <extra_id_5> 2 patients <extra_id_1> <extra_id_0> population <extra_id_5> 2 <extra_id_1> <extra_id_0> treatment <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> dosage <extra_id_5> high cumulative doses <extra_id_1> <extra_id_0> effect <extra_id_5> thrombotic microangiopathy of the kidneys <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "receiving", "args": [{"type": "subject", "offset": [3, 4], "text": "2 patients"}, {"type": "population", "offset": [3], "text": "2"}, {"type": "treatment", "offset": [22], "text": "gemcitabine"}, {"type": "drug", "offset": [22], "text": "gemcitabine"}, {"type": "dosage", "offset": [14, 15, 16], "text": "high cumulative doses"}, {"type": "effect", "offset": [7, 8, 9, 10, 11], "text": "thrombotic microangiopathy of the kidneys"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "dosage", "treatment"], "spot_asoc": [{"span": "receiving", "label": "adverse event", "asoc": [["subject", "2 patients"], ["population", "2"], ["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["dosage", "high cumulative doses"], ["effect", "thrombotic microangiopathy of the kidneys"]]}]}
{"text_id": "18504683_1", "text": "L - asparaginase - induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children .", "tokens": ["L", "-", "asparaginase", "-", "induced", "posterior", "reversible", "encephalopathy", "syndrome", "during", "acute", "lymphoblastic", "leukemia", "treatment", "in", "children", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> children <extra_id_1> <extra_id_0> age <extra_id_5> children <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute lymphoblastic leukemia <extra_id_1> <extra_id_0> treatment <extra_id_5> L - asparaginase <extra_id_1> <extra_id_0> drug <extra_id_5> L - asparaginase <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute lymphoblastic leukemia <extra_id_1> <extra_id_0> effect <extra_id_5> posterior reversible encephalopathy syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "induced", "args": [{"type": "subject", "offset": [15], "text": "children"}, {"type": "age", "offset": [15], "text": "children"}, {"type": "subject disorder", "offset": [10, 11, 12], "text": "acute lymphoblastic leukemia"}, {"type": "treatment", "offset": [0, 1, 2], "text": "L - asparaginase"}, {"type": "drug", "offset": [0, 1, 2], "text": "L - asparaginase"}, {"type": "treatment disorder", "offset": [10, 11, 12], "text": "acute lymphoblastic leukemia"}, {"type": "effect", "offset": [5, 6, 7, 8], "text": "posterior reversible encephalopathy syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "children"], ["age", "children"], ["subject disorder", "acute lymphoblastic leukemia"], ["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["treatment disorder", "acute lymphoblastic leukemia"], ["effect", "posterior reversible encephalopathy syndrome"]]}]}
{"text_id": "527355_2", "text": "Severe acidosis from acetazolamide in a diabetic patient .", "tokens": ["Severe", "acidosis", "from", "acetazolamide", "in", "a", "diabetic", "patient", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> from <extra_id_0> subject <extra_id_5> a diabetic patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> diabetic <extra_id_1> <extra_id_0> treatment <extra_id_5> acetazolamide <extra_id_1> <extra_id_0> drug <extra_id_5> acetazolamide <extra_id_1> <extra_id_0> effect <extra_id_5> Severe acidosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "from", "args": [{"type": "subject", "offset": [5, 6, 7], "text": "a diabetic patient"}, {"type": "subject disorder", "offset": [6], "text": "diabetic"}, {"type": "treatment", "offset": [3], "text": "acetazolamide"}, {"type": "drug", "offset": [3], "text": "acetazolamide"}, {"type": "effect", "offset": [0, 1], "text": "Severe acidosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "from", "label": "adverse event", "asoc": [["subject", "a diabetic patient"], ["subject disorder", "diabetic"], ["treatment", "acetazolamide"], ["drug", "acetazolamide"], ["effect", "Severe acidosis"]]}]}
{"text_id": "582099_2", "text": "Neurotoxicity of intrathecal administration of amphotericin B.", "tokens": ["Neurotoxicity", "of", "intrathecal", "administration", "of", "amphotericin", "B."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> of <extra_id_0> treatment <extra_id_5> intrathecal administration of amphotericin B. <extra_id_1> <extra_id_0> drug <extra_id_5> amphotericin B. <extra_id_1> <extra_id_0> route <extra_id_5> intrathecal <extra_id_1> <extra_id_0> effect <extra_id_5> Neurotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "of", "args": [{"type": "treatment", "offset": [2, 3, 4, 5, 6], "text": "intrathecal administration of amphotericin B."}, {"type": "drug", "offset": [5, 6], "text": "amphotericin B."}, {"type": "route", "offset": [2], "text": "intrathecal"}, {"type": "effect", "offset": [0], "text": "Neurotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "of", "label": "adverse event", "asoc": [["treatment", "intrathecal administration of amphotericin B."], ["drug", "amphotericin B."], ["route", "intrathecal"], ["effect", "Neurotoxicity"]]}]}
{"text_id": "19892516_1", "text": "Ciprofloxacin - induced hemorrhagic vasculitis .", "tokens": ["Ciprofloxacin", "-", "induced", "hemorrhagic", "vasculitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> Ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> hemorrhagic vasculitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Ciprofloxacin"}, {"type": "drug", "offset": [0], "text": "Ciprofloxacin"}, {"type": "effect", "offset": [3, 4], "text": "hemorrhagic vasculitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Ciprofloxacin"], ["drug", "Ciprofloxacin"], ["effect", "hemorrhagic vasculitis"]]}]}
{"text_id": "1261772_3", "text": "These observations indicate that submassive hepatic necrosis may result from treatment with propylthiouracil and are consistent with the notion that sensitization mechanisms may be responsible for the hepatic injury induced by this drug .", "tokens": ["These", "observations", "indicate", "that", "submassive", "hepatic", "necrosis", "may", "result", "from", "treatment", "with", "propylthiouracil", "and", "are", "consistent", "with", "the", "notion", "that", "sensitization", "mechanisms", "may", "be", "responsible", "for", "the", "hepatic", "injury", "induced", "by", "this", "drug", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> result <extra_id_0> treatment <extra_id_5> propylthiouracil <extra_id_1> <extra_id_0> drug <extra_id_5> propylthiouracil <extra_id_1> <extra_id_0> effect <extra_id_5> submassive hepatic necrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "result", "args": [{"type": "treatment", "offset": [12], "text": "propylthiouracil"}, {"type": "drug", "offset": [12], "text": "propylthiouracil"}, {"type": "effect", "offset": [4, 5, 6], "text": "submassive hepatic necrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "result", "label": "adverse event", "asoc": [["treatment", "propylthiouracil"], ["drug", "propylthiouracil"], ["effect", "submassive hepatic necrosis"]]}]}
{"text_id": "19949685_3", "text": "Two days after administration of Kalimate enema , he had profuse hematochezia , and a sigmoidoscopy showed diffuse colonic mucosal necrosis in the rectum and sigmoid colon .", "tokens": ["Two", "days", "after", "administration", "of", "Kalimate", "enema", ",", "he", "had", "profuse", "hematochezia", ",", "and", "a", "sigmoidoscopy", "showed", "diffuse", "colonic", "mucosal", "necrosis", "in", "the", "rectum", "and", "sigmoid", "colon", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> he <extra_id_1> <extra_id_0> gender <extra_id_5> he <extra_id_1> <extra_id_0> treatment <extra_id_5> Two days after administration of Kalimate enema <extra_id_1> <extra_id_0> drug <extra_id_5> Kalimate <extra_id_1> <extra_id_0> route <extra_id_5> enema <extra_id_1> <extra_id_0> time elapsed <extra_id_5> Two days <extra_id_1> <extra_id_0> effect <extra_id_5> profuse hematochezia <extra_id_1> <extra_id_0> effect <extra_id_5> diffuse colonic mucosal necrosis in the rectum <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "after", "args": [{"type": "subject", "offset": [8], "text": "he"}, {"type": "gender", "offset": [8], "text": "he"}, {"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Two days after administration of Kalimate enema"}, {"type": "drug", "offset": [5], "text": "Kalimate"}, {"type": "route", "offset": [6], "text": "enema"}, {"type": "time elapsed", "offset": [0, 1], "text": "Two days"}, {"type": "effect", "offset": [10, 11], "text": "profuse hematochezia"}, {"type": "effect", "offset": [17, 18, 19, 20, 21, 22, 23], "text": "diffuse colonic mucosal necrosis in the rectum"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "route", "subject", "drug", "gender", "treatment"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "he"], ["gender", "he"], ["treatment", "Two days after administration of Kalimate enema"], ["drug", "Kalimate"], ["route", "enema"], ["time elapsed", "Two days"], ["effect", "profuse hematochezia"], ["effect", "diffuse colonic mucosal necrosis in the rectum"]]}]}
{"text_id": "17522786_2", "text": "Neurointensive care management of raised intracranial pressure caused by severe valproic acid intoxication .", "tokens": ["Neurointensive", "care", "management", "of", "raised", "intracranial", "pressure", "caused", "by", "severe", "valproic", "acid", "intoxication", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> valproic acid <extra_id_1> <extra_id_0> drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> effect <extra_id_5> raised intracranial pressure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "caused", "args": [{"type": "treatment", "offset": [10, 11], "text": "valproic acid"}, {"type": "drug", "offset": [10, 11], "text": "valproic acid"}, {"type": "effect", "offset": [4, 5, 6], "text": "raised intracranial pressure"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "valproic acid"], ["drug", "valproic acid"], ["effect", "raised intracranial pressure"]]}]}
{"text_id": "9161656_2", "text": "OBJECTIVE : To describe a patient with asymptomatic bronchial asthma and hypertension who developed an acute asthma attack after receiving sustained - release verapamil .", "tokens": ["OBJECTIVE", ":", "To", "describe", "a", "patient", "with", "asymptomatic", "bronchial", "asthma", "and", "hypertension", "who", "developed", "an", "acute", "asthma", "attack", "after", "receiving", "sustained", "-", "release", "verapamil", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a patient with asymptomatic bronchial asthma and hypertension <extra_id_1> <extra_id_0> subject disorder <extra_id_5> asymptomatic bronchial asthma <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hypertension <extra_id_1> <extra_id_0> treatment <extra_id_5> sustained - release verapamil <extra_id_1> <extra_id_0> drug <extra_id_5> sustained - release verapamil <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hypertension <extra_id_1> <extra_id_0> effect <extra_id_5> acute asthma attack <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "after", "args": [{"type": "subject", "offset": [4, 5, 6, 7, 8, 9, 10, 11], "text": "a patient with asymptomatic bronchial asthma and hypertension"}, {"type": "subject disorder", "offset": [7, 8, 9], "text": "asymptomatic bronchial asthma"}, {"type": "subject disorder", "offset": [11], "text": "hypertension"}, {"type": "treatment", "offset": [20, 21, 22, 23], "text": "sustained - release verapamil"}, {"type": "drug", "offset": [20, 21, 22, 23], "text": "sustained - release verapamil"}, {"type": "treatment disorder", "offset": [11], "text": "hypertension"}, {"type": "effect", "offset": [15, 16, 17], "text": "acute asthma attack"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a patient with asymptomatic bronchial asthma and hypertension"], ["subject disorder", "asymptomatic bronchial asthma"], ["subject disorder", "hypertension"], ["treatment", "sustained - release verapamil"], ["drug", "sustained - release verapamil"], ["treatment disorder", "hypertension"], ["effect", "acute asthma attack"]]}]}
{"text_id": "2292051_2", "text": "Six patients with no previous signs or symptoms suggestive of coronary artery disease developed acute coronary ischemia / infarction shortly after cis - diamine - dichloroplatinum II ( cisplatin ) -based chemotherapy .", "tokens": ["Six", "patients", "with", "no", "previous", "signs", "or", "symptoms", "suggestive", "of", "coronary", "artery", "disease", "developed", "acute", "coronary", "ischemia", "/", "infarction", "shortly", "after", "cis", "-", "diamine", "-", "dichloroplatinum", "II", "(", "cisplatin", ")", "-based", "chemotherapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> Six patients with no previous signs or symptoms suggestive of coronary artery disease <extra_id_1> <extra_id_0> population <extra_id_5> Six <extra_id_1> <extra_id_0> treatment <extra_id_5> cis - diamine - dichloroplatinum II ( cisplatin ) -based chemotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> cis - diamine - dichloroplatinum II <extra_id_1> <extra_id_0> route <extra_id_5> chemotherapy <extra_id_1> <extra_id_0> effect <extra_id_5> acute coronary ischemia / infarction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12], "text": "Six patients with no previous signs or symptoms suggestive of coronary artery disease"}, {"type": "population", "offset": [0], "text": "Six"}, {"type": "treatment", "offset": [21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31], "text": "cis - diamine - dichloroplatinum II ( cisplatin ) -based chemotherapy"}, {"type": "drug", "offset": [21, 22, 23, 24, 25, 26], "text": "cis - diamine - dichloroplatinum II"}, {"type": "route", "offset": [31], "text": "chemotherapy"}, {"type": "effect", "offset": [14, 15, 16, 17, 18], "text": "acute coronary ischemia / infarction"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "route", "subject", "drug", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "Six patients with no previous signs or symptoms suggestive of coronary artery disease"], ["population", "Six"], ["treatment", "cis - diamine - dichloroplatinum II ( cisplatin ) -based chemotherapy"], ["drug", "cis - diamine - dichloroplatinum II"], ["route", "chemotherapy"], ["effect", "acute coronary ischemia / infarction"]]}]}
{"text_id": "16405935_3", "text": "This report describes a case of bilateral ptosis induced by chloroquine .", "tokens": ["This", "report", "describes", "a", "case", "of", "bilateral", "ptosis", "induced", "by", "chloroquine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a case <extra_id_1> <extra_id_0> treatment <extra_id_5> chloroquine <extra_id_1> <extra_id_0> drug <extra_id_5> chloroquine <extra_id_1> <extra_id_0> effect <extra_id_5> bilateral ptosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "induced", "args": [{"type": "subject", "offset": [3, 4], "text": "a case"}, {"type": "treatment", "offset": [10], "text": "chloroquine"}, {"type": "drug", "offset": [10], "text": "chloroquine"}, {"type": "effect", "offset": [6, 7], "text": "bilateral ptosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a case"], ["treatment", "chloroquine"], ["drug", "chloroquine"], ["effect", "bilateral ptosis"]]}]}
{"text_id": "6093724_2", "text": "Sulindac ( Clinoril ) , a nonsteroidal anti - inflammatory agent , has few reported neurologic toxic effects , all of which have been associated with systemic disease .", "tokens": ["Sulindac", "(", "Clinoril", ")", ",", "a", "nonsteroidal", "anti", "-", "inflammatory", "agent", ",", "has", "few", "reported", "neurologic", "toxic", "effects", ",", "all", "of", "which", "have", "been", "associated", "with", "systemic", "disease", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> reported <extra_id_0> treatment <extra_id_5> Sulindac ( Clinoril ) <extra_id_1> <extra_id_0> drug <extra_id_5> Sulindac <extra_id_1> <extra_id_0> effect <extra_id_5> neurologic toxic effects <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "reported", "args": [{"type": "treatment", "offset": [0, 1, 2, 3], "text": "Sulindac ( Clinoril )"}, {"type": "drug", "offset": [0], "text": "Sulindac"}, {"type": "effect", "offset": [15, 16, 17], "text": "neurologic toxic effects"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "reported", "label": "adverse event", "asoc": [["treatment", "Sulindac ( Clinoril )"], ["drug", "Sulindac"], ["effect", "neurologic toxic effects"]]}]}
{"text_id": "8255797_2", "text": "Neutropenia is an infrequent complication following administration of the angiotensin - converting enzyme ( ACE ) inhibitor , captopril .", "tokens": ["Neutropenia", "is", "an", "infrequent", "complication", "following", "administration", "of", "the", "angiotensin", "-", "converting", "enzyme", "(", "ACE", ")", "inhibitor", ",", "captopril", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> the angiotensin - converting enzyme ( ACE ) inhibitor , captopril <extra_id_1> <extra_id_0> drug <extra_id_5> captopril <extra_id_1> <extra_id_0> effect <extra_id_5> Neutropenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "following", "args": [{"type": "treatment", "offset": [8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18], "text": "the angiotensin - converting enzyme ( ACE ) inhibitor , captopril"}, {"type": "drug", "offset": [18], "text": "captopril"}, {"type": "effect", "offset": [0], "text": "Neutropenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "the angiotensin - converting enzyme ( ACE ) inhibitor , captopril"], ["drug", "captopril"], ["effect", "Neutropenia"]]}]}
{"text_id": "11122162_1", "text": "MI related to the use of activated and non - activated PCCs predominantly affects young patients who often have no preceding history of , or risk factors for , MI and tends to be associated with large cumulative doses of concentrate .", "tokens": ["MI", "related", "to", "the", "use", "of", "activated", "and", "non", "-", "activated", "PCCs", "predominantly", "affects", "young", "patients", "who", "often", "have", "no", "preceding", "history", "of", ",", "or", "risk", "factors", "for", ",", "MI", "and", "tends", "to", "be", "associated", "with", "large", "cumulative", "doses", "of", "concentrate", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> subject <extra_id_5> young patients who often have no preceding history of , or risk factors for , MI <extra_id_1> <extra_id_0> age <extra_id_5> young <extra_id_1> <extra_id_0> treatment <extra_id_5> activated and non - activated PCCs <extra_id_1> <extra_id_0> treatment <extra_id_5> large cumulative doses of concentrate <extra_id_1> <extra_id_0> drug <extra_id_5> non - activated PCCs <extra_id_1> <extra_id_0> drug <extra_id_5> activated <extra_id_1> <extra_id_0> drug <extra_id_5> PCCs <extra_id_1> <extra_id_0> dosage <extra_id_5> large cumulative doses <extra_id_1> <extra_id_0> effect <extra_id_5> MI <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "related", "args": [{"type": "subject", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29], "text": "young patients who often have no preceding history of , or risk factors for , MI"}, {"type": "age", "offset": [14], "text": "young"}, {"type": "treatment", "offset": [6, 7, 8, 9, 10, 11], "text": "activated and non - activated PCCs"}, {"type": "treatment", "offset": [36, 37, 38, 39, 40], "text": "large cumulative doses of concentrate"}, {"type": "drug", "offset": [8, 9, 10, 11], "text": "non - activated PCCs"}, {"type": "drug", "offset": [6], "text": "activated"}, {"type": "drug", "offset": [11], "text": "PCCs"}, {"type": "dosage", "offset": [36, 37, 38], "text": "large cumulative doses"}, {"type": "effect", "offset": [0], "text": "MI"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "dosage", "age", "treatment"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["subject", "young patients who often have no preceding history of , or risk factors for , MI"], ["age", "young"], ["treatment", "activated and non - activated PCCs"], ["treatment", "large cumulative doses of concentrate"], ["drug", "non - activated PCCs"], ["drug", "activated"], ["drug", "PCCs"], ["dosage", "large cumulative doses"], ["effect", "MI"]]}]}
{"text_id": "19915794_4", "text": "We report an 82 - year - old man who developed ventricular tachycardia and Torsades de Pointes ( TdP ) after oral administration of garenoxacin , a novel quinolone antibiotic agent that differs from the third - generation quinolones , for pneumonia .", "tokens": ["We", "report", "an", "82", "-", "year", "-", "old", "man", "who", "developed", "ventricular", "tachycardia", "and", "Torsades", "de", "Pointes", "(", "TdP", ")", "after", "oral", "administration", "of", "garenoxacin", ",", "a", "novel", "quinolone", "antibiotic", "agent", "that", "differs", "from", "the", "third", "-", "generation", "quinolones", ",", "for", "pneumonia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> an 82 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 82 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> pneumonia <extra_id_1> <extra_id_0> treatment <extra_id_5> oral administration of garenoxacin <extra_id_1> <extra_id_0> drug <extra_id_5> garenoxacin <extra_id_1> <extra_id_0> route <extra_id_5> oral <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> pneumonia <extra_id_1> <extra_id_0> effect <extra_id_5> ventricular tachycardia and Torsades de Pointes ( TdP ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "after", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7, 8], "text": "an 82 - year - old man"}, {"type": "age", "offset": [3, 4, 5, 6, 7], "text": "82 - year - old"}, {"type": "gender", "offset": [8], "text": "man"}, {"type": "subject disorder", "offset": [41], "text": "pneumonia"}, {"type": "treatment", "offset": [21, 22, 23, 24], "text": "oral administration of garenoxacin"}, {"type": "drug", "offset": [24], "text": "garenoxacin"}, {"type": "route", "offset": [21], "text": "oral"}, {"type": "treatment disorder", "offset": [41], "text": "pneumonia"}, {"type": "effect", "offset": [11, 12, 13, 14, 15, 16, 17, 18, 19], "text": "ventricular tachycardia and Torsades de Pointes ( TdP )"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "an 82 - year - old man"], ["age", "82 - year - old"], ["gender", "man"], ["subject disorder", "pneumonia"], ["treatment", "oral administration of garenoxacin"], ["drug", "garenoxacin"], ["route", "oral"], ["treatment disorder", "pneumonia"], ["effect", "ventricular tachycardia and Torsades de Pointes ( TdP )"]]}]}
{"text_id": "12860350_1", "text": "Acute abdomen due to endometriosis in a premenopausal woman taking tamoxifen .", "tokens": ["Acute", "abdomen", "due", "to", "endometriosis", "in", "a", "premenopausal", "woman", "taking", "tamoxifen", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> taking <extra_id_0> treatment <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> drug <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> effect <extra_id_5> Acute abdomen due to endometriosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "taking", "args": [{"type": "treatment", "offset": [10], "text": "tamoxifen"}, {"type": "drug", "offset": [10], "text": "tamoxifen"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Acute abdomen due to endometriosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "taking", "label": "adverse event", "asoc": [["treatment", "tamoxifen"], ["drug", "tamoxifen"], ["effect", "Acute abdomen due to endometriosis"]]}]}
{"text_id": "8292513_1", "text": "Cerebrovascular complications of L - asparaginase therapy in children with leukemia : aphasia and other neuropsychological deficits .", "tokens": ["Cerebrovascular", "complications", "of", "L", "-", "asparaginase", "therapy", "in", "children", "with", "leukemia", ":", "aphasia", "and", "other", "neuropsychological", "deficits", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complications <extra_id_0> subject <extra_id_5> children with leukemia <extra_id_1> <extra_id_0> age <extra_id_5> children <extra_id_1> <extra_id_0> subject disorder <extra_id_5> leukemia <extra_id_1> <extra_id_0> treatment <extra_id_5> L - asparaginase <extra_id_1> <extra_id_0> drug <extra_id_5> L - asparaginase <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> leukemia <extra_id_1> <extra_id_0> effect <extra_id_5> Cerebrovascular complications <extra_id_1> <extra_id_0> effect <extra_id_5> aphasia and other neuropsychological deficits <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "complications", "args": [{"type": "subject", "offset": [8, 9, 10], "text": "children with leukemia"}, {"type": "age", "offset": [8], "text": "children"}, {"type": "subject disorder", "offset": [10], "text": "leukemia"}, {"type": "treatment", "offset": [3, 4, 5], "text": "L - asparaginase"}, {"type": "drug", "offset": [3, 4, 5], "text": "L - asparaginase"}, {"type": "treatment disorder", "offset": [10], "text": "leukemia"}, {"type": "effect", "offset": [0, 1], "text": "Cerebrovascular complications"}, {"type": "effect", "offset": [12, 13, 14, 15, 16], "text": "aphasia and other neuropsychological deficits"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "complications", "label": "adverse event", "asoc": [["subject", "children with leukemia"], ["age", "children"], ["subject disorder", "leukemia"], ["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["treatment disorder", "leukemia"], ["effect", "Cerebrovascular complications"], ["effect", "aphasia and other neuropsychological deficits"]]}]}
{"text_id": "4054170_3", "text": "EEG abnormalities were observed in two of the nine children during chlorambucil therapy .", "tokens": ["EEG", "abnormalities", "were", "observed", "in", "two", "of", "the", "nine", "children", "during", "chlorambucil", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> observed <extra_id_0> subject <extra_id_5> two of the nine children <extra_id_1> <extra_id_0> age <extra_id_5> children <extra_id_1> <extra_id_0> population <extra_id_5> two of the nine <extra_id_1> <extra_id_0> treatment <extra_id_5> chlorambucil <extra_id_1> <extra_id_0> drug <extra_id_5> chlorambucil <extra_id_1> <extra_id_0> effect <extra_id_5> EEG abnormalities <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "observed", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9], "text": "two of the nine children"}, {"type": "age", "offset": [9], "text": "children"}, {"type": "population", "offset": [5, 6, 7, 8], "text": "two of the nine"}, {"type": "treatment", "offset": [11], "text": "chlorambucil"}, {"type": "drug", "offset": [11], "text": "chlorambucil"}, {"type": "effect", "offset": [0, 1], "text": "EEG abnormalities"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "observed", "label": "adverse event", "asoc": [["subject", "two of the nine children"], ["age", "children"], ["population", "two of the nine"], ["treatment", "chlorambucil"], ["drug", "chlorambucil"], ["effect", "EEG abnormalities"]]}]}
{"text_id": "16225183_7", "text": "SUBSEQUENT COURSE : The nephrosis resolved almost completely once the interferon was stopped and after immunosuppressive treatment .", "tokens": ["SUBSEQUENT", "COURSE", ":", "The", "nephrosis", "resolved", "almost", "completely", "once", "the", "interferon", "was", "stopped", "and", "after", "immunosuppressive", "treatment", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> resolved <extra_id_0> treatment <extra_id_5> interferon was stopped and after immunosuppressive treatment <extra_id_1> <extra_id_0> drug <extra_id_5> interferon <extra_id_1> <extra_id_0> drug <extra_id_5> immunosuppressive <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> nephrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [5], "text": "resolved", "args": [{"type": "treatment", "offset": [10, 11, 12, 13, 14, 15, 16], "text": "interferon was stopped and after immunosuppressive treatment"}, {"type": "drug", "offset": [10], "text": "interferon"}, {"type": "drug", "offset": [15], "text": "immunosuppressive"}, {"type": "treatment disorder", "offset": [4], "text": "nephrosis"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "resolved", "label": "potential therapeutic event", "asoc": [["treatment", "interferon was stopped and after immunosuppressive treatment"], ["drug", "interferon"], ["drug", "immunosuppressive"], ["treatment disorder", "nephrosis"]]}]}
{"text_id": "15504988_2", "text": "We report three patients , all of whom had preexisting diabetic dyslipidemia , who showed a profound reduction in plasma HDL cholesterol and apolipoprotein AI levels soon after the initiation of rosiglitazone therapy .", "tokens": ["We", "report", "three", "patients", ",", "all", "of", "whom", "had", "preexisting", "diabetic", "dyslipidemia", ",", "who", "showed", "a", "profound", "reduction", "in", "plasma", "HDL", "cholesterol", "and", "apolipoprotein", "AI", "levels", "soon", "after", "the", "initiation", "of", "rosiglitazone", "therapy", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> initiation <extra_id_0> subject <extra_id_5> three patients <extra_id_1> <extra_id_0> population <extra_id_5> three <extra_id_1> <extra_id_0> subject disorder <extra_id_5> preexisting diabetic dyslipidemia <extra_id_1> <extra_id_0> treatment <extra_id_5> rosiglitazone therapy <extra_id_1> <extra_id_0> drug <extra_id_5> rosiglitazone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> preexisting diabetic dyslipidemia <extra_id_1> <extra_id_0> effect <extra_id_5> profound reduction in plasma HDL cholesterol and apolipoprotein AI levels <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [29], "text": "initiation", "args": [{"type": "subject", "offset": [2, 3], "text": "three patients"}, {"type": "population", "offset": [2], "text": "three"}, {"type": "subject disorder", "offset": [9, 10, 11], "text": "preexisting diabetic dyslipidemia"}, {"type": "treatment", "offset": [31, 32], "text": "rosiglitazone therapy"}, {"type": "drug", "offset": [31], "text": "rosiglitazone"}, {"type": "treatment disorder", "offset": [9, 10, 11], "text": "preexisting diabetic dyslipidemia"}, {"type": "effect", "offset": [16, 17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "profound reduction in plasma HDL cholesterol and apolipoprotein AI levels"}]}], "spot": ["potential therapeutic event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "initiation", "label": "potential therapeutic event", "asoc": [["subject", "three patients"], ["population", "three"], ["subject disorder", "preexisting diabetic dyslipidemia"], ["treatment", "rosiglitazone therapy"], ["drug", "rosiglitazone"], ["treatment disorder", "preexisting diabetic dyslipidemia"], ["effect", "profound reduction in plasma HDL cholesterol and apolipoprotein AI levels"]]}]}
{"text_id": "9545161_3", "text": "Fatal toxic epidermal necrolysis related to lamotrigine administration .", "tokens": ["Fatal", "toxic", "epidermal", "necrolysis", "related", "to", "lamotrigine", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related to <extra_id_0> treatment <extra_id_5> lamotrigine administration <extra_id_1> <extra_id_0> drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> effect <extra_id_5> Fatal toxic epidermal necrolysis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4, 5], "text": "related to", "args": [{"type": "treatment", "offset": [6, 7], "text": "lamotrigine administration"}, {"type": "drug", "offset": [6], "text": "lamotrigine"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Fatal toxic epidermal necrolysis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "related to", "label": "adverse event", "asoc": [["treatment", "lamotrigine administration"], ["drug", "lamotrigine"], ["effect", "Fatal toxic epidermal necrolysis"]]}]}
{"text_id": "17034541_1", "text": "Late lethal hepatitis B virus reactivation after rituximab treatment of low - grade cutaneous B - cell lymphoma .", "tokens": ["Late", "lethal", "hepatitis", "B", "virus", "reactivation", "after", "rituximab", "treatment", "of", "low", "-", "grade", "cutaneous", "B", "-", "cell", "lymphoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> rituximab <extra_id_1> <extra_id_0> drug <extra_id_5> rituximab <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> low - grade cutaneous B - cell lymphoma <extra_id_1> <extra_id_0> effect <extra_id_5> Late lethal hepatitis B virus reactivation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "after", "args": [{"type": "treatment", "offset": [7], "text": "rituximab"}, {"type": "drug", "offset": [7], "text": "rituximab"}, {"type": "treatment disorder", "offset": [10, 11, 12, 13, 14, 15, 16, 17], "text": "low - grade cutaneous B - cell lymphoma"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "Late lethal hepatitis B virus reactivation"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "rituximab"], ["drug", "rituximab"], ["treatment disorder", "low - grade cutaneous B - cell lymphoma"], ["effect", "Late lethal hepatitis B virus reactivation"]]}]}
{"text_id": "19826099_3", "text": "The Naranjo probability scale indicated a probable relationship between apnea and exposure to lamotrigine through breast - feeding in this infant .", "tokens": ["The", "Naranjo", "probability", "scale", "indicated", "a", "probable", "relationship", "between", "apnea", "and", "exposure", "to", "lamotrigine", "through", "breast", "-", "feeding", "in", "this", "infant", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> a probable relationship <extra_id_0> subject <extra_id_5> in this infant <extra_id_1> <extra_id_0> age <extra_id_5> infant <extra_id_1> <extra_id_0> treatment <extra_id_5> lamotrigine through breast - feeding <extra_id_1> <extra_id_0> drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> route <extra_id_5> breast - feeding <extra_id_1> <extra_id_0> effect <extra_id_5> apnea <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5, 6, 7], "text": "a probable relationship", "args": [{"type": "subject", "offset": [18, 19, 20], "text": "in this infant"}, {"type": "age", "offset": [20], "text": "infant"}, {"type": "treatment", "offset": [13, 14, 15, 16, 17], "text": "lamotrigine through breast - feeding"}, {"type": "drug", "offset": [13], "text": "lamotrigine"}, {"type": "route", "offset": [15, 16, 17], "text": "breast - feeding"}, {"type": "effect", "offset": [9], "text": "apnea"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "a probable relationship", "label": "adverse event", "asoc": [["subject", "in this infant"], ["age", "infant"], ["treatment", "lamotrigine through breast - feeding"], ["drug", "lamotrigine"], ["route", "breast - feeding"], ["effect", "apnea"]]}]}
{"text_id": "8313300_8", "text": "Regression of thyrotoxic ophthalmopathy following lithium withdrawal .", "tokens": ["Regression", "of", "thyrotoxic", "ophthalmopathy", "following", "lithium", "withdrawal", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> Regression <extra_id_0> treatment <extra_id_5> lithium withdrawal <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> thyrotoxic ophthalmopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [0], "text": "Regression", "args": [{"type": "treatment", "offset": [5, 6], "text": "lithium withdrawal"}, {"type": "drug", "offset": [5], "text": "lithium"}, {"type": "treatment disorder", "offset": [2, 3], "text": "thyrotoxic ophthalmopathy"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "Regression", "label": "potential therapeutic event", "asoc": [["treatment", "lithium withdrawal"], ["drug", "lithium"], ["treatment disorder", "thyrotoxic ophthalmopathy"]]}]}
{"text_id": "15543388_2", "text": "Celiac disease onset after pegylated interferon and ribavirin treatment of chronic hepatitis C.", "tokens": ["Celiac", "disease", "onset", "after", "pegylated", "interferon", "and", "ribavirin", "treatment", "of", "chronic", "hepatitis", "C."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> onset <extra_id_0> treatment <extra_id_5> pegylated interferon and ribavirin treatment of chronic hepatitis C. <extra_id_1> <extra_id_0> drug <extra_id_5> pegylated interferon <extra_id_1> <extra_id_0> drug <extra_id_5> ribavirin treatment <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic hepatitis C. <extra_id_1> <extra_id_0> combination drug <extra_id_5> pegylated interferon <extra_id_1> <extra_id_0> combination drug <extra_id_5> ribavirin treatment <extra_id_1> <extra_id_0> effect <extra_id_5> Celiac disease <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "onset", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12], "text": "pegylated interferon and ribavirin treatment of chronic hepatitis C."}, {"type": "drug", "offset": [4, 5], "text": "pegylated interferon"}, {"type": "drug", "offset": [7, 8], "text": "ribavirin treatment"}, {"type": "treatment disorder", "offset": [10, 11, 12], "text": "chronic hepatitis C."}, {"type": "combination drug", "offset": [4, 5], "text": "pegylated interferon"}, {"type": "combination drug", "offset": [7, 8], "text": "ribavirin treatment"}, {"type": "effect", "offset": [0, 1], "text": "Celiac disease"}]}], "spot": ["adverse event"], "asoc": ["effect", "drug", "treatment", "combination drug", "treatment disorder"], "spot_asoc": [{"span": "onset", "label": "adverse event", "asoc": [["treatment", "pegylated interferon and ribavirin treatment of chronic hepatitis C."], ["drug", "pegylated interferon"], ["drug", "ribavirin treatment"], ["treatment disorder", "chronic hepatitis C."], ["combination drug", "pegylated interferon"], ["combination drug", "ribavirin treatment"], ["effect", "Celiac disease"]]}]}
{"text_id": "3982906_2", "text": "However , each infant demonstrated hemodynamic decompensation shortly after verapamil administration and required cardiopulmonary resuscitation .", "tokens": ["However", ",", "each", "infant", "demonstrated", "hemodynamic", "decompensation", "shortly", "after", "verapamil", "administration", "and", "required", "cardiopulmonary", "resuscitation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> demonstrated <extra_id_0> subject <extra_id_5> each infant <extra_id_1> <extra_id_0> age <extra_id_5> infant <extra_id_1> <extra_id_0> treatment <extra_id_5> verapamil <extra_id_1> <extra_id_0> drug <extra_id_5> verapamil <extra_id_1> <extra_id_0> effect <extra_id_5> hemodynamic decompensation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "demonstrated", "args": [{"type": "subject", "offset": [2, 3], "text": "each infant"}, {"type": "age", "offset": [3], "text": "infant"}, {"type": "treatment", "offset": [9], "text": "verapamil"}, {"type": "drug", "offset": [9], "text": "verapamil"}, {"type": "effect", "offset": [5, 6], "text": "hemodynamic decompensation"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "demonstrated", "label": "adverse event", "asoc": [["subject", "each infant"], ["age", "infant"], ["treatment", "verapamil"], ["drug", "verapamil"], ["effect", "hemodynamic decompensation"]]}]}
{"text_id": "11215836_2", "text": "OBJECTIVE : To report on the possible development of serotonin syndrome in a patient receiving clomipramine after clozapine was withdrawn from the treatment regimen .", "tokens": ["OBJECTIVE", ":", "To", "report", "on", "the", "possible", "development", "of", "serotonin", "syndrome", "in", "a", "patient", "receiving", "clomipramine", "after", "clozapine", "was", "withdrawn", "from", "the", "treatment", "regimen", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> receiving <extra_id_0> subject <extra_id_5> patient <extra_id_1> <extra_id_0> treatment <extra_id_5> clomipramine <extra_id_1> <extra_id_0> drug <extra_id_5> clomipramine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> combination drug <extra_id_5> clomipramine <extra_id_1> <extra_id_0> combination drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "receiving", "args": [{"type": "subject", "offset": [13], "text": "patient"}, {"type": "treatment", "offset": [15], "text": "clomipramine"}, {"type": "drug", "offset": [15], "text": "clomipramine"}, {"type": "drug", "offset": [17], "text": "clozapine"}, {"type": "combination drug", "offset": [15], "text": "clomipramine"}, {"type": "combination drug", "offset": [17], "text": "clozapine"}, {"type": "effect", "offset": [9, 10], "text": "serotonin syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "receiving", "label": "adverse event", "asoc": [["subject", "patient"], ["treatment", "clomipramine"], ["drug", "clomipramine"], ["drug", "clozapine"], ["combination drug", "clomipramine"], ["combination drug", "clozapine"], ["effect", "serotonin syndrome"]]}]}
{"text_id": "9719245_3", "text": "Pancytopenia associated with 5 - aminosalicylic acid use in a patient with Crohn 's disease .", "tokens": ["Pancytopenia", "associated", "with", "5", "-", "aminosalicylic", "acid", "use", "in", "a", "patient", "with", "Crohn", "'s", "disease", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> a patient with Crohn 's disease <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> treatment <extra_id_5> 5 - aminosalicylic acid <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - aminosalicylic acid <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> effect <extra_id_5> Pancytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "associated", "args": [{"type": "subject", "offset": [9, 10, 11, 12, 13, 14], "text": "a patient with Crohn 's disease"}, {"type": "subject disorder", "offset": [12, 13, 14], "text": "Crohn 's disease"}, {"type": "treatment", "offset": [3, 4, 5, 6], "text": "5 - aminosalicylic acid"}, {"type": "drug", "offset": [3, 4, 5, 6], "text": "5 - aminosalicylic acid"}, {"type": "treatment disorder", "offset": [12, 13, 14], "text": "Crohn 's disease"}, {"type": "effect", "offset": [0], "text": "Pancytopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "a patient with Crohn 's disease"], ["subject disorder", "Crohn 's disease"], ["treatment", "5 - aminosalicylic acid"], ["drug", "5 - aminosalicylic acid"], ["treatment disorder", "Crohn 's disease"], ["effect", "Pancytopenia"]]}]}
{"text_id": "20190474_1", "text": "Acute kidney injury caused by zonisamide - induced hypersensitivity syndrome .", "tokens": ["Acute", "kidney", "injury", "caused", "by", "zonisamide", "-", "induced", "hypersensitivity", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> zonisamide <extra_id_1> <extra_id_0> drug <extra_id_5> zonisamide <extra_id_1> <extra_id_0> effect <extra_id_5> hypersensitivity syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "induced", "args": [{"type": "treatment", "offset": [5], "text": "zonisamide"}, {"type": "drug", "offset": [5], "text": "zonisamide"}, {"type": "effect", "offset": [8, 9], "text": "hypersensitivity syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "zonisamide"], ["drug", "zonisamide"], ["effect", "hypersensitivity syndrome"]]}]}
{"text_id": "15806568_1", "text": "In this study , we report on three individual patients who received BTX - B and who subsequently developed parasympathetic dysfunction of the visual system after injections of BTX - B at remote sites .", "tokens": ["In", "this", "study", ",", "we", "report", "on", "three", "individual", "patients", "who", "received", "BTX", "-", "B", "and", "who", "subsequently", "developed", "parasympathetic", "dysfunction", "of", "the", "visual", "system", "after", "injections", "of", "BTX", "-", "B", "at", "remote", "sites", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> three individual patients <extra_id_1> <extra_id_0> population <extra_id_5> three <extra_id_1> <extra_id_0> treatment <extra_id_5> BTX - B <extra_id_1> <extra_id_0> treatment <extra_id_5> BTX - B <extra_id_1> <extra_id_0> drug <extra_id_5> BTX - B <extra_id_1> <extra_id_0> drug <extra_id_5> BTX - B <extra_id_1> <extra_id_0> effect <extra_id_5> parasympathetic dysfunction of the visual system <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "developed", "args": [{"type": "subject", "offset": [7, 8, 9], "text": "three individual patients"}, {"type": "population", "offset": [7], "text": "three"}, {"type": "treatment", "offset": [12, 13, 14], "text": "BTX - B"}, {"type": "treatment", "offset": [28, 29, 30], "text": "BTX - B"}, {"type": "drug", "offset": [12, 13, 14], "text": "BTX - B"}, {"type": "drug", "offset": [28, 29, 30], "text": "BTX - B"}, {"type": "effect", "offset": [19, 20, 21, 22, 23, 24], "text": "parasympathetic dysfunction of the visual system"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "three individual patients"], ["population", "three"], ["treatment", "BTX - B"], ["treatment", "BTX - B"], ["drug", "BTX - B"], ["drug", "BTX - B"], ["effect", "parasympathetic dysfunction of the visual system"]]}]}
{"text_id": "12121061_6", "text": "Alone or in combination with corticosteroids , cyclosporine is an effective drug of choice for the resistant patients .", "tokens": ["Alone", "or", "in", "combination", "with", "corticosteroids", ",", "cyclosporine", "is", "an", "effective", "drug", "of", "choice", "for", "the", "resistant", "patients", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> is <extra_id_0> subject <extra_id_5> resistant patients <extra_id_1> <extra_id_0> treatment <extra_id_5> Alone or in combination with corticosteroids , cyclosporine <extra_id_1> <extra_id_0> drug <extra_id_5> corticosteroids <extra_id_1> <extra_id_0> drug <extra_id_5> cyclosporine <extra_id_1> <extra_id_0> combination drug <extra_id_5> corticosteroids <extra_id_1> <extra_id_0> combination drug <extra_id_5> cyclosporine <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [8], "text": "is", "args": [{"type": "subject", "offset": [16, 17], "text": "resistant patients"}, {"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Alone or in combination with corticosteroids , cyclosporine"}, {"type": "drug", "offset": [5], "text": "corticosteroids"}, {"type": "drug", "offset": [7], "text": "cyclosporine"}, {"type": "combination drug", "offset": [5], "text": "corticosteroids"}, {"type": "combination drug", "offset": [7], "text": "cyclosporine"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "combination drug", "drug", "subject"], "spot_asoc": [{"span": "is", "label": "potential therapeutic event", "asoc": [["subject", "resistant patients"], ["treatment", "Alone or in combination with corticosteroids , cyclosporine"], ["drug", "corticosteroids"], ["drug", "cyclosporine"], ["combination drug", "corticosteroids"], ["combination drug", "cyclosporine"]]}]}
{"text_id": "3124393_1", "text": "A woman 38 - year - old , suffering for about ten years from multiple sclerosis and treated with repeated therapy cycles of intrathecal Depo - Medrol , developed a spastic paraparesis at the lower limbs .", "tokens": ["A", "woman", "38", "-", "year", "-", "old", ",", "suffering", "for", "about", "ten", "years", "from", "multiple", "sclerosis", "and", "treated", "with", "repeated", "therapy", "cycles", "of", "intrathecal", "Depo", "-", "Medrol", ",", "developed", "a", "spastic", "paraparesis", "at", "the", "lower", "limbs", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A woman 38 - year - old , suffering for about ten years from multiple sclerosis <extra_id_1> <extra_id_0> age <extra_id_5> 38 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> multiple sclerosis <extra_id_1> <extra_id_0> treatment <extra_id_5> repeated therapy cycles of intrathecal Depo - Medrol <extra_id_1> <extra_id_0> drug <extra_id_5> Depo - Medrol <extra_id_1> <extra_id_0> frequency <extra_id_5> repeated <extra_id_1> <extra_id_0> route <extra_id_5> intrathecal <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> multiple sclerosis <extra_id_1> <extra_id_0> effect <extra_id_5> a spastic paraparesis at the lower limbs <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [28], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "A woman 38 - year - old , suffering for about ten years from multiple sclerosis"}, {"type": "age", "offset": [2, 3, 4, 5, 6], "text": "38 - year - old"}, {"type": "gender", "offset": [1], "text": "woman"}, {"type": "subject disorder", "offset": [14, 15], "text": "multiple sclerosis"}, {"type": "treatment", "offset": [19, 20, 21, 22, 23, 24, 25, 26], "text": "repeated therapy cycles of intrathecal Depo - Medrol"}, {"type": "drug", "offset": [24, 25, 26], "text": "Depo - Medrol"}, {"type": "frequency", "offset": [19], "text": "repeated"}, {"type": "route", "offset": [23], "text": "intrathecal"}, {"type": "treatment disorder", "offset": [14, 15], "text": "multiple sclerosis"}, {"type": "effect", "offset": [29, 30, 31, 32, 33, 34, 35], "text": "a spastic paraparesis at the lower limbs"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment disorder", "drug", "gender", "frequency", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A woman 38 - year - old , suffering for about ten years from multiple sclerosis"], ["age", "38 - year - old"], ["gender", "woman"], ["subject disorder", "multiple sclerosis"], ["treatment", "repeated therapy cycles of intrathecal Depo - Medrol"], ["drug", "Depo - Medrol"], ["frequency", "repeated"], ["route", "intrathecal"], ["treatment disorder", "multiple sclerosis"], ["effect", "a spastic paraparesis at the lower limbs"]]}]}
{"text_id": "10458196_3", "text": "Apparent central nervous system depression in infants after the use of topical brimonidine .", "tokens": ["Apparent", "central", "nervous", "system", "depression", "in", "infants", "after", "the", "use", "of", "topical", "brimonidine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> infants <extra_id_1> <extra_id_0> age <extra_id_5> infants <extra_id_1> <extra_id_0> treatment <extra_id_5> topical brimonidine <extra_id_1> <extra_id_0> drug <extra_id_5> brimonidine <extra_id_1> <extra_id_0> route <extra_id_5> topical <extra_id_1> <extra_id_0> effect <extra_id_5> Apparent central nervous system depression <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "after", "args": [{"type": "subject", "offset": [6], "text": "infants"}, {"type": "age", "offset": [6], "text": "infants"}, {"type": "treatment", "offset": [11, 12], "text": "topical brimonidine"}, {"type": "drug", "offset": [12], "text": "brimonidine"}, {"type": "route", "offset": [11], "text": "topical"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Apparent central nervous system depression"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "infants"], ["age", "infants"], ["treatment", "topical brimonidine"], ["drug", "brimonidine"], ["route", "topical"], ["effect", "Apparent central nervous system depression"]]}]}
{"text_id": "1592841_1", "text": "Falling backward in two elderly patients taking bupropion .", "tokens": ["Falling", "backward", "in", "two", "elderly", "patients", "taking", "bupropion", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> taking <extra_id_0> subject <extra_id_5> two elderly patients <extra_id_1> <extra_id_0> age <extra_id_5> elderly <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> treatment <extra_id_5> bupropion <extra_id_1> <extra_id_0> drug <extra_id_5> bupropion <extra_id_1> <extra_id_0> effect <extra_id_5> Falling backward <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "taking", "args": [{"type": "subject", "offset": [3, 4, 5], "text": "two elderly patients"}, {"type": "age", "offset": [4], "text": "elderly"}, {"type": "population", "offset": [3], "text": "two"}, {"type": "treatment", "offset": [7], "text": "bupropion"}, {"type": "drug", "offset": [7], "text": "bupropion"}, {"type": "effect", "offset": [0, 1], "text": "Falling backward"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "taking", "label": "adverse event", "asoc": [["subject", "two elderly patients"], ["age", "elderly"], ["population", "two"], ["treatment", "bupropion"], ["drug", "bupropion"], ["effect", "Falling backward"]]}]}
{"text_id": "10510156_2", "text": "AIMS : To identify the   human cytochrome P450 enzyme ( s ) involved in the in vitro metabolism of rosiglitazone , a potential oral antidiabetic agent for the treatment of type 2 diabetes - mellitus .", "tokens": ["AIMS", ":", "To", "identify", "the", " ", "human", "cytochrome", "P450", "enzyme", "(", "s", ")", "involved", "in", "the", "in", "vitro", "metabolism", "of", "rosiglitazone", ",", "a", "potential", "oral", "antidiabetic", "agent", "for", "the", "treatment", "of", "type", "2", "diabetes", "-", "mellitus", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> potential oral <extra_id_0> treatment <extra_id_5> rosiglitazone <extra_id_1> <extra_id_0> drug <extra_id_5> rosiglitazone <extra_id_1> <extra_id_0> route <extra_id_5> oral <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> type 2 diabetes - mellitus . <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [23, 24], "text": "potential oral", "args": [{"type": "treatment", "offset": [20], "text": "rosiglitazone"}, {"type": "drug", "offset": [20], "text": "rosiglitazone"}, {"type": "route", "offset": [24], "text": "oral"}, {"type": "treatment disorder", "offset": [31, 32, 33, 34, 35, 36], "text": "type 2 diabetes - mellitus ."}]}], "spot": ["potential therapeutic event"], "asoc": ["route", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "potential oral", "label": "potential therapeutic event", "asoc": [["treatment", "rosiglitazone"], ["drug", "rosiglitazone"], ["route", "oral"], ["treatment disorder", "type 2 diabetes - mellitus ."]]}]}
{"text_id": "10755579_3", "text": "This is the first report of a fluoxetine - related death in a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism .", "tokens": ["This", "is", "the", "first", "report", "of", "a", "fluoxetine", "-", "related", "death", "in", "a", "child", "with", "a", "confirmed", "genetic", "polymorphism", "of", "the", "CYP2D6", "gene", "that", "results", "in", "impaired", "drug", "metabolism", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> subject <extra_id_5> a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism <extra_id_1> <extra_id_0> age <extra_id_5> child <extra_id_1> <extra_id_0> subject disorder <extra_id_5> genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism <extra_id_1> <extra_id_0> treatment <extra_id_5> fluoxetine <extra_id_1> <extra_id_0> drug <extra_id_5> fluoxetine <extra_id_1> <extra_id_0> effect <extra_id_5> death <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "related", "args": [{"type": "subject", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28], "text": "a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism"}, {"type": "age", "offset": [13], "text": "child"}, {"type": "subject disorder", "offset": [17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28], "text": "genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism"}, {"type": "treatment", "offset": [7], "text": "fluoxetine"}, {"type": "drug", "offset": [7], "text": "fluoxetine"}, {"type": "effect", "offset": [10], "text": "death"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["subject", "a child with a confirmed genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism"], ["age", "child"], ["subject disorder", "genetic polymorphism of the CYP2D6 gene that results in impaired drug metabolism"], ["treatment", "fluoxetine"], ["drug", "fluoxetine"], ["effect", "death"]]}]}
{"text_id": "21416219_1", "text": "Long - term efficacy of adding fenofibric acid to moderate - dose statin therapy in patients with persistent elevated triglycerides .", "tokens": ["Long", "-", "term", "efficacy", "of", "adding", "fenofibric", "acid", "to", "moderate", "-", "dose", "statin", "therapy", "in", "patients", "with", "persistent", "elevated", "triglycerides", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> efficacy <extra_id_0> subject <extra_id_5> patients with persistent elevated triglycerides <extra_id_1> <extra_id_0> subject disorder <extra_id_5> persistent elevated triglycerides <extra_id_1> <extra_id_0> treatment <extra_id_5> adding fenofibric acid to moderate - dose statin therapy <extra_id_1> <extra_id_0> drug <extra_id_5> fenofibric acid <extra_id_1> <extra_id_0> drug <extra_id_5> statin <extra_id_1> <extra_id_0> dosage <extra_id_5> moderate - dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> persistent elevated triglycerides <extra_id_1> <extra_id_0> combination drug <extra_id_5> fenofibric acid <extra_id_1> <extra_id_0> combination drug <extra_id_5> statin <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [3], "text": "efficacy", "args": [{"type": "subject", "offset": [15, 16, 17, 18, 19], "text": "patients with persistent elevated triglycerides"}, {"type": "subject disorder", "offset": [17, 18, 19], "text": "persistent elevated triglycerides"}, {"type": "treatment", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13], "text": "adding fenofibric acid to moderate - dose statin therapy"}, {"type": "drug", "offset": [6, 7], "text": "fenofibric acid"}, {"type": "drug", "offset": [12], "text": "statin"}, {"type": "dosage", "offset": [9, 10, 11], "text": "moderate - dose"}, {"type": "treatment disorder", "offset": [17, 18, 19], "text": "persistent elevated triglycerides"}, {"type": "combination drug", "offset": [6, 7], "text": "fenofibric acid"}, {"type": "combination drug", "offset": [12], "text": "statin"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "drug", "treatment", "dosage", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "efficacy", "label": "potential therapeutic event", "asoc": [["subject", "patients with persistent elevated triglycerides"], ["subject disorder", "persistent elevated triglycerides"], ["treatment", "adding fenofibric acid to moderate - dose statin therapy"], ["drug", "fenofibric acid"], ["drug", "statin"], ["dosage", "moderate - dose"], ["treatment disorder", "persistent elevated triglycerides"], ["combination drug", "fenofibric acid"], ["combination drug", "statin"]]}]}
{"text_id": "14693027_2", "text": "Erythema multiforme associated with phenytoin and cranial radiation therapy : a report of three patients and review of the literature .", "tokens": ["Erythema", "multiforme", "associated", "with", "phenytoin", "and", "cranial", "radiation", "therapy", ":", "a", "report", "of", "three", "patients", "and", "review", "of", "the", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> three patients <extra_id_1> <extra_id_0> population <extra_id_5> three <extra_id_1> <extra_id_0> treatment <extra_id_5> phenytoin and cranial radiation therapy <extra_id_1> <extra_id_0> drug <extra_id_5> phenytoin <extra_id_1> <extra_id_0> effect <extra_id_5> Erythema multiforme <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "subject", "offset": [13, 14], "text": "three patients"}, {"type": "population", "offset": [13], "text": "three"}, {"type": "treatment", "offset": [4, 5, 6, 7, 8], "text": "phenytoin and cranial radiation therapy"}, {"type": "drug", "offset": [4], "text": "phenytoin"}, {"type": "effect", "offset": [0, 1], "text": "Erythema multiforme"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "three patients"], ["population", "three"], ["treatment", "phenytoin and cranial radiation therapy"], ["drug", "phenytoin"], ["effect", "Erythema multiforme"]]}]}
{"text_id": "10904571_2", "text": "Colchicine - induced myopathy in renal failure .", "tokens": ["Colchicine", "-", "induced", "myopathy", "in", "renal", "failure", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Colchicine <extra_id_1> <extra_id_0> drug <extra_id_5> Colchicine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> renal failure <extra_id_1> <extra_id_0> effect <extra_id_5> myopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Colchicine"}, {"type": "drug", "offset": [0], "text": "Colchicine"}, {"type": "treatment disorder", "offset": [5, 6], "text": "renal failure"}, {"type": "effect", "offset": [3], "text": "myopathy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Colchicine"], ["drug", "Colchicine"], ["treatment disorder", "renal failure"], ["effect", "myopathy"]]}]}
{"text_id": "8604715_3", "text": "Our patient developed both nephrogenic diabetes insipidus and renal tubular acidosis with a temporal pattern that demonstrated a link between foscarnet therapy and these abnormalities .", "tokens": ["Our", "patient", "developed", "both", "nephrogenic", "diabetes", "insipidus", "and", "renal", "tubular", "acidosis", "with", "a", "temporal", "pattern", "that", "demonstrated", "a", "link", "between", "foscarnet", "therapy", "and", "these", "abnormalities", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> patient <extra_id_1> <extra_id_0> treatment <extra_id_5> foscarnet <extra_id_1> <extra_id_0> drug <extra_id_5> foscarnet <extra_id_1> <extra_id_0> effect <extra_id_5> nephrogenic diabetes insipidus and renal tubular acidosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "developed", "args": [{"type": "subject", "offset": [1], "text": "patient"}, {"type": "treatment", "offset": [20], "text": "foscarnet"}, {"type": "drug", "offset": [20], "text": "foscarnet"}, {"type": "effect", "offset": [4, 5, 6, 7, 8, 9, 10], "text": "nephrogenic diabetes insipidus and renal tubular acidosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "patient"], ["treatment", "foscarnet"], ["drug", "foscarnet"], ["effect", "nephrogenic diabetes insipidus and renal tubular acidosis"]]}]}
{"text_id": "10323129_1", "text": "Possible theophylline toxicity during anesthesia .", "tokens": ["Possible", "theophylline", "toxicity", "during", "anesthesia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> anesthesia <extra_id_1> <extra_id_0> drug <extra_id_5> anesthesia <extra_id_1> <extra_id_0> effect <extra_id_5> theophylline toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "during", "args": [{"type": "treatment", "offset": [4], "text": "anesthesia"}, {"type": "drug", "offset": [4], "text": "anesthesia"}, {"type": "effect", "offset": [1, 2], "text": "theophylline toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "anesthesia"], ["drug", "anesthesia"], ["effect", "theophylline toxicity"]]}]}
{"text_id": "18801826_1", "text": "Olanzapine - induced hyperglycaemic coma and neuroleptic malignant syndrome : case report and review of literature .", "tokens": ["Olanzapine", "-", "induced", "hyperglycaemic", "coma", "and", "neuroleptic", "malignant", "syndrome", ":", "case", "report", "and", "review", "of", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Olanzapine <extra_id_1> <extra_id_0> drug <extra_id_5> Olanzapine <extra_id_1> <extra_id_0> effect <extra_id_5> hyperglycaemic coma and neuroleptic malignant syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Olanzapine"}, {"type": "drug", "offset": [0], "text": "Olanzapine"}, {"type": "effect", "offset": [3, 4, 5, 6, 7, 8], "text": "hyperglycaemic coma and neuroleptic malignant syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Olanzapine"], ["drug", "Olanzapine"], ["effect", "hyperglycaemic coma and neuroleptic malignant syndrome"]]}]}
{"text_id": "4066622_2", "text": "The calcium channel blockers are a group of drugs that have recently become available for the treatment of angina .", "tokens": ["The", "calcium", "channel", "blockers", "are", "a", "group", "of", "drugs", "that", "have", "recently", "become", "available", "for", "the", "treatment", "of", "angina", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> calcium channel blockers <extra_id_1> <extra_id_0> drug <extra_id_5> calcium channel blockers <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> angina <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [16], "text": "treatment", "args": [{"type": "treatment", "offset": [1, 2, 3], "text": "calcium channel blockers"}, {"type": "drug", "offset": [1, 2, 3], "text": "calcium channel blockers"}, {"type": "treatment disorder", "offset": [18], "text": "angina"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "calcium channel blockers"], ["drug", "calcium channel blockers"], ["treatment disorder", "angina"]]}]}
{"text_id": "12460237_2", "text": "Palmar - plantar erythrodysaesthesia ( PPE ) is an uncommon cutaneous complication of cytotoxic chemotherapy which generally presents as a painful erythema involving the palms and soles .", "tokens": ["Palmar", "-", "plantar", "erythrodysaesthesia", "(", "PPE", ")", "is", "an", "uncommon", "cutaneous", "complication", "of", "cytotoxic", "chemotherapy", "which", "generally", "presents", "as", "a", "painful", "erythema", "involving", "the", "palms", "and", "soles", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> cytotoxic chemotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> cytotoxic <extra_id_1> <extra_id_0> route <extra_id_5> chemotherapy <extra_id_1> <extra_id_0> effect <extra_id_5> Palmar - plantar erythrodysaesthesia ( PPE ) <extra_id_1> <extra_id_0> effect <extra_id_5> an uncommon cutaneous complication <extra_id_1> <extra_id_0> effect <extra_id_5> a painful erythema involving the palms and soles <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "complication", "args": [{"type": "treatment", "offset": [13, 14], "text": "cytotoxic chemotherapy"}, {"type": "drug", "offset": [13], "text": "cytotoxic"}, {"type": "route", "offset": [14], "text": "chemotherapy"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Palmar - plantar erythrodysaesthesia ( PPE )"}, {"type": "effect", "offset": [8, 9, 10, 11], "text": "an uncommon cutaneous complication"}, {"type": "effect", "offset": [19, 20, 21, 22, 23, 24, 25, 26], "text": "a painful erythema involving the palms and soles"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "cytotoxic chemotherapy"], ["drug", "cytotoxic"], ["route", "chemotherapy"], ["effect", "Palmar - plantar erythrodysaesthesia ( PPE )"], ["effect", "an uncommon cutaneous complication"], ["effect", "a painful erythema involving the palms and soles"]]}]}
{"text_id": "20126479_3", "text": "Spectral - domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision loss .", "tokens": ["Spectral", "-", "domain", "optical", "coherence", "tomography", "and", "adaptive", "optics", "may", "detect", "hydroxychloroquine", "retinal", "toxicity", "before", "symptomatic", "vision", "loss", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> before <extra_id_0> treatment <extra_id_5> hydroxychloroquine <extra_id_1> <extra_id_0> drug <extra_id_5> hydroxychloroquine <extra_id_1> <extra_id_0> effect <extra_id_5> symptomatic vision loss <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "before", "args": [{"type": "treatment", "offset": [11], "text": "hydroxychloroquine"}, {"type": "drug", "offset": [11], "text": "hydroxychloroquine"}, {"type": "effect", "offset": [15, 16, 17], "text": "symptomatic vision loss"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "before", "label": "adverse event", "asoc": [["treatment", "hydroxychloroquine"], ["drug", "hydroxychloroquine"], ["effect", "symptomatic vision loss"]]}]}
{"text_id": "16632429_1", "text": "We report the case of a lung cancer patient with bronquiloalveolar carcinoma ( BAC ) presenting with BOOP after chemotherapy with docetaxel and gemcitabine producing severe respiratory insufficiency , and simulating a progression of the tumor .", "tokens": ["We", "report", "the", "case", "of", "a", "lung", "cancer", "patient", "with", "bronquiloalveolar", "carcinoma", "(", "BAC", ")", "presenting", "with", "BOOP", "after", "chemotherapy", "with", "docetaxel", "and", "gemcitabine", "producing", "severe", "respiratory", "insufficiency", ",", "and", "simulating", "a", "progression", "of", "the", "tumor", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> lung cancer patient with bronquiloalveolar carcinoma ( BAC ) <extra_id_1> <extra_id_0> subject disorder <extra_id_5> lung cancer <extra_id_1> <extra_id_0> subject disorder <extra_id_5> bronquiloalveolar carcinoma ( BAC ) <extra_id_1> <extra_id_0> treatment <extra_id_5> chemotherapy with docetaxel and gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> docetaxel <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> route <extra_id_5> chemotherapy <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> lung cancer <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> bronquiloalveolar carcinoma ( BAC ) <extra_id_1> <extra_id_0> combination drug <extra_id_5> docetaxel <extra_id_1> <extra_id_0> combination drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> effect <extra_id_5> producing severe respiratory insufficiency , and simulating a progression of the tumor <extra_id_1> <extra_id_0> effect <extra_id_5> BOOP <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "after", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "lung cancer patient with bronquiloalveolar carcinoma ( BAC )"}, {"type": "subject disorder", "offset": [6, 7], "text": "lung cancer"}, {"type": "subject disorder", "offset": [10, 11, 12, 13, 14], "text": "bronquiloalveolar carcinoma ( BAC )"}, {"type": "treatment", "offset": [19, 20, 21, 22, 23], "text": "chemotherapy with docetaxel and gemcitabine"}, {"type": "drug", "offset": [21], "text": "docetaxel"}, {"type": "drug", "offset": [23], "text": "gemcitabine"}, {"type": "route", "offset": [19], "text": "chemotherapy"}, {"type": "treatment disorder", "offset": [6, 7], "text": "lung cancer"}, {"type": "treatment disorder", "offset": [10, 11, 12, 13, 14], "text": "bronquiloalveolar carcinoma ( BAC )"}, {"type": "combination drug", "offset": [21], "text": "docetaxel"}, {"type": "combination drug", "offset": [23], "text": "gemcitabine"}, {"type": "effect", "offset": [24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35], "text": "producing severe respiratory insufficiency , and simulating a progression of the tumor"}, {"type": "effect", "offset": [17], "text": "BOOP"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "lung cancer patient with bronquiloalveolar carcinoma ( BAC )"], ["subject disorder", "lung cancer"], ["subject disorder", "bronquiloalveolar carcinoma ( BAC )"], ["treatment", "chemotherapy with docetaxel and gemcitabine"], ["drug", "docetaxel"], ["drug", "gemcitabine"], ["route", "chemotherapy"], ["treatment disorder", "lung cancer"], ["treatment disorder", "bronquiloalveolar carcinoma ( BAC )"], ["combination drug", "docetaxel"], ["combination drug", "gemcitabine"], ["effect", "producing severe respiratory insufficiency , and simulating a progression of the tumor"], ["effect", "BOOP"]]}]}
{"text_id": "21045170_11", "text": "Caution should be used when coadministering enfuvirtide and niacin to HIV - infected patients .", "tokens": ["Caution", "should", "be", "used", "when", "coadministering", "enfuvirtide", "and", "niacin", "to", "HIV", "-", "infected", "patients", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> used <extra_id_0> subject <extra_id_5> HIV - infected patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> treatment <extra_id_5> coadministering enfuvirtide and niacin <extra_id_1> <extra_id_0> drug <extra_id_5> enfuvirtide <extra_id_1> <extra_id_0> drug <extra_id_5> niacin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> combination drug <extra_id_5> enfuvirtide <extra_id_1> <extra_id_0> combination drug <extra_id_5> niacin <extra_id_1> <extra_id_0> effect <extra_id_5> Caution <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "used", "args": [{"type": "subject", "offset": [10, 11, 12, 13], "text": "HIV - infected patients"}, {"type": "subject disorder", "offset": [10], "text": "HIV"}, {"type": "treatment", "offset": [5, 6, 7, 8], "text": "coadministering enfuvirtide and niacin"}, {"type": "drug", "offset": [6], "text": "enfuvirtide"}, {"type": "drug", "offset": [8], "text": "niacin"}, {"type": "treatment disorder", "offset": [10], "text": "HIV"}, {"type": "combination drug", "offset": [6], "text": "enfuvirtide"}, {"type": "combination drug", "offset": [8], "text": "niacin"}, {"type": "effect", "offset": [0], "text": "Caution"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "used", "label": "adverse event", "asoc": [["subject", "HIV - infected patients"], ["subject disorder", "HIV"], ["treatment", "coadministering enfuvirtide and niacin"], ["drug", "enfuvirtide"], ["drug", "niacin"], ["treatment disorder", "HIV"], ["combination drug", "enfuvirtide"], ["combination drug", "niacin"], ["effect", "Caution"]]}]}
{"text_id": "19145124_3", "text": "Two patients who developed decreased visual acuity after several months of ethambutol treatment for Mycobacterium avium - intracellulare infection had bitemporal visual field defects that suggested optic chiasm damage .", "tokens": ["Two", "patients", "who", "developed", "decreased", "visual", "acuity", "after", "several", "months", "of", "ethambutol", "treatment", "for", "Mycobacterium", "avium", "-", "intracellulare", "infection", "had", "bitemporal", "visual", "field", "defects", "that", "suggested", "optic", "chiasm", "damage", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> Two patients <extra_id_1> <extra_id_0> subject <extra_id_5> Mycobacterium avium - intracellulare infection <extra_id_1> <extra_id_0> population <extra_id_5> Two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Mycobacterium avium - intracellulare infection <extra_id_1> <extra_id_0> treatment <extra_id_5> ethambutol <extra_id_1> <extra_id_0> drug <extra_id_5> ethambutol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Mycobacterium avium - intracellulare infection <extra_id_1> <extra_id_0> effect <extra_id_5> decreased visual acuity <extra_id_1> <extra_id_0> effect <extra_id_5> bitemporal visual field defects <extra_id_1> <extra_id_0> effect <extra_id_5> optic chiasm damage <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "after", "args": [{"type": "subject", "offset": [0, 1], "text": "Two patients"}, {"type": "subject", "offset": [14, 15, 16, 17, 18], "text": "Mycobacterium avium - intracellulare infection"}, {"type": "population", "offset": [0], "text": "Two"}, {"type": "subject disorder", "offset": [14, 15, 16, 17, 18], "text": "Mycobacterium avium - intracellulare infection"}, {"type": "treatment", "offset": [11], "text": "ethambutol"}, {"type": "drug", "offset": [11], "text": "ethambutol"}, {"type": "treatment disorder", "offset": [14, 15, 16, 17, 18], "text": "Mycobacterium avium - intracellulare infection"}, {"type": "effect", "offset": [4, 5, 6], "text": "decreased visual acuity"}, {"type": "effect", "offset": [20, 21, 22, 23], "text": "bitemporal visual field defects"}, {"type": "effect", "offset": [26, 27, 28], "text": "optic chiasm damage"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "Two patients"], ["subject", "Mycobacterium avium - intracellulare infection"], ["population", "Two"], ["subject disorder", "Mycobacterium avium - intracellulare infection"], ["treatment", "ethambutol"], ["drug", "ethambutol"], ["treatment disorder", "Mycobacterium avium - intracellulare infection"], ["effect", "decreased visual acuity"], ["effect", "bitemporal visual field defects"], ["effect", "optic chiasm damage"]]}]}
{"text_id": "8530331_5", "text": "One patient required nursing home placement and a feeding gastrostomy as a result of the worsening parkinsonism during risperidone treatment , but was able to return home and have the gastrostomy removed after switching from risperidone to clozapine .", "tokens": ["One", "patient", "required", "nursing", "home", "placement", "and", "a", "feeding", "gastrostomy", "as", "a", "result", "of", "the", "worsening", "parkinsonism", "during", "risperidone", "treatment", ",", "but", "was", "able", "to", "return", "home", "and", "have", "the", "gastrostomy", "removed", "after", "switching", "from", "risperidone", "to", "clozapine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treatment <extra_id_0> subject <extra_id_5> One patient <extra_id_1> <extra_id_0> population <extra_id_5> One <extra_id_1> <extra_id_0> treatment <extra_id_5> risperidone <extra_id_1> <extra_id_0> drug <extra_id_5> risperidone <extra_id_1> <extra_id_0> effect <extra_id_5> required nursing home placement and a feeding gastrostomy as a result of the worsening parkinsonism <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> after <extra_id_0> subject <extra_id_5> One patient <extra_id_1> <extra_id_0> population <extra_id_5> One <extra_id_1> <extra_id_0> subject disorder <extra_id_5> worsening parkinsonism <extra_id_1> <extra_id_0> treatment <extra_id_5> switching from risperidone to clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> risperidone <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> worsening parkinsonism <extra_id_1> <extra_id_0> effect <extra_id_5> was able to return home and have the gastrostomy removed <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "treatment", "args": [{"type": "subject", "offset": [0, 1], "text": "One patient"}, {"type": "population", "offset": [0], "text": "One"}, {"type": "treatment", "offset": [18], "text": "risperidone"}, {"type": "drug", "offset": [18], "text": "risperidone"}, {"type": "effect", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16], "text": "required nursing home placement and a feeding gastrostomy as a result of the worsening parkinsonism"}]}, {"type": "potential therapeutic event", "offset": [32], "text": "after", "args": [{"type": "subject", "offset": [0, 1], "text": "One patient"}, {"type": "population", "offset": [0], "text": "One"}, {"type": "subject disorder", "offset": [15, 16], "text": "worsening parkinsonism"}, {"type": "treatment", "offset": [33, 34, 35, 36, 37], "text": "switching from risperidone to clozapine"}, {"type": "drug", "offset": [35], "text": "risperidone"}, {"type": "drug", "offset": [37], "text": "clozapine"}, {"type": "treatment disorder", "offset": [15, 16], "text": "worsening parkinsonism"}, {"type": "effect", "offset": [22, 23, 24, 25, 26, 27, 28, 29, 30, 31], "text": "was able to return home and have the gastrostomy removed"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treatment", "label": "adverse event", "asoc": [["subject", "One patient"], ["population", "One"], ["treatment", "risperidone"], ["drug", "risperidone"], ["effect", "required nursing home placement and a feeding gastrostomy as a result of the worsening parkinsonism"]]}, {"span": "after", "label": "potential therapeutic event", "asoc": [["subject", "One patient"], ["population", "One"], ["subject disorder", "worsening parkinsonism"], ["treatment", "switching from risperidone to clozapine"], ["drug", "risperidone"], ["drug", "clozapine"], ["treatment disorder", "worsening parkinsonism"], ["effect", "was able to return home and have the gastrostomy removed"]]}]}
{"text_id": "12221670_5", "text": "When the data of the 57 patients are evaluated , a reversible direct cytotoxic effect of ticlopidine on the pluripotent / bipotent hematopoietic progenitor stem cell is proposed .", "tokens": ["When", "the", "data", "of", "the", "57", "patients", "are", "evaluated", ",", "a", "reversible", "direct", "cytotoxic", "effect", "of", "ticlopidine", "on", "the", "pluripotent", "/", "bipotent", "hematopoietic", "progenitor", "stem", "cell", "is", "proposed", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> proposed <extra_id_0> subject <extra_id_5> 57 patients <extra_id_1> <extra_id_0> population <extra_id_5> 57 <extra_id_1> <extra_id_0> treatment <extra_id_5> ticlopidine <extra_id_1> <extra_id_0> drug <extra_id_5> ticlopidine <extra_id_1> <extra_id_0> effect <extra_id_5> cytotoxic effect <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [27], "text": "proposed", "args": [{"type": "subject", "offset": [5, 6], "text": "57 patients"}, {"type": "population", "offset": [5], "text": "57"}, {"type": "treatment", "offset": [16], "text": "ticlopidine"}, {"type": "drug", "offset": [16], "text": "ticlopidine"}, {"type": "effect", "offset": [13, 14], "text": "cytotoxic effect"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "proposed", "label": "adverse event", "asoc": [["subject", "57 patients"], ["population", "57"], ["treatment", "ticlopidine"], ["drug", "ticlopidine"], ["effect", "cytotoxic effect"]]}]}
{"text_id": "15307435_1", "text": "Case report : life - threatening hypoglycaemia associated with sulfadoxine - pyrimethamine , a commonly used antimalarial drug .", "tokens": ["Case", "report", ":", "life", "-", "threatening", "hypoglycaemia", "associated", "with", "sulfadoxine", "-", "pyrimethamine", ",", "a", "commonly", "used", "antimalarial", "drug", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> Case <extra_id_1> <extra_id_0> treatment <extra_id_5> sulfadoxine - pyrimethamine <extra_id_1> <extra_id_0> drug <extra_id_5> sulfadoxine - pyrimethamine <extra_id_1> <extra_id_0> effect <extra_id_5> life - threatening hypoglycaemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "associated", "args": [{"type": "subject", "offset": [0], "text": "Case"}, {"type": "treatment", "offset": [9, 10, 11], "text": "sulfadoxine - pyrimethamine"}, {"type": "drug", "offset": [9, 10, 11], "text": "sulfadoxine - pyrimethamine"}, {"type": "effect", "offset": [3, 4, 5, 6], "text": "life - threatening hypoglycaemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "Case"], ["treatment", "sulfadoxine - pyrimethamine"], ["drug", "sulfadoxine - pyrimethamine"], ["effect", "life - threatening hypoglycaemia"]]}]}
{"text_id": "9232614_2", "text": "Tamoxifen is suggested to be carcinogenic both through direct genotoxic and epigenetic mechanisms .", "tokens": ["Tamoxifen", "is", "suggested", "to", "be", "carcinogenic", "both", "through", "direct", "genotoxic", "and", "epigenetic", "mechanisms", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> suggested <extra_id_0> treatment <extra_id_5> Tamoxifen <extra_id_1> <extra_id_0> drug <extra_id_5> Tamoxifen <extra_id_1> <extra_id_0> effect <extra_id_5> carcinogenic both through direct genotoxic and epigenetic mechanisms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "suggested", "args": [{"type": "treatment", "offset": [0], "text": "Tamoxifen"}, {"type": "drug", "offset": [0], "text": "Tamoxifen"}, {"type": "effect", "offset": [5, 6, 7, 8, 9, 10, 11, 12], "text": "carcinogenic both through direct genotoxic and epigenetic mechanisms"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "suggested", "label": "adverse event", "asoc": [["treatment", "Tamoxifen"], ["drug", "Tamoxifen"], ["effect", "carcinogenic both through direct genotoxic and epigenetic mechanisms"]]}]}
{"text_id": "16480245_1", "text": "METHOD : We describe two patients who presented with diabetic ketoacidosis after treatment with quetiapine and risperidone , respectively .", "tokens": ["METHOD", ":", "We", "describe", "two", "patients", "who", "presented", "with", "diabetic", "ketoacidosis", "after", "treatment", "with", "quetiapine", "and", "risperidone", ",", "respectively", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> presented <extra_id_0> subject <extra_id_5> two patients <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> treatment <extra_id_5> quetiapine and risperidone <extra_id_1> <extra_id_0> drug <extra_id_5> quetiapine <extra_id_1> <extra_id_0> drug <extra_id_5> risperidone <extra_id_1> <extra_id_0> effect <extra_id_5> diabetic ketoacidosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "presented", "args": [{"type": "subject", "offset": [4, 5], "text": "two patients"}, {"type": "population", "offset": [4], "text": "two"}, {"type": "treatment", "offset": [14, 15, 16], "text": "quetiapine and risperidone"}, {"type": "drug", "offset": [14], "text": "quetiapine"}, {"type": "drug", "offset": [16], "text": "risperidone"}, {"type": "effect", "offset": [9, 10], "text": "diabetic ketoacidosis"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "presented", "label": "adverse event", "asoc": [["subject", "two patients"], ["population", "two"], ["treatment", "quetiapine and risperidone"], ["drug", "quetiapine"], ["drug", "risperidone"], ["effect", "diabetic ketoacidosis"]]}]}
{"text_id": "20190474_3", "text": "The current report describes a man who was prescribed zonisamide for epilepsy and subsequently developed widespread skin rash , acute kidney injury , high - grade fever , eosinophilia , liver dysfunction , lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer .", "tokens": ["The", "current", "report", "describes", "a", "man", "who", "was", "prescribed", "zonisamide", "for", "epilepsy", "and", "subsequently", "developed", "widespread", "skin", "rash", ",", "acute", "kidney", "injury", ",", "high", "-", "grade", "fever", ",", "eosinophilia", ",", "liver", "dysfunction", ",", "lymphadenopathy", "and", "an", "increase", "in", "antihuman", "herpesvirus", "-", "6", "immunoglobulin", "G", "titer", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a man <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> epilepsy <extra_id_1> <extra_id_0> treatment <extra_id_5> zonisamide for epilepsy <extra_id_1> <extra_id_0> drug <extra_id_5> zonisamide <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> epilepsy <extra_id_1> <extra_id_0> effect <extra_id_5> widespread skin rash , acute kidney injury , high - grade fever , eosinophilia , liver dysfunction , lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "developed", "args": [{"type": "subject", "offset": [4, 5], "text": "a man"}, {"type": "gender", "offset": [5], "text": "man"}, {"type": "subject disorder", "offset": [11], "text": "epilepsy"}, {"type": "treatment", "offset": [9, 10, 11], "text": "zonisamide for epilepsy"}, {"type": "drug", "offset": [9], "text": "zonisamide"}, {"type": "treatment disorder", "offset": [11], "text": "epilepsy"}, {"type": "effect", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44], "text": "widespread skin rash , acute kidney injury , high - grade fever , eosinophilia , liver dysfunction , lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a man"], ["gender", "man"], ["subject disorder", "epilepsy"], ["treatment", "zonisamide for epilepsy"], ["drug", "zonisamide"], ["treatment disorder", "epilepsy"], ["effect", "widespread skin rash , acute kidney injury , high - grade fever , eosinophilia , liver dysfunction , lymphadenopathy and an increase in antihuman herpesvirus - 6 immunoglobulin G titer"]]}]}
{"text_id": "18176653_2", "text": "AIM : The aim of this article is to present the clinical characteristics and management of an oral adverse effect stemming from the use of the antiretroviral medication Nevirapine ( NVP ) .", "tokens": ["AIM", ":", "The", "aim", "of", "this", "article", "is", "to", "present", "the", "clinical", "characteristics", "and", "management", "of", "an", "oral", "adverse", "effect", "stemming", "from", "the", "use", "of", "the", "antiretroviral", "medication", "Nevirapine", "(", "NVP", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> from <extra_id_0> treatment <extra_id_5> antiretroviral medication Nevirapine ( NVP ) <extra_id_1> <extra_id_0> drug <extra_id_5> Nevirapine <extra_id_1> <extra_id_0> effect <extra_id_5> adverse effect <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [21], "text": "from", "args": [{"type": "treatment", "offset": [26, 27, 28, 29, 30, 31], "text": "antiretroviral medication Nevirapine ( NVP )"}, {"type": "drug", "offset": [28], "text": "Nevirapine"}, {"type": "effect", "offset": [18, 19], "text": "adverse effect"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "from", "label": "adverse event", "asoc": [["treatment", "antiretroviral medication Nevirapine ( NVP )"], ["drug", "Nevirapine"], ["effect", "adverse effect"]]}]}
{"text_id": "7787496_2", "text": "We present a case of sotalol - induced bradycardia reversed by glucagon .", "tokens": ["We", "present", "a", "case", "of", "sotalol", "-", "induced", "bradycardia", "reversed", "by", "glucagon", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a case <extra_id_1> <extra_id_0> treatment <extra_id_5> sotalol <extra_id_1> <extra_id_0> drug <extra_id_5> sotalol <extra_id_1> <extra_id_0> effect <extra_id_5> bradycardia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "induced", "args": [{"type": "subject", "offset": [2, 3], "text": "a case"}, {"type": "treatment", "offset": [5], "text": "sotalol"}, {"type": "drug", "offset": [5], "text": "sotalol"}, {"type": "effect", "offset": [8], "text": "bradycardia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a case"], ["treatment", "sotalol"], ["drug", "sotalol"], ["effect", "bradycardia"]]}]}
{"text_id": "18607107_4", "text": "She had been on Copaxone 20 mg / day treatment for 2 years when she first exhibited gastrointestinal symptoms .", "tokens": ["She", "had", "been", "on", "Copaxone", "20", "mg", "/", "day", "treatment", "for", "2", "years", "when", "she", "first", "exhibited", "gastrointestinal", "symptoms", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> exhibited <extra_id_0> subject <extra_id_5> she <extra_id_1> <extra_id_0> gender <extra_id_5> she <extra_id_1> <extra_id_0> treatment <extra_id_5> Copaxone 20 mg / day treatment for 2 years <extra_id_1> <extra_id_0> drug <extra_id_5> Copaxone <extra_id_1> <extra_id_0> dosage <extra_id_5> 20 mg / day <extra_id_1> <extra_id_0> duration <extra_id_5> 2 years <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 2 years <extra_id_1> <extra_id_0> effect <extra_id_5> gastrointestinal symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "exhibited", "args": [{"type": "subject", "offset": [14], "text": "she"}, {"type": "gender", "offset": [14], "text": "she"}, {"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12], "text": "Copaxone 20 mg / day treatment for 2 years"}, {"type": "drug", "offset": [4], "text": "Copaxone"}, {"type": "dosage", "offset": [5, 6, 7, 8], "text": "20 mg / day"}, {"type": "duration", "offset": [11, 12], "text": "2 years"}, {"type": "time elapsed", "offset": [11, 12], "text": "2 years"}, {"type": "effect", "offset": [17, 18], "text": "gastrointestinal symptoms"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "duration", "effect", "subject", "drug", "gender", "dosage", "treatment"], "spot_asoc": [{"span": "exhibited", "label": "adverse event", "asoc": [["subject", "she"], ["gender", "she"], ["treatment", "Copaxone 20 mg / day treatment for 2 years"], ["drug", "Copaxone"], ["dosage", "20 mg / day"], ["duration", "2 years"], ["time elapsed", "2 years"], ["effect", "gastrointestinal symptoms"]]}]}
{"text_id": "19540093_1", "text": "According to the Naranjo adverse drug reaction probability scale , tigecycline was the probable cause of her acute pancreatitis .", "tokens": ["According", "to", "the", "Naranjo", "adverse", "drug", "reaction", "probability", "scale", ",", "tigecycline", "was", "the", "probable", "cause", "of", "her", "acute", "pancreatitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> tigecycline <extra_id_1> <extra_id_0> drug <extra_id_5> tigecycline <extra_id_1> <extra_id_0> effect <extra_id_5> acute pancreatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "cause", "args": [{"type": "treatment", "offset": [10], "text": "tigecycline"}, {"type": "drug", "offset": [10], "text": "tigecycline"}, {"type": "effect", "offset": [17, 18], "text": "acute pancreatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "tigecycline"], ["drug", "tigecycline"], ["effect", "acute pancreatitis"]]}]}
{"text_id": "22233409_5", "text": "The adverse events related to ribavirin and drug - drug interactions during therapy for hepatitis C are discussed .", "tokens": ["The", "adverse", "events", "related", "to", "ribavirin", "and", "drug", "-", "drug", "interactions", "during", "therapy", "for", "hepatitis", "C", "are", "discussed", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> treatment <extra_id_5> ribavirin <extra_id_1> <extra_id_0> drug <extra_id_5> ribavirin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hepatitis C <extra_id_1> <extra_id_0> effect <extra_id_5> adverse events <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "related", "args": [{"type": "treatment", "offset": [5], "text": "ribavirin"}, {"type": "drug", "offset": [5], "text": "ribavirin"}, {"type": "treatment disorder", "offset": [14, 15], "text": "hepatitis C"}, {"type": "effect", "offset": [1, 2], "text": "adverse events"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["treatment", "ribavirin"], ["drug", "ribavirin"], ["treatment disorder", "hepatitis C"], ["effect", "adverse events"]]}]}
{"text_id": "9892272_3", "text": "The authors report a case of a patient who received alteplase for acute myocardial infarction and developed spontaneous subfascial hematoma without any evidence of direct trauma .", "tokens": ["The", "authors", "report", "a", "case", "of", "a", "patient", "who", "received", "alteplase", "for", "acute", "myocardial", "infarction", "and", "developed", "spontaneous", "subfascial", "hematoma", "without", "any", "evidence", "of", "direct", "trauma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a case of a patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute myocardial infarction <extra_id_1> <extra_id_0> treatment <extra_id_5> alteplase <extra_id_1> <extra_id_0> drug <extra_id_5> alteplase <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute myocardial infarction <extra_id_1> <extra_id_0> effect <extra_id_5> spontaneous subfascial hematoma without any evidence of direct trauma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7], "text": "a case of a patient"}, {"type": "subject disorder", "offset": [12, 13, 14], "text": "acute myocardial infarction"}, {"type": "treatment", "offset": [10], "text": "alteplase"}, {"type": "drug", "offset": [10], "text": "alteplase"}, {"type": "treatment disorder", "offset": [12, 13, 14], "text": "acute myocardial infarction"}, {"type": "effect", "offset": [17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "spontaneous subfascial hematoma without any evidence of direct trauma"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a case of a patient"], ["subject disorder", "acute myocardial infarction"], ["treatment", "alteplase"], ["drug", "alteplase"], ["treatment disorder", "acute myocardial infarction"], ["effect", "spontaneous subfascial hematoma without any evidence of direct trauma"]]}]}
{"text_id": "18821094_1", "text": "Oxcarbazepine - induced Drug Reaction with Eosinophilia and Systemic Symptoms ( DRESS ) .", "tokens": ["Oxcarbazepine", "-", "induced", "Drug", "Reaction", "with", "Eosinophilia", "and", "Systemic", "Symptoms", "(", "DRESS", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Oxcarbazepine <extra_id_1> <extra_id_0> drug <extra_id_5> Oxcarbazepine <extra_id_1> <extra_id_0> effect <extra_id_5> Eosinophilia and Systemic Symptoms ( DRESS ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Oxcarbazepine"}, {"type": "drug", "offset": [0], "text": "Oxcarbazepine"}, {"type": "effect", "offset": [6, 7, 8, 9, 10, 11, 12], "text": "Eosinophilia and Systemic Symptoms ( DRESS )"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Oxcarbazepine"], ["drug", "Oxcarbazepine"], ["effect", "Eosinophilia and Systemic Symptoms ( DRESS )"]]}]}
{"text_id": "3405528_1", "text": "A case of halothane induced hepatitis is reported in a middle aged woman who underwent gastric surgery for morbid obesity .", "tokens": ["A", "case", "of", "halothane", "induced", "hepatitis", "is", "reported", "in", "a", "middle", "aged", "woman", "who", "underwent", "gastric", "surgery", "for", "morbid", "obesity", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a middle aged woman <extra_id_1> <extra_id_0> age <extra_id_5> middle aged <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> morbid obesity <extra_id_1> <extra_id_0> treatment <extra_id_5> halothane <extra_id_1> <extra_id_0> treatment <extra_id_5> gastric surgery for morbid obesity <extra_id_1> <extra_id_0> drug <extra_id_5> halothane <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> morbid obesity <extra_id_1> <extra_id_0> effect <extra_id_5> hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "induced", "args": [{"type": "subject", "offset": [9, 10, 11, 12], "text": "a middle aged woman"}, {"type": "age", "offset": [10, 11], "text": "middle aged"}, {"type": "gender", "offset": [12], "text": "woman"}, {"type": "subject disorder", "offset": [18, 19], "text": "morbid obesity"}, {"type": "treatment", "offset": [3], "text": "halothane"}, {"type": "treatment", "offset": [15, 16, 17, 18, 19], "text": "gastric surgery for morbid obesity"}, {"type": "drug", "offset": [3], "text": "halothane"}, {"type": "treatment disorder", "offset": [18, 19], "text": "morbid obesity"}, {"type": "effect", "offset": [5], "text": "hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a middle aged woman"], ["age", "middle aged"], ["gender", "woman"], ["subject disorder", "morbid obesity"], ["treatment", "halothane"], ["treatment", "gastric surgery for morbid obesity"], ["drug", "halothane"], ["treatment disorder", "morbid obesity"], ["effect", "hepatitis"]]}]}
{"text_id": "12860350_2", "text": "We describe a premenopausal woman who , while having tamoxifen due to a diagnosis of in situ ductal carcinoma , developed endometriosis requiring surgery .", "tokens": ["We", "describe", "a", "premenopausal", "woman", "who", ",", "while", "having", "tamoxifen", "due", "to", "a", "diagnosis", "of", "in", "situ", "ductal", "carcinoma", ",", "developed", "endometriosis", "requiring", "surgery", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a premenopausal woman <extra_id_1> <extra_id_0> age <extra_id_5> premenopausal <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> in situ ductal carcinoma <extra_id_1> <extra_id_0> treatment <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> drug <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> in situ ductal carcinoma <extra_id_1> <extra_id_0> effect <extra_id_5> endometriosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "developed", "args": [{"type": "subject", "offset": [2, 3, 4], "text": "a premenopausal woman"}, {"type": "age", "offset": [3], "text": "premenopausal"}, {"type": "gender", "offset": [4], "text": "woman"}, {"type": "subject disorder", "offset": [15, 16, 17, 18], "text": "in situ ductal carcinoma"}, {"type": "treatment", "offset": [9], "text": "tamoxifen"}, {"type": "drug", "offset": [9], "text": "tamoxifen"}, {"type": "treatment disorder", "offset": [15, 16, 17, 18], "text": "in situ ductal carcinoma"}, {"type": "effect", "offset": [21], "text": "endometriosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a premenopausal woman"], ["age", "premenopausal"], ["gender", "woman"], ["subject disorder", "in situ ductal carcinoma"], ["treatment", "tamoxifen"], ["drug", "tamoxifen"], ["treatment disorder", "in situ ductal carcinoma"], ["effect", "endometriosis"]]}]}
{"text_id": "7439122_3", "text": "Physicians should therefore be aware of its occurrence and carefully monitor serum levels of CPK , GOT and GPT during the treatment of diabetes insipidus with clofibrate , especially in patients with associated hypothyroidism , latent or overt , which possibly favors the development of myopathy .", "tokens": ["Physicians", "should", "therefore", "be", "aware", "of", "its", "occurrence", "and", "carefully", "monitor", "serum", "levels", "of", "CPK", ",", "GOT", "and", "GPT", "during", "the", "treatment", "of", "diabetes", "insipidus", "with", "clofibrate", ",", "especially", "in", "patients", "with", "associated", "hypothyroidism", ",", "latent", "or", "overt", ",", "which", "possibly", "favors", "the", "development", "of", "myopathy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> development <extra_id_0> subject <extra_id_5> patients with associated hypothyroidism , latent or overt <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hypothyroidism <extra_id_1> <extra_id_0> subject disorder <extra_id_5> latent <extra_id_1> <extra_id_0> subject disorder <extra_id_5> overt <extra_id_1> <extra_id_0> subject disorder <extra_id_5> diabetes insipidus <extra_id_1> <extra_id_0> treatment <extra_id_5> clofibrate <extra_id_1> <extra_id_0> drug <extra_id_5> clofibrate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> diabetes insipidus <extra_id_1> <extra_id_0> effect <extra_id_5> myopathy . <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [43], "text": "development", "args": [{"type": "subject", "offset": [30, 31, 32, 33, 34, 35, 36, 37], "text": "patients with associated hypothyroidism , latent or overt"}, {"type": "subject disorder", "offset": [33], "text": "hypothyroidism"}, {"type": "subject disorder", "offset": [35], "text": "latent"}, {"type": "subject disorder", "offset": [37], "text": "overt"}, {"type": "subject disorder", "offset": [23, 24], "text": "diabetes insipidus"}, {"type": "treatment", "offset": [26], "text": "clofibrate"}, {"type": "drug", "offset": [26], "text": "clofibrate"}, {"type": "treatment disorder", "offset": [23, 24], "text": "diabetes insipidus"}, {"type": "effect", "offset": [45, 46], "text": "myopathy ."}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "development", "label": "adverse event", "asoc": [["subject", "patients with associated hypothyroidism , latent or overt"], ["subject disorder", "hypothyroidism"], ["subject disorder", "latent"], ["subject disorder", "overt"], ["subject disorder", "diabetes insipidus"], ["treatment", "clofibrate"], ["drug", "clofibrate"], ["treatment disorder", "diabetes insipidus"], ["effect", "myopathy ."]]}]}
{"text_id": "19540093_3", "text": "Pancreatitis has been associated with the tetracycline class of antibiotics and concerns about tigecycline - induced acute pancreatitis have recently been raised .", "tokens": ["Pancreatitis", "has", "been", "associated", "with", "the", "tetracycline", "class", "of", "antibiotics", "and", "concerns", "about", "tigecycline", "-", "induced", "acute", "pancreatitis", "have", "recently", "been", "raised", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> tigecycline <extra_id_1> <extra_id_0> drug <extra_id_5> tigecycline <extra_id_1> <extra_id_0> effect <extra_id_5> acute pancreatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "induced", "args": [{"type": "treatment", "offset": [13], "text": "tigecycline"}, {"type": "drug", "offset": [13], "text": "tigecycline"}, {"type": "effect", "offset": [16, 17], "text": "acute pancreatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "tigecycline"], ["drug", "tigecycline"], ["effect", "acute pancreatitis"]]}]}
{"text_id": "2369419_4", "text": "Upon discontinuation of MTX , her ascites resolved , and her arthritis became more active .", "tokens": ["Upon", "discontinuation", "of", "MTX", ",", "her", "ascites", "resolved", ",", "and", "her", "arthritis", "became", "more", "active", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> resolved <extra_id_0> subject <extra_id_5> her <extra_id_1> <extra_id_0> gender <extra_id_5> her <extra_id_1> <extra_id_0> subject disorder <extra_id_5> arthritis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> ascites <extra_id_1> <extra_id_0> treatment <extra_id_5> discontinuation of MTX <extra_id_1> <extra_id_0> drug <extra_id_5> MTX <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> ascites <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> active <extra_id_0> subject <extra_id_5> her <extra_id_1> <extra_id_0> gender <extra_id_5> her <extra_id_1> <extra_id_0> subject disorder <extra_id_5> arthritis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> ascites <extra_id_1> <extra_id_0> treatment <extra_id_5> discontinuation of MTX <extra_id_1> <extra_id_0> drug <extra_id_5> MTX <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> ascites <extra_id_1> <extra_id_0> effect <extra_id_5> arthritis became more active <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [7], "text": "resolved", "args": [{"type": "subject", "offset": [5], "text": "her"}, {"type": "gender", "offset": [5], "text": "her"}, {"type": "subject disorder", "offset": [11], "text": "arthritis"}, {"type": "subject disorder", "offset": [6], "text": "ascites"}, {"type": "treatment", "offset": [1, 2, 3], "text": "discontinuation of MTX"}, {"type": "drug", "offset": [3], "text": "MTX"}, {"type": "treatment disorder", "offset": [6], "text": "ascites"}]}, {"type": "adverse event", "offset": [14], "text": "active", "args": [{"type": "subject", "offset": [5], "text": "her"}, {"type": "gender", "offset": [5], "text": "her"}, {"type": "subject disorder", "offset": [11], "text": "arthritis"}, {"type": "subject disorder", "offset": [6], "text": "ascites"}, {"type": "treatment", "offset": [1, 2, 3], "text": "discontinuation of MTX"}, {"type": "drug", "offset": [3], "text": "MTX"}, {"type": "treatment disorder", "offset": [6], "text": "ascites"}, {"type": "effect", "offset": [11, 12, 13, 14], "text": "arthritis became more active"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "resolved", "label": "potential therapeutic event", "asoc": [["subject", "her"], ["gender", "her"], ["subject disorder", "arthritis"], ["subject disorder", "ascites"], ["treatment", "discontinuation of MTX"], ["drug", "MTX"], ["treatment disorder", "ascites"]]}, {"span": "active", "label": "adverse event", "asoc": [["subject", "her"], ["gender", "her"], ["subject disorder", "arthritis"], ["subject disorder", "ascites"], ["treatment", "discontinuation of MTX"], ["drug", "MTX"], ["treatment disorder", "ascites"], ["effect", "arthritis became more active"]]}]}
{"text_id": "1536494_1", "text": "Aminophylline hypersensitivity apparently due to ethylenediamine .", "tokens": ["Aminophylline", "hypersensitivity", "apparently", "due", "to", "ethylenediamine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> treatment <extra_id_5> ethylenediamine <extra_id_1> <extra_id_0> drug <extra_id_5> ethylenediamine <extra_id_1> <extra_id_0> effect <extra_id_5> Aminophylline hypersensitivity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "due", "args": [{"type": "treatment", "offset": [5], "text": "ethylenediamine"}, {"type": "drug", "offset": [5], "text": "ethylenediamine"}, {"type": "effect", "offset": [0, 1], "text": "Aminophylline hypersensitivity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["treatment", "ethylenediamine"], ["drug", "ethylenediamine"], ["effect", "Aminophylline hypersensitivity"]]}]}
{"text_id": "20456080_4", "text": "Corticosteroid injections are commonly used as effective treatments for a variety of pain disorders .", "tokens": ["Corticosteroid", "injections", "are", "commonly", "used", "as", "effective", "treatments", "for", "a", "variety", "of", "pain", "disorders", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatments <extra_id_0> treatment <extra_id_5> Corticosteroid injections <extra_id_1> <extra_id_0> drug <extra_id_5> Corticosteroid <extra_id_1> <extra_id_0> route <extra_id_5> injections <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> pain disorders <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [7], "text": "treatments", "args": [{"type": "treatment", "offset": [0, 1], "text": "Corticosteroid injections"}, {"type": "drug", "offset": [0], "text": "Corticosteroid"}, {"type": "route", "offset": [1], "text": "injections"}, {"type": "treatment disorder", "offset": [12, 13], "text": "pain disorders"}]}], "spot": ["potential therapeutic event"], "asoc": ["route", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatments", "label": "potential therapeutic event", "asoc": [["treatment", "Corticosteroid injections"], ["drug", "Corticosteroid"], ["route", "injections"], ["treatment disorder", "pain disorders"]]}]}
{"text_id": "1504404_1", "text": "Central nervous system effects secondary to ciprofloxacin treatment are uncommon and usually consist only of minor dizziness or mild headache , although rare occurrences of seizures and hallucinations have been reported .", "tokens": ["Central", "nervous", "system", "effects", "secondary", "to", "ciprofloxacin", "treatment", "are", "uncommon", "and", "usually", "consist", "only", "of", "minor", "dizziness", "or", "mild", "headache", ",", "although", "rare", "occurrences", "of", "seizures", "and", "hallucinations", "have", "been", "reported", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> consist <extra_id_0> treatment <extra_id_5> secondary to ciprofloxacin treatment <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> minor dizziness or mild headache , although rare occurrences of seizures and hallucinations <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "consist", "args": [{"type": "treatment", "offset": [4, 5, 6, 7], "text": "secondary to ciprofloxacin treatment"}, {"type": "drug", "offset": [6], "text": "ciprofloxacin"}, {"type": "effect", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27], "text": "minor dizziness or mild headache , although rare occurrences of seizures and hallucinations"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "consist", "label": "adverse event", "asoc": [["treatment", "secondary to ciprofloxacin treatment"], ["drug", "ciprofloxacin"], ["effect", "minor dizziness or mild headache , although rare occurrences of seizures and hallucinations"]]}]}
{"text_id": "17655376_2", "text": "Oral dapsone has been available for over 60 years and has been used to treat severe acne vulgaris ; however , the oral formulation is known to cause dose - dependent haematological reactions and is currently indicated only for diseases such as dermatitis herpetiformis and Hansen 's disease .", "tokens": ["Oral", "dapsone", "has", "been", "available", "for", "over", "60", "years", "and", "has", "been", "used", "to", "treat", "severe", "acne", "vulgaris", ";", "however", ",", "the", "oral", "formulation", "is", "known", "to", "cause", "dose", "-", "dependent", "haematological", "reactions", "and", "is", "currently", "indicated", "only", "for", "diseases", "such", "as", "dermatitis", "herpetiformis", "and", "Hansen", "'s", "disease", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> Oral dapsone <extra_id_1> <extra_id_0> drug <extra_id_5> dapsone <extra_id_1> <extra_id_0> route <extra_id_5> Oral <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> dermatitis herpetiformis <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Hansen 's disease <extra_id_1> <extra_id_0> effect <extra_id_5> dose - dependent haematological reactions <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [27], "text": "cause", "args": [{"type": "treatment", "offset": [0, 1], "text": "Oral dapsone"}, {"type": "drug", "offset": [1], "text": "dapsone"}, {"type": "route", "offset": [0], "text": "Oral"}, {"type": "treatment disorder", "offset": [42, 43], "text": "dermatitis herpetiformis"}, {"type": "treatment disorder", "offset": [45, 46, 47], "text": "Hansen 's disease"}, {"type": "effect", "offset": [28, 29, 30, 31, 32], "text": "dose - dependent haematological reactions"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "treatment", "treatment disorder"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "Oral dapsone"], ["drug", "dapsone"], ["route", "Oral"], ["treatment disorder", "dermatitis herpetiformis"], ["treatment disorder", "Hansen 's disease"], ["effect", "dose - dependent haematological reactions"]]}]}
{"text_id": "21751692_4", "text": "EA signs were observed in all 7 patients in association with propofol TIVA but did not recur in any of 123 subsequent anesthetics sessions during which low - dose ketamine was added to propofol .", "tokens": ["EA", "signs", "were", "observed", "in", "all", "7", "patients", "in", "association", "with", "propofol", "TIVA", "but", "did", "not", "recur", "in", "any", "of", "123", "subsequent", "anesthetics", "sessions", "during", "which", "low", "-", "dose", "ketamine", "was", "added", "to", "propofol", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> observed <extra_id_0> subject <extra_id_5> all 7 patients <extra_id_1> <extra_id_0> population <extra_id_5> 7 <extra_id_1> <extra_id_0> treatment <extra_id_5> propofol TIVA <extra_id_1> <extra_id_0> treatment <extra_id_5> low - dose ketamine was added to propofol <extra_id_1> <extra_id_0> drug <extra_id_5> propofol <extra_id_1> <extra_id_0> drug <extra_id_5> ketamine <extra_id_1> <extra_id_0> drug <extra_id_5> propofol <extra_id_1> <extra_id_0> dosage <extra_id_5> low - dose <extra_id_1> <extra_id_0> route <extra_id_5> TIVA <extra_id_1> <extra_id_0> combination drug <extra_id_5> propofol <extra_id_1> <extra_id_0> combination drug <extra_id_5> ketamine <extra_id_1> <extra_id_0> effect <extra_id_5> EA signs <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "observed", "args": [{"type": "subject", "offset": [5, 6, 7], "text": "all 7 patients"}, {"type": "population", "offset": [6], "text": "7"}, {"type": "treatment", "offset": [11, 12], "text": "propofol TIVA"}, {"type": "treatment", "offset": [26, 27, 28, 29, 30, 31, 32, 33], "text": "low - dose ketamine was added to propofol"}, {"type": "drug", "offset": [11], "text": "propofol"}, {"type": "drug", "offset": [29], "text": "ketamine"}, {"type": "drug", "offset": [33], "text": "propofol"}, {"type": "dosage", "offset": [26, 27, 28], "text": "low - dose"}, {"type": "route", "offset": [12], "text": "TIVA"}, {"type": "combination drug", "offset": [33], "text": "propofol"}, {"type": "combination drug", "offset": [29], "text": "ketamine"}, {"type": "effect", "offset": [0, 1], "text": "EA signs"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "route", "subject", "drug", "dosage", "combination drug", "treatment"], "spot_asoc": [{"span": "observed", "label": "adverse event", "asoc": [["subject", "all 7 patients"], ["population", "7"], ["treatment", "propofol TIVA"], ["treatment", "low - dose ketamine was added to propofol"], ["drug", "propofol"], ["drug", "ketamine"], ["drug", "propofol"], ["dosage", "low - dose"], ["route", "TIVA"], ["combination drug", "propofol"], ["combination drug", "ketamine"], ["effect", "EA signs"]]}]}
{"text_id": "7973922_3", "text": "Systemic disease , most commonly renal dysfunction , preceded all 30 reported cases of acyclovir neurotoxicity .", "tokens": ["Systemic", "disease", ",", "most", "commonly", "renal", "dysfunction", ",", "preceded", "all", "30", "reported", "cases", "of", "acyclovir", "neurotoxicity", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> preceded <extra_id_0> subject <extra_id_5> 30 reported cases <extra_id_1> <extra_id_0> population <extra_id_5> 30 <extra_id_1> <extra_id_0> treatment <extra_id_5> acyclovir <extra_id_1> <extra_id_0> drug <extra_id_5> acyclovir <extra_id_1> <extra_id_0> effect <extra_id_5> Systemic disease , most commonly renal dysfunction <extra_id_1> <extra_id_0> effect <extra_id_5> neurotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "preceded", "args": [{"type": "subject", "offset": [10, 11, 12], "text": "30 reported cases"}, {"type": "population", "offset": [10], "text": "30"}, {"type": "treatment", "offset": [14], "text": "acyclovir"}, {"type": "drug", "offset": [14], "text": "acyclovir"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Systemic disease , most commonly renal dysfunction"}, {"type": "effect", "offset": [15], "text": "neurotoxicity"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "preceded", "label": "adverse event", "asoc": [["subject", "30 reported cases"], ["population", "30"], ["treatment", "acyclovir"], ["drug", "acyclovir"], ["effect", "Systemic disease , most commonly renal dysfunction"], ["effect", "neurotoxicity"]]}]}
{"text_id": "15549981_1", "text": "We present two cases of anaphylaxis under anaesthesia where return of spontaneous circulation was refractory to epinephrine , but occurred following the administration of the alpha - agonist metaraminol .", "tokens": ["We", "present", "two", "cases", "of", "anaphylaxis", "under", "anaesthesia", "where", "return", "of", "spontaneous", "circulation", "was", "refractory", "to", "epinephrine", ",", "but", "occurred", "following", "the", "administration", "of", "the", "alpha", "-", "agonist", "metaraminol", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> occurred <extra_id_0> treatment <extra_id_5> epinephrine <extra_id_1> <extra_id_0> treatment <extra_id_5> administration of the alpha - agonist metaraminol <extra_id_1> <extra_id_0> drug <extra_id_5> metaraminol <extra_id_1> <extra_id_0> drug <extra_id_5> epinephrine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> anaphylaxis under anaesthesia <extra_id_1> <extra_id_0> combination drug <extra_id_5> epinephrine <extra_id_1> <extra_id_0> combination drug <extra_id_5> metaraminol <extra_id_1> <extra_id_0> effect <extra_id_5> return of spontaneous circulation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [19], "text": "occurred", "args": [{"type": "treatment", "offset": [16], "text": "epinephrine"}, {"type": "treatment", "offset": [22, 23, 24, 25, 26, 27, 28], "text": "administration of the alpha - agonist metaraminol"}, {"type": "drug", "offset": [28], "text": "metaraminol"}, {"type": "drug", "offset": [16], "text": "epinephrine"}, {"type": "treatment disorder", "offset": [5, 6, 7], "text": "anaphylaxis under anaesthesia"}, {"type": "combination drug", "offset": [16], "text": "epinephrine"}, {"type": "combination drug", "offset": [28], "text": "metaraminol"}, {"type": "effect", "offset": [9, 10, 11, 12], "text": "return of spontaneous circulation"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "drug", "treatment", "combination drug", "treatment disorder"], "spot_asoc": [{"span": "occurred", "label": "potential therapeutic event", "asoc": [["treatment", "epinephrine"], ["treatment", "administration of the alpha - agonist metaraminol"], ["drug", "metaraminol"], ["drug", "epinephrine"], ["treatment disorder", "anaphylaxis under anaesthesia"], ["combination drug", "epinephrine"], ["combination drug", "metaraminol"], ["effect", "return of spontaneous circulation"]]}]}
{"text_id": "10524732_2", "text": "We report a case of recurrent torsades de pointes following treatment with pentavalent antimonial drugs and amiodarone .", "tokens": ["We", "report", "a", "case", "of", "recurrent", "torsades", "de", "pointes", "following", "treatment", "with", "pentavalent", "antimonial", "drugs", "and", "amiodarone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treatment with <extra_id_0> treatment <extra_id_5> pentavalent antimonial drugs and amiodarone <extra_id_1> <extra_id_0> drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> drug <extra_id_5> pentavalent antimonial drugs <extra_id_1> <extra_id_0> combination drug <extra_id_5> pentavalent antimonial drugs <extra_id_1> <extra_id_0> combination drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> effect <extra_id_5> recurrent torsades de pointes <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10, 11], "text": "treatment with", "args": [{"type": "treatment", "offset": [12, 13, 14, 15, 16], "text": "pentavalent antimonial drugs and amiodarone"}, {"type": "drug", "offset": [16], "text": "amiodarone"}, {"type": "drug", "offset": [12, 13, 14], "text": "pentavalent antimonial drugs"}, {"type": "combination drug", "offset": [12, 13, 14], "text": "pentavalent antimonial drugs"}, {"type": "combination drug", "offset": [16], "text": "amiodarone"}, {"type": "effect", "offset": [5, 6, 7, 8], "text": "recurrent torsades de pointes"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "treatment with", "label": "adverse event", "asoc": [["treatment", "pentavalent antimonial drugs and amiodarone"], ["drug", "amiodarone"], ["drug", "pentavalent antimonial drugs"], ["combination drug", "pentavalent antimonial drugs"], ["combination drug", "amiodarone"], ["effect", "recurrent torsades de pointes"]]}]}
{"text_id": "18801826_5", "text": "This case raises important questions about non - ketotic , hyperosmolar diabetic coma with antipsychotics , the possible association between hyperglycaemia and hyperthermia , and the direction of causality in this , the recognition of either syndrome when they co - exist and management issues in such patients .", "tokens": ["This", "case", "raises", "important", "questions", "about", "non", "-", "ketotic", ",", "hyperosmolar", "diabetic", "coma", "with", "antipsychotics", ",", "the", "possible", "association", "between", "hyperglycaemia", "and", "hyperthermia", ",", "and", "the", "direction", "of", "causality", "in", "this", ",", "the", "recognition", "of", "either", "syndrome", "when", "they", "co", "-", "exist", "and", "management", "issues", "in", "such", "patients", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> association <extra_id_0> treatment <extra_id_5> antipsychotics <extra_id_1> <extra_id_0> drug <extra_id_5> antipsychotics <extra_id_1> <extra_id_0> effect <extra_id_5> non - ketotic , hyperosmolar diabetic coma <extra_id_1> <extra_id_0> effect <extra_id_5> hyperglycaemia and hyperthermia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "association", "args": [{"type": "treatment", "offset": [14], "text": "antipsychotics"}, {"type": "drug", "offset": [14], "text": "antipsychotics"}, {"type": "effect", "offset": [6, 7, 8, 9, 10, 11, 12], "text": "non - ketotic , hyperosmolar diabetic coma"}, {"type": "effect", "offset": [20, 21, 22], "text": "hyperglycaemia and hyperthermia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "association", "label": "adverse event", "asoc": [["treatment", "antipsychotics"], ["drug", "antipsychotics"], ["effect", "non - ketotic , hyperosmolar diabetic coma"], ["effect", "hyperglycaemia and hyperthermia"]]}]}
{"text_id": "8140860_2", "text": "We present the case of a woman undergoing treatment with acenocoumarol for deep vein thrombosis , who maintained an international normalized ratio ( INR ) of between 2.5 and 4 for 2 months .", "tokens": ["We", "present", "the", "case", "of", "a", "woman", "undergoing", "treatment", "with", "acenocoumarol", "for", "deep", "vein", "thrombosis", ",", "who", "maintained", "an", "international", "normalized", "ratio", "(", "INR", ")", "of", "between", "2.5", "and", "4", "for", "2", "months", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> subject <extra_id_5> a woman <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> deep vein thrombosis <extra_id_1> <extra_id_0> treatment <extra_id_5> acenocoumarol <extra_id_1> <extra_id_0> drug <extra_id_5> acenocoumarol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> deep vein thrombosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [8], "text": "treatment", "args": [{"type": "subject", "offset": [5, 6], "text": "a woman"}, {"type": "gender", "offset": [6], "text": "woman"}, {"type": "subject disorder", "offset": [12, 13, 14], "text": "deep vein thrombosis"}, {"type": "treatment", "offset": [10], "text": "acenocoumarol"}, {"type": "drug", "offset": [10], "text": "acenocoumarol"}, {"type": "treatment disorder", "offset": [12, 13, 14], "text": "deep vein thrombosis"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["subject", "a woman"], ["gender", "woman"], ["subject disorder", "deep vein thrombosis"], ["treatment", "acenocoumarol"], ["drug", "acenocoumarol"], ["treatment disorder", "deep vein thrombosis"]]}]}
{"text_id": "10203437_9", "text": "Patients treated with 5 - ASA compounds who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease should be screened to rule out a lupus - like reaction .", "tokens": ["Patients", "treated", "with", "5", "-", "ASA", "compounds", "who", "experience", "acute", "inflammatory", "symptoms", "or", "clinical", "deterioration", "not", "related", "to", "their", "gastrointestinal", "disease", "should", "be", "screened", "to", "rule", "out", "a", "lupus", "-", "like", "reaction", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> experience <extra_id_0> subject <extra_id_5> Patients <extra_id_1> <extra_id_0> subject <extra_id_5> who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease <extra_id_1> <extra_id_0> subject disorder <extra_id_5> gastrointestinal disease <extra_id_1> <extra_id_0> treatment <extra_id_5> 5 - ASA compounds <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - ASA <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> gastrointestinal disease <extra_id_1> <extra_id_0> effect <extra_id_5> lupus - like reaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "experience", "args": [{"type": "subject", "offset": [0], "text": "Patients"}, {"type": "subject", "offset": [7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease"}, {"type": "subject disorder", "offset": [19, 20], "text": "gastrointestinal disease"}, {"type": "treatment", "offset": [3, 4, 5, 6], "text": "5 - ASA compounds"}, {"type": "drug", "offset": [3, 4, 5], "text": "5 - ASA"}, {"type": "treatment disorder", "offset": [19, 20], "text": "gastrointestinal disease"}, {"type": "effect", "offset": [28, 29, 30, 31], "text": "lupus - like reaction"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "experience", "label": "adverse event", "asoc": [["subject", "Patients"], ["subject", "who experience acute inflammatory symptoms or clinical deterioration not related to their gastrointestinal disease"], ["subject disorder", "gastrointestinal disease"], ["treatment", "5 - ASA compounds"], ["drug", "5 - ASA"], ["treatment disorder", "gastrointestinal disease"], ["effect", "lupus - like reaction"]]}]}
{"text_id": "7854541_1", "text": "Cerebral demyelinating disease developed in a patient during adjuvant therapy with levamisole for malignant melanoma .", "tokens": ["Cerebral", "demyelinating", "disease", "developed", "in", "a", "patient", "during", "adjuvant", "therapy", "with", "levamisole", "for", "malignant", "melanoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> malignant melanoma <extra_id_1> <extra_id_0> treatment <extra_id_5> adjuvant therapy with levamisole <extra_id_1> <extra_id_0> drug <extra_id_5> levamisole <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> malignant melanoma <extra_id_1> <extra_id_0> effect <extra_id_5> Cerebral demyelinating disease <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "during", "args": [{"type": "subject", "offset": [5, 6], "text": "a patient"}, {"type": "subject disorder", "offset": [13, 14], "text": "malignant melanoma"}, {"type": "treatment", "offset": [8, 9, 10, 11], "text": "adjuvant therapy with levamisole"}, {"type": "drug", "offset": [11], "text": "levamisole"}, {"type": "treatment disorder", "offset": [13, 14], "text": "malignant melanoma"}, {"type": "effect", "offset": [0, 1, 2], "text": "Cerebral demyelinating disease"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["subject", "a patient"], ["subject disorder", "malignant melanoma"], ["treatment", "adjuvant therapy with levamisole"], ["drug", "levamisole"], ["treatment disorder", "malignant melanoma"], ["effect", "Cerebral demyelinating disease"]]}]}
{"text_id": "18171260_5", "text": "We describe serotonin syndrome after concomitant use of linezolid and meperidine in a 27 - year - old man with acute leukemia .", "tokens": ["We", "describe", "serotonin", "syndrome", "after", "concomitant", "use", "of", "linezolid", "and", "meperidine", "in", "a", "27", "-", "year", "-", "old", "man", "with", "acute", "leukemia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a 27 - year - old man with acute leukemia <extra_id_1> <extra_id_0> age <extra_id_5> 27 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute leukemia <extra_id_1> <extra_id_0> treatment <extra_id_5> concomitant use of linezolid and meperidine <extra_id_1> <extra_id_0> drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> drug <extra_id_5> meperidine <extra_id_1> <extra_id_0> combination drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> combination drug <extra_id_5> meperidine <extra_id_1> <extra_id_0> effect <extra_id_5> serotonin syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "after", "args": [{"type": "subject", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20, 21], "text": "a 27 - year - old man with acute leukemia"}, {"type": "age", "offset": [13, 14, 15, 16, 17], "text": "27 - year - old"}, {"type": "gender", "offset": [18], "text": "man"}, {"type": "subject disorder", "offset": [20, 21], "text": "acute leukemia"}, {"type": "treatment", "offset": [5, 6, 7, 8, 9, 10], "text": "concomitant use of linezolid and meperidine"}, {"type": "drug", "offset": [8], "text": "linezolid"}, {"type": "drug", "offset": [10], "text": "meperidine"}, {"type": "combination drug", "offset": [8], "text": "linezolid"}, {"type": "combination drug", "offset": [10], "text": "meperidine"}, {"type": "effect", "offset": [2, 3], "text": "serotonin syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "gender", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a 27 - year - old man with acute leukemia"], ["age", "27 - year - old"], ["gender", "man"], ["subject disorder", "acute leukemia"], ["treatment", "concomitant use of linezolid and meperidine"], ["drug", "linezolid"], ["drug", "meperidine"], ["combination drug", "linezolid"], ["combination drug", "meperidine"], ["effect", "serotonin syndrome"]]}]}
{"text_id": "15224368_3", "text": "We report a case of Sweet 's syndrome in association with sargramostim treatment following chemotherapy for acute myelogenous leukemia .", "tokens": ["We", "report", "a", "case", "of", "Sweet", "'s", "syndrome", "in", "association", "with", "sargramostim", "treatment", "following", "chemotherapy", "for", "acute", "myelogenous", "leukemia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> association <extra_id_0> treatment <extra_id_5> sargramostim treatment following chemotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> sargramostim <extra_id_1> <extra_id_0> route <extra_id_5> chemotherapy <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute myelogenous leukemia <extra_id_1> <extra_id_0> effect <extra_id_5> Sweet 's syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "association", "args": [{"type": "treatment", "offset": [11, 12, 13, 14], "text": "sargramostim treatment following chemotherapy"}, {"type": "drug", "offset": [11], "text": "sargramostim"}, {"type": "route", "offset": [14], "text": "chemotherapy"}, {"type": "treatment disorder", "offset": [16, 17, 18], "text": "acute myelogenous leukemia"}, {"type": "effect", "offset": [5, 6, 7], "text": "Sweet 's syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "treatment", "treatment disorder"], "spot_asoc": [{"span": "association", "label": "adverse event", "asoc": [["treatment", "sargramostim treatment following chemotherapy"], ["drug", "sargramostim"], ["route", "chemotherapy"], ["treatment disorder", "acute myelogenous leukemia"], ["effect", "Sweet 's syndrome"]]}]}
{"text_id": "1388041_2", "text": "Paroxetine is a selective serotonin reuptake inhibitor possessing anti - depressant activity .", "tokens": ["Paroxetine", "is", "a", "selective", "serotonin", "reuptake", "inhibitor", "possessing", "anti", "-", "depressant", "activity", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> possessing <extra_id_0> treatment <extra_id_5> Paroxetine <extra_id_1> <extra_id_0> drug <extra_id_5> Paroxetine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> anti - depressant activity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [7], "text": "possessing", "args": [{"type": "treatment", "offset": [0], "text": "Paroxetine"}, {"type": "drug", "offset": [0], "text": "Paroxetine"}, {"type": "treatment disorder", "offset": [8, 9, 10, 11], "text": "anti - depressant activity"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "possessing", "label": "potential therapeutic event", "asoc": [["treatment", "Paroxetine"], ["drug", "Paroxetine"], ["treatment disorder", "anti - depressant activity"]]}]}
{"text_id": "19540093_2", "text": "Following 7 days of tigecycline she developed severe abdominal pain and elevated pancreatic enzymes suggesting acute pancreatitis .", "tokens": ["Following", "7", "days", "of", "tigecycline", "she", "developed", "severe", "abdominal", "pain", "and", "elevated", "pancreatic", "enzymes", "suggesting", "acute", "pancreatitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> she <extra_id_1> <extra_id_0> treatment <extra_id_5> 7 days of tigecycline <extra_id_1> <extra_id_0> drug <extra_id_5> tigecycline <extra_id_1> <extra_id_0> duration <extra_id_5> 7 days <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 7 days <extra_id_1> <extra_id_0> effect <extra_id_5> abdominal pain and elevated pancreatic enzymes <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "developed", "args": [{"type": "subject", "offset": [5], "text": "she"}, {"type": "treatment", "offset": [1, 2, 3, 4], "text": "7 days of tigecycline"}, {"type": "drug", "offset": [4], "text": "tigecycline"}, {"type": "duration", "offset": [1, 2], "text": "7 days"}, {"type": "time elapsed", "offset": [1, 2], "text": "7 days"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13], "text": "abdominal pain and elevated pancreatic enzymes"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "subject", "drug", "time elapsed", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "she"], ["treatment", "7 days of tigecycline"], ["drug", "tigecycline"], ["duration", "7 days"], ["time elapsed", "7 days"], ["effect", "abdominal pain and elevated pancreatic enzymes"]]}]}
{"text_id": "6837655_3", "text": "Within 3 weeks of beginning continuous daily isoniazid and rifampin therapy for pulmonary tuberculosis , a patient developed acute renal failure .", "tokens": ["Within", "3", "weeks", "of", "beginning", "continuous", "daily", "isoniazid", "and", "rifampin", "therapy", "for", "pulmonary", "tuberculosis", ",", "a", "patient", "developed", "acute", "renal", "failure", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> pulmonary tuberculosis <extra_id_1> <extra_id_0> treatment <extra_id_5> Within 3 weeks of beginning continuous daily isoniazid and rifampin <extra_id_1> <extra_id_0> drug <extra_id_5> isoniazid <extra_id_1> <extra_id_0> drug <extra_id_5> rifampin <extra_id_1> <extra_id_0> frequency <extra_id_5> daily <extra_id_1> <extra_id_0> duration <extra_id_5> 3 weeks <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 3 weeks <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> pulmonary tuberculosis <extra_id_1> <extra_id_0> combination drug <extra_id_5> isoniazid <extra_id_1> <extra_id_0> combination drug <extra_id_5> rifampin <extra_id_1> <extra_id_0> effect <extra_id_5> acute renal failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "developed", "args": [{"type": "subject", "offset": [15, 16], "text": "a patient"}, {"type": "subject disorder", "offset": [12, 13], "text": "pulmonary tuberculosis"}, {"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9], "text": "Within 3 weeks of beginning continuous daily isoniazid and rifampin"}, {"type": "drug", "offset": [7], "text": "isoniazid"}, {"type": "drug", "offset": [9], "text": "rifampin"}, {"type": "frequency", "offset": [6], "text": "daily"}, {"type": "duration", "offset": [1, 2], "text": "3 weeks"}, {"type": "time elapsed", "offset": [1, 2], "text": "3 weeks"}, {"type": "treatment disorder", "offset": [12, 13], "text": "pulmonary tuberculosis"}, {"type": "combination drug", "offset": [7], "text": "isoniazid"}, {"type": "combination drug", "offset": [9], "text": "rifampin"}, {"type": "effect", "offset": [18, 19, 20], "text": "acute renal failure"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "subject", "treatment", "duration", "frequency", "drug", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a patient"], ["subject disorder", "pulmonary tuberculosis"], ["treatment", "Within 3 weeks of beginning continuous daily isoniazid and rifampin"], ["drug", "isoniazid"], ["drug", "rifampin"], ["frequency", "daily"], ["duration", "3 weeks"], ["time elapsed", "3 weeks"], ["treatment disorder", "pulmonary tuberculosis"], ["combination drug", "isoniazid"], ["combination drug", "rifampin"], ["effect", "acute renal failure"]]}]}
{"text_id": "527355_1", "text": "An insulin - dependent diabetic patient with nephropathy developed severe acidosis after treatment with acetazolamide for glaucoma .", "tokens": ["An", "insulin", "-", "dependent", "diabetic", "patient", "with", "nephropathy", "developed", "severe", "acidosis", "after", "treatment", "with", "acetazolamide", "for", "glaucoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> An insulin - dependent diabetic patient with nephropathy <extra_id_1> <extra_id_0> subject disorder <extra_id_5> diabetic <extra_id_1> <extra_id_0> subject disorder <extra_id_5> nephropathy <extra_id_1> <extra_id_0> subject disorder <extra_id_5> glaucoma <extra_id_1> <extra_id_0> treatment <extra_id_5> acetazolamide for glaucoma <extra_id_1> <extra_id_0> drug <extra_id_5> acetazolamide <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> glaucoma <extra_id_1> <extra_id_0> effect <extra_id_5> severe acidosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "An insulin - dependent diabetic patient with nephropathy"}, {"type": "subject disorder", "offset": [4], "text": "diabetic"}, {"type": "subject disorder", "offset": [7], "text": "nephropathy"}, {"type": "subject disorder", "offset": [16], "text": "glaucoma"}, {"type": "treatment", "offset": [14, 15, 16], "text": "acetazolamide for glaucoma"}, {"type": "drug", "offset": [14], "text": "acetazolamide"}, {"type": "treatment disorder", "offset": [16], "text": "glaucoma"}, {"type": "effect", "offset": [9, 10], "text": "severe acidosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "An insulin - dependent diabetic patient with nephropathy"], ["subject disorder", "diabetic"], ["subject disorder", "nephropathy"], ["subject disorder", "glaucoma"], ["treatment", "acetazolamide for glaucoma"], ["drug", "acetazolamide"], ["treatment disorder", "glaucoma"], ["effect", "severe acidosis"]]}]}
{"text_id": "3365032_2", "text": "Polymyositis after propylthiouracil treatment for hyperthyroidism .", "tokens": ["Polymyositis", "after", "propylthiouracil", "treatment", "for", "hyperthyroidism", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> propylthiouracil <extra_id_1> <extra_id_0> drug <extra_id_5> propylthiouracil <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hyperthyroidism <extra_id_1> <extra_id_0> effect <extra_id_5> Polymyositis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "after", "args": [{"type": "treatment", "offset": [2], "text": "propylthiouracil"}, {"type": "drug", "offset": [2], "text": "propylthiouracil"}, {"type": "treatment disorder", "offset": [5], "text": "hyperthyroidism"}, {"type": "effect", "offset": [0], "text": "Polymyositis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "propylthiouracil"], ["drug", "propylthiouracil"], ["treatment disorder", "hyperthyroidism"], ["effect", "Polymyositis"]]}]}
{"text_id": "14514135_2", "text": "We report a case of NEH masquerading as cutaneous vasculitis in a woman receiving cyclophosphamide for lupus nephritis .", "tokens": ["We", "report", "a", "case", "of", "NEH", "masquerading", "as", "cutaneous", "vasculitis", "in", "a", "woman", "receiving", "cyclophosphamide", "for", "lupus", "nephritis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> a woman <extra_id_1> <extra_id_0> subject <extra_id_5> for lupus nephritis <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> lupus nephritis . <extra_id_1> <extra_id_0> treatment <extra_id_5> cyclophosphamide <extra_id_1> <extra_id_0> drug <extra_id_5> cyclophosphamide <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> lupus nephritis . <extra_id_1> <extra_id_0> effect <extra_id_5> NEH masquerading as cutaneous vasculitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "in", "args": [{"type": "subject", "offset": [11, 12], "text": "a woman"}, {"type": "subject", "offset": [15, 16, 17], "text": "for lupus nephritis"}, {"type": "gender", "offset": [12], "text": "woman"}, {"type": "subject disorder", "offset": [16, 17, 18], "text": "lupus nephritis ."}, {"type": "treatment", "offset": [14], "text": "cyclophosphamide"}, {"type": "drug", "offset": [14], "text": "cyclophosphamide"}, {"type": "treatment disorder", "offset": [16, 17, 18], "text": "lupus nephritis ."}, {"type": "effect", "offset": [5, 6, 7, 8, 9], "text": "NEH masquerading as cutaneous vasculitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "a woman"], ["subject", "for lupus nephritis"], ["gender", "woman"], ["subject disorder", "lupus nephritis ."], ["treatment", "cyclophosphamide"], ["drug", "cyclophosphamide"], ["treatment disorder", "lupus nephritis ."], ["effect", "NEH masquerading as cutaneous vasculitis"]]}]}
{"text_id": "7673653_3", "text": "However , the occurrence and management of akathisia induced by fluvoxamine have not been described .", "tokens": ["However", ",", "the", "occurrence", "and", "management", "of", "akathisia", "induced", "by", "fluvoxamine", "have", "not", "been", "described", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> fluvoxamine <extra_id_1> <extra_id_0> drug <extra_id_5> fluvoxamine <extra_id_1> <extra_id_0> effect <extra_id_5> akathisia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "induced", "args": [{"type": "treatment", "offset": [10], "text": "fluvoxamine"}, {"type": "drug", "offset": [10], "text": "fluvoxamine"}, {"type": "effect", "offset": [7], "text": "akathisia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "fluvoxamine"], ["drug", "fluvoxamine"], ["effect", "akathisia"]]}]}
{"text_id": "7663030_5", "text": "He began taking propafenone only 6 days prior to admission because of uncontrolled atrial fibrillation and symptoms of fatigue .", "tokens": ["He", "began", "taking", "propafenone", "only", "6", "days", "prior", "to", "admission", "because", "of", "uncontrolled", "atrial", "fibrillation", "and", "symptoms", "of", "fatigue", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> taking <extra_id_0> treatment <extra_id_5> propafenone <extra_id_1> <extra_id_0> drug <extra_id_5> propafenone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> atrial fibrillation <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> fatigue <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [2], "text": "taking", "args": [{"type": "treatment", "offset": [3], "text": "propafenone"}, {"type": "drug", "offset": [3], "text": "propafenone"}, {"type": "treatment disorder", "offset": [13, 14], "text": "atrial fibrillation"}, {"type": "treatment disorder", "offset": [18], "text": "fatigue"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "taking", "label": "potential therapeutic event", "asoc": [["treatment", "propafenone"], ["drug", "propafenone"], ["treatment disorder", "atrial fibrillation"], ["treatment disorder", "fatigue"]]}]}
{"text_id": "12078977_1", "text": "A 31 - year - old female developed multiple episodes of grand mal seizures after combination chemotherapy with cisplatin , vinblastine and bleomycin for germ cell ovarian cancer stage Ic .", "tokens": ["A", "31", "-", "year", "-", "old", "female", "developed", "multiple", "episodes", "of", "grand", "mal", "seizures", "after", "combination", "chemotherapy", "with", "cisplatin", ",", "vinblastine", "and", "bleomycin", "for", "germ", "cell", "ovarian", "cancer", "stage", "Ic", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 31 - year - old female <extra_id_1> <extra_id_0> age <extra_id_5> 31 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> female <extra_id_1> <extra_id_0> subject disorder <extra_id_5> germ cell ovarian cancer stage Ic <extra_id_1> <extra_id_0> treatment <extra_id_5> combination chemotherapy with cisplatin , vinblastine and bleomycin <extra_id_1> <extra_id_0> drug <extra_id_5> bleomycin <extra_id_1> <extra_id_0> drug <extra_id_5> vinblastine <extra_id_1> <extra_id_0> drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> germ cell ovarian cancer stage Ic <extra_id_1> <extra_id_0> combination drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> combination drug <extra_id_5> vinblastine <extra_id_1> <extra_id_0> combination drug <extra_id_5> bleomycin <extra_id_1> <extra_id_0> effect <extra_id_5> multiple episodes of grand mal seizures <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "A 31 - year - old female"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "31 - year - old"}, {"type": "gender", "offset": [6], "text": "female"}, {"type": "subject disorder", "offset": [24, 25, 26, 27, 28, 29], "text": "germ cell ovarian cancer stage Ic"}, {"type": "treatment", "offset": [15, 16, 17, 18, 19, 20, 21, 22], "text": "combination chemotherapy with cisplatin , vinblastine and bleomycin"}, {"type": "drug", "offset": [22], "text": "bleomycin"}, {"type": "drug", "offset": [20], "text": "vinblastine"}, {"type": "drug", "offset": [18], "text": "cisplatin"}, {"type": "treatment disorder", "offset": [24, 25, 26, 27, 28, 29], "text": "germ cell ovarian cancer stage Ic"}, {"type": "combination drug", "offset": [18], "text": "cisplatin"}, {"type": "combination drug", "offset": [20], "text": "vinblastine"}, {"type": "combination drug", "offset": [22], "text": "bleomycin"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13], "text": "multiple episodes of grand mal seizures"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 31 - year - old female"], ["age", "31 - year - old"], ["gender", "female"], ["subject disorder", "germ cell ovarian cancer stage Ic"], ["treatment", "combination chemotherapy with cisplatin , vinblastine and bleomycin"], ["drug", "bleomycin"], ["drug", "vinblastine"], ["drug", "cisplatin"], ["treatment disorder", "germ cell ovarian cancer stage Ic"], ["combination drug", "cisplatin"], ["combination drug", "vinblastine"], ["combination drug", "bleomycin"], ["effect", "multiple episodes of grand mal seizures"]]}]}
{"text_id": "16641839_5", "text": "We report the case of a 27 - year - old Indian woman who developed maculopapular rash and angioedema secondary to carbamazepine administration .", "tokens": ["We", "report", "the", "case", "of", "a", "27", "-", "year", "-", "old", "Indian", "woman", "who", "developed", "maculopapular", "rash", "and", "angioedema", "secondary", "to", "carbamazepine", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a 27 - year - old Indian woman <extra_id_1> <extra_id_0> age <extra_id_5> 27 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> race <extra_id_5> Indian <extra_id_1> <extra_id_0> treatment <extra_id_5> carbamazepine administration <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> route <extra_id_5> administration <extra_id_1> <extra_id_0> effect <extra_id_5> maculopapular rash and angioedema <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "developed", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11, 12], "text": "a 27 - year - old Indian woman"}, {"type": "age", "offset": [6, 7, 8, 9, 10], "text": "27 - year - old"}, {"type": "gender", "offset": [12], "text": "woman"}, {"type": "race", "offset": [11], "text": "Indian"}, {"type": "treatment", "offset": [21, 22], "text": "carbamazepine administration"}, {"type": "drug", "offset": [21], "text": "carbamazepine"}, {"type": "route", "offset": [22], "text": "administration"}, {"type": "effect", "offset": [15, 16, 17, 18], "text": "maculopapular rash and angioedema"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "gender", "treatment", "age", "race"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a 27 - year - old Indian woman"], ["age", "27 - year - old"], ["gender", "woman"], ["race", "Indian"], ["treatment", "carbamazepine administration"], ["drug", "carbamazepine"], ["route", "administration"], ["effect", "maculopapular rash and angioedema"]]}]}
{"text_id": "14566215_1", "text": "In this article lithium is not discussed , although there are a number of concerns about lithium 's potential teratogenicity , and it has been implicated in Epstein 's anomaly , a congenital heart defect among infants born to women taking lithium ; as with other medications , however , the data have specific limitations .", "tokens": ["In", "this", "article", "lithium", "is", "not", "discussed", ",", "although", "there", "are", "a", "number", "of", "concerns", "about", "lithium", "'s", "potential", "teratogenicity", ",", "and", "it", "has", "been", "implicated", "in", "Epstein", "'s", "anomaly", ",", "a", "congenital", "heart", "defect", "among", "infants", "born", "to", "women", "taking", "lithium", ";", "as", "with", "other", "medications", ",", "however", ",", "the", "data", "have", "specific", "limitations", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> implicated <extra_id_0> treatment <extra_id_5> lithium <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> effect <extra_id_5> Epstein 's anomaly <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [25], "text": "implicated", "args": [{"type": "treatment", "offset": [41], "text": "lithium"}, {"type": "drug", "offset": [41], "text": "lithium"}, {"type": "effect", "offset": [27, 28, 29], "text": "Epstein 's anomaly"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "implicated", "label": "adverse event", "asoc": [["treatment", "lithium"], ["drug", "lithium"], ["effect", "Epstein 's anomaly"]]}]}
{"text_id": "9161656_3", "text": "CASE SUMMARY : A 66 - year - old white woman with a 10 - year history of hypertension and bronchial asthma was switched from immediate - release verapamil hydrocloride 40 mg tid to sustained - release verapamil 240 mg / d po for better hypertension control .", "tokens": ["CASE", "SUMMARY", ":", "A", "66", "-", "year", "-", "old", "white", "woman", "with", "a", "10", "-", "year", "history", "of", "hypertension", "and", "bronchial", "asthma", "was", "switched", "from", "immediate", "-", "release", "verapamil", "hydrocloride", "40", "mg", "tid", "to", "sustained", "-", "release", "verapamil", "240", "mg", "/", "d", "po", "for", "better", "hypertension", "control", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> control <extra_id_0> subject <extra_id_5> A 66 - year - old white woman with a 10 - year history of hypertension and bronchial asthma <extra_id_1> <extra_id_0> age <extra_id_5> 66 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> race <extra_id_5> white <extra_id_1> <extra_id_0> subject disorder <extra_id_5> bronchial asthma <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hypertension <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hypertension <extra_id_1> <extra_id_0> treatment <extra_id_5> switched from immediate - release verapamil hydrocloride 40 mg tid to sustained - release verapamil 240 mg / d po <extra_id_1> <extra_id_0> drug <extra_id_5> immediate - release verapamil hydrocloride <extra_id_1> <extra_id_0> drug <extra_id_5> sustained - release verapamil <extra_id_1> <extra_id_0> dosage <extra_id_5> 240 mg / d <extra_id_1> <extra_id_0> dosage <extra_id_5> 40 mg tid <extra_id_1> <extra_id_0> route <extra_id_5> po <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hypertension <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hypertension <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [46], "text": "control", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21], "text": "A 66 - year - old white woman with a 10 - year history of hypertension and bronchial asthma"}, {"type": "age", "offset": [4, 5, 6, 7, 8], "text": "66 - year - old"}, {"type": "gender", "offset": [10], "text": "woman"}, {"type": "race", "offset": [9], "text": "white"}, {"type": "subject disorder", "offset": [20, 21], "text": "bronchial asthma"}, {"type": "subject disorder", "offset": [18], "text": "hypertension"}, {"type": "subject disorder", "offset": [45], "text": "hypertension"}, {"type": "treatment", "offset": [23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42], "text": "switched from immediate - release verapamil hydrocloride 40 mg tid to sustained - release verapamil 240 mg / d po"}, {"type": "drug", "offset": [25, 26, 27, 28, 29], "text": "immediate - release verapamil hydrocloride"}, {"type": "drug", "offset": [34, 35, 36, 37], "text": "sustained - release verapamil"}, {"type": "dosage", "offset": [38, 39, 40, 41], "text": "240 mg / d"}, {"type": "dosage", "offset": [30, 31, 32], "text": "40 mg tid"}, {"type": "route", "offset": [42], "text": "po"}, {"type": "treatment disorder", "offset": [18], "text": "hypertension"}, {"type": "treatment disorder", "offset": [45], "text": "hypertension"}]}], "spot": ["potential therapeutic event"], "asoc": ["dosage", "route", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder", "race"], "spot_asoc": [{"span": "control", "label": "potential therapeutic event", "asoc": [["subject", "A 66 - year - old white woman with a 10 - year history of hypertension and bronchial asthma"], ["age", "66 - year - old"], ["gender", "woman"], ["race", "white"], ["subject disorder", "bronchial asthma"], ["subject disorder", "hypertension"], ["subject disorder", "hypertension"], ["treatment", "switched from immediate - release verapamil hydrocloride 40 mg tid to sustained - release verapamil 240 mg / d po"], ["drug", "immediate - release verapamil hydrocloride"], ["drug", "sustained - release verapamil"], ["dosage", "240 mg / d"], ["dosage", "40 mg tid"], ["route", "po"], ["treatment disorder", "hypertension"], ["treatment disorder", "hypertension"]]}]}
{"text_id": "19281746_1", "text": "Aliskiren - associated acute renal failure with hyperkalemia .", "tokens": ["Aliskiren", "-", "associated", "acute", "renal", "failure", "with", "hyperkalemia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Aliskiren <extra_id_1> <extra_id_0> drug <extra_id_5> Aliskiren <extra_id_1> <extra_id_0> effect <extra_id_5> acute renal failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Aliskiren"}, {"type": "drug", "offset": [0], "text": "Aliskiren"}, {"type": "effect", "offset": [3, 4, 5], "text": "acute renal failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Aliskiren"], ["drug", "Aliskiren"], ["effect", "acute renal failure"]]}]}
{"text_id": "20456080_1", "text": "Triamcinolone acetonide induced secondary adrenal insufficiency related to impaired CYP3A4 metabolism by coadministration of nefazodone .", "tokens": ["Triamcinolone", "acetonide", "induced", "secondary", "adrenal", "insufficiency", "related", "to", "impaired", "CYP3A4", "metabolism", "by", "coadministration", "of", "nefazodone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Triamcinolone acetonide <extra_id_1> <extra_id_0> treatment <extra_id_5> coadministration of nefazodone <extra_id_1> <extra_id_0> drug <extra_id_5> Triamcinolone acetonide <extra_id_1> <extra_id_0> drug <extra_id_5> nefazodone <extra_id_1> <extra_id_0> combination drug <extra_id_5> nefazodone <extra_id_1> <extra_id_0> combination drug <extra_id_5> Triamcinolone acetonide <extra_id_1> <extra_id_0> effect <extra_id_5> secondary adrenal insufficiency <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0, 1], "text": "Triamcinolone acetonide"}, {"type": "treatment", "offset": [12, 13, 14], "text": "coadministration of nefazodone"}, {"type": "drug", "offset": [0, 1], "text": "Triamcinolone acetonide"}, {"type": "drug", "offset": [14], "text": "nefazodone"}, {"type": "combination drug", "offset": [14], "text": "nefazodone"}, {"type": "combination drug", "offset": [0, 1], "text": "Triamcinolone acetonide"}, {"type": "effect", "offset": [3, 4, 5], "text": "secondary adrenal insufficiency"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Triamcinolone acetonide"], ["treatment", "coadministration of nefazodone"], ["drug", "Triamcinolone acetonide"], ["drug", "nefazodone"], ["combination drug", "nefazodone"], ["combination drug", "Triamcinolone acetonide"], ["effect", "secondary adrenal insufficiency"]]}]}
{"text_id": "14760958_1", "text": "Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon beta - 1a .", "tokens": ["Scleromyxedema", "in", "a", "patient", "with", "multiple", "sclerosis", "and", "monoclonal", "gammopathy", "on", "interferon", "beta", "-", "1a", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> on <extra_id_0> subject <extra_id_5> a patient with multiple sclerosis and monoclonal gammopathy <extra_id_1> <extra_id_0> subject disorder <extra_id_5> monoclonal gammopathy <extra_id_1> <extra_id_0> subject disorder <extra_id_5> multiple sclerosis <extra_id_1> <extra_id_0> treatment <extra_id_5> interferon beta - 1a <extra_id_1> <extra_id_0> drug <extra_id_5> interferon beta - 1a <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> multiple sclerosis <extra_id_1> <extra_id_0> effect <extra_id_5> Scleromyxedema <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "on", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7, 8, 9], "text": "a patient with multiple sclerosis and monoclonal gammopathy"}, {"type": "subject disorder", "offset": [8, 9], "text": "monoclonal gammopathy"}, {"type": "subject disorder", "offset": [5, 6], "text": "multiple sclerosis"}, {"type": "treatment", "offset": [11, 12, 13, 14], "text": "interferon beta - 1a"}, {"type": "drug", "offset": [11, 12, 13, 14], "text": "interferon beta - 1a"}, {"type": "treatment disorder", "offset": [5, 6], "text": "multiple sclerosis"}, {"type": "effect", "offset": [0], "text": "Scleromyxedema"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "on", "label": "adverse event", "asoc": [["subject", "a patient with multiple sclerosis and monoclonal gammopathy"], ["subject disorder", "monoclonal gammopathy"], ["subject disorder", "multiple sclerosis"], ["treatment", "interferon beta - 1a"], ["drug", "interferon beta - 1a"], ["treatment disorder", "multiple sclerosis"], ["effect", "Scleromyxedema"]]}]}
{"text_id": "18585545_2", "text": "CONCLUSION : The new quinolone derivatives ( levofloxacin , sparfloxacin , grepafloxacin , trovafloxacin , gatifloxacin and moxifloxacin ) , also called gyrase inhibitors , are known for their potential to cause central nervous system - related adverse effects , including headache , dizziness and insomnia .", "tokens": ["CONCLUSION", ":", "The", "new", "quinolone", "derivatives", "(", "levofloxacin", ",", "sparfloxacin", ",", "grepafloxacin", ",", "trovafloxacin", ",", "gatifloxacin", "and", "moxifloxacin", ")", ",", "also", "called", "gyrase", "inhibitors", ",", "are", "known", "for", "their", "potential", "to", "cause", "central", "nervous", "system", "-", "related", "adverse", "effects", ",", "including", "headache", ",", "dizziness", "and", "insomnia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> The new quinolone derivatives ( levofloxacin , sparfloxacin , grepafloxacin , trovafloxacin , gatifloxacin and moxifloxacin ) , also called gyrase inhibitors <extra_id_1> <extra_id_0> drug <extra_id_5> levofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> sparfloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> grepafloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> trovafloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> gatifloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> moxifloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> central nervous system - related adverse effects , including headache , dizziness and insomnia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [31], "text": "cause", "args": [{"type": "treatment", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23], "text": "The new quinolone derivatives ( levofloxacin , sparfloxacin , grepafloxacin , trovafloxacin , gatifloxacin and moxifloxacin ) , also called gyrase inhibitors"}, {"type": "drug", "offset": [7], "text": "levofloxacin"}, {"type": "drug", "offset": [9], "text": "sparfloxacin"}, {"type": "drug", "offset": [11], "text": "grepafloxacin"}, {"type": "drug", "offset": [13], "text": "trovafloxacin"}, {"type": "drug", "offset": [15], "text": "gatifloxacin"}, {"type": "drug", "offset": [17], "text": "moxifloxacin"}, {"type": "effect", "offset": [32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45], "text": "central nervous system - related adverse effects , including headache , dizziness and insomnia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "The new quinolone derivatives ( levofloxacin , sparfloxacin , grepafloxacin , trovafloxacin , gatifloxacin and moxifloxacin ) , also called gyrase inhibitors"], ["drug", "levofloxacin"], ["drug", "sparfloxacin"], ["drug", "grepafloxacin"], ["drug", "trovafloxacin"], ["drug", "gatifloxacin"], ["drug", "moxifloxacin"], ["effect", "central nervous system - related adverse effects , including headache , dizziness and insomnia"]]}]}
{"text_id": "7776854_2", "text": "Severe hepatotoxicity related to benzarone : a report of three cases with two fatalities .", "tokens": ["Severe", "hepatotoxicity", "related", "to", "benzarone", ":", "a", "report", "of", "three", "cases", "with", "two", "fatalities", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> subject <extra_id_5> three cases <extra_id_1> <extra_id_0> population <extra_id_5> three <extra_id_1> <extra_id_0> treatment <extra_id_5> benzarone <extra_id_1> <extra_id_0> drug <extra_id_5> benzarone <extra_id_1> <extra_id_0> effect <extra_id_5> hepatotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "related", "args": [{"type": "subject", "offset": [9, 10], "text": "three cases"}, {"type": "population", "offset": [9], "text": "three"}, {"type": "treatment", "offset": [4], "text": "benzarone"}, {"type": "drug", "offset": [4], "text": "benzarone"}, {"type": "effect", "offset": [1], "text": "hepatotoxicity"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["subject", "three cases"], ["population", "three"], ["treatment", "benzarone"], ["drug", "benzarone"], ["effect", "hepatotoxicity"]]}]}
{"text_id": "9247841_1", "text": "Propylthiouracil - induced cutaneous vasculitis .", "tokens": ["Propylthiouracil", "-", "induced", "cutaneous", "vasculitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Propylthiouracil <extra_id_1> <extra_id_0> drug <extra_id_5> Propylthiouracil <extra_id_1> <extra_id_0> effect <extra_id_5> cutaneous vasculitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Propylthiouracil"}, {"type": "drug", "offset": [0], "text": "Propylthiouracil"}, {"type": "effect", "offset": [3, 4], "text": "cutaneous vasculitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Propylthiouracil"], ["drug", "Propylthiouracil"], ["effect", "cutaneous vasculitis"]]}]}
{"text_id": "6529939_2", "text": "Alternating sinus rhythm and intermittent sinoatrial ( S - A ) block was observed in a 57 - year - old woman , under treatment for angina with 80 mg propranolol daily .", "tokens": ["Alternating", "sinus", "rhythm", "and", "intermittent", "sinoatrial", "(", "S", "-", "A", ")", "block", "was", "observed", "in", "a", "57", "-", "year", "-", "old", "woman", ",", "under", "treatment", "for", "angina", "with", "80", "mg", "propranolol", "daily", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treatment <extra_id_0> subject <extra_id_5> a 57 - year - old woman <extra_id_1> <extra_id_0> age <extra_id_5> 57 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> angina <extra_id_1> <extra_id_0> treatment <extra_id_5> 80 mg propranolol daily . <extra_id_1> <extra_id_0> drug <extra_id_5> propranolol <extra_id_1> <extra_id_0> dosage <extra_id_5> 80 mg <extra_id_1> <extra_id_0> frequency <extra_id_5> daily <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> angina <extra_id_1> <extra_id_0> effect <extra_id_5> Alternating sinus rhythm and intermittent sinoatrial ( S - A ) block <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [24], "text": "treatment", "args": [{"type": "subject", "offset": [15, 16, 17, 18, 19, 20, 21], "text": "a 57 - year - old woman"}, {"type": "age", "offset": [16, 17, 18, 19, 20], "text": "57 - year - old"}, {"type": "gender", "offset": [21], "text": "woman"}, {"type": "subject disorder", "offset": [26], "text": "angina"}, {"type": "treatment", "offset": [28, 29, 30, 31, 32], "text": "80 mg propranolol daily ."}, {"type": "drug", "offset": [30], "text": "propranolol"}, {"type": "dosage", "offset": [28, 29], "text": "80 mg"}, {"type": "frequency", "offset": [31], "text": "daily"}, {"type": "treatment disorder", "offset": [26], "text": "angina"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11], "text": "Alternating sinus rhythm and intermittent sinoatrial ( S - A ) block"}]}], "spot": ["adverse event"], "asoc": ["dosage", "effect", "subject", "treatment disorder", "drug", "gender", "frequency", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "treatment", "label": "adverse event", "asoc": [["subject", "a 57 - year - old woman"], ["age", "57 - year - old"], ["gender", "woman"], ["subject disorder", "angina"], ["treatment", "80 mg propranolol daily ."], ["drug", "propranolol"], ["dosage", "80 mg"], ["frequency", "daily"], ["treatment disorder", "angina"], ["effect", "Alternating sinus rhythm and intermittent sinoatrial ( S - A ) block"]]}]}
{"text_id": "17852449_2", "text": "All - trans - retinoic acid ( ATRA ) has been proved to be an effective treatment for acute promyelocytic leukemia ( APL ) , inducing remission in more than 90 % of cases .", "tokens": ["All", "-", "trans", "-", "retinoic", "acid", "(", "ATRA", ")", "has", "been", "proved", "to", "be", "an", "effective", "treatment", "for", "acute", "promyelocytic", "leukemia", "(", "APL", ")", ",", "inducing", "remission", "in", "more", "than", "90", "%", "of", "cases", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> proved <extra_id_0> subject <extra_id_5> more than 90 % of cases <extra_id_1> <extra_id_0> population <extra_id_5> more than 90 % <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute promyelocytic leukemia ( APL ) <extra_id_1> <extra_id_0> treatment <extra_id_5> All - trans - retinoic acid ( ATRA ) <extra_id_1> <extra_id_0> drug <extra_id_5> All - trans - retinoic acid <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute promyelocytic leukemia ( APL ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [11], "text": "proved", "args": [{"type": "subject", "offset": [28, 29, 30, 31, 32, 33], "text": "more than 90 % of cases"}, {"type": "population", "offset": [28, 29, 30, 31], "text": "more than 90 %"}, {"type": "subject disorder", "offset": [18, 19, 20, 21, 22, 23], "text": "acute promyelocytic leukemia ( APL )"}, {"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8], "text": "All - trans - retinoic acid ( ATRA )"}, {"type": "drug", "offset": [0, 1, 2, 3, 4, 5], "text": "All - trans - retinoic acid"}, {"type": "treatment disorder", "offset": [18, 19, 20, 21, 22, 23], "text": "acute promyelocytic leukemia ( APL )"}]}], "spot": ["potential therapeutic event"], "asoc": ["population", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "proved", "label": "potential therapeutic event", "asoc": [["subject", "more than 90 % of cases"], ["population", "more than 90 %"], ["subject disorder", "acute promyelocytic leukemia ( APL )"], ["treatment", "All - trans - retinoic acid ( ATRA )"], ["drug", "All - trans - retinoic acid"], ["treatment disorder", "acute promyelocytic leukemia ( APL )"]]}]}
{"text_id": "15482394_3", "text": "Despite the low dosage of warfarin , international normalized ratio ( INR ) was markedly elevated from 1.15 to 11.28 for only 4 days , and bleeding symptoms concurrently developed .", "tokens": ["Despite", "the", "low", "dosage", "of", "warfarin", ",", "international", "normalized", "ratio", "(", "INR", ")", "was", "markedly", "elevated", "from", "1.15", "to", "11.28", "for", "only", "4", "days", ",", "and", "bleeding", "symptoms", "concurrently", "developed", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> treatment <extra_id_5> low dosage of warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> dosage <extra_id_5> low dosage <extra_id_1> <extra_id_0> effect <extra_id_5> international normalized ratio ( INR ) was markedly elevated from 1.15 to 11.28 for only 4 days , and bleeding symptoms concurrently developed <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [29], "text": "developed", "args": [{"type": "treatment", "offset": [2, 3, 4, 5], "text": "low dosage of warfarin"}, {"type": "drug", "offset": [5], "text": "warfarin"}, {"type": "dosage", "offset": [2, 3], "text": "low dosage"}, {"type": "effect", "offset": [7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29], "text": "international normalized ratio ( INR ) was markedly elevated from 1.15 to 11.28 for only 4 days , and bleeding symptoms concurrently developed"}]}], "spot": ["adverse event"], "asoc": ["dosage", "treatment", "drug", "effect"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["treatment", "low dosage of warfarin"], ["drug", "warfarin"], ["dosage", "low dosage"], ["effect", "international normalized ratio ( INR ) was markedly elevated from 1.15 to 11.28 for only 4 days , and bleeding symptoms concurrently developed"]]}]}
{"text_id": "17667216_2", "text": "Metformin - associated lactic acidosis precipitated by diarrhea .", "tokens": ["Metformin", "-", "associated", "lactic", "acidosis", "precipitated", "by", "diarrhea", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> Metformin <extra_id_1> <extra_id_0> drug <extra_id_5> Metformin <extra_id_1> <extra_id_0> effect <extra_id_5> lactic acidosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [0], "text": "Metformin"}, {"type": "drug", "offset": [0], "text": "Metformin"}, {"type": "effect", "offset": [3, 4], "text": "lactic acidosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "Metformin"], ["drug", "Metformin"], ["effect", "lactic acidosis"]]}]}
{"text_id": "7519913_1", "text": "However , there remain questions concerning whether these drugs , especially methimazole ( MMI ) , may be associated with aplasia cutis congenita ( ACC ) and how best to avoid impairment of fetal thyroid function during their use .", "tokens": ["However", ",", "there", "remain", "questions", "concerning", "whether", "these", "drugs", ",", "especially", "methimazole", "(", "MMI", ")", ",", "may", "be", "associated", "with", "aplasia", "cutis", "congenita", "(", "ACC", ")", "and", "how", "best", "to", "avoid", "impairment", "of", "fetal", "thyroid", "function", "during", "their", "use", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> methimazole <extra_id_1> <extra_id_0> drug <extra_id_5> methimazole ( MMI ) <extra_id_1> <extra_id_0> effect <extra_id_5> aplasia cutis congenita <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "associated", "args": [{"type": "treatment", "offset": [11], "text": "methimazole"}, {"type": "drug", "offset": [11, 12, 13, 14], "text": "methimazole ( MMI )"}, {"type": "effect", "offset": [20, 21, 22], "text": "aplasia cutis congenita"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "methimazole"], ["drug", "methimazole ( MMI )"], ["effect", "aplasia cutis congenita"]]}]}
{"text_id": "9545161_4", "text": "It was hypothesized that valproic acid may interfere with glucuronidation of lamotrigine , leading to increased serum lamotrigine levels , or perhaps alter the drug 's metabolism , resulting in accumulation of a toxic intermediate metabolite .", "tokens": ["It", "was", "hypothesized", "that", "valproic", "acid", "may", "interfere", "with", "glucuronidation", "of", "lamotrigine", ",", "leading", "to", "increased", "serum", "lamotrigine", "levels", ",", "or", "perhaps", "alter", "the", "drug", "'s", "metabolism", ",", "resulting", "in", "accumulation", "of", "a", "toxic", "intermediate", "metabolite", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> leading <extra_id_0> treatment <extra_id_5> valproic acid may interfere with glucuronidation of lamotrigine <extra_id_1> <extra_id_0> drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> combination drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> combination drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> effect <extra_id_5> increased serum lamotrigine levels , or perhaps alter the drug 's metabolism , resulting in accumulation of a toxic intermediate metabolite <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "leading", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10, 11], "text": "valproic acid may interfere with glucuronidation of lamotrigine"}, {"type": "drug", "offset": [4, 5], "text": "valproic acid"}, {"type": "drug", "offset": [11], "text": "lamotrigine"}, {"type": "combination drug", "offset": [4, 5], "text": "valproic acid"}, {"type": "combination drug", "offset": [11], "text": "lamotrigine"}, {"type": "effect", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35], "text": "increased serum lamotrigine levels , or perhaps alter the drug 's metabolism , resulting in accumulation of a toxic intermediate metabolite"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "leading", "label": "adverse event", "asoc": [["treatment", "valproic acid may interfere with glucuronidation of lamotrigine"], ["drug", "valproic acid"], ["drug", "lamotrigine"], ["combination drug", "valproic acid"], ["combination drug", "lamotrigine"], ["effect", "increased serum lamotrigine levels , or perhaps alter the drug 's metabolism , resulting in accumulation of a toxic intermediate metabolite"]]}]}
{"text_id": "24791374_6", "text": "Propafenone is an established class IC antiarrhythmic drug commonly used in the treatment of atrial fibrillation .", "tokens": ["Propafenone", "is", "an", "established", "class", "IC", "antiarrhythmic", "drug", "commonly", "used", "in", "the", "treatment", "of", "atrial", "fibrillation", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> Propafenone <extra_id_1> <extra_id_0> drug <extra_id_5> Propafenone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> atrial fibrillation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [12], "text": "treatment", "args": [{"type": "treatment", "offset": [0], "text": "Propafenone"}, {"type": "drug", "offset": [0], "text": "Propafenone"}, {"type": "treatment disorder", "offset": [14, 15], "text": "atrial fibrillation"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "Propafenone"], ["drug", "Propafenone"], ["treatment disorder", "atrial fibrillation"]]}]}
{"text_id": "8313300_9", "text": "The exophthalmos improved dramatically within 72 hours of the withdrawal of lithium .", "tokens": ["The", "exophthalmos", "improved", "dramatically", "within", "72", "hours", "of", "the", "withdrawal", "of", "lithium", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> improved <extra_id_0> treatment <extra_id_5> within 72 hours of the withdrawal of lithium <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> duration <extra_id_5> 72 hours <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> exophthalmos <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [2], "text": "improved", "args": [{"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10, 11], "text": "within 72 hours of the withdrawal of lithium"}, {"type": "drug", "offset": [11], "text": "lithium"}, {"type": "duration", "offset": [5, 6], "text": "72 hours"}, {"type": "treatment disorder", "offset": [1], "text": "exophthalmos"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder", "duration"], "spot_asoc": [{"span": "improved", "label": "potential therapeutic event", "asoc": [["treatment", "within 72 hours of the withdrawal of lithium"], ["drug", "lithium"], ["duration", "72 hours"], ["treatment disorder", "exophthalmos"]]}]}
{"text_id": "11033734_2", "text": "Incidence of seizures in pediatric cancer patients treated with imipenem / cilastatin .", "tokens": ["Incidence", "of", "seizures", "in", "pediatric", "cancer", "patients", "treated", "with", "imipenem", "/", "cilastatin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated <extra_id_0> subject <extra_id_5> pediatric cancer patients <extra_id_1> <extra_id_0> age <extra_id_5> pediatric <extra_id_1> <extra_id_0> subject disorder <extra_id_5> cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> imipenem / cilastatin <extra_id_1> <extra_id_0> drug <extra_id_5> imipenem <extra_id_1> <extra_id_0> drug <extra_id_5> cilastatin <extra_id_1> <extra_id_0> combination drug <extra_id_5> imipenem <extra_id_1> <extra_id_0> combination drug <extra_id_5> cilastatin <extra_id_1> <extra_id_0> effect <extra_id_5> seizures <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "treated", "args": [{"type": "subject", "offset": [4, 5, 6], "text": "pediatric cancer patients"}, {"type": "age", "offset": [4], "text": "pediatric"}, {"type": "subject disorder", "offset": [5], "text": "cancer"}, {"type": "treatment", "offset": [9, 10, 11], "text": "imipenem / cilastatin"}, {"type": "drug", "offset": [9], "text": "imipenem"}, {"type": "drug", "offset": [11], "text": "cilastatin"}, {"type": "combination drug", "offset": [9], "text": "imipenem"}, {"type": "combination drug", "offset": [11], "text": "cilastatin"}, {"type": "effect", "offset": [2], "text": "seizures"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "adverse event", "asoc": [["subject", "pediatric cancer patients"], ["age", "pediatric"], ["subject disorder", "cancer"], ["treatment", "imipenem / cilastatin"], ["drug", "imipenem"], ["drug", "cilastatin"], ["combination drug", "imipenem"], ["combination drug", "cilastatin"], ["effect", "seizures"]]}]}
{"text_id": "12013364_2", "text": "Atypical neuroleptic malignant syndrome associated with olanzapine .", "tokens": ["Atypical", "neuroleptic", "malignant", "syndrome", "associated", "with", "olanzapine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> olanzapine <extra_id_1> <extra_id_0> drug <extra_id_5> olanzapine <extra_id_1> <extra_id_0> effect <extra_id_5> Atypical neuroleptic malignant syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "associated", "args": [{"type": "treatment", "offset": [6], "text": "olanzapine"}, {"type": "drug", "offset": [6], "text": "olanzapine"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Atypical neuroleptic malignant syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "olanzapine"], ["drug", "olanzapine"], ["effect", "Atypical neuroleptic malignant syndrome"]]}]}
{"text_id": "15628319_3", "text": "Drug eruption caused by azathioprine : value of using the drug - induced lymphocytes stimulation test for diagnosis .", "tokens": ["Drug", "eruption", "caused", "by", "azathioprine", ":", "value", "of", "using", "the", "drug", "-", "induced", "lymphocytes", "stimulation", "test", "for", "diagnosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> azathioprine <extra_id_1> <extra_id_0> drug <extra_id_5> azathioprine <extra_id_1> <extra_id_0> effect <extra_id_5> Drug eruption <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "caused", "args": [{"type": "treatment", "offset": [4], "text": "azathioprine"}, {"type": "drug", "offset": [4], "text": "azathioprine"}, {"type": "effect", "offset": [0, 1], "text": "Drug eruption"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "azathioprine"], ["drug", "azathioprine"], ["effect", "Drug eruption"]]}]}
{"text_id": "19039026_2", "text": "We report the first biopsy confirmed occurrence of acute interstitial nephritis in a patient receiving treatment with Sunitinib for metastatic renal cell cancer .", "tokens": ["We", "report", "the", "first", "biopsy", "confirmed", "occurrence", "of", "acute", "interstitial", "nephritis", "in", "a", "patient", "receiving", "treatment", "with", "Sunitinib", "for", "metastatic", "renal", "cell", "cancer", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurrence <extra_id_0> subject <extra_id_5> patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> metastatic renal cell cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> Sunitinib <extra_id_1> <extra_id_0> drug <extra_id_5> Sunitinib <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> metastatic renal cell cancer <extra_id_1> <extra_id_0> effect <extra_id_5> acute interstitial nephritis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "occurrence", "args": [{"type": "subject", "offset": [13], "text": "patient"}, {"type": "subject disorder", "offset": [19, 20, 21, 22], "text": "metastatic renal cell cancer"}, {"type": "treatment", "offset": [17], "text": "Sunitinib"}, {"type": "drug", "offset": [17], "text": "Sunitinib"}, {"type": "treatment disorder", "offset": [19, 20, 21, 22], "text": "metastatic renal cell cancer"}, {"type": "effect", "offset": [8, 9, 10], "text": "acute interstitial nephritis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "occurrence", "label": "adverse event", "asoc": [["subject", "patient"], ["subject disorder", "metastatic renal cell cancer"], ["treatment", "Sunitinib"], ["drug", "Sunitinib"], ["treatment disorder", "metastatic renal cell cancer"], ["effect", "acute interstitial nephritis"]]}]}
{"text_id": "489527_1", "text": "Renal damage associated with long term use of lithium carbonate .", "tokens": ["Renal", "damage", "associated", "with", "long", "term", "use", "of", "lithium", "carbonate", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> lithium carbonate <extra_id_1> <extra_id_0> drug <extra_id_5> lithium carbonate . <extra_id_1> <extra_id_0> effect <extra_id_5> Renal damage <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [8, 9], "text": "lithium carbonate"}, {"type": "drug", "offset": [8, 9, 10], "text": "lithium carbonate ."}, {"type": "effect", "offset": [0, 1], "text": "Renal damage"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "lithium carbonate"], ["drug", "lithium carbonate ."], ["effect", "Renal damage"]]}]}
{"text_id": "1504404_4", "text": "OBJECTIVE : To report a case of ciprofloxacin - induced psychosis and to discuss occurrence rates , risk factors , possible etiologies , preventive measures , and treatment courses for this adverse reaction .", "tokens": ["OBJECTIVE", ":", "To", "report", "a", "case", "of", "ciprofloxacin", "-", "induced", "psychosis", "and", "to", "discuss", "occurrence", "rates", ",", "risk", "factors", ",", "possible", "etiologies", ",", "preventive", "measures", ",", "and", "treatment", "courses", "for", "this", "adverse", "reaction", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> psychosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "induced", "args": [{"type": "treatment", "offset": [7], "text": "ciprofloxacin"}, {"type": "drug", "offset": [7], "text": "ciprofloxacin"}, {"type": "effect", "offset": [10], "text": "psychosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "ciprofloxacin"], ["drug", "ciprofloxacin"], ["effect", "psychosis"]]}]}
{"text_id": "2369419_2", "text": "Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate .", "tokens": ["Hepatitis", "with", "bridging", "fibrosis", "and", "reversible", "hepatic", "insufficiency", "in", "a", "woman", "with", "rheumatoid", "arthritis", "taking", "methotrexate", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> taking <extra_id_0> subject <extra_id_5> a woman with rheumatoid arthritis <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> methotrexate <extra_id_1> <extra_id_0> drug <extra_id_5> methotrexate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> effect <extra_id_5> Hepatitis with bridging fibrosis and reversible hepatic insufficiency <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "taking", "args": [{"type": "subject", "offset": [9, 10, 11, 12, 13], "text": "a woman with rheumatoid arthritis"}, {"type": "gender", "offset": [10], "text": "woman"}, {"type": "subject disorder", "offset": [12, 13], "text": "rheumatoid arthritis"}, {"type": "treatment", "offset": [15], "text": "methotrexate"}, {"type": "drug", "offset": [15], "text": "methotrexate"}, {"type": "treatment disorder", "offset": [12, 13], "text": "rheumatoid arthritis"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Hepatitis with bridging fibrosis and reversible hepatic insufficiency"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "taking", "label": "adverse event", "asoc": [["subject", "a woman with rheumatoid arthritis"], ["gender", "woman"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "methotrexate"], ["drug", "methotrexate"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "Hepatitis with bridging fibrosis and reversible hepatic insufficiency"]]}]}
{"text_id": "1393348_4", "text": "SLE receded after withdrawal of carbamazepine and treatment with anti - inflammatory drugs .", "tokens": ["SLE", "receded", "after", "withdrawal", "of", "carbamazepine", "and", "treatment", "with", "anti", "-", "inflammatory", "drugs", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> after <extra_id_0> treatment <extra_id_5> withdrawal of carbamazepine and treatment with anti - inflammatory drugs <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> anti - inflammatory <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> SLE <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [2], "text": "after", "args": [{"type": "treatment", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12], "text": "withdrawal of carbamazepine and treatment with anti - inflammatory drugs"}, {"type": "drug", "offset": [5], "text": "carbamazepine"}, {"type": "drug", "offset": [9, 10, 11], "text": "anti - inflammatory"}, {"type": "treatment disorder", "offset": [0], "text": "SLE"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "after", "label": "potential therapeutic event", "asoc": [["treatment", "withdrawal of carbamazepine and treatment with anti - inflammatory drugs"], ["drug", "carbamazepine"], ["drug", "anti - inflammatory"], ["treatment disorder", "SLE"]]}]}
{"text_id": "2728526_4", "text": "This article reports the occurrence of rifampin - associated thrombocytopenia in an indigent patient after a four - month lapse in therapy for pulmonary tuberculosis .", "tokens": ["This", "article", "reports", "the", "occurrence", "of", "rifampin", "-", "associated", "thrombocytopenia", "in", "an", "indigent", "patient", "after", "a", "four", "-", "month", "lapse", "in", "therapy", "for", "pulmonary", "tuberculosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> an indigent patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> pulmonary tuberculosis <extra_id_1> <extra_id_0> treatment <extra_id_5> rifampin <extra_id_1> <extra_id_0> treatment <extra_id_5> after a four - month lapse in therapy for pulmonary tuberculosis <extra_id_1> <extra_id_0> drug <extra_id_5> rifampin <extra_id_1> <extra_id_0> time elapsed <extra_id_5> four - month <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> pulmonary tuberculosis <extra_id_1> <extra_id_0> effect <extra_id_5> thrombocytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "associated", "args": [{"type": "subject", "offset": [11, 12, 13], "text": "an indigent patient"}, {"type": "subject disorder", "offset": [23, 24], "text": "pulmonary tuberculosis"}, {"type": "treatment", "offset": [6], "text": "rifampin"}, {"type": "treatment", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24], "text": "after a four - month lapse in therapy for pulmonary tuberculosis"}, {"type": "drug", "offset": [6], "text": "rifampin"}, {"type": "time elapsed", "offset": [16, 17, 18], "text": "four - month"}, {"type": "treatment disorder", "offset": [23, 24], "text": "pulmonary tuberculosis"}, {"type": "effect", "offset": [9], "text": "thrombocytopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "time elapsed", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "an indigent patient"], ["subject disorder", "pulmonary tuberculosis"], ["treatment", "rifampin"], ["treatment", "after a four - month lapse in therapy for pulmonary tuberculosis"], ["drug", "rifampin"], ["time elapsed", "four - month"], ["treatment disorder", "pulmonary tuberculosis"], ["effect", "thrombocytopenia"]]}]}
{"text_id": "2299784_3", "text": "To our knowledge , this is the first reported case of bromide intoxication due to pyridostigmine bromide administration .", "tokens": ["To", "our", "knowledge", ",", "this", "is", "the", "first", "reported", "case", "of", "bromide", "intoxication", "due", "to", "pyridostigmine", "bromide", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> subject <extra_id_5> first reported case <extra_id_1> <extra_id_0> population <extra_id_5> first <extra_id_1> <extra_id_0> treatment <extra_id_5> pyridostigmine bromide <extra_id_1> <extra_id_0> drug <extra_id_5> pyridostigmine bromide <extra_id_1> <extra_id_0> effect <extra_id_5> bromide intoxication <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "due", "args": [{"type": "subject", "offset": [7, 8, 9], "text": "first reported case"}, {"type": "population", "offset": [7], "text": "first"}, {"type": "treatment", "offset": [15, 16], "text": "pyridostigmine bromide"}, {"type": "drug", "offset": [15, 16], "text": "pyridostigmine bromide"}, {"type": "effect", "offset": [11, 12], "text": "bromide intoxication"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["subject", "first reported case"], ["population", "first"], ["treatment", "pyridostigmine bromide"], ["drug", "pyridostigmine bromide"], ["effect", "bromide intoxication"]]}]}
{"text_id": "921427_1", "text": "An elderly man with procainamide hydrochloride - induced lupus syndrome had a circulating anticoagulant against factor XI and a biologic false - positive ( BFP ) test result for syphilis .", "tokens": ["An", "elderly", "man", "with", "procainamide", "hydrochloride", "-", "induced", "lupus", "syndrome", "had", "a", "circulating", "anticoagulant", "against", "factor", "XI", "and", "a", "biologic", "false", "-", "positive", "(", "BFP", ")", "test", "result", "for", "syphilis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> An elderly man <extra_id_1> <extra_id_0> age <extra_id_5> elderly <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> procainamide hydrochloride <extra_id_1> <extra_id_0> drug <extra_id_5> procainamide hydrochloride <extra_id_1> <extra_id_0> effect <extra_id_5> lupus <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "induced", "args": [{"type": "subject", "offset": [0, 1, 2], "text": "An elderly man"}, {"type": "age", "offset": [1], "text": "elderly"}, {"type": "gender", "offset": [2], "text": "man"}, {"type": "treatment", "offset": [4, 5], "text": "procainamide hydrochloride"}, {"type": "drug", "offset": [4, 5], "text": "procainamide hydrochloride"}, {"type": "effect", "offset": [8], "text": "lupus"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "An elderly man"], ["age", "elderly"], ["gender", "man"], ["treatment", "procainamide hydrochloride"], ["drug", "procainamide hydrochloride"], ["effect", "lupus"]]}]}
{"text_id": "18176653_3", "text": "BACKGROUND : NVP is a non - nucleoside reverse transcriptase inhibitor used in the treatment of Human Immunodeficiency Virus ( HIV ) infection .", "tokens": ["BACKGROUND", ":", "NVP", "is", "a", "non", "-", "nucleoside", "reverse", "transcriptase", "inhibitor", "used", "in", "the", "treatment", "of", "Human", "Immunodeficiency", "Virus", "(", "HIV", ")", "infection", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> used <extra_id_0> treatment <extra_id_5> NVP <extra_id_1> <extra_id_0> drug <extra_id_5> NVP <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Human Immunodeficiency Virus ( HIV ) infection <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [11], "text": "used", "args": [{"type": "treatment", "offset": [2], "text": "NVP"}, {"type": "drug", "offset": [2], "text": "NVP"}, {"type": "treatment disorder", "offset": [16, 17, 18, 19, 20, 21, 22], "text": "Human Immunodeficiency Virus ( HIV ) infection"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "used", "label": "potential therapeutic event", "asoc": [["treatment", "NVP"], ["drug", "NVP"], ["treatment disorder", "Human Immunodeficiency Virus ( HIV ) infection"]]}]}
{"text_id": "15300114_2", "text": "In each of the three reported patients , alteration of eyelid appearance with deepening of the lid sulcus was evident as the result of topical bimatoprost therapy .", "tokens": ["In", "each", "of", "the", "three", "reported", "patients", ",", "alteration", "of", "eyelid", "appearance", "with", "deepening", "of", "the", "lid", "sulcus", "was", "evident", "as", "the", "result", "of", "topical", "bimatoprost", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> evident <extra_id_0> subject <extra_id_5> three reported patients <extra_id_1> <extra_id_0> population <extra_id_5> three <extra_id_1> <extra_id_0> treatment <extra_id_5> topical bimatoprost <extra_id_1> <extra_id_0> drug <extra_id_5> bimatoprost <extra_id_1> <extra_id_0> effect <extra_id_5> alteration of eyelid appearance with deepening of the lid sulcus <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "evident", "args": [{"type": "subject", "offset": [4, 5, 6], "text": "three reported patients"}, {"type": "population", "offset": [4], "text": "three"}, {"type": "treatment", "offset": [24, 25], "text": "topical bimatoprost"}, {"type": "drug", "offset": [25], "text": "bimatoprost"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13, 14, 15, 16, 17], "text": "alteration of eyelid appearance with deepening of the lid sulcus"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "evident", "label": "adverse event", "asoc": [["subject", "three reported patients"], ["population", "three"], ["treatment", "topical bimatoprost"], ["drug", "bimatoprost"], ["effect", "alteration of eyelid appearance with deepening of the lid sulcus"]]}]}
{"text_id": "15543388_1", "text": "AIM : Report of a case of a woman patient who developed celiac disease after pegylated interferon alpha - 2a and ribavirin use for chronic hepatitis C.", "tokens": ["AIM", ":", "Report", "of", "a", "case", "of", "a", "woman", "patient", "who", "developed", "celiac", "disease", "after", "pegylated", "interferon", "alpha", "-", "2a", "and", "ribavirin", "use", "for", "chronic", "hepatitis", "C."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a woman patient <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> chronic hepatitis C. <extra_id_1> <extra_id_0> treatment <extra_id_5> pegylated interferon alpha - 2a and ribavirin use for chronic hepatitis C. <extra_id_1> <extra_id_0> drug <extra_id_5> pegylated interferon alpha - 2a <extra_id_1> <extra_id_0> drug <extra_id_5> ribavirin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic hepatitis C. <extra_id_1> <extra_id_0> combination drug <extra_id_5> ribavirin <extra_id_1> <extra_id_0> combination drug <extra_id_5> pegylated interferon alpha - 2a <extra_id_1> <extra_id_0> effect <extra_id_5> celiac disease <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "developed", "args": [{"type": "subject", "offset": [7, 8, 9], "text": "a woman patient"}, {"type": "gender", "offset": [8], "text": "woman"}, {"type": "subject disorder", "offset": [24, 25, 26], "text": "chronic hepatitis C."}, {"type": "treatment", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26], "text": "pegylated interferon alpha - 2a and ribavirin use for chronic hepatitis C."}, {"type": "drug", "offset": [15, 16, 17, 18, 19], "text": "pegylated interferon alpha - 2a"}, {"type": "drug", "offset": [21], "text": "ribavirin"}, {"type": "treatment disorder", "offset": [24, 25, 26], "text": "chronic hepatitis C."}, {"type": "combination drug", "offset": [21], "text": "ribavirin"}, {"type": "combination drug", "offset": [15, 16, 17, 18, 19], "text": "pegylated interferon alpha - 2a"}, {"type": "effect", "offset": [12, 13], "text": "celiac disease"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "gender", "drug", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a woman patient"], ["gender", "woman"], ["subject disorder", "chronic hepatitis C."], ["treatment", "pegylated interferon alpha - 2a and ribavirin use for chronic hepatitis C."], ["drug", "pegylated interferon alpha - 2a"], ["drug", "ribavirin"], ["treatment disorder", "chronic hepatitis C."], ["combination drug", "ribavirin"], ["combination drug", "pegylated interferon alpha - 2a"], ["effect", "celiac disease"]]}]}
{"text_id": "11918514_1", "text": "CONCLUSIONS : Although mirtazapine offers clinicians a combination of strong efficacy and good safety , we suggest bearing SS in mind when prescribing this drug , especially in frail , elderly patients with underlying chronic conditions .", "tokens": ["CONCLUSIONS", ":", "Although", "mirtazapine", "offers", "clinicians", "a", "combination", "of", "strong", "efficacy", "and", "good", "safety", ",", "we", "suggest", "bearing", "SS", "in", "mind", "when", "prescribing", "this", "drug", ",", "especially", "in", "frail", ",", "elderly", "patients", "with", "underlying", "chronic", "conditions", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> bearing <extra_id_0> subject <extra_id_5> frail , elderly patients with underlying chronic conditions <extra_id_1> <extra_id_0> age <extra_id_5> elderly <extra_id_1> <extra_id_0> subject disorder <extra_id_5> underlying chronic conditions <extra_id_1> <extra_id_0> treatment <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> drug <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> effect <extra_id_5> SS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "bearing", "args": [{"type": "subject", "offset": [28, 29, 30, 31, 32, 33, 34, 35], "text": "frail , elderly patients with underlying chronic conditions"}, {"type": "age", "offset": [30], "text": "elderly"}, {"type": "subject disorder", "offset": [33, 34, 35], "text": "underlying chronic conditions"}, {"type": "treatment", "offset": [3], "text": "mirtazapine"}, {"type": "drug", "offset": [3], "text": "mirtazapine"}, {"type": "effect", "offset": [18], "text": "SS"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "bearing", "label": "adverse event", "asoc": [["subject", "frail , elderly patients with underlying chronic conditions"], ["age", "elderly"], ["subject disorder", "underlying chronic conditions"], ["treatment", "mirtazapine"], ["drug", "mirtazapine"], ["effect", "SS"]]}]}
{"text_id": "1440123_1", "text": "This case report describes a 38 - year - old male in whom SIADH was strongly suspected secondary to Tegretol therapy to control a seizure disorder .", "tokens": ["This", "case", "report", "describes", "a", "38", "-", "year", "-", "old", "male", "in", "whom", "SIADH", "was", "strongly", "suspected", "secondary", "to", "Tegretol", "therapy", "to", "control", "a", "seizure", "disorder", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> suspected <extra_id_0> subject <extra_id_5> 38 - year - old male <extra_id_1> <extra_id_0> subject <extra_id_5> a seizure disorder <extra_id_1> <extra_id_0> age <extra_id_5> 38 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> male <extra_id_1> <extra_id_0> subject disorder <extra_id_5> seizure <extra_id_1> <extra_id_0> treatment <extra_id_5> Tegretol <extra_id_1> <extra_id_0> drug <extra_id_5> Tegretol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> seizure <extra_id_1> <extra_id_0> effect <extra_id_5> SIADH <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "suspected", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10], "text": "38 - year - old male"}, {"type": "subject", "offset": [23, 24, 25], "text": "a seizure disorder"}, {"type": "age", "offset": [5, 6, 7, 8, 9], "text": "38 - year - old"}, {"type": "gender", "offset": [10], "text": "male"}, {"type": "subject disorder", "offset": [24], "text": "seizure"}, {"type": "treatment", "offset": [19], "text": "Tegretol"}, {"type": "drug", "offset": [19], "text": "Tegretol"}, {"type": "treatment disorder", "offset": [24], "text": "seizure"}, {"type": "effect", "offset": [13], "text": "SIADH"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "suspected", "label": "adverse event", "asoc": [["subject", "38 - year - old male"], ["subject", "a seizure disorder"], ["age", "38 - year - old"], ["gender", "male"], ["subject disorder", "seizure"], ["treatment", "Tegretol"], ["drug", "Tegretol"], ["treatment disorder", "seizure"], ["effect", "SIADH"]]}]}
{"text_id": "1743388_1", "text": "Cutaneous ulceration : an unusual complication of intravenous pentamidine therapy .", "tokens": ["Cutaneous", "ulceration", ":", "an", "unusual", "complication", "of", "intravenous", "pentamidine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> intravenous pentamidine <extra_id_1> <extra_id_0> drug <extra_id_5> pentamidine <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> effect <extra_id_5> Cutaneous ulceration <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "complication", "args": [{"type": "treatment", "offset": [7, 8], "text": "intravenous pentamidine"}, {"type": "drug", "offset": [8], "text": "pentamidine"}, {"type": "route", "offset": [7], "text": "intravenous"}, {"type": "effect", "offset": [0, 1], "text": "Cutaneous ulceration"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "intravenous pentamidine"], ["drug", "pentamidine"], ["route", "intravenous"], ["effect", "Cutaneous ulceration"]]}]}
{"text_id": "10923593_2", "text": "Serum sickness consists of a systemic reaction resulting from the formation of soluble circulating immunocomplexes after the introduction of a foreign substance into the body We studied a 38 - year - old woman diagnosed with anxiety , depression and right sacroileitis who was treated with phenylbutazone , ranitidine , clomipramine and levomepromazine .", "tokens": ["Serum", "sickness", "consists", "of", "a", "systemic", "reaction", "resulting", "from", "the", "formation", "of", "soluble", "circulating", "immunocomplexes", "after", "the", "introduction", "of", "a", "foreign", "substance", "into", "the", "body", "We", "studied", "a", "38", "-", "year", "-", "old", "woman", "diagnosed", "with", "anxiety", ",", "depression", "and", "right", "sacroileitis", "who", "was", "treated", "with", "phenylbutazone", ",", "ranitidine", ",", "clomipramine", "and", "levomepromazine", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treated <extra_id_0> subject <extra_id_5> a 38 - year - old woman diagnosed with anxiety , depression and right sacroileitis <extra_id_1> <extra_id_0> age <extra_id_5> 38 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> anxiety , depression and right sacroileitis <extra_id_1> <extra_id_0> treatment <extra_id_5> phenylbutazone , ranitidine , clomipramine and levomepromazine <extra_id_1> <extra_id_0> drug <extra_id_5> phenylbutazone <extra_id_1> <extra_id_0> drug <extra_id_5> clomipramine <extra_id_1> <extra_id_0> drug <extra_id_5> levomepromazine <extra_id_1> <extra_id_0> drug <extra_id_5> ranitidine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> anxiety , depression and right sacroileitis <extra_id_1> <extra_id_0> combination drug <extra_id_5> levomepromazine <extra_id_1> <extra_id_0> combination drug <extra_id_5> clomipramine <extra_id_1> <extra_id_0> combination drug <extra_id_5> ranitidine <extra_id_1> <extra_id_0> combination drug <extra_id_5> phenylbutazone <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [44], "text": "treated", "args": [{"type": "subject", "offset": [27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41], "text": "a 38 - year - old woman diagnosed with anxiety , depression and right sacroileitis"}, {"type": "age", "offset": [28, 29, 30, 31, 32], "text": "38 - year - old"}, {"type": "gender", "offset": [33], "text": "woman"}, {"type": "subject disorder", "offset": [36, 37, 38, 39, 40, 41], "text": "anxiety , depression and right sacroileitis"}, {"type": "treatment", "offset": [46, 47, 48, 49, 50, 51, 52], "text": "phenylbutazone , ranitidine , clomipramine and levomepromazine"}, {"type": "drug", "offset": [46], "text": "phenylbutazone"}, {"type": "drug", "offset": [50], "text": "clomipramine"}, {"type": "drug", "offset": [52], "text": "levomepromazine"}, {"type": "drug", "offset": [48], "text": "ranitidine"}, {"type": "treatment disorder", "offset": [36, 37, 38, 39, 40, 41], "text": "anxiety , depression and right sacroileitis"}, {"type": "combination drug", "offset": [52], "text": "levomepromazine"}, {"type": "combination drug", "offset": [50], "text": "clomipramine"}, {"type": "combination drug", "offset": [48], "text": "ranitidine"}, {"type": "combination drug", "offset": [46], "text": "phenylbutazone"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment disorder", "drug", "gender", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "potential therapeutic event", "asoc": [["subject", "a 38 - year - old woman diagnosed with anxiety , depression and right sacroileitis"], ["age", "38 - year - old"], ["gender", "woman"], ["subject disorder", "anxiety , depression and right sacroileitis"], ["treatment", "phenylbutazone , ranitidine , clomipramine and levomepromazine"], ["drug", "phenylbutazone"], ["drug", "clomipramine"], ["drug", "levomepromazine"], ["drug", "ranitidine"], ["treatment disorder", "anxiety , depression and right sacroileitis"], ["combination drug", "levomepromazine"], ["combination drug", "clomipramine"], ["combination drug", "ranitidine"], ["combination drug", "phenylbutazone"]]}]}
{"text_id": "3892171_1", "text": "Protamine - induced fatal anaphylaxis .", "tokens": ["Protamine", "-", "induced", "fatal", "anaphylaxis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Protamine <extra_id_1> <extra_id_0> drug <extra_id_5> Protamine <extra_id_1> <extra_id_0> effect <extra_id_5> anaphylaxis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Protamine"}, {"type": "drug", "offset": [0], "text": "Protamine"}, {"type": "effect", "offset": [4], "text": "anaphylaxis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Protamine"], ["drug", "Protamine"], ["effect", "anaphylaxis"]]}]}
{"text_id": "9512187_1", "text": "Because the combination of bleomycin and vinca alkaloids is commonly used for the treatment of AIDS - related Kaposi 's sarcoma , clinicians should be aware of the risk of provoking acral necrosis in patients who develop Raynaud 's phenomenon under chemotherapy .", "tokens": ["Because", "the", "combination", "of", "bleomycin", "and", "vinca", "alkaloids", "is", "commonly", "used", "for", "the", "treatment", "of", "AIDS", "-", "related", "Kaposi", "'s", "sarcoma", ",", "clinicians", "should", "be", "aware", "of", "the", "risk", "of", "provoking", "acral", "necrosis", "in", "patients", "who", "develop", "Raynaud", "'s", "phenomenon", "under", "chemotherapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> provoking <extra_id_0> treatment <extra_id_5> bleomycin <extra_id_1> <extra_id_0> treatment <extra_id_5> vinca alkaloids <extra_id_1> <extra_id_0> drug <extra_id_5> bleomycin <extra_id_1> <extra_id_0> drug <extra_id_5> vinca alkaloids <extra_id_1> <extra_id_0> combination drug <extra_id_5> bleomycin <extra_id_1> <extra_id_0> combination drug <extra_id_5> vinca alkaloids <extra_id_1> <extra_id_0> effect <extra_id_5> acral necrosis <extra_id_1> <extra_id_0> effect <extra_id_5> Raynaud 's phenomenon <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [30], "text": "provoking", "args": [{"type": "treatment", "offset": [4], "text": "bleomycin"}, {"type": "treatment", "offset": [6, 7], "text": "vinca alkaloids"}, {"type": "drug", "offset": [4], "text": "bleomycin"}, {"type": "drug", "offset": [6, 7], "text": "vinca alkaloids"}, {"type": "combination drug", "offset": [4], "text": "bleomycin"}, {"type": "combination drug", "offset": [6, 7], "text": "vinca alkaloids"}, {"type": "effect", "offset": [31, 32], "text": "acral necrosis"}, {"type": "effect", "offset": [37, 38, 39], "text": "Raynaud 's phenomenon"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "provoking", "label": "adverse event", "asoc": [["treatment", "bleomycin"], ["treatment", "vinca alkaloids"], ["drug", "bleomycin"], ["drug", "vinca alkaloids"], ["combination drug", "bleomycin"], ["combination drug", "vinca alkaloids"], ["effect", "acral necrosis"], ["effect", "Raynaud 's phenomenon"]]}]}
{"text_id": "18171260_1", "text": "Serotonin syndrome after concomitant treatment with linezolid and meperidine .", "tokens": ["Serotonin", "syndrome", "after", "concomitant", "treatment", "with", "linezolid", "and", "meperidine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> concomitant treatment with linezolid and meperidine <extra_id_1> <extra_id_0> drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> drug <extra_id_5> meperidine <extra_id_1> <extra_id_0> combination drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> combination drug <extra_id_5> meperidine <extra_id_1> <extra_id_0> effect <extra_id_5> Serotonin syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "after", "args": [{"type": "treatment", "offset": [3, 4, 5, 6, 7, 8], "text": "concomitant treatment with linezolid and meperidine"}, {"type": "drug", "offset": [6], "text": "linezolid"}, {"type": "drug", "offset": [8], "text": "meperidine"}, {"type": "combination drug", "offset": [6], "text": "linezolid"}, {"type": "combination drug", "offset": [8], "text": "meperidine"}, {"type": "effect", "offset": [0, 1], "text": "Serotonin syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "concomitant treatment with linezolid and meperidine"], ["drug", "linezolid"], ["drug", "meperidine"], ["combination drug", "linezolid"], ["combination drug", "meperidine"], ["effect", "Serotonin syndrome"]]}]}
{"text_id": "3195622_3", "text": "Case report : dapsone hypersensitivity syndrome associated with treatment of the bite of a brown recluse spider .", "tokens": ["Case", "report", ":", "dapsone", "hypersensitivity", "syndrome", "associated", "with", "treatment", "of", "the", "bite", "of", "a", "brown", "recluse", "spider", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> dapsone <extra_id_1> <extra_id_0> drug <extra_id_5> dapsone <extra_id_1> <extra_id_0> effect <extra_id_5> hypersensitivity syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "associated", "args": [{"type": "treatment", "offset": [3], "text": "dapsone"}, {"type": "drug", "offset": [3], "text": "dapsone"}, {"type": "effect", "offset": [4, 5], "text": "hypersensitivity syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "dapsone"], ["drug", "dapsone"], ["effect", "hypersensitivity syndrome"]]}]}
{"text_id": "12584153_3", "text": "Amprenavir is a human immunodeficiency virus - 1 ( HIV - 1 ) protease inhibitor intended to be used to treat HIV - infected children .", "tokens": ["Amprenavir", "is", "a", "human", "immunodeficiency", "virus", "-", "1", "(", "HIV", "-", "1", ")", "protease", "inhibitor", "intended", "to", "be", "used", "to", "treat", "HIV", "-", "infected", "children", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treat <extra_id_0> subject <extra_id_5> children <extra_id_1> <extra_id_0> age <extra_id_5> children <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HIV - infected <extra_id_1> <extra_id_0> treatment <extra_id_5> Amprenavir <extra_id_1> <extra_id_0> drug <extra_id_5> Amprenavir <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HIV - infected <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [20], "text": "treat", "args": [{"type": "subject", "offset": [24], "text": "children"}, {"type": "age", "offset": [24], "text": "children"}, {"type": "subject disorder", "offset": [21, 22, 23], "text": "HIV - infected"}, {"type": "treatment", "offset": [0], "text": "Amprenavir"}, {"type": "drug", "offset": [0], "text": "Amprenavir"}, {"type": "treatment disorder", "offset": [21, 22, 23], "text": "HIV - infected"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "treat", "label": "potential therapeutic event", "asoc": [["subject", "children"], ["age", "children"], ["subject disorder", "HIV - infected"], ["treatment", "Amprenavir"], ["drug", "Amprenavir"], ["treatment disorder", "HIV - infected"]]}]}
{"text_id": "7779233_2", "text": "This case study describes an atypical case of refractory , sodium warfarin - induced necrotizing fasciitis and myonecrosis .", "tokens": ["This", "case", "study", "describes", "an", "atypical", "case", "of", "refractory", ",", "sodium", "warfarin", "-", "induced", "necrotizing", "fasciitis", "and", "myonecrosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> sodium warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> sodium warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> necrotizing fasciitis and myonecrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "induced", "args": [{"type": "treatment", "offset": [10, 11], "text": "sodium warfarin"}, {"type": "drug", "offset": [10, 11], "text": "sodium warfarin"}, {"type": "effect", "offset": [14, 15, 16, 17], "text": "necrotizing fasciitis and myonecrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "sodium warfarin"], ["drug", "sodium warfarin"], ["effect", "necrotizing fasciitis and myonecrosis"]]}]}
{"text_id": "458006_1", "text": "Squamous - cell carcinoma arising in a basal - cell epithelioma treated with 5 - fluorouracil .", "tokens": ["Squamous", "-", "cell", "carcinoma", "arising", "in", "a", "basal", "-", "cell", "epithelioma", "treated", "with", "5", "-", "fluorouracil", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated <extra_id_0> treatment <extra_id_5> 5 - fluorouracil <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - fluorouracil <extra_id_1> <extra_id_0> effect <extra_id_5> Squamous - cell carcinoma arising <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "treated", "args": [{"type": "treatment", "offset": [13, 14, 15], "text": "5 - fluorouracil"}, {"type": "drug", "offset": [13, 14, 15], "text": "5 - fluorouracil"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Squamous - cell carcinoma arising"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "treated", "label": "adverse event", "asoc": [["treatment", "5 - fluorouracil"], ["drug", "5 - fluorouracil"], ["effect", "Squamous - cell carcinoma arising"]]}]}
{"text_id": "412488_2", "text": "Three patients developed proteinuria following gold therapy for rheumatoid arthritis .", "tokens": ["Three", "patients", "developed", "proteinuria", "following", "gold", "therapy", "for", "rheumatoid", "arthritis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> subject <extra_id_5> Three patients <extra_id_1> <extra_id_0> population <extra_id_5> Three <extra_id_1> <extra_id_0> subject disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> gold <extra_id_1> <extra_id_0> drug <extra_id_5> gold <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> effect <extra_id_5> proteinuria <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "following", "args": [{"type": "subject", "offset": [0, 1], "text": "Three patients"}, {"type": "population", "offset": [0], "text": "Three"}, {"type": "subject disorder", "offset": [8, 9], "text": "rheumatoid arthritis"}, {"type": "treatment", "offset": [5], "text": "gold"}, {"type": "drug", "offset": [5], "text": "gold"}, {"type": "treatment disorder", "offset": [8, 9], "text": "rheumatoid arthritis"}, {"type": "effect", "offset": [3], "text": "proteinuria"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["subject", "Three patients"], ["population", "Three"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "gold"], ["drug", "gold"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "proteinuria"]]}]}
{"text_id": "19390192_2", "text": "The uncomplicated long - term use of adequately - dosed AZA and stable non - toxic metabolite levels could not acknowledge TPMT deficiency as a primary cause of the leukopenia .", "tokens": ["The", "uncomplicated", "long", "-", "term", "use", "of", "adequately", "-", "dosed", "AZA", "and", "stable", "non", "-", "toxic", "metabolite", "levels", "could", "not", "acknowledge", "TPMT", "deficiency", "as", "a", "primary", "cause", "of", "the", "leukopenia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> long - term use of adequately - dosed AZA and stable non - toxic metabolite levels could not acknowledge TPMT deficiency <extra_id_1> <extra_id_0> drug <extra_id_5> AZA <extra_id_1> <extra_id_0> dosage <extra_id_5> adequately - dosed <extra_id_1> <extra_id_0> effect <extra_id_5> leukopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [26], "text": "cause", "args": [{"type": "treatment", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22], "text": "long - term use of adequately - dosed AZA and stable non - toxic metabolite levels could not acknowledge TPMT deficiency"}, {"type": "drug", "offset": [10], "text": "AZA"}, {"type": "dosage", "offset": [7, 8, 9], "text": "adequately - dosed"}, {"type": "effect", "offset": [29], "text": "leukopenia"}]}], "spot": ["adverse event"], "asoc": ["dosage", "treatment", "drug", "effect"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "long - term use of adequately - dosed AZA and stable non - toxic metabolite levels could not acknowledge TPMT deficiency"], ["drug", "AZA"], ["dosage", "adequately - dosed"], ["effect", "leukopenia"]]}]}
{"text_id": "11243427_2", "text": "Differential diagnoses included ocular rosacea with cicatrizing conjunctivitis and 5 - FU - induced ectropion .", "tokens": ["Differential", "diagnoses", "included", "ocular", "rosacea", "with", "cicatrizing", "conjunctivitis", "and", "5", "-", "FU", "-", "induced", "ectropion", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> effect <extra_id_5> ectropion <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "induced", "args": [{"type": "treatment", "offset": [9, 10, 11], "text": "5 - FU"}, {"type": "drug", "offset": [9, 10, 11], "text": "5 - FU"}, {"type": "effect", "offset": [14], "text": "ectropion"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "5 - FU"], ["drug", "5 - FU"], ["effect", "ectropion"]]}]}
{"text_id": "7249424_2", "text": "Nephrotic syndrome associated with lithium therapy .", "tokens": ["Nephrotic", "syndrome", "associated", "with", "lithium", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> lithium therapy <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> effect <extra_id_5> Nephrotic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [4, 5], "text": "lithium therapy"}, {"type": "drug", "offset": [4], "text": "lithium"}, {"type": "effect", "offset": [0, 1], "text": "Nephrotic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "lithium therapy"], ["drug", "lithium"], ["effect", "Nephrotic syndrome"]]}]}
{"text_id": "21751666_1", "text": "Post - exposure prophylaxis for H1N1 with oseltamivir in renal allograft recipient -- safe and effective without any immunosuppresive drug interaction .", "tokens": ["Post", "-", "exposure", "prophylaxis", "for", "H1N1", "with", "oseltamivir", "in", "renal", "allograft", "recipient", "--", "safe", "and", "effective", "without", "any", "immunosuppresive", "drug", "interaction", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> Post - exposure prophylaxis <extra_id_0> subject <extra_id_5> renal allograft recipient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> renal allograft <extra_id_1> <extra_id_0> subject disorder <extra_id_5> H1N1 <extra_id_1> <extra_id_0> treatment <extra_id_5> oseltamivir <extra_id_1> <extra_id_0> drug <extra_id_5> oseltamivir <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> H1N1 <extra_id_1> <extra_id_0> effect <extra_id_5> safe and effective without any immunosuppresive drug interaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [0, 1, 2, 3], "text": "Post - exposure prophylaxis", "args": [{"type": "subject", "offset": [9, 10, 11], "text": "renal allograft recipient"}, {"type": "subject disorder", "offset": [9, 10], "text": "renal allograft"}, {"type": "subject disorder", "offset": [5], "text": "H1N1"}, {"type": "treatment", "offset": [7], "text": "oseltamivir"}, {"type": "drug", "offset": [7], "text": "oseltamivir"}, {"type": "treatment disorder", "offset": [5], "text": "H1N1"}, {"type": "effect", "offset": [13, 14, 15, 16, 17, 18, 19, 20], "text": "safe and effective without any immunosuppresive drug interaction"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "Post - exposure prophylaxis", "label": "potential therapeutic event", "asoc": [["subject", "renal allograft recipient"], ["subject disorder", "renal allograft"], ["subject disorder", "H1N1"], ["treatment", "oseltamivir"], ["drug", "oseltamivir"], ["treatment disorder", "H1N1"], ["effect", "safe and effective without any immunosuppresive drug interaction"]]}]}
{"text_id": "2554727_5", "text": "Peripheral nerve dysfunction is a potentially serious complication of high - dose cytosine arabinoside .", "tokens": ["Peripheral", "nerve", "dysfunction", "is", "a", "potentially", "serious", "complication", "of", "high", "-", "dose", "cytosine", "arabinoside", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> of <extra_id_0> treatment <extra_id_5> cytosine arabinoside <extra_id_1> <extra_id_0> drug <extra_id_5> cytosine arabinoside <extra_id_1> <extra_id_0> dosage <extra_id_5> high - dose <extra_id_1> <extra_id_0> effect <extra_id_5> Peripheral nerve dysfunction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "of", "args": [{"type": "treatment", "offset": [12, 13], "text": "cytosine arabinoside"}, {"type": "drug", "offset": [12, 13], "text": "cytosine arabinoside"}, {"type": "dosage", "offset": [9, 10, 11], "text": "high - dose"}, {"type": "effect", "offset": [0, 1, 2], "text": "Peripheral nerve dysfunction"}]}], "spot": ["adverse event"], "asoc": ["dosage", "treatment", "drug", "effect"], "spot_asoc": [{"span": "of", "label": "adverse event", "asoc": [["treatment", "cytosine arabinoside"], ["drug", "cytosine arabinoside"], ["dosage", "high - dose"], ["effect", "Peripheral nerve dysfunction"]]}]}
{"text_id": "11302479_1", "text": "She developed a severe urticarial rash 3 weeks following initiation of therapy with Enoxaparin .", "tokens": ["She", "developed", "a", "severe", "urticarial", "rash", "3", "weeks", "following", "initiation", "of", "therapy", "with", "Enoxaparin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> treatment <extra_id_5> Enoxaparin <extra_id_1> <extra_id_0> drug <extra_id_5> Enoxaparin <extra_id_1> <extra_id_0> duration <extra_id_5> 3 weeks <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 3 weeks <extra_id_1> <extra_id_0> effect <extra_id_5> urticarial rash <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "developed", "args": [{"type": "treatment", "offset": [13], "text": "Enoxaparin"}, {"type": "drug", "offset": [13], "text": "Enoxaparin"}, {"type": "duration", "offset": [6, 7], "text": "3 weeks"}, {"type": "time elapsed", "offset": [6, 7], "text": "3 weeks"}, {"type": "effect", "offset": [4, 5], "text": "urticarial rash"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "drug", "time elapsed", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["treatment", "Enoxaparin"], ["drug", "Enoxaparin"], ["duration", "3 weeks"], ["time elapsed", "3 weeks"], ["effect", "urticarial rash"]]}]}
{"text_id": "6683487_2", "text": "Thrombotic thrombocytopenic purpura ( TTP ) developed in a patient with seropositive rheumatoid arthritis ( RA ) after 2 1/2 months of treatment with penicillamine .", "tokens": ["Thrombotic", "thrombocytopenic", "purpura", "(", "TTP", ")", "developed", "in", "a", "patient", "with", "seropositive", "rheumatoid", "arthritis", "(", "RA", ")", "after", "2", "1/2", "months", "of", "treatment", "with", "penicillamine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a patient with seropositive rheumatoid arthritis ( RA ) <extra_id_1> <extra_id_0> subject disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> treatment <extra_id_5> 2 1/2 months of treatment with penicillamine <extra_id_1> <extra_id_0> drug <extra_id_5> penicillamine <extra_id_1> <extra_id_0> duration <extra_id_5> 2 1/2 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 2 1/2 months <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> effect <extra_id_5> Thrombotic thrombocytopenic purpura ( TTP ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "developed", "args": [{"type": "subject", "offset": [8, 9, 10, 11, 12, 13, 14, 15, 16], "text": "a patient with seropositive rheumatoid arthritis ( RA )"}, {"type": "subject disorder", "offset": [12, 13], "text": "rheumatoid arthritis"}, {"type": "treatment", "offset": [18, 19, 20, 21, 22, 23, 24], "text": "2 1/2 months of treatment with penicillamine"}, {"type": "drug", "offset": [24], "text": "penicillamine"}, {"type": "duration", "offset": [18, 19, 20], "text": "2 1/2 months"}, {"type": "time elapsed", "offset": [18, 19, 20], "text": "2 1/2 months"}, {"type": "treatment disorder", "offset": [12, 13], "text": "rheumatoid arthritis"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "Thrombotic thrombocytopenic purpura ( TTP )"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "subject", "treatment", "duration", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a patient with seropositive rheumatoid arthritis ( RA )"], ["subject disorder", "rheumatoid arthritis"], ["treatment", "2 1/2 months of treatment with penicillamine"], ["drug", "penicillamine"], ["duration", "2 1/2 months"], ["time elapsed", "2 1/2 months"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "Thrombotic thrombocytopenic purpura ( TTP )"]]}]}
{"text_id": "8292513_2", "text": "Children with acute lymphoblastic leukemia ( ALL ) , treated with L - asparaginase are at risk for cerebral thrombosis or hemorrhage because of coagulation protein deficiencies .", "tokens": ["Children", "with", "acute", "lymphoblastic", "leukemia", "(", "ALL", ")", ",", "treated", "with", "L", "-", "asparaginase", "are", "at", "risk", "for", "cerebral", "thrombosis", "or", "hemorrhage", "because", "of", "coagulation", "protein", "deficiencies", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> risk <extra_id_0> subject <extra_id_5> Children with acute lymphoblastic leukemia ( ALL ) <extra_id_1> <extra_id_0> age <extra_id_5> Children <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute lymphoblastic leukemia ( ALL ) <extra_id_1> <extra_id_0> treatment <extra_id_5> L - asparaginase <extra_id_1> <extra_id_0> drug <extra_id_5> L - asparaginase <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute lymphoblastic leukemia ( ALL ) <extra_id_1> <extra_id_0> effect <extra_id_5> cerebral thrombosis or hemorrhage <extra_id_1> <extra_id_0> effect <extra_id_5> coagulation protein deficiencies <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "risk", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Children with acute lymphoblastic leukemia ( ALL )"}, {"type": "age", "offset": [0], "text": "Children"}, {"type": "subject disorder", "offset": [2, 3, 4, 5, 6, 7], "text": "acute lymphoblastic leukemia ( ALL )"}, {"type": "treatment", "offset": [11, 12, 13], "text": "L - asparaginase"}, {"type": "drug", "offset": [11, 12, 13], "text": "L - asparaginase"}, {"type": "treatment disorder", "offset": [2, 3, 4, 5, 6, 7], "text": "acute lymphoblastic leukemia ( ALL )"}, {"type": "effect", "offset": [18, 19, 20, 21], "text": "cerebral thrombosis or hemorrhage"}, {"type": "effect", "offset": [24, 25, 26], "text": "coagulation protein deficiencies"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "treatment", "drug", "age", "subject disorder"], "spot_asoc": [{"span": "risk", "label": "adverse event", "asoc": [["subject", "Children with acute lymphoblastic leukemia ( ALL )"], ["age", "Children"], ["subject disorder", "acute lymphoblastic leukemia ( ALL )"], ["treatment", "L - asparaginase"], ["drug", "L - asparaginase"], ["treatment disorder", "acute lymphoblastic leukemia ( ALL )"], ["effect", "cerebral thrombosis or hemorrhage"], ["effect", "coagulation protein deficiencies"]]}]}
{"text_id": "9579301_1", "text": "Increased ocular pressure in two patients with narrow angle glaucoma treated with venlafaxine .", "tokens": ["Increased", "ocular", "pressure", "in", "two", "patients", "with", "narrow", "angle", "glaucoma", "treated", "with", "venlafaxine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> two patients with narrow angle glaucoma <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> narrow angle glaucoma <extra_id_1> <extra_id_0> treatment <extra_id_5> venlafaxine <extra_id_1> <extra_id_0> drug <extra_id_5> venlafaxine <extra_id_1> <extra_id_0> effect <extra_id_5> Increased ocular pressure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "in", "args": [{"type": "subject", "offset": [4, 5, 6, 7, 8, 9], "text": "two patients with narrow angle glaucoma"}, {"type": "population", "offset": [4], "text": "two"}, {"type": "subject disorder", "offset": [7, 8, 9], "text": "narrow angle glaucoma"}, {"type": "treatment", "offset": [12], "text": "venlafaxine"}, {"type": "drug", "offset": [12], "text": "venlafaxine"}, {"type": "effect", "offset": [0, 1, 2], "text": "Increased ocular pressure"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "two patients with narrow angle glaucoma"], ["population", "two"], ["subject disorder", "narrow angle glaucoma"], ["treatment", "venlafaxine"], ["drug", "venlafaxine"], ["effect", "Increased ocular pressure"]]}]}
{"text_id": "10084639_2", "text": "CONCLUSION : The results suggest that olanzapine may be useful in treating patients with clozapine - induced granulocytopenia without the risk of recurrence of hematologic side effects .", "tokens": ["CONCLUSION", ":", "The", "results", "suggest", "that", "olanzapine", "may", "be", "useful", "in", "treating", "patients", "with", "clozapine", "-", "induced", "granulocytopenia", "without", "the", "risk", "of", "recurrence", "of", "hematologic", "side", "effects", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treating <extra_id_0> subject <extra_id_5> patients with clozapine - induced granulocytopenia <extra_id_1> <extra_id_0> treatment <extra_id_5> olanzapine <extra_id_1> <extra_id_0> drug <extra_id_5> olanzapine <extra_id_1> <extra_id_0> effect <extra_id_5> without the risk of recurrence of hematologic side effects <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> clozapine - induced granulocytopenia <extra_id_1> <extra_id_0> effect <extra_id_5> granulocytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [11], "text": "treating", "args": [{"type": "subject", "offset": [12, 13, 14, 15, 16, 17], "text": "patients with clozapine - induced granulocytopenia"}, {"type": "treatment", "offset": [6], "text": "olanzapine"}, {"type": "drug", "offset": [6], "text": "olanzapine"}, {"type": "effect", "offset": [18, 19, 20, 21, 22, 23, 24, 25, 26], "text": "without the risk of recurrence of hematologic side effects"}]}, {"type": "adverse event", "offset": [16], "text": "induced", "args": [{"type": "treatment", "offset": [14], "text": "clozapine"}, {"type": "drug", "offset": [14], "text": "clozapine"}, {"type": "treatment disorder", "offset": [14, 15, 16, 17], "text": "clozapine - induced granulocytopenia"}, {"type": "effect", "offset": [17], "text": "granulocytopenia"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "treatment disorder"], "spot_asoc": [{"span": "treating", "label": "potential therapeutic event", "asoc": [["subject", "patients with clozapine - induced granulocytopenia"], ["treatment", "olanzapine"], ["drug", "olanzapine"], ["effect", "without the risk of recurrence of hematologic side effects"]]}, {"span": "induced", "label": "adverse event", "asoc": [["treatment", "clozapine"], ["drug", "clozapine"], ["treatment disorder", "clozapine - induced granulocytopenia"], ["effect", "granulocytopenia"]]}]}
{"text_id": "16298824_6", "text": "We report the case of a 43 - year - old man with ITP refractory to steroids and intravenous immunoglobulin who developed acute respiratory distress syndrome ( ARDS ) after a single infusion of rituximab .", "tokens": ["We", "report", "the", "case", "of", "a", "43", "-", "year", "-", "old", "man", "with", "ITP", "refractory", "to", "steroids", "and", "intravenous", "immunoglobulin", "who", "developed", "acute", "respiratory", "distress", "syndrome", "(", "ARDS", ")", "after", "a", "single", "infusion", "of", "rituximab", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> the case of a 43 - year - old man with ITP refractory to steroids and intravenous immunoglobulin <extra_id_1> <extra_id_0> age <extra_id_5> 43 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> refractory to steroids and intravenous immunoglobulin <extra_id_1> <extra_id_0> subject disorder <extra_id_5> ITP <extra_id_1> <extra_id_0> treatment <extra_id_5> single infusion of rituximab <extra_id_1> <extra_id_0> drug <extra_id_5> rituximab <extra_id_1> <extra_id_0> route <extra_id_5> infusion <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> ITP <extra_id_1> <extra_id_0> effect <extra_id_5> acute respiratory distress syndrome ( ARDS ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [21], "text": "developed", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19], "text": "the case of a 43 - year - old man with ITP refractory to steroids and intravenous immunoglobulin"}, {"type": "age", "offset": [6, 7, 8, 9, 10], "text": "43 - year - old"}, {"type": "gender", "offset": [11], "text": "man"}, {"type": "subject disorder", "offset": [14, 15, 16, 17, 18, 19], "text": "refractory to steroids and intravenous immunoglobulin"}, {"type": "subject disorder", "offset": [13], "text": "ITP"}, {"type": "treatment", "offset": [31, 32, 33, 34], "text": "single infusion of rituximab"}, {"type": "drug", "offset": [34], "text": "rituximab"}, {"type": "route", "offset": [32], "text": "infusion"}, {"type": "treatment disorder", "offset": [13], "text": "ITP"}, {"type": "effect", "offset": [22, 23, 24, 25, 26, 27, 28], "text": "acute respiratory distress syndrome ( ARDS )"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "the case of a 43 - year - old man with ITP refractory to steroids and intravenous immunoglobulin"], ["age", "43 - year - old"], ["gender", "man"], ["subject disorder", "refractory to steroids and intravenous immunoglobulin"], ["subject disorder", "ITP"], ["treatment", "single infusion of rituximab"], ["drug", "rituximab"], ["route", "infusion"], ["treatment disorder", "ITP"], ["effect", "acute respiratory distress syndrome ( ARDS )"]]}]}
{"text_id": "25157214_3", "text": "The aim of this post - hoc analysis of data from a Phase III clinical trial ( VISTA ; NCT00298831 ) was to investigate the impact of antibiotics on recovery from rocuronium - induced NMB after administration of sugammadex for reversal , and compared the neuromuscular recovery in patients who received antibiotics preoperatively with those who did not .", "tokens": ["The", "aim", "of", "this", "post", "-", "hoc", "analysis", "of", "data", "from", "a", "Phase", "III", "clinical", "trial", "(", "VISTA", ";", "NCT00298831", ")", "was", "to", "investigate", "the", "impact", "of", "antibiotics", "on", "recovery", "from", "rocuronium", "-", "induced", "NMB", "after", "administration", "of", "sugammadex", "for", "reversal", ",", "and", "compared", "the", "neuromuscular", "recovery", "in", "patients", "who", "received", "antibiotics", "preoperatively", "with", "those", "who", "did", "not", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> rocuronium <extra_id_1> <extra_id_0> drug <extra_id_5> rocuronium <extra_id_1> <extra_id_0> effect <extra_id_5> NMB <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> recovery <extra_id_0> treatment <extra_id_5> antibiotics <extra_id_1> <extra_id_0> drug <extra_id_5> antibiotics <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rocuronium - induced NMB <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [33], "text": "induced", "args": [{"type": "treatment", "offset": [31], "text": "rocuronium"}, {"type": "drug", "offset": [31], "text": "rocuronium"}, {"type": "effect", "offset": [34], "text": "NMB"}]}, {"type": "potential therapeutic event", "offset": [29], "text": "recovery", "args": [{"type": "treatment", "offset": [27], "text": "antibiotics"}, {"type": "drug", "offset": [27], "text": "antibiotics"}, {"type": "treatment disorder", "offset": [31, 32, 33, 34], "text": "rocuronium - induced NMB"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "rocuronium"], ["drug", "rocuronium"], ["effect", "NMB"]]}, {"span": "recovery", "label": "potential therapeutic event", "asoc": [["treatment", "antibiotics"], ["drug", "antibiotics"], ["treatment disorder", "rocuronium - induced NMB"]]}]}
{"text_id": "6519218_2", "text": "Interstitial pneumopathy and low - dosage amiodarone .", "tokens": ["Interstitial", "pneumopathy", "and", "low", "-", "dosage", "amiodarone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> and <extra_id_0> treatment <extra_id_5> low - dosage amiodarone <extra_id_1> <extra_id_0> drug <extra_id_5> amiodarone <extra_id_1> <extra_id_0> dosage <extra_id_5> low - dosage <extra_id_1> <extra_id_0> effect <extra_id_5> Interstitial pneumopathy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "and", "args": [{"type": "treatment", "offset": [3, 4, 5, 6], "text": "low - dosage amiodarone"}, {"type": "drug", "offset": [6], "text": "amiodarone"}, {"type": "dosage", "offset": [3, 4, 5], "text": "low - dosage"}, {"type": "effect", "offset": [0, 1], "text": "Interstitial pneumopathy"}]}], "spot": ["adverse event"], "asoc": ["dosage", "treatment", "drug", "effect"], "spot_asoc": [{"span": "and", "label": "adverse event", "asoc": [["treatment", "low - dosage amiodarone"], ["drug", "amiodarone"], ["dosage", "low - dosage"], ["effect", "Interstitial pneumopathy"]]}]}
{"text_id": "7962394_3", "text": "Hypo - oestrogenic and anabolic / androgenic side - effects of danazol are well known by the gynaecologist and some of them are present in > 50 % of patients being treated for endometriosis .", "tokens": ["Hypo", "-", "oestrogenic", "and", "anabolic", "/", "androgenic", "side", "-", "effects", "of", "danazol", "are", "well", "known", "by", "the", "gynaecologist", "and", "some", "of", "them", "are", "present", "in", ">", "50", "%", "of", "patients", "being", "treated", "for", "endometriosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> side - effects <extra_id_0> treatment <extra_id_5> danazol <extra_id_1> <extra_id_0> drug <extra_id_5> danazol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> endometriosis <extra_id_1> <extra_id_0> effect <extra_id_5> Hypo - oestrogenic and anabolic / androgenic <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7, 8, 9], "text": "side - effects", "args": [{"type": "treatment", "offset": [11], "text": "danazol"}, {"type": "drug", "offset": [11], "text": "danazol"}, {"type": "treatment disorder", "offset": [33], "text": "endometriosis"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Hypo - oestrogenic and anabolic / androgenic"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "side - effects", "label": "adverse event", "asoc": [["treatment", "danazol"], ["drug", "danazol"], ["treatment disorder", "endometriosis"], ["effect", "Hypo - oestrogenic and anabolic / androgenic"]]}]}
{"text_id": "12523465_2", "text": "Visual hallucinations associated with zonisamide .", "tokens": ["Visual", "hallucinations", "associated", "with", "zonisamide", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated with <extra_id_0> treatment <extra_id_5> zonisamide <extra_id_1> <extra_id_0> drug <extra_id_5> zonisamide <extra_id_1> <extra_id_0> effect <extra_id_5> Visual hallucinations <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2, 3], "text": "associated with", "args": [{"type": "treatment", "offset": [4], "text": "zonisamide"}, {"type": "drug", "offset": [4], "text": "zonisamide"}, {"type": "effect", "offset": [0, 1], "text": "Visual hallucinations"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated with", "label": "adverse event", "asoc": [["treatment", "zonisamide"], ["drug", "zonisamide"], ["effect", "Visual hallucinations"]]}]}
{"text_id": "17324248_2", "text": "CONCLUSIONS : The piloerection observed after the replacement of fluvoxamine with milnacipran in this patient appears to have been due to an increase in the alpha(1) - adrenoceptor occupancy by endogenous norepinephrine induced by milnacipran .", "tokens": ["CONCLUSIONS", ":", "The", "piloerection", "observed", "after", "the", "replacement", "of", "fluvoxamine", "with", "milnacipran", "in", "this", "patient", "appears", "to", "have", "been", "due", "to", "an", "increase", "in", "the", "alpha(1)", "-", "adrenoceptor", "occupancy", "by", "endogenous", "norepinephrine", "induced", "by", "milnacipran", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> milnacipran <extra_id_1> <extra_id_0> drug <extra_id_5> milnacipran <extra_id_1> <extra_id_0> effect <extra_id_5> an increase in the alpha(1) - adrenoceptor occupancy by endogenous norepinephrine <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> observed <extra_id_0> subject <extra_id_5> this patient <extra_id_1> <extra_id_0> treatment <extra_id_5> milnacipran <extra_id_1> <extra_id_0> drug <extra_id_5> milnacipran <extra_id_1> <extra_id_0> effect <extra_id_5> piloerection <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [32], "text": "induced", "args": [{"type": "treatment", "offset": [34], "text": "milnacipran"}, {"type": "drug", "offset": [34], "text": "milnacipran"}, {"type": "effect", "offset": [21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31], "text": "an increase in the alpha(1) - adrenoceptor occupancy by endogenous norepinephrine"}]}, {"type": "adverse event", "offset": [4], "text": "observed", "args": [{"type": "subject", "offset": [13, 14], "text": "this patient"}, {"type": "treatment", "offset": [11], "text": "milnacipran"}, {"type": "drug", "offset": [11], "text": "milnacipran"}, {"type": "effect", "offset": [3], "text": "piloerection"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "milnacipran"], ["drug", "milnacipran"], ["effect", "an increase in the alpha(1) - adrenoceptor occupancy by endogenous norepinephrine"]]}, {"span": "observed", "label": "adverse event", "asoc": [["subject", "this patient"], ["treatment", "milnacipran"], ["drug", "milnacipran"], ["effect", "piloerection"]]}]}
{"text_id": "10891991_7", "text": "The polycystic changes disappeared from the ovaries in 2 of the women after valproate therapy was discontinued , and the 2 women who had gained weight and developed amenorrhea while being treated with valproate lost weight and resumed menstruating after the change in medication .", "tokens": ["The", "polycystic", "changes", "disappeared", "from", "the", "ovaries", "in", "2", "of", "the", "women", "after", "valproate", "therapy", "was", "discontinued", ",", "and", "the", "2", "women", "who", "had", "gained", "weight", "and", "developed", "amenorrhea", "while", "being", "treated", "with", "valproate", "lost", "weight", "and", "resumed", "menstruating", "after", "the", "change", "in", "medication", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> disappeared <extra_id_0> subject <extra_id_5> 2 of the women <extra_id_1> <extra_id_0> gender <extra_id_5> women <extra_id_1> <extra_id_0> population <extra_id_5> 2 <extra_id_1> <extra_id_0> treatment <extra_id_5> after valproate therapy was discontinued <extra_id_1> <extra_id_0> drug <extra_id_5> valproate <extra_id_1> <extra_id_0> effect <extra_id_5> polycystic changes disappeared from the ovaries <extra_id_1> <extra_id_0> effect <extra_id_5> lost weight and resumed menstruating <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> while <extra_id_0> subject <extra_id_5> 2 women <extra_id_1> <extra_id_0> gender <extra_id_5> women <extra_id_1> <extra_id_0> population <extra_id_5> 2 <extra_id_1> <extra_id_0> treatment <extra_id_5> valproate <extra_id_1> <extra_id_0> drug <extra_id_5> valproate <extra_id_1> <extra_id_0> effect <extra_id_5> gained weight and developed amenorrhea <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [3], "text": "disappeared", "args": [{"type": "subject", "offset": [8, 9, 10, 11], "text": "2 of the women"}, {"type": "gender", "offset": [11], "text": "women"}, {"type": "population", "offset": [8], "text": "2"}, {"type": "treatment", "offset": [12, 13, 14, 15, 16], "text": "after valproate therapy was discontinued"}, {"type": "drug", "offset": [13], "text": "valproate"}, {"type": "effect", "offset": [1, 2, 3, 4, 5, 6], "text": "polycystic changes disappeared from the ovaries"}, {"type": "effect", "offset": [34, 35, 36, 37, 38], "text": "lost weight and resumed menstruating"}]}, {"type": "adverse event", "offset": [29], "text": "while", "args": [{"type": "subject", "offset": [20, 21], "text": "2 women"}, {"type": "gender", "offset": [21], "text": "women"}, {"type": "population", "offset": [20], "text": "2"}, {"type": "treatment", "offset": [33], "text": "valproate"}, {"type": "drug", "offset": [33], "text": "valproate"}, {"type": "effect", "offset": [24, 25, 26, 27, 28], "text": "gained weight and developed amenorrhea"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["population", "effect", "subject", "drug", "gender", "treatment"], "spot_asoc": [{"span": "disappeared", "label": "potential therapeutic event", "asoc": [["subject", "2 of the women"], ["gender", "women"], ["population", "2"], ["treatment", "after valproate therapy was discontinued"], ["drug", "valproate"], ["effect", "polycystic changes disappeared from the ovaries"], ["effect", "lost weight and resumed menstruating"]]}, {"span": "while", "label": "adverse event", "asoc": [["subject", "2 women"], ["gender", "women"], ["population", "2"], ["treatment", "valproate"], ["drug", "valproate"], ["effect", "gained weight and developed amenorrhea"]]}]}
{"text_id": "15580406_1", "text": "Here , we describe a case of Vogt - Koyanagi - Harada disease occurring 4 months after the start of interferon alpha treatment , probably induced by the immunomodulatory effects of interferon .", "tokens": ["Here", ",", "we", "describe", "a", "case", "of", "Vogt", "-", "Koyanagi", "-", "Harada", "disease", "occurring", "4", "months", "after", "the", "start", "of", "interferon", "alpha", "treatment", ",", "probably", "induced", "by", "the", "immunomodulatory", "effects", "of", "interferon", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurring <extra_id_0> subject <extra_id_5> a case <extra_id_1> <extra_id_0> treatment <extra_id_5> 4 months after the start of interferon alpha <extra_id_1> <extra_id_0> drug <extra_id_5> interferon alpha <extra_id_1> <extra_id_0> duration <extra_id_5> 4 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 4 months <extra_id_1> <extra_id_0> effect <extra_id_5> Vogt - Koyanagi - Harada disease <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "occurring", "args": [{"type": "subject", "offset": [4, 5], "text": "a case"}, {"type": "treatment", "offset": [14, 15, 16, 17, 18, 19, 20, 21], "text": "4 months after the start of interferon alpha"}, {"type": "drug", "offset": [20, 21], "text": "interferon alpha"}, {"type": "duration", "offset": [14, 15], "text": "4 months"}, {"type": "time elapsed", "offset": [14, 15], "text": "4 months"}, {"type": "effect", "offset": [7, 8, 9, 10, 11, 12], "text": "Vogt - Koyanagi - Harada disease"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "subject", "drug", "time elapsed", "treatment"], "spot_asoc": [{"span": "occurring", "label": "adverse event", "asoc": [["subject", "a case"], ["treatment", "4 months after the start of interferon alpha"], ["drug", "interferon alpha"], ["duration", "4 months"], ["time elapsed", "4 months"], ["effect", "Vogt - Koyanagi - Harada disease"]]}]}
{"text_id": "6484655_1", "text": "Although they had complex medical problems , the high serum concentrations of ampicillin at the time of seizures without their recurrence after discontinuing the antibiotic suggest that the seizures were related to the ampicillin therapy .", "tokens": ["Although", "they", "had", "complex", "medical", "problems", ",", "the", "high", "serum", "concentrations", "of", "ampicillin", "at", "the", "time", "of", "seizures", "without", "their", "recurrence", "after", "discontinuing", "the", "antibiotic", "suggest", "that", "the", "seizures", "were", "related", "to", "the", "ampicillin", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> treatment <extra_id_5> ampicillin therapy <extra_id_1> <extra_id_0> drug <extra_id_5> ampicillin <extra_id_1> <extra_id_0> effect <extra_id_5> seizures <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [30], "text": "related", "args": [{"type": "treatment", "offset": [33, 34], "text": "ampicillin therapy"}, {"type": "drug", "offset": [33], "text": "ampicillin"}, {"type": "effect", "offset": [28], "text": "seizures"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["treatment", "ampicillin therapy"], ["drug", "ampicillin"], ["effect", "seizures"]]}]}
{"text_id": "12460237_5", "text": "Contrary to previous recommendations , our experience cautions against the further use of high - dose cytarabine in patients who develop PPE , and is a timely reminder of the potential toxicity of this agent , which is now increasingly being used as first - line treatment in the management of haematologic malignancies .", "tokens": ["Contrary", "to", "previous", "recommendations", ",", "our", "experience", "cautions", "against", "the", "further", "use", "of", "high", "-", "dose", "cytarabine", "in", "patients", "who", "develop", "PPE", ",", "and", "is", "a", "timely", "reminder", "of", "the", "potential", "toxicity", "of", "this", "agent", ",", "which", "is", "now", "increasingly", "being", "used", "as", "first", "-", "line", "treatment", "in", "the", "management", "of", "haematologic", "malignancies", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> toxicity <extra_id_0> treatment <extra_id_5> high - dose cytarabine <extra_id_1> <extra_id_0> drug <extra_id_5> cytarabine <extra_id_1> <extra_id_0> dosage <extra_id_5> high - dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> haematologic malignancies <extra_id_1> <extra_id_0> effect <extra_id_5> PPE <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [31], "text": "toxicity", "args": [{"type": "treatment", "offset": [13, 14, 15, 16], "text": "high - dose cytarabine"}, {"type": "drug", "offset": [16], "text": "cytarabine"}, {"type": "dosage", "offset": [13, 14, 15], "text": "high - dose"}, {"type": "treatment disorder", "offset": [51, 52], "text": "haematologic malignancies"}, {"type": "effect", "offset": [21], "text": "PPE"}]}], "spot": ["adverse event"], "asoc": ["effect", "drug", "dosage", "treatment disorder", "treatment"], "spot_asoc": [{"span": "toxicity", "label": "adverse event", "asoc": [["treatment", "high - dose cytarabine"], ["drug", "cytarabine"], ["dosage", "high - dose"], ["treatment disorder", "haematologic malignancies"], ["effect", "PPE"]]}]}
{"text_id": "11431864_1", "text": "After the dose of methylprednisolone was reduced from 40 mg to 20 mg i.v . q6h and shifted to other anti - asthma treatment by procaterol metered dose inhaler via spacer , the psychotic reaction disappeared a few hours later .", "tokens": ["After", "the", "dose", "of", "methylprednisolone", "was", "reduced", "from", "40", "mg", "to", "20", "mg", "i.v", ".", "q6h", "and", "shifted", "to", "other", "anti", "-", "asthma", "treatment", "by", "procaterol", "metered", "dose", "inhaler", "via", "spacer", ",", "the", "psychotic", "reaction", "disappeared", "a", "few", "hours", "later", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> disappeared <extra_id_0> treatment <extra_id_5> After the dose of methylprednisolone was reduced from 40 mg to 20 mg i.v . q6h and shifted to other anti - asthma treatment by procaterol metered dose inhaler via spacer <extra_id_1> <extra_id_0> treatment <extra_id_5> a few hours later <extra_id_1> <extra_id_0> drug <extra_id_5> methylprednisolone <extra_id_1> <extra_id_0> dosage <extra_id_5> reduced from 40 mg to 20 mg i.v . q6h <extra_id_1> <extra_id_0> route <extra_id_5> spacer <extra_id_1> <extra_id_0> duration <extra_id_5> a few hours <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> psychotic reaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [35], "text": "disappeared", "args": [{"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30], "text": "After the dose of methylprednisolone was reduced from 40 mg to 20 mg i.v . q6h and shifted to other anti - asthma treatment by procaterol metered dose inhaler via spacer"}, {"type": "treatment", "offset": [36, 37, 38, 39], "text": "a few hours later"}, {"type": "drug", "offset": [4], "text": "methylprednisolone"}, {"type": "dosage", "offset": [6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "reduced from 40 mg to 20 mg i.v . q6h"}, {"type": "route", "offset": [30], "text": "spacer"}, {"type": "duration", "offset": [36, 37, 38], "text": "a few hours"}, {"type": "treatment disorder", "offset": [33, 34], "text": "psychotic reaction"}]}], "spot": ["potential therapeutic event"], "asoc": ["route", "drug", "duration", "dosage", "treatment disorder", "treatment"], "spot_asoc": [{"span": "disappeared", "label": "potential therapeutic event", "asoc": [["treatment", "After the dose of methylprednisolone was reduced from 40 mg to 20 mg i.v . q6h and shifted to other anti - asthma treatment by procaterol metered dose inhaler via spacer"], ["treatment", "a few hours later"], ["drug", "methylprednisolone"], ["dosage", "reduced from 40 mg to 20 mg i.v . q6h"], ["route", "spacer"], ["duration", "a few hours"], ["treatment disorder", "psychotic reaction"]]}]}
{"text_id": "18585545_4", "text": "Levofloxacin - induced delirium with psychotic features .", "tokens": ["Levofloxacin", "-", "induced", "delirium", "with", "psychotic", "features", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Levofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> Levofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> delirium with psychotic features <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Levofloxacin"}, {"type": "drug", "offset": [0], "text": "Levofloxacin"}, {"type": "effect", "offset": [3, 4, 5, 6], "text": "delirium with psychotic features"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Levofloxacin"], ["drug", "Levofloxacin"], ["effect", "delirium with psychotic features"]]}]}
{"text_id": "7914463_1", "text": "Flumazenil reversal of benzodiazepine - induced sedation for a patient with severe pre - ECT anxiety .", "tokens": ["Flumazenil", "reversal", "of", "benzodiazepine", "-", "induced", "sedation", "for", "a", "patient", "with", "severe", "pre", "-", "ECT", "anxiety", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a patient with severe pre - ECT anxiety <extra_id_1> <extra_id_0> subject disorder <extra_id_5> severe pre - ECT anxiety <extra_id_1> <extra_id_0> treatment <extra_id_5> benzodiazepine <extra_id_1> <extra_id_0> drug <extra_id_5> benzodiazepine <extra_id_1> <extra_id_0> effect <extra_id_5> sedation <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> reversal <extra_id_0> subject <extra_id_5> a patient with severe pre - ECT anxiety <extra_id_1> <extra_id_0> subject disorder <extra_id_5> severe pre - ECT anxiety <extra_id_1> <extra_id_0> subject disorder <extra_id_5> benzodiazepine - induced sedation <extra_id_1> <extra_id_0> treatment <extra_id_5> Flumazenil <extra_id_1> <extra_id_0> drug <extra_id_5> Flumazenil <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> benzodiazepine - induced sedation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "induced", "args": [{"type": "subject", "offset": [8, 9, 10, 11, 12, 13, 14, 15], "text": "a patient with severe pre - ECT anxiety"}, {"type": "subject disorder", "offset": [11, 12, 13, 14, 15], "text": "severe pre - ECT anxiety"}, {"type": "treatment", "offset": [3], "text": "benzodiazepine"}, {"type": "drug", "offset": [3], "text": "benzodiazepine"}, {"type": "effect", "offset": [6], "text": "sedation"}]}, {"type": "potential therapeutic event", "offset": [1], "text": "reversal", "args": [{"type": "subject", "offset": [8, 9, 10, 11, 12, 13, 14, 15], "text": "a patient with severe pre - ECT anxiety"}, {"type": "subject disorder", "offset": [11, 12, 13, 14, 15], "text": "severe pre - ECT anxiety"}, {"type": "subject disorder", "offset": [3, 4, 5, 6], "text": "benzodiazepine - induced sedation"}, {"type": "treatment", "offset": [0], "text": "Flumazenil"}, {"type": "drug", "offset": [0], "text": "Flumazenil"}, {"type": "treatment disorder", "offset": [3, 4, 5, 6], "text": "benzodiazepine - induced sedation"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a patient with severe pre - ECT anxiety"], ["subject disorder", "severe pre - ECT anxiety"], ["treatment", "benzodiazepine"], ["drug", "benzodiazepine"], ["effect", "sedation"]]}, {"span": "reversal", "label": "potential therapeutic event", "asoc": [["subject", "a patient with severe pre - ECT anxiety"], ["subject disorder", "severe pre - ECT anxiety"], ["subject disorder", "benzodiazepine - induced sedation"], ["treatment", "Flumazenil"], ["drug", "Flumazenil"], ["treatment disorder", "benzodiazepine - induced sedation"]]}]}
{"text_id": "18717612_3", "text": "We report the first case of a 54 - year - old Turkish woman who presented with ceftriaxone - induced FDE .", "tokens": ["We", "report", "the", "first", "case", "of", "a", "54", "-", "year", "-", "old", "Turkish", "woman", "who", "presented", "with", "ceftriaxone", "-", "induced", "FDE", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a 54 - year - old Turkish woman <extra_id_1> <extra_id_0> age <extra_id_5> 54 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> race <extra_id_5> Turkish <extra_id_1> <extra_id_0> treatment <extra_id_5> ceftriaxone <extra_id_1> <extra_id_0> drug <extra_id_5> ceftriaxone <extra_id_1> <extra_id_0> effect <extra_id_5> FDE <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "induced", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10, 11, 12, 13], "text": "a 54 - year - old Turkish woman"}, {"type": "age", "offset": [7, 8, 9, 10, 11], "text": "54 - year - old"}, {"type": "gender", "offset": [13], "text": "woman"}, {"type": "race", "offset": [12], "text": "Turkish"}, {"type": "treatment", "offset": [17], "text": "ceftriaxone"}, {"type": "drug", "offset": [17], "text": "ceftriaxone"}, {"type": "effect", "offset": [20], "text": "FDE"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "gender", "treatment", "age", "race"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a 54 - year - old Turkish woman"], ["age", "54 - year - old"], ["gender", "woman"], ["race", "Turkish"], ["treatment", "ceftriaxone"], ["drug", "ceftriaxone"], ["effect", "FDE"]]}]}
{"text_id": "12121061_2", "text": "A 50 - year - old diabetic and hypertensive male patient is reported who had ticlopidine - induced marrow aplasia partially responsive to colony - stimulating factors and corticosteroids , but experienced complete recovery with cyclosporine .", "tokens": ["A", "50", "-", "year", "-", "old", "diabetic", "and", "hypertensive", "male", "patient", "is", "reported", "who", "had", "ticlopidine", "-", "induced", "marrow", "aplasia", "partially", "responsive", "to", "colony", "-", "stimulating", "factors", "and", "corticosteroids", ",", "but", "experienced", "complete", "recovery", "with", "cyclosporine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> 50 - year - old diabetic and hypertensive male patient <extra_id_1> <extra_id_0> age <extra_id_5> 50 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> male <extra_id_1> <extra_id_0> subject disorder <extra_id_5> diabetic and hypertensive <extra_id_1> <extra_id_0> treatment <extra_id_5> ticlopidine <extra_id_1> <extra_id_0> drug <extra_id_5> ticlopidine <extra_id_1> <extra_id_0> effect <extra_id_5> marrow aplasia <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> with <extra_id_0> subject <extra_id_5> 50 - year - old diabetic and hypertensive male patient <extra_id_1> <extra_id_0> age <extra_id_5> 50 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> male <extra_id_1> <extra_id_0> subject disorder <extra_id_5> diabetic and hypertensive <extra_id_1> <extra_id_0> subject disorder <extra_id_5> ticlopidine - induced marrow aplasia <extra_id_1> <extra_id_0> treatment <extra_id_5> cyclosporine <extra_id_1> <extra_id_0> drug <extra_id_5> cyclosporine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> ticlopidine - induced marrow aplasia <extra_id_1> <extra_id_0> effect <extra_id_5> experienced complete recovery <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "induced", "args": [{"type": "subject", "offset": [1, 2, 3, 4, 5, 6, 7, 8, 9, 10], "text": "50 - year - old diabetic and hypertensive male patient"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "50 - year - old"}, {"type": "gender", "offset": [9], "text": "male"}, {"type": "subject disorder", "offset": [6, 7, 8], "text": "diabetic and hypertensive"}, {"type": "treatment", "offset": [15], "text": "ticlopidine"}, {"type": "drug", "offset": [15], "text": "ticlopidine"}, {"type": "effect", "offset": [18, 19], "text": "marrow aplasia"}]}, {"type": "potential therapeutic event", "offset": [34], "text": "with", "args": [{"type": "subject", "offset": [1, 2, 3, 4, 5, 6, 7, 8, 9, 10], "text": "50 - year - old diabetic and hypertensive male patient"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "50 - year - old"}, {"type": "gender", "offset": [9], "text": "male"}, {"type": "subject disorder", "offset": [6, 7, 8], "text": "diabetic and hypertensive"}, {"type": "subject disorder", "offset": [15, 16, 17, 18, 19], "text": "ticlopidine - induced marrow aplasia"}, {"type": "treatment", "offset": [35], "text": "cyclosporine"}, {"type": "drug", "offset": [35], "text": "cyclosporine"}, {"type": "treatment disorder", "offset": [15, 16, 17, 18, 19], "text": "ticlopidine - induced marrow aplasia"}, {"type": "effect", "offset": [31, 32, 33], "text": "experienced complete recovery"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "50 - year - old diabetic and hypertensive male patient"], ["age", "50 - year - old"], ["gender", "male"], ["subject disorder", "diabetic and hypertensive"], ["treatment", "ticlopidine"], ["drug", "ticlopidine"], ["effect", "marrow aplasia"]]}, {"span": "with", "label": "potential therapeutic event", "asoc": [["subject", "50 - year - old diabetic and hypertensive male patient"], ["age", "50 - year - old"], ["gender", "male"], ["subject disorder", "diabetic and hypertensive"], ["subject disorder", "ticlopidine - induced marrow aplasia"], ["treatment", "cyclosporine"], ["drug", "cyclosporine"], ["treatment disorder", "ticlopidine - induced marrow aplasia"], ["effect", "experienced complete recovery"]]}]}
{"text_id": "17285101_3", "text": "This is the first report of pulmonary hypertension in an adult patient during lithium therapy .", "tokens": ["This", "is", "the", "first", "report", "of", "pulmonary", "hypertension", "in", "an", "adult", "patient", "during", "lithium", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> subject <extra_id_5> an adult patient <extra_id_1> <extra_id_0> age <extra_id_5> adult <extra_id_1> <extra_id_0> treatment <extra_id_5> lithium therapy . <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary hypertension <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "during", "args": [{"type": "subject", "offset": [9, 10, 11], "text": "an adult patient"}, {"type": "age", "offset": [10], "text": "adult"}, {"type": "treatment", "offset": [13, 14, 15], "text": "lithium therapy ."}, {"type": "drug", "offset": [13], "text": "lithium"}, {"type": "effect", "offset": [6, 7], "text": "pulmonary hypertension"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["subject", "an adult patient"], ["age", "adult"], ["treatment", "lithium therapy ."], ["drug", "lithium"], ["effect", "pulmonary hypertension"]]}]}
{"text_id": "10650865_2", "text": "We report on a 14 - year - old boy with severe haemophilia A who developed a portal vein thrombosis during continuous infusion of F VIII .", "tokens": ["We", "report", "on", "a", "14", "-", "year", "-", "old", "boy", "with", "severe", "haemophilia", "A", "who", "developed", "a", "portal", "vein", "thrombosis", "during", "continuous", "infusion", "of", "F", "VIII", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a 14 - year - old boy with severe haemophilia A <extra_id_1> <extra_id_0> age <extra_id_5> 14 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> boy <extra_id_1> <extra_id_0> subject disorder <extra_id_5> haemophilia A <extra_id_1> <extra_id_0> treatment <extra_id_5> continuous infusion of F VIII <extra_id_1> <extra_id_0> drug <extra_id_5> F VIII <extra_id_1> <extra_id_0> frequency <extra_id_5> continuous <extra_id_1> <extra_id_0> route <extra_id_5> infusion <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> haemophilia A <extra_id_1> <extra_id_0> effect <extra_id_5> a portal vein thrombosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13], "text": "a 14 - year - old boy with severe haemophilia A"}, {"type": "age", "offset": [4, 5, 6, 7, 8], "text": "14 - year - old"}, {"type": "gender", "offset": [9], "text": "boy"}, {"type": "subject disorder", "offset": [12, 13], "text": "haemophilia A"}, {"type": "treatment", "offset": [21, 22, 23, 24, 25], "text": "continuous infusion of F VIII"}, {"type": "drug", "offset": [24, 25], "text": "F VIII"}, {"type": "frequency", "offset": [21], "text": "continuous"}, {"type": "route", "offset": [22], "text": "infusion"}, {"type": "treatment disorder", "offset": [12, 13], "text": "haemophilia A"}, {"type": "effect", "offset": [16, 17, 18, 19], "text": "a portal vein thrombosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment disorder", "drug", "gender", "frequency", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a 14 - year - old boy with severe haemophilia A"], ["age", "14 - year - old"], ["gender", "boy"], ["subject disorder", "haemophilia A"], ["treatment", "continuous infusion of F VIII"], ["drug", "F VIII"], ["frequency", "continuous"], ["route", "infusion"], ["treatment disorder", "haemophilia A"], ["effect", "a portal vein thrombosis"]]}]}
{"text_id": "18343993_2", "text": "A female patient with HER2 positive , metastatic breast cancer presented with pulmonary infiltrates , and a plural effusion dyspnoea after several months of trastuzumab treatment .", "tokens": ["A", "female", "patient", "with", "HER2", "positive", ",", "metastatic", "breast", "cancer", "presented", "with", "pulmonary", "infiltrates", ",", "and", "a", "plural", "effusion", "dyspnoea", "after", "several", "months", "of", "trastuzumab", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> presented <extra_id_0> subject <extra_id_5> A female patient with HER2 positive , metastatic breast cancer <extra_id_1> <extra_id_0> gender <extra_id_5> female <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HER2 positive , metastatic breast cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> trastuzumab <extra_id_1> <extra_id_0> drug <extra_id_5> trastuzumab <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HER2 positive , metastatic breast cancer <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary infiltrates , and a plural effusion dyspnoea <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "presented", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9], "text": "A female patient with HER2 positive , metastatic breast cancer"}, {"type": "gender", "offset": [1], "text": "female"}, {"type": "subject disorder", "offset": [4, 5, 6, 7, 8, 9], "text": "HER2 positive , metastatic breast cancer"}, {"type": "treatment", "offset": [24], "text": "trastuzumab"}, {"type": "drug", "offset": [24], "text": "trastuzumab"}, {"type": "treatment disorder", "offset": [4, 5, 6, 7, 8, 9], "text": "HER2 positive , metastatic breast cancer"}, {"type": "effect", "offset": [12, 13, 14, 15, 16, 17, 18, 19], "text": "pulmonary infiltrates , and a plural effusion dyspnoea"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "presented", "label": "adverse event", "asoc": [["subject", "A female patient with HER2 positive , metastatic breast cancer"], ["gender", "female"], ["subject disorder", "HER2 positive , metastatic breast cancer"], ["treatment", "trastuzumab"], ["drug", "trastuzumab"], ["treatment disorder", "HER2 positive , metastatic breast cancer"], ["effect", "pulmonary infiltrates , and a plural effusion dyspnoea"]]}]}
{"text_id": "17044380_2", "text": "Warfarin - induced skin necrosis and heparin - induced thrombocytopenia following mitral valve replacement for marantic endocarditis .", "tokens": ["Warfarin", "-", "induced", "skin", "necrosis", "and", "heparin", "-", "induced", "thrombocytopenia", "following", "mitral", "valve", "replacement", "for", "marantic", "endocarditis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> Warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> skin necrosis <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> heparin <extra_id_1> <extra_id_0> drug <extra_id_5> heparin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> marantic endocarditis <extra_id_1> <extra_id_0> effect <extra_id_5> thrombocytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Warfarin"}, {"type": "drug", "offset": [0], "text": "Warfarin"}, {"type": "effect", "offset": [3, 4], "text": "skin necrosis"}]}, {"type": "adverse event", "offset": [8], "text": "induced", "args": [{"type": "treatment", "offset": [6], "text": "heparin"}, {"type": "drug", "offset": [6], "text": "heparin"}, {"type": "treatment disorder", "offset": [15, 16], "text": "marantic endocarditis"}, {"type": "effect", "offset": [9], "text": "thrombocytopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Warfarin"], ["drug", "Warfarin"], ["effect", "skin necrosis"]]}, {"span": "induced", "label": "adverse event", "asoc": [["treatment", "heparin"], ["drug", "heparin"], ["treatment disorder", "marantic endocarditis"], ["effect", "thrombocytopenia"]]}]}
{"text_id": "17122225_2", "text": "Serotonin syndrome is a potentially lethal adverse drug reaction that may occur in patients taking proserotoninergic medications .", "tokens": ["Serotonin", "syndrome", "is", "a", "potentially", "lethal", "adverse", "drug", "reaction", "that", "may", "occur", "in", "patients", "taking", "proserotoninergic", "medications", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occur <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Serotonin syndrome <extra_id_1> <extra_id_0> treatment <extra_id_5> proserotoninergic medications <extra_id_1> <extra_id_0> drug <extra_id_5> proserotoninergic <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Serotonin syndrome <extra_id_1> <extra_id_0> effect <extra_id_5> Serotonin syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "occur", "args": [{"type": "subject", "offset": [13], "text": "patients"}, {"type": "subject disorder", "offset": [0, 1], "text": "Serotonin syndrome"}, {"type": "treatment", "offset": [15, 16], "text": "proserotoninergic medications"}, {"type": "drug", "offset": [15], "text": "proserotoninergic"}, {"type": "treatment disorder", "offset": [0, 1], "text": "Serotonin syndrome"}, {"type": "effect", "offset": [0, 1], "text": "Serotonin syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "occur", "label": "adverse event", "asoc": [["subject", "patients"], ["subject disorder", "Serotonin syndrome"], ["treatment", "proserotoninergic medications"], ["drug", "proserotoninergic"], ["treatment disorder", "Serotonin syndrome"], ["effect", "Serotonin syndrome"]]}]}
{"text_id": "18698687_2", "text": "Vanishing bile duct and Stevens - Johnson syndrome associated with ciprofloxacin treated with tacrolimus .", "tokens": ["Vanishing", "bile", "duct", "and", "Stevens", "-", "Johnson", "syndrome", "associated", "with", "ciprofloxacin", "treated", "with", "tacrolimus", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> Vanishing bile duct and Stevens - Johnson syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "associated", "args": [{"type": "treatment", "offset": [10], "text": "ciprofloxacin"}, {"type": "drug", "offset": [10], "text": "ciprofloxacin"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7], "text": "Vanishing bile duct and Stevens - Johnson syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "ciprofloxacin"], ["drug", "ciprofloxacin"], ["effect", "Vanishing bile duct and Stevens - Johnson syndrome"]]}]}
{"text_id": "8832451_1", "text": "A noninvasive method in the differential diagnosis of vecuronium - induced and magnesium - induced protracted neuromuscular block in a severely preeclamptic patient .", "tokens": ["A", "noninvasive", "method", "in", "the", "differential", "diagnosis", "of", "vecuronium", "-", "induced", "and", "magnesium", "-", "induced", "protracted", "neuromuscular", "block", "in", "a", "severely", "preeclamptic", "patient", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> severely preeclamptic patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> severely preeclamptic <extra_id_1> <extra_id_0> treatment <extra_id_5> vecuronium <extra_id_1> <extra_id_0> drug <extra_id_5> vecuronium <extra_id_1> <extra_id_0> effect <extra_id_5> protracted neuromuscular block <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> severely preeclamptic patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> severely preeclamptic <extra_id_1> <extra_id_0> treatment <extra_id_5> magnesium <extra_id_1> <extra_id_0> drug <extra_id_5> magnesium <extra_id_1> <extra_id_0> effect <extra_id_5> protracted neuromuscular block <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "induced", "args": [{"type": "subject", "offset": [20, 21, 22], "text": "severely preeclamptic patient"}, {"type": "subject disorder", "offset": [20, 21], "text": "severely preeclamptic"}, {"type": "treatment", "offset": [8], "text": "vecuronium"}, {"type": "drug", "offset": [8], "text": "vecuronium"}, {"type": "effect", "offset": [15, 16, 17], "text": "protracted neuromuscular block"}]}, {"type": "adverse event", "offset": [14], "text": "induced", "args": [{"type": "subject", "offset": [20, 21, 22], "text": "severely preeclamptic patient"}, {"type": "subject disorder", "offset": [20, 21], "text": "severely preeclamptic"}, {"type": "treatment", "offset": [12], "text": "magnesium"}, {"type": "drug", "offset": [12], "text": "magnesium"}, {"type": "effect", "offset": [15, 16, 17], "text": "protracted neuromuscular block"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "severely preeclamptic patient"], ["subject disorder", "severely preeclamptic"], ["treatment", "vecuronium"], ["drug", "vecuronium"], ["effect", "protracted neuromuscular block"]]}, {"span": "induced", "label": "adverse event", "asoc": [["subject", "severely preeclamptic patient"], ["subject disorder", "severely preeclamptic"], ["treatment", "magnesium"], ["drug", "magnesium"], ["effect", "protracted neuromuscular block"]]}]}
{"text_id": "16527771_1", "text": "Acute unilateral total visual loss after retrogasserian phenol injection for the treatment of trigeminal neuralgia : a case report .", "tokens": ["Acute", "unilateral", "total", "visual", "loss", "after", "retrogasserian", "phenol", "injection", "for", "the", "treatment", "of", "trigeminal", "neuralgia", ":", "a", "case", "report", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> retrogasserian phenol injection <extra_id_1> <extra_id_0> drug <extra_id_5> retrogasserian phenol <extra_id_1> <extra_id_0> route <extra_id_5> injection <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> trigeminal neuralgia <extra_id_1> <extra_id_0> effect <extra_id_5> Acute unilateral total visual loss <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "after", "args": [{"type": "treatment", "offset": [6, 7, 8], "text": "retrogasserian phenol injection"}, {"type": "drug", "offset": [6, 7], "text": "retrogasserian phenol"}, {"type": "route", "offset": [8], "text": "injection"}, {"type": "treatment disorder", "offset": [13, 14], "text": "trigeminal neuralgia"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Acute unilateral total visual loss"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "treatment", "treatment disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "retrogasserian phenol injection"], ["drug", "retrogasserian phenol"], ["route", "injection"], ["treatment disorder", "trigeminal neuralgia"], ["effect", "Acute unilateral total visual loss"]]}]}
{"text_id": "2595431_3", "text": "Their parkinsonism improved on discontinuation of metoclopramide therapy .", "tokens": ["Their", "parkinsonism", "improved", "on", "discontinuation", "of", "metoclopramide", "therapy", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> improved <extra_id_0> subject <extra_id_5> Their parkinsonism <extra_id_1> <extra_id_0> subject disorder <extra_id_5> parkinsonism <extra_id_1> <extra_id_0> treatment <extra_id_5> discontinuation of metoclopramide therapy <extra_id_1> <extra_id_0> drug <extra_id_5> metoclopramide <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> parkinsonism <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [2], "text": "improved", "args": [{"type": "subject", "offset": [0, 1], "text": "Their parkinsonism"}, {"type": "subject disorder", "offset": [1], "text": "parkinsonism"}, {"type": "treatment", "offset": [4, 5, 6, 7], "text": "discontinuation of metoclopramide therapy"}, {"type": "drug", "offset": [6], "text": "metoclopramide"}, {"type": "treatment disorder", "offset": [1], "text": "parkinsonism"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "improved", "label": "potential therapeutic event", "asoc": [["subject", "Their parkinsonism"], ["subject disorder", "parkinsonism"], ["treatment", "discontinuation of metoclopramide therapy"], ["drug", "metoclopramide"], ["treatment disorder", "parkinsonism"]]}]}
{"text_id": "7594371_4", "text": "We report the case of a 20 - year - old female with polyarteritis nodosa ( PAN ) who developed bilateral sensorineural hearing loss 25 minutes after receiving 30 mg of intravenous ketoralac .", "tokens": ["We", "report", "the", "case", "of", "a", "20", "-", "year", "-", "old", "female", "with", "polyarteritis", "nodosa", "(", "PAN", ")", "who", "developed", "bilateral", "sensorineural", "hearing", "loss", "25", "minutes", "after", "receiving", "30", "mg", "of", "intravenous", "ketoralac", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> 20 - year - old female with polyarteritis nodosa ( PAN ) <extra_id_1> <extra_id_0> age <extra_id_5> 20 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> female <extra_id_1> <extra_id_0> subject disorder <extra_id_5> polyarteritis nodosa <extra_id_1> <extra_id_0> treatment <extra_id_5> 30 mg of intravenous ketoralac <extra_id_1> <extra_id_0> drug <extra_id_5> ketoralac <extra_id_1> <extra_id_0> dosage <extra_id_5> 30 mg <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 25 minutes after <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> polyarteritis nodosa <extra_id_1> <extra_id_0> effect <extra_id_5> bilateral sensorineural hearing loss <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "developed", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17], "text": "20 - year - old female with polyarteritis nodosa ( PAN )"}, {"type": "age", "offset": [6, 7, 8, 9, 10], "text": "20 - year - old"}, {"type": "gender", "offset": [11], "text": "female"}, {"type": "subject disorder", "offset": [13, 14], "text": "polyarteritis nodosa"}, {"type": "treatment", "offset": [28, 29, 30, 31, 32], "text": "30 mg of intravenous ketoralac"}, {"type": "drug", "offset": [32], "text": "ketoralac"}, {"type": "dosage", "offset": [28, 29], "text": "30 mg"}, {"type": "route", "offset": [31], "text": "intravenous"}, {"type": "time elapsed", "offset": [24, 25, 26], "text": "25 minutes after"}, {"type": "treatment disorder", "offset": [13, 14], "text": "polyarteritis nodosa"}, {"type": "effect", "offset": [20, 21, 22, 23], "text": "bilateral sensorineural hearing loss"}]}], "spot": ["adverse event"], "asoc": ["dosage", "time elapsed", "effect", "route", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "20 - year - old female with polyarteritis nodosa ( PAN )"], ["age", "20 - year - old"], ["gender", "female"], ["subject disorder", "polyarteritis nodosa"], ["treatment", "30 mg of intravenous ketoralac"], ["drug", "ketoralac"], ["dosage", "30 mg"], ["route", "intravenous"], ["time elapsed", "25 minutes after"], ["treatment disorder", "polyarteritis nodosa"], ["effect", "bilateral sensorineural hearing loss"]]}]}
{"text_id": "6529939_3", "text": "The abnormal rhythm disappeared with the withdrawal of propranolol and when the drug was restarted a 2/1 S - A block was seen .", "tokens": ["The", "abnormal", "rhythm", "disappeared", "with", "the", "withdrawal", "of", "propranolol", "and", "when", "the", "drug", "was", "restarted", "a", "2/1", "S", "-", "A", "block", "was", "seen", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> seen <extra_id_0> treatment <extra_id_5> propranolol <extra_id_1> <extra_id_0> drug <extra_id_5> propranolol <extra_id_1> <extra_id_0> effect <extra_id_5> 2/1 S - A block <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [22], "text": "seen", "args": [{"type": "treatment", "offset": [8], "text": "propranolol"}, {"type": "drug", "offset": [8], "text": "propranolol"}, {"type": "effect", "offset": [16, 17, 18, 19, 20], "text": "2/1 S - A block"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "seen", "label": "adverse event", "asoc": [["treatment", "propranolol"], ["drug", "propranolol"], ["effect", "2/1 S - A block"]]}]}
{"text_id": "665845_1", "text": "A case history of a 15 - year - old boy who developed incapacitating tardive dyskinesia that resolved during treatment with deanol is presented .", "tokens": ["A", "case", "history", "of", "a", "15", "-", "year", "-", "old", "boy", "who", "developed", "incapacitating", "tardive", "dyskinesia", "that", "resolved", "during", "treatment", "with", "deanol", "is", "presented", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> resolved <extra_id_0> subject <extra_id_5> a 15 - year - old boy <extra_id_1> <extra_id_0> age <extra_id_5> 15 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> boy <extra_id_1> <extra_id_0> treatment <extra_id_5> deanol <extra_id_1> <extra_id_0> drug <extra_id_5> deanol <extra_id_1> <extra_id_0> effect <extra_id_5> incapacitating tardive dyskinesia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [17], "text": "resolved", "args": [{"type": "subject", "offset": [4, 5, 6, 7, 8, 9, 10], "text": "a 15 - year - old boy"}, {"type": "age", "offset": [5, 6, 7, 8, 9], "text": "15 - year - old"}, {"type": "gender", "offset": [10], "text": "boy"}, {"type": "treatment", "offset": [21], "text": "deanol"}, {"type": "drug", "offset": [21], "text": "deanol"}, {"type": "effect", "offset": [13, 14, 15], "text": "incapacitating tardive dyskinesia"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "resolved", "label": "potential therapeutic event", "asoc": [["subject", "a 15 - year - old boy"], ["age", "15 - year - old"], ["gender", "boy"], ["treatment", "deanol"], ["drug", "deanol"], ["effect", "incapacitating tardive dyskinesia"]]}]}
{"text_id": "19707032_1", "text": "Acute ocular ischemic change may be associated with intravitreal injection of bevacizumab in patients with vascular compromised diabetic retinopathy and/or underlying stenosis of the carotid artery .", "tokens": ["Acute", "ocular", "ischemic", "change", "may", "be", "associated", "with", "intravitreal", "injection", "of", "bevacizumab", "in", "patients", "with", "vascular", "compromised", "diabetic", "retinopathy", "and/or", "underlying", "stenosis", "of", "the", "carotid", "artery", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> patients with vascular compromised diabetic retinopathy and/or underlying stenosis of the carotid artery <extra_id_1> <extra_id_0> subject disorder <extra_id_5> vascular compromised diabetic retinopathy <extra_id_1> <extra_id_0> subject disorder <extra_id_5> underlying stenosis of the carotid artery <extra_id_1> <extra_id_0> treatment <extra_id_5> intravitreal injection of bevacizumab <extra_id_1> <extra_id_0> drug <extra_id_5> bevacizumab <extra_id_1> <extra_id_0> dosage <extra_id_5> intravitreal injection <extra_id_1> <extra_id_0> effect <extra_id_5> Acute ocular ischemic change <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "associated", "args": [{"type": "subject", "offset": [13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25], "text": "patients with vascular compromised diabetic retinopathy and/or underlying stenosis of the carotid artery"}, {"type": "subject disorder", "offset": [15, 16, 17, 18], "text": "vascular compromised diabetic retinopathy"}, {"type": "subject disorder", "offset": [20, 21, 22, 23, 24, 25], "text": "underlying stenosis of the carotid artery"}, {"type": "treatment", "offset": [8, 9, 10, 11], "text": "intravitreal injection of bevacizumab"}, {"type": "drug", "offset": [11], "text": "bevacizumab"}, {"type": "dosage", "offset": [8, 9], "text": "intravitreal injection"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Acute ocular ischemic change"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "dosage", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "patients with vascular compromised diabetic retinopathy and/or underlying stenosis of the carotid artery"], ["subject disorder", "vascular compromised diabetic retinopathy"], ["subject disorder", "underlying stenosis of the carotid artery"], ["treatment", "intravitreal injection of bevacizumab"], ["drug", "bevacizumab"], ["dosage", "intravitreal injection"], ["effect", "Acute ocular ischemic change"]]}]}
{"text_id": "16765687_1", "text": "PURPOSE : Topiramate - induced angle - closure glaucoma ( TiACG ) is believed to be related to its sulfonamide moiety .", "tokens": ["PURPOSE", ":", "Topiramate", "-", "induced", "angle", "-", "closure", "glaucoma", "(", "TiACG", ")", "is", "believed", "to", "be", "related", "to", "its", "sulfonamide", "moiety", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Topiramate <extra_id_1> <extra_id_0> drug <extra_id_5> Topiramate <extra_id_1> <extra_id_0> effect <extra_id_5> angle - closure glaucoma ( TiACG ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "induced", "args": [{"type": "treatment", "offset": [2], "text": "Topiramate"}, {"type": "drug", "offset": [2], "text": "Topiramate"}, {"type": "effect", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "angle - closure glaucoma ( TiACG )"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Topiramate"], ["drug", "Topiramate"], ["effect", "angle - closure glaucoma ( TiACG )"]]}]}
{"text_id": "10410183_2", "text": "OBJECTIVE : To report a case of marked elevation of serum creatine kinase ( CK ) associated with olanzapine therapy .", "tokens": ["OBJECTIVE", ":", "To", "report", "a", "case", "of", "marked", "elevation", "of", "serum", "creatine", "kinase", "(", "CK", ")", "associated", "with", "olanzapine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> olanzapine <extra_id_1> <extra_id_0> drug <extra_id_5> olanzapine <extra_id_1> <extra_id_0> effect <extra_id_5> marked elevation of serum creatine kinase <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "associated", "args": [{"type": "treatment", "offset": [18], "text": "olanzapine"}, {"type": "drug", "offset": [18], "text": "olanzapine"}, {"type": "effect", "offset": [7, 8, 9, 10, 11, 12], "text": "marked elevation of serum creatine kinase"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "olanzapine"], ["drug", "olanzapine"], ["effect", "marked elevation of serum creatine kinase"]]}]}
{"text_id": "18431096_2", "text": "We report 4 patients , 2 on methylphenidate and 2 on dextroamphetamine who presented with acral cyanosis , livedo reticularis , or Raynaud phenomenon .", "tokens": ["We", "report", "4", "patients", ",", "2", "on", "methylphenidate", "and", "2", "on", "dextroamphetamine", "who", "presented", "with", "acral", "cyanosis", ",", "livedo", "reticularis", ",", "or", "Raynaud", "phenomenon", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> presented <extra_id_0> subject <extra_id_5> 2 <extra_id_1> <extra_id_0> treatment <extra_id_5> dextroamphetamine <extra_id_1> <extra_id_0> drug <extra_id_5> dextroamphetamine <extra_id_1> <extra_id_0> effect <extra_id_5> acral cyanosis , livedo reticularis , or Raynaud phenomenon <extra_id_1> <extra_id_0> subject <extra_id_5> 4 patients , 2 on <extra_id_1> <extra_id_0> treatment <extra_id_5> methylphenidate <extra_id_1> <extra_id_0> drug <extra_id_5> methylphenidate <extra_id_1> <extra_id_0> effect <extra_id_5> acral cyanosis , livedo reticularis , or Raynaud phenomenon <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "presented", "args": [{"type": "subject", "offset": [9], "text": "2"}, {"type": "treatment", "offset": [11], "text": "dextroamphetamine"}, {"type": "drug", "offset": [11], "text": "dextroamphetamine"}, {"type": "effect", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23], "text": "acral cyanosis , livedo reticularis , or Raynaud phenomenon"}]}, {"type": "adverse event", "offset": [13], "text": "presented", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6], "text": "4 patients , 2 on"}, {"type": "treatment", "offset": [7], "text": "methylphenidate"}, {"type": "drug", "offset": [7], "text": "methylphenidate"}, {"type": "effect", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23], "text": "acral cyanosis , livedo reticularis , or Raynaud phenomenon"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "presented", "label": "adverse event", "asoc": [["subject", "2"], ["treatment", "dextroamphetamine"], ["drug", "dextroamphetamine"], ["effect", "acral cyanosis , livedo reticularis , or Raynaud phenomenon"], ["subject", "4 patients , 2 on"], ["treatment", "methylphenidate"], ["drug", "methylphenidate"], ["effect", "acral cyanosis , livedo reticularis , or Raynaud phenomenon"]]}]}
{"text_id": "8832451_2", "text": "The occurrence of neuromuscular blockade and the resulting potentiation of muscle relaxants during magnesium sulfate ( MgSO4 ) administration is well known .", "tokens": ["The", "occurrence", "of", "neuromuscular", "blockade", "and", "the", "resulting", "potentiation", "of", "muscle", "relaxants", "during", "magnesium", "sulfate", "(", "MgSO4", ")", "administration", "is", "well", "known", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> magnesium sulfate <extra_id_1> <extra_id_0> drug <extra_id_5> magnesium sulfate ( MgSO4 ) <extra_id_1> <extra_id_0> effect <extra_id_5> neuromuscular blockade <extra_id_1> <extra_id_0> effect <extra_id_5> potentiation of muscle relaxants <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "during", "args": [{"type": "treatment", "offset": [13, 14], "text": "magnesium sulfate"}, {"type": "drug", "offset": [13, 14, 15, 16, 17], "text": "magnesium sulfate ( MgSO4 )"}, {"type": "effect", "offset": [3, 4], "text": "neuromuscular blockade"}, {"type": "effect", "offset": [8, 9, 10, 11], "text": "potentiation of muscle relaxants"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "magnesium sulfate"], ["drug", "magnesium sulfate ( MgSO4 )"], ["effect", "neuromuscular blockade"], ["effect", "potentiation of muscle relaxants"]]}]}
{"text_id": "18854289_1", "text": "Consolidation therapy with bortezomib / lenalidomide/ dexamethasone versus bortezomib / dexamethasone after a dexamethasone - based induction regimen in patients with multiple myeloma : a randomized phase III trial .", "tokens": ["Consolidation", "therapy", "with", "bortezomib", "/", "lenalidomide/", "dexamethasone", "versus", "bortezomib", "/", "dexamethasone", "after", "a", "dexamethasone", "-", "based", "induction", "regimen", "in", "patients", "with", "multiple", "myeloma", ":", "a", "randomized", "phase", "III", "trial", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> in <extra_id_0> subject <extra_id_5> patients with multiple myeloma <extra_id_1> <extra_id_0> subject disorder <extra_id_5> multiple myeloma <extra_id_1> <extra_id_0> treatment <extra_id_5> Consolidation therapy with bortezomib / lenalidomide/ dexamethasone versus bortezomib / dexamethasone after a dexamethasone - based induction regimen <extra_id_1> <extra_id_0> drug <extra_id_5> bortezomib <extra_id_1> <extra_id_0> drug <extra_id_5> lenalidomide/ <extra_id_1> <extra_id_0> drug <extra_id_5> dexamethasone <extra_id_1> <extra_id_0> drug <extra_id_5> bortezomib <extra_id_1> <extra_id_0> drug <extra_id_5> dexamethasone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> multiple myeloma <extra_id_1> <extra_id_0> combination drug <extra_id_5> bortezomib <extra_id_1> <extra_id_0> combination drug <extra_id_5> lenalidomide/ <extra_id_1> <extra_id_0> combination drug <extra_id_5> dexamethasone <extra_id_1> <extra_id_0> combination drug <extra_id_5> bortezomib <extra_id_1> <extra_id_0> combination drug <extra_id_5> dexamethasone <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [18], "text": "in", "args": [{"type": "subject", "offset": [19, 20, 21, 22], "text": "patients with multiple myeloma"}, {"type": "subject disorder", "offset": [21, 22], "text": "multiple myeloma"}, {"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17], "text": "Consolidation therapy with bortezomib / lenalidomide/ dexamethasone versus bortezomib / dexamethasone after a dexamethasone - based induction regimen"}, {"type": "drug", "offset": [3], "text": "bortezomib"}, {"type": "drug", "offset": [5], "text": "lenalidomide/"}, {"type": "drug", "offset": [6], "text": "dexamethasone"}, {"type": "drug", "offset": [8], "text": "bortezomib"}, {"type": "drug", "offset": [10], "text": "dexamethasone"}, {"type": "treatment disorder", "offset": [21, 22], "text": "multiple myeloma"}, {"type": "combination drug", "offset": [3], "text": "bortezomib"}, {"type": "combination drug", "offset": [5], "text": "lenalidomide/"}, {"type": "combination drug", "offset": [6], "text": "dexamethasone"}, {"type": "combination drug", "offset": [8], "text": "bortezomib"}, {"type": "combination drug", "offset": [10], "text": "dexamethasone"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment", "drug", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "in", "label": "potential therapeutic event", "asoc": [["subject", "patients with multiple myeloma"], ["subject disorder", "multiple myeloma"], ["treatment", "Consolidation therapy with bortezomib / lenalidomide/ dexamethasone versus bortezomib / dexamethasone after a dexamethasone - based induction regimen"], ["drug", "bortezomib"], ["drug", "lenalidomide/"], ["drug", "dexamethasone"], ["drug", "bortezomib"], ["drug", "dexamethasone"], ["treatment disorder", "multiple myeloma"], ["combination drug", "bortezomib"], ["combination drug", "lenalidomide/"], ["combination drug", "dexamethasone"], ["combination drug", "bortezomib"], ["combination drug", "dexamethasone"]]}]}
{"text_id": "18344455_5", "text": "This article discusses the possibility that simultaneous use of valproic acid , lamotrigine , and phenytoin could give this combination of toxicities and that concurrent viral infection may increase this risk .", "tokens": ["This", "article", "discusses", "the", "possibility", "that", "simultaneous", "use", "of", "valproic", "acid", ",", "lamotrigine", ",", "and", "phenytoin", "could", "give", "this", "combination", "of", "toxicities", "and", "that", "concurrent", "viral", "infection", "may", "increase", "this", "risk", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> give <extra_id_0> treatment <extra_id_5> valproic acid , lamotrigine , and phenytoin <extra_id_1> <extra_id_0> drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> drug <extra_id_5> phenytoin <extra_id_1> <extra_id_0> combination drug <extra_id_5> valproic acid <extra_id_1> <extra_id_0> combination drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> combination drug <extra_id_5> phenytoin <extra_id_1> <extra_id_0> effect <extra_id_5> toxicities <extra_id_1> <extra_id_0> effect <extra_id_5> concurrent viral infection <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "give", "args": [{"type": "treatment", "offset": [9, 10, 11, 12, 13, 14, 15], "text": "valproic acid , lamotrigine , and phenytoin"}, {"type": "drug", "offset": [9, 10], "text": "valproic acid"}, {"type": "drug", "offset": [12], "text": "lamotrigine"}, {"type": "drug", "offset": [15], "text": "phenytoin"}, {"type": "combination drug", "offset": [9, 10], "text": "valproic acid"}, {"type": "combination drug", "offset": [12], "text": "lamotrigine"}, {"type": "combination drug", "offset": [15], "text": "phenytoin"}, {"type": "effect", "offset": [21], "text": "toxicities"}, {"type": "effect", "offset": [24, 25, 26], "text": "concurrent viral infection"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "give", "label": "adverse event", "asoc": [["treatment", "valproic acid , lamotrigine , and phenytoin"], ["drug", "valproic acid"], ["drug", "lamotrigine"], ["drug", "phenytoin"], ["combination drug", "valproic acid"], ["combination drug", "lamotrigine"], ["combination drug", "phenytoin"], ["effect", "toxicities"], ["effect", "concurrent viral infection"]]}]}
{"text_id": "489527_2", "text": "The authors report 2 cases of renal damage associated with lithium carbonate treatment .", "tokens": ["The", "authors", "report", "2", "cases", "of", "renal", "damage", "associated", "with", "lithium", "carbonate", "treatment", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> 2 cases <extra_id_1> <extra_id_0> population <extra_id_5> 2 <extra_id_1> <extra_id_0> treatment <extra_id_5> lithium carbonate treatment <extra_id_1> <extra_id_0> drug <extra_id_5> lithium carbonate <extra_id_1> <extra_id_0> effect <extra_id_5> renal damage <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "associated", "args": [{"type": "subject", "offset": [3, 4], "text": "2 cases"}, {"type": "population", "offset": [3], "text": "2"}, {"type": "treatment", "offset": [10, 11, 12], "text": "lithium carbonate treatment"}, {"type": "drug", "offset": [10, 11], "text": "lithium carbonate"}, {"type": "effect", "offset": [6, 7], "text": "renal damage"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "2 cases"], ["population", "2"], ["treatment", "lithium carbonate treatment"], ["drug", "lithium carbonate"], ["effect", "renal damage"]]}]}
{"text_id": "7663030_12", "text": "Propafenone 's distribution , clearance , and structural similarity to propranolol contribute to its central nervous system effects .", "tokens": ["Propafenone", "'s", "distribution", ",", "clearance", ",", "and", "structural", "similarity", "to", "propranolol", "contribute", "to", "its", "central", "nervous", "system", "effects", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> contribute <extra_id_0> treatment <extra_id_5> Propafenone <extra_id_1> <extra_id_0> drug <extra_id_5> propranolol <extra_id_1> <extra_id_0> drug <extra_id_5> Propafenone <extra_id_1> <extra_id_0> effect <extra_id_5> central nervous system effects <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [11], "text": "contribute", "args": [{"type": "treatment", "offset": [0], "text": "Propafenone"}, {"type": "drug", "offset": [10], "text": "propranolol"}, {"type": "drug", "offset": [0], "text": "Propafenone"}, {"type": "effect", "offset": [14, 15, 16, 17], "text": "central nervous system effects"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "contribute", "label": "potential therapeutic event", "asoc": [["treatment", "Propafenone"], ["drug", "propranolol"], ["drug", "Propafenone"], ["effect", "central nervous system effects"]]}]}
{"text_id": "19707032_5", "text": "Three days after intravitreal injection of bevacizumab , acute ocular ischemic syndrome occurred .", "tokens": ["Three", "days", "after", "intravitreal", "injection", "of", "bevacizumab", ",", "acute", "ocular", "ischemic", "syndrome", "occurred", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurred <extra_id_0> treatment <extra_id_5> Three days after intravitreal injection of bevacizumab <extra_id_1> <extra_id_0> drug <extra_id_5> bevacizumab <extra_id_1> <extra_id_0> route <extra_id_5> intravitreal injection <extra_id_1> <extra_id_0> time elapsed <extra_id_5> Three days <extra_id_1> <extra_id_0> effect <extra_id_5> acute ocular ischemic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [12], "text": "occurred", "args": [{"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Three days after intravitreal injection of bevacizumab"}, {"type": "drug", "offset": [6], "text": "bevacizumab"}, {"type": "route", "offset": [3, 4], "text": "intravitreal injection"}, {"type": "time elapsed", "offset": [0, 1], "text": "Three days"}, {"type": "effect", "offset": [8, 9, 10, 11], "text": "acute ocular ischemic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "drug", "time elapsed", "treatment"], "spot_asoc": [{"span": "occurred", "label": "adverse event", "asoc": [["treatment", "Three days after intravitreal injection of bevacizumab"], ["drug", "bevacizumab"], ["route", "intravitreal injection"], ["time elapsed", "Three days"], ["effect", "acute ocular ischemic syndrome"]]}]}
{"text_id": "4038927_1", "text": "Atrial fibrillation was induced by diltiazem in two patients and verapamil induced syncope in one patient .", "tokens": ["Atrial", "fibrillation", "was", "induced", "by", "diltiazem", "in", "two", "patients", "and", "verapamil", "induced", "syncope", "in", "one", "patient", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> two patients <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> treatment <extra_id_5> diltiazem <extra_id_1> <extra_id_0> drug <extra_id_5> diltiazem <extra_id_1> <extra_id_0> effect <extra_id_5> Atrial fibrillation <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> one patient <extra_id_1> <extra_id_0> population <extra_id_5> one <extra_id_1> <extra_id_0> treatment <extra_id_5> verapamil <extra_id_1> <extra_id_0> drug <extra_id_5> verapamil <extra_id_1> <extra_id_0> effect <extra_id_5> syncope <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "induced", "args": [{"type": "subject", "offset": [7, 8], "text": "two patients"}, {"type": "population", "offset": [7], "text": "two"}, {"type": "treatment", "offset": [5], "text": "diltiazem"}, {"type": "drug", "offset": [5], "text": "diltiazem"}, {"type": "effect", "offset": [0, 1], "text": "Atrial fibrillation"}]}, {"type": "adverse event", "offset": [11], "text": "induced", "args": [{"type": "subject", "offset": [14, 15], "text": "one patient"}, {"type": "population", "offset": [14], "text": "one"}, {"type": "treatment", "offset": [10], "text": "verapamil"}, {"type": "drug", "offset": [10], "text": "verapamil"}, {"type": "effect", "offset": [12], "text": "syncope"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "two patients"], ["population", "two"], ["treatment", "diltiazem"], ["drug", "diltiazem"], ["effect", "Atrial fibrillation"]]}, {"span": "induced", "label": "adverse event", "asoc": [["subject", "one patient"], ["population", "one"], ["treatment", "verapamil"], ["drug", "verapamil"], ["effect", "syncope"]]}]}
{"text_id": "18607107_2", "text": "Development of Crohn 's disease in a patient with multiple sclerosis treated with copaxone .", "tokens": ["Development", "of", "Crohn", "'s", "disease", "in", "a", "patient", "with", "multiple", "sclerosis", "treated", "with", "copaxone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> Development <extra_id_0> subject <extra_id_5> a patient with multiple sclerosis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> multiple sclerosis <extra_id_1> <extra_id_0> treatment <extra_id_5> copaxone <extra_id_1> <extra_id_0> drug <extra_id_5> copaxone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> multiple sclerosis <extra_id_1> <extra_id_0> effect <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [0], "text": "Development", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10], "text": "a patient with multiple sclerosis"}, {"type": "subject disorder", "offset": [9, 10], "text": "multiple sclerosis"}, {"type": "treatment", "offset": [13], "text": "copaxone"}, {"type": "drug", "offset": [13], "text": "copaxone"}, {"type": "treatment disorder", "offset": [9, 10], "text": "multiple sclerosis"}, {"type": "effect", "offset": [2, 3, 4], "text": "Crohn 's disease"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "Development", "label": "adverse event", "asoc": [["subject", "a patient with multiple sclerosis"], ["subject disorder", "multiple sclerosis"], ["treatment", "copaxone"], ["drug", "copaxone"], ["treatment disorder", "multiple sclerosis"], ["effect", "Crohn 's disease"]]}]}
{"text_id": "16405935_2", "text": "Ptosis occurring 24 h after chloroquine therapy , with full recovery 48 h after cessation of chloroquine , has not been described previously .", "tokens": ["Ptosis", "occurring", "24", "h", "after", "chloroquine", "therapy", ",", "with", "full", "recovery", "48", "h", "after", "cessation", "of", "chloroquine", ",", "has", "not", "been", "described", "previously", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurring <extra_id_0> treatment <extra_id_5> chloroquine therapy <extra_id_1> <extra_id_0> drug <extra_id_5> chloroquine <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 24 h <extra_id_1> <extra_id_0> effect <extra_id_5> Ptosis <extra_id_1> <extra_id_0> effect <extra_id_5> full recovery 48 h after cessation of chloroquine <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "occurring", "args": [{"type": "treatment", "offset": [5, 6], "text": "chloroquine therapy"}, {"type": "drug", "offset": [5], "text": "chloroquine"}, {"type": "time elapsed", "offset": [2, 3], "text": "24 h"}, {"type": "effect", "offset": [0], "text": "Ptosis"}, {"type": "effect", "offset": [9, 10, 11, 12, 13, 14, 15, 16], "text": "full recovery 48 h after cessation of chloroquine"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "time elapsed"], "spot_asoc": [{"span": "occurring", "label": "adverse event", "asoc": [["treatment", "chloroquine therapy"], ["drug", "chloroquine"], ["time elapsed", "24 h"], ["effect", "Ptosis"], ["effect", "full recovery 48 h after cessation of chloroquine"]]}]}
{"text_id": "2327115_2", "text": "Renal toxicities have been reported in less than one percent of the patients receiving ciprofloxacin therapy .", "tokens": ["Renal", "toxicities", "have", "been", "reported", "in", "less", "than", "one", "percent", "of", "the", "patients", "receiving", "ciprofloxacin", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> reported <extra_id_0> subject <extra_id_5> less than one percent of the patients <extra_id_1> <extra_id_0> population <extra_id_5> less than one percent <extra_id_1> <extra_id_0> treatment <extra_id_5> ciprofloxacin therapy . <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> Renal toxicities <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "reported", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10, 11, 12], "text": "less than one percent of the patients"}, {"type": "population", "offset": [6, 7, 8, 9], "text": "less than one percent"}, {"type": "treatment", "offset": [14, 15, 16], "text": "ciprofloxacin therapy ."}, {"type": "drug", "offset": [14], "text": "ciprofloxacin"}, {"type": "effect", "offset": [0, 1], "text": "Renal toxicities"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "reported", "label": "adverse event", "asoc": [["subject", "less than one percent of the patients"], ["population", "less than one percent"], ["treatment", "ciprofloxacin therapy ."], ["drug", "ciprofloxacin"], ["effect", "Renal toxicities"]]}]}
{"text_id": "21712512_11", "text": "This case highlights rapid onset of adrenal insufficiency in a patient with CF - related liver disease treated briefly with a moderate CYP3A4 inhibitor .", "tokens": ["This", "case", "highlights", "rapid", "onset", "of", "adrenal", "insufficiency", "in", "a", "patient", "with", "CF", "-", "related", "liver", "disease", "treated", "briefly", "with", "a", "moderate", "CYP3A4", "inhibitor", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> onset <extra_id_0> subject <extra_id_5> a patient with CF - related liver disease <extra_id_1> <extra_id_0> subject disorder <extra_id_5> CF - related liver disease <extra_id_1> <extra_id_0> treatment <extra_id_5> briefly with a moderate CYP3A4 inhibitor <extra_id_1> <extra_id_0> drug <extra_id_5> CYP3A4 inhibitor <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> CF - related liver disease <extra_id_1> <extra_id_0> effect <extra_id_5> rapid onset of adrenal insufficiency <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "onset", "args": [{"type": "subject", "offset": [9, 10, 11, 12, 13, 14, 15, 16], "text": "a patient with CF - related liver disease"}, {"type": "subject disorder", "offset": [12, 13, 14, 15, 16], "text": "CF - related liver disease"}, {"type": "treatment", "offset": [18, 19, 20, 21, 22, 23], "text": "briefly with a moderate CYP3A4 inhibitor"}, {"type": "drug", "offset": [22, 23], "text": "CYP3A4 inhibitor"}, {"type": "treatment disorder", "offset": [12, 13, 14, 15, 16], "text": "CF - related liver disease"}, {"type": "effect", "offset": [3, 4, 5, 6, 7], "text": "rapid onset of adrenal insufficiency"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "onset", "label": "adverse event", "asoc": [["subject", "a patient with CF - related liver disease"], ["subject disorder", "CF - related liver disease"], ["treatment", "briefly with a moderate CYP3A4 inhibitor"], ["drug", "CYP3A4 inhibitor"], ["treatment disorder", "CF - related liver disease"], ["effect", "rapid onset of adrenal insufficiency"]]}]}
{"text_id": "16298824_3", "text": "ARDS is rarely associated with rituximab infusion for lympho - proliferative disorders , but it should be considered by those administering rituximab , especially when a patient develops severe pulmonary symptoms soon after infusion .", "tokens": ["ARDS", "is", "rarely", "associated", "with", "rituximab", "infusion", "for", "lympho", "-", "proliferative", "disorders", ",", "but", "it", "should", "be", "considered", "by", "those", "administering", "rituximab", ",", "especially", "when", "a", "patient", "develops", "severe", "pulmonary", "symptoms", "soon", "after", "infusion", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> infusion <extra_id_1> <extra_id_0> treatment <extra_id_5> rituximab <extra_id_1> <extra_id_0> drug <extra_id_5> rituximab <extra_id_1> <extra_id_0> route <extra_id_5> infusion <extra_id_1> <extra_id_0> effect <extra_id_5> ARDS <extra_id_1> <extra_id_0> effect <extra_id_5> severe pulmonary symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [32], "text": "after", "args": [{"type": "subject", "offset": [25, 26], "text": "a patient"}, {"type": "treatment", "offset": [33], "text": "infusion"}, {"type": "treatment", "offset": [21], "text": "rituximab"}, {"type": "drug", "offset": [21], "text": "rituximab"}, {"type": "route", "offset": [33], "text": "infusion"}, {"type": "effect", "offset": [0], "text": "ARDS"}, {"type": "effect", "offset": [28, 29, 30], "text": "severe pulmonary symptoms"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "treatment"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "infusion"], ["treatment", "rituximab"], ["drug", "rituximab"], ["route", "infusion"], ["effect", "ARDS"], ["effect", "severe pulmonary symptoms"]]}]}
{"text_id": "1115340_6", "text": "There is the risk of convulsions occurring in susceptible patients following the use of the new anaesthetic agents which are capable of inducing CNS excitability .", "tokens": ["There", "is", "the", "risk", "of", "convulsions", "occurring", "in", "susceptible", "patients", "following", "the", "use", "of", "the", "new", "anaesthetic", "agents", "which", "are", "capable", "of", "inducing", "CNS", "excitability", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurring <extra_id_0> subject <extra_id_5> susceptible patients <extra_id_1> <extra_id_0> treatment <extra_id_5> the use of the new anaesthetic agents which are capable of inducing CNS excitability <extra_id_1> <extra_id_0> drug <extra_id_5> anaesthetic <extra_id_1> <extra_id_0> effect <extra_id_5> convulsions <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "occurring", "args": [{"type": "subject", "offset": [8, 9], "text": "susceptible patients"}, {"type": "treatment", "offset": [11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24], "text": "the use of the new anaesthetic agents which are capable of inducing CNS excitability"}, {"type": "drug", "offset": [16], "text": "anaesthetic"}, {"type": "effect", "offset": [5], "text": "convulsions"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "occurring", "label": "adverse event", "asoc": [["subject", "susceptible patients"], ["treatment", "the use of the new anaesthetic agents which are capable of inducing CNS excitability"], ["drug", "anaesthetic"], ["effect", "convulsions"]]}]}
{"text_id": "7416268_3", "text": "Although useful in the management of chronic alcoholism , disulfiram is being increasingly associated with a wide spectrum of side effects and untoward medical sequelae , which now include catatonia .", "tokens": ["Although", "useful", "in", "the", "management", "of", "chronic", "alcoholism", ",", "disulfiram", "is", "being", "increasingly", "associated", "with", "a", "wide", "spectrum", "of", "side", "effects", "and", "untoward", "medical", "sequelae", ",", "which", "now", "include", "catatonia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> disulfiram <extra_id_1> <extra_id_0> drug <extra_id_5> disulfiram <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic alcoholism <extra_id_1> <extra_id_0> effect <extra_id_5> a wide spectrum of side effects and untoward medical sequelae , which now include catatonia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "associated", "args": [{"type": "treatment", "offset": [9], "text": "disulfiram"}, {"type": "drug", "offset": [9], "text": "disulfiram"}, {"type": "treatment disorder", "offset": [6, 7], "text": "chronic alcoholism"}, {"type": "effect", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29], "text": "a wide spectrum of side effects and untoward medical sequelae , which now include catatonia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "disulfiram"], ["drug", "disulfiram"], ["treatment disorder", "chronic alcoholism"], ["effect", "a wide spectrum of side effects and untoward medical sequelae , which now include catatonia"]]}]}
{"text_id": "11918514_2", "text": "DISCUSSION : A review of the cases of SS with implication of mirtazapine as the cause was performed .", "tokens": ["DISCUSSION", ":", "A", "review", "of", "the", "cases", "of", "SS", "with", "implication", "of", "mirtazapine", "as", "the", "cause", "was", "performed", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> implication of <extra_id_0> treatment <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> drug <extra_id_5> mirtazapine <extra_id_1> <extra_id_0> effect <extra_id_5> SS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10, 11], "text": "implication of", "args": [{"type": "treatment", "offset": [12], "text": "mirtazapine"}, {"type": "drug", "offset": [12], "text": "mirtazapine"}, {"type": "effect", "offset": [8], "text": "SS"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "implication of", "label": "adverse event", "asoc": [["treatment", "mirtazapine"], ["drug", "mirtazapine"], ["effect", "SS"]]}]}
{"text_id": "10987357_7", "text": "When pilsicainide is prescribed in patients with coronary artery disease or renal dysfunction , close attention must be paid to avoid life - threatening arrhythmias due to high plasma concentrations of the drug .", "tokens": ["When", "pilsicainide", "is", "prescribed", "in", "patients", "with", "coronary", "artery", "disease", "or", "renal", "dysfunction", ",", "close", "attention", "must", "be", "paid", "to", "avoid", "life", "-", "threatening", "arrhythmias", "due", "to", "high", "plasma", "concentrations", "of", "the", "drug", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> subject <extra_id_5> patients with coronary artery disease or renal dysfunction , <extra_id_1> <extra_id_0> subject disorder <extra_id_5> coronary artery disease <extra_id_1> <extra_id_0> subject disorder <extra_id_5> renal dysfunction <extra_id_1> <extra_id_0> treatment <extra_id_5> pilsicainide <extra_id_1> <extra_id_0> drug <extra_id_5> pilsicainide <extra_id_1> <extra_id_0> effect <extra_id_5> life - threatening arrhythmias <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [25], "text": "due", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13], "text": "patients with coronary artery disease or renal dysfunction ,"}, {"type": "subject disorder", "offset": [7, 8, 9], "text": "coronary artery disease"}, {"type": "subject disorder", "offset": [11, 12], "text": "renal dysfunction"}, {"type": "treatment", "offset": [1], "text": "pilsicainide"}, {"type": "drug", "offset": [1], "text": "pilsicainide"}, {"type": "effect", "offset": [21, 22, 23, 24], "text": "life - threatening arrhythmias"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["subject", "patients with coronary artery disease or renal dysfunction ,"], ["subject disorder", "coronary artery disease"], ["subject disorder", "renal dysfunction"], ["treatment", "pilsicainide"], ["drug", "pilsicainide"], ["effect", "life - threatening arrhythmias"]]}]}
{"text_id": "12324937_4", "text": "Mean time between initiation of gemcitabine therapy and onset of HUS was 7.4 + / - 3.5 months , or 21.9 + / - 10.9 doses of gemcitabine .", "tokens": ["Mean", "time", "between", "initiation", "of", "gemcitabine", "therapy", "and", "onset", "of", "HUS", "was", "7.4", "+", "/", "-", "3.5", "months", ",", "or", "21.9", "+", "/", "-", "10.9", "doses", "of", "gemcitabine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> onset <extra_id_0> treatment <extra_id_5> 7.4 + / - 3.5 months , or 21.9 + / - 10.9 doses of gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> dosage <extra_id_5> 21.9 + / - 10.9 doses <extra_id_1> <extra_id_0> duration <extra_id_5> 7.4 + / - 3.5 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 7.4 + / - 3.5 months <extra_id_1> <extra_id_0> effect <extra_id_5> HUS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "onset", "args": [{"type": "treatment", "offset": [12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27], "text": "7.4 + / - 3.5 months , or 21.9 + / - 10.9 doses of gemcitabine"}, {"type": "drug", "offset": [27], "text": "gemcitabine"}, {"type": "dosage", "offset": [20, 21, 22, 23, 24, 25], "text": "21.9 + / - 10.9 doses"}, {"type": "duration", "offset": [12, 13, 14, 15, 16, 17], "text": "7.4 + / - 3.5 months"}, {"type": "time elapsed", "offset": [12, 13, 14, 15, 16, 17], "text": "7.4 + / - 3.5 months"}, {"type": "effect", "offset": [10], "text": "HUS"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "drug", "time elapsed", "dosage", "treatment"], "spot_asoc": [{"span": "onset", "label": "adverse event", "asoc": [["treatment", "7.4 + / - 3.5 months , or 21.9 + / - 10.9 doses of gemcitabine"], ["drug", "gemcitabine"], ["dosage", "21.9 + / - 10.9 doses"], ["duration", "7.4 + / - 3.5 months"], ["time elapsed", "7.4 + / - 3.5 months"], ["effect", "HUS"]]}]}
{"text_id": "15628319_4", "text": "We report AZA - induced drug eruption that developed in two cases of systemic scleroderma with polymyositis .", "tokens": ["We", "report", "AZA", "-", "induced", "drug", "eruption", "that", "developed", "in", "two", "cases", "of", "systemic", "scleroderma", "with", "polymyositis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> two cases of systemic scleroderma with polymyositis <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> systemic scleroderma with polymyositis <extra_id_1> <extra_id_0> treatment <extra_id_5> AZA <extra_id_1> <extra_id_0> drug <extra_id_5> AZA <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> systemic scleroderma with polymyositis <extra_id_1> <extra_id_0> effect <extra_id_5> drug eruption <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "induced", "args": [{"type": "subject", "offset": [10, 11, 12, 13, 14, 15, 16], "text": "two cases of systemic scleroderma with polymyositis"}, {"type": "population", "offset": [10], "text": "two"}, {"type": "subject disorder", "offset": [13, 14, 15, 16], "text": "systemic scleroderma with polymyositis"}, {"type": "treatment", "offset": [2], "text": "AZA"}, {"type": "drug", "offset": [2], "text": "AZA"}, {"type": "treatment disorder", "offset": [13, 14, 15, 16], "text": "systemic scleroderma with polymyositis"}, {"type": "effect", "offset": [5, 6], "text": "drug eruption"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "two cases of systemic scleroderma with polymyositis"], ["population", "two"], ["subject disorder", "systemic scleroderma with polymyositis"], ["treatment", "AZA"], ["drug", "AZA"], ["treatment disorder", "systemic scleroderma with polymyositis"], ["effect", "drug eruption"]]}]}
{"text_id": "10357715_3", "text": "The present observation suggests , that a batch of different testing doses , including lower testing doses may help to differentiate between an allergic type of contact dermatitis and an irritant type of reaction after treatment with calcipotriol .", "tokens": ["The", "present", "observation", "suggests", ",", "that", "a", "batch", "of", "different", "testing", "doses", ",", "including", "lower", "testing", "doses", "may", "help", "to", "differentiate", "between", "an", "allergic", "type", "of", "contact", "dermatitis", "and", "an", "irritant", "type", "of", "reaction", "after", "treatment", "with", "calcipotriol", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after treatment <extra_id_0> treatment <extra_id_5> calcipotriol <extra_id_1> <extra_id_0> drug <extra_id_5> calcipotriol <extra_id_1> <extra_id_0> effect <extra_id_5> an allergic type of contact dermatitis <extra_id_1> <extra_id_0> effect <extra_id_5> an irritant type of reaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [34, 35], "text": "after treatment", "args": [{"type": "treatment", "offset": [37], "text": "calcipotriol"}, {"type": "drug", "offset": [37], "text": "calcipotriol"}, {"type": "effect", "offset": [22, 23, 24, 25, 26, 27], "text": "an allergic type of contact dermatitis"}, {"type": "effect", "offset": [29, 30, 31, 32, 33], "text": "an irritant type of reaction"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "after treatment", "label": "adverse event", "asoc": [["treatment", "calcipotriol"], ["drug", "calcipotriol"], ["effect", "an allergic type of contact dermatitis"], ["effect", "an irritant type of reaction"]]}]}
{"text_id": "16416684_1", "text": "This is a rare case of ARDS associated with lithium intoxication .", "tokens": ["This", "is", "a", "rare", "case", "of", "ARDS", "associated", "with", "lithium", "intoxication", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> lithium <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> effect <extra_id_5> ARDS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "associated", "args": [{"type": "treatment", "offset": [9], "text": "lithium"}, {"type": "drug", "offset": [9], "text": "lithium"}, {"type": "effect", "offset": [6], "text": "ARDS"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "lithium"], ["drug", "lithium"], ["effect", "ARDS"]]}]}
{"text_id": "19226083_17", "text": "Patients who commonly require linezolid as an antimicrobial are those with complex infections where other antibiotic treatment has failed .", "tokens": ["Patients", "who", "commonly", "require", "linezolid", "as", "an", "antimicrobial", "are", "those", "with", "complex", "infections", "where", "other", "antibiotic", "treatment", "has", "failed", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> require <extra_id_0> subject <extra_id_5> Patients <extra_id_1> <extra_id_0> subject <extra_id_5> complex infections <extra_id_1> <extra_id_0> subject disorder <extra_id_5> complex infections <extra_id_1> <extra_id_0> treatment <extra_id_5> linezolid as an antimicrobial <extra_id_1> <extra_id_0> drug <extra_id_5> linezolid <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> complex infections <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [3], "text": "require", "args": [{"type": "subject", "offset": [0], "text": "Patients"}, {"type": "subject", "offset": [11, 12], "text": "complex infections"}, {"type": "subject disorder", "offset": [11, 12], "text": "complex infections"}, {"type": "treatment", "offset": [4, 5, 6, 7], "text": "linezolid as an antimicrobial"}, {"type": "drug", "offset": [4], "text": "linezolid"}, {"type": "treatment disorder", "offset": [11, 12], "text": "complex infections"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "require", "label": "potential therapeutic event", "asoc": [["subject", "Patients"], ["subject", "complex infections"], ["subject disorder", "complex infections"], ["treatment", "linezolid as an antimicrobial"], ["drug", "linezolid"], ["treatment disorder", "complex infections"]]}]}
{"text_id": "12153007_2", "text": "To the best of our knowledge only two previous cases of AML have been linked to treatment of HCL with purine analogs , both with 2 - chlorodeoxyadenosine .", "tokens": ["To", "the", "best", "of", "our", "knowledge", "only", "two", "previous", "cases", "of", "AML", "have", "been", "linked", "to", "treatment", "of", "HCL", "with", "purine", "analogs", ",", "both", "with", "2", "-", "chlorodeoxyadenosine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> linked <extra_id_0> treatment <extra_id_5> purine analogs , both with 2 - chlorodeoxyadenosine <extra_id_1> <extra_id_0> drug <extra_id_5> 2 - chlorodeoxyadenosine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HCL <extra_id_1> <extra_id_0> effect <extra_id_5> AML <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [14], "text": "linked", "args": [{"type": "treatment", "offset": [20, 21, 22, 23, 24, 25, 26, 27], "text": "purine analogs , both with 2 - chlorodeoxyadenosine"}, {"type": "drug", "offset": [25, 26, 27], "text": "2 - chlorodeoxyadenosine"}, {"type": "treatment disorder", "offset": [18], "text": "HCL"}, {"type": "effect", "offset": [11], "text": "AML"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "linked", "label": "adverse event", "asoc": [["treatment", "purine analogs , both with 2 - chlorodeoxyadenosine"], ["drug", "2 - chlorodeoxyadenosine"], ["treatment disorder", "HCL"], ["effect", "AML"]]}]}
{"text_id": "18665833_2", "text": "This therapy was also complicated by Warfarin - induced skin necrosis .", "tokens": ["This", "therapy", "was", "also", "complicated", "by", "Warfarin", "-", "induced", "skin", "necrosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> Warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> skin necrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "induced", "args": [{"type": "treatment", "offset": [6], "text": "Warfarin"}, {"type": "drug", "offset": [6], "text": "Warfarin"}, {"type": "effect", "offset": [9, 10], "text": "skin necrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Warfarin"], ["drug", "Warfarin"], ["effect", "skin necrosis"]]}]}
{"text_id": "19826099_1", "text": "OBJECTIVE : To report a case of severe apnea in an infant exposed to lamotrigine through breast - feeding .", "tokens": ["OBJECTIVE", ":", "To", "report", "a", "case", "of", "severe", "apnea", "in", "an", "infant", "exposed", "to", "lamotrigine", "through", "breast", "-", "feeding", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> an infant <extra_id_1> <extra_id_0> age <extra_id_5> infant <extra_id_1> <extra_id_0> treatment <extra_id_5> exposed to lamotrigine through breast - feeding <extra_id_1> <extra_id_0> drug <extra_id_5> lamotrigine <extra_id_1> <extra_id_0> route <extra_id_5> breast - feeding <extra_id_1> <extra_id_0> effect <extra_id_5> severe apnea <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "in", "args": [{"type": "subject", "offset": [10, 11], "text": "an infant"}, {"type": "age", "offset": [11], "text": "infant"}, {"type": "treatment", "offset": [12, 13, 14, 15, 16, 17, 18], "text": "exposed to lamotrigine through breast - feeding"}, {"type": "drug", "offset": [14], "text": "lamotrigine"}, {"type": "route", "offset": [16, 17, 18], "text": "breast - feeding"}, {"type": "effect", "offset": [7, 8], "text": "severe apnea"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "an infant"], ["age", "infant"], ["treatment", "exposed to lamotrigine through breast - feeding"], ["drug", "lamotrigine"], ["route", "breast - feeding"], ["effect", "severe apnea"]]}]}
{"text_id": "17655376_1", "text": "Pharmacokinetics of dapsone gel , 5 % for the treatment of acne vulgaris .", "tokens": ["Pharmacokinetics", "of", "dapsone", "gel", ",", "5", "%", "for", "the", "treatment", "of", "acne", "vulgaris", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> dapsone gel , 5 % <extra_id_1> <extra_id_0> drug <extra_id_5> dapsone <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acne vulgaris <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [9], "text": "treatment", "args": [{"type": "treatment", "offset": [2, 3, 4, 5, 6], "text": "dapsone gel , 5 %"}, {"type": "drug", "offset": [2], "text": "dapsone"}, {"type": "treatment disorder", "offset": [11, 12], "text": "acne vulgaris"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "dapsone gel , 5 %"], ["drug", "dapsone"], ["treatment disorder", "acne vulgaris"]]}]}
{"text_id": "6529939_4", "text": "This was accepted as evidence for propranolol being the cause of this conduction disorder .", "tokens": ["This", "was", "accepted", "as", "evidence", "for", "propranolol", "being", "the", "cause", "of", "this", "conduction", "disorder", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> propranolol <extra_id_1> <extra_id_0> drug <extra_id_5> propranolol <extra_id_1> <extra_id_0> effect <extra_id_5> conduction disorder <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "cause", "args": [{"type": "treatment", "offset": [6], "text": "propranolol"}, {"type": "drug", "offset": [6], "text": "propranolol"}, {"type": "effect", "offset": [12, 13], "text": "conduction disorder"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "propranolol"], ["drug", "propranolol"], ["effect", "conduction disorder"]]}]}
{"text_id": "9232614_3", "text": "We report two cases that developed acute myeloid leukaemia ( AML ) during tamoxifen therapy for breast cancer .", "tokens": ["We", "report", "two", "cases", "that", "developed", "acute", "myeloid", "leukaemia", "(", "AML", ")", "during", "tamoxifen", "therapy", "for", "breast", "cancer", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> two cases <extra_id_1> <extra_id_0> population <extra_id_5> two <extra_id_1> <extra_id_0> subject disorder <extra_id_5> breast cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> tamoxifen therapy for breast cancer <extra_id_1> <extra_id_0> drug <extra_id_5> tamoxifen <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> breast cancer <extra_id_1> <extra_id_0> effect <extra_id_5> acute myeloid leukaemia ( AML ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "developed", "args": [{"type": "subject", "offset": [2, 3], "text": "two cases"}, {"type": "population", "offset": [2], "text": "two"}, {"type": "subject disorder", "offset": [16, 17], "text": "breast cancer"}, {"type": "treatment", "offset": [13, 14, 15, 16, 17], "text": "tamoxifen therapy for breast cancer"}, {"type": "drug", "offset": [13], "text": "tamoxifen"}, {"type": "treatment disorder", "offset": [16, 17], "text": "breast cancer"}, {"type": "effect", "offset": [6, 7, 8, 9, 10, 11], "text": "acute myeloid leukaemia ( AML )"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "two cases"], ["population", "two"], ["subject disorder", "breast cancer"], ["treatment", "tamoxifen therapy for breast cancer"], ["drug", "tamoxifen"], ["treatment disorder", "breast cancer"], ["effect", "acute myeloid leukaemia ( AML )"]]}]}
{"text_id": "17224428_1", "text": "Cardiac hypersensitivity and myopericarditis have been reported during long - term treatment with mesalazine .", "tokens": ["Cardiac", "hypersensitivity", "and", "myopericarditis", "have", "been", "reported", "during", "long", "-", "term", "treatment", "with", "mesalazine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> reported <extra_id_0> treatment <extra_id_5> long - term treatment with mesalazine <extra_id_1> <extra_id_0> drug <extra_id_5> mesalazine <extra_id_1> <extra_id_0> effect <extra_id_5> Cardiac hypersensitivity and myopericarditis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "reported", "args": [{"type": "treatment", "offset": [8, 9, 10, 11, 12, 13], "text": "long - term treatment with mesalazine"}, {"type": "drug", "offset": [13], "text": "mesalazine"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Cardiac hypersensitivity and myopericarditis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "reported", "label": "adverse event", "asoc": [["treatment", "long - term treatment with mesalazine"], ["drug", "mesalazine"], ["effect", "Cardiac hypersensitivity and myopericarditis"]]}]}
{"text_id": "11174414_2", "text": "Nevirapine is a non - nucleoside reverse transcriptase inhibitor widely used in combination with other antiretroviral agents for the treatment of HIV infection .", "tokens": ["Nevirapine", "is", "a", "non", "-", "nucleoside", "reverse", "transcriptase", "inhibitor", "widely", "used", "in", "combination", "with", "other", "antiretroviral", "agents", "for", "the", "treatment", "of", "HIV", "infection", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> Nevirapine is a non - nucleoside reverse transcriptase inhibitor widely used in combination with other antiretroviral agents <extra_id_1> <extra_id_0> drug <extra_id_5> Nevirapine <extra_id_1> <extra_id_0> drug <extra_id_5> other antiretroviral agents <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HIV infection <extra_id_1> <extra_id_0> combination drug <extra_id_5> Nevirapine <extra_id_1> <extra_id_0> combination drug <extra_id_5> other antiretroviral agents <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [19], "text": "treatment", "args": [{"type": "treatment", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16], "text": "Nevirapine is a non - nucleoside reverse transcriptase inhibitor widely used in combination with other antiretroviral agents"}, {"type": "drug", "offset": [0], "text": "Nevirapine"}, {"type": "drug", "offset": [14, 15, 16], "text": "other antiretroviral agents"}, {"type": "treatment disorder", "offset": [21, 22], "text": "HIV infection"}, {"type": "combination drug", "offset": [0], "text": "Nevirapine"}, {"type": "combination drug", "offset": [14, 15, 16], "text": "other antiretroviral agents"}]}], "spot": ["potential therapeutic event"], "asoc": ["treatment", "combination drug", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "Nevirapine is a non - nucleoside reverse transcriptase inhibitor widely used in combination with other antiretroviral agents"], ["drug", "Nevirapine"], ["drug", "other antiretroviral agents"], ["treatment disorder", "HIV infection"], ["combination drug", "Nevirapine"], ["combination drug", "other antiretroviral agents"]]}]}
{"text_id": "2413037_1", "text": "Hemolytic uremic syndrome in a patient on cis - platinum , vinblastine and bleomycin .", "tokens": ["Hemolytic", "uremic", "syndrome", "in", "a", "patient", "on", "cis", "-", "platinum", ",", "vinblastine", "and", "bleomycin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> cis - platinum , vinblastine and bleomycin <extra_id_1> <extra_id_0> drug <extra_id_5> cis - platinum <extra_id_1> <extra_id_0> drug <extra_id_5> vinblastine <extra_id_1> <extra_id_0> drug <extra_id_5> bleomycin <extra_id_1> <extra_id_0> effect <extra_id_5> Hemolytic uremic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "in", "args": [{"type": "subject", "offset": [4, 5], "text": "a patient"}, {"type": "treatment", "offset": [7, 8, 9, 10, 11, 12, 13], "text": "cis - platinum , vinblastine and bleomycin"}, {"type": "drug", "offset": [7, 8, 9], "text": "cis - platinum"}, {"type": "drug", "offset": [11], "text": "vinblastine"}, {"type": "drug", "offset": [13], "text": "bleomycin"}, {"type": "effect", "offset": [0, 1, 2], "text": "Hemolytic uremic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "cis - platinum , vinblastine and bleomycin"], ["drug", "cis - platinum"], ["drug", "vinblastine"], ["drug", "bleomycin"], ["effect", "Hemolytic uremic syndrome"]]}]}
{"text_id": "3310776_1", "text": "A 51 - yr - old nonsmoking male patient without any history of previous allergies , asthma , hay fever , or urticaria developed attacks of asthma when captopril was added to the nadolol and dyazide treatment for his high blood pressure .", "tokens": ["A", "51", "-", "yr", "-", "old", "nonsmoking", "male", "patient", "without", "any", "history", "of", "previous", "allergies", ",", "asthma", ",", "hay", "fever", ",", "or", "urticaria", "developed", "attacks", "of", "asthma", "when", "captopril", "was", "added", "to", "the", "nadolol", "and", "dyazide", "treatment", "for", "his", "high", "blood", "pressure", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 51 - yr - old nonsmoking male patient without any history of previous allergies , asthma , hay fever , or urticaria <extra_id_1> <extra_id_0> age <extra_id_5> 51 - yr - old <extra_id_1> <extra_id_0> gender <extra_id_5> male <extra_id_1> <extra_id_0> subject disorder <extra_id_5> high blood pressure <extra_id_1> <extra_id_0> treatment <extra_id_5> captopril was added to the nadolol and dyazide <extra_id_1> <extra_id_0> drug <extra_id_5> captopril <extra_id_1> <extra_id_0> drug <extra_id_5> nadolol <extra_id_1> <extra_id_0> drug <extra_id_5> dyazide <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> high blood pressure <extra_id_1> <extra_id_0> combination drug <extra_id_5> captopril <extra_id_1> <extra_id_0> combination drug <extra_id_5> nadolol <extra_id_1> <extra_id_0> combination drug <extra_id_5> dyazide <extra_id_1> <extra_id_0> effect <extra_id_5> attacks of asthma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [23], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22], "text": "A 51 - yr - old nonsmoking male patient without any history of previous allergies , asthma , hay fever , or urticaria"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "51 - yr - old"}, {"type": "gender", "offset": [7], "text": "male"}, {"type": "subject disorder", "offset": [39, 40, 41], "text": "high blood pressure"}, {"type": "treatment", "offset": [28, 29, 30, 31, 32, 33, 34, 35], "text": "captopril was added to the nadolol and dyazide"}, {"type": "drug", "offset": [28], "text": "captopril"}, {"type": "drug", "offset": [33], "text": "nadolol"}, {"type": "drug", "offset": [35], "text": "dyazide"}, {"type": "treatment disorder", "offset": [39, 40, 41], "text": "high blood pressure"}, {"type": "combination drug", "offset": [28], "text": "captopril"}, {"type": "combination drug", "offset": [33], "text": "nadolol"}, {"type": "combination drug", "offset": [35], "text": "dyazide"}, {"type": "effect", "offset": [24, 25, 26], "text": "attacks of asthma"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 51 - yr - old nonsmoking male patient without any history of previous allergies , asthma , hay fever , or urticaria"], ["age", "51 - yr - old"], ["gender", "male"], ["subject disorder", "high blood pressure"], ["treatment", "captopril was added to the nadolol and dyazide"], ["drug", "captopril"], ["drug", "nadolol"], ["drug", "dyazide"], ["treatment disorder", "high blood pressure"], ["combination drug", "captopril"], ["combination drug", "nadolol"], ["combination drug", "dyazide"], ["effect", "attacks of asthma"]]}]}
{"text_id": "3124393_2", "text": "Calcification and ossification of the spinal arachnoid after intrathecal administration of Depo - Medrol .", "tokens": ["Calcification", "and", "ossification", "of", "the", "spinal", "arachnoid", "after", "intrathecal", "administration", "of", "Depo", "-", "Medrol", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> intrathecal administration of Depo - Medrol <extra_id_1> <extra_id_0> drug <extra_id_5> Depo - Medrol <extra_id_1> <extra_id_0> route <extra_id_5> intrathecal <extra_id_1> <extra_id_0> effect <extra_id_5> Calcification and ossification of the spinal arachnoid <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "after", "args": [{"type": "treatment", "offset": [8, 9, 10, 11, 12, 13], "text": "intrathecal administration of Depo - Medrol"}, {"type": "drug", "offset": [11, 12, 13], "text": "Depo - Medrol"}, {"type": "route", "offset": [8], "text": "intrathecal"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Calcification and ossification of the spinal arachnoid"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "intrathecal administration of Depo - Medrol"], ["drug", "Depo - Medrol"], ["route", "intrathecal"], ["effect", "Calcification and ossification of the spinal arachnoid"]]}]}
{"text_id": "9602881_1", "text": "We report a 76 - year - old man who developed an acute blistering eruption following high - dose penicillin treatment for pneumococcal septicaemia .", "tokens": ["We", "report", "a", "76", "-", "year", "-", "old", "man", "who", "developed", "an", "acute", "blistering", "eruption", "following", "high", "-", "dose", "penicillin", "treatment", "for", "pneumococcal", "septicaemia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> 76 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 76 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> pneumococcal septicaemia <extra_id_1> <extra_id_0> treatment <extra_id_5> high - dose penicillin treatment <extra_id_1> <extra_id_0> drug <extra_id_5> penicillin <extra_id_1> <extra_id_0> dosage <extra_id_5> high - dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> pneumococcal septicaemia <extra_id_1> <extra_id_0> effect <extra_id_5> acute blistering eruption <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8], "text": "76 - year - old man"}, {"type": "age", "offset": [3, 4, 5, 6, 7], "text": "76 - year - old"}, {"type": "gender", "offset": [8], "text": "man"}, {"type": "subject disorder", "offset": [22, 23], "text": "pneumococcal septicaemia"}, {"type": "treatment", "offset": [16, 17, 18, 19, 20], "text": "high - dose penicillin treatment"}, {"type": "drug", "offset": [19], "text": "penicillin"}, {"type": "dosage", "offset": [16, 17, 18], "text": "high - dose"}, {"type": "treatment disorder", "offset": [22, 23], "text": "pneumococcal septicaemia"}, {"type": "effect", "offset": [12, 13, 14], "text": "acute blistering eruption"}]}], "spot": ["adverse event"], "asoc": ["dosage", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "76 - year - old man"], ["age", "76 - year - old"], ["gender", "man"], ["subject disorder", "pneumococcal septicaemia"], ["treatment", "high - dose penicillin treatment"], ["drug", "penicillin"], ["dosage", "high - dose"], ["treatment disorder", "pneumococcal septicaemia"], ["effect", "acute blistering eruption"]]}]}
{"text_id": "9161656_1", "text": "Acute asthma associated with sustained - release verapamil .", "tokens": ["Acute", "asthma", "associated", "with", "sustained", "-", "release", "verapamil", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> sustained - release verapamil <extra_id_1> <extra_id_0> drug <extra_id_5> sustained - release verapamil <extra_id_1> <extra_id_0> effect <extra_id_5> Acute asthma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "treatment", "offset": [4, 5, 6, 7], "text": "sustained - release verapamil"}, {"type": "drug", "offset": [4, 5, 6, 7], "text": "sustained - release verapamil"}, {"type": "effect", "offset": [0, 1], "text": "Acute asthma"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "sustained - release verapamil"], ["drug", "sustained - release verapamil"], ["effect", "Acute asthma"]]}]}
{"text_id": "1420650_2", "text": "In this report we present four patients treated with a combination of different psychotropic drugs , in whom asterixis was triggered either by adding carbamazepine ( CBZ ) to a treatment regimen , or by increasing its dosage .", "tokens": ["In", "this", "report", "we", "present", "four", "patients", "treated", "with", "a", "combination", "of", "different", "psychotropic", "drugs", ",", "in", "whom", "asterixis", "was", "triggered", "either", "by", "adding", "carbamazepine", "(", "CBZ", ")", "to", "a", "treatment", "regimen", ",", "or", "by", "increasing", "its", "dosage", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> triggered <extra_id_0> subject <extra_id_5> four patients <extra_id_1> <extra_id_0> population <extra_id_5> four <extra_id_1> <extra_id_0> treatment <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> effect <extra_id_5> asterixis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "triggered", "args": [{"type": "subject", "offset": [5, 6], "text": "four patients"}, {"type": "population", "offset": [5], "text": "four"}, {"type": "treatment", "offset": [24], "text": "carbamazepine"}, {"type": "drug", "offset": [24], "text": "carbamazepine"}, {"type": "effect", "offset": [18], "text": "asterixis"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "triggered", "label": "adverse event", "asoc": [["subject", "four patients"], ["population", "four"], ["treatment", "carbamazepine"], ["drug", "carbamazepine"], ["effect", "asterixis"]]}]}
{"text_id": "19949685_1", "text": "Colonic mucosal necrosis following administration of calcium polystryrene sulfonate ( Kalimate ) in a uremic patient .", "tokens": ["Colonic", "mucosal", "necrosis", "following", "administration", "of", "calcium", "polystryrene", "sulfonate", "(", "Kalimate", ")", "in", "a", "uremic", "patient", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> administration <extra_id_0> subject <extra_id_5> uremic patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> uremic <extra_id_1> <extra_id_0> treatment <extra_id_5> calcium polystryrene sulfonate ( Kalimate ) <extra_id_1> <extra_id_0> drug <extra_id_5> calcium polystryrene sulfonate <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> uremic <extra_id_1> <extra_id_0> effect <extra_id_5> Colonic mucosal necrosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "administration", "args": [{"type": "subject", "offset": [14, 15], "text": "uremic patient"}, {"type": "subject disorder", "offset": [14], "text": "uremic"}, {"type": "treatment", "offset": [6, 7, 8, 9, 10, 11], "text": "calcium polystryrene sulfonate ( Kalimate )"}, {"type": "drug", "offset": [6, 7, 8], "text": "calcium polystryrene sulfonate"}, {"type": "treatment disorder", "offset": [14], "text": "uremic"}, {"type": "effect", "offset": [0, 1, 2], "text": "Colonic mucosal necrosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "administration", "label": "adverse event", "asoc": [["subject", "uremic patient"], ["subject disorder", "uremic"], ["treatment", "calcium polystryrene sulfonate ( Kalimate )"], ["drug", "calcium polystryrene sulfonate"], ["treatment disorder", "uremic"], ["effect", "Colonic mucosal necrosis"]]}]}
{"text_id": "25157214_2", "text": "The effectiveness of sugammadex in reversing rocuronium - induced neuromuscular blockade ( NMB ) in the presence of drugs that may potentiate NMB remains to be fully established .", "tokens": ["The", "effectiveness", "of", "sugammadex", "in", "reversing", "rocuronium", "-", "induced", "neuromuscular", "blockade", "(", "NMB", ")", "in", "the", "presence", "of", "drugs", "that", "may", "potentiate", "NMB", "remains", "to", "be", "fully", "established", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> rocuronium <extra_id_1> <extra_id_0> drug <extra_id_5> rocuronium <extra_id_1> <extra_id_0> effect <extra_id_5> neuromuscular blockade ( NMB ) <extra_id_1> <extra_id_1> <extra_id_0> potential therapeutic event <extra_id_5> reversing <extra_id_0> treatment <extra_id_5> sugammadex <extra_id_1> <extra_id_0> treatment <extra_id_5> in the presence of drugs that may potentiate NMB <extra_id_1> <extra_id_0> drug <extra_id_5> sugammadex <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rocuronium - induced neuromuscular blockade ( NMB ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "induced", "args": [{"type": "treatment", "offset": [6], "text": "rocuronium"}, {"type": "drug", "offset": [6], "text": "rocuronium"}, {"type": "effect", "offset": [9, 10, 11, 12, 13], "text": "neuromuscular blockade ( NMB )"}]}, {"type": "potential therapeutic event", "offset": [5], "text": "reversing", "args": [{"type": "treatment", "offset": [3], "text": "sugammadex"}, {"type": "treatment", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22], "text": "in the presence of drugs that may potentiate NMB"}, {"type": "drug", "offset": [3], "text": "sugammadex"}, {"type": "treatment disorder", "offset": [6, 7, 8, 9, 10, 11, 12, 13], "text": "rocuronium - induced neuromuscular blockade ( NMB )"}]}], "spot": ["potential therapeutic event", "adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "rocuronium"], ["drug", "rocuronium"], ["effect", "neuromuscular blockade ( NMB )"]]}, {"span": "reversing", "label": "potential therapeutic event", "asoc": [["treatment", "sugammadex"], ["treatment", "in the presence of drugs that may potentiate NMB"], ["drug", "sugammadex"], ["treatment disorder", "rocuronium - induced neuromuscular blockade ( NMB )"]]}]}
{"text_id": "9177620_2", "text": "The authors report a case of acute pancreatitis ( AP ) occurring in a patient under treatment with carbamazepine ( CBZ ) for post - traumatic petit mal epilepsy , and review the current literature of drug - induced AP .", "tokens": ["The", "authors", "report", "a", "case", "of", "acute", "pancreatitis", "(", "AP", ")", "occurring", "in", "a", "patient", "under", "treatment", "with", "carbamazepine", "(", "CBZ", ")", "for", "post", "-", "traumatic", "petit", "mal", "epilepsy", ",", "and", "review", "the", "current", "literature", "of", "drug", "-", "induced", "AP", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurring <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> post - traumatic petit mal epilepsy <extra_id_1> <extra_id_0> treatment <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> post - traumatic petit mal epilepsy <extra_id_1> <extra_id_0> effect <extra_id_5> acute pancreatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "occurring", "args": [{"type": "subject", "offset": [13, 14], "text": "a patient"}, {"type": "subject disorder", "offset": [23, 24, 25, 26, 27, 28], "text": "post - traumatic petit mal epilepsy"}, {"type": "treatment", "offset": [18], "text": "carbamazepine"}, {"type": "drug", "offset": [18], "text": "carbamazepine"}, {"type": "treatment disorder", "offset": [23, 24, 25, 26, 27, 28], "text": "post - traumatic petit mal epilepsy"}, {"type": "effect", "offset": [6, 7], "text": "acute pancreatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "occurring", "label": "adverse event", "asoc": [["subject", "a patient"], ["subject disorder", "post - traumatic petit mal epilepsy"], ["treatment", "carbamazepine"], ["drug", "carbamazepine"], ["treatment disorder", "post - traumatic petit mal epilepsy"], ["effect", "acute pancreatitis"]]}]}
{"text_id": "18648015_4", "text": "Use of the Naranjo probability scale determined the association between cephalosporin use and leukopenia to be probable .", "tokens": ["Use", "of", "the", "Naranjo", "probability", "scale", "determined", "the", "association", "between", "cephalosporin", "use", "and", "leukopenia", "to", "be", "probable", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> use <extra_id_0> treatment <extra_id_5> cephalosporin <extra_id_1> <extra_id_0> drug <extra_id_5> cephalosporin <extra_id_1> <extra_id_0> effect <extra_id_5> leukopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "use", "args": [{"type": "treatment", "offset": [10], "text": "cephalosporin"}, {"type": "drug", "offset": [10], "text": "cephalosporin"}, {"type": "effect", "offset": [13], "text": "leukopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "use", "label": "adverse event", "asoc": [["treatment", "cephalosporin"], ["drug", "cephalosporin"], ["effect", "leukopenia"]]}]}
{"text_id": "19707032_6", "text": "Three days after receiving intravitreal injection of bevacizumab ( 1.25 mg in 0.1 ml ) , he developed acute vision loss and change of consciousness .", "tokens": ["Three", "days", "after", "receiving", "intravitreal", "injection", "of", "bevacizumab", "(", "1.25", "mg", "in", "0.1", "ml", ")", ",", "he", "developed", "acute", "vision", "loss", "and", "change", "of", "consciousness", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> he <extra_id_1> <extra_id_0> gender <extra_id_5> he <extra_id_1> <extra_id_0> treatment <extra_id_5> intravitreal injection of bevacizumab ( 1.25 mg in 0.1 ml ) , <extra_id_1> <extra_id_0> drug <extra_id_5> bevacizumab <extra_id_1> <extra_id_0> dosage <extra_id_5> 1.25 mg in 0.1 ml <extra_id_1> <extra_id_0> route <extra_id_5> intravitreal injection <extra_id_1> <extra_id_0> effect <extra_id_5> acute vision loss and change of consciousness <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "developed", "args": [{"type": "subject", "offset": [16], "text": "he"}, {"type": "gender", "offset": [16], "text": "he"}, {"type": "treatment", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "intravitreal injection of bevacizumab ( 1.25 mg in 0.1 ml ) ,"}, {"type": "drug", "offset": [7], "text": "bevacizumab"}, {"type": "dosage", "offset": [9, 10, 11, 12, 13], "text": "1.25 mg in 0.1 ml"}, {"type": "route", "offset": [4, 5], "text": "intravitreal injection"}, {"type": "effect", "offset": [18, 19, 20, 21, 22, 23, 24], "text": "acute vision loss and change of consciousness"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "drug", "gender", "dosage", "treatment"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "he"], ["gender", "he"], ["treatment", "intravitreal injection of bevacizumab ( 1.25 mg in 0.1 ml ) ,"], ["drug", "bevacizumab"], ["dosage", "1.25 mg in 0.1 ml"], ["route", "intravitreal injection"], ["effect", "acute vision loss and change of consciousness"]]}]}
{"text_id": "12656748_2", "text": "Emergence of Philadelphia positive chronic myeloid leukaemia during treatment with hydroxyurea for Philadelphia negative essential thrombocythaemia .", "tokens": ["Emergence", "of", "Philadelphia", "positive", "chronic", "myeloid", "leukaemia", "during", "treatment", "with", "hydroxyurea", "for", "Philadelphia", "negative", "essential", "thrombocythaemia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> hydroxyurea <extra_id_1> <extra_id_0> drug <extra_id_5> hydroxyurea <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Philadelphia negative essential thrombocythaemia <extra_id_1> <extra_id_0> effect <extra_id_5> Emergence of Philadelphia positive chronic myeloid leukaemia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "treatment", "args": [{"type": "treatment", "offset": [10], "text": "hydroxyurea"}, {"type": "drug", "offset": [10], "text": "hydroxyurea"}, {"type": "treatment disorder", "offset": [12, 13, 14, 15], "text": "Philadelphia negative essential thrombocythaemia"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Emergence of Philadelphia positive chronic myeloid leukaemia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "treatment", "label": "adverse event", "asoc": [["treatment", "hydroxyurea"], ["drug", "hydroxyurea"], ["treatment disorder", "Philadelphia negative essential thrombocythaemia"], ["effect", "Emergence of Philadelphia positive chronic myeloid leukaemia"]]}]}
{"text_id": "6529939_1", "text": "Alternating sinus rhythm and intermittent sinoatrial block induced by propranolol .", "tokens": ["Alternating", "sinus", "rhythm", "and", "intermittent", "sinoatrial", "block", "induced", "by", "propranolol", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> propranolol <extra_id_1> <extra_id_0> drug <extra_id_5> propranolol <extra_id_1> <extra_id_0> effect <extra_id_5> Alternating sinus rhythm and intermittent sinoatrial block <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "induced", "args": [{"type": "treatment", "offset": [9], "text": "propranolol"}, {"type": "drug", "offset": [9], "text": "propranolol"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Alternating sinus rhythm and intermittent sinoatrial block"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "propranolol"], ["drug", "propranolol"], ["effect", "Alternating sinus rhythm and intermittent sinoatrial block"]]}]}
{"text_id": "12114387_3", "text": "We report a case of a patient with pulmonary hypertension and undifferentiated connective tissue disease who , after 2 months of treatment with epoprostenol , presented with rapidly progressive erythema , scaling , nausea and vomiting , and fever .", "tokens": ["We", "report", "a", "case", "of", "a", "patient", "with", "pulmonary", "hypertension", "and", "undifferentiated", "connective", "tissue", "disease", "who", ",", "after", "2", "months", "of", "treatment", "with", "epoprostenol", ",", "presented", "with", "rapidly", "progressive", "erythema", ",", "scaling", ",", "nausea", "and", "vomiting", ",", "and", "fever", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> presented <extra_id_0> subject <extra_id_5> a patient with pulmonary hypertension and undifferentiated connective tissue disease <extra_id_1> <extra_id_0> subject disorder <extra_id_5> pulmonary hypertension <extra_id_1> <extra_id_0> subject disorder <extra_id_5> undifferentiated connective tissue disease <extra_id_1> <extra_id_0> treatment <extra_id_5> 2 months of treatment with epoprostenol <extra_id_1> <extra_id_0> drug <extra_id_5> epoprostenol <extra_id_1> <extra_id_0> duration <extra_id_5> 2 months <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 2 months <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> pulmonary hypertension <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> undifferentiated connective tissue disease <extra_id_1> <extra_id_0> effect <extra_id_5> rapidly progressive erythema , scaling , nausea and vomiting , and fever <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [25], "text": "presented", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13, 14], "text": "a patient with pulmonary hypertension and undifferentiated connective tissue disease"}, {"type": "subject disorder", "offset": [8, 9], "text": "pulmonary hypertension"}, {"type": "subject disorder", "offset": [11, 12, 13, 14], "text": "undifferentiated connective tissue disease"}, {"type": "treatment", "offset": [18, 19, 20, 21, 22, 23], "text": "2 months of treatment with epoprostenol"}, {"type": "drug", "offset": [23], "text": "epoprostenol"}, {"type": "duration", "offset": [18, 19], "text": "2 months"}, {"type": "time elapsed", "offset": [18, 19], "text": "2 months"}, {"type": "treatment disorder", "offset": [8, 9], "text": "pulmonary hypertension"}, {"type": "treatment disorder", "offset": [11, 12, 13, 14], "text": "undifferentiated connective tissue disease"}, {"type": "effect", "offset": [27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38], "text": "rapidly progressive erythema , scaling , nausea and vomiting , and fever"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "subject", "treatment", "duration", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "presented", "label": "adverse event", "asoc": [["subject", "a patient with pulmonary hypertension and undifferentiated connective tissue disease"], ["subject disorder", "pulmonary hypertension"], ["subject disorder", "undifferentiated connective tissue disease"], ["treatment", "2 months of treatment with epoprostenol"], ["drug", "epoprostenol"], ["duration", "2 months"], ["time elapsed", "2 months"], ["treatment disorder", "pulmonary hypertension"], ["treatment disorder", "undifferentiated connective tissue disease"], ["effect", "rapidly progressive erythema , scaling , nausea and vomiting , and fever"]]}]}
{"text_id": "1743388_2", "text": "This is a report of a renal transplant patient with Pneumocystis pneumonia who developed chemical cellulitis and ulceration following the extravasation of intravenous pentamidine into the soft tissues of the left hand and forearm .", "tokens": ["This", "is", "a", "report", "of", "a", "renal", "transplant", "patient", "with", "Pneumocystis", "pneumonia", "who", "developed", "chemical", "cellulitis", "and", "ulceration", "following", "the", "extravasation", "of", "intravenous", "pentamidine", "into", "the", "soft", "tissues", "of", "the", "left", "hand", "and", "forearm", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a renal transplant patient with Pneumocystis pneumonia <extra_id_1> <extra_id_0> subject disorder <extra_id_5> renal transplant <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Pneumocystis pneumonia <extra_id_1> <extra_id_0> treatment <extra_id_5> intravenous pentamidine into the soft tissues of the left hand and forearm <extra_id_1> <extra_id_0> drug <extra_id_5> pentamidine <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Pneumocystis pneumonia <extra_id_1> <extra_id_0> effect <extra_id_5> chemical cellulitis and ulceration <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "developed", "args": [{"type": "subject", "offset": [5, 6, 7, 8, 9, 10, 11], "text": "a renal transplant patient with Pneumocystis pneumonia"}, {"type": "subject disorder", "offset": [6, 7], "text": "renal transplant"}, {"type": "subject disorder", "offset": [10, 11], "text": "Pneumocystis pneumonia"}, {"type": "treatment", "offset": [22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33], "text": "intravenous pentamidine into the soft tissues of the left hand and forearm"}, {"type": "drug", "offset": [23], "text": "pentamidine"}, {"type": "route", "offset": [22], "text": "intravenous"}, {"type": "treatment disorder", "offset": [10, 11], "text": "Pneumocystis pneumonia"}, {"type": "effect", "offset": [14, 15, 16, 17], "text": "chemical cellulitis and ulceration"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a renal transplant patient with Pneumocystis pneumonia"], ["subject disorder", "renal transplant"], ["subject disorder", "Pneumocystis pneumonia"], ["treatment", "intravenous pentamidine into the soft tissues of the left hand and forearm"], ["drug", "pentamidine"], ["route", "intravenous"], ["treatment disorder", "Pneumocystis pneumonia"], ["effect", "chemical cellulitis and ulceration"]]}]}
{"text_id": "3612639_1", "text": "Pulmonary edema as a delayed complication of ritodrine therapy .", "tokens": ["Pulmonary", "edema", "as", "a", "delayed", "complication", "of", "ritodrine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complication <extra_id_0> treatment <extra_id_5> ritodrine <extra_id_1> <extra_id_0> drug <extra_id_5> ritodrine <extra_id_1> <extra_id_0> effect <extra_id_5> Pulmonary edema <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "complication", "args": [{"type": "treatment", "offset": [7], "text": "ritodrine"}, {"type": "drug", "offset": [7], "text": "ritodrine"}, {"type": "effect", "offset": [0, 1], "text": "Pulmonary edema"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "complication", "label": "adverse event", "asoc": [["treatment", "ritodrine"], ["drug", "ritodrine"], ["effect", "Pulmonary edema"]]}]}
{"text_id": "18020545_1", "text": "Surprisingly , we found that three patients appeared to develop tardive OGC while taking clozapine .", "tokens": ["Surprisingly", ",", "we", "found", "that", "three", "patients", "appeared", "to", "develop", "tardive", "OGC", "while", "taking", "clozapine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> develop <extra_id_0> subject <extra_id_5> three patients <extra_id_1> <extra_id_0> population <extra_id_5> three <extra_id_1> <extra_id_0> treatment <extra_id_5> clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> clozapine <extra_id_1> <extra_id_0> effect <extra_id_5> tardive OGC <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "develop", "args": [{"type": "subject", "offset": [5, 6], "text": "three patients"}, {"type": "population", "offset": [5], "text": "three"}, {"type": "treatment", "offset": [14], "text": "clozapine"}, {"type": "drug", "offset": [14], "text": "clozapine"}, {"type": "effect", "offset": [10, 11], "text": "tardive OGC"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "develop", "label": "adverse event", "asoc": [["subject", "three patients"], ["population", "three"], ["treatment", "clozapine"], ["drug", "clozapine"], ["effect", "tardive OGC"]]}]}
{"text_id": "19904536_15", "text": "Fatal gemcitabine - induced pulmonary toxicity in metastatic    gallbladder adenocarcinoma .", "tokens": ["Fatal", "gemcitabine", "-", "induced", "pulmonary", "toxicity", "in", "metastatic", "  ", "gallbladder", "adenocarcinoma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> metastatic    gallbladder adenocarcinoma <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "induced", "args": [{"type": "treatment", "offset": [1], "text": "gemcitabine"}, {"type": "drug", "offset": [1], "text": "gemcitabine"}, {"type": "treatment disorder", "offset": [7, 8, 9, 10], "text": "metastatic    gallbladder adenocarcinoma"}, {"type": "effect", "offset": [4, 5], "text": "pulmonary toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["treatment disorder", "metastatic    gallbladder adenocarcinoma"], ["effect", "pulmonary toxicity"]]}]}
{"text_id": "2320800_6", "text": "Ifosfamide is a known nephrotoxic drug with demonstrated tubulopathies .", "tokens": ["Ifosfamide", "is", "a", "known", "nephrotoxic", "drug", "with", "demonstrated", "tubulopathies", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> with <extra_id_0> treatment <extra_id_5> Ifosfamide <extra_id_1> <extra_id_0> drug <extra_id_5> Ifosfamide <extra_id_1> <extra_id_0> effect <extra_id_5> tubulopathies <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "with", "args": [{"type": "treatment", "offset": [0], "text": "Ifosfamide"}, {"type": "drug", "offset": [0], "text": "Ifosfamide"}, {"type": "effect", "offset": [8], "text": "tubulopathies"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "with", "label": "adverse event", "asoc": [["treatment", "Ifosfamide"], ["drug", "Ifosfamide"], ["effect", "tubulopathies"]]}]}
{"text_id": "12460237_1", "text": "Recurrent palmar - plantar erythrodysaesthesia following high - dose cytarabine treatment for acute lymphoblastic leukemia .", "tokens": ["Recurrent", "palmar", "-", "plantar", "erythrodysaesthesia", "following", "high", "-", "dose", "cytarabine", "treatment", "for", "acute", "lymphoblastic", "leukemia", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treatment <extra_id_0> treatment <extra_id_5> high - dose cytarabine <extra_id_1> <extra_id_0> drug <extra_id_5> cytarabine <extra_id_1> <extra_id_0> dosage <extra_id_5> high - dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute lymphoblastic leukemia <extra_id_1> <extra_id_0> effect <extra_id_5> palmar - plantar erythrodysaesthesia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [10], "text": "treatment", "args": [{"type": "treatment", "offset": [6, 7, 8, 9], "text": "high - dose cytarabine"}, {"type": "drug", "offset": [9], "text": "cytarabine"}, {"type": "dosage", "offset": [6, 7, 8], "text": "high - dose"}, {"type": "treatment disorder", "offset": [12, 13, 14], "text": "acute lymphoblastic leukemia"}, {"type": "effect", "offset": [1, 2, 3, 4], "text": "palmar - plantar erythrodysaesthesia"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "drug", "dosage", "treatment disorder", "treatment"], "spot_asoc": [{"span": "treatment", "label": "potential therapeutic event", "asoc": [["treatment", "high - dose cytarabine"], ["drug", "cytarabine"], ["dosage", "high - dose"], ["treatment disorder", "acute lymphoblastic leukemia"], ["effect", "palmar - plantar erythrodysaesthesia"]]}]}
{"text_id": "19915794_2", "text": "Therefore , although garenoxacin reportedly causes fewer adverse reactions for cardiac rhythms than third - generation quinolone antibiotics , one must be cautious of the interference of other drugs during hypokalemia in order to prevent TdP.", "tokens": ["Therefore", ",", "although", "garenoxacin", "reportedly", "causes", "fewer", "adverse", "reactions", "for", "cardiac", "rhythms", "than", "third", "-", "generation", "quinolone", "antibiotics", ",", "one", "must", "be", "cautious", "of", "the", "interference", "of", "other", "drugs", "during", "hypokalemia", "in", "order", "to", "prevent", "TdP."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> causes <extra_id_0> treatment <extra_id_5> garenoxacin <extra_id_1> <extra_id_0> drug <extra_id_5> garenoxacin <extra_id_1> <extra_id_0> effect <extra_id_5> adverse reactions for cardiac rhythms <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> prevent <extra_id_0> subject <extra_id_5> hypokalemia <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hypokalemia <extra_id_1> <extra_id_0> treatment <extra_id_5> garenoxacin <extra_id_1> <extra_id_0> drug <extra_id_5> garenoxacin <extra_id_1> <extra_id_0> effect <extra_id_5> TdP. <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "causes", "args": [{"type": "treatment", "offset": [3], "text": "garenoxacin"}, {"type": "drug", "offset": [3], "text": "garenoxacin"}, {"type": "effect", "offset": [7, 8, 9, 10, 11], "text": "adverse reactions for cardiac rhythms"}]}, {"type": "adverse event", "offset": [34], "text": "prevent", "args": [{"type": "subject", "offset": [30], "text": "hypokalemia"}, {"type": "subject disorder", "offset": [30], "text": "hypokalemia"}, {"type": "treatment", "offset": [3], "text": "garenoxacin"}, {"type": "drug", "offset": [3], "text": "garenoxacin"}, {"type": "effect", "offset": [35], "text": "TdP."}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "subject disorder"], "spot_asoc": [{"span": "causes", "label": "adverse event", "asoc": [["treatment", "garenoxacin"], ["drug", "garenoxacin"], ["effect", "adverse reactions for cardiac rhythms"]]}, {"span": "prevent", "label": "adverse event", "asoc": [["subject", "hypokalemia"], ["subject disorder", "hypokalemia"], ["treatment", "garenoxacin"], ["drug", "garenoxacin"], ["effect", "TdP."]]}]}
{"text_id": "15379082_3", "text": "This case describes fulminant hepatic failure in a patient taking disulfiram with no previous liver disease and report of being compliant with alcohol abstinence .", "tokens": ["This", "case", "describes", "fulminant", "hepatic", "failure", "in", "a", "patient", "taking", "disulfiram", "with", "no", "previous", "liver", "disease", "and", "report", "of", "being", "compliant", "with", "alcohol", "abstinence", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> disulfiram <extra_id_1> <extra_id_0> drug <extra_id_5> disulfiram <extra_id_1> <extra_id_0> effect <extra_id_5> fulminant hepatic failure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "in", "args": [{"type": "subject", "offset": [7, 8], "text": "a patient"}, {"type": "treatment", "offset": [10], "text": "disulfiram"}, {"type": "drug", "offset": [10], "text": "disulfiram"}, {"type": "effect", "offset": [3, 4, 5], "text": "fulminant hepatic failure"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "disulfiram"], ["drug", "disulfiram"], ["effect", "fulminant hepatic failure"]]}]}
{"text_id": "11886466_5", "text": "We speculate that platelet activation induced by pFVIII may have contributed to thrombosis and suggest that pFVIII be used with caution in elderly patients with pre - existing cardiovascular risk factors .", "tokens": ["We", "speculate", "that", "platelet", "activation", "induced", "by", "pFVIII", "may", "have", "contributed", "to", "thrombosis", "and", "suggest", "that", "pFVIII", "be", "used", "with", "caution", "in", "elderly", "patients", "with", "pre", "-", "existing", "cardiovascular", "risk", "factors", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> contributed <extra_id_0> treatment <extra_id_5> pFVIII <extra_id_1> <extra_id_0> drug <extra_id_5> pFVIII <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> cardiovascular <extra_id_1> <extra_id_0> effect <extra_id_5> thrombosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "contributed", "args": [{"type": "treatment", "offset": [7], "text": "pFVIII"}, {"type": "drug", "offset": [7], "text": "pFVIII"}, {"type": "treatment disorder", "offset": [28], "text": "cardiovascular"}, {"type": "effect", "offset": [12], "text": "thrombosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "contributed", "label": "adverse event", "asoc": [["treatment", "pFVIII"], ["drug", "pFVIII"], ["treatment disorder", "cardiovascular"], ["effect", "thrombosis"]]}]}
{"text_id": "15190230_1", "text": "Acute dystonia during pegylated interferon alpha therapy in a case with chronic hepatitis B infection .", "tokens": ["Acute", "dystonia", "during", "pegylated", "interferon", "alpha", "therapy", "in", "a", "case", "with", "chronic", "hepatitis", "B", "infection", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> therapy <extra_id_0> treatment <extra_id_5> pegylated interferon alpha <extra_id_1> <extra_id_0> drug <extra_id_5> pegylated interferon alpha <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic hepatitis B infection <extra_id_1> <extra_id_0> effect <extra_id_5> Acute dystonia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "therapy", "args": [{"type": "treatment", "offset": [3, 4, 5], "text": "pegylated interferon alpha"}, {"type": "drug", "offset": [3, 4, 5], "text": "pegylated interferon alpha"}, {"type": "treatment disorder", "offset": [11, 12, 13, 14], "text": "chronic hepatitis B infection"}, {"type": "effect", "offset": [0, 1], "text": "Acute dystonia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "therapy", "label": "adverse event", "asoc": [["treatment", "pegylated interferon alpha"], ["drug", "pegylated interferon alpha"], ["treatment disorder", "chronic hepatitis B infection"], ["effect", "Acute dystonia"]]}]}
{"text_id": "8730143_3", "text": "We describe 2 patients with cutaneous lupus erythematosus who developed severe dapsone reaction after low dose therapy , with a fatal outcome in one .", "tokens": ["We", "describe", "2", "patients", "with", "cutaneous", "lupus", "erythematosus", "who", "developed", "severe", "dapsone", "reaction", "after", "low", "dose", "therapy", ",", "with", "a", "fatal", "outcome", "in", "one", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> 2 patients with cutaneous lupus erythematosus <extra_id_1> <extra_id_0> population <extra_id_5> 2 <extra_id_1> <extra_id_0> subject disorder <extra_id_5> cutaneous lupus erythematosus <extra_id_1> <extra_id_0> treatment <extra_id_5> low dose therapy <extra_id_1> <extra_id_0> drug <extra_id_5> dapsone <extra_id_1> <extra_id_0> dosage <extra_id_5> low dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> cutaneous lupus erythematosus <extra_id_1> <extra_id_0> effect <extra_id_5> severe dapsone reaction <extra_id_1> <extra_id_0> effect <extra_id_5> with a fatal outcome in one <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "after", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7], "text": "2 patients with cutaneous lupus erythematosus"}, {"type": "population", "offset": [2], "text": "2"}, {"type": "subject disorder", "offset": [5, 6, 7], "text": "cutaneous lupus erythematosus"}, {"type": "treatment", "offset": [14, 15, 16], "text": "low dose therapy"}, {"type": "drug", "offset": [11], "text": "dapsone"}, {"type": "dosage", "offset": [14, 15], "text": "low dose"}, {"type": "treatment disorder", "offset": [5, 6, 7], "text": "cutaneous lupus erythematosus"}, {"type": "effect", "offset": [10, 11, 12], "text": "severe dapsone reaction"}, {"type": "effect", "offset": [18, 19, 20, 21, 22, 23], "text": "with a fatal outcome in one"}]}], "spot": ["adverse event"], "asoc": ["dosage", "population", "effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "2 patients with cutaneous lupus erythematosus"], ["population", "2"], ["subject disorder", "cutaneous lupus erythematosus"], ["treatment", "low dose therapy"], ["drug", "dapsone"], ["dosage", "low dose"], ["treatment disorder", "cutaneous lupus erythematosus"], ["effect", "severe dapsone reaction"], ["effect", "with a fatal outcome in one"]]}]}
{"text_id": "10357715_2", "text": "Calcipotriol ( Daivonex R ; Leo Pharmaceuticals , Zurich , Switzerland ) may cause irritation of the skin , whereas allergic reactions are less common .", "tokens": ["Calcipotriol", "(", "Daivonex", "R", ";", "Leo", "Pharmaceuticals", ",", "Zurich", ",", "Switzerland", ")", "may", "cause", "irritation", "of", "the", "skin", ",", "whereas", "allergic", "reactions", "are", "less", "common", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> Calcipotriol <extra_id_1> <extra_id_0> drug <extra_id_5> Calcipotriol <extra_id_1> <extra_id_0> effect <extra_id_5> irritation of the skin <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "cause", "args": [{"type": "treatment", "offset": [0], "text": "Calcipotriol"}, {"type": "drug", "offset": [0], "text": "Calcipotriol"}, {"type": "effect", "offset": [14, 15, 16, 17], "text": "irritation of the skin"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "Calcipotriol"], ["drug", "Calcipotriol"], ["effect", "irritation of the skin"]]}]}
{"text_id": "12221670_2", "text": "The second was an 82 - year - old man receiving ticlopidine for 2 years when , during a febrile episode , he was found neutropenic with marrow aplasia .", "tokens": ["The", "second", "was", "an", "82", "-", "year", "-", "old", "man", "receiving", "ticlopidine", "for", "2", "years", "when", ",", "during", "a", "febrile", "episode", ",", "he", "was", "found", "neutropenic", "with", "marrow", "aplasia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> found <extra_id_0> subject <extra_id_5> 82 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 82 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> receiving ticlopidine for 2 years <extra_id_1> <extra_id_0> drug <extra_id_5> ticlopidine <extra_id_1> <extra_id_0> duration <extra_id_5> 2 years <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 2 years <extra_id_1> <extra_id_0> effect <extra_id_5> neutropenic with marrow aplasia . <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [24], "text": "found", "args": [{"type": "subject", "offset": [4, 5, 6, 7, 8, 9], "text": "82 - year - old man"}, {"type": "age", "offset": [4, 5, 6, 7, 8], "text": "82 - year - old"}, {"type": "gender", "offset": [9], "text": "man"}, {"type": "treatment", "offset": [10, 11, 12, 13, 14], "text": "receiving ticlopidine for 2 years"}, {"type": "drug", "offset": [11], "text": "ticlopidine"}, {"type": "duration", "offset": [13, 14], "text": "2 years"}, {"type": "time elapsed", "offset": [13, 14], "text": "2 years"}, {"type": "effect", "offset": [25, 26, 27, 28, 29], "text": "neutropenic with marrow aplasia ."}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "duration", "effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "found", "label": "adverse event", "asoc": [["subject", "82 - year - old man"], ["age", "82 - year - old"], ["gender", "man"], ["treatment", "receiving ticlopidine for 2 years"], ["drug", "ticlopidine"], ["duration", "2 years"], ["time elapsed", "2 years"], ["effect", "neutropenic with marrow aplasia ."]]}]}
{"text_id": "20298401_7", "text": "Six days after taking erlotinib , a chest radiograph showed rapid progression of reticular infiltration in both lung fields .", "tokens": ["Six", "days", "after", "taking", "erlotinib", ",", "a", "chest", "radiograph", "showed", "rapid", "progression", "of", "reticular", "infiltration", "in", "both", "lung", "fields", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> Six days <extra_id_1> <extra_id_0> treatment <extra_id_5> erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> time elapsed <extra_id_5> Six days <extra_id_1> <extra_id_0> effect <extra_id_5> rapid progression of reticular infiltration in both lung fields <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "after", "args": [{"type": "treatment", "offset": [0, 1], "text": "Six days"}, {"type": "treatment", "offset": [4], "text": "erlotinib"}, {"type": "drug", "offset": [4], "text": "erlotinib"}, {"type": "time elapsed", "offset": [0, 1], "text": "Six days"}, {"type": "effect", "offset": [10, 11, 12, 13, 14, 15, 16, 17, 18], "text": "rapid progression of reticular infiltration in both lung fields"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "time elapsed"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "Six days"], ["treatment", "erlotinib"], ["drug", "erlotinib"], ["time elapsed", "Six days"], ["effect", "rapid progression of reticular infiltration in both lung fields"]]}]}
{"text_id": "18176653_1", "text": "Oral adverse effects due to the use of Nevirapine .", "tokens": ["Oral", "adverse", "effects", "due", "to", "the", "use", "of", "Nevirapine", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> treatment <extra_id_5> Nevirapine <extra_id_1> <extra_id_0> drug <extra_id_5> Nevirapine <extra_id_1> <extra_id_0> route <extra_id_5> Oral <extra_id_1> <extra_id_0> effect <extra_id_5> adverse effects <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "due", "args": [{"type": "treatment", "offset": [8], "text": "Nevirapine"}, {"type": "drug", "offset": [8], "text": "Nevirapine"}, {"type": "route", "offset": [0], "text": "Oral"}, {"type": "effect", "offset": [1, 2], "text": "adverse effects"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "treatment", "drug"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["treatment", "Nevirapine"], ["drug", "Nevirapine"], ["route", "Oral"], ["effect", "adverse effects"]]}]}
{"text_id": "21751692_5", "text": "Based on this experience , we suggest that low - dose ketamine added to propofol may be associated with prevention of EA in children with a history of EA with propofol TIVA .", "tokens": ["Based", "on", "this", "experience", ",", "we", "suggest", "that", "low", "-", "dose", "ketamine", "added", "to", "propofol", "may", "be", "associated", "with", "prevention", "of", "EA", "in", "children", "with", "a", "history", "of", "EA", "with", "propofol", "TIVA", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> prevention <extra_id_0> subject <extra_id_5> children with a history of EA with propofol TIVA <extra_id_1> <extra_id_0> age <extra_id_5> children <extra_id_1> <extra_id_0> subject disorder <extra_id_5> EA with propofol TIVA <extra_id_1> <extra_id_0> subject disorder <extra_id_5> EA <extra_id_1> <extra_id_0> treatment <extra_id_5> low - dose ketamine added to propofol <extra_id_1> <extra_id_0> drug <extra_id_5> ketamine <extra_id_1> <extra_id_0> drug <extra_id_5> propofol <extra_id_1> <extra_id_0> dosage <extra_id_5> low - dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> EA <extra_id_1> <extra_id_0> combination drug <extra_id_5> ketamine <extra_id_1> <extra_id_0> combination drug <extra_id_5> propofol <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [19], "text": "prevention", "args": [{"type": "subject", "offset": [23, 24, 25, 26, 27, 28, 29, 30, 31], "text": "children with a history of EA with propofol TIVA"}, {"type": "age", "offset": [23], "text": "children"}, {"type": "subject disorder", "offset": [28, 29, 30, 31], "text": "EA with propofol TIVA"}, {"type": "subject disorder", "offset": [21], "text": "EA"}, {"type": "treatment", "offset": [8, 9, 10, 11, 12, 13, 14], "text": "low - dose ketamine added to propofol"}, {"type": "drug", "offset": [11], "text": "ketamine"}, {"type": "drug", "offset": [14], "text": "propofol"}, {"type": "dosage", "offset": [8, 9, 10], "text": "low - dose"}, {"type": "treatment disorder", "offset": [21], "text": "EA"}, {"type": "combination drug", "offset": [11], "text": "ketamine"}, {"type": "combination drug", "offset": [14], "text": "propofol"}]}], "spot": ["potential therapeutic event"], "asoc": ["dosage", "subject", "treatment disorder", "treatment", "drug", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "prevention", "label": "potential therapeutic event", "asoc": [["subject", "children with a history of EA with propofol TIVA"], ["age", "children"], ["subject disorder", "EA with propofol TIVA"], ["subject disorder", "EA"], ["treatment", "low - dose ketamine added to propofol"], ["drug", "ketamine"], ["drug", "propofol"], ["dosage", "low - dose"], ["treatment disorder", "EA"], ["combination drug", "ketamine"], ["combination drug", "propofol"]]}]}
{"text_id": "9366852_3", "text": "It occasionally accompanies the heparin - associated thrombocytopenia and thrombosis syndrome .", "tokens": ["It", "occasionally", "accompanies", "the", "heparin", "-", "associated", "thrombocytopenia", "and", "thrombosis", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> heparin <extra_id_1> <extra_id_0> drug <extra_id_5> heparin <extra_id_1> <extra_id_0> effect <extra_id_5> thrombocytopenia and thrombosis syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "associated", "args": [{"type": "treatment", "offset": [4], "text": "heparin"}, {"type": "drug", "offset": [4], "text": "heparin"}, {"type": "effect", "offset": [7, 8, 9, 10], "text": "thrombocytopenia and thrombosis syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "heparin"], ["drug", "heparin"], ["effect", "thrombocytopenia and thrombosis syndrome"]]}]}
{"text_id": "8742573_4", "text": "OBJECTIVE : To evaluate the efficacy of the administration of insulin by a jet - injector device in stopping and reversing severe human insulin - induced lipoatrophy .", "tokens": ["OBJECTIVE", ":", "To", "evaluate", "the", "efficacy", "of", "the", "administration", "of", "insulin", "by", "a", "jet", "-", "injector", "device", "in", "stopping", "and", "reversing", "severe", "human", "insulin", "-", "induced", "lipoatrophy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> insulin <extra_id_1> <extra_id_0> drug <extra_id_5> insulin <extra_id_1> <extra_id_0> effect <extra_id_5> severe human <extra_id_1> <extra_id_0> effect <extra_id_5> lipoatrophy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [25], "text": "induced", "args": [{"type": "treatment", "offset": [23], "text": "insulin"}, {"type": "drug", "offset": [23], "text": "insulin"}, {"type": "effect", "offset": [21, 22], "text": "severe human"}, {"type": "effect", "offset": [26], "text": "lipoatrophy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "insulin"], ["drug", "insulin"], ["effect", "severe human"], ["effect", "lipoatrophy"]]}]}
{"text_id": "12581772_2", "text": "Rapamycin / sirolimus - induced pneumonitis has been described previously in renal transplant recipients , and this report describes a stable heart - lung transplant recipient who developed a pulmonary infiltrate that reversed after ceasing SR therapy .", "tokens": ["Rapamycin", "/", "sirolimus", "-", "induced", "pneumonitis", "has", "been", "described", "previously", "in", "renal", "transplant", "recipients", ",", "and", "this", "report", "describes", "a", "stable", "heart", "-", "lung", "transplant", "recipient", "who", "developed", "a", "pulmonary", "infiltrate", "that", "reversed", "after", "ceasing", "SR", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Rapamycin / sirolimus <extra_id_1> <extra_id_0> drug <extra_id_5> Rapamycin <extra_id_1> <extra_id_0> drug <extra_id_5> sirolimus <extra_id_1> <extra_id_0> combination drug <extra_id_5> Rapamycin <extra_id_1> <extra_id_0> combination drug <extra_id_5> sirolimus <extra_id_1> <extra_id_0> effect <extra_id_5> pneumonitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "induced", "args": [{"type": "treatment", "offset": [0, 1, 2], "text": "Rapamycin / sirolimus"}, {"type": "drug", "offset": [0], "text": "Rapamycin"}, {"type": "drug", "offset": [2], "text": "sirolimus"}, {"type": "combination drug", "offset": [0], "text": "Rapamycin"}, {"type": "combination drug", "offset": [2], "text": "sirolimus"}, {"type": "effect", "offset": [5], "text": "pneumonitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Rapamycin / sirolimus"], ["drug", "Rapamycin"], ["drug", "sirolimus"], ["combination drug", "Rapamycin"], ["combination drug", "sirolimus"], ["effect", "pneumonitis"]]}]}
{"text_id": "2327115_3", "text": "Suspected ciprofloxacin - induced interstitial nephritis .", "tokens": ["Suspected", "ciprofloxacin", "-", "induced", "interstitial", "nephritis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> interstitial nephritis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "induced", "args": [{"type": "treatment", "offset": [1], "text": "ciprofloxacin"}, {"type": "drug", "offset": [1], "text": "ciprofloxacin"}, {"type": "effect", "offset": [4, 5], "text": "interstitial nephritis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "ciprofloxacin"], ["drug", "ciprofloxacin"], ["effect", "interstitial nephritis"]]}]}
{"text_id": "9719245_4", "text": "We report a case of pancytopenia in a 23 - year - old man with Crohn 's disease who was treated with 5 - aminosalicylic acid ( Pentasa ; Nisshin , Tokyo , Japan ) 3.0 g / day .", "tokens": ["We", "report", "a", "case", "of", "pancytopenia", "in", "a", "23", "-", "year", "-", "old", "man", "with", "Crohn", "'s", "disease", "who", "was", "treated", "with", "5", "-", "aminosalicylic", "acid", "(", "Pentasa", ";", "Nisshin", ",", "Tokyo", ",", "Japan", ")", "3.0", "g", "/", "day", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated with <extra_id_0> subject <extra_id_5> a 23 - year - old man with Crohn 's disease <extra_id_1> <extra_id_0> age <extra_id_5> 23 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> treatment <extra_id_5> 5 - aminosalicylic acid ( Pentasa ; Nisshin , Tokyo , Japan ) 3.0 g / day <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - aminosalicylic acid <extra_id_1> <extra_id_0> drug <extra_id_5> Pentasa <extra_id_1> <extra_id_0> dosage <extra_id_5> 3.0 g / day <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Crohn 's disease <extra_id_1> <extra_id_0> effect <extra_id_5> pancytopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20, 21], "text": "treated with", "args": [{"type": "subject", "offset": [7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17], "text": "a 23 - year - old man with Crohn 's disease"}, {"type": "age", "offset": [8, 9, 10, 11, 12], "text": "23 - year - old"}, {"type": "gender", "offset": [13], "text": "man"}, {"type": "subject disorder", "offset": [15, 16, 17], "text": "Crohn 's disease"}, {"type": "treatment", "offset": [22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38], "text": "5 - aminosalicylic acid ( Pentasa ; Nisshin , Tokyo , Japan ) 3.0 g / day"}, {"type": "drug", "offset": [22, 23, 24, 25], "text": "5 - aminosalicylic acid"}, {"type": "drug", "offset": [27], "text": "Pentasa"}, {"type": "dosage", "offset": [35, 36, 37, 38], "text": "3.0 g / day"}, {"type": "treatment disorder", "offset": [15, 16, 17], "text": "Crohn 's disease"}, {"type": "effect", "offset": [5], "text": "pancytopenia"}]}], "spot": ["adverse event"], "asoc": ["dosage", "effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "treated with", "label": "adverse event", "asoc": [["subject", "a 23 - year - old man with Crohn 's disease"], ["age", "23 - year - old"], ["gender", "man"], ["subject disorder", "Crohn 's disease"], ["treatment", "5 - aminosalicylic acid ( Pentasa ; Nisshin , Tokyo , Japan ) 3.0 g / day"], ["drug", "5 - aminosalicylic acid"], ["drug", "Pentasa"], ["dosage", "3.0 g / day"], ["treatment disorder", "Crohn 's disease"], ["effect", "pancytopenia"]]}]}
{"text_id": "7776854_4", "text": "We stress the potential of benzarone to cause hepatotoxicity , which usually resembles severe chronic active hepatitis .", "tokens": ["We", "stress", "the", "potential", "of", "benzarone", "to", "cause", "hepatotoxicity", ",", "which", "usually", "resembles", "severe", "chronic", "active", "hepatitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> benzarone <extra_id_1> <extra_id_0> drug <extra_id_5> benzarone <extra_id_1> <extra_id_0> effect <extra_id_5> hepatotoxicity <extra_id_1> <extra_id_0> effect <extra_id_5> severe chronic active hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "cause", "args": [{"type": "treatment", "offset": [5], "text": "benzarone"}, {"type": "drug", "offset": [5], "text": "benzarone"}, {"type": "effect", "offset": [8], "text": "hepatotoxicity"}, {"type": "effect", "offset": [13, 14, 15, 16], "text": "severe chronic active hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "benzarone"], ["drug", "benzarone"], ["effect", "hepatotoxicity"], ["effect", "severe chronic active hepatitis"]]}]}
{"text_id": "2320800_7", "text": "We strongly suspect that this lethal anuria was mainly due to ifosfamide , occurring in a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension .", "tokens": ["We", "strongly", "suspect", "that", "this", "lethal", "anuria", "was", "mainly", "due", "to", "ifosfamide", ",", "occurring", "in", "a", "patient", "having", "received", "previous", "cisplatin", "chemotherapy", "and", "with", "poor", "kidney", "perfusion", "due", "to", "transient", "hypotension", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occurring <extra_id_0> subject <extra_id_5> a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension <extra_id_1> <extra_id_0> subject disorder <extra_id_5> poor kidney perfusion <extra_id_1> <extra_id_0> treatment <extra_id_5> ifosfamide <extra_id_1> <extra_id_0> treatment <extra_id_5> having received previous cisplatin chemotherapy <extra_id_1> <extra_id_0> drug <extra_id_5> ifosfamide <extra_id_1> <extra_id_0> drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> combination drug <extra_id_5> ifosfamide <extra_id_1> <extra_id_0> combination drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> effect <extra_id_5> lethal anuria <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "occurring", "args": [{"type": "subject", "offset": [15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30], "text": "a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension"}, {"type": "subject disorder", "offset": [24, 25, 26], "text": "poor kidney perfusion"}, {"type": "treatment", "offset": [11], "text": "ifosfamide"}, {"type": "treatment", "offset": [17, 18, 19, 20, 21], "text": "having received previous cisplatin chemotherapy"}, {"type": "drug", "offset": [11], "text": "ifosfamide"}, {"type": "drug", "offset": [20], "text": "cisplatin"}, {"type": "combination drug", "offset": [11], "text": "ifosfamide"}, {"type": "combination drug", "offset": [20], "text": "cisplatin"}, {"type": "effect", "offset": [5, 6], "text": "lethal anuria"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "combination drug", "subject disorder"], "spot_asoc": [{"span": "occurring", "label": "adverse event", "asoc": [["subject", "a patient having received previous cisplatin chemotherapy and with poor kidney perfusion due to transient hypotension"], ["subject disorder", "poor kidney perfusion"], ["treatment", "ifosfamide"], ["treatment", "having received previous cisplatin chemotherapy"], ["drug", "ifosfamide"], ["drug", "cisplatin"], ["combination drug", "ifosfamide"], ["combination drug", "cisplatin"], ["effect", "lethal anuria"]]}]}
{"text_id": "7661076_2", "text": "Life - threatening alterations in heart rate after the use of adenosine in atrial flutter .", "tokens": ["Life", "-", "threatening", "alterations", "in", "heart", "rate", "after", "the", "use", "of", "adenosine", "in", "atrial", "flutter", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> adenosine <extra_id_1> <extra_id_0> drug <extra_id_5> adenosine <extra_id_1> <extra_id_0> effect <extra_id_5> Life - threatening alterations in heart rate <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "after", "args": [{"type": "treatment", "offset": [11], "text": "adenosine"}, {"type": "drug", "offset": [11], "text": "adenosine"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Life - threatening alterations in heart rate"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "adenosine"], ["drug", "adenosine"], ["effect", "Life - threatening alterations in heart rate"]]}]}
{"text_id": "3725284_1", "text": "Paroxysmal supraventricular tachycardia during treatment with cisplatin and etoposide combination .", "tokens": ["Paroxysmal", "supraventricular", "tachycardia", "during", "treatment", "with", "cisplatin", "and", "etoposide", "combination", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> during <extra_id_0> treatment <extra_id_5> cisplatin and etoposide combination <extra_id_1> <extra_id_0> drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> drug <extra_id_5> etoposide <extra_id_1> <extra_id_0> combination drug <extra_id_5> etoposide <extra_id_1> <extra_id_0> combination drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> effect <extra_id_5> Paroxysmal supraventricular tachycardia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "during", "args": [{"type": "treatment", "offset": [6, 7, 8, 9], "text": "cisplatin and etoposide combination"}, {"type": "drug", "offset": [6], "text": "cisplatin"}, {"type": "drug", "offset": [8], "text": "etoposide"}, {"type": "combination drug", "offset": [8], "text": "etoposide"}, {"type": "combination drug", "offset": [6], "text": "cisplatin"}, {"type": "effect", "offset": [0, 1, 2], "text": "Paroxysmal supraventricular tachycardia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "during", "label": "adverse event", "asoc": [["treatment", "cisplatin and etoposide combination"], ["drug", "cisplatin"], ["drug", "etoposide"], ["combination drug", "etoposide"], ["combination drug", "cisplatin"], ["effect", "Paroxysmal supraventricular tachycardia"]]}]}
{"text_id": "18665833_3", "text": "We report a rare case of recurrent ( stuttering ) priapism in a patient with protein C deficiency while maintained on Warfarin therapy .", "tokens": ["We", "report", "a", "rare", "case", "of", "recurrent", "(", "stuttering", ")", "priapism", "in", "a", "patient", "with", "protein", "C", "deficiency", "while", "maintained", "on", "Warfarin", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> while <extra_id_0> subject <extra_id_5> a patient with protein C deficiency <extra_id_1> <extra_id_0> subject disorder <extra_id_5> protein C deficiency <extra_id_1> <extra_id_0> treatment <extra_id_5> maintained on Warfarin therapy <extra_id_1> <extra_id_0> drug <extra_id_5> Warfarin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> protein C deficiency <extra_id_1> <extra_id_0> effect <extra_id_5> recurrent ( stuttering ) priapism <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "while", "args": [{"type": "subject", "offset": [12, 13, 14, 15, 16, 17], "text": "a patient with protein C deficiency"}, {"type": "subject disorder", "offset": [15, 16, 17], "text": "protein C deficiency"}, {"type": "treatment", "offset": [19, 20, 21, 22], "text": "maintained on Warfarin therapy"}, {"type": "drug", "offset": [21], "text": "Warfarin"}, {"type": "treatment disorder", "offset": [15, 16, 17], "text": "protein C deficiency"}, {"type": "effect", "offset": [6, 7, 8, 9, 10], "text": "recurrent ( stuttering ) priapism"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "while", "label": "adverse event", "asoc": [["subject", "a patient with protein C deficiency"], ["subject disorder", "protein C deficiency"], ["treatment", "maintained on Warfarin therapy"], ["drug", "Warfarin"], ["treatment disorder", "protein C deficiency"], ["effect", "recurrent ( stuttering ) priapism"]]}]}
{"text_id": "11033836_2", "text": "Placebo - controlled clinical trials of recombinant human interleukin - 11 ( rhIL - 11 , also known as oprelvekin [ Neumega ] ) in patients with nonmyeloid malignancies have demonstrated significant efficacy in preventing postchemotherapy platelet nadirs of < or = 20,000 / microL , and reducing the need for platelet transfusions while continuing chemotherapy without dose reductions .", "tokens": ["Placebo", "-", "controlled", "clinical", "trials", "of", "recombinant", "human", "interleukin", "-", "11", "(", "rhIL", "-", "11", ",", "also", "known", "as", "oprelvekin", "[", "Neumega", "]", ")", "in", "patients", "with", "nonmyeloid", "malignancies", "have", "demonstrated", "significant", "efficacy", "in", "preventing", "postchemotherapy", "platelet", "nadirs", "of", "<", "or", "=", "20,000", "/", "microL", ",", "and", "reducing", "the", "need", "for", "platelet", "transfusions", "while", "continuing", "chemotherapy", "without", "dose", "reductions", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> preventing <extra_id_0> subject <extra_id_5> patients with nonmyeloid malignancies <extra_id_1> <extra_id_0> subject disorder <extra_id_5> nonmyeloid malignancies <extra_id_1> <extra_id_0> subject disorder <extra_id_5> postchemotherapy platelet nadirs of < or = 20,000 / microL <extra_id_1> <extra_id_0> treatment <extra_id_5> recombinant human interleukin - 11 ( rhIL - 11 , also known as oprelvekin [ Neumega ] ) <extra_id_1> <extra_id_0> drug <extra_id_5> recombinant human interleukin - 11 <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> postchemotherapy platelet nadirs of < or = 20,000 / microL <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [34], "text": "preventing", "args": [{"type": "subject", "offset": [25, 26, 27, 28], "text": "patients with nonmyeloid malignancies"}, {"type": "subject disorder", "offset": [27, 28], "text": "nonmyeloid malignancies"}, {"type": "subject disorder", "offset": [35, 36, 37, 38, 39, 40, 41, 42, 43, 44], "text": "postchemotherapy platelet nadirs of < or = 20,000 / microL"}, {"type": "treatment", "offset": [6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23], "text": "recombinant human interleukin - 11 ( rhIL - 11 , also known as oprelvekin [ Neumega ] )"}, {"type": "drug", "offset": [6, 7, 8, 9, 10], "text": "recombinant human interleukin - 11"}, {"type": "treatment disorder", "offset": [35, 36, 37, 38, 39, 40, 41, 42, 43, 44], "text": "postchemotherapy platelet nadirs of < or = 20,000 / microL"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "preventing", "label": "potential therapeutic event", "asoc": [["subject", "patients with nonmyeloid malignancies"], ["subject disorder", "nonmyeloid malignancies"], ["subject disorder", "postchemotherapy platelet nadirs of < or = 20,000 / microL"], ["treatment", "recombinant human interleukin - 11 ( rhIL - 11 , also known as oprelvekin [ Neumega ] )"], ["drug", "recombinant human interleukin - 11"], ["treatment disorder", "postchemotherapy platelet nadirs of < or = 20,000 / microL"]]}]}
{"text_id": "17420198_10", "text": "Facial , tongue , and arm movements were first reported approximately five weeks after the initiation of aripiprazole .", "tokens": ["Facial", ",", "tongue", ",", "and", "arm", "movements", "were", "first", "reported", "approximately", "five", "weeks", "after", "the", "initiation", "of", "aripiprazole", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> initiation of aripiprazole <extra_id_1> <extra_id_0> drug <extra_id_5> aripiprazole <extra_id_1> <extra_id_0> duration <extra_id_5> five weeks <extra_id_1> <extra_id_0> time elapsed <extra_id_5> five weeks <extra_id_1> <extra_id_0> effect <extra_id_5> Facial , tongue , and arm movements <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "after", "args": [{"type": "treatment", "offset": [15, 16, 17], "text": "initiation of aripiprazole"}, {"type": "drug", "offset": [17], "text": "aripiprazole"}, {"type": "duration", "offset": [11, 12], "text": "five weeks"}, {"type": "time elapsed", "offset": [11, 12], "text": "five weeks"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6], "text": "Facial , tongue , and arm movements"}]}], "spot": ["adverse event"], "asoc": ["duration", "effect", "drug", "time elapsed", "treatment"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "initiation of aripiprazole"], ["drug", "aripiprazole"], ["duration", "five weeks"], ["time elapsed", "five weeks"], ["effect", "Facial , tongue , and arm movements"]]}]}
{"text_id": "15224368_2", "text": "Sweet 's syndrome is an acute febrile neutrophilic dermatosis that is a known complication of the administration of filgrastim , a drug that causes increased neutrophil proliferation and differentiation .", "tokens": ["Sweet", "'s", "syndrome", "is", "an", "acute", "febrile", "neutrophilic", "dermatosis", "that", "is", "a", "known", "complication", "of", "the", "administration", "of", "filgrastim", ",", "a", "drug", "that", "causes", "increased", "neutrophil", "proliferation", "and", "differentiation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> causes <extra_id_0> treatment <extra_id_5> filgrastim <extra_id_1> <extra_id_0> drug <extra_id_5> filgrastim <extra_id_1> <extra_id_0> effect <extra_id_5> Sweet 's syndrome is an acute febrile neutrophilic dermatosis <extra_id_1> <extra_id_0> effect <extra_id_5> increased neutrophil proliferation and differentiation <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [23], "text": "causes", "args": [{"type": "treatment", "offset": [18], "text": "filgrastim"}, {"type": "drug", "offset": [18], "text": "filgrastim"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8], "text": "Sweet 's syndrome is an acute febrile neutrophilic dermatosis"}, {"type": "effect", "offset": [24, 25, 26, 27, 28], "text": "increased neutrophil proliferation and differentiation"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "causes", "label": "adverse event", "asoc": [["treatment", "filgrastim"], ["drug", "filgrastim"], ["effect", "Sweet 's syndrome is an acute febrile neutrophilic dermatosis"], ["effect", "increased neutrophil proliferation and differentiation"]]}]}
{"text_id": "9260733_1", "text": "Clozapine induced polyserositis .", "tokens": ["Clozapine", "induced", "polyserositis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Clozapine <extra_id_1> <extra_id_0> drug <extra_id_5> Clozapine <extra_id_1> <extra_id_0> effect <extra_id_5> polyserositis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Clozapine"}, {"type": "drug", "offset": [0], "text": "Clozapine"}, {"type": "effect", "offset": [2], "text": "polyserositis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Clozapine"], ["drug", "Clozapine"], ["effect", "polyserositis"]]}]}
{"text_id": "9796135_1", "text": "A 65 - year - old woman with angina pectoris presented with syncope after sublingual ingestion of isosorbide dinitrate ( 5 mg ) .", "tokens": ["A", "65", "-", "year", "-", "old", "woman", "with", "angina", "pectoris", "presented", "with", "syncope", "after", "sublingual", "ingestion", "of", "isosorbide", "dinitrate", "(", "5", "mg", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> presented <extra_id_0> subject <extra_id_5> A 65 - year - old woman with angina pectoris <extra_id_1> <extra_id_0> age <extra_id_5> 65 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> angina pectoris <extra_id_1> <extra_id_0> treatment <extra_id_5> sublingual ingestion of isosorbide dinitrate ( 5 mg ) <extra_id_1> <extra_id_0> drug <extra_id_5> isosorbide dinitrate <extra_id_1> <extra_id_0> dosage <extra_id_5> 5 mg <extra_id_1> <extra_id_0> route <extra_id_5> sublingual ingestion <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> angina pectoris <extra_id_1> <extra_id_0> effect <extra_id_5> syncope <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "presented", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9], "text": "A 65 - year - old woman with angina pectoris"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "65 - year - old"}, {"type": "gender", "offset": [6], "text": "woman"}, {"type": "subject disorder", "offset": [8, 9], "text": "angina pectoris"}, {"type": "treatment", "offset": [14, 15, 16, 17, 18, 19, 20, 21, 22], "text": "sublingual ingestion of isosorbide dinitrate ( 5 mg )"}, {"type": "drug", "offset": [17, 18], "text": "isosorbide dinitrate"}, {"type": "dosage", "offset": [20, 21], "text": "5 mg"}, {"type": "route", "offset": [14, 15], "text": "sublingual ingestion"}, {"type": "treatment disorder", "offset": [8, 9], "text": "angina pectoris"}, {"type": "effect", "offset": [12], "text": "syncope"}]}], "spot": ["adverse event"], "asoc": ["dosage", "effect", "route", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "presented", "label": "adverse event", "asoc": [["subject", "A 65 - year - old woman with angina pectoris"], ["age", "65 - year - old"], ["gender", "woman"], ["subject disorder", "angina pectoris"], ["treatment", "sublingual ingestion of isosorbide dinitrate ( 5 mg )"], ["drug", "isosorbide dinitrate"], ["dosage", "5 mg"], ["route", "sublingual ingestion"], ["treatment disorder", "angina pectoris"], ["effect", "syncope"]]}]}
{"text_id": "2554727_4", "text": "We describe a patient with acute leukemia who developed Horner 's syndrome and a severe demyelinating peripheral neuropathy leading to death after receiving high - dose cytosine arabinoside .", "tokens": ["We", "describe", "a", "patient", "with", "acute", "leukemia", "who", "developed", "Horner", "'s", "syndrome", "and", "a", "severe", "demyelinating", "peripheral", "neuropathy", "leading", "to", "death", "after", "receiving", "high", "-", "dose", "cytosine", "arabinoside", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a patient with acute leukemia <extra_id_1> <extra_id_0> subject disorder <extra_id_5> acute leukemia <extra_id_1> <extra_id_0> treatment <extra_id_5> high - dose cytosine arabinoside . <extra_id_1> <extra_id_0> drug <extra_id_5> cytosine arabinoside <extra_id_1> <extra_id_0> dosage <extra_id_5> high - dose <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> acute leukemia <extra_id_1> <extra_id_0> effect <extra_id_5> Horner 's syndrome and a severe demyelinating peripheral neuropathy leading to death <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [8], "text": "developed", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6], "text": "a patient with acute leukemia"}, {"type": "subject disorder", "offset": [5, 6], "text": "acute leukemia"}, {"type": "treatment", "offset": [23, 24, 25, 26, 27, 28], "text": "high - dose cytosine arabinoside ."}, {"type": "drug", "offset": [26, 27], "text": "cytosine arabinoside"}, {"type": "dosage", "offset": [23, 24, 25], "text": "high - dose"}, {"type": "treatment disorder", "offset": [5, 6], "text": "acute leukemia"}, {"type": "effect", "offset": [9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "Horner 's syndrome and a severe demyelinating peripheral neuropathy leading to death"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "treatment", "dosage", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a patient with acute leukemia"], ["subject disorder", "acute leukemia"], ["treatment", "high - dose cytosine arabinoside ."], ["drug", "cytosine arabinoside"], ["dosage", "high - dose"], ["treatment disorder", "acute leukemia"], ["effect", "Horner 's syndrome and a severe demyelinating peripheral neuropathy leading to death"]]}]}
{"text_id": "16298824_2", "text": "ARDS has been associated with the administration of other monoclonal antibodies , such as infliximab , gemtuzumab ozogamicin , and OKT3 and is believed to be directly mediated by release of proinflammatory cytokines .", "tokens": ["ARDS", "has", "been", "associated", "with", "the", "administration", "of", "other", "monoclonal", "antibodies", ",", "such", "as", "infliximab", ",", "gemtuzumab", "ozogamicin", ",", "and", "OKT3", "and", "is", "believed", "to", "be", "directly", "mediated", "by", "release", "of", "proinflammatory", "cytokines", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> the administration of other monoclonal antibodies , such as infliximab , gemtuzumab ozogamicin , and OKT3 <extra_id_1> <extra_id_0> drug <extra_id_5> infliximab <extra_id_1> <extra_id_0> drug <extra_id_5> gemtuzumab <extra_id_1> <extra_id_0> drug <extra_id_5> ozogamicin <extra_id_1> <extra_id_0> drug <extra_id_5> OKT3 <extra_id_1> <extra_id_0> effect <extra_id_5> ARDS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [3], "text": "associated", "args": [{"type": "treatment", "offset": [5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20], "text": "the administration of other monoclonal antibodies , such as infliximab , gemtuzumab ozogamicin , and OKT3"}, {"type": "drug", "offset": [14], "text": "infliximab"}, {"type": "drug", "offset": [16], "text": "gemtuzumab"}, {"type": "drug", "offset": [17], "text": "ozogamicin"}, {"type": "drug", "offset": [20], "text": "OKT3"}, {"type": "effect", "offset": [0], "text": "ARDS"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "the administration of other monoclonal antibodies , such as infliximab , gemtuzumab ozogamicin , and OKT3"], ["drug", "infliximab"], ["drug", "gemtuzumab"], ["drug", "ozogamicin"], ["drug", "OKT3"], ["effect", "ARDS"]]}]}
{"text_id": "20298401_1", "text": "Fatal interstitial lung disease after erlotinib administration in a patient with radiation fibrosis .", "tokens": ["Fatal", "interstitial", "lung", "disease", "after", "erlotinib", "administration", "in", "a", "patient", "with", "radiation", "fibrosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a patient with radiation fibrosis <extra_id_1> <extra_id_0> subject disorder <extra_id_5> radiation fibrosis <extra_id_1> <extra_id_0> treatment <extra_id_5> erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> effect <extra_id_5> interstitial lung disease <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "after", "args": [{"type": "subject", "offset": [8, 9, 10, 11, 12], "text": "a patient with radiation fibrosis"}, {"type": "subject disorder", "offset": [11, 12], "text": "radiation fibrosis"}, {"type": "treatment", "offset": [5], "text": "erlotinib"}, {"type": "drug", "offset": [5], "text": "erlotinib"}, {"type": "effect", "offset": [1, 2, 3], "text": "interstitial lung disease"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "subject disorder"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a patient with radiation fibrosis"], ["subject disorder", "radiation fibrosis"], ["treatment", "erlotinib"], ["drug", "erlotinib"], ["effect", "interstitial lung disease"]]}]}
{"text_id": "15533031_1", "text": "Paradoxical cerebral cortical hyperexcitability following flupirtine overdose .", "tokens": ["Paradoxical", "cerebral", "cortical", "hyperexcitability", "following", "flupirtine", "overdose", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> following <extra_id_0> treatment <extra_id_5> flupirtine overdose <extra_id_1> <extra_id_0> drug <extra_id_5> flupirtine <extra_id_1> <extra_id_0> dosage <extra_id_5> overdose <extra_id_1> <extra_id_0> effect <extra_id_5> Paradoxical cerebral cortical hyperexcitability <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "following", "args": [{"type": "treatment", "offset": [5, 6], "text": "flupirtine overdose"}, {"type": "drug", "offset": [5], "text": "flupirtine"}, {"type": "dosage", "offset": [6], "text": "overdose"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Paradoxical cerebral cortical hyperexcitability"}]}], "spot": ["adverse event"], "asoc": ["dosage", "treatment", "drug", "effect"], "spot_asoc": [{"span": "following", "label": "adverse event", "asoc": [["treatment", "flupirtine overdose"], ["drug", "flupirtine"], ["dosage", "overdose"], ["effect", "Paradoxical cerebral cortical hyperexcitability"]]}]}
{"text_id": "8828999_4", "text": "Several cases of lithium - induced Creutzfeldt - Jakob syndrome have been reported to date ; all of them were elderly patients and a half had \" therapeutic \" lithium serum levels .", "tokens": ["Several", "cases", "of", "lithium", "-", "induced", "Creutzfeldt", "-", "Jakob", "syndrome", "have", "been", "reported", "to", "date", ";", "all", "of", "them", "were", "elderly", "patients", "and", "a", "half", "had", "\"", "therapeutic", "\"", "lithium", "serum", "levels", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> elderly patients <extra_id_1> <extra_id_0> age <extra_id_5> elderly <extra_id_1> <extra_id_0> treatment <extra_id_5> lithium <extra_id_1> <extra_id_0> treatment <extra_id_5> \" therapeutic \" lithium serum levels <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> drug <extra_id_5> lithium <extra_id_1> <extra_id_0> effect <extra_id_5> Creutzfeldt - Jakob syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "induced", "args": [{"type": "subject", "offset": [20, 21], "text": "elderly patients"}, {"type": "age", "offset": [20], "text": "elderly"}, {"type": "treatment", "offset": [3], "text": "lithium"}, {"type": "treatment", "offset": [26, 27, 28, 29, 30, 31], "text": "\" therapeutic \" lithium serum levels"}, {"type": "drug", "offset": [3], "text": "lithium"}, {"type": "drug", "offset": [29], "text": "lithium"}, {"type": "effect", "offset": [6, 7, 8, 9], "text": "Creutzfeldt - Jakob syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "elderly patients"], ["age", "elderly"], ["treatment", "lithium"], ["treatment", "\" therapeutic \" lithium serum levels"], ["drug", "lithium"], ["drug", "lithium"], ["effect", "Creutzfeldt - Jakob syndrome"]]}]}
{"text_id": "19151423_1", "text": "Rhabdomyolysis due to an uncommon interaction of ciprofloxacin with simvastatin .", "tokens": ["Rhabdomyolysis", "due", "to", "an", "uncommon", "interaction", "of", "ciprofloxacin", "with", "simvastatin", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> due <extra_id_0> treatment <extra_id_5> interaction of ciprofloxacin with simvastatin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> simvastatin <extra_id_1> <extra_id_0> combination drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> combination drug <extra_id_5> simvastatin <extra_id_1> <extra_id_0> effect <extra_id_5> Rhabdomyolysis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "due", "args": [{"type": "treatment", "offset": [5, 6, 7, 8, 9], "text": "interaction of ciprofloxacin with simvastatin"}, {"type": "drug", "offset": [7], "text": "ciprofloxacin"}, {"type": "drug", "offset": [9], "text": "simvastatin"}, {"type": "combination drug", "offset": [7], "text": "ciprofloxacin"}, {"type": "combination drug", "offset": [9], "text": "simvastatin"}, {"type": "effect", "offset": [0], "text": "Rhabdomyolysis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "due", "label": "adverse event", "asoc": [["treatment", "interaction of ciprofloxacin with simvastatin"], ["drug", "ciprofloxacin"], ["drug", "simvastatin"], ["combination drug", "ciprofloxacin"], ["combination drug", "simvastatin"], ["effect", "Rhabdomyolysis"]]}]}
{"text_id": "20118434_4", "text": "OBJECTIVE : The authors described a case of interferon - induced psychosis as a framework to review the literature and discuss the decision to pursue antiviral treatment in psychiatrically ill patients with hepatitis C.", "tokens": ["OBJECTIVE", ":", "The", "authors", "described", "a", "case", "of", "interferon", "-", "induced", "psychosis", "as", "a", "framework", "to", "review", "the", "literature", "and", "discuss", "the", "decision", "to", "pursue", "antiviral", "treatment", "in", "psychiatrically", "ill", "patients", "with", "hepatitis", "C."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> psychiatrically ill patients with hepatitis C. <extra_id_1> <extra_id_0> subject disorder <extra_id_5> psychiatrically ill <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hepatitis C. <extra_id_1> <extra_id_0> treatment <extra_id_5> interferon <extra_id_1> <extra_id_0> drug <extra_id_5> interferon <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hepatitis C. <extra_id_1> <extra_id_0> effect <extra_id_5> psychosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "induced", "args": [{"type": "subject", "offset": [28, 29, 30, 31, 32, 33], "text": "psychiatrically ill patients with hepatitis C."}, {"type": "subject disorder", "offset": [28, 29], "text": "psychiatrically ill"}, {"type": "subject disorder", "offset": [32, 33], "text": "hepatitis C."}, {"type": "treatment", "offset": [8], "text": "interferon"}, {"type": "drug", "offset": [8], "text": "interferon"}, {"type": "treatment disorder", "offset": [32, 33], "text": "hepatitis C."}, {"type": "effect", "offset": [11], "text": "psychosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "psychiatrically ill patients with hepatitis C."], ["subject disorder", "psychiatrically ill"], ["subject disorder", "hepatitis C."], ["treatment", "interferon"], ["drug", "interferon"], ["treatment disorder", "hepatitis C."], ["effect", "psychosis"]]}]}
{"text_id": "2042691_1", "text": "Amiodarone was discontinued , and thyrotoxicosis gradually abated .", "tokens": ["Amiodarone", "was", "discontinued", ",", "and", "thyrotoxicosis", "gradually", "abated", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> was discontinued <extra_id_0> treatment <extra_id_5> Amiodarone <extra_id_1> <extra_id_0> drug <extra_id_5> Amiodarone <extra_id_1> <extra_id_0> effect <extra_id_5> thyrotoxicosis gradually abated <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [1, 2], "text": "was discontinued", "args": [{"type": "treatment", "offset": [0], "text": "Amiodarone"}, {"type": "drug", "offset": [0], "text": "Amiodarone"}, {"type": "effect", "offset": [5, 6, 7], "text": "thyrotoxicosis gradually abated"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "was discontinued", "label": "potential therapeutic event", "asoc": [["treatment", "Amiodarone"], ["drug", "Amiodarone"], ["effect", "thyrotoxicosis gradually abated"]]}]}
{"text_id": "15373932_2", "text": "Fungal infection is a significant comorbidity in patients with diabetes mellitus , and ketoconazole , an antifungal agent , causes a number of drug interactions with coadministered drugs .", "tokens": ["Fungal", "infection", "is", "a", "significant", "comorbidity", "in", "patients", "with", "diabetes", "mellitus", ",", "and", "ketoconazole", ",", "an", "antifungal", "agent", ",", "causes", "a", "number", "of", "drug", "interactions", "with", "coadministered", "drugs", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> causes <extra_id_0> subject <extra_id_5> patients with diabetes mellitus <extra_id_1> <extra_id_0> subject disorder <extra_id_5> diabetes mellitus <extra_id_1> <extra_id_0> subject disorder <extra_id_5> Fungal infection <extra_id_1> <extra_id_0> treatment <extra_id_5> ketoconazole <extra_id_1> <extra_id_0> drug <extra_id_5> ketoconazole <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> Fungal infection <extra_id_1> <extra_id_0> effect <extra_id_5> a number of drug interactions with coadministered drugs <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "causes", "args": [{"type": "subject", "offset": [7, 8, 9, 10], "text": "patients with diabetes mellitus"}, {"type": "subject disorder", "offset": [9, 10], "text": "diabetes mellitus"}, {"type": "subject disorder", "offset": [0, 1], "text": "Fungal infection"}, {"type": "treatment", "offset": [13], "text": "ketoconazole"}, {"type": "drug", "offset": [13], "text": "ketoconazole"}, {"type": "treatment disorder", "offset": [0, 1], "text": "Fungal infection"}, {"type": "effect", "offset": [20, 21, 22, 23, 24, 25, 26, 27], "text": "a number of drug interactions with coadministered drugs"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "causes", "label": "adverse event", "asoc": [["subject", "patients with diabetes mellitus"], ["subject disorder", "diabetes mellitus"], ["subject disorder", "Fungal infection"], ["treatment", "ketoconazole"], ["drug", "ketoconazole"], ["treatment disorder", "Fungal infection"], ["effect", "a number of drug interactions with coadministered drugs"]]}]}
{"text_id": "9796135_4", "text": "Syncope in a 65 - year - old woman after nitrate ingestion .", "tokens": ["Syncope", "in", "a", "65", "-", "year", "-", "old", "woman", "after", "nitrate", "ingestion", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> subject <extra_id_5> a 65 - year - old woman <extra_id_1> <extra_id_0> age <extra_id_5> 65 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> treatment <extra_id_5> nitrate ingestion <extra_id_1> <extra_id_0> drug <extra_id_5> nitrate <extra_id_1> <extra_id_0> route <extra_id_5> ingestion <extra_id_1> <extra_id_0> effect <extra_id_5> Syncope <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "after", "args": [{"type": "subject", "offset": [2, 3, 4, 5, 6, 7, 8], "text": "a 65 - year - old woman"}, {"type": "age", "offset": [3, 4, 5, 6, 7], "text": "65 - year - old"}, {"type": "gender", "offset": [8], "text": "woman"}, {"type": "treatment", "offset": [10, 11], "text": "nitrate ingestion"}, {"type": "drug", "offset": [10], "text": "nitrate"}, {"type": "route", "offset": [11], "text": "ingestion"}, {"type": "effect", "offset": [0], "text": "Syncope"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["subject", "a 65 - year - old woman"], ["age", "65 - year - old"], ["gender", "woman"], ["treatment", "nitrate ingestion"], ["drug", "nitrate"], ["route", "ingestion"], ["effect", "Syncope"]]}]}
{"text_id": "11026106_3", "text": "We describe the clinical and liver biopsy morphologic features for 4 patients with minocycline - induced autoimmune hepatitis ( group 1 ) .", "tokens": ["We", "describe", "the", "clinical", "and", "liver", "biopsy", "morphologic", "features", "for", "4", "patients", "with", "minocycline", "-", "induced", "autoimmune", "hepatitis", "(", "group", "1", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> 4 patients <extra_id_1> <extra_id_0> population <extra_id_5> 4 <extra_id_1> <extra_id_0> treatment <extra_id_5> minocycline <extra_id_1> <extra_id_0> drug <extra_id_5> minocycline <extra_id_1> <extra_id_0> effect <extra_id_5> autoimmune hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "induced", "args": [{"type": "subject", "offset": [10, 11], "text": "4 patients"}, {"type": "population", "offset": [10], "text": "4"}, {"type": "treatment", "offset": [13], "text": "minocycline"}, {"type": "drug", "offset": [13], "text": "minocycline"}, {"type": "effect", "offset": [16, 17], "text": "autoimmune hepatitis"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "4 patients"], ["population", "4"], ["treatment", "minocycline"], ["drug", "minocycline"], ["effect", "autoimmune hepatitis"]]}]}
{"text_id": "10410183_1", "text": "Marked elevation of serum creatine kinase associated with olanzapine therapy .", "tokens": ["Marked", "elevation", "of", "serum", "creatine", "kinase", "associated", "with", "olanzapine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> olanzapine therapy <extra_id_1> <extra_id_0> drug <extra_id_5> olanzapine <extra_id_1> <extra_id_0> effect <extra_id_5> Marked elevation of serum creatine kinase <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "associated", "args": [{"type": "treatment", "offset": [8, 9], "text": "olanzapine therapy"}, {"type": "drug", "offset": [8], "text": "olanzapine"}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5], "text": "Marked elevation of serum creatine kinase"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "olanzapine therapy"], ["drug", "olanzapine"], ["effect", "Marked elevation of serum creatine kinase"]]}]}
{"text_id": "15580406_2", "text": "Retinal abnormalities , including retinal hemorrhage and \" cotton - wool \" spots , often occur within the first 8 weeks in the course of interferon therapy in patients with chronic hepatitis C.", "tokens": ["Retinal", "abnormalities", ",", "including", "retinal", "hemorrhage", "and", "\"", "cotton", "-", "wool", "\"", "spots", ",", "often", "occur", "within", "the", "first", "8", "weeks", "in", "the", "course", "of", "interferon", "therapy", "in", "patients", "with", "chronic", "hepatitis", "C."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> occur <extra_id_0> subject <extra_id_5> patients with chronic hepatitis C. <extra_id_1> <extra_id_0> subject disorder <extra_id_5> chronic hepatitis C. <extra_id_1> <extra_id_0> treatment <extra_id_5> interferon <extra_id_1> <extra_id_0> drug <extra_id_5> interferon <extra_id_1> <extra_id_0> duration <extra_id_5> 8 weeks <extra_id_1> <extra_id_0> time elapsed <extra_id_5> 8 weeks <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> chronic hepatitis C. <extra_id_1> <extra_id_0> effect <extra_id_5> Retinal abnormalities , including retinal hemorrhage and \" cotton - wool \" spots <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "occur", "args": [{"type": "subject", "offset": [28, 29, 30, 31, 32], "text": "patients with chronic hepatitis C."}, {"type": "subject disorder", "offset": [30, 31, 32], "text": "chronic hepatitis C."}, {"type": "treatment", "offset": [25], "text": "interferon"}, {"type": "drug", "offset": [25], "text": "interferon"}, {"type": "duration", "offset": [19, 20], "text": "8 weeks"}, {"type": "time elapsed", "offset": [19, 20], "text": "8 weeks"}, {"type": "treatment disorder", "offset": [30, 31, 32], "text": "chronic hepatitis C."}, {"type": "effect", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12], "text": "Retinal abnormalities , including retinal hemorrhage and \" cotton - wool \" spots"}]}], "spot": ["adverse event"], "asoc": ["time elapsed", "effect", "subject", "treatment", "duration", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "occur", "label": "adverse event", "asoc": [["subject", "patients with chronic hepatitis C."], ["subject disorder", "chronic hepatitis C."], ["treatment", "interferon"], ["drug", "interferon"], ["duration", "8 weeks"], ["time elapsed", "8 weeks"], ["treatment disorder", "chronic hepatitis C."], ["effect", "Retinal abnormalities , including retinal hemorrhage and \" cotton - wool \" spots"]]}]}
{"text_id": "19857154_5", "text": "The first patient was a 57 - year - old man with HIV and bipolar disease who developed rapid and severe weight gain when quetiapine was added to a stable atazanavir - ritonavir - based antiretroviral regimen .", "tokens": ["The", "first", "patient", "was", "a", "57", "-", "year", "-", "old", "man", "with", "HIV", "and", "bipolar", "disease", "who", "developed", "rapid", "and", "severe", "weight", "gain", "when", "quetiapine", "was", "added", "to", "a", "stable", "atazanavir", "-", "ritonavir", "-", "based", "antiretroviral", "regimen", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> a 57 - year - old man with HIV and bipolar disease <extra_id_1> <extra_id_0> age <extra_id_5> 57 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> subject disorder <extra_id_5> bipolar disease <extra_id_1> <extra_id_0> treatment <extra_id_5> quetiapine was added to a stable atazanavir - ritonavir - based antiretroviral regimen <extra_id_1> <extra_id_0> drug <extra_id_5> atazanavir <extra_id_1> <extra_id_0> drug <extra_id_5> ritonavir <extra_id_1> <extra_id_0> drug <extra_id_5> quetiapine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> bipolar disease <extra_id_1> <extra_id_0> combination drug <extra_id_5> quetiapine <extra_id_1> <extra_id_0> combination drug <extra_id_5> atazanavir <extra_id_1> <extra_id_0> combination drug <extra_id_5> ritonavir <extra_id_1> <extra_id_0> effect <extra_id_5> rapid and severe weight gain <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "developed", "args": [{"type": "subject", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15], "text": "a 57 - year - old man with HIV and bipolar disease"}, {"type": "age", "offset": [5, 6, 7, 8, 9], "text": "57 - year - old"}, {"type": "gender", "offset": [10], "text": "man"}, {"type": "subject disorder", "offset": [12], "text": "HIV"}, {"type": "subject disorder", "offset": [14, 15], "text": "bipolar disease"}, {"type": "treatment", "offset": [24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36], "text": "quetiapine was added to a stable atazanavir - ritonavir - based antiretroviral regimen"}, {"type": "drug", "offset": [30], "text": "atazanavir"}, {"type": "drug", "offset": [32], "text": "ritonavir"}, {"type": "drug", "offset": [24], "text": "quetiapine"}, {"type": "treatment disorder", "offset": [12], "text": "HIV"}, {"type": "treatment disorder", "offset": [14, 15], "text": "bipolar disease"}, {"type": "combination drug", "offset": [24], "text": "quetiapine"}, {"type": "combination drug", "offset": [30], "text": "atazanavir"}, {"type": "combination drug", "offset": [32], "text": "ritonavir"}, {"type": "effect", "offset": [18, 19, 20, 21, 22], "text": "rapid and severe weight gain"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "a 57 - year - old man with HIV and bipolar disease"], ["age", "57 - year - old"], ["gender", "man"], ["subject disorder", "HIV"], ["subject disorder", "bipolar disease"], ["treatment", "quetiapine was added to a stable atazanavir - ritonavir - based antiretroviral regimen"], ["drug", "atazanavir"], ["drug", "ritonavir"], ["drug", "quetiapine"], ["treatment disorder", "HIV"], ["treatment disorder", "bipolar disease"], ["combination drug", "quetiapine"], ["combination drug", "atazanavir"], ["combination drug", "ritonavir"], ["effect", "rapid and severe weight gain"]]}]}
{"text_id": "18784429_2", "text": "CONCLUSIONS : Life - threatening adrenal suppression , requiring hydrocortisone supplementation and intensive therapy , was observed and successfully treated in a newborn , whose mother had received high - dose methylprednisolone in late pregnancy .", "tokens": ["CONCLUSIONS", ":", "Life", "-", "threatening", "adrenal", "suppression", ",", "requiring", "hydrocortisone", "supplementation", "and", "intensive", "therapy", ",", "was", "observed", "and", "successfully", "treated", "in", "a", "newborn", ",", "whose", "mother", "had", "received", "high", "-", "dose", "methylprednisolone", "in", "late", "pregnancy", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> requiring <extra_id_0> subject <extra_id_5> a newborn , whose mother had received high - dose methylprednisolone in late pregnancy <extra_id_1> <extra_id_0> age <extra_id_5> newborn <extra_id_1> <extra_id_0> treatment <extra_id_5> hydrocortisone supplementation and intensive therapy <extra_id_1> <extra_id_0> drug <extra_id_5> hydrocortisone <extra_id_1> <extra_id_0> effect <extra_id_5> successfully treated <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [8], "text": "requiring", "args": [{"type": "subject", "offset": [21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34], "text": "a newborn , whose mother had received high - dose methylprednisolone in late pregnancy"}, {"type": "age", "offset": [22], "text": "newborn"}, {"type": "treatment", "offset": [9, 10, 11, 12, 13], "text": "hydrocortisone supplementation and intensive therapy"}, {"type": "drug", "offset": [9], "text": "hydrocortisone"}, {"type": "effect", "offset": [18, 19], "text": "successfully treated"}]}], "spot": ["potential therapeutic event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "requiring", "label": "potential therapeutic event", "asoc": [["subject", "a newborn , whose mother had received high - dose methylprednisolone in late pregnancy"], ["age", "newborn"], ["treatment", "hydrocortisone supplementation and intensive therapy"], ["drug", "hydrocortisone"], ["effect", "successfully treated"]]}]}
{"text_id": "921427_2", "text": "Circulating anticoagulant in the procainamide - induced lupus syndrome .", "tokens": ["Circulating", "anticoagulant", "in", "the", "procainamide", "-", "induced", "lupus", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> procainamide <extra_id_1> <extra_id_0> drug <extra_id_5> procainamide <extra_id_1> <extra_id_0> effect <extra_id_5> lupus syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "induced", "args": [{"type": "treatment", "offset": [4], "text": "procainamide"}, {"type": "drug", "offset": [4], "text": "procainamide"}, {"type": "effect", "offset": [7, 8], "text": "lupus syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "procainamide"], ["drug", "procainamide"], ["effect", "lupus syndrome"]]}]}
{"text_id": "9161656_15", "text": "CONCLUSIONS : Sustained - release verapamil is thought to be the cause of the asthma attack in this patient because she was not taking any other preparations ; the symptoms started with the administration of sustained - release verapamil and were relieved after its discontinuation .", "tokens": ["CONCLUSIONS", ":", "Sustained", "-", "release", "verapamil", "is", "thought", "to", "be", "the", "cause", "of", "the", "asthma", "attack", "in", "this", "patient", "because", "she", "was", "not", "taking", "any", "other", "preparations", ";", "the", "symptoms", "started", "with", "the", "administration", "of", "sustained", "-", "release", "verapamil", "and", "were", "relieved", "after", "its", "discontinuation", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> treatment <extra_id_5> Sustained - release verapamil <extra_id_1> <extra_id_0> drug <extra_id_5> verapamil <extra_id_1> <extra_id_0> effect <extra_id_5> asthma attack <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "cause", "args": [{"type": "treatment", "offset": [2, 3, 4, 5], "text": "Sustained - release verapamil"}, {"type": "drug", "offset": [5], "text": "verapamil"}, {"type": "effect", "offset": [14, 15], "text": "asthma attack"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["treatment", "Sustained - release verapamil"], ["drug", "verapamil"], ["effect", "asthma attack"]]}]}
{"text_id": "18682542_2", "text": "DISCUSSION : To our knowledge , this is the first case report illustrating neuralgic amyotrophy triggered by exposure to the antibiotics vancomycin , tobramycin , and piperacillin / tazobactam .", "tokens": ["DISCUSSION", ":", "To", "our", "knowledge", ",", "this", "is", "the", "first", "case", "report", "illustrating", "neuralgic", "amyotrophy", "triggered", "by", "exposure", "to", "the", "antibiotics", "vancomycin", ",", "tobramycin", ",", "and", "piperacillin", "/", "tazobactam", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> triggered <extra_id_0> treatment <extra_id_5> antibiotics vancomycin , tobramycin , and piperacillin / tazobactam <extra_id_1> <extra_id_0> drug <extra_id_5> vancomycin <extra_id_1> <extra_id_0> drug <extra_id_5> tobramycin <extra_id_1> <extra_id_0> drug <extra_id_5> piperacillin <extra_id_1> <extra_id_0> drug <extra_id_5> tazobactam <extra_id_1> <extra_id_0> combination drug <extra_id_5> vancomycin <extra_id_1> <extra_id_0> combination drug <extra_id_5> tobramycin <extra_id_1> <extra_id_0> combination drug <extra_id_5> piperacillin <extra_id_1> <extra_id_0> combination drug <extra_id_5> tazobactam <extra_id_1> <extra_id_0> effect <extra_id_5> neuralgic amyotrophy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "triggered", "args": [{"type": "treatment", "offset": [20, 21, 22, 23, 24, 25, 26, 27, 28], "text": "antibiotics vancomycin , tobramycin , and piperacillin / tazobactam"}, {"type": "drug", "offset": [21], "text": "vancomycin"}, {"type": "drug", "offset": [23], "text": "tobramycin"}, {"type": "drug", "offset": [26], "text": "piperacillin"}, {"type": "drug", "offset": [28], "text": "tazobactam"}, {"type": "combination drug", "offset": [21], "text": "vancomycin"}, {"type": "combination drug", "offset": [23], "text": "tobramycin"}, {"type": "combination drug", "offset": [26], "text": "piperacillin"}, {"type": "combination drug", "offset": [28], "text": "tazobactam"}, {"type": "effect", "offset": [13, 14], "text": "neuralgic amyotrophy"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "triggered", "label": "adverse event", "asoc": [["treatment", "antibiotics vancomycin , tobramycin , and piperacillin / tazobactam"], ["drug", "vancomycin"], ["drug", "tobramycin"], ["drug", "piperacillin"], ["drug", "tazobactam"], ["combination drug", "vancomycin"], ["combination drug", "tobramycin"], ["combination drug", "piperacillin"], ["combination drug", "tazobactam"], ["effect", "neuralgic amyotrophy"]]}]}
{"text_id": "8038468_1", "text": "CONCLUSIONS : This case describes the clinically significant increase of INR in an elderly patient after adding a chemotherapy regimen of levamisole and 5 - FU to a previous regimen of warfarin alone .", "tokens": ["CONCLUSIONS", ":", "This", "case", "describes", "the", "clinically", "significant", "increase", "of", "INR", "in", "an", "elderly", "patient", "after", "adding", "a", "chemotherapy", "regimen", "of", "levamisole", "and", "5", "-", "FU", "to", "a", "previous", "regimen", "of", "warfarin", "alone", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> in <extra_id_0> subject <extra_id_5> an elderly patient <extra_id_1> <extra_id_0> age <extra_id_5> elderly <extra_id_1> <extra_id_0> treatment <extra_id_5> levamisole and 5 - FU <extra_id_1> <extra_id_0> treatment <extra_id_5> warfarin <extra_id_1> <extra_id_0> drug <extra_id_5> levamisole <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> combination drug <extra_id_5> levamisole <extra_id_1> <extra_id_0> combination drug <extra_id_5> 5 - FU <extra_id_1> <extra_id_0> combination drug <extra_id_5> warfarin <extra_id_1> <extra_id_0> effect <extra_id_5> increase of INR <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [11], "text": "in", "args": [{"type": "subject", "offset": [12, 13, 14], "text": "an elderly patient"}, {"type": "age", "offset": [13], "text": "elderly"}, {"type": "treatment", "offset": [21, 22, 23, 24, 25], "text": "levamisole and 5 - FU"}, {"type": "treatment", "offset": [31], "text": "warfarin"}, {"type": "drug", "offset": [21], "text": "levamisole"}, {"type": "drug", "offset": [23, 24, 25], "text": "5 - FU"}, {"type": "drug", "offset": [31], "text": "warfarin"}, {"type": "combination drug", "offset": [21], "text": "levamisole"}, {"type": "combination drug", "offset": [23, 24, 25], "text": "5 - FU"}, {"type": "combination drug", "offset": [31], "text": "warfarin"}, {"type": "effect", "offset": [8, 9, 10], "text": "increase of INR"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "combination drug", "age", "treatment"], "spot_asoc": [{"span": "in", "label": "adverse event", "asoc": [["subject", "an elderly patient"], ["age", "elderly"], ["treatment", "levamisole and 5 - FU"], ["treatment", "warfarin"], ["drug", "levamisole"], ["drug", "5 - FU"], ["drug", "warfarin"], ["combination drug", "levamisole"], ["combination drug", "5 - FU"], ["combination drug", "warfarin"], ["effect", "increase of INR"]]}]}
{"text_id": "8140860_5", "text": "In this case , the increase in the INR value with associated bruising after the addition of amoxycillin suggests a drug interaction between acenocoumarol and amoxycillin , other possible causes having been eliminated .", "tokens": ["In", "this", "case", ",", "the", "increase", "in", "the", "INR", "value", "with", "associated", "bruising", "after", "the", "addition", "of", "amoxycillin", "suggests", "a", "drug", "interaction", "between", "acenocoumarol", "and", "amoxycillin", ",", "other", "possible", "causes", "having", "been", "eliminated", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> amoxycillin <extra_id_1> <extra_id_0> drug <extra_id_5> amoxycillin <extra_id_1> <extra_id_0> drug <extra_id_5> acenocoumarol <extra_id_1> <extra_id_0> drug <extra_id_5> amoxycillin <extra_id_1> <extra_id_0> combination drug <extra_id_5> acenocoumarol <extra_id_1> <extra_id_0> combination drug <extra_id_5> amoxycillin <extra_id_1> <extra_id_0> effect <extra_id_5> the increase in the INR value with associated bruising <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "after", "args": [{"type": "treatment", "offset": [17], "text": "amoxycillin"}, {"type": "drug", "offset": [17], "text": "amoxycillin"}, {"type": "drug", "offset": [23], "text": "acenocoumarol"}, {"type": "drug", "offset": [25], "text": "amoxycillin"}, {"type": "combination drug", "offset": [23], "text": "acenocoumarol"}, {"type": "combination drug", "offset": [25], "text": "amoxycillin"}, {"type": "effect", "offset": [4, 5, 6, 7, 8, 9, 10, 11, 12], "text": "the increase in the INR value with associated bruising"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "amoxycillin"], ["drug", "amoxycillin"], ["drug", "acenocoumarol"], ["drug", "amoxycillin"], ["combination drug", "acenocoumarol"], ["combination drug", "amoxycillin"], ["effect", "the increase in the INR value with associated bruising"]]}]}
{"text_id": "12324937_1", "text": "BACKGROUND : Gemcitabine has mild renal toxicity , but cases of gemcitabine - associated hemolytic - uremic syndrome ( HUS ) have been reported .", "tokens": ["BACKGROUND", ":", "Gemcitabine", "has", "mild", "renal", "toxicity", ",", "but", "cases", "of", "gemcitabine", "-", "associated", "hemolytic", "-", "uremic", "syndrome", "(", "HUS", ")", "have", "been", "reported", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> cases <extra_id_1> <extra_id_0> treatment <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> drug <extra_id_5> gemcitabine <extra_id_1> <extra_id_0> effect <extra_id_5> hemolytic - uremic syndrome ( HUS ) <extra_id_1> <extra_id_0> effect <extra_id_5> renal toxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [13], "text": "associated", "args": [{"type": "subject", "offset": [9], "text": "cases"}, {"type": "treatment", "offset": [11], "text": "gemcitabine"}, {"type": "drug", "offset": [11], "text": "gemcitabine"}, {"type": "effect", "offset": [14, 15, 16, 17, 18, 19, 20], "text": "hemolytic - uremic syndrome ( HUS )"}, {"type": "effect", "offset": [5, 6], "text": "renal toxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "cases"], ["treatment", "gemcitabine"], ["drug", "gemcitabine"], ["effect", "hemolytic - uremic syndrome ( HUS )"], ["effect", "renal toxicity"]]}]}
{"text_id": "12187348_6", "text": "She had been on a combined treatment of steroid and lobenzarit disodium for the first 3 years , and then continued with a combined treatment of steroid and bucillamine for the following years until she was found to have pulmonary tuberculosis , at which time the steroid was suspended 10 months before she visited the authors ' clinic .", "tokens": ["She", "had", "been", "on", "a", "combined", "treatment", "of", "steroid", "and", "lobenzarit", "disodium", "for", "the", "first", "3", "years", ",", "and", "then", "continued", "with", "a", "combined", "treatment", "of", "steroid", "and", "bucillamine", "for", "the", "following", "years", "until", "she", "was", "found", "to", "have", "pulmonary", "tuberculosis", ",", "at", "which", "time", "the", "steroid", "was", "suspended", "10", "months", "before", "she", "visited", "the", "authors", "'", "clinic", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> found <extra_id_0> treatment <extra_id_5> steroid and lobenzarit disodium for the first 3 years , and then continued with a combined treatment of steroid and bucillamine for the following years <extra_id_1> <extra_id_0> drug <extra_id_5> steroid <extra_id_1> <extra_id_0> drug <extra_id_5> bucillamine <extra_id_1> <extra_id_0> drug <extra_id_5> lobenzarit disodium <extra_id_1> <extra_id_0> drug <extra_id_5> steroid <extra_id_1> <extra_id_0> combination drug <extra_id_5> steroid <extra_id_1> <extra_id_0> combination drug <extra_id_5> bucillamine <extra_id_1> <extra_id_0> combination drug <extra_id_5> lobenzarit disodium <extra_id_1> <extra_id_0> combination drug <extra_id_5> steroid <extra_id_1> <extra_id_0> effect <extra_id_5> pulmonary tuberculosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [36], "text": "found", "args": [{"type": "treatment", "offset": [8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32], "text": "steroid and lobenzarit disodium for the first 3 years , and then continued with a combined treatment of steroid and bucillamine for the following years"}, {"type": "drug", "offset": [26], "text": "steroid"}, {"type": "drug", "offset": [28], "text": "bucillamine"}, {"type": "drug", "offset": [10, 11], "text": "lobenzarit disodium"}, {"type": "drug", "offset": [8], "text": "steroid"}, {"type": "combination drug", "offset": [26], "text": "steroid"}, {"type": "combination drug", "offset": [28], "text": "bucillamine"}, {"type": "combination drug", "offset": [10, 11], "text": "lobenzarit disodium"}, {"type": "combination drug", "offset": [8], "text": "steroid"}, {"type": "effect", "offset": [39, 40], "text": "pulmonary tuberculosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "combination drug", "drug"], "spot_asoc": [{"span": "found", "label": "adverse event", "asoc": [["treatment", "steroid and lobenzarit disodium for the first 3 years , and then continued with a combined treatment of steroid and bucillamine for the following years"], ["drug", "steroid"], ["drug", "bucillamine"], ["drug", "lobenzarit disodium"], ["drug", "steroid"], ["combination drug", "steroid"], ["combination drug", "bucillamine"], ["combination drug", "lobenzarit disodium"], ["combination drug", "steroid"], ["effect", "pulmonary tuberculosis"]]}]}
{"text_id": "18344455_1", "text": "Simultaneous toxicities in a child on multiple anticonvulsants .", "tokens": ["Simultaneous", "toxicities", "in", "a", "child", "on", "multiple", "anticonvulsants", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> on <extra_id_0> subject <extra_id_5> a child <extra_id_1> <extra_id_0> age <extra_id_5> child <extra_id_1> <extra_id_0> treatment <extra_id_5> multiple anticonvulsants . <extra_id_1> <extra_id_0> drug <extra_id_5> anticonvulsants <extra_id_1> <extra_id_0> effect <extra_id_5> Simultaneous toxicities <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "on", "args": [{"type": "subject", "offset": [3, 4], "text": "a child"}, {"type": "age", "offset": [4], "text": "child"}, {"type": "treatment", "offset": [6, 7, 8], "text": "multiple anticonvulsants ."}, {"type": "drug", "offset": [7], "text": "anticonvulsants"}, {"type": "effect", "offset": [0, 1], "text": "Simultaneous toxicities"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "age", "treatment"], "spot_asoc": [{"span": "on", "label": "adverse event", "asoc": [["subject", "a child"], ["age", "child"], ["treatment", "multiple anticonvulsants ."], ["drug", "anticonvulsants"], ["effect", "Simultaneous toxicities"]]}]}
{"text_id": "20298401_10", "text": "CONCLUSION : Our case shows a fatal side effect of erlotinib .", "tokens": ["CONCLUSION", ":", "Our", "case", "shows", "a", "fatal", "side", "effect", "of", "erlotinib", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> of <extra_id_0> treatment <extra_id_5> erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> effect <extra_id_5> side effect <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "of", "args": [{"type": "treatment", "offset": [10], "text": "erlotinib"}, {"type": "drug", "offset": [10], "text": "erlotinib"}, {"type": "effect", "offset": [7, 8], "text": "side effect"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "of", "label": "adverse event", "asoc": [["treatment", "erlotinib"], ["drug", "erlotinib"], ["effect", "side effect"]]}]}
{"text_id": "25157214_11", "text": "These findings suggest that prophylactic antibiotic use is unlikely to have a major impact on the recovery time from rocuronium - induced NMB with sugammadex reversal .", "tokens": ["These", "findings", "suggest", "that", "prophylactic", "antibiotic", "use", "is", "unlikely", "to", "have", "a", "major", "impact", "on", "the", "recovery", "time", "from", "rocuronium", "-", "induced", "NMB", "with", "sugammadex", "reversal", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> use <extra_id_0> treatment <extra_id_5> prophylactic antibiotic <extra_id_1> <extra_id_0> drug <extra_id_5> prophylactic antibiotic <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rocuronium - induced NMB with sugammadex reversal <extra_id_1> <extra_id_0> effect <extra_id_5> unlikely to have a major impact on the recovery time <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> rocuronium <extra_id_1> <extra_id_0> drug <extra_id_5> rocuronium <extra_id_1> <extra_id_0> effect <extra_id_5> NMB with sugammadex reversal <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "use", "args": [{"type": "treatment", "offset": [4, 5], "text": "prophylactic antibiotic"}, {"type": "drug", "offset": [4, 5], "text": "prophylactic antibiotic"}, {"type": "treatment disorder", "offset": [19, 20, 21, 22, 23, 24, 25], "text": "rocuronium - induced NMB with sugammadex reversal"}, {"type": "effect", "offset": [8, 9, 10, 11, 12, 13, 14, 15, 16, 17], "text": "unlikely to have a major impact on the recovery time"}]}, {"type": "adverse event", "offset": [21], "text": "induced", "args": [{"type": "treatment", "offset": [19], "text": "rocuronium"}, {"type": "drug", "offset": [19], "text": "rocuronium"}, {"type": "effect", "offset": [22, 23, 24, 25], "text": "NMB with sugammadex reversal"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "use", "label": "adverse event", "asoc": [["treatment", "prophylactic antibiotic"], ["drug", "prophylactic antibiotic"], ["treatment disorder", "rocuronium - induced NMB with sugammadex reversal"], ["effect", "unlikely to have a major impact on the recovery time"]]}, {"span": "induced", "label": "adverse event", "asoc": [["treatment", "rocuronium"], ["drug", "rocuronium"], ["effect", "NMB with sugammadex reversal"]]}]}
{"text_id": "10203437_1", "text": "Lupus - like syndrome caused by 5 - aminosalicylic acid in patients with inflammatory bowel disease .", "tokens": ["Lupus", "-", "like", "syndrome", "caused", "by", "5", "-", "aminosalicylic", "acid", "in", "patients", "with", "inflammatory", "bowel", "disease", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> subject <extra_id_5> patients with inflammatory bowel disease <extra_id_1> <extra_id_0> subject disorder <extra_id_5> inflammatory bowel disease <extra_id_1> <extra_id_0> treatment <extra_id_5> 5 - aminosalicylic acid <extra_id_1> <extra_id_0> drug <extra_id_5> 5 - aminosalicylic acid <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> inflammatory bowel disease <extra_id_1> <extra_id_0> effect <extra_id_5> Lupus - like syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "caused", "args": [{"type": "subject", "offset": [11, 12, 13, 14, 15], "text": "patients with inflammatory bowel disease"}, {"type": "subject disorder", "offset": [13, 14, 15], "text": "inflammatory bowel disease"}, {"type": "treatment", "offset": [6, 7, 8, 9], "text": "5 - aminosalicylic acid"}, {"type": "drug", "offset": [6, 7, 8, 9], "text": "5 - aminosalicylic acid"}, {"type": "treatment disorder", "offset": [13, 14, 15], "text": "inflammatory bowel disease"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Lupus - like syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["subject", "patients with inflammatory bowel disease"], ["subject disorder", "inflammatory bowel disease"], ["treatment", "5 - aminosalicylic acid"], ["drug", "5 - aminosalicylic acid"], ["treatment disorder", "inflammatory bowel disease"], ["effect", "Lupus - like syndrome"]]}]}
{"text_id": "6837655_1", "text": "Prior reports have emphasized the tubular and interstitial lesions associated with intermittent or discontinuous rifampin therapy for tuberculosis .", "tokens": ["Prior", "reports", "have", "emphasized", "the", "tubular", "and", "interstitial", "lesions", "associated", "with", "intermittent", "or", "discontinuous", "rifampin", "therapy", "for", "tuberculosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> intermittent or discontinuous rifampin therapy <extra_id_1> <extra_id_0> drug <extra_id_5> rifampin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> tuberculosis <extra_id_1> <extra_id_0> effect <extra_id_5> tubular and interstitial lesions <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [9], "text": "associated", "args": [{"type": "treatment", "offset": [11, 12, 13, 14, 15], "text": "intermittent or discontinuous rifampin therapy"}, {"type": "drug", "offset": [14], "text": "rifampin"}, {"type": "treatment disorder", "offset": [17], "text": "tuberculosis"}, {"type": "effect", "offset": [5, 6, 7, 8], "text": "tubular and interstitial lesions"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "intermittent or discontinuous rifampin therapy"], ["drug", "rifampin"], ["treatment disorder", "tuberculosis"], ["effect", "tubular and interstitial lesions"]]}]}
{"text_id": "11033734_4", "text": "Three of these patients had convulsions attributed to imipenem / cilastatin ; 3.6 % of the patients had seizure , or 2 % of imipenem / cilastatin administrations was followed by a seizure attack .", "tokens": ["Three", "of", "these", "patients", "had", "convulsions", "attributed", "to", "imipenem", "/", "cilastatin", ";", "3.6", "%", "of", "the", "patients", "had", "seizure", ",", "or", "2", "%", "of", "imipenem", "/", "cilastatin", "administrations", "was", "followed", "by", "a", "seizure", "attack", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> attributed <extra_id_0> subject <extra_id_5> Three of these patients <extra_id_1> <extra_id_0> population <extra_id_5> Three <extra_id_1> <extra_id_0> treatment <extra_id_5> imipenem / cilastatin <extra_id_1> <extra_id_0> drug <extra_id_5> imipenem <extra_id_1> <extra_id_0> drug <extra_id_5> cilastatin <extra_id_1> <extra_id_0> combination drug <extra_id_5> imipenem <extra_id_1> <extra_id_0> combination drug <extra_id_5> cilastatin <extra_id_1> <extra_id_0> effect <extra_id_5> convulsions <extra_id_1> <extra_id_1> <extra_id_0> adverse event <extra_id_5> followed <extra_id_0> subject <extra_id_5> 2 % <extra_id_1> <extra_id_0> population <extra_id_5> 2 % <extra_id_1> <extra_id_0> treatment <extra_id_5> imipenem / cilastatin <extra_id_1> <extra_id_0> drug <extra_id_5> imipenem <extra_id_1> <extra_id_0> drug <extra_id_5> cilastatin <extra_id_1> <extra_id_0> combination drug <extra_id_5> imipenem <extra_id_1> <extra_id_0> combination drug <extra_id_5> cilastatin <extra_id_1> <extra_id_0> effect <extra_id_5> seizure <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "attributed", "args": [{"type": "subject", "offset": [0, 1, 2, 3], "text": "Three of these patients"}, {"type": "population", "offset": [0], "text": "Three"}, {"type": "treatment", "offset": [8, 9, 10], "text": "imipenem / cilastatin"}, {"type": "drug", "offset": [8], "text": "imipenem"}, {"type": "drug", "offset": [10], "text": "cilastatin"}, {"type": "combination drug", "offset": [8], "text": "imipenem"}, {"type": "combination drug", "offset": [10], "text": "cilastatin"}, {"type": "effect", "offset": [5], "text": "convulsions"}]}, {"type": "adverse event", "offset": [29], "text": "followed", "args": [{"type": "subject", "offset": [21, 22], "text": "2 %"}, {"type": "population", "offset": [21, 22], "text": "2 %"}, {"type": "treatment", "offset": [24, 25, 26], "text": "imipenem / cilastatin"}, {"type": "drug", "offset": [24], "text": "imipenem"}, {"type": "drug", "offset": [26], "text": "cilastatin"}, {"type": "combination drug", "offset": [24], "text": "imipenem"}, {"type": "combination drug", "offset": [26], "text": "cilastatin"}, {"type": "effect", "offset": [32], "text": "seizure"}]}], "spot": ["adverse event"], "asoc": ["population", "effect", "subject", "drug", "treatment", "combination drug"], "spot_asoc": [{"span": "attributed", "label": "adverse event", "asoc": [["subject", "Three of these patients"], ["population", "Three"], ["treatment", "imipenem / cilastatin"], ["drug", "imipenem"], ["drug", "cilastatin"], ["combination drug", "imipenem"], ["combination drug", "cilastatin"], ["effect", "convulsions"]]}, {"span": "followed", "label": "adverse event", "asoc": [["subject", "2 %"], ["population", "2 %"], ["treatment", "imipenem / cilastatin"], ["drug", "imipenem"], ["drug", "cilastatin"], ["combination drug", "imipenem"], ["combination drug", "cilastatin"], ["effect", "seizure"]]}]}
{"text_id": "19540093_4", "text": "Tigecycline - induced acute pancreatitis : case report and literature review .", "tokens": ["Tigecycline", "-", "induced", "acute", "pancreatitis", ":", "case", "report", "and", "literature", "review", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Tigecycline <extra_id_1> <extra_id_0> drug <extra_id_5> Tigecycline <extra_id_1> <extra_id_0> effect <extra_id_5> acute pancreatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Tigecycline"}, {"type": "drug", "offset": [0], "text": "Tigecycline"}, {"type": "effect", "offset": [3, 4], "text": "acute pancreatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Tigecycline"], ["drug", "Tigecycline"], ["effect", "acute pancreatitis"]]}]}
{"text_id": "6721543_1", "text": "Drug - induced psychosis resulted from the administration of quinacrine hydrochloride at a dosage of 100 mg twice daily for the treatment of discoid lupus .", "tokens": ["Drug", "-", "induced", "psychosis", "resulted", "from", "the", "administration", "of", "quinacrine", "hydrochloride", "at", "a", "dosage", "of", "100", "mg", "twice", "daily", "for", "the", "treatment", "of", "discoid", "lupus", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> administration of quinacrine hydrochloride at a dosage of 100 mg twice daily <extra_id_1> <extra_id_0> drug <extra_id_5> quinacrine hydrochloride <extra_id_1> <extra_id_0> dosage <extra_id_5> 100 mg <extra_id_1> <extra_id_0> frequency <extra_id_5> twice daily <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> discoid lupus <extra_id_1> <extra_id_0> effect <extra_id_5> psychosis resulted <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18], "text": "administration of quinacrine hydrochloride at a dosage of 100 mg twice daily"}, {"type": "drug", "offset": [9, 10], "text": "quinacrine hydrochloride"}, {"type": "dosage", "offset": [15, 16], "text": "100 mg"}, {"type": "frequency", "offset": [17, 18], "text": "twice daily"}, {"type": "treatment disorder", "offset": [23, 24], "text": "discoid lupus"}, {"type": "effect", "offset": [3, 4], "text": "psychosis resulted"}]}], "spot": ["adverse event"], "asoc": ["effect", "drug", "frequency", "dosage", "treatment disorder", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "administration of quinacrine hydrochloride at a dosage of 100 mg twice daily"], ["drug", "quinacrine hydrochloride"], ["dosage", "100 mg"], ["frequency", "twice daily"], ["treatment disorder", "discoid lupus"], ["effect", "psychosis resulted"]]}]}
{"text_id": "11174414_4", "text": "Though physicians treating large populations of patients with HIV are well aware of this complication , only one other report of nevirapine - associated SJS has been documented in the dermatology literature .", "tokens": ["Though", "physicians", "treating", "large", "populations", "of", "patients", "with", "HIV", "are", "well", "aware", "of", "this", "complication", ",", "only", "one", "other", "report", "of", "nevirapine", "-", "associated", "SJS", "has", "been", "documented", "in", "the", "dermatology", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> patients with HIV <extra_id_1> <extra_id_0> subject disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> treatment <extra_id_5> nevirapine <extra_id_1> <extra_id_0> drug <extra_id_5> nevirapine <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> HIV <extra_id_1> <extra_id_0> effect <extra_id_5> SJS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [23], "text": "associated", "args": [{"type": "subject", "offset": [6, 7, 8], "text": "patients with HIV"}, {"type": "subject disorder", "offset": [8], "text": "HIV"}, {"type": "treatment", "offset": [21], "text": "nevirapine"}, {"type": "drug", "offset": [21], "text": "nevirapine"}, {"type": "treatment disorder", "offset": [8], "text": "HIV"}, {"type": "effect", "offset": [24], "text": "SJS"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "patients with HIV"], ["subject disorder", "HIV"], ["treatment", "nevirapine"], ["drug", "nevirapine"], ["treatment disorder", "HIV"], ["effect", "SJS"]]}]}
{"text_id": "6635723_1", "text": "Metabolic balance studies and rechallenge with hydrochlorothiazide were undertaken to investigate the mechanism of the thiazide - induced hyponatremia .", "tokens": ["Metabolic", "balance", "studies", "and", "rechallenge", "with", "hydrochlorothiazide", "were", "undertaken", "to", "investigate", "the", "mechanism", "of", "the", "thiazide", "-", "induced", "hyponatremia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> thiazide <extra_id_1> <extra_id_0> drug <extra_id_5> hydrochlorothiazide <extra_id_1> <extra_id_0> drug <extra_id_5> thiazide <extra_id_1> <extra_id_0> effect <extra_id_5> hyponatremia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [17], "text": "induced", "args": [{"type": "treatment", "offset": [15], "text": "thiazide"}, {"type": "drug", "offset": [6], "text": "hydrochlorothiazide"}, {"type": "drug", "offset": [15], "text": "thiazide"}, {"type": "effect", "offset": [18], "text": "hyponatremia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "thiazide"], ["drug", "hydrochlorothiazide"], ["drug", "thiazide"], ["effect", "hyponatremia"]]}]}
{"text_id": "3310776_3", "text": "This confirmed the history of captopril - related asthma .", "tokens": ["This", "confirmed", "the", "history", "of", "captopril", "-", "related", "asthma", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> related <extra_id_0> treatment <extra_id_5> captopril <extra_id_1> <extra_id_0> drug <extra_id_5> captopril <extra_id_1> <extra_id_0> effect <extra_id_5> asthma <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "related", "args": [{"type": "treatment", "offset": [5], "text": "captopril"}, {"type": "drug", "offset": [5], "text": "captopril"}, {"type": "effect", "offset": [8], "text": "asthma"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "related", "label": "adverse event", "asoc": [["treatment", "captopril"], ["drug", "captopril"], ["effect", "asthma"]]}]}
{"text_id": "3725284_2", "text": "We report a case of a 60 - year - old woman affected by squamous lung carcinoma , who developed paroxysmal supraventricular tachycardia during cisplatin and etoposide combination chemotherapy .", "tokens": ["We", "report", "a", "case", "of", "a", "60", "-", "year", "-", "old", "woman", "affected", "by", "squamous", "lung", "carcinoma", ",", "who", "developed", "paroxysmal", "supraventricular", "tachycardia", "during", "cisplatin", "and", "etoposide", "combination", "chemotherapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> 60 - year - old woman affected by squamous lung carcinoma <extra_id_1> <extra_id_0> age <extra_id_5> 60 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> squamous lung carcinoma , <extra_id_1> <extra_id_0> treatment <extra_id_5> cisplatin and etoposide combination <extra_id_1> <extra_id_0> drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> drug <extra_id_5> etoposide <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> squamous lung carcinoma , <extra_id_1> <extra_id_0> combination drug <extra_id_5> etoposide <extra_id_1> <extra_id_0> combination drug <extra_id_5> cisplatin <extra_id_1> <extra_id_0> effect <extra_id_5> paroxysmal supraventricular tachycardia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [19], "text": "developed", "args": [{"type": "subject", "offset": [6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16], "text": "60 - year - old woman affected by squamous lung carcinoma"}, {"type": "age", "offset": [6, 7, 8, 9, 10], "text": "60 - year - old"}, {"type": "gender", "offset": [11], "text": "woman"}, {"type": "subject disorder", "offset": [14, 15, 16, 17], "text": "squamous lung carcinoma ,"}, {"type": "treatment", "offset": [24, 25, 26, 27], "text": "cisplatin and etoposide combination"}, {"type": "drug", "offset": [24], "text": "cisplatin"}, {"type": "drug", "offset": [26], "text": "etoposide"}, {"type": "treatment disorder", "offset": [14, 15, 16, 17], "text": "squamous lung carcinoma ,"}, {"type": "combination drug", "offset": [26], "text": "etoposide"}, {"type": "combination drug", "offset": [24], "text": "cisplatin"}, {"type": "effect", "offset": [20, 21, 22], "text": "paroxysmal supraventricular tachycardia"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "combination drug", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "60 - year - old woman affected by squamous lung carcinoma"], ["age", "60 - year - old"], ["gender", "woman"], ["subject disorder", "squamous lung carcinoma ,"], ["treatment", "cisplatin and etoposide combination"], ["drug", "cisplatin"], ["drug", "etoposide"], ["treatment disorder", "squamous lung carcinoma ,"], ["combination drug", "etoposide"], ["combination drug", "cisplatin"], ["effect", "paroxysmal supraventricular tachycardia"]]}]}
{"text_id": "17873198_4", "text": "This case and other published evidence should alert physicians to the possibility of fatal erlotinib - induced ILD .", "tokens": ["This", "case", "and", "other", "published", "evidence", "should", "alert", "physicians", "to", "the", "possibility", "of", "fatal", "erlotinib", "-", "induced", "ILD", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> This case <extra_id_1> <extra_id_0> treatment <extra_id_5> erlotinib <extra_id_1> <extra_id_0> drug <extra_id_5> erlotinib <extra_id_1> <extra_id_0> effect <extra_id_5> ILD <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "induced", "args": [{"type": "subject", "offset": [0, 1], "text": "This case"}, {"type": "treatment", "offset": [14], "text": "erlotinib"}, {"type": "drug", "offset": [14], "text": "erlotinib"}, {"type": "effect", "offset": [17], "text": "ILD"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "This case"], ["treatment", "erlotinib"], ["drug", "erlotinib"], ["effect", "ILD"]]}]}
{"text_id": "3346128_2", "text": "Erosion of psoriatic plaques after chronic methotrexate administration .", "tokens": ["Erosion", "of", "psoriatic", "plaques", "after", "chronic", "methotrexate", "administration", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> after <extra_id_0> treatment <extra_id_5> methotrexate <extra_id_1> <extra_id_0> drug <extra_id_5> methotrexate <extra_id_1> <extra_id_0> effect <extra_id_5> Erosion of psoriatic plaques <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "after", "args": [{"type": "treatment", "offset": [6], "text": "methotrexate"}, {"type": "drug", "offset": [6], "text": "methotrexate"}, {"type": "effect", "offset": [0, 1, 2, 3], "text": "Erosion of psoriatic plaques"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "after", "label": "adverse event", "asoc": [["treatment", "methotrexate"], ["drug", "methotrexate"], ["effect", "Erosion of psoriatic plaques"]]}]}
{"text_id": "18648015_2", "text": "CONCLUSIONS : Cefazolin was a probable cause of this patient 's leukopenia .", "tokens": ["CONCLUSIONS", ":", "Cefazolin", "was", "a", "probable", "cause", "of", "this", "patient", "'s", "leukopenia", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> cause <extra_id_0> subject <extra_id_5> patient <extra_id_1> <extra_id_0> treatment <extra_id_5> Cefazolin <extra_id_1> <extra_id_0> drug <extra_id_5> Cefazolin <extra_id_1> <extra_id_0> effect <extra_id_5> leukopenia <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "cause", "args": [{"type": "subject", "offset": [9], "text": "patient"}, {"type": "treatment", "offset": [2], "text": "Cefazolin"}, {"type": "drug", "offset": [2], "text": "Cefazolin"}, {"type": "effect", "offset": [11], "text": "leukopenia"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "cause", "label": "adverse event", "asoc": [["subject", "patient"], ["treatment", "Cefazolin"], ["drug", "Cefazolin"], ["effect", "leukopenia"]]}]}
{"text_id": "2140997_3", "text": "Severe hepatitis caused by cyproterone acetate .", "tokens": ["Severe", "hepatitis", "caused", "by", "cyproterone", "acetate", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> caused <extra_id_0> treatment <extra_id_5> cyproterone acetate <extra_id_1> <extra_id_0> drug <extra_id_5> cyproterone acetate <extra_id_1> <extra_id_0> effect <extra_id_5> Severe hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "caused", "args": [{"type": "treatment", "offset": [4, 5], "text": "cyproterone acetate"}, {"type": "drug", "offset": [4, 5], "text": "cyproterone acetate"}, {"type": "effect", "offset": [0, 1], "text": "Severe hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "caused", "label": "adverse event", "asoc": [["treatment", "cyproterone acetate"], ["drug", "cyproterone acetate"], ["effect", "Severe hepatitis"]]}]}
{"text_id": "18698687_3", "text": "We report a case of a patient with ciprofloxacin - induced SJS and acute onset of VBDS , and reviewed the related literature .", "tokens": ["We", "report", "a", "case", "of", "a", "patient", "with", "ciprofloxacin", "-", "induced", "SJS", "and", "acute", "onset", "of", "VBDS", ",", "and", "reviewed", "the", "related", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> a patient <extra_id_1> <extra_id_0> treatment <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> SJS <extra_id_1> <extra_id_0> effect <extra_id_5> acute onset of VBDS <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "induced", "args": [{"type": "subject", "offset": [5, 6], "text": "a patient"}, {"type": "treatment", "offset": [8], "text": "ciprofloxacin"}, {"type": "drug", "offset": [8], "text": "ciprofloxacin"}, {"type": "effect", "offset": [11], "text": "SJS"}, {"type": "effect", "offset": [13, 14, 15, 16], "text": "acute onset of VBDS"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "subject"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "a patient"], ["treatment", "ciprofloxacin"], ["drug", "ciprofloxacin"], ["effect", "SJS"], ["effect", "acute onset of VBDS"]]}]}
{"text_id": "17228132_2", "text": "CONTEXT : Acute drug induced hepatitis has not been commonly associated with epidermal growth factor receptor ( EGFR ) inhibitors .", "tokens": ["CONTEXT", ":", "Acute", "drug", "induced", "hepatitis", "has", "not", "been", "commonly", "associated", "with", "epidermal", "growth", "factor", "receptor", "(", "EGFR", ")", "inhibitors", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> epidermal growth factor receptor ( EGFR ) inhibitors <extra_id_1> <extra_id_0> drug <extra_id_5> epidermal growth factor receptor <extra_id_1> <extra_id_0> drug <extra_id_5> inhibitors <extra_id_1> <extra_id_0> effect <extra_id_5> Acute drug induced hepatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [10], "text": "associated", "args": [{"type": "treatment", "offset": [12, 13, 14, 15, 16, 17, 18, 19], "text": "epidermal growth factor receptor ( EGFR ) inhibitors"}, {"type": "drug", "offset": [12, 13, 14, 15], "text": "epidermal growth factor receptor"}, {"type": "drug", "offset": [19], "text": "inhibitors"}, {"type": "effect", "offset": [2, 3, 4, 5], "text": "Acute drug induced hepatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "epidermal growth factor receptor ( EGFR ) inhibitors"], ["drug", "epidermal growth factor receptor"], ["drug", "inhibitors"], ["effect", "Acute drug induced hepatitis"]]}]}
{"text_id": "16225183_1", "text": "Nephrotic syndrome in a multiple sclerosis patient treated with interferon beta 1a .", "tokens": ["Nephrotic", "syndrome", "in", "a", "multiple", "sclerosis", "patient", "treated", "with", "interferon", "beta", "1a", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> treated <extra_id_0> subject <extra_id_5> a multiple sclerosis patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> multiple sclerosis <extra_id_1> <extra_id_0> treatment <extra_id_5> interferon beta 1a <extra_id_1> <extra_id_0> drug <extra_id_5> interferon beta 1a <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> multiple sclerosis <extra_id_1> <extra_id_0> effect <extra_id_5> Nephrotic syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "treated", "args": [{"type": "subject", "offset": [3, 4, 5, 6], "text": "a multiple sclerosis patient"}, {"type": "subject disorder", "offset": [4, 5], "text": "multiple sclerosis"}, {"type": "treatment", "offset": [9, 10, 11], "text": "interferon beta 1a"}, {"type": "drug", "offset": [9, 10, 11], "text": "interferon beta 1a"}, {"type": "treatment disorder", "offset": [4, 5], "text": "multiple sclerosis"}, {"type": "effect", "offset": [0, 1], "text": "Nephrotic syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "adverse event", "asoc": [["subject", "a multiple sclerosis patient"], ["subject disorder", "multiple sclerosis"], ["treatment", "interferon beta 1a"], ["drug", "interferon beta 1a"], ["treatment disorder", "multiple sclerosis"], ["effect", "Nephrotic syndrome"]]}]}
{"text_id": "17852449_1", "text": "Outcome of pregnancy in women treated with all - trans retinoic acid ; a case report and review of literature .", "tokens": ["Outcome", "of", "pregnancy", "in", "women", "treated", "with", "all", "-", "trans", "retinoic", "acid", ";", "a", "case", "report", "and", "review", "of", "literature", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treated <extra_id_0> subject <extra_id_5> pregnancy in women <extra_id_1> <extra_id_0> gender <extra_id_5> women <extra_id_1> <extra_id_0> subject disorder <extra_id_5> pregnancy <extra_id_1> <extra_id_0> treatment <extra_id_5> all - trans retinoic acid <extra_id_1> <extra_id_0> drug <extra_id_5> all - trans retinoic acid <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> pregnancy <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [5], "text": "treated", "args": [{"type": "subject", "offset": [2, 3, 4], "text": "pregnancy in women"}, {"type": "gender", "offset": [4], "text": "women"}, {"type": "subject disorder", "offset": [2], "text": "pregnancy"}, {"type": "treatment", "offset": [7, 8, 9, 10, 11], "text": "all - trans retinoic acid"}, {"type": "drug", "offset": [7, 8, 9, 10, 11], "text": "all - trans retinoic acid"}, {"type": "treatment disorder", "offset": [2], "text": "pregnancy"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment", "gender", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "potential therapeutic event", "asoc": [["subject", "pregnancy in women"], ["gender", "women"], ["subject disorder", "pregnancy"], ["treatment", "all - trans retinoic acid"], ["drug", "all - trans retinoic acid"], ["treatment disorder", "pregnancy"]]}]}
{"text_id": "19145124_1", "text": "Multifocal electroretinographic abnormalities in ethambutol - induced visual loss .", "tokens": ["Multifocal", "electroretinographic", "abnormalities", "in", "ethambutol", "-", "induced", "visual", "loss", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> ethambutol <extra_id_1> <extra_id_0> drug <extra_id_5> ethambutol <extra_id_1> <extra_id_0> effect <extra_id_5> visual loss <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [6], "text": "induced", "args": [{"type": "treatment", "offset": [4], "text": "ethambutol"}, {"type": "drug", "offset": [4], "text": "ethambutol"}, {"type": "effect", "offset": [7, 8], "text": "visual loss"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "ethambutol"], ["drug", "ethambutol"], ["effect", "visual loss"]]}]}
{"text_id": "7673653_4", "text": "In the presented case fluvoxamine - induced akathisia in an OCD patient was partially resistant to the anticholinergic agent biperiden , and was successfully treated with the 5 - HT2A/5 - HT2C antagonist mianserin .", "tokens": ["In", "the", "presented", "case", "fluvoxamine", "-", "induced", "akathisia", "in", "an", "OCD", "patient", "was", "partially", "resistant", "to", "the", "anticholinergic", "agent", "biperiden", ",", "and", "was", "successfully", "treated", "with", "the", "5", "-", "HT2A/5", "-", "HT2C", "antagonist", "mianserin", "."], "record": "<extra_id_0> <extra_id_0> potential therapeutic event <extra_id_5> treated <extra_id_0> subject <extra_id_5> fluvoxamine - induced akathisia in an OCD patient <extra_id_1> <extra_id_0> subject disorder <extra_id_5> akathisia <extra_id_1> <extra_id_0> subject disorder <extra_id_5> OCD <extra_id_1> <extra_id_0> treatment <extra_id_5> 5 - HT2A/5 - HT2C antagonist mianserin <extra_id_1> <extra_id_0> drug <extra_id_5> mianserin <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> akathisia <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> OCD <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "potential therapeutic event", "offset": [24], "text": "treated", "args": [{"type": "subject", "offset": [4, 5, 6, 7, 8, 9, 10, 11], "text": "fluvoxamine - induced akathisia in an OCD patient"}, {"type": "subject disorder", "offset": [7], "text": "akathisia"}, {"type": "subject disorder", "offset": [10], "text": "OCD"}, {"type": "treatment", "offset": [27, 28, 29, 30, 31, 32, 33], "text": "5 - HT2A/5 - HT2C antagonist mianserin"}, {"type": "drug", "offset": [33], "text": "mianserin"}, {"type": "treatment disorder", "offset": [7], "text": "akathisia"}, {"type": "treatment disorder", "offset": [10], "text": "OCD"}]}], "spot": ["potential therapeutic event"], "asoc": ["subject", "treatment", "drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "treated", "label": "potential therapeutic event", "asoc": [["subject", "fluvoxamine - induced akathisia in an OCD patient"], ["subject disorder", "akathisia"], ["subject disorder", "OCD"], ["treatment", "5 - HT2A/5 - HT2C antagonist mianserin"], ["drug", "mianserin"], ["treatment disorder", "akathisia"], ["treatment disorder", "OCD"]]}]}
{"text_id": "8667442_2", "text": "This article presents a patient with hypoparathyroidism who was treated with calcium carbonate and calcitriol resulting in two admissions to the hospital for milk - alkali syndrome .", "tokens": ["This", "article", "presents", "a", "patient", "with", "hypoparathyroidism", "who", "was", "treated", "with", "calcium", "carbonate", "and", "calcitriol", "resulting", "in", "two", "admissions", "to", "the", "hospital", "for", "milk", "-", "alkali", "syndrome", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> resulting <extra_id_0> subject <extra_id_5> a patient with hypoparathyroidism <extra_id_1> <extra_id_0> subject disorder <extra_id_5> hypoparathyroidism <extra_id_1> <extra_id_0> treatment <extra_id_5> calcium carbonate and calcitriol <extra_id_1> <extra_id_0> drug <extra_id_5> calcium carbonate <extra_id_1> <extra_id_0> drug <extra_id_5> calcitriol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> hypoparathyroidism <extra_id_1> <extra_id_0> combination drug <extra_id_5> calcium carbonate <extra_id_1> <extra_id_0> combination drug <extra_id_5> calcitriol <extra_id_1> <extra_id_0> effect <extra_id_5> two admissions to the hospital for milk - alkali syndrome <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [15], "text": "resulting", "args": [{"type": "subject", "offset": [3, 4, 5, 6], "text": "a patient with hypoparathyroidism"}, {"type": "subject disorder", "offset": [6], "text": "hypoparathyroidism"}, {"type": "treatment", "offset": [11, 12, 13, 14], "text": "calcium carbonate and calcitriol"}, {"type": "drug", "offset": [11, 12], "text": "calcium carbonate"}, {"type": "drug", "offset": [14], "text": "calcitriol"}, {"type": "treatment disorder", "offset": [6], "text": "hypoparathyroidism"}, {"type": "combination drug", "offset": [11, 12], "text": "calcium carbonate"}, {"type": "combination drug", "offset": [14], "text": "calcitriol"}, {"type": "effect", "offset": [17, 18, 19, 20, 21, 22, 23, 24, 25, 26], "text": "two admissions to the hospital for milk - alkali syndrome"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment", "drug", "combination drug", "treatment disorder", "subject disorder"], "spot_asoc": [{"span": "resulting", "label": "adverse event", "asoc": [["subject", "a patient with hypoparathyroidism"], ["subject disorder", "hypoparathyroidism"], ["treatment", "calcium carbonate and calcitriol"], ["drug", "calcium carbonate"], ["drug", "calcitriol"], ["treatment disorder", "hypoparathyroidism"], ["combination drug", "calcium carbonate"], ["combination drug", "calcitriol"], ["effect", "two admissions to the hospital for milk - alkali syndrome"]]}]}
{"text_id": "7973922_1", "text": "Acyclovir neurotoxicity : clinical experience and review of the literature .", "tokens": ["Acyclovir", "neurotoxicity", ":", "clinical", "experience", "and", "review", "of", "the", "literature", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> experience <extra_id_0> treatment <extra_id_5> Acyclovir <extra_id_1> <extra_id_0> drug <extra_id_5> Acyclovir <extra_id_1> <extra_id_0> effect <extra_id_5> neurotoxicity <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [4], "text": "experience", "args": [{"type": "treatment", "offset": [0], "text": "Acyclovir"}, {"type": "drug", "offset": [0], "text": "Acyclovir"}, {"type": "effect", "offset": [1], "text": "neurotoxicity"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "experience", "label": "adverse event", "asoc": [["treatment", "Acyclovir"], ["drug", "Acyclovir"], ["effect", "neurotoxicity"]]}]}
{"text_id": "6833205_2", "text": "Desipramine - associated SIADH in an elderly woman : case report .", "tokens": ["Desipramine", "-", "associated", "SIADH", "in", "an", "elderly", "woman", ":", "case", "report", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> subject <extra_id_5> an elderly woman <extra_id_1> <extra_id_0> age <extra_id_5> elderly <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> treatment <extra_id_5> Desipramine <extra_id_1> <extra_id_0> drug <extra_id_5> Desipramine <extra_id_1> <extra_id_0> effect <extra_id_5> SIADH <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "associated", "args": [{"type": "subject", "offset": [5, 6, 7], "text": "an elderly woman"}, {"type": "age", "offset": [6], "text": "elderly"}, {"type": "gender", "offset": [7], "text": "woman"}, {"type": "treatment", "offset": [0], "text": "Desipramine"}, {"type": "drug", "offset": [0], "text": "Desipramine"}, {"type": "effect", "offset": [3], "text": "SIADH"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["subject", "an elderly woman"], ["age", "elderly"], ["gender", "woman"], ["treatment", "Desipramine"], ["drug", "Desipramine"], ["effect", "SIADH"]]}]}
{"text_id": "20118434_1", "text": "Interferon - based treatments have the potential to decrease the burden of disease , but are complicated by side effects , including neuropsychiatric symptoms .", "tokens": ["Interferon", "-", "based", "treatments", "have", "the", "potential", "to", "decrease", "the", "burden", "of", "disease", ",", "but", "are", "complicated", "by", "side", "effects", ",", "including", "neuropsychiatric", "symptoms", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> complicated <extra_id_0> treatment <extra_id_5> Interferon <extra_id_1> <extra_id_0> drug <extra_id_5> Interferon <extra_id_1> <extra_id_0> effect <extra_id_5> neuropsychiatric symptoms <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [16], "text": "complicated", "args": [{"type": "treatment", "offset": [0], "text": "Interferon"}, {"type": "drug", "offset": [0], "text": "Interferon"}, {"type": "effect", "offset": [22, 23], "text": "neuropsychiatric symptoms"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "complicated", "label": "adverse event", "asoc": [["treatment", "Interferon"], ["drug", "Interferon"], ["effect", "neuropsychiatric symptoms"]]}]}
{"text_id": "2140997_2", "text": "Monitoring of liver function tests should be mandatory in patients receiving high doses of cyproterone acetate ; the drug should be withdrawn immediately if abnormal liver function tests are found .", "tokens": ["Monitoring", "of", "liver", "function", "tests", "should", "be", "mandatory", "in", "patients", "receiving", "high", "doses", "of", "cyproterone", "acetate", ";", "the", "drug", "should", "be", "withdrawn", "immediately", "if", "abnormal", "liver", "function", "tests", "are", "found", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> abnormal <extra_id_0> subject <extra_id_5> patients <extra_id_1> <extra_id_0> treatment <extra_id_5> receiving high doses of cyproterone acetate <extra_id_1> <extra_id_0> drug <extra_id_5> cyproterone acetate <extra_id_1> <extra_id_0> dosage <extra_id_5> high doses <extra_id_1> <extra_id_0> effect <extra_id_5> abnormal liver function <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [24], "text": "abnormal", "args": [{"type": "subject", "offset": [9], "text": "patients"}, {"type": "treatment", "offset": [10, 11, 12, 13, 14, 15], "text": "receiving high doses of cyproterone acetate"}, {"type": "drug", "offset": [14, 15], "text": "cyproterone acetate"}, {"type": "dosage", "offset": [11, 12], "text": "high doses"}, {"type": "effect", "offset": [24, 25, 26], "text": "abnormal liver function"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "dosage", "treatment"], "spot_asoc": [{"span": "abnormal", "label": "adverse event", "asoc": [["subject", "patients"], ["treatment", "receiving high doses of cyproterone acetate"], ["drug", "cyproterone acetate"], ["dosage", "high doses"], ["effect", "abnormal liver function"]]}]}
{"text_id": "2442958_3", "text": "This paper reports an autopsy case of a 78 - year - old male with multiple nodules in the liver developed after long - termed administration of phosphate diethylstilbestrol ( PDES ) for prostatic cancer .", "tokens": ["This", "paper", "reports", "an", "autopsy", "case", "of", "a", "78", "-", "year", "-", "old", "male", "with", "multiple", "nodules", "in", "the", "liver", "developed", "after", "long", "-", "termed", "administration", "of", "phosphate", "diethylstilbestrol", "(", "PDES", ")", "for", "prostatic", "cancer", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> an autopsy case of a 78 - year - old male <extra_id_1> <extra_id_0> subject <extra_id_5> prostatic cancer <extra_id_1> <extra_id_0> age <extra_id_5> 78 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> male <extra_id_1> <extra_id_0> subject disorder <extra_id_5> prostatic cancer <extra_id_1> <extra_id_0> treatment <extra_id_5> phosphate diethylstilbestrol ( PDES ) <extra_id_1> <extra_id_0> drug <extra_id_5> phosphate diethylstilbestrol <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> prostatic cancer <extra_id_1> <extra_id_0> effect <extra_id_5> multiple nodules in the liver <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [20], "text": "developed", "args": [{"type": "subject", "offset": [3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13], "text": "an autopsy case of a 78 - year - old male"}, {"type": "subject", "offset": [33, 34], "text": "prostatic cancer"}, {"type": "age", "offset": [8, 9, 10, 11, 12], "text": "78 - year - old"}, {"type": "gender", "offset": [13], "text": "male"}, {"type": "subject disorder", "offset": [33, 34], "text": "prostatic cancer"}, {"type": "treatment", "offset": [27, 28, 29, 30, 31], "text": "phosphate diethylstilbestrol ( PDES )"}, {"type": "drug", "offset": [27, 28], "text": "phosphate diethylstilbestrol"}, {"type": "treatment disorder", "offset": [33, 34], "text": "prostatic cancer"}, {"type": "effect", "offset": [15, 16, 17, 18, 19], "text": "multiple nodules in the liver"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "an autopsy case of a 78 - year - old male"], ["subject", "prostatic cancer"], ["age", "78 - year - old"], ["gender", "male"], ["subject disorder", "prostatic cancer"], ["treatment", "phosphate diethylstilbestrol ( PDES )"], ["drug", "phosphate diethylstilbestrol"], ["treatment disorder", "prostatic cancer"], ["effect", "multiple nodules in the liver"]]}]}
{"text_id": "9177620_3", "text": "The evidence of high plasmatic levels of CBZ and the absence of other aetiologic factors lead the authors to conclude that the overdose of CBZ could have represented the precipitating of the episode of acute pancreatitis .", "tokens": ["The", "evidence", "of", "high", "plasmatic", "levels", "of", "CBZ", "and", "the", "absence", "of", "other", "aetiologic", "factors", "lead", "the", "authors", "to", "conclude", "that", "the", "overdose", "of", "CBZ", "could", "have", "represented", "the", "precipitating", "of", "the", "episode", "of", "acute", "pancreatitis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> precipitating <extra_id_0> treatment <extra_id_5> overdose of CBZ <extra_id_1> <extra_id_0> drug <extra_id_5> CBZ <extra_id_1> <extra_id_0> effect <extra_id_5> acute pancreatitis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [29], "text": "precipitating", "args": [{"type": "treatment", "offset": [22, 23, 24], "text": "overdose of CBZ"}, {"type": "drug", "offset": [7], "text": "CBZ"}, {"type": "effect", "offset": [34, 35], "text": "acute pancreatitis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "precipitating", "label": "adverse event", "asoc": [["treatment", "overdose of CBZ"], ["drug", "CBZ"], ["effect", "acute pancreatitis"]]}]}
{"text_id": "12095907_1", "text": "The authors describe valproate - induced hyperammonemia and mental status changes in an 88 - year - old man , the first known reported case in an elderly patient .", "tokens": ["The", "authors", "describe", "valproate", "-", "induced", "hyperammonemia", "and", "mental", "status", "changes", "in", "an", "88", "-", "year", "-", "old", "man", ",", "the", "first", "known", "reported", "case", "in", "an", "elderly", "patient", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> subject <extra_id_5> an 88 - year - old man <extra_id_1> <extra_id_0> age <extra_id_5> 88 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> man <extra_id_1> <extra_id_0> treatment <extra_id_5> valproate <extra_id_1> <extra_id_0> drug <extra_id_5> valproate <extra_id_1> <extra_id_0> effect <extra_id_5> hyperammonemia and mental status changes <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "induced", "args": [{"type": "subject", "offset": [12, 13, 14, 15, 16, 17, 18], "text": "an 88 - year - old man"}, {"type": "age", "offset": [13, 14, 15, 16, 17], "text": "88 - year - old"}, {"type": "gender", "offset": [18], "text": "man"}, {"type": "treatment", "offset": [3], "text": "valproate"}, {"type": "drug", "offset": [3], "text": "valproate"}, {"type": "effect", "offset": [6, 7, 8, 9, 10], "text": "hyperammonemia and mental status changes"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "gender", "drug", "age", "treatment"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["subject", "an 88 - year - old man"], ["age", "88 - year - old"], ["gender", "man"], ["treatment", "valproate"], ["drug", "valproate"], ["effect", "hyperammonemia and mental status changes"]]}]}
{"text_id": "16196187_3", "text": "We present a case of acute epinephrine toxicity resulting in acute myocardial ischemia in a young boy with combined variable immunodeficiency syndrome who developed severe allergic reaction to intravenous immunoglobulin , and was subsequently given epinephrine by mistake intravenously rather than subcutaneously .", "tokens": ["We", "present", "a", "case", "of", "acute", "epinephrine", "toxicity", "resulting", "in", "acute", "myocardial", "ischemia", "in", "a", "young", "boy", "with", "combined", "variable", "immunodeficiency", "syndrome", "who", "developed", "severe", "allergic", "reaction", "to", "intravenous", "immunoglobulin", ",", "and", "was", "subsequently", "given", "epinephrine", "by", "mistake", "intravenously", "rather", "than", "subcutaneously", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> toxicity <extra_id_0> subject <extra_id_5> a young boy with combined variable immunodeficiency syndrome <extra_id_1> <extra_id_0> age <extra_id_5> young <extra_id_1> <extra_id_0> gender <extra_id_5> boy <extra_id_1> <extra_id_0> subject disorder <extra_id_5> combined variable immunodeficiency syndrome <extra_id_1> <extra_id_0> treatment <extra_id_5> acute epinephrine <extra_id_1> <extra_id_0> treatment <extra_id_5> intravenous immunoglobulin , and was subsequently given epinephrine by mistake intravenously rather than subcutaneously <extra_id_1> <extra_id_0> drug <extra_id_5> epinephrine <extra_id_1> <extra_id_0> drug <extra_id_5> immunoglobulin <extra_id_1> <extra_id_0> route <extra_id_5> intravenously <extra_id_1> <extra_id_0> route <extra_id_5> intravenous <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> combined variable immunodeficiency syndrome <extra_id_1> <extra_id_0> effect <extra_id_5> acute myocardial ischemia <extra_id_1> <extra_id_0> effect <extra_id_5> severe allergic reaction <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [7], "text": "toxicity", "args": [{"type": "subject", "offset": [14, 15, 16, 17, 18, 19, 20, 21], "text": "a young boy with combined variable immunodeficiency syndrome"}, {"type": "age", "offset": [15], "text": "young"}, {"type": "gender", "offset": [16], "text": "boy"}, {"type": "subject disorder", "offset": [18, 19, 20, 21], "text": "combined variable immunodeficiency syndrome"}, {"type": "treatment", "offset": [5, 6], "text": "acute epinephrine"}, {"type": "treatment", "offset": [28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41], "text": "intravenous immunoglobulin , and was subsequently given epinephrine by mistake intravenously rather than subcutaneously"}, {"type": "drug", "offset": [6], "text": "epinephrine"}, {"type": "drug", "offset": [29], "text": "immunoglobulin"}, {"type": "route", "offset": [38], "text": "intravenously"}, {"type": "route", "offset": [28], "text": "intravenous"}, {"type": "treatment disorder", "offset": [18, 19, 20, 21], "text": "combined variable immunodeficiency syndrome"}, {"type": "effect", "offset": [10, 11, 12], "text": "acute myocardial ischemia"}, {"type": "effect", "offset": [24, 25, 26], "text": "severe allergic reaction"}]}], "spot": ["adverse event"], "asoc": ["effect", "route", "subject", "treatment disorder", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "toxicity", "label": "adverse event", "asoc": [["subject", "a young boy with combined variable immunodeficiency syndrome"], ["age", "young"], ["gender", "boy"], ["subject disorder", "combined variable immunodeficiency syndrome"], ["treatment", "acute epinephrine"], ["treatment", "intravenous immunoglobulin , and was subsequently given epinephrine by mistake intravenously rather than subcutaneously"], ["drug", "epinephrine"], ["drug", "immunoglobulin"], ["route", "intravenously"], ["route", "intravenous"], ["treatment disorder", "combined variable immunodeficiency syndrome"], ["effect", "acute myocardial ischemia"], ["effect", "severe allergic reaction"]]}]}
{"text_id": "8396491_1", "text": "Interference with the cortisol axis by the microtubule antagonist , CPH82 .", "tokens": ["Interference", "with", "the", "cortisol", "axis", "by", "the", "microtubule", "antagonist", ",", "CPH82", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> by <extra_id_0> treatment <extra_id_5> CPH82 <extra_id_1> <extra_id_0> drug <extra_id_5> CPH82 <extra_id_1> <extra_id_0> effect <extra_id_5> Interference with the cortisol axis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [5], "text": "by", "args": [{"type": "treatment", "offset": [10], "text": "CPH82"}, {"type": "drug", "offset": [10], "text": "CPH82"}, {"type": "effect", "offset": [0, 1, 2, 3, 4], "text": "Interference with the cortisol axis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "by", "label": "adverse event", "asoc": [["treatment", "CPH82"], ["drug", "CPH82"], ["effect", "Interference with the cortisol axis"]]}]}
{"text_id": "7226916_1", "text": "A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions developed complete heart block ( CHB ) following administration of disopyramide phosphate ( Norpace ) .", "tokens": ["A", "57", "-", "year", "-", "old", "woman", "with", "right", "bundle", "branch", "block", "+", "LPH", "and", "ventricular", "premature", "contractions", "developed", "complete", "heart", "block", "(", "CHB", ")", "following", "administration", "of", "disopyramide", "phosphate", "(", "Norpace", ")", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> developed <extra_id_0> subject <extra_id_5> A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions <extra_id_1> <extra_id_0> age <extra_id_5> 57 - year - old <extra_id_1> <extra_id_0> gender <extra_id_5> woman <extra_id_1> <extra_id_0> subject disorder <extra_id_5> right bundle branch block + LPH <extra_id_1> <extra_id_0> subject disorder <extra_id_5> ventricular premature contractions <extra_id_1> <extra_id_0> treatment <extra_id_5> disopyramide phosphate ( Norpace ) <extra_id_1> <extra_id_0> drug <extra_id_5> disopyramide phosphate <extra_id_1> <extra_id_0> effect <extra_id_5> complete heart block ( CHB ) <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [18], "text": "developed", "args": [{"type": "subject", "offset": [0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17], "text": "A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions"}, {"type": "age", "offset": [1, 2, 3, 4, 5], "text": "57 - year - old"}, {"type": "gender", "offset": [6], "text": "woman"}, {"type": "subject disorder", "offset": [8, 9, 10, 11, 12, 13], "text": "right bundle branch block + LPH"}, {"type": "subject disorder", "offset": [15, 16, 17], "text": "ventricular premature contractions"}, {"type": "treatment", "offset": [28, 29, 30, 31, 32], "text": "disopyramide phosphate ( Norpace )"}, {"type": "drug", "offset": [28, 29], "text": "disopyramide phosphate"}, {"type": "effect", "offset": [19, 20, 21, 22, 23, 24], "text": "complete heart block ( CHB )"}]}], "spot": ["adverse event"], "asoc": ["effect", "subject", "drug", "gender", "treatment", "age", "subject disorder"], "spot_asoc": [{"span": "developed", "label": "adverse event", "asoc": [["subject", "A 57 - year - old woman with right bundle branch block + LPH and ventricular premature contractions"], ["age", "57 - year - old"], ["gender", "woman"], ["subject disorder", "right bundle branch block + LPH"], ["subject disorder", "ventricular premature contractions"], ["treatment", "disopyramide phosphate ( Norpace )"], ["drug", "disopyramide phosphate"], ["effect", "complete heart block ( CHB )"]]}]}
{"text_id": "412488_7", "text": "These findings are consistent with an immune - complex form of glomerulopathy in which gold is neither the antigen nor a hapten in the glomerular deposits , and they suggest the hypothesis that antibodies to tubular epithelial antigens induced by gold therapy may be a causative factor in the renal disease associated with gold therapy in rheumatoid arthritis .", "tokens": ["These", "findings", "are", "consistent", "with", "an", "immune", "-", "complex", "form", "of", "glomerulopathy", "in", "which", "gold", "is", "neither", "the", "antigen", "nor", "a", "hapten", "in", "the", "glomerular", "deposits", ",", "and", "they", "suggest", "the", "hypothesis", "that", "antibodies", "to", "tubular", "epithelial", "antigens", "induced", "by", "gold", "therapy", "may", "be", "a", "causative", "factor", "in", "the", "renal", "disease", "associated", "with", "gold", "therapy", "in", "rheumatoid", "arthritis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> associated <extra_id_0> treatment <extra_id_5> gold therapy in rheumatoid arthritis <extra_id_1> <extra_id_0> drug <extra_id_5> gold <extra_id_1> <extra_id_0> treatment disorder <extra_id_5> rheumatoid arthritis <extra_id_1> <extra_id_0> effect <extra_id_5> renal disease <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [51], "text": "associated", "args": [{"type": "treatment", "offset": [53, 54, 55, 56, 57], "text": "gold therapy in rheumatoid arthritis"}, {"type": "drug", "offset": [53], "text": "gold"}, {"type": "treatment disorder", "offset": [56, 57], "text": "rheumatoid arthritis"}, {"type": "effect", "offset": [49, 50], "text": "renal disease"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug", "treatment disorder"], "spot_asoc": [{"span": "associated", "label": "adverse event", "asoc": [["treatment", "gold therapy in rheumatoid arthritis"], ["drug", "gold"], ["treatment disorder", "rheumatoid arthritis"], ["effect", "renal disease"]]}]}
{"text_id": "1504404_2", "text": "Ciprofloxacin - induced psychosis .", "tokens": ["Ciprofloxacin", "-", "induced", "psychosis", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> Ciprofloxacin <extra_id_1> <extra_id_0> drug <extra_id_5> Ciprofloxacin <extra_id_1> <extra_id_0> effect <extra_id_5> psychosis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [2], "text": "induced", "args": [{"type": "treatment", "offset": [0], "text": "Ciprofloxacin"}, {"type": "drug", "offset": [0], "text": "Ciprofloxacin"}, {"type": "effect", "offset": [3], "text": "psychosis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "Ciprofloxacin"], ["drug", "Ciprofloxacin"], ["effect", "psychosis"]]}]}
{"text_id": "1420650_1", "text": "Asterixis induced by carbamazepine therapy .", "tokens": ["Asterixis", "induced", "by", "carbamazepine", "therapy", "."], "record": "<extra_id_0> <extra_id_0> adverse event <extra_id_5> induced <extra_id_0> treatment <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> drug <extra_id_5> carbamazepine <extra_id_1> <extra_id_0> effect <extra_id_5> Asterixis <extra_id_1> <extra_id_1> <extra_id_1>", "entity": [], "relation": [], "event": [{"type": "adverse event", "offset": [1], "text": "induced", "args": [{"type": "treatment", "offset": [3], "text": "carbamazepine"}, {"type": "drug", "offset": [3], "text": "carbamazepine"}, {"type": "effect", "offset": [0], "text": "Asterixis"}]}], "spot": ["adverse event"], "asoc": ["effect", "treatment", "drug"], "spot_asoc": [{"span": "induced", "label": "adverse event", "asoc": [["treatment", "carbamazepine"], ["drug", "carbamazepine"], ["effect", "Asterixis"]]}]}
